
<html lang="en"     class="pb-page"  data-request-id="3ef8e63a-33c0-43de-8caf-6461e04f2070"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;article:article:10.1021/jm5001858;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-22"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring" /></meta><meta name="dc.Creator" content="Markus  Piel" /></meta><meta name="dc.Creator" content="Ingo  Vernaleken" /></meta><meta name="dc.Creator" content="Frank  Rösch" /></meta><meta name="dc.Description" content="Molecular imaging methods such as positron emission tomography (PET) are increasingly involved in the development of new drugs. Using radioactive tracers as imaging probes, PET allows the determina..." /></meta><meta name="Description" content="Molecular imaging methods such as positron emission tomography (PET) are increasingly involved in the development of new drugs. Using radioactive tracers as imaging probes, PET allows the determina..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="September 10, 2014" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5001858" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5001858" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5001858" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5001858" /></link>
        
    
    

<title>Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5001858" /></meta><meta property="og:title" content="Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0025.jpeg" /></meta><meta property="og:description" content="Molecular imaging methods such as positron emission tomography (PET) are increasingly involved in the development of new drugs. Using radioactive tracers as imaging probes, PET allows the determination of the pharmacokinetic and pharmacodynamic properties of a drug candidate, via recording target engagement, the pattern of distribution, and metabolism. Because of the noninvasive nature and quantitative end point obtainable by molecular imaging, it seems inherently suited for the examination of a pharmaceutical’s behavior in the brain. Molecular imaging, most especially PET, can therefore be a valuable tool in CNS drug research. In this Perspective, we present the basic principles of PET, the importance of appropriate tracer selection, the impact of improved radiopharmaceutical chemistry in radiotracer development, and the different roles that PET can fulfill in CNS drug research." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5001858"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5001858">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5001858&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5001858&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5001858&amp;href=/doi/10.1021/jm5001858" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 22</span><span class="cit-fg-pageRange">, 9232-9258</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/22" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm500734a" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm500828f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Piel">Markus Piel</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ingo++Vernaleken">Ingo Vernaleken</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++R%C3%B6sch">Frank Rösch</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Institute of Nuclear Chemistry, Johannes Gutenberg-University, Fritz-Strassmann-Weg 2, D-55128 Mainz, Germany</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Psychiatry, Psychotherapy, and Psychosomatics, RWTH Aachen University, Pauwelsstraße 30, D-52074 Aachen, Germany</span></div><div class="corresp-info"><strong>*</strong>Phone: +49-6131-3925701. Fax: +49-6131-3926606. E-mail: <a href="/cdn-cgi/l/email-protection#aedec7cbc2eedbc0c783c3cfc7c0d480cacb"><span class="__cf_email__" data-cfemail="e999808c85a99c8780c48488808793c78d8c">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5001858&amp;href=/doi/10.1021%2Fjm5001858" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 22</span><span class="cit-pageRange">, 9232–9258</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 21, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>3 February 2014</li><li><span class="item_label"><b>Published</b> online</span>10 September 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 November 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5001858" title="DOI URL">https://doi.org/10.1021/jm5001858</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9232%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarkus%2BPiel%252C%2BIngo%2BVernaleken%252C%2BFrank%2BR%25C3%25B6sch%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D22%26contentID%3Djm5001858%26title%3DPositron%2BEmission%2BTomography%2Bin%2BCNS%2BDrug%2BDiscovery%2Band%2BDrug%2BMonitoring%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9258%26publicationDate%3DNovember%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5001858"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3341</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">84</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5001858" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Positron Emission Tomography in CNS Drug Discovery and Drug Monitoring&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Piel&quot;},{&quot;first_name&quot;:&quot;Ingo&quot;,&quot;last_name&quot;:&quot;Vernaleken&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Rösch&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;09&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;22&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;9232-9258&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5001858&quot;},&quot;abstract&quot;:&quot;Molecular imaging methods such as positron emission tomography (PET) are increasingly involved in the development of new drugs. Using radioactive tracers as imaging probes, PET allows the determination of the pharmacokinetic and pharmacodynamic properties of a drug candidate, via recording target engagement, the pattern of distribution, and metabolism. Because of the noninvasive nature and quantitative end point obtainable by molecular imaging, it seems inherently suited for the examination of a pharmaceutical’s behavior in the brain. Molecular imaging, most especially PET, can therefore be a valuable tool in CNS drug research. In this Perspective, we present the basic principles of PET, the importance of appropriate tracer selection, the impact of improved radiopharmaceutical chemistry in radiotracer development, and the different roles that PET can fulfill in CNS drug research.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001858&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001858" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001858&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001858" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5001858&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001858" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5001858&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5001858&amp;href=/doi/10.1021/jm5001858" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5001858" /></input><a href="/doi/pdf/10.1021/jm5001858" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5001858&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5001858%26sid%3Dliteratum%253Aachs%26pmid%3D25144329%26genre%3Darticle%26aulast%3DPiel%26date%3D2014%26atitle%3DPositron%2BEmission%2BTomography%2Bin%2BCNS%2BDrug%2BDiscovery%2Band%2BDrug%2BMonitoring%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D22%26spage%3D9232%26epage%3D9258%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291663" title="Positron emission tomography">Positron emission tomography</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/22" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jmcmar.2014.57.issue-22/20141126/jmcmar.2014.57.issue-22.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Molecular imaging methods such as positron emission tomography (PET) are increasingly involved in the development of new drugs. Using radioactive tracers as imaging probes, PET allows the determination of the pharmacokinetic and pharmacodynamic properties of a drug candidate, via recording target engagement, the pattern of distribution, and metabolism. Because of the noninvasive nature and quantitative end point obtainable by molecular imaging, it seems inherently suited for the examination of a pharmaceutical’s behavior in the brain. Molecular imaging, most especially PET, can therefore be a valuable tool in CNS drug research. In this Perspective, we present the basic principles of PET, the importance of appropriate tracer selection, the impact of improved radiopharmaceutical chemistry in radiotracer development, and the different roles that PET can fulfill in CNS drug research.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_42167" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_42167" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Modern medical imaging techniques have become important tools for the early diagnosis and therapy management of various diseases of the central nervous system (CNS) and other organs. Morphological imaging techniques, e.g., computed tomography (CT) or magnetic resonance imaging (MRI), provide valuable information on biological structures or anatomy, whereas functional or spectroscopic MRI provides certain types of information about brain function. In contrast, molecular imaging techniques such as positron emission tomography (PET) and single-photon emission computed tomography (SPECT), through the detection of radiotracer molecules, allow the visualization of biological processes in the living organism.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The main processes of interest are cerebral blood flow, intra- and extracellular enzymatic reactions, which can reveal rates of metabolism or protein synthesis, and receptor–ligand interactions, which are relevant to studies of neurotransmission. Using these imaging modalities, it is possible to detect a pathophysiological state, arising from a deregulated biochemical process, before any discernible anatomical changes occur. Because of the high sensitivity of both modalities, PET and SPECT, their radiotracers can be applied in very small amounts. Hence, they are administered at doses usually devoid of any pharmacological effects, which prevents the perturbance of biological processes in vivo. PET is preferable to SPECT for many purposes, as PET recordings are quantifiable and are generally of higher sensitivity and better temporal and spatial resolution.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div><div class="NLM_p">For some neuropsychiatric disorders, PET and SPECT tracers serve as imaging probes to detect a disease (in particular, neurodegenerative disorders), but they can also be applied as a valuable tool in the development of new molecular entities or for the evaluation of the pharmacological behavior of drug candidates in a fast and efficient manner.</div><div class="NLM_p">Neurodegenerative disorders as well as most mental disorders cause a strong and long-lasting burden of disease, reduce relevantly the quality of life, and finally are responsible for high economic losses. Hence, it is a crucial task to further improve our understanding of such illnesses, with an aim to develop better therapeutic strategies. Molecular imaging methods, especially PET, are playing an important role in addressing these concerns because they are the only available methods that enable molecule-specific results in the living brain.</div><div class="NLM_p last">Our objective in this Perspective is to elucidate the principles of functional imaging with PET, the design of radiotracers for the CNS, their application in different strategies, and their roles in drug research. Furthermore, we link these contents with the real-life situation of PET in drug development, by reviewing this process based on the example of antipsychotic drug development: the use of PET in schizophrenia research and its association to antipsychotic drug development has a long history and covers all possible facets and pitfalls.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Principles of Positron Emission Tomography</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33153" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33153" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Most PET tracers consist of a pharmacophore and a positron-emitting radionuclide. While the pharmacophore is responsible for the pharmacological behavior of the tracer, the radionuclide provides the means for detection, which subsequently serves for source mapping, commonly known as imaging. The process of coupling the radionuclide to the pharmacophore is generally referred to as labeling or radiolabeling. Chemically, this is achieved via the formation of covalent bonds for nonmetallic radioisotopes (such as carbon, nitrogen, oxygen, and the halogens) and dative bonds whenever metallic radionuclides are concerned.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Synthesis of Radiotracers</h3><div class="NLM_p">Because of the generally short half-life of the neutron-deficient, positron-emitting radionuclides used for molecular imaging, these radionuclides usually have to be produced on a daily basis or even in the hour of intended use.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Particularly for the synthesis of radiotracers for biological targets in the living brain, a very high specific radioactivity (cf. choice of the radionuclide) of the radionuclide produced is often mandatory. The positron-emitting radionuclide is first generated with a cyclotron and then reacted with a suitable precursor, which is a molecule allowing the incorporation of the radionuclide in a fast and efficient manner. Radiolabeling is performed as late as possible in the synthetic procedure and should not entail many subsequent synthetic steps or complicated purification protocols for isolating the product, since each passing minute reduces the final radioactivity of the labeled product. Because the precursor is used in large excess compared to the radionuclide, the unreacted precursor should be separated from the radiotracer to obtain high chemical purity and avoid pharmacological and/or toxic effects from carryover of the precursor. After purification of the tracer, it is usually formulated in isotonic sodium chloride solution or other suitable buffers, sometimes with the addition of up to 10% v/v ethanol as required for solubility. Finally, the formulated tracer undergoes quality control for important parameters such as purity (chemical, radiochemical and radionuclidic), pH, and sterility, as required by current good manufacturing practice (cGMP, see below) requirements for the preparation of products intended for intravenous administration.</div><div class="NLM_p">For tracers routinely applied in human studies, the synthesis is often carried out using automated synthesis modules. These modules permit fully automated one- or, sometimes, two-step reactions, which not only increases the reliability of the synthesis but also reduces the radiation exposure of the staff. A typical automated synthesis module and schematic plan for the production of <sup>18</sup>F-fluorinated tracers is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Automated synthesis module (SynChrom R&D, RAYTEST) for the synthesis of <sup>18</sup>F-labeled tracers (left). The programming and control of the different reaction steps is performed via a graphical interface (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Because of the short half-lives of the radionuclides and the requirements for radiation protection and cGMP, the synthesis and quality control of radiotracers for PET studies is a demanding task for the radiopharmacy. Thus, special procedures had to be developed for efficient synthesis, quality control, and formulation, which also contribute to a GMP-compliant tracer production.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Regulatory Requirements</h3><div class="NLM_p last">Because radiotracers are considered to be drugs with respect to regulation, their production must follow the rules of cGMP. This guarantees a high standard for the quality of the radiotracer and also guarantees its chemical identity and purity. Hence, the synthesis and quality control must be performed using established and documented procedures and practices.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Furthermore, since December 2011, PET tracers must be manufactured in compliance with 21 Code of Federal Regulations Part (CFR) 212 in the U.S.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Consequently, all producers for PET tracers must be operating under an approved new drug application (NDA) or abbreviated new drug application (ANDA) for clinical tracers or under an investigational new drug application (IND) for research tracers.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Positron Emission and PET Measurement</h3><div class="NLM_p">The distinct advantage of PET over other molecular imaging methods is the higher degree of spatial and temporal resolution of recordings of the tracer’s distribution and the possibility of quantifying its concentration as a function of time. These advantages arise from the special decay characteristics of positron-emitting radionuclides. The positron released from the decaying neutron-deficient radionuclide travels a short distance (typically ranging from 1 mm to 2 cm), depositing its kinetic energy in the surrounding matter, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, in a process known as thermalization. After losing most of its kinetic energy, the antimatter positron can interact with its ordinary matter counterpart, an electron; annihilation of the two elementary particles releases their mass energy as radiation. The annihilation generates two photons of exactly 511 keV, emitted at almost 180° to each other.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic diagram of a radionuclide emitting a positron, resulting annihilation, production of two 511 keV photons, and the coincident detection of the photons in a PET scanner.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Coincident detection of these photons by a pair of radiation detectors on either side of the annihilation event provides the so-called line of response, which provides information about the approximate spatial location of the radionuclide. Modern PET scanners consist of several rings, each containing numerous detectors, which all are interconnected (cf. left side of Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) by coincidence circuits. Upon counting of millions of annihilation events, a final source map can be calculated, typically with spatial resolution of 3–5 mm for contemporary human PET scanners and even <1 mm can be obtained for small animal PET scanners (μPET scanners). In addition to the superior spatial resolution of those detector arrays, the detectors also possess dead times on the order of nano- to picoseconds. Because of statistical requirements and other factors, this property allows dynamic PET measurements of tracers in a temporal resolution of seconds.</div><div class="NLM_p last">Because even photons are scattered in condensed matter, a transmission scan is performed to determine correction factors for this scattering, which are then used to correct the emission scan for signal loss. The combination of transmission and emission scan allows an absolute quantification of the measured activity (becquerels per milliliter), which corresponds to the concentration of the tracer in the tissue.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Processing of PET Data and Compartmental Modeling</h3><div class="NLM_p">In research studies, most of the emission scans are still acquired as a dynamic series, in the manner of a motion picture. Here, as series of static recordings is separated in so-called time frames, each of which depicts a map of the activity concentration in the tissue in absolute units of kilobecquerels per milliliter for a certain time interval after tracer injection (usually in incrementally increasing time frame lengths). The definition of time frames depends on the tissue kinetics of the ligand used; if kinetics are unknown, then the storage and acquisition of event-by-event data (list mode) provides much better flexibility in the posthoc definition of dynamic recording frames and also improves the possibility for movement correction.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Indeed, in cases of long acquisition times lasting up to several hours, head movements are very frequent and pronounced, even when using head fixation systems (e.g., vacuum masks). When using predefined time frames, slow shifts in head position can be corrected by mathematical algorithms, whereas rapid intraframe movements are not amenable to this kind of correction, unless list-mode data is available. Another problem can arise from the paucity of anatomical information within the PET-recordings. Whereas ligands with high cortical uptake (e.g., 2-deoxy-2-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">d</span>-glucose, 2-[<sup>18</sup>F]FDG<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a>) provide sufficient anatomical information for motion correction between frames, this can be difficult for late frame recordings of other tracers characterized by substantial washout from cortex, i.e., dopamine D<sub>2/3</sub>-receptor ligands. PET/CT and PET/MRI hybrid systems can be helpful in this event. In any event, PET-to-MRI coregistrations (e.g., to ICBM 452 templates) serve to spatially normalize the dynamic PET recordings to standard spatial coordinates. Although nonlinear normalization algorithms have been improved in recent years, this step of PET data processing is one of the highest sources of bias, especially in cases with a differing extent of ventricular enlargement, as occurs in neurodegenerative disease.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p">A key aspect of data PET analysis is to separate different pools of activity signals within the total signal. In particular, the activity detected by the tomograph might result from free/unbound tracer in brain together with a specifically bound component, as in the case of ligands for receptors or transporters or metabolically trapped ligands such as the glucose analogue 2-[<sup>18</sup>F]FDG or the dopamine synthesis tracer 6-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">l</span>-dopa ([<sup>18</sup>F]FDOPA).<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> In addition, kinetic analysis must consider activity derived from tracers in small blood vessels and capillaries in the tissue as well as radioactive metabolites in the blood compartment. Each of these sources of activity is defined by a specific component of a compartmental kinetic model. Ligand binding reactions can be considered reversible, such that bound tracer in brain is free to return to an unbound compartment. Kinetic models describing all of these processes can be highly complex and tend to be overspecified or unstable due to noisy data. For scientific purposes, it may be necessary to record not only the PET signal but also the tracer and its metabolite concentrations in samples of arterial plasma. Nevertheless, an overcomplicated model does not necessarily improve the interpretability of the results, as in the particularly complex case of [<sup>18</sup>F]FDOPA.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Usually, researchers employ a two-tissue compartment model (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>), based on the arterial blood plasma (<i>C</i><sub>FP</sub>(<i>t</i>)), and the total concentration in brain of free/unbound tracer in the tissue (<i>C</i><sub>FT</sub>(<i>t</i>)) and tracer specifically bound to its biological target (<i>C</i><sub>S</sub>(<i>t</i>)). These models necessarily simplify the real biological situation to a set of linear equations, by applying certain assumptions; solution of the equations either graphically or mathematically give estimates of the relevant rate constants and biological parameters, which are assumed to be constant for the duration of the PET recording. The typical outcome parameter is the binding potential (<i>BP</i>), which is proportional to the ratio between the concentration of the binding site (<i>B</i><sub>max</sub>) and the affinity of the ligand to this site (expressed as the dissociation constant <i>K</i><sub>D</sub>) relative to the free fractions of the tracer in tissue or plasma. The term <i>BP</i><sub>P</sub> refers to <i>BP</i> relative to the free plasma concentration, which is calculated on the basis of analysis of arterial blood sampled during the PET recording. Blood sampling is frequently impractical, so specific binding can calculated relative to uptake in a brain region with only nondisplaceable (ND) binding, which yields <i>BP</i><sub><i>ND</i></sub> as presented by Innis et al.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> This outcome parameter is convenient to obtain, but it suffers from a caveat arising from the assumptions about the nonbinding reference region.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Diagrammatic representation of the two-tissue compartment model, consisting of blood (<i>C</i><sub>FP</sub>), free tracer in tissue (<i>C</i><sub>FT</sub>), specific binding (<i>C</i><sub>S</sub>) and nonspecific binding (<i>C</i><sub>NS</sub>) compartments, and the blood–brain unidirectional clearance (<i>K</i><sub>1</sub>), rate constant for clearance back to circulation (<i>k</i><sub>2</sub>), and the relevant association and dissociation rate constants (<i>k</i><sub>3</sub><i>–k</i><sub>6</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Hybrid Systems</h3><div class="NLM_p">Although PET gives important scientific and/or diagnostic information about biological processes, the addition of morphological imaging is essential for proper anatomic assignment and can simplify the modeling process. Hybrid systems for both clinical and preclinical imaging have been developed to perform functional and morphological imaging in a single examination (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The detailed anatomical information provided by fusion imaging with PET/CT scanners dramatically improves the diagnostic accuracy of the PET scan.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Furthermore, the CT scan can be used for attenuation correction, thus sparing the subject an additional radiation exposure. Because proton MRI offers superior anatomical information to CT in soft tissues, hybrid PET/MRI scanners were recently developed and show great potential for increasing further the accuracy of PET for studying neurological conditions and brain abnormalities such as dementia, cerebrovascular disorders, or epilepsy.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> The hybrid technology affords improved motion correction and the potential for simultaneous functional MRI acquisitions as well as MR-based attenuation correction, although this remains a technical challenge.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Images of a human PET/CT-Scanner (Discovery PET/CT 610; GE Healthcare) and a preclinical μPET/MRI-Scanner (nanoScanPM; Mediso Medical Imaging Systems).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">For a more comprehensive review of radioisotope production, radiopharmaceutical chemistry, PET imaging, and kinetic modeling, the reader is referred to recent reviews and books.<a onclick="showRef(event, 'ref15 ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref17 ref18 ref19">(15-19)</a></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Design of PET Tracers for the Central Nervous System</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05280" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05280" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Choice of the Radionuclide</h3><div class="NLM_p">The radionuclides can be generally divided into organic isotopes (representing the constituent elements of organic molecules), which are coupled to the pharmacophore via a covalent bond (e.g., <sup>18</sup>F and <sup>11</sup>C), and the metallic isotopes (e.g., <sup>68</sup>Ga), which are usually attached to a pharmacophore via a chelator. The nonmetallic positron-emitting radionuclides that have been used for visualization of processes in the CNS are listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Physical Properties and Production Routes of Important Radionuclides Usable for PET Imaging of the Central Nervous System<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">nuclide</th><th class="colsep0 rowsep0" align="center" char=".">half-life <i>t</i><sub>1/2</sub></th><th class="colsep0 rowsep0" align="center">decay mode<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">production</th><th class="colsep0 rowsep0" align="center">product</th><th class="colsep0 rowsep0" align="center" char=".">maximum specific activity (GBq/μmol)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>15</sup>O</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">2.04 min</td><td class="colsep0 rowsep0" align="left">β<sup>+</sup> (99.9%)</td><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>15</sup>N(d,n)<sup>15</sup>O</td><td class="colsep0 rowsep0" rowspan="2" align="left">[<sup>15</sup>O]O<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">3.4 × 10<sup>6</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC (0.01%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>11</sup>C</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">20.39 min</td><td class="colsep0 rowsep0" align="left">β<sup>+</sup> (99.8%)</td><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>14</sup>N(p,α)<sup>11</sup>C</td><td class="colsep0 rowsep0" align="left">[<sup>11</sup>C]CO<sub>2</sub></td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">3.4 × 10<sup>5</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC (0.2%)</td><td class="colsep0 rowsep0" align="left">[<sup>11</sup>C]CH<sub>4</sub></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>13</sup>N</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">9.97 min</td><td class="colsep0 rowsep0" align="left">β<sup>+</sup> (99.8%)</td><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>16</sup>O(p,α)<sup>13</sup>N</td><td class="colsep0 rowsep0" rowspan="2" align="left">[<sup>13</sup>N]NH<sub>3</sub></td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">7.0 × 10<sup>5</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC (0.2%)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>18</sup>F</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">109.8 min</td><td class="colsep0 rowsep0" align="left">β<sup>+</sup> (96.7%)</td><td class="colsep0 rowsep0" align="left"><sup>18</sup>O(p,n)<sup>18</sup>F</td><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]F<sup>–</sup><sub>aq</sub></td><td class="colsep0 rowsep0" align="char" char=".">6.3 × 10<sup>4</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC (3.3%)</td><td class="colsep0 rowsep0" align="left"><sup>20</sup>Ne(d,α)<sup>18</sup>F</td><td class="colsep0 rowsep0" align="left">[<sup>18</sup>F]F<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char="."> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>76</sup>Br</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">16.0 h</td><td class="colsep0 rowsep0" align="left">β<sup>+</sup> (54.0%)</td><td class="colsep0 rowsep0" align="left"><sup>75</sup>As(<sup>3</sup>He,3n)<sup>76</sup>Br</td><td class="colsep0 rowsep0" rowspan="2" align="left">[<sup>76</sup>Br]Br<sup>–</sup></td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">7.2 × 10<sup>3</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC (46.0%)</td><td class="colsep0 rowsep0" align="left"><sup>76</sup>Se(p,n)<sup>76</sup>Br</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>124</sup>I</td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">4.17 days</td><td class="colsep0 rowsep0" align="left">β<sup>+</sup> (22.8%)</td><td class="colsep0 rowsep0" rowspan="2" align="left"><sup>124</sup>Te(p,n)<sup>124</sup>I</td><td class="colsep0 rowsep0" rowspan="2" align="left">[<sup>124</sup>I]I<sup>–</sup></td><td class="colsep0 rowsep0" rowspan="2" align="char" char=".">1.2 × 10<sup>3</sup></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">EC (11.0%)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">β<sup>+</sup>, positron emission; EC, electron capture</p></div></div></div><div class="NLM_p">Besides this general differentiation between organic and metallic radionuclides, other properties relevant to the selection of the radionuclide include physical half-life, decay modes, production routes, specific activity, and chemical species obtained from the irradiation. These topics are discussed below:</div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> Half-Life</h4><div class="NLM_p last">One of the most important physical properties of the radionuclide is its half-life, since it establishes the time-limit on the period available for scanning from a given radiosynthesis and thus also restricts possible radiosynthetic routes of the radiotracer. Very short-lived nuclides, e.g., <sup>15</sup>O (<i>t</i><sub>1/2</sub> = 2.04 min), are inappropriate for performing complex preparations, and their applications are thus limited to very fast radiosyntheses and tracers with rapid kinetics. Because of their short half-lives, <sup>13</sup>N and <sup>15</sup>O can be used only for the synthesis of simple molecules, such as the perfusion tracers [<sup>15</sup>O]H<sub>2</sub>O or [<sup>13</sup>N]NH<sub>3</sub>; as a general rule, the production and quality control of a radiotracer should be finished within three half-lives to permit sufficient time for imaging. Furthermore, the half-life of the radionuclide should correlate with the biochemical process to be visualized, to allow a high enrichment of the tracer in the target region while retaining sufficient radioactivity for a quantitative determination of the tracer’s distribution. Thus, <sup>11</sup>C (<i>t</i><sub>1/2</sub> = 20.39 min) is generally well suited for studying the brain with small tracer molecules, but it is not suited for the investigation of antigen–antibody interactions, which have much slower kinetics; enrichment at the target area for antibodies typically requires several hours. On the other hand, using a long-lived radionuclide to investigate a rapid process will frequently result in an unnecessary radiation burden for the patient.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> Production Route</h4><div class="NLM_p last">Although not a physical property of the radionuclide itself, the production route represents an important factor for the logistics of radiochemistry and later application in PET imaging. A prominent example for the significance of the production route is <sup>18</sup>F-fluorine, which either can be produced via the <sup>18</sup>O(p,n)<sup>18</sup>F-reaction (producing nucleophilic [<sup>18</sup>F]F<sup>–</sup><sub>aq</sub>) or via the <sup>20</sup>Ne(d,α)<sup>18</sup>F-reaction (producing electrophilic [<sup>18</sup>F]F<sub>2</sub>). These routes result in different chemical species and consequently require different labeling strategies. Furthermore, the specific activities that can be obtained from these routes differ enormously, attaining more than 370 GBq/μmol for the <sup>18</sup>O(p,n)-reaction versus only 0.4 GBq/μmol for the <sup>20</sup>Ne(d,α)-reaction, with obvious implications for specific activity.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Specific Activity</h4><div class="NLM_p last">An especially crucial parameter for CNS tracers is the specific activity, which is defined as the radioactivity per total mass of all isotopic compounds, typically expressed as a molar amount (gigabecquerels per micromole). A high specific activity not only avoids pharmacological or toxicological effects from the tracer but also is a crucial requirement for visualization of targets with a very low abundance or low density, such as dopamine D<sub>2/3</sub> receptors in nonstriatal regions. The importance of a high specific activity for CNS imaging, in particular for μPET studies, has been demonstrated recently for [<sup>11</sup>C]raclopride (3,5-dichloro-<i>N</i>-{[(2<i>S</i>)-1-ethyl-2-pyrrolidinyl]methyl}-2-hydroxy-6-[<sup>11</sup>C]methoxybenzamide).<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> If specific activity is too low, then significant occupancy of the binding site occurs, which reduces the magnitude of <i>BP<sub>ND</sub></i>. In a rat PET study, tracer batches with a high specific activity (∼150 GBq/μmol) gave a <i>BP<sub>ND</sub></i> of about 2.5, whereas batches with a low specific activity (∼150 MBq/μmol) gave a <i>BP<sub>ND</sub></i> of only about 0.3, due to violation of the assumption for pharmacokinetic modeling that only a small fraction of the receptors is occupied by the tracer (typically <5%).<a onclick="showRef(event, 'ref12 ref21'); return false;" href="javascript:void(0);" class="ref ref12 ref21">(12, 21)</a> When using tracers of low specific activity, this assumption is no longer valid, and the coinjected unlabeled tracer blocks the receptor, thereby reducing the enrichment of the labeled compound. For preclinical studies, the specific activity is a very crucial point, since a much higher ratio of injected radioactivity/body weight is frequently used.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Isotope and Analogue Tracers</h4><div class="NLM_p">Because most physiologically interesting lead compounds consist of carbon, oxygen, and nitrogen, the positron-emitting radionuclides <sup>11</sup>C, <sup>13</sup>N, and <sup>15</sup>O are of particular interest. Tracers labeled by such an isotopic substitution, where the stable isotope of an organic element in the final radiotracer is replaced by a positron emitter, are known as isotope tracers. In this event, the chemical properties of the radiolabeled molecule do not differ from those of the nonlabeled, stable molecule. For <sup>18</sup>F or <sup>124</sup>I on the other hand, such an isotopic substitution is impossible if biomolecules and radiotracer candidates do not already contain fluorine or iodine or if the halogenated position is not accessible via typical labeling strategies. In this case, the initial molecules structure has to be chemically modified to allow a radiolabeling, which generates a derivative known as an analogue tracer.</div><div class="NLM_p">To minimize unwanted effects on the biological properties of the tracer, chemically similar exchanges are often utilized. For example, moieties with similar electronic (OH vs F) or steric (CH<sub>3</sub> vs I; H vs F) characteristics would be preferred for a substitution. In radiopharmacy, in contrast to the pharmaceutical research, these bioisosteric concepts are not used to improve the absorption, distribution, metabolism, or excretion (ADME) of drugs but to introduce the radioisotope at a suitable position by taking into account the available labeling techniques. A high in vivo stability of the radioisotope, introduced via such a modification of the lead compound, is a major focus of this approach. However, such bioisosteric modifications seldom lead to an exact mimic of the original molecule. For example, an F-for-H exchange, due to the unique properties of fluorine, not only commonly results in an increased lipophilicity but also can influence the metabolism, conformation, membrane permeability, or pharmacological potency of the molecule in a manner unpredictable in direction and extent.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22, 23)</a> A prominent example for the examination of such modifications is <i>N</i>-[<sup>11</sup>C]methyl-spiperone (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), an established radiotracer to study the dopaminergic and serotonergic neurotransmission in vivo.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Because of the short half-life of <sup>11</sup>C, limiting the clinical application, different fluorinated analogues were examined as possible alternatives. Hence, different <i>N</i>-alkylated and <i>N</i>-fluoroalkylated derivatives were synthesized, and their properties were evaluated.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> While a lower affinity for the dopamine receptor was observed for the <i>N</i>-(2-fluoroethyl)-spiperone, in comparison with that for <i>N</i>-ethyl-spiperone, the <i>N</i>-(3-fluoropropyl)-spiperone showed a higher affinity than the propyl-spiperone. Interestingly, this study also showed that the metabolites of <i>N</i>-(2-[<sup>18</sup>F]fluoroethyl)-spiperone were enriched in the brain, whereas for the metabolites of <i>N</i>-(3-[<sup>18</sup>F]fluoropropyl)-spiperone no significant brain uptake was observed. Thus, <i>N</i>-(3-[<sup>18</sup>F]fluoropropyl)-spiperone is the preferred <sup>18</sup>F-labeled spiperone analogue for PET studies in vivo.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of the dopamine and serotonin receptor antagonists <i>N</i>-[<sup>11</sup>C]methyl-spiperone (left), <i>N</i>-(2-[<sup>18</sup>F]fluoroethyl)-spiperone (middle), and <i>N</i>-(3-[<sup>18</sup>F]fluoropropyl)-spiperone (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">For the case of <sup>18</sup>F, a special approach is frequently used for the introduction of the radioisotope. Lead structures containing methyl groups (such as ROCH<sub>3</sub> or R<sub>2</sub>NCH<sub>3</sub>) are generally not accessible via F vs H substitution, due to the metabolic instability of the resulting fluoromethyl compound, which is prone to defluorination. In these cases, the methyl group is often substituted by a fluoroethyl moiety, usually resulting in a more stable compound compared to that of the fluoromethyl derivative, with an affinity not significantly different than that of the lead compound. In contrast to direct <sup>18</sup>F-fluorination, <sup>18</sup>F-fluoroethylation is performed via a secondary labeling precursor. This term refers to very reactive small molecules accessible from the irradiation products in a fast and reliable manner. Thus, for example, [<sup>18</sup>F]fluoride is reacted with a molecule consisting of an ethylene group and two leaving groups, usually ethylene ditosylate (<b>1</b>), giving the <sup>18</sup>F-fluorethylating agent. Subsequently, this secondary labeling precursor is reacted with the demethylated lead structure (the precursor), to obtain the <sup>18</sup>F-fluoroethylated compound <b>3</b>, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Synthesis of 2-[<sup>18</sup>F]fluoroethyltosylate (<b>2</b>) and subsequent labeling step using this secondary labeling precursor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To avoid the need for pharmacological re-evaluation of modified compounds, isotopic labeling methods are generally preferred. To make this possible, a diverse number of procedures and reactions need to be developed to make all positions/atoms in a compound accessible for rapid and efficient isotopic labeling. This is even more crucial for elements seldom occurring in lead structures, such as fluorine or iodine. Fluorine is often present in drug candidate molecules as the trifluoromethyl group, because trifluoromethylation is a common approach for lead optimization in drug research. However, <sup>18</sup>F-labeling of this moiety is usually accompanied by harsh reaction conditions, elaborate multistep reactions, and low reactivity of the leaving groups, which result in low radiochemical yields and/or low specific activities.<a onclick="showRef(event, 'ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28">(26-28)</a> For example, the synthesis of 1-(2-((4-([<sup>18</sup>F]trifluoromethyl)(4-(trifluoromethyl)phenyl)methoxy)ethyl)piperidine-3-carboxylic acid (<b>6</b>, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>), a GABA uptake inhibitor, was prepared via an <sup>18</sup>F-direct fluorination of <b>4</b> in a five-step reaction.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> After optimization of the reaction sequence, the radiotracer <b>6</b> finally was obtained in radiochemical yields of 17–28% after a synthesis time of 150 min and with specific activities of about 74 GBq/μmol. Although this example shows that <sup>18</sup>F-trifluoromethylated radiotracers can be synthesized, in principle, the disadvantages described above severely limit their application in clinical PET studies.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Synthesis of the GABA uptake inhibitor <b>6</b> via <sup>18</sup>F-direct fluorination of <b>4</b> in a five-step reaction sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Recently, this problem was addressed by developing new approaches for the synthesis of aliphatic and aromatic <sup>18</sup>F-labeled trifluoromethyl moieties (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>).<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29, 30)</a> In comparison to the previous methods, these new approaches avoid low radiochemical yields and insufficient specific activities, making the synthesis of [<sup>18</sup>F]trifluoromethyl moieties more attractive for routine applications.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Production pathways for the synthesis of aliphatic (upper row) and aromatic (lower row) <sup>18</sup>F-labeled trifluoromethyl moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Labeling Position</h4><div class="NLM_p">The position at which labeling occurs on the precursor is of crucial importance for CNS tracers. While this is necessarily true for analogue tracers, it also applies to isotope tracers, for which several positions in a lead structure can be considered for labeling. Because tracer metabolism often cannot be avoided, the position at which the radiolabel is introduced then determines which metabolites are radioactive and which are not. Only metabolites with the radionuclide attached will still be visible in a PET scan. If, for example, the radioactive metabolite possesses a moderate affinity for the target and enriches there, then its formation may hamper evaluation of the PET signal. Consequently, polar radioactive metabolites are preferred, because these either fail to cross the blood–brain barrier (BBB) or are rapidly washed out from brain and therefore do not contribute importantly to the recording. For example, defluorination of <sup>18</sup>F-fluorinated tracers releases anionic [<sup>18</sup>F]fluoride, which is rapidly cleared from the brain. This can result in labeling of the skull during longer scans and can be a significant factor interfering in the quantitation of small animal PET scans.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a></div><div class="NLM_p">An illustrative example for the importance of the labeling position is provided by the synthesis of the 5-HT<sub>2A</sub>-ligand [<sup>11</sup>C]volinanserin ([<sup>11</sup>C]MDL-100,907).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In this case, <sup>11</sup>C-methylation is a preferred reaction for introducing the <sup>11</sup>C-label, for which volinanserin offers two different positions: the 2- and the 3-position of the aromatic ring (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). In previous studies, it was shown that volinanserin is partly metabolized to its 3-OH analogue. Hence, <sup>11</sup>C-methylation in the 2-position would result in the formation of a lipophilic <sup>11</sup>C-labeled metabolite, which can be expected to enter the brain and potentially increase nonspecific binding or indeed bind to receptors. In contrast, <sup>11</sup>C-methylation at the 3-position of the precursor <b>7</b> results in the formation of polar metabolites, such that selection of this labeling position is much preferable.</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Labeling reaction and metabolization of [<sup>11</sup>C]volinanserin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Design of the Pharmacophore</h3><div class="NLM_p">In addition to the choice of radionuclide, the properties of the pharmacophore also significantly influence functional imaging. Hence, some essential aspects of the pharmacophore, including its permeability across the BBB, its binding affinity and selectivity for the target, and its vulnerability to metabolism (noted above), have to be considered.</div><div id="sec3_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Permeability</h4><div class="NLM_p">In order to reach the CNS, tracers need to cross the BBB. Lipinski et al. developed a set of empirical rules predicting BBB permeability, which are based on rough estimates of lipid solubility and membrane penetration.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The so-called Lipinski rule of five, which is based on a database of the properties of ∼2500 compounds, states that compounds with a log P (logarithm of the partition coefficient octanol/water) less than 5, a molecular weight less than 500, five or fewer hydrogen-bond donors (HBD), and 10 or fewer hydrogen-bond acceptors generally show good entry into brain.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Although originally developed for the oral bioavailability of drugs, these rules are applicable for the case of CNS PET tracers. Low BBB permeability remains one of the most frequent causes for the failure of promising CNS tracers and recently motivated the development of a prediction model specifically for CNS PET tracers. This method incorporates calculated distribution coefficients at pH 7.4 (cLog D<sub>7.4</sub>), molecular weight, the topological polar surface area (TPSA), the number of hydrogen-bond donors (HBD), and the protonation constant p<i>K</i><sub>a</sub> of the most basic center.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Prediction models are important tools for the identification of promising structure–transport correlations and can spare a resource-intensive and expensive development of tracers ultimately proving to have unfavorable properties. While low lipophilicity of the tracer reduces BBB permeability, very high lipophilicity results in excessive nonspecific binding, imparting high background signal, which makes the quantitation of the specific binding signal difficult. Furthermore, unspecific binding increases the radiation burden to the patient.</div><div class="NLM_p last">The uptake of tracers into the CNS can also be restricted by a number of efflux transporters located in the BBB.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> P-glycoprotein (P-gp), the most prominent of these, occurs at the luminal side of brain capillary endothelium cells and acts as an active (ATP-driven) efflux pump for a wide range of compounds. Hence, cerebral permeability of CNS tracers that are substrates of P-gp is attenuated, which can be a source of variability of tracer uptake and binding.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A number of studies, both in vitro and in vivo, have been performed recently to examine possible interactions of established radiotracers and P-gp.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec3_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Affinity and Selectivity</h4><div class="NLM_p">Most brain targets are expressed at very low levels, which demand a very high affinity of the radiotracer for its particular target. Because PET tracers, in contrast to normal pharmaceuticals, are typically administered in submicrogram amounts, a high affinity is especially crucial, as the radiotracer often has to compete with endogenous ligands for the binding sites of their common target. CNS PET tracers should preferably show an affinity for their target in the low nanomolar to subnanomolar range. As mentioned before, the binding potential primarily depends on <i>B</i><sub>max</sub> and <i>K</i><sub>D</sub>. Thus, lower <i>K</i><sub>D</sub> (higher affinity at the target) increase these values.</div><div class="NLM_p last">Equally important is a high selectivity for the target, which results in fewer specific interactions with other binding sites, such as other receptors, receptor subtypes, or transporters. The required selectivity of the tracer depends not only on the relative affinity for competing biological structures but also on the level of expression and distribution of those targets in the brain. For example, a labeled D<sub>4</sub> receptor ligand requires a much higher selectivity over other D<sub>2</sub>-like receptors than does a radiotracer targeting the D<sub>2</sub> receptor, due to the much lower expression levels of the D<sub>4</sub> receptor. Selectivity over other binding sites of at least 30-fold is recommended to obtain adequate selectivity and unambiguous results.</div></div><div id="sec3_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Targets</h4><div class="NLM_p last">Because of the properties of the organic positron emitters and the various requirements for the final radiotracer, not all interesting CNS targets can be readily investigated by existing methods. As noted above, large molecules such as proteins or nanoparticles are not amenable to application with the generally short-lived PET nuclides due to the slower kinetics of their binding at target sites and their low permeability to the BBB. Hitherto, most useful brain PET tracers have been small molecules targeting transmembrane receptors and transporters and intracellular and extracellular enzymes of high activity.</div></div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Strategies for the Development of Radiotracers</h3><div class="NLM_p">The development and optimization of totally new lead structures for biological targets is a time-intensive and costly endeavor. Because most radiotracers are developed in academic facilities, which usually suffer from limited resources, new tracers are typically based on lead structures derived from other natural science departments, e.g., pharmacy or biology, or are adopted from structures that were developed by pharmaceutical companies but did not proceed to clinical evaluations. This is unavoidable, since the properties required for clinically effective drugs and those for radiotracers differ substantially. However, in recent years, there has been a tremendous increase in interest in the part of pharmaceutical companies in the development of new PET tracers, e.g., Piramal Healthcare, GE Healthcare, or Avid Radiopharmaceuticals. This is true in particular for the design of new tracers visualizing beta-amyloid (Aβ) plaques in Alzheimer’s disease (AD) or mild cognitive impairment (MCI). Whereas the reference method for differential diagnosis of diverse neurodegenerative disorders is still based on histology (which is clinically, however, not helpful), the clinical differentiation between dementias (even including anatomical imaging) is not entirely robust. Consequently, there is great interest in finding diagnostic methods for the presence and distribution of Aβ plaques and neurofibrillary tangles in the brain, which are the pathologic hallmarks of AD. This interest is driven by the burgeoning prevalence of dementias and by the search for effective interventions. A classic example of PET tracer development began with the compound Thioflavin T (<b>6</b>, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), a dye long used for the histological staining of Aβ plaques. Because such a benzothiazole salt does not cross the BBB, a research team from the University of Pittsburgh optimized this lead structure by demethylation of the thiazole ring and derivatization of the aniline and the methyl group in 6-position, finally obtaining 2-(4′-methylaminophenyl)-6-hydroxybenzothiazole, the so-called Pittsburgh compound B (PiB, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> In the first PET study with this tracer in AD patients, tracer uptake was enriched in areas of the cerebral cortex, known from postmortem studies to contain significant amounts of Aβ plaques in dementia patients.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> However, due to the short half-life of carbon-11, this tracer can be used only by PET sites with an on-site cyclotron. To circumvent this limitation and to allow a broader application of this type of tracer, an <sup>18</sup>F-fluorinated derivative was developed. By means of H-to-F substitution (cf. <a class="ref internalNav" href="#sec3_1_4" aria-label="Isotope and Analogue Tracers">Isotope and Analogue Tracers</a>) of the hydrogen in ortho-position to the aniline function, [<sup>18</sup>F]flutemetamol (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) was obtained,<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> which shows a distribution in AD brain comparable to that of [<sup>11</sup>C]PiB.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Congo Red (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) is another dye used for staining Aβ plaques, which served as an alternative lead compound for an AD PET tracer. To decrease the molecular weight and to increase the metabolic stability and lipophilicity of the Congo Red pharmacophore, derivatives of salicylic acid, e.g., chrysamine G, and divinylbenzene compounds such as X-34, were developed.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Although these compounds showed high logD values, they failed to exhibit good brain uptake in preclinical studies. To enhance passage of the BBB, polar moieties were removed, and the molecular weight was further reduced, yielding stilbene derivatives as promising lead structures. A cooperative effort between a research group of the University of Pennsylvania and the newly founded company Avid Radiopharmaceuticals was started to further optimize this lead structure, an effort that finally resulted in the development of [<sup>18</sup>F]florbetaben<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> and [<sup>18</sup>F]florbetapir.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Hence, by adding a polyethylene moiety to the stilbene, a more appropriate lipophilicity was obtained, without loss of specificity; these tracers show good uptake in Aβ plaques as well as rapid clearance of nonspecific bound tracer. All three fluorinated tracers, [<sup>18</sup>F]flutemetamol, [<sup>18</sup>F]florbetaben, and [<sup>18</sup>F]florbetapir, received FDA approval for the estimation of Aβ plaque density in the human brain by means of PET; it remains uncertain which of the three is most suitable.</div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of the lead compounds for the diagnosis of Alzheimer’s disease and the corresponding <sup>18</sup>F-fluorinated tracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">PET in CNS Drug Discovery</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Significant improvements in human longevity and health have resulted from the development of new pharmaceuticals during recent decades. During this time, the standards for research and development (R&D) of new drugs became significantly more stringent, especially through the introduction of good manufacturing practice (GMP) in the U.S. at the end of the 1930s. Later, these guidelines were expanded to improve further quality management by the introduction of good laboratory practice (GLP) and good clinical practice (GCP). Adherence to these guidelines has increased the expenditure of time and money required for the development of new pharmaceuticals, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>. For example, haloperidol, an antipsychotic (AP) drug for the treatment of schizophrenia, was licensed for the first time in Belgium within 2 years after its development had begun in 1957. In contrast, new pharmaceuticals reach the market nowadays after an average of about 13 years of development.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> On the other hand, new methods for efficient investigation of drugs have been established; these innovations include databases for an improved identification of lead compounds, combinatorial chemistry, which drastically increases the number of compounds a chemist can synthesize per year, and high-throughput screening, which allowed for faster testing of a library of compounds. Despite these innovations, the number of new molecular entities getting approval has steadily declined over recent decades (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>).</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Graphical representation of new molecular entities developed versus research and development (R&D) expenditure of the pharmaceutical industry during the past 20 years.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In 2004, the U.S. Food and Drug Administration (FDA) introduced a <i>critical path initiative</i> to modernize and increase the efficiency of drug development and to overcome the stagnation in the registration of new pharmaceuticals.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The critical path, as specified in that initiative, outlines the typical development route for new drugs, starting after the initial research and discovery phase but consisting of the preclinical, clinical ,and approval phases, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>. The aim of the initiative was to implement new scientific tools within the critical path of drug development, to increase R&D efficiency, and to improve the product development. Increased R&D efficiency is desirable, since today only 1 to 2 of every 10 000 substances synthesized in the basic research phase will successfully pass all stages of the critical path and finally achieve approval. Even in the clinical phases, there is a high rate of failure, resulting in an especially high financial expenditure at this late point. For example, only 12% of the compounds recently tested in the clinical phase II were ultimately approved, even though some 40% of the total R&D expenditures to develop a new drug are already spent at this stage.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> In order to ameliorate this state of affairs, molecular imaging is one of the key technologies explicitly mentioned in that initiative.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> PET can support this program by giving fast access to in vivo data in the preclinical phases to verify the proof of concept or in the clinical phases to optimize the dosage and establish the efficacy of the drug.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Diagrammatic representation of the critical path initiative for drug development, showing the typical time span for each development phase and percentage chance that a drug candidate in that phase has of achieving final approval.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Measurement Techniques for PET in CNS Research</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Different PET techniques can be used for the determination of pharmacokinetic and pharmacodynamic properties of drug candidates during the preclinical and clinical phases of development. The choice of technique depends on the availability of validated PET tracers as well as on the properties of the drug candidate and the end point parameters of interest. Approaches can be structured into direct and indirect categories: the selection of the method naturally influences the nature of the end-point parameters to be measured. If the new drug can be labeled, then its pharmacokinetic properties can be measured via the direct method, while pharmacodynamic properties are examined using indirect methods, relative to effects on established radiotracers, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>.</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Determination of pharmacokinetics and pharmacodynamics via direct or indirect measurement. Labeling for the direct method is mainly performed using <sup>11</sup>C-carbon, but <sup>18</sup>F-fluorine may be preferred if the molecule contains fluorine. For indirect methods, the radionuclide used depends on the molecular structure of the established tracer, which usually entails <sup>11</sup>C- or <sup>18</sup>F-labeling, although radionuclides such as <sup>76</sup>Br or <sup>124</sup>I are occasionally used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the direct method the drug candidate itself is labeled to allow measurement of its biological parameters from the PET data. Parameters such as uptake across the BBB, distribution, reversibility of target binding, and wash out can be quantified by application of compartmental models. To avoid any changes in its pharmacology, the drug candidate must be isotopically labeled, most frequently with <sup>11</sup>C or <sup>18</sup>F (if applicable). For example, FK960 (<i>N</i>-(4-acetyl-1-piperazinyl)-<i>p</i>-fluorobenzamide) is a drug candidate for the treatment of dementia, which acts by raising acetylcholinergic levels in the brain hippocampus via somatostatin release.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> It had shown promising properties in rodent and nonhuman primate models of dementia. Because FK960 showed a bell-shaped dose–response relationship, it was isotopically labeled with <sup>18</sup>F-fluorine in order to examine the basis of this relationship in vivo. Subsequently, a PET study in rhesus monkey was performed, which showed that [<sup>18</sup>F]FK960 penetrated the BBB and distributed dose dependently throughout brain. The results also suggested that this PET imaging method could be used to determine the optimal FK960 brain concentrations in humans and to objectively establish the threshold for the declining phase of the dose–response relationship.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">In contrast, the indirect method makes use of a well-known, i.e., validated, PET tracer to examine the drug candidates behavior. Here, the PET tracer is selected to reveal direct or indirect competition with the drug candidate for the biological target of interest. In the case of receptors and transporters, this can give important information such as total density and/or availability of target receptors (<i>B</i><sub>max</sub>), the effect of the drug on apparent affinity (<i>K</i><sub>D</sub>), or the ratio of the Michaelis–Menten constants, corresponding to the ligand binding potential (<i>BP</i>). The indirect methods also allow determination of the dose-dependent receptor occupancy, which provides insight into the maximum dose or dosing interval of the drug candidates. For example, the striatal dopamine receptor occupancy obtained with increasing doses of the atypical antipsychotic amisulpride was determined via this indirect method using the fluorinated D<sub>2/3</sub> radiotracer [<sup>18</sup>F]desmethoxyfallypride (5-(3-[<sup>18</sup>F]fluoropropyl)-2-methoxy-<i>N</i>-[(2<i>S</i>)-1-prop-2-enylpyrrolidin-2-yl]methyl]benzamide, [<sup>18</sup>F]DMFP), cf. Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Reduced [<sup>18</sup>F]desmethoxyfallypride binding at dopamine D<sub>2/3</sub> receptors due to increasing receptor occupancy level by amisulpride. The image shows tracer binding under drug-free conditions (0 mg/day) and under stable daily doses of 400 and 1000 mg of amisulpride, respectively. The normally high binding (indicated by red) of the radiotracer in striatum, where D<sub>2/3</sub> receptors are most abundant, is 80% blocked at very high doses of amisulpride. The 80% threshold is considered to be relevant to the emergence of extrapyramidal side effects of AP treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Detection of receptor occupancies by intra- (repeated measurement) or interindividual (control group) comparisons, using receptor ligands, provides usually reliable information about the binding properties of drugs. The receptor occupancy can be easily calculated by comparing the relative changes of binding potential according to the equation (<i>BP</i><sub>control</sub> – <i>BP</i><sub>treatment</sub>)/<i>BP</i><sub>control</sub> × 100. For most drugs, these investigations are sufficiently reliable to calculate a plasama level vs occupancy relationship: occupancy (%) = occupancy<sub>max</sub> × <i>C</i><sub>drug</sub>/EC<sub>50</sub><i>+ C</i><sub>drug</sub>. Sometimes, the endeavored drug effect, however, is driven by secondary modulations of endogenous transmitter concentrations. This is frequently done by the inhibition of reuptake inhibitors (e.g., selective serotonine reuptake inhibitors) or by the use complex interactions of a transmitter system (e.g., agomelatine associated dopamine release by 5-HT<sub>2C</sub> antagonism). To estimate these modulations in transmitter release, intraindividual comparisons of binding potentials in receptor PET can be used to quantify the ligand competition to endogenous transmitters. This frequently used paradigm appears to be straightforward but practically suffers from some limitations. Thus, in most cases, these changes in ligand binding fail to be congruent with results (time course and concentrations) of microdialysis measurements. This depends on ligand properties and is most likely explained by biological reactions caused by the challenge (e.g., receptor internalization). Thus, these endogenous transmitter challenge paradigms usually provide only surrogate parameters with more or less face validity. Furthermore, the effects are rather low (e.g., 10% to a max of 30% <i>BP<sub>ND</sub></i> decrease of low-affinity D<sub>2</sub> receptor ligands even after intake of dopaminergic stimulants like amphetamine or methylphenidate). Whereas most of these studies were done with antagonistic ligands, recently, an emerging number of studies used agonist ligands, which show distinct binding properties at high/low activity states of receptors and might provide higher sensitivities.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><div class="NLM_p">Another indirect approach can also be applied by measuring a functional activity response, such as the influence a drug candidate on brain metabolism or cerebral blood flow. There are well-established radiotracers like [<sup>15</sup>O]H<sub>2</sub>O, which is used for measuring cerebral blood flow, and glucose metabolism is measured with the analogue 2-[<sup>18</sup>F]FDG. Because of its wide use in nuclear medicine, 2-[<sup>18</sup>F]FDG is one of the most important PET tracers and is especially relevant to CNS drug development because of its well-understood metabolism and simple modeling. Glucose is transferred into living cells via the glucose transporters (GLUT1–6), where it is phosphorylated to glucose-6-phosphate and then either shunted to a glycogen pool or decomposed via anaerobic and aerobic respiration to carbon dioxide and water (Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>), with net production of ATP. Like natural glucose, 2-[<sup>18</sup>F]FDG is a substrate for GLUT and for phosphorylation. However, the product 2-[<sup>18</sup>F]FDG-6-phosphate does not proceed further in the glycolytic pathway and is trapped in the living cell such that its accumulation with time is an indicator of the glycolysis rate of cells. In the CNS, glycolysis is normally the only source of metabolic energy.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Metabolic pathways of glucose and 2-[<sup>18</sup>F]FDG (GLUT, glucose transporter; HK, hexokinase).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">2-[<sup>18</sup>F]FDG PET has been used in hundreds of studies with pharmacological challenge. One such study evaluated selegiline as a pharmacologic adjunct in the treatment of cocaine addiction (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a>), aiming to reduce the euphoria caused by cocaine infusion. Earlier PET studies had demonstrated that cocaine infusions globally reduced cerebral glucose metabolism in the brain.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Consequently, the influence of the monoamine oxidase B inhibitor selegiline on the cerebrometabolic effects of cocaine could be evaluated using 2-[<sup>18</sup>F]FDG as a surrogate marker for local glucose consumption. Results showed that selegiline altered glucose utilization in most brain regions<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> and supported its use as a candidate for the treatment of cocaine addiction.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of 2-[<sup>18</sup>F]FDG and selegiline.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">Roles of PET CNS Drug Research</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32480" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32480" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">PET can fulfill different roles in the development of CNS drugs. The use of PET includes, but is not limited to, four principal roles in drug research: (1) proof of biology studies, to determine if the biological target is associated with a specific disease, (2) proof of concept studies, to examine the drug candidate’s biodistribution and target engagement, (3) drug dosing studies, to determine sufficient drug dosing for a clinical benefit, and (4) mechanism of action studies, to provide further insight into a drug’s pharmacological behavior, such as duration of the target engagement or possible interaction with other biological targets.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Proof of Biology</h3><div class="NLM_p">Molecular imaging can be an important tool in the identification of a biological target, which is associated with a specific disease. Highly effective drugs exist for many diseases, but identifying new biological modes of action can substantially improve the efficiency of pharmacotherapy. The identification of new biological targets brings with it a better understanding of the pathogenesis of the disease or syndrome.</div><div class="NLM_p last">For example, migraine is a common neurovascular disorder, although a complete understanding of its pathophysiology remains elusive. Recent findings indicate that the calcitonin gene related peptide (CGRP) and its receptors (CGRP-Rs) play a crucial role in the pathogenesis and have potential for guiding development of new treatment options of migraine. The CGRP-Rs are widely distributed in the brain, in particular in the trigeminal ganglion and in the cerebellum, and are also present in the periphery on vascular muscle cells and mediate neuroinflammatory aspects of migraine. Furthermore, CGRP-R antagonists, like telcagepant or olcegepant, showed good clinical efficacy, although their primary biological target, central or peripheral CGRP-Rs, was not identified. Hence, a PET ligand for the CGRP-Rs, [<sup>11</sup>C]MK-4232 (2-[(8R)-8-(3,5-difluorophenyl)-6,8-dimethyl-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-<i>N</i>-[(2<i>R</i>)-2′-oxospiro[1,3-dihydroindene-2,3′-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine]-5-yl]acetamide),<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> was undertaken to address this question.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> In PET studies in healthy volunteers and in migraineurs, telcagepant in efficacious doses only results in low-to-moderate occupancies at the central CGRP-Rs, which strongly implies that an action at peripheral CGRP-Rs is at least partially involved in the treatment of migraine pain. Similar methods could help to identify substances with higher occupancies to the central receptors, which might offer additional treatment effects.</div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> Proof of Concept</h3><div class="NLM_p">The aim of a proof of concept study is to examine the drug candidate’s biological parameters, which may include target engagement, nonspecific binding, passage across the BBB, and metabolism. Conclusions may be then drawn concerning the suitability of the drug candidate to treat the disease of interest. As noted above, the most relevant way to obtain this information is to label the drug candidate with a positron emitter, usually <sup>11</sup>C or <sup>18</sup>F, without altering its molecular structure, since this allows direct measurement of these parameters for the actual drug. The occurrence of alkyl functional groups in many drug candidates makes labeling with <sup>11</sup>C-carbon an obvious choice. <sup>11</sup>C chemistry is well-understood, and, besides the direct irradiation products, [<sup>11</sup>C]CO<sub>2</sub> and [<sup>11</sup>C]CH<sub>4</sub>, a wide number of secondary labeling synthons are also available.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> These synthons increase the versatility and applicability of <sup>11</sup>C-labeling pathways, despite the short half-life of the radionuclide. Prominent examples are [<sup>11</sup>C]CH<sub>3</sub>I and [<sup>11</sup>C]CH<sub>3</sub>OTf, both of which can be used for the methylation of nitrogen, oxygen, or sulfur atoms.</div><div class="NLM_p">The short half-life of <sup>11</sup>C remains a major limitation in the logistics of performing PET studies with a large number of patients or volunteers, since each study requires a new radiosynthesis. In comparison, <sup>18</sup>F-fluorine, with a half-life of 109.7 min, is more appropriate for more complex synthetic routes and extended imaging time periods and can permit many human PET examinations from a single production batch.</div><div class="NLM_p">The presence of fluorine in pharmaceutical lead structures, a prerequisite for isotopic labeling, has increased in recent decades, due to its favorable influence on pharmacological parameters, which include improved stability, reduced metabolism, improved affinity, and enhanced lipophilicity.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> However, <sup>18</sup>F-labeling strategies remain much more limited than those of <sup>11</sup>C-carbon. Electrophilic <sup>18</sup>F-fluorinations are possible but result in radiotracers of low specific activity. Isotopic <sup>18</sup>F-labeling via nucleophilic reactions with <sup>18</sup>F-fluoride generally combine high radiochemical yields with high specific activities, but this requires very harsh reaction conditions for labeling.<a onclick="showRef(event, 'ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref61 ref62">(61, 62)</a> This type of radiofluorination is preferred for the labeling of aliphatic and activated aromatic moieties, and occasionally <sup>18</sup>F-direct fluorination of a nonactivated aromatic position is also possible. For example, flumazenil, an established <sup>11</sup>C-labeled tracer for the visualization of the benzodiazepine binding site of the GABA receptor, has also been labeled with <sup>18</sup>F-fluorine, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a>. Although the meta-position of the aromatic ring of compound <b>9</b> is not activated, [<sup>18</sup>F]flumazenil could be obtained in radiochemical yields of about 15–20% by <sup>18</sup>F-direct fluorination.</div><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Synthesis of [<sup>11</sup>C]flumazenil and [<sup>18</sup>F]flumazenil, via <sup>11</sup>C-methylation of the desmethyl precursor <b>8</b> and direct nucleophilic <sup>18</sup>F-fluorination of the nitro-functionalized precursor <b>9</b>, respectively. The asterisks indicate the potential labeling positions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The development of fluorinated drug candidates amendable to<sup>18</sup>F-labeling would allow a better implementation of PET in the preclinical and clinical phases. However, most drug candidates do not contain fluorine, or, if present, the fluorine is not accessible via the established <sup>18</sup>F-labeling strategies; this issue severely limits the application of <sup>18</sup>F-fluorine in CNS drug research.</div><div class="NLM_p">An illustrative example for the usefulness of PET for proof of concept studies with the labeled drug candidate is provided by the evaluation of two different neurokinin 1 receptor (NK1) antagonists in preclinical studies: GR203040 ((2-methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine)<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> and GR205171 ((2<i>S</i>,3<i>S</i>)-<i>N</i>-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> The NK1 receptor, a subclass of the tachykinin receptor, is involved in diverse processes in the CNS, which include emotional behavior, stress, depression, anxiety, migraine, alcohol addiction, and neurodegeneration.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Antagonists of the NK1 receptor are therefore promising compounds for the treatment of relevant diseases. Because both GR203040 and GR205171 showed a high affinity for NK1 receptors in vitro, they were subsequently evaluated in PET studies in monkeys using the <sup>11</sup>C-labeled compounds (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a>).<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Brain uptake, distribution pattern, and binding selectivity of the tracers revealed a superior brain uptake and lower nonspecific binding for [<sup>11</sup>C]GR205171, highlighting it as the preferred candidate. GR205171 was further evaluated as a drug for the treatment of postoperative nausea, motion sickness, and migraines until its termination during phase II clinical trials.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of the <sup>11</sup>C-labeled NK1 receptor radiotracers [<sup>11</sup>C]GR203040 and [<sup>11</sup>C]GR205171.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Determination of Drug Dosing</h3><div class="NLM_p">The determination of optimal dosing of a drug candidate represents one of the most important roles of PET in CNS research, because wrong dosing is one of the four major causes of failure in drug development.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Because PET can very often help to identify an appropriate dose range using only a small group of healthy volunteers, it can not only accelerate drug development but also may minimize the risk of adverse events and reduce the required group size for clinical trials. Neglecting the frequently performed retrospective dose/binding characterizations, dose-finding studies should usually be performed in phase I clinical trials but can sometimes contribute to phase II or even phase IV. However, phase IV dosing studies are mostly conducted as retests or in the context of a new indication for the drug. Neuroreceptor ligand dose finding by PET is now an established method, in particular for drugs targeting the dopaminergic and serotonergic systems. It even became a recommended requirement for an FDA registration of certain classes of new drugs.</div><div class="NLM_p">In this indirect PET technique for receptor occupancy studies, a validated tracer such as [<sup>18</sup>F]desmethoxyfallypride (see above) is used to label the receptor, which is then challenged with different doses of the drug candidate, to determine the drug’s target engagement.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69, 70)</a> Because this process is well-examined, validated radiotracers are needed for the determination of receptor occupancy; most of these studies to date have been performed for drug candidates targeting postsynaptic D<sub>2/3</sub>-like neuroreceptors, given the wide availability of established radiotracers (see below).</div><div class="NLM_p">In general, dose/binding or concentration/binding studies in humans follow two strategies: (A) an occupancy or binding range is known or can reasonably be assumed for the drug candidate. Then, the dose (or plasma concentration) can be calculated from in vivo PET data. Prominent examples of this in neuropsychiatry are the establishment of D<sub>2/3</sub> receptor binding curves of antipsychotics and the characterization of presynaptic transporter blockade by antidepressants. (B) Retrospectively, a reference drug with well-known clinical efficacy should be evaluated with respect to the effective target binding ratio in order to obtain a standard occupancy/binding range for new drugs. For instance, this was carried out to provide insight into the mechanisms of antipsychotics with low-extrapyramidal motor symptoms (EPMS). In preclinical PET investigations, often performed with dedicated small animal PET instruments, a broad range of plasma concentrations can be investigated in order to evaluate the drug-binding curves and to assign the behavioral or cognitive surrogate markers of efficacy. In accordance with new strategies in drug R&D, this information becomes necessary to convey a first impression of the relevant drug-to-target binding and to detect possible efficacy thresholds or biphasic properties in its clinical action; we present an example below for the case of novel glycine transporter inhibitors.</div><div class="NLM_p">Pruvanserin (EMD-281,014), a highly selective 5-HT<sub>2A</sub> receptor antagonist (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a>), showed promising therapeutic properties for the treatment of insomnia, depression, and anxiety in animal models.<a onclick="showRef(event, 'ref71 ref72'); return false;" href="javascript:void(0);" class="ref ref71 ref72">(71, 72)</a> Hence, in advance of clinical trials, a receptor occupancy study in humans was performed using the established 5-HT<sub>2A</sub> tracer [<sup>18</sup>F]setoperone.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> The aims of this study were to find the oral dose of pruvanserin producing 50–90% receptor occupancy and to illuminate the relationship between dose and plasma levels. The study demonstrated that even the lowest pruvanserin dose resulted in receptor occupancies of about 63%. Furthermore, the half-life of receptor occupancy, which was approximately 24 h for the three doses used in the study, was considerably longer than the half-life in the plasma. Because of these promising results, pruvanserin was further evaluated in clinical trials extending to the end of phase II.</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of the 5-HT<sub>2A</sub> receptor antagonist pruvanserin and the <sup>18</sup>F-labeled 5-HT<sub>2A</sub> radiotracer [<sup>18</sup>F]setoperone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Mechanism of Action of the Drug</h3><div class="NLM_p">Mechanism of action studies aim at providing a deeper understanding of the biological interactions and properties of a drug candidate. Key mechanistic questions are whether there is a relationship between the plasma levels of a drug candidate and the target engagement and if a drug effect is caused by interaction with one or several biological targets. In an exemplary study, Gründer et al. established the relationship of receptor occupancy and plasma levels in healthy subjects after single oral doses (10 or 20 mg) of volinanserin, a potent 5-HT<sub>2A</sub> receptor antagonist.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a><i>N</i>-[<sup>11</sup>C]Methylspiperone was applied to determine the receptor occupancy in the frontal cortex, while plasma levels were determined using HPLC and mass spectroscopy (Figure <a data-tab="pane-pcw-Figures" href="#fig20" id="" class=" internalNav">20</a>). Interestingly, although a fast plasma washout was observed for both doses, stable 5-HT<sub>2A</sub> receptor occupancies of about 85% occurred for 24 h for the 20 mg dose, whereas the 10 mg dose resulted in this occupancy for only 8 h, followed by a slow decrease to 70%. Hence, this study showed that there is a discrepancy between the central pharmacodynamic effects of volinanserin and its peripheral pharmacokinetics.</div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. 5-HT<sub>2A</sub> receptor occupancy in the frontal cortex (mean 6 SD), expressed in percent decrease in <i>BP<sub>ND</sub></i> of <i>N</i>-[<sup>11</sup>C]methylspiperone from baseline (left <i>y</i> axis, represented by circles), and plasma concentrations for 10 mg (black) and 20 mg (white) oral doses of volinanserin (right <i>y</i> axis, represented by squares).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Another example for this approach is the systematic characterization of 5-HT<sub>2A</sub>-binding properties of antipsychotics with low EPMS properties.<a onclick="showRef(event, 'ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref123 ref124 ref125">(123-125)</a> These PET investigations detected occupancy levels exceeding 80% for a clinically effective dose regimen. Subsequent investigations were designed to prove whether this 5-HT<sub>2A</sub> antagonism is likely to perturb dopaminergic transmission. In particular, these indirect challenge investigations were frequently performed to identify interactions between two neurotransmission systems. Knowledge of these interactions is important to establish new hypothesis of drug actions.</div><div class="NLM_p last">In this context, several studies have focused on the interaction between NMDA receptor antagonism and increased dopamine transmission. Together with clinical data, these results raise the importance of new drug strategies to manipulate the NMDA receptor action for improving the outcome in the treatment of schizophrenia. Another example is an [<sup>18</sup>F]FDOPA PET study on the dopamine/norepinephrine transporter inhibition by methylphenidate (MPH), which revealed a persistent increase in dopamine synthesis capacity after short-term MPH challenge. Other investigations linked opioidergic as well as endocannabinoid systems with dopamine transmission.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> The latter results may help in the development of anticraving substances and properly belong to the category of proof of biology investigations.</div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Species Differences in PET Studies</h3><div class="NLM_p">Because most of the study designs described above can be performed in both preclinical and clinical phases, it must be considered that results obtained in animal studies (mostly rodent models) need not apply perfectly to humans. For example, [<i>O</i>-methyl-<sup>11</sup>C]WAY-100,635<sup>76</sup>, a <sup>11</sup>C-labeled radiotracer of the 5-HT<sub>1A</sub> receptor antagonist WAY-100,635, showed very high affinity and selectivity in vitro. The rat in vivo studies showed the expected high uptake in the hippocampus, a 5-HT<sub>1A</sub>-rich region, and low uptake in the cerebellum, a region with low 5-HT<sub>1A</sub> expression.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> However, in humans, a substantially lower ratio between receptor-rich and receptor-poor regions was measured.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> An explanation for this differing in vivo behavior of [<i>O</i>-methyl-<sup>11</sup>C]WAY-100,635 was provided by the differing metabolic pathways of the radiotracer in rats and humans. While in rats the tracer is metabolized by demethylation of the <sup>11</sup>CH<sub>3</sub>-moiety, in humans the primary metabolic pathway is through hydrolysis of the amide bond, resulting in the formation of [<sup>11</sup>C]WAY-100,634 (cf. Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a>). This is an active metabolite with 5-HT<sub>1A</sub> binding and also high affinity for α<sub>1</sub>-adrenergic receptors in brain. Its formation in humans reduces the serotonergic signal-to-noise ratio and complicates the modeling of [<i>O</i>-methyl-<sup>11</sup>C]WAY-100,635.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Hence, WAY-100,635 was labeled at the amide function, resulting in [carbonyl-<sup>11</sup>C]WAY-100,635,<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> thereby circumventing the problem of the different pathways in rats and humans.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a></div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structure of [<sup>11</sup>C]WAY-100,635, indicating the possible labeling positions by an asterik ([carbonyl-<sup>11</sup>C]WAY-100,635 and [<i>O</i>-methyl-<sup>11</sup>C]WAY-100,635) causing different metabolic pathways in rats and humans.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">However, it is not always possible to solve problem arising from species differences by changing the labeling position. This limitation clearly demonstrates the significance of validated PET tracers in CNS drug research, which is especially important for tracers used with the indirect PET techniques, since unanticipated results might prove to be caused by an unexpected property of the drug or the tracer.</div></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">PET in Clinical Drug Development Using the Example of Antipsychotics</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The major issues in drug development can be summarized as proof of biology, proof of concept, dose finding, and evaluation of drug action, as noted above. PET may impact each of these issues via different technical approaches. Whereas it is nearly self-evident that PET can help in dose finding when suitable ligands are available, reasonable applications in the fields of proof of biology and proof of concept are much more complex. Its use is generally more favorable in drug development when underlying concepts and biology are not fully clear or are insufficiently grounded. In CNS drug development, in particular for mental disorders, this is frequently precisely the situation. Historically, it might be argued that nearly all relevant treatment strategies for neuopsychiatric disorders depend on incidentally discovered drug effects. PET was not available until the 1980s, long past the early developmental stages of antipsychotics and antidepressants. However, the potential for these old treatment strategies appears now to be exhausted, and conventional drug discovery programs have been disappointing in terms of innovative psychiatric treatment options. This is particularly true for antipsychotic drugs. Nevertheless, scientists and drug developers soon came to realize the potential impact of PET in this field. PET aids in antipsychotic drug (AP) development not only for dose-finding but also now extends to all four key aspects of drug discovery. While PET cut its teeth with highly retrospective analyses, pharmaceutical companies now make use of PET in the entire pathway of the developmental process. There is hardly another field making as much use of PET. In the next section, we focus on the prototypic process of drug development in psychiatry, emphasizing schizophrenia.</div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> The Dopamine System in Psychiatry</h3><div class="NLM_p last">We do not propose to review the entire literature on PET studies provided for CNS drug discovery but to focus on the dopamine system. The historical emphasis on dopamine imaging arose for three reasons. First, the dopamine system was among the first neurotransmitter systems to be linked with a neuropsychiatric disorder. Second, brain dopamine was one of the earliest targets of CNS PET studies, and, third, PET studies have had considerable impact of dopaminergic drug discovery. Thus, the case of dopamine is an illustrative example for the demands, principles, and challenges of drug discovery in psychiatry, as reflected by its historical importance in the history of drug development. Modulating dopamine transmission is an essential mechanism in the treatment of several neuropsychiatric diseases and syndromes, e.g., schizophrenia, psychotic syndromes in mood disorders, states of delirium, Tourette’s syndrome, and attention-deficit hyperactivity disorder (ADHD). Furthermore, brain dopamine is highly implicated in the neuropathology of addictive disorders, obsessive-compulsive disorders (OCD), certain variants of dementias/neurodegenerative disorders, and aggressive syndromes. Early studies focused on the anatomical pathways, receptor function, and physiology of this neurotransmitter system, which has a importance disproportionate with the numerically small population of dopamine neurons. Animals studies ex vivo and human postmortem examinations employed histological and electrophysiogical methods. The pioneering work of Dahlström and Fuxe (1964)<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> established the nomenclature of the catecholamine cell groups. In psychiatry, the A8-A10 neurons are of particular importance: A8, the retrorubal field projects to the amygdala, A9, the substantia nigra projects to dorsal striatal regions with mainly motor-associated functions, and A10, the ventral tegmental area (VTA) neurons, which projects to mesocortical and mesolimbic structures including the nucleus accumbens. In the target regions, dopamine exerts its actions via two classes of receptors: D<sub>1</sub>-like receptors consist of D<sub>1</sub>/D<sub>5</sub> receptors, and D<sub>2</sub>-like receptors consist of D<sub>2</sub>/D<sub>3</sub>/D<sub>4</sub> receptors. The five subtypes have very distinct distributions and concentrations as well as differing affinity for dopamine and differing signal transduction pathways. Consequently, the effects of dopamine at the respective receptors provide some kind of functional antagonism and equilibrium between these pathways. Certain models for D<sub>1</sub> and D<sub>2</sub> receptors (cf. reviews by Seamans and Yang<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> as well as Durstewitz and co-workers<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a>) suggest that liberal vs conservative information processing is modulated by the predominant activation of either D<sub>1</sub>- or D<sub>2</sub>-like receptors. Keeping in mind that APs are necessarily D<sub>2</sub>-like receptor antagonists, it appeared reasonable that disequilibrium might explain aspects of the pathophysiology in schizophrenia. PET methods are unsuited to investigating the fine structure of receptor distributions and function, due to lack of spatial and temporal resolution. However, PET has now attained spatial resolution as low as 1 mm and remains the only way to reveal neuroreceptors in the living brain.</div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> PET Radiotracers for Use in Schizophrenia Research</h3><div class="NLM_p">It is beyond the scope of this Perspective to provide a complete overview on PET ligands used in schizophrenia research. A vast number of candidates have been evaluated; however, in practice, only some ligands are frequently used and provide the necessities of a suitable ligand as before mentioned. The translational scientist needs a palette of tracers that could image a reasonably broad range of the physiological and anatomical cornerstones of the transmitter system. Furthermore, these ligands should be able to be reliably synthesized, easily modeled, and, in some cases, subject to dynamic changes (competition paradigms).</div><div class="NLM_p">In the dopamine system, this comprises the characterization of (1) dopamine synthesis, (2) the vesicular uptake transporter, (3) diverse receptor subtypes, (4) reuptake transporter, (5) enzymes of degradation, (6) second messenger systems, and finally, indirectly, any ligand that binds to structures that are in tight association with the dopamine system (e.g., cannabinoid system, adenosine receptors). Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a> shows a selection of radiotracers that are in use for clinical investigations.</div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Diagrammatic representation of a striatal dopaminergic synapse, showing relevant steps of dopaminergic neurotransmission: (1) presynaptic <span class="smallcaps smallerCapital">l</span>-Dopa uptake and decarboxylation, (2) vesicular monoamine uptake, (3) oxidative deamination of dopamine by the MAO, (4) presynaptic dopamine transporter binding, and (5) postsynaptic dopamine receptor binding; the corresponding most prominent radiotracers for visualizing the individual biological targets are also shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> The Dopamine System in R&D</h3><div class="NLM_p last">An appreciation of the clinical/behavioral impact of the dopamine system as well as knowledge of dopamine-associated pathophysiology in mental disorders has been predominantly increased by the wisdom of hindsight. Early drug developments (in particular, the antipsychotic D<sub>2</sub> antagonists) depended initially on accidental observations and empirical evidence rather than theory. The antipsychotic profile was incidentally observed during the development of a sedative drug and was later linked to blockade of dopamine receptors (cf. the Nobel Prize in Physiology or Medicine, 2000, awarded jointly to Arvid Carlsson, Paul Greengard, and Eric R. Kandel).<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> There remains a common tenet that clinically effective antipsychotic treatment necessarily depends on sufficient D<sub>2</sub> receptor blockade in excess. However, this mechanism is also responsible for the extrapyramidal motor side effects. In fact, more recently investigated antipsychotic mechanisms such as inhibition of the glycine transporter or mGluR<sub>2/3</sub> receptor agonists lack sufficient efficacy or are designed as add-on therapeutics. Pharmaceutical companies initially intended to produce D<sub>2</sub>-like receptor antagonists of higher affinity and with lesser sedative properties. Consequently, the development of agents with lower incidence of EPMS, while retaining antipsychotic efficacy, was of increasing interest; these are the so-called atypical antipsychotics, now better known as second-generation antipsychotics, SGA. The first SGAs with a so-called atypical profile of action arose from the retrospective and accidental observations/evaluation of known antipsychotics.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> For the intentional design of SGA drugs, it was necessary to possess a deeper knowledge about dopaminergic regulation in the living brain and the binding properties of antipsychotic drugs. In the 1980s, PET was applied retrospectively in R&D and was mainly driven by academic institutions. As long as the pharmaceutical industry retained focus on specific targets such as the D<sub>2</sub> receptor, the impact of PET followed proof of biology and dose finding rather than proof of concept issues. However, these early studies laid the foundation for later drug development strategies.</div></div><div id="sec7_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> PET Studies of the Presynaptic Dopamine System</h3><div class="NLM_p last">As mentioned above, PET is unsuited to investigate the fine structure of dopamine transmission, due to its inherently low spatial and temporal resolution. Furthermore, the palette of available tracers does not capture the entire range of dopaminergic targets. Nevertheless, some key structures of the dopamine system are well-quantified and characterized by PET. Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a> shows a selection of the most important radiotracers, which target (mainly) postsynaptic D<sub>2/3</sub> receptors and presynaptic dopamine reuptake transporters or are substrates/ligands of aromatic amino acid decarboxylase (AADC) and monoamine oxidase A. Using such radiotracers, the pathway for dopamine synthesis, binding, reuptake, and metabolism of dopamine can be investigated, with implications for treatment strategies and for translational research informed by an understanding of pharmacological manipulations of target structures in vivo and of factors imparting vulnerability to neuropsychiatric disease. No other method is of similar significance for specifically characterizing molecular processes in the brain under in vivo conditions. Thus, the investigations described below have contributed to drug development in terms of the proof of biology approach.</div></div><div id="sec7_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> PET Studies of Dopamine Synthesis Capacity</h3><div class="NLM_p">On the basis of early autoradiographic analysis ex vivo using tritiated <span class="smallcaps smallerCapital">l</span>-Dopa,<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> the synthesis and application of [<sup>18</sup>F]FDOPA arose as one of the first developments for clinical and scientific brain PET investigations.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> [<sup>18</sup>F]FDOPA remains a very important radiotracer, in spite of its complex metabolism, relatively low signal-to-noise ratio, and difficult neurophysiological interpretation (see below). Similar to the well-known and commonly used brain metabolism marker 2-[<sup>18</sup>F]FDG, and unlike most other radiotracers, [<sup>18</sup>F]FDOPA is an enzyme substrate, which is metabolically trapped in neurons terminals. [<sup>18</sup>F]FDOPA, together with its peripheral metabolite <i>O</i>-methyl-[<sup>18</sup>F]FDOPA, is cleared from blood to brain by the common amino acid transporter for the <span class="smallcaps smallerCapital">l</span>-Dopa precursor <span class="smallcaps smallerCapital">l</span>-tyrosine as well as several other amino acids. Therefore, [<sup>18</sup>F]FDOPA-PET subjects are advised to abstain from protein consumption in the hours prior to scanning to minimize competition at the BBB amino acid transporter. In nerve cells, [<sup>18</sup>F]FDOPA (analogously to <span class="smallcaps smallerCapital">l</span>-Dopa) is a substrate of aromatic amino acid decarboxylase (AADC), yielding 6-[<sup>18</sup>F]fluorodopamine.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> This product is stored in the vesicles; its trapping can be considered irreversible in the course of 1 h PET scans. The interpretation of [<sup>18</sup>F]FDOPA scans is complicated since AADC is an enzyme of high capacity and is clearly not the rate-limiting step of dopamine synthesis. Nevertheless, Cumming and Gjedde<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> argued that AADC is also potentially regulated, since its activity defines the fraction of <span class="smallcaps smallerCapital">l</span>-Dopa that will proceed to dopamine synthesis or will diffuse out of the brain. Many [<sup>18</sup>F]FDOPA-PET studies report as their end point the net blood/brain clearance (<i>K</i>), a macroparameter that can be described as the dopamine synthesis capacity. This parameter mirrors the anatomical and structural density of dopaminergic terminals (a rather stable influencing factor), but it is also subject to regulatory processes altering AADC activity under environmental or pharmacological challenges. A high dopamine synthesis capacity does not necessarily depict a high rate of dopamine transmission, but rather indicates that the system can respond with high capacity if needed, in the way an idling car engine can respond upon engagement of the (mechanical) transmission. Using standard compartment models for [<sup>18</sup>F]FDOPA analysis, the rate of AADC activity (<i>k</i><sub>3</sub>) can be calculated in striatum, which predicts the capacity for dopamine synthesis from endogenous brain <span class="smallcaps smallerCapital">l</span>-Dopa. Notwithstanding its complexity, [<sup>18</sup>F]FDOPA-PET has yielded a vast amount of clinically and scientifically important findings. In neurology, [<sup>18</sup>F]FDOPA served as an important tool to detect and monitor pathologies in the nigrostriatal dopamine system, in particular, for the diagnosis of Parkinson’s disease.<a onclick="showRef(event, 'ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref91 ref92">(91, 92)</a></div><div class="NLM_p">[<sup>18</sup>F]FDOPA-PET is no standard routine in neurology, in part due to the availability of cheaper SPECT/PET ligands for presynaptic dopamine transporters. With respect to basic investigations of mental diseases, however, its relevance continues to increase. An early [<sup>18</sup>F]FDOPA-PET study showed a 10–20% increase in dopamine synthesis capacity in schizophrenia. This finding has been replicated many times and is in some studies associated with the extent of psychotic symptoms.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> However, due to the modest test–retest reliability and the interindividual variance of [<sup>18</sup>F]FDOPA-PET, group-separating differences have not been revealed in studies of schizophrenia. This could be improved by the implementation of a more sophisticated analytical approach. Using PET recordings lasting several hours and an extended compartmental model affords the estimation of the rate constant for turnover of 6-[<sup>18</sup>F]fluorodopamine formed in brain (<i>k</i><sub>loss</sub> [min<sup>–1</sup>]); it could be observed that trapping conditions were no more stable when acquiring the dynamic PET scans for much longer than 1 h (e.g., 4 h).<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a></div><div class="NLM_p">6-[<sup>18</sup>F]Fluorodopamine is protected against degradation when entrapped in synaptic vesicles, but it is vulnerable to deamination by MAO-A when passing through the cytosol, either as a newly synthesized molecule or upon vesicular release and subsequent reuptake. According to this model, <i>k</i><sub>loss</sub> is a surrogate parameter for the presynaptic dopamine turnover occurring during a prolonged [<sup>18</sup>F]FDOPA PET scan. The estimation of <i>k</i><sub>loss</sub> is, however, complicated, entailing the uses of some procedure for subtracting the contribution of <i>O</i>-methyl-[<sup>18</sup>F]FDOPA to the brain signal to isolate the radioactivity due to [<sup>18</sup>F]FDOPA, [<sup>18</sup>F]fluorodopamine, and deaminated metabolites.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> On the basis of tracer concentrations measured in arterial plasma samples during a 2 h PET scan, <i>k</i><sub>loss</sub> can be calculated for striatal regions and the midbrain. Although <i>k</i><sub>loss</sub> does not have a simple physiological interpretation, it is a depiction of the washout or turnover of tracer dopamine and has yielded astonishing results, such as in a clinical PET study of schizophrenia. A 10–20% increase in synthesis capacity was detected, as reported in the meta-analysis, while the dopamine turnover rate was doubled, which can be considered one of the most pronounced neurobiological findings in schizophrenia research.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> This finding implies what might be described as churning, which might subserve the positive symptoms of psychosis but is also in accordance with theories to explain the neurocognitive impairments in schizophrenia.</div><div class="NLM_p">Whereas the impact of APs on the postsynaptic sites has been a focus of drug development, the consequences of AP action on presynaptic regulation of dopamine metabolism has been neglected. [<sup>18</sup>F]FDOPA-PET studies, however, have shown that that APs do not simply block signaling at postsynaptic D<sub>2/3</sub> sites but cause initial upregulations and later a profound downregulation of dopamine synthesis capacity or AADC activity.<a onclick="showRef(event, 'ref98 ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref98 ref99 ref100">(98-100)</a> These investigations focus on acute modulation and finally on the normalization of elevated dopamine synthesis capacity, one of the oldest PET findings in schizophrenia. Whereas in pigs an acute AP challenge increased <i>K</i>, this effect was observed in humans after treatment for 3 days.<a onclick="showRef(event, 'ref99 ref101'); return false;" href="javascript:void(0);" class="ref ref99 ref101">(99, 101)</a> A significant decrease of <i>k</i><sub>3</sub> was reported by Gründer and co-workers after 4 weeks of ongoing haloperidol treatment according to clinical needs of acutely psychotic schizophrenia patients.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Both effects on dopamine synthesis and turnover, the initial increase as well as the later decrease, were of substantial magnitude (approximately 20–30%). Thus, prolonged antipsychotic treatment normalized the pathologically upregulated dopamine system in the basal ganglia. This effect correlated with the clinical outcome for negative symptoms, in spite of rather low group sizes. The PET data support very early investigations in the cerebrospinal fluid (CSF) of patients suffering from schizophrenia, which also gave a similar impression of dopaminergic regulation in the course of AP treatment. One such CSF study showed, in fact, just such an association between the metabolite levels and the later treatment response.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div><div class="NLM_p">Whereas these investigation are designed to better understand the mechanisms of the pathophysiology in well-diagnosed states of schizophrenia, including the respective treatment effects, [<sup>18</sup>F]FDOPA PET was also recently used to provide evidence for the stratification of patients in the prodromal state.<a onclick="showRef(event, 'ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref103 ref104">(103, 104)</a> The clinical management of prodromal patients suffering from attenuated symptoms of psychosis or only brief periods of positive symptoms, without meeting critera for diagnosis of schizophrenia, is a current focus of discussion in psychiatry. While we understand the importance of timely initiation of AP treatment in order to improve the clinical outcome, the substantial side effects of APs are problematic in subjects for whom conversion to psychosis is uncertain. The conventional clinical tools are insufficient to define a risk threshold above which treatment is more beneficial than harmful, because only a minority of patients with prodromal states convert to manifest chronic schizophrenia. Several [<sup>18</sup>F]FDOPA-PET studies could, in fact, show that increased dopamine synthesis capacity is present in groups of prodromal patients and that the extent of the increase is predictive of conversion.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a></div><div class="NLM_p last">Although PET seems unlikely to become a standard tool for diagnosis of mental disorders (with the possible exception of Alzheimer’s dementia), findings in prodromal patients might help to stratify patients with respect to their clinical risks and treatment options. In the context of drug development, these data are an important contribution to the proof of biology approach; nevertheless, such results remain somewhat orphaned with respect to target development and are not yet linked to further proof of concept investigations. Nevertheless, it might prove to be crucial for treatment to reestablish a normal state of dopaminergic transmission. PET is the only tool to observe these drug effects directly in patients.</div></div><div id="sec7_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> PET Studies of Dopamine Receptors</h3><div class="NLM_p">Compared to [<sup>18</sup>F]FDOPA, labeled D<sub>2/3</sub> receptor ligands are much more integrated in the process of drug R&D. This is due to the strict association between D<sub>2/3</sub> antagonism and antipsychotic effects. The intention of a number of PET investigations was to retrospectively find biological markers of the disease as well as to optimize dosing and characterize the mode of action. Early PET studies of dopamine receptors used rather nonspecific radiotracers of moderate affinity, thus revealing only the abundant receptors in striatum. Data of several investigations were equivocal; overall, there is evidence for a 10–15% increase in striatal D<sub>2/3</sub> receptor availability in patients with schizophrenia.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> Concerning extrastriatal regions, some studies showed decreased D<sub>2/3</sub> receptor binding, whereas others suggested an increase.<a onclick="showRef(event, 'ref107 ref108 ref109 ref110'); return false;" href="javascript:void(0);" class="ref ref107 ref108 ref109 ref110">(107-110)</a> These incongruent results may be due to group differences in duration of disease, drug-free interval, and predominant symptomatology. Importantly, the results suggest that any increase in receptor availability is less related to symptom severity but seems highest at the beginning of the pathology. Thus, increased striatal D<sub>2/3</sub> receptor availability in the striatum may well occur in prodromal states. Taken together, postsynaptic D<sub>2/3</sub> receptor imaging has not proven to be as informative as [<sup>18</sup>F]FDOPA with regard to the mechanisms of psychosis.</div><div class="NLM_p">Interestingly, receptor imaging has had considerable impact on drug dosing and has yielded knowledge about drug action. Besides characterizing the target structure of APs, an early application was to define the clinically most appropriate concentration of APs, which has long been an issue in psychiatry. After discovering the crucial mechanism of D<sub>2/3</sub> anatgonism, researchers have endeavored to develop substances of very high affinity and comparatively high selectivity for D<sub>2/3</sub> receptors. Well-known agents like haloperidol, benperidol, or fluphenazine were launched and remain in clinical use. Some decades ago, it was believed that very high occupancies at D<sub>2/3</sub> receptors were desirable, albeit with the risk of evoking side effects. For a time, EPMS were regarded to be inseparable from antipsychotic efficacy.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p">In the late 1980s, radiolabeled spiperone derivatives were introduced (e.g., [<sup>76</sup>Br]bromospiperone;<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Cambon et al.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a>) for the detection of D<sub>2</sub>-like receptors in the brain of patients under antipsychotic medication. By the use of graphical analytical methods, under approximately equilibrium conditions, the specific binding could be estimated.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Receptor availability in vivo depends on the target receptor concentration, the ligand’s affinity, and upon competition from endogenous and exogenous ligands. Consequently, AP-evoked reductions in <i>BP</i> depict the concentration of the drug in the brain. Intraindividual (baseline vs AP-challenge or AP-treated vs drug-withdrawal) or intergroup comparisons (untreated vs treated subjects) then enabled the calculation of CNS receptor occupancies. Initial PET investigations in large groups of naturalistically treated patients with schizophrenia demonstrated a broad range of D<sub>2/3</sub> receptor occupancies, e.g., Baron et al. showed 5–72% occupancy.<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> Unfortunately, these early investigations suffered from highly diverse disease spectra (schizophrenia, dementia, alcohol hallucinations, etc.), nonselective radiotracers, and missing drug plasma concentrations.</div><div class="NLM_p">A very important improvement was the radiolabeling of substituted benzamides. The most important of these remains [<sup>11</sup>C]raclopride, which possesses moderate affinity and high selectivity at D<sub>2/3</sub> receptors.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> Using this radiotracer, Farde and co-workers<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> as well as Nordström and co-workers<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> published some of the most influential clinical PET studies. Patients suffering from schizophrenia and receiving effective antipsychotic treatment showed 65–85% D<sub>2/3</sub> receptor occupancy in the striatum (extrastriatal receptors can scarcely be detected with [<sup>11</sup>C]raclopride). Exceeding the threshold of 80% occupancy dramatically increases the risk for EPMS such as dystonia, akathisia, and parkinsonism.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Thus, there appeared to be a range of receptor occupancy providing clinical efficacy at least against so-called positive symptoms, with lesser risk of EPMS. Discovery of this 65–80% range caused a tremendous rethinking of AP treatment regimens and gave further inspiration to later drug development. In a patient sample of Farde and co-workers, most of those agents causing lesser or no EPMS at their clinically effective daily dose were described as atypical, in contrast to typicals such as haloperidol.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> In particular, clozapine and thioridazine were unlikely to EPMS. Clozapine showed clinically effective striatal receptor occupancies in a range of only 38 to 63%, i.e., less than the 65% threshold. Thioridazine, in contrast, showed comparatively high occupancies of 74–81%.</div><div class="NLM_p">R&D focused on attempts to produce effective APs with less EPMS. For development of suitable agents, it was necessary to understand whether the absence of EPMS is simply a question of correct dosage or depends on additional (non-dopaminergic) properties of the drug. Investigations addressed these questions by dual-tracer investigations, entailing high-affinity radiotracers, along with improved analytical approaches. Early studies of non-D<sub>2/3</sub> receptor binding showed antagonism at M1-cholinergic receptors to be an effective mechanism to reduce EPMS.<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> Both thioridazine and clozapine (which were first described to exert atypical properties) show this anticholinergic receptor profile which, unfortunately, causes its own adverse effects. On the basis of the work of Meltzer and co-workers,<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> antagonism at the 5-HT<sub>2A</sub> receptor was also detected for some APs. Dual-tracer PET studies using standard 5-HT<sub>2A</sub> as well as D<sub>2</sub> receptor radiotracers showed in fact a comparably high relative occupancy at the former target for a variety of second-generation APs at doses producing the before above-mentioned 65–80% D<sub>2/3</sub> receptor therapeutic window. The extent of 5-HT<sub>2A</sub> occupancy was shown to consistently exceed 80% for risperidone, olanzapine, and ziprasidone in the clinically effective dose range.<a onclick="showRef(event, 'ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref123 ref124 ref125">(123-125)</a> The dual-tracer approach remains invaluable for characterizing new drugs.</div><div class="NLM_p">Thus, PET studies have taught drug developers to design D<sub>2</sub> antagonists that should show only a modest slope of dose/binding curves for striatal D<sub>2</sub> receptors and/or provide a extensive 5HT<sub>2A</sub> binding at doses evoking 65–80% D<sub>2/3</sub> occupancy. For example, this approach served for evaluation of the recently launched AP lurasidone: Nakazawa and co-workers showed that this compound attained lesser 5-HT<sub>2A</sub> occupancy than did olanzapine, as revealed with the highly selective radiotracer [<sup>11</sup>C]volinanserin.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a> Clinical dose findings for this compound was also performed with [<sup>11</sup>C]raclopride PET, revealing that more than 40 mg is necessary to provide effective D<sub>2/3</sub> receptor occupancies.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> Another PET investigation of lurasidone in a large group of schizophrenia patients, however, showed that daily doses only modestly correlate with receptor occupancies, which were, however, predicted by plasma levels of the compound, along with its active metabolites.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> It is well-known in therapeutic drug monitoring (TDM) that daily doses may fail to reliably predict plasma levels, clinical response, or side effects.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> PET investigations, however, also uncovered that some agents, notably the AP quetiapine, fail to even reveal plasma concentration vs occupancy relationships, which calls into question the validity of simple daily dose suggestions for this compound.<a onclick="showRef(event, 'ref130 ref131'); return false;" href="javascript:void(0);" class="ref ref130 ref131">(130, 131)</a> For lurasidone, however, PET studies revealed that TDM is highly suitable. The case of lurasidone also made evident that drug characterization is not always completed during drug development. Despite the existence of suitable ligands, interesting questions regarding lurasidone’s clinical binding properties at 5-HT<sub>1A</sub> as well as the promising target 5-HT<sub>7</sub> remain unanswered, although in vitro affinity predicts occupancy at these sites.<a onclick="showRef(event, 'ref132 ref133'); return false;" href="javascript:void(0);" class="ref ref132 ref133">(132, 133)</a> Emerging knowledge about the entire in vivo properties at central nervous receptors, however, is necessary in order to better predict clinical effects in the future.</div><div class="NLM_p">A suitable AP efficacy-to-EPMS ratio does not necessarily depend on multireceptor binding profiles. For example, sulpiride, a substituted benzamide, was early considered to possess atypical action and was used as an antidepressant.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> The PET study noted above revealed it to have 78% D<sub>2/3</sub> receptor occupancy.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Amisulpride, another substituted benzamide, which assumed a greater popularity, was much better evaluated by D<sub>2/3</sub> receptor PET and the use of high-affinity ligands.<a onclick="showRef(event, 'ref135 ref136'); return false;" href="javascript:void(0);" class="ref ref135 ref136">(135, 136)</a> These investigations were of notable interest since amisulpride shares atypical properties but, paradoxically, acts only at D<sub>2/3</sub> receptors; thus, it does not depend on any 5-HT<sub>2A</sub> or M<sub>1</sub> antagonism (possible 5-HT<sub>7</sub> antagonism remains to be established<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a>). PET studies revealed that two different mechanisms might contribute to this property. Mainly based on the moderate affinity of amisulpride at the target receptors, the striatal plasma concentration vs occupancy curve in the striatum was less steep in comparison to that of high-affinity drugs.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> When including data from high-affinity ligands, it became apparent that the corresponding curves in striatal and extrastriatal curves were not identical: in extrastriatal regions, the occupancy was very high at lower doses when striatal occupancies were still rather low. These so-called preferential binding properties<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> were and are still a matter of controversy discussion, since some authors claim this effect to be an experimental artifact, attributable to partial volume effects or other factors such as specific binding in the reference region. Nevertheless, several different research groups reported comparable extrastriatal binding properties for many second-generation antipsychotics.<a onclick="showRef(event, 'ref135 ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref135 ref138 ref139">(135, 138, 139)</a> In particular for amisuplride, ziprasidone, quetiapine, and clozapine, profound occupancy differences between the regions were detected. The highest differences were found for clozapine, which was early found to bind only moderately to D<sub>2/3</sub> sites in the striatum.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Nevertheless, it showed much higher (>20%) occupancies in extrastriatal regions (i.e., thalamus and cortex). Although failing to reach the crucial 65% threshold in striatum, this threshold was readily attained in the temporal cortex and the medial thalamus. Similar results were obtained for quetiapine, which may lead to questioning the unique importance of striatal occupancy for AP action. Using the high-affinity ligand [<sup>18</sup>F]fallypride,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> a broad sample of second-generation antipsychotics have been investigated using comparable analytical techniques. Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a> juxtaposes the occupancy curves with the agent’s affinity at the D<sub>2</sub> receptor. Apparently, the preferential extrastriatal binding effect is associated with lower affinities, suggesting that it might arise from regional differences in competition from endogenous dopamine. In association with the naturally less steep increase of receptor binding for low-affinity ligands, a moderate-to-low affinity at D<sub>2/3</sub> sites appears to be a relevant factor for atypicality, even in the absence of additional receptor binding properties. PET studies show that moderate affinity APs attain the 65–80% occupancy window for a broad range of plasma concentrations, whereas high-affinity agents usually provide only a narrow range, difficult to attain in individual patients.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Association between steepness of D<sub>2</sub> receptor binding characteristics as well as preferential extrastriatal binding with respect to the drug’s affinity at D<sub>2</sub> receptors. Occupancy curves for striatum (blue) and temporal cortex (red) are illustrated for three antipsychotics: clozapine<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> (low affinity), amisulpride<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> (moderate affinity), and aripiprazole<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> (high affinity) using [<sup>18</sup>F]fallypride. The green bar depicts the desired 60–80% occupancy range.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Meanwhile, another mechanism to avoid EPMS was developed; aripiprazole is an antipsychotic with partial agonist properties approximately 30% that of dopamine at the D<sub>2/3</sub> receptor.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> In this case, AP efficacy is obtained at nearly complete receptor occupancy. Again, PET helped to provide important information about reasonable drug concentrations for aripiprazole.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a> displays the steep course of the occupancy curve, such that concentrations exceeding 100 ng/mL are very likely to cause more than 80% occupancy. This is nearly guaranteed to occur at daily doses of 15 mg or more. But daily doses below 10 mg generally achieve only low occupancies. These conclusions based on PET data are in full accordance with the results of clinical trials.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Another important issue of this study is that striatal as well as extrastriatal curves are fully congruent in their course, providing evidence that preferential extrastriatal binding for many other APs are not in fact due to some analytical artifact. The absence of this effect in aripiprazole and its all-or-none binding properties can be explained by its high affinity at the D<sub>2</sub> receptor, which exceeds that for every other second-generation antipsychotic in clinical use.</div><div class="NLM_p">Another important question posed in PET investigations concerns the possible correlation between occupancy levels and clinical treatment effects. Because of necessarily low group sizes in PET studies, clarification of this question is generally limited by insufficient statistical power. In fact, a highly esteemed work of Agid and co-workers mentioned positive associations between clinical improvement in positive symptoms and D<sub>2/3</sub> receptor occupancy in striatal but not extrastriatal regions.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> However, the majority of PET occupancy investigations do not mention such associations. Given that most research groups perform clinical characterization of psychopathology and treatment effects, the absence of sufficient replication studies questions this association. In general, PET investigations rather suggest a threshold effect in accordance to the pioneering investigations of Farde and co-workers, noted above.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a></div><div class="NLM_p">Most of the recent PET investigations in the field of AP development focused on dose finding as well as the optimization of antipsychotic vs side effect ratios. However, two problems in AP treatment remain unsolved. First, APs are effective only against productive positive symptoms, whereas cognitive as well as negative impairments are only modestly responsive to these compounds. The second and even more critical point is the fact that at least 40% of patients suffering from schizophrenia do not sufficiently respond to antipsychotics, even with respect to positive symptoms. Several decades on, clozapine remains the only tool for treatment resistance, with the penalty of the side effects and complications that are associated with its application. Unfortunately, many patients also fail to respond to clozapine. Until now, little has been known about the factors responsible for treatment resistance. Nevertheless, only few investigations have focused on this phenomenon. PET investigations (in particular, using presynaptic radiotracers as well as multitracer characterizations) would be very helpful in the future for the stratification of treatment-resistant patients and could inform new strategies to treat these subjects.</div><div class="NLM_p last">Returning to our theme of the principles of R&D, D<sub>2/3</sub> receptor PET could highly contribute to dose finding and the proof of mechanism; a major problem has been that these investigations were mainly done retrospectively, i.e., at times after the drug was already launched. A much earlier integration in R&D is demanded to widen its relevance also for proof of concept investigations. This early integration has been attempted in the development of drugs that focus on the glutamate system rather than on the dopamine transmission.</div></div><div id="sec7_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> PET Studies on the Glutamate System in Schizophrenia</h3><div class="NLM_p">The improvement of negative symptoms as well as cognitive impairments is a focus of recent R&D. The original dopamine hypothesis of schizophrenia was soon expanded by hypotheses that might explain the excess of dopamine transmission in the limbic system.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> On the basis of functional (e.g., fMRI, CBF, and 2-[<sup>18</sup>F]FDG PET) studies<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> in schizophrenia, it was proposed that prefrontal hypofunction might cause a disbalanced cortico–striatal feedback, in turn causing impaired mesocortical but increased mesolimbic dopamine transmission. The latter mechanism might contribute to positive symptoms, whereas the downregulated mesocortical transmission might further impair cognitive functions and activity.<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> This hypothesis is supported by the good face-validity of experimental psychoses caused by glutamatergic NMDA receptor antagonists neglecting the critical construct validity that psychoses caused by these agents cannot be reversed by D<sub>2/3</sub> antagonists.<a onclick="showRef(event, 'ref148 ref149'); return false;" href="javascript:void(0);" class="ref ref148 ref149">(148, 149)</a> Although microanatomical investigations have failed to report consistent deficiencies in the NMDA receptor system of patients, a series of clinical investigations in the last decades supported the influence of the glutamate system in the pathophysiology of schizophrenia. There is a tight interplay of dopamine signaling and NMDA-mediated signal transduction directly at cortical pyramidal cells or mediated by GABAergic interneurons. Excessive direct activation of the NMDA receptor, however, causes neurotoxic effects. Modulation of NMDA receptors is mediated by glycine, which is an essential coagonist for the opening of the NMDA receptor channel. Glycine levels at the NMDA receptor are regulated via the glycine transporter type-1 (GlyT1). Thus, antagonists of this transporter should result in an activation of NMDA receptors; GlyT1 is thus a promising biological target for the treatment of schizophrenia. In fact, pioneering work of Heresco-Levy beginning in the 1980s showed marked improvements in the negative symptoms (approximately 15%) and cognition in schizophrenia by administration of glycine or the agonists <span class="smallcaps smallerCapital">d</span>-cycloserine or <span class="smallcaps smallerCapital">d</span>-alanine.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> The clinical use of this approach, however, was clearly limited by the poor blood–brain permeability of these agents. The next step was then to increase glycine in the CNS by inhibition of GlyT. This approach was very early accompanied by the development of suitable GlyT1 radiotracers [<sup>11</sup>C]GSK931145<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> and [<sup>18</sup>F]MK-6577,<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> which have potential for occupancy investigations, cf. Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a>. Both tracers showed high brain uptake and a displaceable distribution pattern that matched the known GlyT1 expression in brain. Very recent animal data yielded the astonishing result that the glycine transporter need only be blocked to a limited extent, whereas higher occupancies cause an inverse effect. For the GlyT1-anatgonist bitopertin,<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> for example, the range of effective GlyT1 binding was between 10 and 30%. Eddins and co-workers reported that this range of occupancies evoked significant improvement in a model of schizophrenia negative symptoms, scopolamine-induced impairments of object retrieval.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of bitopertin and the <sup>11</sup>C- and <sup>18</sup>F-labeled PET tracers [<sup>11</sup>C]GSK931145 and [<sup>18</sup>F]MK-6577 for visualization of GlyT1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Concerning the human GlyT1 transporter, PET has already been used to establish reliable concentration–occupancy relationships.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Although some phase III studies had difficulties in showing the effectiveness of the new compounds against the primary end-point parameters, the development of glycine transporter antagonists is an encouraging example of the implementation of PET in R&D of neuropsychiatric disorders.</div><div class="NLM_p">Finally, second messenger systems are a focus on new strategies in R&D. In particular, the degradation of cyclic adenosine/guanosine monophosphate (cAMP/cGMP) by phosphodiesterase (PDE) isoenzymes is an emerging topic in psychiatry in recent years. Within this superfamily of 11 isoenzyme families consisting of even more splice variants, in particular, PDE2a, PDE4, PDE5, and PDE10 are of interest for pharmacological interventions. Blockade of PDE may result in increased cAMP and cGMP levels, an effect that is comparable to the result of D<sub>2</sub> receptor blockade. However, not only has the theoretical background encouraged further target development but also disturbed PDE regulation in mental disorders and effects on animal models of cognition and antipsychotic effects have been reported.<a onclick="showRef(event, 'ref156 ref157'); return false;" href="javascript:void(0);" class="ref ref156 ref157">(156, 157)</a> In order to provide suitable tools for in vivo target evaluation and candidate characterization, PET could be helpful, as mentioned before. In fact, for the development of PDE10 antagonists, the development of PDE10 ligands parallels the early phases of candidate evaluation. The evaluation of the specific PDE10 ligand [<sup>18</sup>F]JNJ42259152 (2-((4-(1-(2-[<sup>18</sup>F]fluoroethyl)-4-(pyridin-4-yl)-1<i>H</i>-pyrazol-3-yl)phenoxy)methyl)-3,5-dimethylpyridine)<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> was originally warranted by the therapeutic impact of this second messenger system.<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a></div><div class="NLM_p last">Looking back at the history and status of R&D focusing on APs, the impact of PET as well as a shift in its use over the years becomes apparent. Initially, PET focused on the empirically defined target of well-established agents. Later, available drugs were better characterized by PET not only in their therapeutic effects but also in their dose/effect relationship. Today, PET is an accepted tool for drug development. Although frequently not implemented in very early phases of R&D, it contributes to identifying targets and rational dose finding.</div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Strategies, New Progress, and New Challenges</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66656" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66656" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Because most of PET tracer development is still done in academic facilities, which often lack the capacity for complete lead optimization, the development of radiotracers for new biological targets usually depends on the availability of suitable lead compounds. Hence, while, for some CNS systems, a broader array of suitable radiotracers exists (e.g., dopamine, serotonin), for others they are still missing (NMDA, GABA). Furthermore, the development of new radiotracers is also influenced by the current paradigms and research hypotheses of those science departments, which finally apply them in PET studies, e.g., nuclear medicine, psychiatry, and others. Thus, the crucial question of whether to improve the properties of radiotracers for known targets or to develop radiotracers for new biological targets cannot be answered by the radiopharmaceutical chemist alone.</div><div class="NLM_p">However, there is no doubt that molecular imaging with PET tracers can have a significant, even decisive, impact on R&D of new drug candidates. While there remain some problems related to its more widespread use, there has been great progress.</div><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Chemical Aspects</h3><div id="sec8_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> Isotopic Tracers I</h4><div class="NLM_p last">The resynthesis of a certain drug candidate yielding the identical yet <sup>11</sup>C-containing molecule, in general, demands an appropriate, i.e., efficient and fast, <sup>11</sup>C-radiopharmaceutical chemistry. Although impressive progress has been made here over the last 2 decades, important new developments are ongoing. Issues still awaiting substantial progress include finding a useable route to introduce <sup>11</sup>C directly into the structure of an aromatic ring.<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a></div></div><div id="sec8_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> Isotopic Tracers II</h4><div class="NLM_p last">Because of the logistic advantages of <sup>18</sup>F vs <sup>11</sup>C, <sup>18</sup>F-labeled isotopic tracers would be an ideal option for cases when the drug candidate already contains fluorine in its structure. Interestingly, there has been a growing tendency toward a more frequent use of fluorine as an inherent constituent of drug candidates. Nevertheless, in many cases, the introduction of <sup>18</sup>F into the labeling precursor requires sophisticated radiopharmaceutical chemistry. A key challenge here concerns nucleophilic substitutions in weakly activated aromatic rings, which was recently addressed by Ritter and co-workers.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a></div></div></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> Tracers as Lead Structures</h3><div class="NLM_p last">The systematic development of <sup>11</sup>C- and <sup>18</sup>F-labeled tracers for basic neuroscience research as well as for patient diagnoses has provided an impressive number of high-affinity and highly specific PET tracers targeting a variety of brain neuroreceptors and their many subtypes. These well-studied tracers can serve as a database for the development of new drug candidates, constituting a drug surrogate, at a given target. The many tracers already available to characterize dopaminergic neurotransmission present an excellent example. Radiopharmaceutical chemistry research strives to develop adequate radiotracers for a broader range of neurotransmitter systems. In parallel, <sup>11</sup>C- and <sup>18</sup>F-labeled tracers have become available for other targets in the brain, such as amyloid plaques or neurofibrillary tangles. Hence, drug candidates aiming at newer biological targets may easily benefit from the exisiting database of diagnostic PET tracers.</div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> Clinical Aspects</h3><div class="NLM_p last">The implementation of PET in clinical drug development is highly advanced with respect to dose-finding studies. Whereas this indication was previously performed rather retrospectively, it now frequently accompanies the R&D plan. Furthermore, the proof of biology, i.e., studies investigating the mechanisms of diseases, is now an emerging field in drug development, which rather indirectly supports R&D strategies. However, PET still needs to be better integrated in the developmental process at an early phase, using a choice of radiotracers well-suited to the target or treatment effect. Another important demand is the establishment of patient stratification studies using PET, aiming to identify biologically defined subgroups showing different pathophysiology or treatment response. Such strategies are expensive, considering the costs of large-scale PET studies in patients, and will depend on a close collaboration and interrelation among clinicians, chemists, and pharmacists.</div></div><div id="sec8_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Logistic/Financial Aspects</h3><div class="NLM_p">Despite promising developments in radiopharmaceutical chemistry, there are new challenges. The use of radioactive probes in, for example, clinical trials must strictly follow the many regulations in drug development and application. The synthesis of PET tracers for human application is subject to the same laws, and the need to follow GMP regulations brings serious challenges to the radiopharmacy.</div><div class="NLM_p last">Finally, the synthesis of PET tracers is by no means cheap. Costs include the radionuclide production in cyclotrons such as <sup>11</sup>C and <sup>18</sup>F and the subsequent preparative and analytical chemistry. Pharmaceutical companies have balked at the enormous investment for establishing cyclotron and radiochemistry laboratories, typically preferring to undertake contract research at academic centers that already possess the necessary technical expertise and infrastructure.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm5001858" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45682" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45682" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Piel</span> - <span class="hlFld-Affiliation affiliation">Institute
of Nuclear Chemistry, Johannes Gutenberg-University, Fritz-Strassmann-Weg 2, D-55128 Mainz, Germany</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#06766f636a4673686f2b6b676f687c286263"><span class="__cf_email__" data-cfemail="62120b070e22170c0b4f0f030b0c184c0607">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingo Vernaleken</span> - <span class="hlFld-Affiliation affiliation">Department
of Psychiatry, Psychotherapy, and Psychosomatics, RWTH Aachen University, Pauwelsstraße 30, D-52074 Aachen, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Rösch</span> - <span class="hlFld-Affiliation affiliation">Institute
of Nuclear Chemistry, Johannes Gutenberg-University, Fritz-Strassmann-Weg 2, D-55128 Mainz, Germany</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63323" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63323" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Markus Piel</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=BIO-d3895e2808-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Markus Piel</b> was born in Wiesbaden, Germany, in 1968. He studied chemistry at the Johannes Gutenberg-University (JGU) in Mainz and graduated in 1997. He received his Ph.D. in Nuclear Chemistry in 2001 at the JGU on the synthesis and evaluation of <sup>18</sup>F-fluorinated NMDA antagonists. Currently, he is Senior Research Associate at the Institute of Nuclear Chemistry at the JGU, working on a wide variety of projects using different radioisotopes for labeling, with a focus on <sup>18</sup>F and *I. Since 2004, he is also Qualified Person and Head of the Quality control at the Institute of Nuclear Chemistry. His scientific research interests include the synthesis and evaluation of tracers for the CNS, μPET imaging in rodent models, and the development of new radiolabeling strategies.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Ingo Vernaleken</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=BIO-d3895e2819-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ingo Vernaleken</b> was born in Bad Pyrmont, Germany (1970). He studied human medicine at the University of Saarland (graduated in 1998). He obtained his medical degree in 2000 at the Institute of Pharmacology and Toxicology in Homburg-Saar. His clinical engagement began in the Department of Psychiatry at the University of Mainz. Early in his medical career, he became involved in translational PET studies. In 2005, he became a senior physician to the Department of Psychiatry and Psychotherapy at the RWTH Aachen University, Germany. From 2009 to 2010, he served as Professor at JARA-Brain (Jülich/Aachen, Germany). In 2010, he accepted a professorship in Experimental Psychopathology at the RWTH Aachen, Germany. His scientific work is focused on PET studies of antipsychotic treatment strategies, schizophrenia, addiction, and behavioral control.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Frank Rösch</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=BIO-d3895e2824-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Frank Rösch</b> was born in Chemnitz, Germany, in 1955. He studied nuclear and radiochemistry at the Technical University Dresden, graduated in 1981, and obtained his Ph.D. in 1984. Subsequently, he had fellowships at the Laboratory for Nuclear Problems, Dubna, Sowjet Union, at the ZfK Rossendorf, Dresden, Germany, and, since 1992, at the Research Centre Jülich, Germany. In 1996, he was appointed Professor of Nuclear Chemistry at the Institute of Nuclear Chemistry at the Johannes Gutenberg-University Mainz, Germany. He is carrying out research in fundamental and applied radiochemistry and radiopharmaceutical chemistry. Apart from molecular imaging of the human brain, he also has an interest in radiometals and radionuclide generators and their application in the synthesis and clinical use of new radiotracers in the context of theranostics.</p></figure></div><div class="ack" id="ACK-d3895e2829-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81158" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81158" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We are very grateful to Bradley Waldron for constructive comments and for proofreading this Perspective, and we note professional revisions by Inglewood Biomedical Editing. We thank Benedikt Sandhöfer for his assistance in preparing some of the figures.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i48" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i48"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i49" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i49"> Abbreviations Used</h2><tr><td class="NLM_term">2-[<sup>18</sup>F]FDG</td><td class="NLM_def"><p class="first last">2-deoxy-2-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">d</span>-glucose</p></td></tr><tr><td class="NLM_term">AADC</td><td class="NLM_def"><p class="first last">aromatic amino acid decarboxylase, AP, antipsychotic</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood–brain barrier</p></td></tr><tr><td class="NLM_term"><i>BP</i><sub><i>ND</i></sub></td><td class="NLM_def"><p class="first last">nondisplaceable binding potential</p></td></tr><tr><td class="NLM_term">CGRP-R</td><td class="NLM_def"><p class="first last">calcitonin gene-related peptide receptor</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CT</td><td class="NLM_def"><p class="first last">computed tomography</p></td></tr><tr><td class="NLM_term">EPMS</td><td class="NLM_def"><p class="first last">extrapyramidal motor side effects</p></td></tr><tr><td class="NLM_term">[<sup>18</sup>F]FDOPA</td><td class="NLM_def"><p class="first last">6-[<sup>18</sup>F]fluoro-<span class="smallcaps smallerCapital">l</span>-dopa</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">food and drug administration</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">GLUT</td><td class="NLM_def"><p class="first last">glucose transporter</p></td></tr><tr><td class="NLM_term">GlyT1</td><td class="NLM_def"><p class="first last">glycine transporter type 1</p></td></tr><tr><td class="NLM_term">GMP</td><td class="NLM_def"><p class="first last">good manufacturing practice</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">MAO-A</td><td class="NLM_def"><p class="first last">monoamine oxidase A</p></td></tr><tr><td class="NLM_term">MRI</td><td class="NLM_def"><p class="first last">magnetic resonance imaging</p></td></tr><tr><td class="NLM_term">NK1</td><td class="NLM_def"><p class="first last">neurokinin 1-receptor</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">R&D</td><td class="NLM_def"><p class="first last">research and development</p></td></tr><tr><td class="NLM_term">SGA</td><td class="NLM_def"><p class="first last">second-generation antipsychotics</p></td></tr><tr><td class="NLM_term">SPECT</td><td class="NLM_def"><p class="first last">single-photon emission computed tomography</p></td></tr><tr><td class="NLM_term">VTA</td><td class="NLM_def"><p class="first last">ventral tegmental area</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88114" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88114" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 161 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Phelps, M. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography provides molecular imaging of biological processes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">9226</span><span class="NLM_x">–</span> <span class="NLM_lpage">9233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1073%2Fpnas.97.16.9226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10922074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12ksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9226-9233&author=M.+E.+Phelps&title=Positron+emission+tomography+provides+molecular+imaging+of+biological+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography provides molecular imaging of biological processes</span></div><div class="casAuthors">Phelps, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">9226-9233</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review with 55 refs.  Diseases are biol. processes, and mol. imaging with positron emission tomog. (PET) is sensitive to and informative of these processes.  This is illustrated by detection of biol. abnormalities in neurol. disorders with no computed tomog. or MRI anat. changes, as well as even before symptoms are expressed.  PET whole body imaging in cancer provides the means to (i) identify early disease, (ii) differentiate benign from malignant lesions, (iii) examine all organs for metastases, and (iv) det. therapeutic effectiveness.  Diagnostic accuracy of PET is 8-43% higher than conventional procedures and changes treatment in 20-40% of the patients, depending on the clin. question, in lung and colorectal cancers, melanoma, and lymphoma, with similar findings in breast, ovarian, head and neck, and renal cancers.  A microPET scanner for mice, in concert with human PET systems, provides a novel technol. for mol. imaging assays of metab. and signal transduction to gene expression, from mice to patients: e.g., PET reporter gene assays are used to trace the location and temporal level of expression of therapeutic and endogenous genes.  PET probes and drugs are being developed together-in low mass amts., as mol. imaging probes to image the function of targets without disturbing them, and in mass amts. to modify the target's function as a drug.  Mol. imaging by PET, optical technologies, magnetic resonance imaging, single photon emission tomog., and other technologies are assisting in moving research findings from in vitro biol. to in vivo integrative mammalian biol. of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmqGEDEVXsm7Vg90H21EOLACvtfcHk0liiB21L3O0XJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12ksb8%253D&md5=626fe877fe63468137626fd9f3744558</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.16.9226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.16.9226%26sid%3Dliteratum%253Aachs%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520provides%2520molecular%2520imaging%2520of%2520biological%2520processes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D9226%26epage%3D9233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Rahmim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, H.</span><span> </span><span class="NLM_article-title">PET versus SPECT: strengths, limitations and challenges</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2FMNM.0b013e3282f3a515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=18349789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ptFSqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=193-207&author=A.+Rahmimauthor=H.+Zaidi&title=PET+versus+SPECT%3A+strengths%2C+limitations+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PET versus SPECT: strengths, limitations and challenges</span></div><div class="casAuthors">Rahmim Arman; Zaidi Habib</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-207</span>
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    </div><div class="casAbstract">The recent introduction of high-resolution molecular imaging technology is considered by many experts as a major breakthrough that will potentially lead to a revolutionary paradigm shift in health care and revolutionize clinical practice.  This paper intends to balance the capabilities of the two major molecular imaging modalities used in nuclear medicine, namely positron emission tomography (PET) and single photon emission computed tomography (SPECT).  The motivations are many-fold: (1) to gain a better understanding of the strengths and limitations of the two imaging modalities in the context of recent and ongoing developments in hardware and software design; (2) to emphasize that certain issues, historically and commonly thought as limitations of one technology, may now instead be viewed as challenges that can be addressed; (3) to point out that current state of the art PET and SPECT scanners can (greatly) benefit from improvements in innovative image reconstruction algorithms; and (4) to identify important areas of research in PET and SPECT imaging that will be instrumental to further improvements in the two modalities.  Both technologies are poised to advance molecular imaging and have a direct impact on clinical and research practice to influence the future of molecular medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSduSpNz8K1GresJRIHUP1ofW6udTcc2eYAj94zVrErKrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ptFSqsA%253D%253D&md5=514250c2c02cbf69bb9a73b2c068aae3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2FMNM.0b013e3282f3a515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNM.0b013e3282f3a515%26sid%3Dliteratum%253Aachs%26aulast%3DRahmim%26aufirst%3DA.%26aulast%3DZaidi%26aufirst%3DH.%26atitle%3DPET%2520versus%2520SPECT%253A%2520strengths%252C%2520limitations%2520and%2520challenges%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2008%26volume%3D29%26spage%3D193%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Qaim, S. M.</span><span> </span><span class="NLM_article-title">Cyclotron production of medical radionuclides</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1903</span><span class="NLM_x">–</span> <span class="NLM_lpage">1933</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-4419-0720-2_39" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1903-1933&author=S.+M.+Qaimauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0720-2_39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-0720-2_39%26sid%3Dliteratum%253Aachs%26aulast%3DQaim%26aufirst%3DS.%2BM.%26atitle%3DCyclotron%2520production%2520of%2520medical%2520radionuclides%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011%26spage%3D1903%26epage%3D1933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span>PET Drugs—Current Good  Manufacturing Practice (CGMP); <span class="NLM_publisher-name">U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM266640.pdf" class="extLink">http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM266640.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PET+Drugs%E2%80%94Current+Good+Manufacturing+Practice+%28CGMP%29%3B+U.S.+Department+of+Health+and+Human+Services%2C+Food+and+Drug+Administration%2C+Center+for+Drug+Evaluation+and+Research%3A+Silver+Spring%2C+MD%2C+2011%3B+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FDrugs%2FGuidanceComplianceRegulatoryInformation%2FGuidances%2FUCM266640.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DPET%2520Drugs%25E2%2580%2594Current%2520Good%2520%2520Manufacturing%2520Practice%2520%2528CGMP%2529%26pub%3DU.S.%2520Department%2520of%2520Health%2520and%2520Human%2520Services%252C%2520Food%2520and%2520Drug%2520Administration%252C%2520Center%2520for%2520Drug%2520Evaluation%2520and%2520Research%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Norenberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanBrocklin, H.</span><span> </span><span class="NLM_article-title">FDA cGMP requirements for PET drugs</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">16N</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=16N&author=J.+P.+Norenbergauthor=S.+Schwarzauthor=H.+VanBrocklin&title=FDA+cGMP+requirements+for+PET+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorenberg%26aufirst%3DJ.%2BP.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DVanBrocklin%26aufirst%3DH.%26atitle%3DFDA%2520cGMP%2520requirements%2520for%2520PET%2520drugs%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D16N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Ache, H. J.</span><span> </span><span class="NLM_article-title">Chemistry of the positron and of positronium</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=179-199&author=H.+J.+Ache&title=Chemistry+of+the+positron+and+of+positronium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAche%26aufirst%3DH.%2BJ.%26atitle%3DChemistry%2520of%2520the%2520positron%2520and%2520of%2520positronium%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1972%26volume%3D11%26spage%3D179%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Watabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, H.</span><span> </span><span class="NLM_article-title">Performance of list mode data acquisition with ECAT EXACT HR and ECAT EXACT HR positron emission scanners</span> <span class="citation_source-journal">Ann. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2FBF03027429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16715949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD283os1Cqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=189-194&author=H.+Watabeauthor=K.+Matsumotoauthor=M.+Sendaauthor=H.+Iida&title=Performance+of+list+mode+data+acquisition+with+ECAT+EXACT+HR+and+ECAT+EXACT+HR+positron+emission+scanners"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Performance of list mode data acquisition with ECAT EXACT HR and ECAT EXACT HR+ positron emission scanners</span></div><div class="casAuthors">Watabe Hiroshi; Matsumoto Keiichi; Senda Michio; Iida Hidehiro</div><div class="citationInfo"><span class="NLM_cas:title">Annals of nuclear medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-94</span>
        ISSN:<span class="NLM_cas:issn">0914-7187</span>.
    </div><div class="casAbstract">Recently, list mode (event-by-event) data acquisition with positron emission tomography (PET) has been widely noticed because list mode acquisition is superior to conventional frame mode data acquisition in terms of (1) higher efficiency of data storage, (2) higher temporal resolution, and (3) higher flexibility of data manipulation.  The aim of this study is to investigate the performance of list mode data acquisition with ECAT EXACT HR and HR+ PET scanners (CTI PET Systems) and its feasibility in clinical applications.  A cylindrical phantom (16 cm in diameter and length) filled with a 11C solution for the HR and a 15O solution for the HR+ was scanned several times by varying the radioactivity concentration with the list mode and frame mode acquisitions.  The scans were also carried out with a septa (2D mode) and without a septa (3D mode) in order to evaluate the effect of the interplane septa on the quality of the list mode data.  The acquired list mode data were sorted into a sinogram and reconstructed using a filtered back-projection algorithm.  The count rate performance of the list mode data was comparable to that of the frame mode data.  However, the list mode acquisition could not be performed when the radioactivity concentration in the field-of-view was high (exceeding 24 kBq/ml for the 3D mode) due to a lack of sufficient transfer speed for sending data from the memory to hard disk.  In order to estimate the pixel noise in a reconstructed image, ten replicated data sets were generated from one list mode data.  The reconstructed images with the 3D mode had a signal-to-noise ratio that was more than 60% better than that of the image with the 2D mode.  The file size of the generated list mode data was also evaluated.  In the case of ECAT EXACT HR+ with the 3D list mode, the list mode data with a generated file size of 2.31 Mbytes/ s were generated for 37 MBq injections.  Our results suggest that careful attention must be paid to the protocol of the list mode data acquisition in order to obtain the highest performance of the PET scanner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_-rk2FbzBdFVwdslNBF-tfW6udTcc2ebF2D9qKGfs6Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283os1Cqsg%253D%253D&md5=62c3e6bc6e8675dc93d99ed3c54a2a2f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2FBF03027429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03027429%26sid%3Dliteratum%253Aachs%26aulast%3DWatabe%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DSenda%26aufirst%3DM.%26aulast%3DIida%26aufirst%3DH.%26atitle%3DPerformance%2520of%2520list%2520mode%2520data%2520acquisition%2520with%2520ECAT%2520EXACT%2520HR%2520and%2520ECAT%2520EXACT%2520HR%2520positron%2520emission%2520scanners%26jtitle%3DAnn.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D20%26spage%3D189%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Gallagher, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutterson, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A. P.</span><span> </span><span class="NLM_article-title">Metabolic trapping as a principle of radiopharmaceutical design: Some factors responsible for the biodistribution of [<sup>18</sup>F] 2-deoxy-2-fluoro-<span class="smallcaps smallerCapital">d</span>-glucose</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1978&pages=1154-1161&author=B.+M.+Gallagherauthor=J.+S.+Fowlerauthor=N.+I.+Guttersonauthor=R.+R.+MacGregorauthor=C.+W.+Wanauthor=A.+P.+Wolf&title=Metabolic+trapping+as+a+principle+of+radiopharmaceutical+design%3A+Some+factors+responsible+for+the+biodistribution+of+%5B18F%5D+2-deoxy-2-fluoro-d-glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGallagher%26aufirst%3DB.%2BM.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DGutterson%26aufirst%3DN.%2BI.%26aulast%3DMacGregor%26aufirst%3DR.%2BR.%26aulast%3DWan%26aufirst%3DC.%2BW.%26aulast%3DWolf%26aufirst%3DA.%2BP.%26atitle%3DMetabolic%2520trapping%2520as%2520a%2520principle%2520of%2520radiopharmaceutical%2520design%253A%2520Some%2520factors%2520responsible%2520for%2520the%2520biodistribution%2520of%2520%255B18F%255D%25202-deoxy-2-fluoro-d-glucose%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1978%26volume%3D19%26spage%3D1154%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Reig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gispert, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barreno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desco, M.</span><span> </span><span class="NLM_article-title">Impact of ventricular enlargement on the measurement of metabolic activity in spatially normalized PET</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=748-758&author=S.+Reigauthor=M.+Penedoauthor=J.+D.+Gispertauthor=J.+Pascauauthor=J.+Sanchez-Gonzalezauthor=P.+Garcia-Barrenoauthor=M.+Desco&title=Impact+of+ventricular+enlargement+on+the+measurement+of+metabolic+activity+in+spatially+normalized+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReig%26aufirst%3DS.%26aulast%3DPenedo%26aufirst%3DM.%26aulast%3DGispert%26aufirst%3DJ.%2BD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DSanchez-Gonzalez%26aufirst%3DJ.%26aulast%3DGarcia-Barreno%26aufirst%3DP.%26aulast%3DDesco%26aufirst%3DM.%26atitle%3DImpact%2520of%2520ventricular%2520enlargement%2520on%2520the%2520measurement%2520of%2520metabolic%2520activity%2520in%2520spatially%2520normalized%2520PET%26jtitle%3DNeuroImage%26date%3D2007%26volume%3D35%26spage%3D748%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Garnett, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firnau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahmias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirakal, R.</span><span> </span><span class="NLM_article-title">Striatal dopamine metabolism in living monkeys examined by positron emission tomography</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0006-8993%2883%2991187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=6418330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL2cXhvVemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1983&pages=169-171&author=E.+S.+Garnettauthor=G.+Firnauauthor=C.+Nahmiasauthor=R.+Chirakal&title=Striatal+dopamine+metabolism+in+living+monkeys+examined+by+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal dopamine metabolism in living monkeys examined by positron emission tomography</span></div><div class="casAuthors">Garnett, Stephen; Firnau, Gunter; Nahmias, Claude; Chirakal, Raman</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-71</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Positron emission tomog., using the dopa analog [18F]6-fluoro-L-dopa, was used to depict the neostriatum in living monkeys.  The amt. of 18F that accumulated preferentially in the striatum could be augmented by a peripheral decarboxylase inhibitor.  Striatal 18F could also be discharged with reserpine.  This is the 1st time that the regional distribution of a neurotransmitter has been demonstrated in monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaUqU57b1dsLVg90H21EOLACvtfcHk0lg78uwcCotjvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhvVemug%253D%253D&md5=831f99f6a5652bc09e516d8254f2d249</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2883%2991187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252883%252991187-3%26sid%3Dliteratum%253Aachs%26aulast%3DGarnett%26aufirst%3DE.%2BS.%26aulast%3DFirnau%26aufirst%3DG.%26aulast%3DNahmias%26aufirst%3DC.%26aulast%3DChirakal%26aufirst%3DR.%26atitle%3DStriatal%2520dopamine%2520metabolism%2520in%2520living%2520monkeys%2520examined%2520by%2520positron%2520emission%2520tomography%26jtitle%3DBrain%2520Res.%26date%3D1983%26volume%3D280%26spage%3D169%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=635-650&author=Y.+Kumakuraauthor=P.+Cumming&title=PET+studies+of+cerebral+levodopa+metabolism%3A+a+review+of+clinical+findings+and+modeling+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DPET%2520studies%2520of%2520cerebral%2520levodopa%2520metabolism%253A%2520a%2520review%2520of%2520clinical%2520findings%2520and%2520modeling%2520approaches%26jtitle%3DNeuroscientist%26date%3D2009%26volume%3D15%26spage%3D635%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delforge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuuti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votaw, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span> </span><span class="NLM_article-title">Consensus nomenclature for in vivo imaging of reversibly binding radioligands</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1533</span><span class="NLM_x">–</span> <span class="NLM_lpage">1539</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fsj.jcbfm.9600493" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1533-1539&author=R.+B.+Innisauthor=V.+J.+Cunninghamauthor=J.+Delforgeauthor=M.+Fujitaauthor=A.+Gjeddeauthor=R.+N.+Gunnauthor=J.+Holdenauthor=S.+Houleauthor=S.+C.+Huangauthor=M.+Ichiseauthor=H.+Iidaauthor=H.+Itoauthor=Y.+Kimuraauthor=R.+A.+Koeppeauthor=G.+M.+Knudsenauthor=J.+Knuutiauthor=A.+A.+Lammertsmaauthor=M.+Laruelleauthor=J.+Loganauthor=R.+P.+Maguireauthor=M.+A.+Mintunauthor=E.+D.+Morrisauthor=R.+Parseyauthor=J.+C.+Priceauthor=M.+Slifsteinauthor=V.+Sossiauthor=T.+Suharaauthor=J.+R.+Votawauthor=D.+F.+Wongauthor=R.+E.+Carson&title=Consensus+nomenclature+for+in+vivo+imaging+of+reversibly+binding+radioligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600493%26sid%3Dliteratum%253Aachs%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DCunningham%26aufirst%3DV.%2BJ.%26aulast%3DDelforge%26aufirst%3DJ.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DHolden%26aufirst%3DJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DIchise%26aufirst%3DM.%26aulast%3DIida%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DKoeppe%26aufirst%3DR.%2BA.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DKnuuti%26aufirst%3DJ.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DMaguire%26aufirst%3DR.%2BP.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DMorris%26aufirst%3DE.%2BD.%26aulast%3DParsey%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DVotaw%26aufirst%3DJ.%2BR.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26atitle%3DConsensus%2520nomenclature%2520for%2520in%2520vivo%2520imaging%2520of%2520reversibly%2520binding%2520radioligands%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2009%26volume%3D27%26spage%3D1533%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Griffeth, L. K.</span><span> </span><span class="NLM_article-title">Use of PET/CT scanning in cancer patients: technical and practical considerations</span> <span class="citation_source-journal">Proc. (Bayl. Univ. Med. Cent.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16252023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2MrnsVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=321-330&author=L.+K.+Griffeth&title=Use+of+PET%2FCT+scanning+in+cancer+patients%3A+technical+and+practical+considerations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Use of PET/CT scanning in cancer patients: technical and practical considerations</span></div><div class="casAuthors">Griffeth Landis K</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings (Baylor University. Medical Center)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-30</span>
        ISSN:<span class="NLM_cas:issn">0899-8280</span>.
    </div><div class="casAbstract">This overview of the oncologic applications of positron emission tomography (PET) focuses on the technical aspects and clinical applications of a newer technique: the combination of a PET scanner and a computed tomography (CT) scanner in a single (PET/CT) device.  Examples illustrate how PET/CT contributes to patient care and improves upon the previous state-of-the-art method of comparing a PET scan with a separate CT scan.  Finally, the author presents some of the results from studies of PET/CT imaging that are beginning to appear in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLHmLk27e9DZPq5LRczm8ffW6udTcc2ebdT2oMJPPqlbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrnsVeksw%253D%253D&md5=e6572567e1b0839a035220b0ed95820b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffeth%26aufirst%3DL.%2BK.%26atitle%3DUse%2520of%2520PET%252FCT%2520scanning%2520in%2520cancer%2520patients%253A%2520technical%2520and%2520practical%2520considerations%26jtitle%3DProc.%2520%2528Bayl.%2520Univ.%2520Med.%2520Cent.%2529%26date%3D2005%26volume%3D18%26spage%3D321%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Catana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzezga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiss, W.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, B. R.</span><span> </span><span class="NLM_article-title">PET/MRI for neurologic applications</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1916-1925&author=C.+Catanaauthor=A.+Drzezgaauthor=W.-D.+Heissauthor=B.+R.+Rosen&title=PET%2FMRI+for+neurologic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DDrzezga%26aufirst%3DA.%26aulast%3DHeiss%26aufirst%3DW.-D.%26aulast%3DRosen%26aufirst%3DB.%2BR.%26atitle%3DPET%252FMRI%2520for%2520neurologic%2520applications%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D1916%26epage%3D1925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Rösch, F.</span><span> </span><span class="NLM_article-title">Radiochemistry and radiopharmaceutical chemistry in life sciences</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=F.+R%C3%B6schauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26atitle%3DRadiochemistry%2520and%2520radiopharmaceutical%2520chemistry%2520in%2520life%2520sciences%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Saha, G. B.</span> <span class="citation_source-book">Basics of PET Imaging</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+B.+Saha&title=Basics+of+PET+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DG.%2BB.%26btitle%3DBasics%2520of%2520PET%2520Imaging%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Virdee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caprioli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jupp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalley, J. W.</span><span> </span><span class="NLM_article-title">Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=1188-1216&author=K.+Virdeeauthor=P.+Cummingauthor=D.+Caprioliauthor=B.+Juppauthor=A.+Romingerauthor=F.+I.+Aigbirhioauthor=T.+D.+Fryerauthor=P.+J.+Rissauthor=J.+W.+Dalley&title=Applications+of+positron+emission+tomography+in+animal+models+of+neurological+and+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVirdee%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DCaprioli%26aufirst%3DD.%26aulast%3DJupp%26aufirst%3DB.%26aulast%3DRominger%26aufirst%3DA.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26aulast%3DFryer%26aufirst%3DT.%2BD.%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DDalley%26aufirst%3DJ.%2BW.%26atitle%3DApplications%2520of%2520positron%2520emission%2520tomography%2520in%2520animal%2520models%2520of%2520neurological%2520and%2520neuropsychiatric%2520disorders%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2012%26volume%3D36%26spage%3D1188%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Frankle, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span> </span><span class="NLM_article-title">Neuroreceptor imaging in psychiatry: theory and applications</span> <span class="citation_source-journal">Neuroimaging, Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2FS0074-7742%2805%2967011-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=385-440&author=W.+G.+Frankleauthor=M.+Slifsteinauthor=P.+S.+Talbotauthor=M.+Laruelle&title=Neuroreceptor+imaging+in+psychiatry%3A+theory+and+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2805%2967011-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252805%252967011-0%26sid%3Dliteratum%253Aachs%26aulast%3DFrankle%26aufirst%3DW.%2BG.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DTalbot%26aufirst%3DP.%2BS.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DNeuroreceptor%2520imaging%2520in%2520psychiatry%253A%2520theory%2520and%2520applications%26jtitle%3DNeuroimaging%252C%2520Part%2520B%26date%3D2005%26volume%3D67%26spage%3D385%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Gründer, G.</span> <span class="citation_source-book">Molecular Imaging in the Clinical Neurosciences</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-61779-989-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Gr%C3%BCnder&title=Molecular+Imaging+in+the+Clinical+Neurosciences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-989-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-61779-989-1%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26btitle%3DMolecular%2520Imaging%2520in%2520the%2520Clinical%2520Neurosciences%26pub%3DHumana%2520Press%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Fischer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judenhofer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannheim, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reischl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichler, B. J.</span><span> </span><span class="NLM_article-title">Noninvasive nuclear imaging enables the in vivo quantification of striatal dopamine receptor expression and raclopride affinity in mice</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1133-1141&author=K.+Fischerauthor=V.+Sossiauthor=A.+Schmidauthor=M.+Thunemannauthor=F.+C.+Maierauthor=M.+S.+Judenhoferauthor=J.+G.+Mannheimauthor=G.+Reischlauthor=B.+J.+Pichler&title=Noninvasive+nuclear+imaging+enables+the+in+vivo+quantification+of+striatal+dopamine+receptor+expression+and+raclopride+affinity+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DSchmid%26aufirst%3DA.%26aulast%3DThunemann%26aufirst%3DM.%26aulast%3DMaier%26aufirst%3DF.%2BC.%26aulast%3DJudenhofer%26aufirst%3DM.%2BS.%26aulast%3DMannheim%26aufirst%3DJ.%2BG.%26aulast%3DReischl%26aufirst%3DG.%26aulast%3DPichler%26aufirst%3DB.%2BJ.%26atitle%3DNoninvasive%2520nuclear%2520imaging%2520enables%2520the%2520in%2520vivo%2520quantification%2520of%2520striatal%2520dopamine%2520receptor%2520expression%2520and%2520raclopride%2520affinity%2520in%2520mice%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1133%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T.</span><span> </span><span class="NLM_article-title">Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs002590050211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=9473266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=173-176&author=S.+P.+Humeauthor=R.+N.+Gunnauthor=T.+Jones&title=Pharmacological+constraints+associated+with+positron+emission+tomographic+scanning+of+small+laboratory+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals</span></div><div class="casAuthors">Hume, Susan P.; Gunn, Roger N.; Jones, Terry</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-176</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">With the stated aim of scanning small regions of interest in mice, several high-resoln. positron emission tomog. (PET) systems are presently under development.  Some, however, have low sensitivity and require high doses of radioactivity to achieve count statistics adequate to reconstruct small vols.  Using in vivo dissocn. consts. for three carbon-11 labeled ligands previously measured in rat brain, the present paper utilises simple satn. kinetics to est. the limits on radioactivity and specific activity, to minimize the degree of receptor occupancy and achieve maximal specific binding of the radioligand.  The extent of the problem is exemplified by considering a high-affinity ligand (dissocn. const. in vitro ∼0.1 nM; in vivo ∼5 nmol/kg i.v. injected dose), where routinely produced levels of specific activity (∼100 MBq/nmol) would limit the activity injected into mice to ∼0.1 MBq for a 1 receptor occupancy.  If, as is feasible, the new generation of high resoln. PET systems requires an injected activity >10 MBq, then a >100-fold increase in specific activity would be needed for tracer kinetics to hold.  The paper highlights the need to consider realistically achievable goals if high-resoln. PET is to be accepted as a viable methodol. to acquire pharmacol. and physiol. accurate ligand-receptor binding data in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbaBeWHthNKLVg90H21EOLACvtfcHk0lg-mA4l_RgC0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWisL4%253D&md5=93ff49dc00c72a50016e7a028db9f5b6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs002590050211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050211%26sid%3Dliteratum%253Aachs%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DJones%26aufirst%3DT.%26atitle%3DPharmacological%2520constraints%2520associated%2520with%2520positron%2520emission%2520tomographic%2520scanning%2520of%2520small%2520laboratory%2520animals%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D1998%26volume%3D25%26spage%3D173%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisoteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisoteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisoteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span> </span><span class="NLM_article-title">Fluorine-for-hydrogen: a strategy for radiolabeling, not a replacement</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.nucmedbio.2013.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=24074943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFent7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=956-958&author=M.+R.+Kilbourn&title=Fluorine-for-hydrogen%3A+a+strategy+for+radiolabeling%2C+not+a+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-for-hydrogen: a strategy for radiolabeling, not a replacement</span></div><div class="casAuthors">Kilbourn, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">956-958</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  This article discusses the development of fluorine-for-hydrogen substitutions using fluorinated radiotracer provide useful biochem. information compared to the parent, hydrogen-contg. radiotracer.  The fluorine-for-hydrogen substitutions actually improve in vivo characteristics of the radiotracer for radiotracers targeting high-affinity binding sites on proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7sIy0u8sOFrVg90H21EOLACvtfcHk0liX6F0qbFwpbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFent7vL&md5=4c5969b83b5a74f49128f3575aea4326</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2013.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2013.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26atitle%3DFluorine-for-hydrogen%253A%2520a%2520strategy%2520for%2520radiolabeling%252C%2520not%2520a%2520replacement%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2013%26volume%3D40%26spage%3D956%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Hagglund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquilonius, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckernas, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartvig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langström, B.</span><span> </span><span class="NLM_article-title">Dopamine receptor properties in Parkinson’s disease and Huntington’s chorea evaluated by positron emission tomography using <sup>11</sup>C-N-methyl-spiperone</span> <span class="citation_source-journal">Acta Neurol. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1600-0404.1987.tb07900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2953165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL2s3gvV2nug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1987&pages=87-94&author=J.+Hagglundauthor=S.+M.+Aquiloniusauthor=S.+A.+Eckernasauthor=P.+Hartvigauthor=H.+Lundquistauthor=P.+Gullbergauthor=B.+Langstr%C3%B6m&title=Dopamine+receptor+properties+in+Parkinson%E2%80%99s+disease+and+Huntington%E2%80%99s+chorea+evaluated+by+positron+emission+tomography+using+11C-N-methyl-spiperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone</span></div><div class="casAuthors">Hagglund J; Aquilonius S M; Eckernas S A; Hartvig P; Lundquist H; Gullberg P; Langstrom B</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurologica Scandinavica</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-94</span>
        ISSN:<span class="NLM_cas:issn">0001-6314</span>.
    </div><div class="casAbstract">Dopaminergic receptor properties in the striatum of patients with Parkinson's disease (PD) and Huntington's chorea (HD) were studied by positron emission tomography (PET), using 11C-N-methyl-spiperone as a dopamine D2 receptor ligand.  The time-dependent regional radioactive uptake in the caudate nucleus and the putamen was measured and fitted to a 3-compartment pharmacokinetic model.  The rate constant k3 for specific binding to the receptor compartment in the striatum was determined in relation to the binding in regions with a low density of specific binding sites, such as the cerebellum and the frontal cortex . k3, which is a measure of the receptor density, was reduced in one patient with HD but less affected in PD in comparison with healthy controls.  The pattern of k3 values calculated from the 6 PD patients is discussed in relation to any side-to-side differences in dopamine receptor densities in hemiparkinsonism and to possible "hypersensitivity" of dopamine receptors in the early stage of the disease and down-regulation in more advanced disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxnTGIhuBxXrHHuJhbyicZfW6udTcc2ebNIoD5cj9W77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3gvV2nug%253D%253D&md5=57fb827ab6f60a16b32ba228aac5aaef</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0404.1987.tb07900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0404.1987.tb07900.x%26sid%3Dliteratum%253Aachs%26aulast%3DHagglund%26aufirst%3DJ.%26aulast%3DAquilonius%26aufirst%3DS.%2BM.%26aulast%3DEckernas%26aufirst%3DS.%2BA.%26aulast%3DHartvig%26aufirst%3DP.%26aulast%3DLundquist%26aufirst%3DH.%26aulast%3DGullberg%26aufirst%3DP.%26aulast%3DLangstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DDopamine%2520receptor%2520properties%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520Huntington%25E2%2580%2599s%2520chorea%2520evaluated%2520by%2520positron%2520emission%2520tomography%2520using%252011C-N-methyl-spiperone%26jtitle%3DActa%2520Neurol.%2520Scand.%26date%3D1987%26volume%3D75%26spage%3D87%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodack, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dence, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilboum, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raichle, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TerPogossian, M. M.</span><span> </span><span class="NLM_article-title">N-(3-[<sup>18</sup>F]Fluoropropyl)-spiperone: the preferred <sup>18</sup>F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=83-97&author=M.+J.+Welchauthor=J.+A.+Katzenellenbogenauthor=C.+J.+Mathiasauthor=J.+W.+Brodackauthor=K.+E.+Carlsonauthor=D.+Y.+Chiauthor=C.+S.+Denceauthor=M.+R.+Kilboumauthor=J.+S.+Perlmutterauthor=M.+E.+Raichleauthor=M.+M.+TerPogossian&title=N-%283-%5B18F%5DFluoropropyl%29-spiperone%3A+the+preferred+18F+labeled+spiperone+analog+for+positron+emission+tomographic+studies+of+the+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DMathias%26aufirst%3DC.%2BJ.%26aulast%3DBrodack%26aufirst%3DJ.%2BW.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DDence%26aufirst%3DC.%2BS.%26aulast%3DKilboum%26aufirst%3DM.%2BR.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DRaichle%26aufirst%3DM.%2BE.%26aulast%3DTerPogossian%26aufirst%3DM.%2BM.%26atitle%3DN-%25283-%255B18F%255DFluoropropyl%2529-spiperone%253A%2520the%2520preferred%252018F%2520labeled%2520spiperone%2520analog%2520for%2520positron%2520emission%2520tomographic%2520studies%2520of%2520the%2520dopamine%2520receptor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1998%26volume%3D15%26spage%3D83%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavia, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span> </span><span class="NLM_article-title">Synthesis of fluorine-18 labeled GABA uptake inhibitors</span> <span class="citation_source-journal">Int. J. Radiat. Appl. Instrum., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0883-2889%2890%2990059-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2176190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK3M%252Fpt12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1990&pages=823-828&author=M.+R.+Kilbournauthor=M.+R.+Paviaauthor=V.+E.+Gregor&title=Synthesis+of+fluorine-18+labeled+GABA+uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of fluorine-18 labeled GABA uptake inhibitors</span></div><div class="casAuthors">Kilbourn M R; Pavia M R; Gregor V E</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">823-8</span>
        ISSN:<span class="NLM_cas:issn">0883-2889</span>.
    </div><div class="casAbstract">The first syntheses of fluorine-18 labeled inhibitors of GABA reuptake [(R,S)-1-[2-[4-[18F]fluorophenyl]phenyl]methoxyethyl]piperidine- 3-carboxylic acid, (R,S)-1-[2-[(4-[18F]trifluoromethyl)phenyl][(4- trifluoromethyl)phenyl]-methoxyethyl]piperidine-3-carboxylic acid] are described.  These N-substituted nipecotic acid derivatives were prepared in no-carrier-added form by the condensation of the appropriately substituted [18F]benzhydryl chlorides (prepared in three steps from [18F]fluoride ion) with N-(2-hydroxyethyl)nipecotic acid ethyl ester, followed by ester hydrolysis.  Overall radiochemical yields were 17-28% (corrected, 150 min synthesis time).  A simple new method for synthesis of a [18F]trifluoromethyl group by the nucleophilic substitution of a bromodifluoromethyl substituent has also been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUG33o-4GNvZHZzFRCXxVKfW6udTcc2ebNIoD5cj9W77ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252Fpt12hsg%253D%253D&md5=b4541a2621812cd9d629ae10a1d79824</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0883-2889%2890%2990059-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0883-2889%252890%252990059-P%26sid%3Dliteratum%253Aachs%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DPavia%26aufirst%3DM.%2BR.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26atitle%3DSynthesis%2520of%2520fluorine-18%2520labeled%2520GABA%2520uptake%2520inhibitors%26jtitle%3DInt.%2520J.%2520Radiat.%2520Appl.%2520Instrum.%252C%2520Part%2520A%26date%3D1990%26volume%3D41%26spage%3D823%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Josse, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grégoire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand-Brynaert, J.</span><span> </span><span class="NLM_article-title">Synthesis of [<sup>18</sup>F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=665-675&author=O.+Josseauthor=D.+Labarauthor=B.+Georgesauthor=V.+Gr%C3%A9goireauthor=J.+Marchand-Brynaert&title=Synthesis+of+%5B18F%5D-labeled+EF3+%5B2-%282-nitroimidazol-1-yl%29-N-%283%2C3%2C3-trifluoropropyl%29-acetamide%5D%2C+a+marker+for+PET+detection+of+hypoxia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJosse%26aufirst%3DO.%26aulast%3DLabar%26aufirst%3DD.%26aulast%3DGeorges%26aufirst%3DB.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DV.%26aulast%3DMarchand-Brynaert%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520%255B18F%255D-labeled%2520EF3%2520%255B2-%25282-nitroimidazol-1-yl%2529-N-%25283%252C3%252C3-trifluoropropyl%2529-acetamide%255D%252C%2520a%2520marker%2520for%2520PET%2520detection%2520of%2520hypoxia%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D665%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Dolbier, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiue, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachur, A. V.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2FS0969-8043%2800%2900102-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11144255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVKrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=73-80&author=W.+R.+Dolbierauthor=A.+R.+Liauthor=C.+J.+Kochauthor=C.+Y.+Shiueauthor=A.+V.+Kachur&title=%5B18F%5D-EF5%2C+a+marker+for+PET+detection+of+hypoxia%3A+synthesis+of+precursor+and+a+new+fluorination+procedure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure</span></div><div class="casAuthors">Dolbier, W. R.; Li, A.-R.; Koch, C. J.; Shiue, C.-Y.; Kachur, A. V.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-80</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">There is a great deal of clin. and exptl. interest in detg. tissue hypoxia using non-invasive imaging methods.  The authors have previously developed EF5, 2-(2-nitro-1[H]-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide, with both invasive and non-invasive hypoxia detection in mind.  EF5 and other 2-nitroimidazoles are used to detect hypoxia, because the rate of their bioreductive metab. is inversely dependent on oxygen partial pressure.  Such metab. leads to the formation of covalent adducts within the metabolizing cells.  Previously, the authors have described the invasive detection of these adducts by highly specific monoclonal antibodies after tissue biopsy.  In this work, the authors synthesized 18F-labeled EF5, [18F]-2-(2-nitro-1[H]-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide, in greater than 10% yield by direct fluorination of the newly synthesized precursor 2-(2-nitro-1[H]-imidazol-1-yl)-N-(2,3,3-trifluoroallyl)acetamide by [18F]-F2 in trifluoroacetic acid.  The objective was to optimize the electrophilic fluorination of the fluorinated alkene bond with fluorine gas, a new method of 18F-labeling of polyfluorinated mols.  Previous biodistribution studies in mice have demonstrated uniform access of EF5 to all tissues with bioelimination dominated by renal excretion.  When [18F]-EF5 was injected into a rat followed by urine collection and anal., the authors found no detectable metab. to other radioactive compds.  Thus, [18F]-EF5 should be well suited for use as a non-invasive hypoxia marker with detection using positron emission tomog. (PET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprUnx1N3heu7Vg90H21EOLACvtfcHk0liXiOWYmaEEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVKrtb8%253D&md5=252b721bc6e98e72c1108e7ceacb891c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2800%2900102-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252800%252900102-0%26sid%3Dliteratum%253Aachs%26aulast%3DDolbier%26aufirst%3DW.%2BR.%26aulast%3DLi%26aufirst%3DA.%2BR.%26aulast%3DKoch%26aufirst%3DC.%2BJ.%26aulast%3DShiue%26aufirst%3DC.%2BY.%26aulast%3DKachur%26aufirst%3DA.%2BV.%26atitle%3D%255B18F%255D-EF5%252C%2520a%2520marker%2520for%2520PET%2520detection%2520of%2520hypoxia%253A%2520synthesis%2520of%2520precursor%2520and%2520a%2520new%2520fluorination%2520procedure%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2001%26volume%3D54%26spage%3D73%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span> </span><span class="NLM_article-title">A simple rapid procedure for nucleophilic radiosynthesis of aliphatic [<sup>18</sup>F]trifluoromethyl groups</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">11873</span><span class="NLM_x">–</span> <span class="NLM_lpage">11875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=11873-11875&author=P.+J.+Rissauthor=F.+I.+Aigbirhio&title=A+simple+rapid+procedure+for+nucleophilic+radiosynthesis+of+aliphatic+%5B18F%5Dtrifluoromethyl+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DA%2520simple%2520rapid%2520procedure%2520for%2520nucleophilic%2520radiosynthesis%2520of%2520aliphatic%2520%255B18F%255Dtrifluoromethyl%2520groups%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D11873%26epage%3D11875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Huiban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouverneur, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passchier, J.</span><span> </span><span class="NLM_article-title">A broadly applicable [<sup>18</sup>F]trifluoromethylation of aryl and heteroaryl iodides for PET imaging</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fnchem.1756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=24153372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=941-944&author=M.+Huibanauthor=M.+Tredwellauthor=S.+Mizutaauthor=Z.+Wanauthor=X.+Zhangauthor=T.+L.+Collierauthor=V.+Gouverneurauthor=J.+Passchier&title=A+broadly+applicable+%5B18F%5Dtrifluoromethylation+of+aryl+and+heteroaryl+iodides+for+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A broadly applicable [18F]trifluoromethylation of aryl and heteroaryl iodides for PET imaging</span></div><div class="casAuthors">Huiban, Mickael; Tredwell, Matthew; Mizuta, Satoshi; Wan, Zehong; Zhang, Xiaomin; Collier, Thomas Lee; Gouverneur, Veronique; Passchier, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">941-944</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mols. labeled with the unnatural isotope fluorine-18 are used for positron emission tomog.  Currently, this mol. imaging technol. is not exploited at its full potential because many 18F-labeled probes are inaccessible or notoriously difficult to produce.  Typical challenges assocd. with 18F radiochem. are the short half-life of 18F (<2 h), the use of sub-stoichiometric amts. of 18F, relative to the precursor and other reagents, as well as the limited availability of parent 18F sources of suitable reactivity ([18F]F- and [18F]F2).  There is a high-priority demand for general methods allowing access to [18F]CF3-substituted mols. for application in pharmaceutical discovery programs.  We report the development of a process for the late-stage [18F]trifluoromethylation of (hetero)arenes from [18F]fluoride using com. available reagents and (hetero)aryl iodides.  This [18F]CuCF3-based protocol benefits from a large substrate scope and is characterized by its operational simplicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2wsZQqGFtZbVg90H21EOLACvtfcHk0liXiOWYmaEEvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSht7fF&md5=3afb862eeb57e84a6a0c194ee7dfcb78</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1756%26sid%3Dliteratum%253Aachs%26aulast%3DHuiban%26aufirst%3DM.%26aulast%3DTredwell%26aufirst%3DM.%26aulast%3DMizuta%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DGouverneur%26aufirst%3DV.%26aulast%3DPasschier%26aufirst%3DJ.%26atitle%3DA%2520broadly%2520applicable%2520%255B18F%255Dtrifluoromethylation%2520of%2520aryl%2520and%2520heteroaryl%2520iodides%2520for%2520PET%2520imaging%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D941%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Mille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Fougère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böning, G.</span><span> </span><span class="NLM_article-title">Compensation for cranial spilling into the cerebellum improves quantitation of striatal dopamine D<sub>2/3</sub> receptors in rats with prolonged [<sup>18</sup>F]DMFP infusions</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=705-713&author=E.+Milleauthor=P.+Cummingauthor=A.+Romingerauthor=C.+La+Foug%C3%A8reauthor=K.+Tatschauthor=B.+W%C3%A4nglerauthor=P.+Bartensteinauthor=G.+B%C3%B6ning&title=Compensation+for+cranial+spilling+into+the+cerebellum+improves+quantitation+of+striatal+dopamine+D2%2F3+receptors+in+rats+with+prolonged+%5B18F%5DDMFP+infusions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMille%26aufirst%3DE.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DRominger%26aufirst%3DA.%26aulast%3DLa%2BFoug%25C3%25A8re%26aufirst%3DC.%26aulast%3DTatsch%26aufirst%3DK.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DB%25C3%25B6ning%26aufirst%3DG.%26atitle%3DCompensation%2520for%2520cranial%2520spilling%2520into%2520the%2520cerebellum%2520improves%2520quantitation%2520of%2520striatal%2520dopamine%2520D2%252F3%2520receptors%2520in%2520rats%2520with%2520prolonged%2520%255B18F%255DDMFP%2520infusions%26jtitle%3DSynapse%26date%3D2012%26volume%3D66%26spage%3D705%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Lundkvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, F.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]MDL 100907, a radioligand for selective imaging of 5-HT<sub>2A</sub> receptors with positron emission tomography</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=187-192&author=C.+Lundkvistauthor=C.+Halldinauthor=N.+Ginovartauthor=S.+Nybergauthor=C.+G.+Swahnauthor=A.+A.+Carrauthor=F.+Brunnerauthor=F.+Farde&title=%5B11C%5DMDL+100907%2C+a+radioligand+for+selective+imaging+of+5-HT2A+receptors+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLundkvist%26aufirst%3DC.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DNyberg%26aufirst%3DS.%26aulast%3DSwahn%26aufirst%3DC.%2BG.%26aulast%3DCarr%26aufirst%3DA.%2BA.%26aulast%3DBrunner%26aufirst%3DF.%26aulast%3DFarde%26aufirst%3DF.%26atitle%3D%255B11C%255DMDL%2520100907%252C%2520a%2520radioligand%2520for%2520selective%2520imaging%2520of%25205-HT2A%2520receptors%2520with%2520positron%2520emission%2520tomography%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lgxqaYWtI0hYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lgxqaYWtI0hYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Dutheil, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauchy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sazdovitch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloarec, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellottée, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bièche, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingelman-Sundberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinois, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Waziers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaune, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Declèves, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyckaerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriot, M. A.</span><span> </span><span class="NLM_article-title">Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=165-174&author=F.+Dutheilauthor=S.+Dauchyauthor=M.+Diryauthor=V.+Sazdovitchauthor=O.+Cloarecauthor=L.+Mellott%C3%A9eauthor=I.+Bi%C3%A8cheauthor=M.+Ingelman-Sundbergauthor=J.+P.+Flinoisauthor=I.+de+Waziersauthor=P.+Beauneauthor=X.+Decl%C3%A8vesauthor=C.+Duyckaertsauthor=M.+A.+Loriot&title=Xenobiotic-metabolizing+enzymes+and+transporters+in+the+normal+human+brain%3A+regional+and+cellular+mapping+as+a+basis+for+putative+roles+in+cerebral+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutheil%26aufirst%3DF.%26aulast%3DDauchy%26aufirst%3DS.%26aulast%3DDiry%26aufirst%3DM.%26aulast%3DSazdovitch%26aufirst%3DV.%26aulast%3DCloarec%26aufirst%3DO.%26aulast%3DMellott%25C3%25A9e%26aufirst%3DL.%26aulast%3DBi%25C3%25A8che%26aufirst%3DI.%26aulast%3DIngelman-Sundberg%26aufirst%3DM.%26aulast%3DFlinois%26aufirst%3DJ.%2BP.%26aulast%3Dde%2BWaziers%26aufirst%3DI.%26aulast%3DBeaune%26aufirst%3DP.%26aulast%3DDecl%25C3%25A8ves%26aufirst%3DX.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DLoriot%26aufirst%3DM.%2BA.%26atitle%3DXenobiotic-metabolizing%2520enzymes%2520and%2520transporters%2520in%2520the%2520normal%2520human%2520brain%253A%2520regional%2520and%2520cellular%2520mapping%2520as%2520a%2520basis%2520for%2520putative%2520roles%2520in%2520cerebral%2520function%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Bartmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuest, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">la Fougere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Just, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlichtiger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekcec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soerensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potschka, H.</span><span> </span><span class="NLM_article-title">Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy</span> <span class="citation_source-journal">Epilepsia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1780</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1780-1790&author=H.+Bartmannauthor=C.+Fuestauthor=C.+la+Fougereauthor=G.+Xiongauthor=T.+Justauthor=J.+Schlichtigerauthor=P.+Winterauthor=G.+Boningauthor=B.+W%C3%A4nglerauthor=A.+Pekcecauthor=J.+Soerensenauthor=P.+Bartensteinauthor=P.+Cummingauthor=H.+Potschka&title=Imaging+of+P-glycoprotein-mediated+pharmacoresistance+in+the+hippocampus%3A+proof-of-concept+in+a+chronic+rat+model+of+temporal+lobe+epilepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartmann%26aufirst%3DH.%26aulast%3DFuest%26aufirst%3DC.%26aulast%3Dla%2BFougere%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DG.%26aulast%3DJust%26aufirst%3DT.%26aulast%3DSchlichtiger%26aufirst%3DJ.%26aulast%3DWinter%26aufirst%3DP.%26aulast%3DBoning%26aufirst%3DG.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DPekcec%26aufirst%3DA.%26aulast%3DSoerensen%26aufirst%3DJ.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DPotschka%26aufirst%3DH.%26atitle%3DImaging%2520of%2520P-glycoprotein-mediated%2520pharmacoresistance%2520in%2520the%2520hippocampus%253A%2520proof-of-concept%2520in%2520a%2520chronic%2520rat%2520model%2520of%2520temporal%2520lobe%2520epilepsy%26jtitle%3DEpilepsia%26date%3D2010%26volume%3D51%26spage%3D1780%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Tournier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyronneau, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goutal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhnast, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cisternino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottlaender, M.</span><span> </span><span class="NLM_article-title">Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=415-423&author=N.+Tournierauthor=H.+Valetteauthor=M.+A.+Peyronneauauthor=W.+Sabaauthor=S.+Goutalauthor=B.+Kuhnastauthor=F.+Doll%C3%A9author=J.+M.+Scherrmannauthor=S.+Cisterninoauthor=M.+Bottlaender&title=Transport+of+selected+PET+radiotracers+by+human+P-glycoprotein+%28ABCB1%29+and+breast+cancer+resistance+protein+%28ABCG2%29%3A+an+in+vitro+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTournier%26aufirst%3DN.%26aulast%3DValette%26aufirst%3DH.%26aulast%3DPeyronneau%26aufirst%3DM.%2BA.%26aulast%3DSaba%26aufirst%3DW.%26aulast%3DGoutal%26aufirst%3DS.%26aulast%3DKuhnast%26aufirst%3DB.%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DCisternino%26aufirst%3DS.%26aulast%3DBottlaender%26aufirst%3DM.%26atitle%3DTransport%2520of%2520selected%2520PET%2520radiotracers%2520by%2520human%2520P-glycoprotein%2520%2528ABCB1%2529%2520and%2520breast%2520cancer%2520resistance%2520protein%2520%2528ABCG2%2529%253A%2520an%2520in%2520vitro%2520screening%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D415%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of <sup>11</sup>C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2740</span><span class="NLM_x">–</span> <span class="NLM_lpage">2754</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030026b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2740-2754&author=C.+A.+Mathisauthor=Y.+Wangauthor=D.+P.+Holtauthor=G.-F.+Huangauthor=M.+L.+Debnathauthor=W.+E.+Klunk&title=Synthesis+and+evaluation+of+11C-labeled+6-substituted+2-arylbenzothiazoles+as+amyloid+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm030026b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030026b%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DHuang%26aufirst%3DG.-F.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%252011C-labeled%25206-substituted%25202-arylbenzothiazoles%2520as%2520amyloid%2520imaging%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2740%26epage%3D2754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitcheva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ausén, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivisto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longström, B.</span><span> </span><span class="NLM_article-title">Imaging brain amyloid in Alzheimer’s disease with Pittsburg Compound-B</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2Fana.20009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=14991808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=306-319&author=W.+E.+Klunkauthor=H.+Englerauthor=A.+Nordbergauthor=Y.+Wangauthor=G.+Blomqvistauthor=D.+P.+Holtauthor=M.+Bergstr%C3%B6mauthor=I.+Savitchevaauthor=G.+F.+Huangauthor=S.+Estradaauthor=B.+Aus%C3%A9nauthor=M.+L.+Debnathauthor=J.+Barlettaauthor=J.+C.+Priceauthor=J.+Sandellauthor=B.+J.+Loprestiauthor=A.+Wallauthor=P.+Koivistoauthor=G.+Antoniauthor=C.+A.+Mathisauthor=B.+Longstr%C3%B6m&title=Imaging+brain+amyloid+in+Alzheimer%E2%80%99s+disease+with+Pittsburg+Compound-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B</span></div><div class="casAuthors">Klunk, William E.; Engler, Henry; Nordberg, Agneta; Wang, Yanming; Blomqvist, Gunnar; Holt, Daniel P.; Bergstrom, Mats; Savitcheva, Irina; Huang, Guo-feng; Estrada, Sergio; Ausen, Birgitta; Debnath, Manik L.; Barletta, Julien; Price, Julie C.; Sandell, Johan; Lopresti, Brian J.; Wall, Anders; Koivisto, Pernilla; Antoni, Gunnar; Mathis, Chester A.; Langstrom, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-319</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This report describes the first human study of a novel amyloid-imaging positron emission tomog. (PET) tracer, termed Pittsburgh Compd.-B (PIB), in 16 patients with diagnosed mild AD and 9 controls.  Compared with controls, AD patients typically showed marked retention of PIB in areas of assocn. cortex known to contain large amts. of amyloid deposits in AD.  In the AD patient group, PIB retention was increased most prominently in frontal cortex (1.94-fold, p = 0.0001).  Large increases also were obsd. in parietal (1.71-fold, p = 0.0002), temporal (1.52-fold, p = 0.002), and occipital (1.54-fold, p = 0.002) cortex and the striatum (1.76-fold, p = 0.0001).  PIB retention was equiv. in AD patients and controls in areas known to be relatively unaffected by amyloid deposition (such as subcortical white matter, pons, and cerebellum).  Studies in three young (21 yr) and six older healthy controls (69.5±11 yr) showed low PIB retention in cortical areas and no significant group differences between young and older controls.  In cortical areas, PIB retention correlated inversely with cerebral glucose metab. detd. with 18F-fluorodeoxyglucose.  This relationship was most robust in the parietal cortex (r = -0.72; p = 0.0001).  The results suggest that PET imaging with the novel tracer, PIB, can provide quant. information on amyloid deposits in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXxBSvpITSxLVg90H21EOLACvtfcHk0ljqQLN4iqHz_w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D&md5=3e036dca56dcb81e0cf131a5b100f95f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fana.20009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20009%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DEngler%26aufirst%3DH.%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBlomqvist%26aufirst%3DG.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSavitcheva%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DEstrada%26aufirst%3DS.%26aulast%3DAus%25C3%25A9n%26aufirst%3DB.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DBarletta%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DKoivisto%26aufirst%3DP.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DLongstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DImaging%2520brain%2520amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520Pittsburg%2520Compound-B%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D306%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Klunk, W. E.; Mathis, C. A.,  Jr.; Wang, Y.</span>Benzothiazole Derivative Compounds, Compositions and Uses. Patent WO2004083195 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">134</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+E.+Klunk&author=C.+A.+Mathis&author=Y.+Wang&title=Benzothiazole+Derivative+Compounds%2C+Compositions+and+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26jtitle%3DBenzothiazole%2520Derivative%2520Compounds%252C%2520Compositions%2520and%2520Uses%26date%3D2004%26spage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Hatashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakebe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, H.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]Flutemetamol amyloid-beta PET imaging compared with [<sup>11</sup>C]PIB across the spectrum of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs00259-013-2564-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=24085503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKjurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=290-300&author=S.+Hatashitaauthor=H.+Yamasakiauthor=Y.+Suzukiauthor=K.+Tanakaauthor=D.+Wakebeauthor=H.+Hayakawa&title=%5B18F%5DFlutemetamol+amyloid-beta+PET+imaging+compared+with+%5B11C%5DPIB+across+the+spectrum+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease</span></div><div class="casAuthors">Hatashita, Shizuo; Yamasaki, Hidetomo; Suzuki, Yutaka; Tanaka, Kumiko; Wakebe, Daichi; Hayakawa, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">290-300</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The aim was to identify the amyloid beta (Aβ) deposition by positron emission tomog. (PET) imaging with the 18F-labeled Pittsburgh compd. B (PIB) deriv. [18F]flutemetamol (FMM) across a spectrum of Alzheimer's disease (AD) and to compare Aβ deposition between [18F]FMM and [11C]PIB PET imaging.  Methods: The study included 36 patients with AD, 68 subjects with mild cognitive impairment (MCI), 41 older healthy controls (HC) (aged ≥56), 11 young HC (aged ≤45), and 10 transitional HC (aged 46-55).  All 166 subjects underwent 30-min static [18F]FMM PET 85 min after injection, 60-min dynamic [11C]PIB PET, and cognitive testing. [18F]FMM scans were assessed visually, and standardized uptake value ratios (SUVR) were defined quant. in regions of interest identified on coregistered MRI (cerebellar cortex as a ref. region).  The PIB distribution vol. ratios (DVR) were detd. in the same regions.  Results: Of 36 AD patients, 35 had pos. scans, while 36 of 41 older HC subjects had neg. scans. [18F]FMM scans had a sensitivity of 97.2 % and specificity of 85.3 % in distinguishing AD patients from older HC subjects, and a specificity of 100 % for young and transitional HC subjects.  The [11C]PIB scan had the same results.  Interreader agreement was excellent (kappa score = 0.81).  The cortical FMM SUVR in AD patients was significantly greater than in older HC subjects (1.76 ± 0.23 vs 1.30 ± 0.26, p < 0.01).  Of the MCI patients, 68 had a bimodal distribution of SUVR, and 29 of them (42.6 %) had pos. scans.  Cortical FMM SUVR values were strongly correlated with PIB DVR (r = 0.94, n = 145, p < 0.001).  Conclusion: [18F]FMM PET imaging detects Aβ deposition in patients along the continuum from normal cognitive status to dementia of AD and discriminates AD patients from HC subjects, similar to [11C]PIB PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUDZFRg1D2WbVg90H21EOLACvtfcHk0ljdhx56NS83qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKjurjE&md5=55ac4685816a4c192a811bd19229f1b3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2564-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2564-y%26sid%3Dliteratum%253Aachs%26aulast%3DHatashita%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DWakebe%26aufirst%3DD.%26aulast%3DHayakawa%26aufirst%3DH.%26atitle%3D%255B18F%255DFlutemetamol%2520amyloid-beta%2520PET%2520imaging%2520compared%2520with%2520%255B11C%255DPIB%2520across%2520the%2520spectrum%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D290%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Development of positron emission tomography beta-amyloid plaque imaging agents</span> <span class="citation_source-journal">Semin. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1053%2Fj.semnuclmed.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=23026364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=423-432&author=C.+A.+Mathisauthor=N.+S.+Masonauthor=B.+J.+Loprestiauthor=W.+E.+Klunk&title=Development+of+positron+emission+tomography+beta-amyloid+plaque+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Development of positron emission tomography β-amyloid plaque imaging agents</span></div><div class="casAuthors">Mathis Chester A; Mason N Scott; Lopresti Brian J; Klunk William E</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">For 100 years, β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) have been recognized as the neuropathological hallmarks of Alzheimer's disease (AD), and their presence or absence could only be assessed postmortem using stains and dyes that identified these microscopic structures.  Approximately 10 years ago, the first successful Aβ plaque-specific positron emission tomography (PET) imaging study was conducted in a living human subject clinically diagnosed with probable AD using the (11)C-labeled radiopharmaceutical Pittsburgh Compound B (PiB).  Laboratory studies and preclinical evaluations to design PiB began a decade earlier than the first human PiB PET study and involved chemical modifications of different well-known dyes that bound specifically to the extended β-pleated sheets that comprise the fibrils of amyloid proteins such as Aβ plaques, NFTs, α-synuclein deposits, and prions.  These preclinical studies were conducted in our laboratories at the University of Pittsburgh, starting with Congo red derivatives, followed by Chrysamine G derivatives, followed by X-series compounds, and finally with neutral derivatives of thioflavin-T.  The in vitro and in vivo evaluations of the different derivatives as candidate PET radioligands for imaging Aβ plaques and neurofibrillary tangles in human brain are described in this review, along with the specific evaluation criteria by which the candidate radioligands were judged.  Out of these studies came PiB, a PET radioligand that binds selectively and with high affinity to only fibrillar forms of Aβ.  PiB has been used in many different human research protocols throughout the world and has demonstrated the usefulness of assessing the Aβ plaque status of subjects many years before the clinical diagnosis of probable AD.  Recently, longer-lived (18)F-radiolabeled Aβ-selective radiopharmaceuticals have been developed.  It is likely that the full clinical impact of these imaging agents will be realized by identifying presymptomatic subjects who would benefit from early drug treatments with future disease-modifying AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5GsYnd2H3WtyzdcP07UmufW6udTcc2eb1u8yEdGklebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D&md5=e9c01e3c4335a6b85dd838c64277e0ee</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DDevelopment%2520of%2520positron%2520emission%2520tomography%2520beta-amyloid%2520plaque%2520imaging%2520agents%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D42%26spage%3D423%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Barthel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, O.</span><span> </span><span class="NLM_article-title">Florbetaben to trance amyloid-β in the Alzheimer brain by means of PET</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=21971456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=117-121&author=H.+Barthelauthor=O.+Sabri&title=Florbetaben+to+trance+amyloid-%CE%B2+in+the+Alzheimer+brain+by+means+of+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Florbetaben to Trace Amyloid-β in the Alzheimer Brain by Means of PET</span></div><div class="casAuthors">Ashford, J. Wesson; Rosen, Allyson; Adamson, Maheen; Bayley, Peter; Sabri, Osama; Furst, Ansgar; Black, Sandra E.; Weiner, Michael; Barthel, Henryk; Sabri, Osama</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">117-121</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  PET imaging of amyloid-β has recently emerged as a valuable biomarker to support the in vivo diagnosis of Alzheimer's disease (AD).  So far, however, no tracer is available suitable for general clin. routine application.  Florbetaben is a promising 18F-labeled amyloid-β-targeted PET tracer currently in Phase2/3 clin. development.  This review provides an overview on the current knowledge and future research activities on florbetaben.  Recently, the first worldwide multi-center trial to test the diagnostic performance of amyloid-β PET in AD was conducted with this tracer.  From this trial, a sensitivity and specificity of 80 and 91% in the discrimination between patients with probable AD and age-matched healthy controls was reported.  Ongoing florbetaben PET trials deal with correlating the in vivo PET signal to post mortem histopathol. evaluation, and with investigating the value of the tracer to predict progression to AD at the stage of mild cognitive impairment.  The preclin. and clin. data currently available verify florbetaben as a safe and efficacious PET tracer suitable for detection of amyloid-β deposition in the brain.  The results of the ongoing trials will contribute to current knowledge on the characteristics of florbetaben, and will help to det. the future potential of florbetaben PET imaging as a visual adjunct to supplement the routine clin. "AD diagnostic toolbox".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoevrjRGosWBrVg90H21EOLACvtfcHk0ljdhx56NS83qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gs7%252FO&md5=1b61b0f7e6fcba764d905fd87d403105</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DH.%26aulast%3DSabri%26aufirst%3DO.%26atitle%3DFlorbetaben%2520to%2520trance%2520amyloid-%25CE%25B2%2520in%2520the%2520Alzheimer%2520brain%2520by%2520means%2520of%2520PET%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D26%26spage%3D117%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanessa Raymont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brašić, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M. J.</span><span> </span><span class="NLM_article-title">In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand <sup>18</sup>F-AV-45 (flobetapir F-18)</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=913-920&author=D.+F.+Wongauthor=P.+B.+Rosenbergauthor=Y.+Zhouauthor=A.+Kumarauthor=V.+Vanessa+Raymontauthor=H.+T.+Ravertauthor=R.+F.+Dannalsauthor=A.+Nandiauthor=J.+R.+Bra%C5%A1i%C4%87author=W.+Yeauthor=J.+Hiltonauthor=C.+Lyketsosauthor=H.+F.+Kungauthor=A.+D.+Joshiauthor=D.+M.+Skovronskyauthor=M.+J.+Pontecorvo&title=In+vivo+imaging+of+amyloid+deposition+in+Alzheimer+disease+using+the+radioligand+18F-AV-45+%28flobetapir+F-18%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DRosenberg%26aufirst%3DP.%2BB.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DVanessa%2BRaymont%26aufirst%3DV.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DNandi%26aufirst%3DA.%26aulast%3DBra%25C5%25A1i%25C4%2587%26aufirst%3DJ.%2BR.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DLyketsos%26aufirst%3DC.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DSkovronsky%26aufirst%3DD.%2BM.%26aulast%3DPontecorvo%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520amyloid%2520deposition%2520in%2520Alzheimer%2520disease%2520using%2520the%2520radioligand%252018F-AV-45%2520%2528flobetapir%2520F-18%2529%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D913%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Lopéz-Muñoz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alamos, C.</span><span> </span><span class="NLM_article-title">The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.brainresbull.2009.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=19186209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVOju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2009&pages=130-141&author=F.+Lop%C3%A9z-Mu%C3%B1ozauthor=C.+Alamos&title=The+consolidation+of+neuroleptic+therapy%3A+Janssen%2C+the+discovery+of+haloperidol+and+its+introduction+into+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice</span></div><div class="casAuthors">Lopez-Munoz, Francisco; Alamo, Cecilio</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-141</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of haloperidol at the end of the 1950s constitutes one of the greatest advances of 20th century psychiatry.  This antipsychotic drug has their origin in the research process of central analgesic mols. derived from pethidine and methadone, carried out by the Belgian company Janssen Phamaceutica.  After the synthesis of phenoperidine, numerous analogs of this compd. were studied, and chemists at Janssen took the decision to substitute the propiophenone group for a butyrophenone group.  One of these compds. went the R-1625, a stronger agent with specifically neuroleptic properties but lacking morphine-like activity.  This substance was synthesized on the 11th Feb. 1958 and received the generic name of haloperidol because of the two halogenated substitutes incorporated into the mol.  Clin. development of haloperidol was conducted, primarily, by psychiatric research team at the University of Liege that confirmed its efficacy in the treatment of various psychiatric disorders such as acute and chronic paranoid psychosis, mania, or chronic treatment-resistant schizophrenia.  Under the brand name Haldol, haloperidol was licensed and marketed in Belgium in Oct. 1959.  The direct and differed consequences of its introduction into the psychiatric practice have been multiple, involving different areas of socio-sanitary reality.  Moreover, haloperidol has contributed substantially to the development of biol. psychiatry and currently neuroscience, because it made possible the development of new exptl. models for predicting the effects of antipsychotics, and allowed the postulate of the firsts biol. hypotheses about the schizophrenia etiol.  Haloperidol has been included in the World Health Organization's list of essential medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2lPuh0GeqILVg90H21EOLACvtfcHk0lidG3E_-gp7qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVOju7o%253D&md5=76765632a32254cc2386150a6ce52cfa</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2009.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2009.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLop%25C3%25A9z-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DAlamos%26aufirst%3DC.%26atitle%3DThe%2520consolidation%2520of%2520neuroleptic%2520therapy%253A%2520Janssen%252C%2520the%2520discovery%2520of%2520haloperidol%2520and%2520its%2520introduction%2520into%2520clinical%2520practice%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2009%26volume%3D79%26spage%3D130%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Berger, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Cruz, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleasure, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, E. L.</span><span> </span><span class="NLM_article-title">Importance and hurdles to drug discovery for neurological disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2Fana.23893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=441-446&author=J.+R.+Bergerauthor=D.+Choiauthor=H.+J.+Kaminskiauthor=M.+F.+Gordonauthor=O.+Hurkoauthor=O.+N.+D%E2%80%99Cruzauthor=S.+J.+Pleasureauthor=E.+L.+Feldman&title=Importance+and+hurdles+to+drug+discovery+for+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Importance and hurdles to drug discovery for neurological disease</span></div><div class="casAuthors">Berger, Joseph R.; Choi, Dennis; Kaminski, Henry J.; Gordon, Mark F.; Hurko, Orest; D'Cruz, O'Neill; Pleasure, Samuel J.; Feldman, Eva L.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-446</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  This is a crit. time in neurotherapeutics.  The prevalence of neurol. disease, such as dementia, stroke, and peripheral neuropathy, is large and growing consequent to the aging population.  The personal and societal impact of these disorders is enormous, and the no. of novel therapies in the pipeline for these disorders has been contracting.  Support for the development of neurotherapies must continue from the bench to their ultimate place at the bedside.  Academic medicine must continue to play a crit. role, in league with industry and government, in the development of novel neurotherapies desperately needed by an ever-expanding population.  Crit. steps include the identification and adoption of reliable, valid, and reproducible biomarkers to serve as primary endpoints in clin. trials of neurol. disease.  Ann Neurol 2013;74:441-446.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRhoCCkdeOLVg90H21EOLACvtfcHk0lidG3E_-gp7qg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnt77L&md5=b363326145d8692f997ce4e1d8be67c5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fana.23893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.23893%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BR.%26aulast%3DChoi%26aufirst%3DD.%26aulast%3DKaminski%26aufirst%3DH.%2BJ.%26aulast%3DGordon%26aufirst%3DM.%2BF.%26aulast%3DHurko%26aufirst%3DO.%26aulast%3DD%25E2%2580%2599Cruz%26aufirst%3DO.%2BN.%26aulast%3DPleasure%26aufirst%3DS.%2BJ.%26aulast%3DFeldman%26aufirst%3DE.%2BL.%26atitle%3DImportance%2520and%2520hurdles%2520to%2520drug%2520discovery%2520for%2520neurological%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2013%26volume%3D74%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span>Innovation or Stagnation:  Challenge and Opportunity on the Critical Path to New Medical Products; <span class="NLM_publisher-name">U.S. Food and Drug Administration</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span><a href="http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm" class="extLink">http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Innovation+or+Stagnation%3A+Challenge+and+Opportunity+on+the+Critical+Path+to+New+Medical+Products%3B+U.S.+Food+and+Drug+Administration%3A+Silver+Spring%2C+MD%2C+2004%3B+http%3A%2F%2Fwww.fda.gov%2FScienceResearch%2FSpecialTopics%2FCriticalPathInitiative%2FCriticalPathOpportunitiesReports%2Fucm077262.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DInnovation%2520or%2520Stagnation%253A%2520%2520Challenge%2520and%2520Opportunity%2520on%2520the%2520Critical%2520Path%2520to%2520New%2520Medical%2520Products%26pub%3DU.S.%2520Food%2520and%2520Drug%2520Administration%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span>The Pharmaceutical Industry in Figures; <span class="NLM_publisher-name">European Federation of Pharmaceutica Industries and Associations</span>: <span class="NLM_publisher-loc">Brussels, Belgium</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.efpia.eu/uploads/Modules/Documents/figures-key-data-2013.pdf" class="extLink">http://www.efpia.eu/uploads/Modules/Documents/figures-key-data-2013.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Pharmaceutical+Industry+in+Figures%3B+European+Federation+of+Pharmaceutica+Industries+and+Associations%3A+Brussels%2C+Belgium%2C+2013%3B+http%3A%2F%2Fwww.efpia.eu%2Fuploads%2FModules%2FDocuments%2Ffigures-key-data-2013.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Pharmaceutical%2520Industry%2520in%2520Figures%26pub%3DEuropean%2520Federation%2520of%2520Pharmaceutica%2520Industries%2520and%2520Associations%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Woodcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woosley, R.</span><span> </span><span class="NLM_article-title">The FDA critical path initiative and its influence on new drug development</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=1-12&author=J.+Woodcockauthor=R.+Woosley&title=The+FDA+critical+path+initiative+and+its+influence+on+new+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodcock%26aufirst%3DJ.%26aulast%3DWoosley%26aufirst%3DR.%26atitle%3DThe%2520FDA%2520critical%2520path%2520initiative%2520and%2520its%2520influence%2520on%2520new%2520drug%2520development%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2008%26volume%3D59%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span>Annual R&D General Metrics Study Highlights: New Success Rate and Cycle Time Data. <a href="https://www.kmrgroup.com/PressReleases/2012_08_08%20KMR%20PBF%20Success%20Rate%20&amp;%20Cycle%20Time%20Press%20Release.pdf" class="extLink">https://www.kmrgroup.com/PressReleases/2012_08_08%20KMR%20PBF%20Success%20Rate%20&%20Cycle%20Time%20Press%20Release.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Annual+R%26D+General+Metrics+Study+Highlights%3A+New+Success+Rate+and+Cycle+Time+Data.+https%3A%2F%2Fwww.kmrgroup.com%2FPressReleases%2F2012_08_08%2520KMR%2520PBF%2520Success%2520Rate%2520%26%2520Cycle%2520Time%2520Press%2520Release.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520R%2526D%2520General%2520Metrics%2520Study%2520Highlights%253A%2520New%2520Success%2520Rate%2520and%2520Cycle%2520Time%2520Data" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Matsuoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainer, T. G.</span><span> </span><span class="NLM_article-title">FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=9067304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2mt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1997&pages=1201-1209&author=N.+Matsuokaauthor=T.+G.+Ainer&title=FK960+%5BN-%284-acetyl-1-piperazinyl%29-p-fluorobenzamide+monohydrate%5D%2C+a+novel+potential+antidementia+drug%2C+improves+visual+recognition+memory+in+rhesus+monkeys%3A+comparison+with+physostigmine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine</span></div><div class="casAuthors">Matsuoka, Nobuya; Aigner, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1201-1209</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Our previous studies demonstrated that FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel antidementia piperazine deriv., exerts beneficial effects on memory deficits in various rodent models of amnesia, through activation of the somatostatin neuronal system.  To extend the antiamnesic action of FK960 to nonhuman primates, FK960 was evaluated for its ability to reverse the deficits in visual recognition memory produced by muscarinic cholinergic receptor blockade by scopolamine or N-methyl-D-aspartate receptor blockade by dizocilpine (MK-801) in four rhesus monkeys performing a computer-automated version of delayed nonmatching to sample, with a list length of 20 trial-unique graphic symbols.  Furthermore, the effects of FK960 were compared with those of physostigmine, a cholinesterase inhibitor.  Doses of FK960 (1, 3.2, 10, 32, 100, 320 or 1000 μg/kg) injected i.m. 30 min before testing minimally affected visual recognition memory when administered alone.  FK960 (1, 3.2, 10 or 32 μg/kg) significantly antagonized the deficits in visual recognition memory produced by scopolamine (10 μg/kg); the same doses of the drug minimally affected the deficits produced by dizocilpine (32 μg/kg).  Similarly, physostigmine (3.2, 10 or 32 μg/kg) significantly and dose-dependently restored the visual recognition memory deficits produced by scopolamine (10 μg/kg) but not those produced by dizocilpine (32 μg/kg).  From these results, we conclude that FK960 improves deficits in recognition memory assocd. with central cholinergic hypofunction in nonhuman primates, and we suggest that the therapeutic potential of this drug for patients with dementia should be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxySX2vsdGZrVg90H21EOLACvtfcHk0lhVO4EGWO20wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2mt7k%253D&md5=01cdae99e56666dc054dc7a22e08a64a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DN.%26aulast%3DAiner%26aufirst%3DT.%2BG.%26atitle%3DFK960%2520%255BN-%25284-acetyl-1-piperazinyl%2529-p-fluorobenzamide%2520monohydrate%255D%252C%2520a%2520novel%2520potential%2520antidementia%2520drug%252C%2520improves%2520visual%2520recognition%2520memory%2520in%2520rhesus%2520monkeys%253A%2520comparison%2520with%2520physostigmine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D280%26spage%3D1201%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span> </span><span class="NLM_article-title">Measurement of brain concentration of FK960 for development of a novel antidementia drug: a PET study in conscious rhesus monkeys</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=105-108&author=A.+Nodaauthor=H.+Takamatsuauthor=Y.+Murakamiauthor=K.+Yajimaauthor=M.+Tatsumiauthor=R.+Ichiseauthor=S.+Nishimura&title=Measurement+of+brain+concentration+of+FK960+for+development+of+a+novel+antidementia+drug%3A+a+PET+study+in+conscious+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DTakamatsu%26aufirst%3DH.%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DYajima%26aufirst%3DK.%26aulast%3DTatsumi%26aufirst%3DM.%26aulast%3DIchise%26aufirst%3DR.%26aulast%3DNishimura%26aufirst%3DS.%26atitle%3DMeasurement%2520of%2520brain%2520concentration%2520of%2520FK960%2520for%2520development%2520of%2520a%2520novel%2520antidementia%2520drug%253A%2520a%2520PET%2520study%2520in%2520conscious%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D105%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härtter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gründer, G.</span><span> </span><span class="NLM_article-title">High striatal occupancy of D<sub>2</sub>-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1017%2FS1461145704004353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15683553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=421-430&author=I.+Vernalekenauthor=T.+Siessmeierauthor=H.+G.+Buchholzauthor=S.+H%C3%A4rtterauthor=C.+Hiemkeauthor=P.+Stoeterauthor=F.+R%C3%B6schauthor=P.+Bartensteinauthor=G.+Gr%C3%BCnder&title=High+striatal+occupancy+of+D2-like+dopamine+receptors+by+amisulpride+in+the+brain+of+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span></div><div class="casAuthors">Vernaleken, Ingo; Siessmeier, Thomas; Buchholz, Hans-Georg; Haertter, Sebastian; Hiemke, Christoph; Stoeter, Peter; Roesch, Frank; Bartenstein, Peter; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The 'atypicality' of the antipsychotic drug, amisulpride, has been attributed to preferential extrastriatal binding.  Previous investigations of striatal D2 receptor occupancy by amisulpride revealed conflicting results.  The aim of this PET study was to measure the striatal occupancy by amisulpride and to correlate it with the corresponding drug plasma concns.  Nine amisulpride-treated patients and 12 healthy volunteers serving as controls were studied with PET and [18F]desmethoxyfallypride.  Occupancy values and plasma concns. were nonlinearly fitted to an Emax model.  Results showed 43-85% (putamen) and 67-90% (caudate) D2-like receptor occupancy.  Plasma amisulpride concns. at the time of tracer injection, but not administered doses, were significantly nonlinearly correlated to occupancy levels (putamen: rS=0.88, p=0.0017; caudate: rS=0.78, p=0.0127).  Calcd. Emax was similar in both caudate and putamen, but occupancy levels were lower in caudate at lower amisulpride plasma concns.  Calcd. plasma levels to attain 60-80% receptor occupancy ranged from 119 to 474 ng/mL (caudate) and from 241 to 732 ng/mL (putamen).  This reveals a broad range of plasma concns. producing less than 80% striatal receptor occupancy.  However, our data show high striatal D2-like receptor occupancies under rising plasma concns.  Using the full range of recommended amisulpride dosage, striatal occupancies up to 90% can be measured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6q7vccCXi7Vg90H21EOLACvtfcHk0lhVO4EGWO20wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D&md5=deadbde0ae4eaf69e5f3d96ab47f1e25</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1017%2FS1461145704004353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145704004353%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DH%25C3%25A4rtter%26aufirst%3DS.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DHigh%2520striatal%2520occupancy%2520of%2520D2-like%2520dopamine%2520receptors%2520by%2520amisulpride%2520in%2520the%2520brain%2520of%2520patients%2520with%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2004%26volume%3D7%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Willeit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusjan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitcu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">First human evidence of <span class="smallcaps smallerCapital">d</span>-amphetamine induced displacement of a D<sub>2/3</sub> agonist radioligand: a [<sup>11</sup>C]-(+)-PHNO positron emission tomography study</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=279-289&author=M.+Willeitauthor=N.+Ginovartauthor=A.+Graffauthor=P.+Rusjanauthor=I.+Vitcuauthor=S.+Houleauthor=P.+Seemanauthor=A.+A.+Wilsonauthor=S.+Kapur&title=First+human+evidence+of+d-amphetamine+induced+displacement+of+a+D2%2F3+agonist+radioligand%3A+a+%5B11C%5D-%28%2B%29-PHNO+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilleit%26aufirst%3DM.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DRusjan%26aufirst%3DP.%26aulast%3DVitcu%26aufirst%3DI.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DFirst%2520human%2520evidence%2520of%2520d-amphetamine%2520induced%2520displacement%2520of%2520a%2520D2%252F3%2520agonist%2520radioligand%253A%2520a%2520%255B11C%255D-%2528%252B%2529-PHNO%2520positron%2520emission%2520tomography%2520study%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">London, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascella, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Links, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herning, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, H. N.</span><span> </span><span class="NLM_article-title">Cocaine-induced reduction of glucose utilization in human brain</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.1990.01810180067010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2350209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=567-574&author=E.+D.+Londonauthor=N.+G.+Cascellaauthor=D.+F.+Wongauthor=R.+L.+Philipsauthor=R.+F.+Dannalsauthor=J.+M.+Linksauthor=R.+Herningauthor=R.+Graysonauthor=J.+H.+Jaffeauthor=H.+N.+Wagner&title=Cocaine-induced+reduction+of+glucose+utilization+in+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine-induced reduction of glucose utilization in human brain.  A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose</span></div><div class="casAuthors">London, Edythe D.; Cascella, Nicola G.; Wong, Dean F.; Phillips, Robert L.; Dannals, Robert F.; Links, Jonathan M.; Herning, Ronald; Grayson, Roger; Jaffe, Jerome H.; Wagner, Henry N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-74</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">The authors examd. the effects of cocaine hydrochloride (40 mg i.v.) on regional cerebral metabolic rates for glucose and on subjective self-reports of eight polydrug abusers in a double-blind, placebo-controlled, crossover study.  The regional cerebral metabolic rate for glucose was measured by the [fluorine 18]-fluorodeoxyglucose method, using positron emission tomog.  With eyes covered, subjects listened to a tape that presented white noise, "beep" prompts, and questions about subjective effects of cocaine or saline.  Cocaine produced euphoria and reduced glucose utilization globally (mean redn., 14%).  Twenty-six of 29 brain regions (all neocortical areas, basal ganglia, portions of the hippocampal formation, thalamus, and midbrain) showed significant decrements (5-26%) in the regional cerebral metabolic rate for glucose.  No significant effects of cocaine were obsd. in the pons, the cerebellar cortex, or the vermis.  Right-greater-than-left hemispheric asymmetry of regional cerebral metabolic rates for glucose occurred in the lateral thalamus.  The findings demonstrate that reduced cerebral metab. is assocd. with cocaine-induced euphoria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRzDNuNkul5LVg90H21EOLACvtfcHk0lhAXyLapOrDkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFKitw%253D%253D&md5=d3877ead43d8d2a21b346cafd49b4ce4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1990.01810180067010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1990.01810180067010%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DE.%2BD.%26aulast%3DCascella%26aufirst%3DN.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DPhilips%26aufirst%3DR.%2BL.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DLinks%26aufirst%3DJ.%2BM.%26aulast%3DHerning%26aufirst%3DR.%26aulast%3DGrayson%26aufirst%3DR.%26aulast%3DJaffe%26aufirst%3DJ.%2BH.%26aulast%3DWagner%26aufirst%3DH.%2BN.%26atitle%3DCocaine-induced%2520reduction%2520of%2520glucose%2520utilization%2520in%2520human%2520brain%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1990%26volume%3D47%26spage%3D567%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Bartzokis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkern, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridge, T. P.</span><span> </span><span class="NLM_article-title">Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=583-590&author=G.+Bartzokisauthor=M.+Becksonauthor=T.+Newtonauthor=M.+Mandelkernauthor=J.+Mintzauthor=J.+A.+Fosterauthor=W.+Lingauthor=T.+P.+Bridge&title=Selegiline+effects+on+cocaine-induced+changes+in+medial+temporal+lobe+metabolism+and+subjective+ratings+of+euphoria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartzokis%26aufirst%3DG.%26aulast%3DBeckson%26aufirst%3DM.%26aulast%3DNewton%26aufirst%3DT.%26aulast%3DMandelkern%26aufirst%3DM.%26aulast%3DMintz%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DJ.%2BA.%26aulast%3DLing%26aufirst%3DW.%26aulast%3DBridge%26aufirst%3DT.%2BP.%26atitle%3DSelegiline%2520effects%2520on%2520cocaine-induced%2520changes%2520in%2520medial%2520temporal%2520lobe%2520metabolism%2520and%2520subjective%2520ratings%2520of%2520euphoria%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D583%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmerer, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWherter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohórquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zartman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]MK-4232: the first positron emission tomography tracer for the calcitonin gene-related peptide receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400199p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=863-868&author=I.+M.+Bellauthor=S.+N.+Gallicchioauthor=C.+A.+Stumpauthor=J.+G.+Brunoauthor=H.+Fanauthor=L.+T.+Gantertauthor=E.+D.+Hostetlerauthor=A.+L.+Kemmererauthor=M.+McWherterauthor=E.+L.+Mooreauthor=S.+D.+Mosserauthor=M.+L.+Purcellauthor=K.+Riffelauthor=C.+A.+Salvatoreauthor=S.+Sanabria-Boh%C3%B3rquezauthor=D.+D.+Staasauthor=R.+B.+Whiteauthor=M.+Williamsauthor=C.+B.+Zartmanauthor=J.+J.+Cookauthor=R.+J.+Hargreavesauthor=S.+A.+Kaneauthor=S.+L.+Grahamauthor=H.+G.+Selnick&title=%5B11C%5DMK-4232%3A+the+first+positron+emission+tomography+tracer+for+the+calcitonin+gene-related+peptide+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml400199p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400199p%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DStump%26aufirst%3DC.%2BA.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DGantert%26aufirst%3DL.%2BT.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DKemmerer%26aufirst%3DA.%2BL.%26aulast%3DMcWherter%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DE.%2BL.%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DPurcell%26aufirst%3DM.%2BL.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DSanabria-Boh%25C3%25B3rquez%26aufirst%3DS.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DZartman%26aufirst%3DC.%2BB.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26atitle%3D%255B11C%255DMK-4232%253A%2520the%2520first%2520positron%2520emission%2520tomography%2520tracer%2520for%2520the%2520calcitonin%2520gene-related%2520peptide%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D863%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohórquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Hecken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdelinckx, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynders, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Declercq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lepeleire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcantonio, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span> </span><span class="NLM_article-title">In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [<sup>11</sup>C]MK-4232</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1124%2Fjpet.113.206458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=23975906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=478-486&author=E.+D.+Hostetlerauthor=A.+D.+Joshiauthor=S.+Sanabria-Boh%C3%B3rquezauthor=H.+Fanauthor=Z.+Zengauthor=M.+Purcellauthor=L.+Gantertauthor=K.+Riffelauthor=M.+Williamsauthor=S.+O%E2%80%99Malleyauthor=P.+Millerauthor=H.+G.+Selnickauthor=S.+N.+Gallicchioauthor=I.+M.+Bellauthor=C.+A.+Salvatoreauthor=S.+A.+Kaneauthor=C.+C.+Liauthor=R.+J.+Hargreavesauthor=T.+de+Grootauthor=G.+Bormansauthor=A.+Van+Heckenauthor=I.+Derdelinckxauthor=J.+de+Hoonauthor=T.+Reyndersauthor=R.+Declercqauthor=I.+De+Lepeleireauthor=W.+P.+Kennedyauthor=R.+Blanchardauthor=E.+E.+Marcantonioauthor=C.+Surauthor=J.+J.+Cookauthor=K.+Van+Laereauthor=J.+L.+Evelhoch&title=In+vivo+quantification+of+calcitonin+gene-related+peptide+receptor+occupancy+by+telcagepant+in+rhesus+monkey+and+human+brain+using+the+positron+emission+tomography+tracer+%5B11C%5DMK-4232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo quantification of calcitonin gene-related peptide receptor occupancy by Telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232</span></div><div class="casAuthors">Hostetler, Eric D.; Joshi, Aniket D.; Sanabria-Bohorquez, Sandra; Fan, Hong; Zeng, Zhizhen; Purcell, Mona; Gantert, Liza; Riffel, Kerry; Williams, Mangay; O'Malley, Stacey; Miller, Patricia; Selnick, Harold G.; Gallicchio, Steven N.; Bell, Ian M.; Salvatore, Christopher A.; Kane, Stefanie A.; Li, Chi-Chung; Hargreaves, Richard J.; de Groot, Tjibbe; Bormans, Guy; Van Hecken, Anne; Derdelinckx, Inge; de Hoon, Jan; Reynders, Tom; Declercq, Ruben; De Lepeleire, Inge; Kennedy, W. P.; Blanchard, Rebecca; Marcantonio, Eugene E.; Sur, Cyrille; Cook, Jacquelynn J.; Van Laere, Koen; Evelhoch, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">478-486</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Calcitonin gene-related peptide (CGRP) is a potent neuropeptide whose agonist interaction with the CGRP receptor (CGRP-R) in the periphery promotes vasodilation, neurogenic inflammation and trigemino-vascular sensory activation.  This process is implicated in the cause of migraine headaches, and CGRP-R antagonists in clin. development have proven effective in treating migraine-related pain in humans.  CGRP-R is expressed on blood vessel smooth muscle and sensory trigeminal neurons and fibers in the periphery as well as in the central nervous system.  However, it is not clear what role the inhibition of central CGRP-R plays in migraine pain relief.  To this end, the CGRP-R positron emission tomog. (PET) tracer [11C]MK-4232 (2-[(8R)-8-(3,5-difluorophenyl)-6,8-[6-11C]dimethyl-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(2R)-2'-oxospiro[1,3-dihydroindene-2,3'-1H-pyrrolo[2,3-b]pyridine]-5-yl]acetamide) was discovered and developed for use in clin. PET studies.  In rhesus monkeys and humans, [11C]MK-4232 displayed rapid brain uptake and a regional brain distribution consistent with the known distribution of CGRP-R.  Monkey PET studies with [11C]MK-4232 after i.v. dosing with CGRP-R antagonists validated the ability of [11C]MK-4232 to detect changes in CGRP-R occupancy in proportion to drug plasma concn.  Application of [11C]MK-4232 in human PET studies revealed that Telcagepant achieved only low receptor occupancy at an efficacious dose (140 mg PO).  Therefore, it is unlikely that antagonism of central CGRP-R is required for migraine efficacy.  However, it is not known whether high central CGRP-R antagonism may provide addnl. therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-pRUySstGbVg90H21EOLACvtfcHk0lhAXyLapOrDkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrK&md5=75cb284982d94eea2117ed26697a6cfd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.206458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.206458%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DSanabria-Boh%25C3%25B3rquez%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DC.%2BC.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26aulast%3Dde%2BGroot%26aufirst%3DT.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BHecken%26aufirst%3DA.%26aulast%3DDerdelinckx%26aufirst%3DI.%26aulast%3Dde%2BHoon%26aufirst%3DJ.%26aulast%3DReynders%26aufirst%3DT.%26aulast%3DDeclercq%26aufirst%3DR.%26aulast%3DDe%2BLepeleire%26aufirst%3DI.%26aulast%3DKennedy%26aufirst%3DW.%2BP.%26aulast%3DBlanchard%26aufirst%3DR.%26aulast%3DMarcantonio%26aufirst%3DE.%2BE.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26atitle%3DIn%2520vivo%2520quantification%2520of%2520calcitonin%2520gene-related%2520peptide%2520receptor%2520occupancy%2520by%2520telcagepant%2520in%2520rhesus%2520monkey%2520and%2520human%2520brain%2520using%2520the%2520positron%2520emission%2520tomography%2520tracer%2520%255B11C%255DMK-4232%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D478%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Antoni, G.; Kihlberg, T.; Langström, B.</span><span> </span><span class="NLM_article-title"><sup>11</sup>C: Labeling chemistry and labeled compounds</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1977</span><span class="NLM_x">–</span> <span class="NLM_lpage">2019</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-4419-0720-2_41" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1977-2019&author=G.+Antoni&author=T.+Kihlberg&author=B.+Langstr%C3%B6mauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0720-2_41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-0720-2_41%26sid%3Dliteratum%253Aachs%26aulast%3DAntoni%26aufirst%3DG.%26atitle%3D11C%253A%2520Labeling%2520chemistry%2520and%2520labeled%2520compounds%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011%26spage%3D1977%26epage%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1881</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+M%C3%BCllerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceuticals: Looking Beyond Intuition</span></div><div class="casAuthors">Mueller, Klaus; Faeh, Christoph; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-1886</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all phys. and adsorption, distribution, metab., and excretion properties of a lead compd.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on mol. conformation of the drug, has only recently begun.  Here, we review exptl. progress in this vein and add complementary anal. based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwX-YnONRc3LVg90H21EOLACvtfcHk0liqsvY1ozcpmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN&md5=f804876c801518e48d0bdb7d87b7fb1c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Ross, T. L.; Wester, H. J.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F: labeling chemistry and labeled compounds</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2071</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-4419-0720-2_42" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=2021-2071&author=T.+L.+Ross&author=H.+J.+Westerauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0720-2_42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-0720-2_42%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DT.%2BL.%26atitle%3D18F%253A%2520labeling%2520chemistry%2520and%2520labeled%2520compounds%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011%26spage%3D2021%26epage%3D2071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Snyder, S. E.; Kilbourn, M. R.</span><span> </span><span class="NLM_article-title">Chemistry of fluorine-18 radiopharmaceuticals</span>. In  <span class="citation_source-book">Handbook of Radiopharmaceuticals, Radiochemistry and Applications</span>; <span class="NLM_contrib-group">Welch, M. J.; Redvanly, C. S.</span>, Eds.; <span class="NLM_publisher-name">Wiley & Sons Ltd</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=195-228&author=S.+E.+Snyder&author=M.+R.+Kilbournauthor=M.+J.+Welch&author=C.+S.+Redvanly&title=Handbook+of+Radiopharmaceuticals%2C+Radiochemistry+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DS.%2BE.%26atitle%3DChemistry%2520of%2520fluorine-18%2520radiopharmaceuticals%26btitle%3DHandbook%2520of%2520Radiopharmaceuticals%252C%2520Radiochemistry%2520and%2520Applications%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26pub%3DWiley%2520%2526%2520Sons%2520Ltd%26date%3D2003%26spage%3D195%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Beattie, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span> </span><span class="NLM_article-title">The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">3149</span><span class="NLM_x">–</span> <span class="NLM_lpage">3157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1476-5381.1995.tb15117.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8719789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK28XitFWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1995&pages=3149-3157&author=D.+T.+Beattieauthor=I.+J.+Beresfordauthor=H.+E.+Connorauthor=F.+Marshallauthor=A.+B.+Hancockauthor=R.+M.+Haganauthor=J.+Bowersauthor=P.+J.+Birchauthor=P.+Ward&title=The+pharmacology+of+GR203040%2C+a+novel%2C+potent+and+selective+non-peptide+tachykinin+NK1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist</span></div><div class="casAuthors">Beattie, D. T.; Beresford, I. J. M.; Connor, H. E.; Marshall, F. H.; Hawcock, A. B.; Hagan, R. M.; Bowers, J.; Birch, P. J.; Ward, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3149-57</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The in vitro and in vivo pharmacol. of GR203040 ((2S, 3S)-2-methoxy-5-tetrazol-1-yl-benzyl-(2-phenyl-piperidin-3-yl)-amine), a novel, highly potent and selective non-peptide tachykinin NK1 receptor antagonist, was investigated in the present study.  GR203040 potently inhibited [3H]-substance P binding to human NK1 receptors expressed in Chinese hamster ovary (CHO) and U373 MG astrocytoma cells, and NK1 receptors in ferret and gerbil cortex (pKi values of 10.3, 10.5, 10.1 and 10.1 resp.).  GR203040 had lower affinity at rat NK1 receptors (pKi = 8.6) and little affinity for human NK2 receptors (pKi <5.0) in CHO cells and NK3 receptors in guinea-pig cortex (pKi <6.0).  With the exception of the histamine H1 receptor (pIC50 = 7.5), GR203040 had little affinity (pIC50 <6.0) at all non-NK1 receptors and ion channels examd.  Furthermore, GR203040 produced only weak inhibition of Na+ currents in SH-SY5Y neuroblastoma and superior cervical ganglion cells (pIC50 values <4.0).  GR203040 produced only weak antagonism of Ca2+-evoked contractions of rat isolated portal vein (pKB = 4.1).  The enantiomer of GR203040, GR205608 ((2R, 3R)-2-methoxy-5-tetrazol-1-yl-benzyl-(2-phenyl-piperidin-3-yl)-amine), had 10,000 fold lower affinity at the human NK1 receptor expressed in CHO cells (pKi = 6.3).  In gerbil ex vivo binding expts., GR203040 produced a dose-dependent inhibition of the binding of [3H]-substance P to cerebral cortical membranes (ED50 = 15 μg kg-1 s.c. and 0.42 mg kg-1 p.o.).  At 10 μg kg-1 s.c., the inhibition of [3H]-substance P binding was maintained for >6 h.  In the rat, GR203040 was less potent (ED50 = 15.4 mg kg-1 s.c.) probably reflecting, at least in part, its lower affinity at the rat NK1 receptor.  In guinea-pig isolated ileum and dog isolated middle cerebral and basilar arteries GR203040 produced a rightward displacement of the concn.-effect curves to substance P Me ester (SPOMe) with suppression of the max. agonist response (apparent pKB values of 11.9, 11.2 and 11.1 resp.).  In anesthetized rabbits, GR203040 antagonized redns. in carotid arterial vascular resistance evoked by SPOMe, injected via the lingual artery (DR10 (i.e. the dose producing a dose-ratio of 10) = 1.1 μg kg-1 i.v.).  At a dose 20 fold grater than its DR10 value (i.e. 22 μg kg-1, i.v.) significant antagonism was evident more than 2 h after GR203040 administration.  In anesthetized rats, GR203040 (3 and 10 mg kg-1, i.v.) produced a dose-dependent inhibition of plasma protein extravasation in dura mater, conjunctiva, eyelid and lip in response to elec. stimulation of the trigeminal ganglion.  It is concluded that GR203040 is one of the most potent and selective NK1 receptor antagonists yet described, and as such, has considerable potential as a pharmacol. tool to characterize the physiol. and pathol. roles of substance P and NK1 receptors.  GR203040 may also have potential as a novel therapeutic agent for the treatment of conditions such as migraine, emesis and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkMSmUHY0bbrVg90H21EOLACvtfcHk0lg_ZRatbU5Qhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFWktA%253D%253D&md5=f8825fcc8f891c49604619a1ff31ae31</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb15117.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb15117.x%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DBeresford%26aufirst%3DI.%2BJ.%26aulast%3DConnor%26aufirst%3DH.%2BE.%26aulast%3DMarshall%26aufirst%3DF.%26aulast%3DHancock%26aufirst%3DA.%2BB.%26aulast%3DHagan%26aufirst%3DR.%2BM.%26aulast%3DBowers%26aufirst%3DJ.%26aulast%3DBirch%26aufirst%3DP.%2BJ.%26aulast%3DWard%26aufirst%3DP.%26atitle%3DThe%2520pharmacology%2520of%2520GR203040%252C%2520a%2520novel%252C%2520potent%2520and%2520selective%2520non-peptide%2520tachykinin%2520NK1%2520receptor%2520antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D116%26spage%3D3149%26epage%3D3157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Gardner, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawcock, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twissell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span> </span><span class="NLM_article-title">GR 205171: A novel antagonist with high affinity for the tachykinin NK-1 receptor and potent broad-spectrum anti-emetic activity</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0167-0115%2896%2900071-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8876035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK28XkvFansro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=45-53&author=C.+J.+Gardnerauthor=D.+R.+Armourauthor=D.+T.+Beattieauthor=J.+D.+Galeauthor=A.+B.+Hawcockauthor=G.+J.+Kilpatrickauthor=D.+J.+Twissellauthor=P.+Ward&title=GR+205171%3A+A+novel+antagonist+with+high+affinity+for+the+tachykinin+NK-1+receptor+and+potent+broad-spectrum+anti-emetic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">GR 205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity</span></div><div class="casAuthors">Gardner, C. J.; Armour, D. R.; Beattie, D. T.; Gale, J. D.; Hawcock, A. B.; Kilpatrick, G. J.; Twissell, D. J.; Ward, P.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">It has been demonstrated recently that antagonists of the tachykinin NK1 receptor, specifically CP-99994 and GR 203040, possess antiemetic activity in a range of species.  To optimize this activity, a series of analogs based around the structure of GR 203040 have been synthesized and their affinity at the human tachykinin NK1 receptor detd.  In addn., the potency of these analogs to inhibit emesis induced in the ferret by whole-body X-irradn. has been examd.  A range of substitutions at the C-1 position of the tetrazole moiety in GR 203040 were explored in vitro and in vivo.  The trifluoromethyl compd., GR 205171, was the most potent antagonist with regard to the ability to inhibit emesis induced by X-irradn.  This compd. was demonstrated to have a broad spectrum of anti-emetic activity, inhibiting emesis in the ferret induced by cisplatin, cyclophosphamide, morphine, ipecacuanha and copper sulfate.  Furthermore, emesis was also inhibited in the house-musk shrew, Suncus murinus, when induced by either motion or cisplatin, and in the dog when induced by ipecacuanha.  GR 205171 has the most potent anti-emetic activity of any tachykinin NK1 receptor antagonist described to date.  The compd. is orally active in the ferret and dog, long-lasting, and warrants further investigation as a potential broad-spectrum anti-emetic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-dLTgedcZ7Vg90H21EOLACvtfcHk0lg_ZRatbU5Qhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFansro%253D&md5=79cba2eb7f51dfc4a0d90c7fa5859fcf</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0167-0115%2896%2900071-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-0115%252896%252900071-7%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DC.%2BJ.%26aulast%3DArmour%26aufirst%3DD.%2BR.%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DGale%26aufirst%3DJ.%2BD.%26aulast%3DHawcock%26aufirst%3DA.%2BB.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DTwissell%26aufirst%3DD.%2BJ.%26aulast%3DWard%26aufirst%3DP.%26atitle%3DGR%2520205171%253A%2520A%2520novel%2520antagonist%2520with%2520high%2520affinity%2520for%2520the%2520tachykinin%2520NK-1%2520receptor%2520and%2520potent%2520broad-spectrum%2520anti-emetic%2520activity%26jtitle%3DRegul.%2520Pept.%26date%3D1996%26volume%3D65%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Muñoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coveñaz, R.</span><span> </span><span class="NLM_article-title">NK-1 receptor antagonists: a new paradigm in pharmacological therapy</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1831</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.2174%2F092986711795496746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=21466470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Cntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1820-1831&author=M.+Mu%C3%B1ozauthor=R.+Cove%C3%B1az&title=NK-1+receptor+antagonists%3A+a+new+paradigm+in+pharmacological+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">NK-1 receptor antagonists: a new paradigm in pharmacological therapy</span></div><div class="casAuthors">Munoz, M.; Covenas, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1820-1831</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The neuropeptide substance P (SP) shows a widespread distribution in both the central and peripheral nervous systems and it is known that after binding to the neurokinin-1 (NK-1) receptors, SP regulates many biol. functions in the central nervous system such as emotional behavior, stress, depression, anxiety, emesis, migraine, alc. addiction and neurodegeneration.  SP was also implicated in pain, inflammation, hepatotoxicity and in virus proliferation, and it plays an important role in cancer (e.g., tumor cell proliferation, angiogenesis, and the migration of tumor cells for invasion and metastasis).  By contrast, it is known that after binding to NK-1 receptors, NK-1 receptor antagonists specifically inhibit the above-mentioned biol. functions mediated by SP.  Thus, these antagonists exert an anxyolitic, antidepressant, antiemetic, antimigraine, antialc. addiction or neuroprotector effect in the central nervous system, and they play a role in analgesic, antiinflammatory, hepatoprotector processes and in antivirus proliferation.  Regarding cancer, NK-1 receptor antagonists exert an antitumor action (inducing tumor cell death by apoptosis), and induce antiangiogenesis and inhibit the migration of tumor cells.  It is also known that NK-1 receptors have a widespread distribution and that they are overexpressed in tumor cells.  Thus, NK-1 receptor antagonists are molecularly targeted agents.  In general, current drugs have a single therapeutic effect, although less commonly they may exert several.  However, the data reported above indicate that NK-1 receptor antagonists are promising drugs, exerting many therapeutic effects (the action of such antagonists is dose-dependent and, depending on the concn., has more pos. effects).  In this review, we update the multiple therapeutic effects exerted by NK-1 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJXrZR2GmS8rVg90H21EOLACvtfcHk0lg_ZRatbU5Qhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Cntr0%253D&md5=570fec14114e3ae37b9db8ff7b07cac8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2174%2F092986711795496746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795496746%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DCove%25C3%25B1az%26aufirst%3DR.%26atitle%3DNK-1%2520receptor%2520antagonists%253A%2520a%2520new%2520paradigm%2520in%2520pharmacological%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1820%26epage%3D1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Bergström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasth, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipperman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langström, B.</span><span> </span><span class="NLM_article-title">Brain uptake and receptor binding of two [<sup>11</sup>C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171 – PET studies in rhesus monkey</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=664-670&author=M.+Bergstr%C3%B6mauthor=K.+J.+Fasthauthor=G.+Kilpatrickauthor=P.+Wardauthor=K.+M.+Cableauthor=M.+D.+Wippermanauthor=D.+R.+Sutherlandauthor=B.+Langstr%C3%B6m&title=Brain+uptake+and+receptor+binding+of+two+%5B11C%5Dlabelled+selective+high+affinity+NK1-antagonists%2C+GR203040+and+GR205171+%E2%80%93+PET+studies+in+rhesus+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DFasth%26aufirst%3DK.%2BJ.%26aulast%3DKilpatrick%26aufirst%3DG.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DCable%26aufirst%3DK.%2BM.%26aulast%3DWipperman%26aufirst%3DM.%2BD.%26aulast%3DSutherland%26aufirst%3DD.%2BR.%26aulast%3DLangstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DBrain%2520uptake%2520and%2520receptor%2520binding%2520of%2520two%2520%255B11C%255Dlabelled%2520selective%2520high%2520affinity%2520NK1-antagonists%252C%2520GR203040%2520and%2520GR205171%2520%25E2%2580%2593%2520PET%2520studies%2520in%2520rhesus%2520monkey%26jtitle%3DNeuropharmacology%26date%3D2000%26volume%3D39%26spage%3D664%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Quartara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, M.</span><span> </span><span class="NLM_article-title">Tachykinin receptors antagonists: from research to clinic</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.2174%2F138945006778019381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16918326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=975-992&author=L.+Quartaraauthor=M.+Altamura&title=Tachykinin+receptors+antagonists%3A+from+research+to+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Tachykinin receptors antagonists: from research to clinic</span></div><div class="casAuthors">Quartara, Laura; Altamura, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">975-992</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In this chapter it is described how, starting from different approaches and through extensive medicinal chem. studies, several discovery compds. were optimized and reached the development stage.  The first tachykinin receptor antagonist to reach the market in 2003 for chemotherapy-induced emesis has been aprepitant.  Other clin. candidates (for central nervous system disorders: osanetant, talnetant and saredutant; for irritable bowel syndrome: nepadutant and saredutant) are in advanced clin. phase.  The clin. studies reported in the literature and the destiny of the clin. candidates, where available, will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqyVMlWvL_ibVg90H21EOLACvtfcHk0lgGVEHbjDw3Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslCls7o%253D&md5=b7b74fa43a517992ff90306e9ca470e2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F138945006778019381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006778019381%26sid%3Dliteratum%253Aachs%26aulast%3DQuartara%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DM.%26atitle%3DTachykinin%2520receptors%2520antagonists%253A%2520from%2520research%2520to%2520clinic%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D975%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Hurko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. L.</span><span> </span><span class="NLM_article-title">Translational research in central nervous system drug discovery</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=671-682&author=O.+Hurkoauthor=J.+L.+Ryan&title=Translational+research+in+central+nervous+system+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurko%26aufirst%3DO.%26aulast%3DRyan%26aufirst%3DJ.%2BL.%26atitle%3DTranslational%2520research%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D671%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaalburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span> </span><span class="NLM_article-title">Measuring drug-related receptor occupancy with positron emission tomography</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=278-286&author=J.+Passchierauthor=A.+Geeauthor=A.+Willemsenauthor=W.+Vaalburgauthor=A.+van+Waarde&title=Measuring+drug-related+receptor+occupancy+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGee%26aufirst%3DA.%26aulast%3DWillemsen%26aufirst%3DA.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26atitle%3DMeasuring%2520drug-related%2520receptor%2520occupancy%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMethods%26date%3D2002%26volume%3D27%26spage%3D278%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Muly, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votaw, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, L. L.</span><span> </span><span class="NLM_article-title">Relationship between dose, drug levels, and D<sub>2</sub> receptor occupancy for the atypical antipsychotics risperidone and paliperidone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1124%2Fjpet.111.189076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=22214649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVagtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=81-89&author=E.+C.+Mulyauthor=J.+R.+Votawauthor=L.+L.+Howell&title=Relationship+between+dose%2C+drug+levels%2C+and+D2+receptor+occupancy+for+the+atypical+antipsychotics+risperidone+and+paliperidone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone</span></div><div class="casAuthors">Muly, E. C.; Votaw, J. R.; Ritchie, J.; Howell, L. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Blockade of D2 family dopamine receptors (D2Rs) is a fundamental property of antipsychotics, and the degree of striatal D2R occupancy has been related to antipsychotic and motor effects of these drugs.  Recent studies suggest the D2R occupancy of antipsychotics may differ in extrastriatal regions compared with the dorsal striatum.  We studied this issue in macaque monkeys by using a within-subjects design.  [18F]fallypride positron emission tomog. scans were obtained on four different doses of risperidone and paliperidone (the 9-OH metabolite of risperidone) and compared with multiple off-drug scans in each animal.  The half-life of the two drugs in these monkeys was detd. to be between 3 and 4 h, and drug was administered by a const. infusion through an intragastric catheter.  The D2R occupancy of antipsychotic was detd. in the caudate, putamen, ventral striatum, and four prefrontal and temporal cortical regions and was related to serum and cerebrospinal fluid drug levels.  Repeated 2-wk treatment with risperidone or paliperidone did not produce lasting changes in D2R binding potential in any region examd.  As expected, D2R binding potential was highest in the caudate and putamen and was approx. one-third that level in the ventral striatum and 2% of that level in the cortical regions.  We found dose-dependent D2R occupancy for both risperidone and paliperidone in both basal ganglia and cortical regions of interest.  We could not find evidence of regional variation in D2R occupancy of either drug.  Comparison of D2R occupancy and serum drug levels supports a target of 40 to 80 ng/mL active drug for these two atypical antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9w7SZvp2gbLVg90H21EOLACvtfcHk0lgGVEHbjDw3Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVagtbs%253D&md5=c81293066e4db710684b7d5ade14872f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.189076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.189076%26sid%3Dliteratum%253Aachs%26aulast%3DMuly%26aufirst%3DE.%2BC.%26aulast%3DVotaw%26aufirst%3DJ.%2BR.%26aulast%3DHowell%26aufirst%3DL.%2BL.%26atitle%3DRelationship%2520between%2520dose%252C%2520drug%2520levels%252C%2520and%2520D2%2520receptor%2520occupancy%2520for%2520the%2520atypical%2520antipsychotics%2520risperidone%2520and%2520paliperidone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span> </span><span class="NLM_article-title">Effects of the serotonin 5-HT<sub>2A/2C</sub> receptor agonist and of the selective 5-HT<sub>2A</sub> or 5-HT<sub>2C</sub> receptor antagonists EMD 281014 and SB- 243213, respectively, on sleep and waking in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.ejphar.2006.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17059817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=163-167&author=J.+M.+Montiauthor=H.+Jantos&title=Effects+of+the+serotonin+5-HT2A%2F2C+receptor+agonist+and+of+the+selective+5-HT2A+or+5-HT2C+receptor+antagonists+EMD+281014+and+SB-+243213%2C+respectively%2C+on+sleep+and+waking+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat</span></div><div class="casAuthors">Monti, Jaime M.; Jantos, Hector</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects of the serotonin 5-HT2A/2C receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and of the selective 5-HT2A or 5-HT2C receptor antagonists 7-{4-[2-(4-fluoro-phenyl)-ethyl]-piperazine-1-carbonyl}-1H-indole-3-carbonitrile HCl (EMD 281014) and 5-methyl-1-[[-2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline HCl (SB-243213), resp., on spontaneous sleep were studied in adult rats implanted for chronic sleep recordings.  S.c. administration of DOI (0.35-0.7 mmol/kg) significantly increased waking and light sleep and reduced slow wave sleep, rapid-eye-movement (REM) sleep, and the no. of REM periods.  With s.c. EMD 281014 (1.2-4.8 mmol/kg) or SB-243213 (1.2-4.8 mmol/kg) a significant redn. in time spent in REM sleep was also seen.  Pretreatment with EMD 281014 prevented the DOI-induced increase of waking and light sleep and the redn. of slow wave sleep.  However, REM sleep remained suppressed.  SB-243213 failed to reverse the changes of sleep and waking induced by DOI.  Thus, on the basis of these results it appears that serotonin 5-HT2A receptor mechanisms might be responsible for the DOI-induced effects on waking and slow wave sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYNE3-PqoT7Vg90H21EOLACvtfcHk0lgGVEHbjDw3Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM&md5=562384708b4da429f87b73286570f5de</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26atitle%3DEffects%2520of%2520the%2520serotonin%25205-HT2A%252F2C%2520receptor%2520agonist%2520and%2520of%2520the%2520selective%25205-HT2A%2520or%25205-HT2C%2520receptor%2520antagonists%2520EMD%2520281014%2520and%2520SB-%2520243213%252C%2520respectively%252C%2520on%2520sleep%2520and%2520waking%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D163%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Adamec, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creamer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, P.</span><span> </span><span class="NLM_article-title">Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">504</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.ejphar.2004.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15507224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFansLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2004&pages=79-96&author=R.+Adamecauthor=K.+Creamerauthor=G.+D.+Bartoszykauthor=P.+Burton&title=Prophylactic+and+therapeutic+effects+of+acute+systemic+injections+of+EMD+281014%2C+a+selective+serotonin+2A+receptor+antagonist+on+anxiety+induced+by+predator+stress+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats</span></div><div class="casAuthors">Adamec, Robert; Creamer, Katherine; Bartoszyk, Gerd D.; Burton, Paul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">79-96</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effect of the selective serotonin 2A (5-HT2A) receptor antagonist 7-[4-[2-(4-fluorophenyl)ethyl]piperazine-1-carbonyl]-1H-indole-3-carbonitrile HCl (EMD 281014) [Bartoszyk, G.D., van Amsterdam, C., Bottcher, H., Seyfried, C.A., 2003. EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. Eur. J. Pharmacol. 473, 229-230.] on change in affect following predator stress.  Predator stress involved a 5 min unprotected exposure of rats to a domestic cat.  Behavioral effects of stress were evaluated with hole board, plus maze, light/dark box and acoustic startle tests 1 wk after stress.  Predator stress increased anxiety-like behavior in the plus maze, light/dark box, and elevated response to acoustic startle.  EMD 281014 (0.001, 0.01, 0.1, 1 or 10 mg/kg) and vehicle injection (i.p.) occurred either 10 min after predator stress (prophylactic testing), or 90 min prior to behavioral testing for the effects of predator stress (therapeutic testing 1 wk after predator stress).  In prophylactic testing, EMD 281014 prevented stress potentiation of startle in a dose dependent manner, though the most EDs were midrange (0.01 and 0.1 mg/kg).  Prophylactic administration of EMD 281014 also prevented stress-induced increase of open arm avoidance in the plus maze in a clear dose dependent manner (from 0.01 mg/kg onward).  In therapeutic testing, EMD 281014 had no clear drug dependent effects on stress elevation of startle or on behavior of stressed rats in the elevated plus maze.  Finally, EMD 281014 did not block the effects of stress on behavior in the light/dark box when given prophylactically or therapeutically.  Findings implicate 5-HT2A receptors in initiation of some but not all lasting changes in anxiety-like behavior following predator stress.  Potential clin. significance of findings are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHlt-leiRZjrVg90H21EOLACvtfcHk0lgoG1Lm_EDQkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFansLw%253D&md5=0c2c8d980c46cbd2714df6d44dfb9ef7</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DAdamec%26aufirst%3DR.%26aulast%3DCreamer%26aufirst%3DK.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26aulast%3DBurton%26aufirst%3DP.%26atitle%3DProphylactic%2520and%2520therapeutic%2520effects%2520of%2520acute%2520systemic%2520injections%2520of%2520EMD%2520281014%252C%2520a%2520selective%2520serotonin%25202A%2520receptor%2520antagonist%2520on%2520anxiety%2520induced%2520by%2520predator%2520stress%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D504%26spage%3D79%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Mamo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romach, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">EMD 281014, a specific and potent 5-HT<sub>2</sub> antagonist in humans: a dose-finding PET study</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2004&pages=382-388&author=D.+Mamoauthor=E.+Sedmanauthor=J.+Tillnerauthor=E.+M.+Sellersauthor=M.+K.+Romachauthor=S.+Kapur&title=EMD+281014%2C+a+specific+and+potent+5-HT2+antagonist+in+humans%3A+a+dose-finding+PET+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMamo%26aufirst%3DD.%26aulast%3DSedman%26aufirst%3DE.%26aulast%3DTillner%26aufirst%3DJ.%26aulast%3DSellers%26aufirst%3DE.%2BM.%26aulast%3DRomach%26aufirst%3DM.%2BK.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DEMD%2520281014%252C%2520a%2520specific%2520and%2520potent%25205-HT2%2520antagonist%2520in%2520humans%253A%2520a%2520dose-finding%2520PET%2520study%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D175%26spage%3D382%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offord, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzmann, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymanski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span> </span><span class="NLM_article-title">Time course of 5-HT<sub>2A</sub> receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=175-185&author=G.+Gr%C3%BCnderauthor=F.+Yokoiauthor=S.+J.+Offordauthor=H.+T.+Ravertauthor=R.+F.+Dannalsauthor=J.+K.+Salzmannauthor=S.+Szymanskiauthor=P.+D.+Wilsonauthor=D.+R.+Howardauthor=D.+F.+Wong&title=Time+course+of+5-HT2A+receptor+occupancy+in+the+human+brain+after+a+single+oral+dose+of+the+putative+antipsychotic+drug+MDL+100%2C907+measured+by+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DYokoi%26aufirst%3DF.%26aulast%3DOfford%26aufirst%3DS.%2BJ.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DSalzmann%26aufirst%3DJ.%2BK.%26aulast%3DSzymanski%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DP.%2BD.%26aulast%3DHoward%26aufirst%3DD.%2BR.%26aulast%3DWong%26aufirst%3DD.%2BF.%26atitle%3DTime%2520course%2520of%25205-HT2A%2520receptor%2520occupancy%2520in%2520the%2520human%2520brain%2520after%2520a%2520single%2520oral%2520dose%2520of%2520the%2520putative%2520antipsychotic%2520drug%2520MDL%2520100%252C907%2520measured%2520by%2520positron%2520emission%2520tomography%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D17%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Spreckelmeyer, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulzen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltus, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffrath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waesberghe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gründer, G.</span><span> </span><span class="NLM_article-title">Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [<sup>18</sup>F]fallypride positron emission tomography study</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.biopsych.2011.05.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=21802658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=770-776&author=K.+N.+Spreckelmeyerauthor=M.+Paulzenauthor=M.+Raptisauthor=T.+Baltusauthor=S.+Schaffrathauthor=J.+Van+Waesbergheauthor=M.+M.+Zalewskiauthor=F.+R%C3%B6schauthor=I.+Vernalekenauthor=W.+M.+Sch%C3%A4ferauthor=G.+Gr%C3%BCnder&title=Opiate-induced+dopamine+release+is+modulated+by+severity+of+alcohol+dependence%3A+an+%5B18F%5Dfallypride+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Opiate-Induced Dopamine Release Is Modulated by Severity of Alcohol Dependence: An [18F]Fallypride Positron Emission Tomography Study</span></div><div class="casAuthors">Spreckelmeyer, Katja N.; Paulzen, Michael; Raptis, Mardjan; Baltus, Thomas; Schaffrath, Sabrina; Van Waesberghe, Julia; Zalewski, Magdalena M.; Roesch, Frank; Vernaleken, Ingo; Schaefer, Wolfgang M.; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">770-776</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Preclin. data implicate the reinforcing effects of alc. to be mediated by interaction between the opioid and dopamine systems of the brain.  Specifically, alc.-induced release of β-endorphins stimulates μ-opioid receptors (MORs), which is believed to cause dopamine release in the brain reward system.  Individual differences in opioid or dopamine neurotransmission have been suggested to be responsible for enhanced liability to abuse alc.  In the present study, a single dose of the MOR agonist remifentanil was administered in detoxified alc.-dependent patients and healthy control subjects to mimic the β-endorphin-releasing properties of ethanol and to assess the effects of direct MOR stimulation on dopamine release in the mesolimbic reward system.  Methods: Availability of D2/3 receptors was assessed before and after single-dose administration of the MOR agonist remifentanil in 11 detoxified alc.-dependent patients and 11 healthy control subjects with positron emission tomog. with the radiotracer [18F]fallypride.  Severity of dependence as assessed with the Alc. Use Disorders Identification Test was compared with remifentanil-induced percentage change in [18F]fallypride binding (Δ%BPND).  Results: The [18F]fallypride binding potentials (BPNDs) were significantly reduced in the ventral striatum, dorsal putamen, and amygdala after remifentanil application in both patients and control subjects.  In the patient group, ventral striatum Δ%BPND was correlated with the Alc. Use Disorders Identification Test score.  Conclusions: The data provide evidence for a MOR-mediated interaction between the opioid and the dopamine system, supporting the assumption that one way by which alc. unfolds its rewarding effects is via a MOR-(γ-aminobutyric acid)-dopamine pathway.  No difference in dopamine release was found between patients and control subjects, but evidence for a patient-specific assocn. between sensitivity to MOR stimulation and severity of alc. dependence was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9_rmQS3VgALVg90H21EOLACvtfcHk0lgoG1Lm_EDQkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GntrnI&md5=e744c940295d315c45a9f50c83e8aa12</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2011.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2011.05.035%26sid%3Dliteratum%253Aachs%26aulast%3DSpreckelmeyer%26aufirst%3DK.%2BN.%26aulast%3DPaulzen%26aufirst%3DM.%26aulast%3DRaptis%26aufirst%3DM.%26aulast%3DBaltus%26aufirst%3DT.%26aulast%3DSchaffrath%26aufirst%3DS.%26aulast%3DVan%2BWaesberghe%26aufirst%3DJ.%26aulast%3DZalewski%26aufirst%3DM.%2BM.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DW.%2BM.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DOpiate-induced%2520dopamine%2520release%2520is%2520modulated%2520by%2520severity%2520of%2520alcohol%2520dependence%253A%2520an%2520%255B18F%255Dfallypride%2520positron%2520emission%2520tomography%2520study%26jtitle%3DBiol.%2520Psychiatry%26date%3D2011%26volume%3D70%26spage%3D770%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinahan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]WAY-100,635: a radioligand for imaging 5-HT<sub>1A</sub> receptors with position emission tomography</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1994&pages=403-407&author=C.+A.+Mathisauthor=N.+R.+Simpsonauthor=K.+Mahmoodauthor=P.+E.+Kinahanauthor=M.+A.+Mintun&title=%5B11C%5DWAY-100%2C635%3A+a+radioligand+for+imaging+5-HT1A+receptors+with+position+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DSimpson%26aufirst%3DN.%2BR.%26aulast%3DMahmood%26aufirst%3DK.%26aulast%3DKinahan%26aufirst%3DP.%2BE.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3D%255B11C%255DWAY-100%252C635%253A%2520a%2520radioligand%2520for%2520imaging%25205-HT1A%2520receptors%2520with%2520position%2520emission%2520tomography%26jtitle%3DLife%2520Sci.%26date%3D1994%26volume%3D55%26spage%3D403%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malizia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, C. J.</span><span> </span><span class="NLM_article-title">First delineation of 5-HT1A receptors in human brain with PET and [<sup>11</sup>C]WAY-100,635</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">R1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1995&pages=R1-3&author=V.+W.+Pikeauthor=J.+A.+McCarronauthor=A.+A.+Lammertsmaauthor=S.+P.+Humeauthor=K.+Pooleauthor=P.+M.+Grasbyauthor=A.+Maliziaauthor=I.+A.+Cliffeauthor=A.+Fletcherauthor=C.+J.+Bench&title=First+delineation+of+5-HT1A+receptors+in+human+brain+with+PET+and+%5B11C%5DWAY-100%2C635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DPoole%26aufirst%3DK.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26aulast%3DMalizia%26aufirst%3DA.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DBench%26aufirst%3DC.%2BJ.%26atitle%3DFirst%2520delineation%2520of%25205-HT1A%2520receptors%2520in%2520human%2520brain%2520with%2520PET%2520and%2520%255B11C%255DWAY-100%252C635%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D283%26spage%3DR1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Osman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lut5hra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Characterization of the radioactive metabolites of the 5-HT<sub>1A</sub> receptor radioligand, [O-methyl-<sup>11</sup>C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0969-8051%2896%2900061-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8905828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK28XlsVamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=627-634&author=S.+Osmanauthor=C.+Lundkvistauthor=V.+W.+Pikeauthor=C.+Halldinauthor=J.+A.+McCarronauthor=C.+G.+Swahnauthor=N.+Ginovartauthor=S.+K.+Lut5hraauthor=C.+J.+Benchauthor=P.+M.+Grasbyauthor=H.+Wikstr%C3%B6mauthor=T.+Barfauthor=I.+A.+Cliffeauthor=A.+Fletcherauthor=L.+Farde&title=Characterization+of+the+radioactive+metabolites+of+the+5-HT1A+receptor+radioligand%2C+%5BO-methyl-11C%5DWAY-100635%2C+in+monkey+and+human+plasma+by+HPLC%3A+comparison+of+the+behaviour+of+an+identified+radioactive+metabolite+with+parent+radioligand+in+monkey+using+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behavior of an identified radioactive metabolite with parent radioligand in monkey using PET</span></div><div class="casAuthors">Osman, Safiye; Lundkvist, Camilla; Pike, Victor W.; Halldin, Christer; McCarron, Julie A.; Swahn, Carl-Gunnar; Ginovart, Natalie; Luthra, Sajinder K.; Bench, Christopher J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">627-634</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">N-(2-(4-(2-Methoxy-phenyl)-1-piperazin-1-yl)ethyl)-N-(2-pyridyl)cyclohexanecarboxamide (WAY-100635), labeled in the O-Me group with carbon-11 (t1/2 = 20.4 min), is a promising radioligand for application with positron emission tomog. (PET) to the study of 5-HT1A receptors in living human brain.  An understanding of the metab. of this new radioligand is crucial to the development of a biomathematical model for the interpretation of the kinetics of radioactivity uptake in brain in terms of receptor-binding parameters.  After i.v. injection of [O-methyl-11C]WAY-100635 into humans, radioactivity was found to clear rapidly from blood and plasma.  By using established methods for the anal. of radioactivity in plasma, it was found that i.v. injected [O-methyl-11C]WAY-100635 is rapidly metabolized to more polar radioactive compds. in a cynomolgus monkey and in humans.  Thus, at 60 min postinjection, parent radioligand represented 40% and 5% of the radioactivity in monkey and human plasma, resp.  In monkey and human, one of the radioactive metabolites was identified as the descyclohexanecarbonyl analog of the parent radioligand, namely [O-methyl-11C]WAY-100634.  This compd. a known to have high affinity for 5-HT1A receptors and α1-adrenoceptors.  In a PET expt. it was demonstrated that, after IV injection of [O-methyl-11C]WAY-100634 into a cynomolgus monkey, radioactivity was avidly taken up by brain.  Uptake of radioactivity was higher in 5-HT1A receptor-rich frontal cortex than in cerebellum, which is devoid of 5-HT1A receptors.  Polar radioactive metabolites appeared in plasma.  The results suggest that the use of WAY-100635 labeled with carbon-11 in its cyclohexanecarbonyl moiety may provide enhanced signal contrast in PET studies and a possibility to develop a simple biomathematical model for regional brain radioactivity uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTwy2VRP0sXLVg90H21EOLACvtfcHk0ljJt5m3Gd4U4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsVamur0%253D&md5=dacf9d3783924316113749f6efc63a9c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2896%2900061-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252896%252900061-3%26sid%3Dliteratum%253Aachs%26aulast%3DOsman%26aufirst%3DS.%26aulast%3DLundkvist%26aufirst%3DC.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DSwahn%26aufirst%3DC.%2BG.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DLut5hra%26aufirst%3DS.%2BK.%26aulast%3DBench%26aufirst%3DC.%2BJ.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DH.%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520the%2520radioactive%2520metabolites%2520of%2520the%25205-HT1A%2520receptor%2520radioligand%252C%2520%255BO-methyl-11C%255DWAY-100635%252C%2520in%2520monkey%2520and%2520human%2520plasma%2520by%2520HPLC%253A%2520comparison%2520of%2520the%2520behaviour%2520of%2520an%2520identified%2520radioactive%2520metabolite%2520with%2520parent%2520radioligand%2520in%2520monkey%2520using%2520PET%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1996%26volume%3D23%26spage%3D627%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Parsey, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Dargham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawlawi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span> </span><span class="NLM_article-title">Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-<sup>11</sup>C]WAY-100635 in humans: comparison of arterial and reference tissue input functions</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2F00004647-200007000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10908045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFOmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1111-1133&author=R.+V.+Parseyauthor=M.+Slifsteinauthor=D.+R.+Hwangauthor=A.+Abi-Darghamauthor=N.+Simpsonauthor=O.+Mawlawiauthor=N.+N.+Guoauthor=H.+R.+Vanauthor=J.+J.+Mannauthor=M.+Laruelle&title=Validation+and+reproducibility+of+measurement+of+5-HT1A+receptor+parameters+with+%5Bcarbonyl-11C%5DWAY-100635+in+humans%3A+comparison+of+arterial+and+reference+tissue+input+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: Comparison of arterial and reference tissue input functions</span></div><div class="casAuthors">Parsey, Ramin V.; Slifstein, Mark; Hwang, Dah-Ren; Abi-Dargham, Anissa; Simpson, Norman; Mawlawi, Osama; Guo, Ning-Ning; Van Heertum, Ronald; Mann, J. John; Laruelle, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1111-1133</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonin 5-HT1A receptors are implicated in the pathophysiol. of neuropsychiatric conditions.  The goal of this study was to evaluate methods to derive 5-HT1A receptor parameters in the human brain with positron emission tomog. (PET) and [carbonyl-11C]WAY 100635.  Five healthy volunteer subjects were studied twice.  Three methods of anal. were used to derive the binding potential (BP), and the specific to nonspecific equil. partition coeff. (k3/k4).  Two methods, kinetic anal. based on a three compartment model and graphical anal., used the arterial plasma time-activity curves as the input function to derive BP and k3/k4.  A third method, the simplified ref. tissue model (SRTM), derived the input function from uptake data of a region of ref., the cerebellum, and provided only k3/k4.  All methods provided ests. of regional 5-HT1A receptor parameters that were highly correlated.  Results were consistent with the known distribution of 5-HT1A receptors in the human brain.  Compared with kinetic BP, graphical anal. slightly underestimated BP, and this phenomenon was mostly apparent in small size-high noise regions.  Compared with kinetic k3/k4, the ref. tissue method underestimated k3/k4 and the underestimation was apparent primarily in regions with high receptor d.  Derivation of BP by both kinetic and graphical anal. was highly reliable, with an intraclass correlation coeff. (ICC) of 0.84 ± 0.14 (mean ± SD of 15 regions) and 0.84 ± 0.19, resp.  In contrast, the reliability of k3/k4 was lower, with ICC of 0.53 ± 0.28, 0.47 ± 0.28, and 0.55 ± 0.29 for kinetic, graphical, and ref. tissue methods, resp.  In conclusion, derivation of BP by kinetic anal. using the arterial plasma input function appeared as the method of choice because of its higher test-retest reproducibility, lower vulnerability to exptl. noise, and absence of bias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWSXlzXvpqdLVg90H21EOLACvtfcHk0lhZT7_Xu7H0IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFOmu74%253D&md5=2e708aa8a52b0e2fb28f5fac867e92ff</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1097%2F00004647-200007000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200007000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DParsey%26aufirst%3DR.%2BV.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHwang%26aufirst%3DD.%2BR.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DN.%26aulast%3DMawlawi%26aufirst%3DO.%26aulast%3DGuo%26aufirst%3DN.%2BN.%26aulast%3DVan%26aufirst%3DH.%2BR.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DValidation%2520and%2520reproducibility%2520of%2520measurement%2520of%25205-HT1A%2520receptor%2520parameters%2520with%2520%255Bcarbonyl-11C%255DWAY-100635%2520in%2520humans%253A%2520comparison%2520of%2520arterial%2520and%2520reference%2520tissue%2520input%2520functions%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2000%26volume%3D20%26spage%3D1111%26epage%3D1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">Exquisite delineation of 5-HT<sub>1A</sub> receptors in human brain with PET and [carbonyl-<sup>11</sup>C]WAY-100635</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">R5</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=1996&pages=R5-7&author=V.+W.+Pikeauthor=J.+A.+McCarronauthor=A.+A.+Lammertsmaauthor=S.+Osmanauthor=S.+P.+Humeauthor=P.+A.+Sargentauthor=C.+J.+Benchauthor=I.+A.+Cliffeauthor=A.+Fletcherauthor=P.+M.+Grasby&title=Exquisite+delineation+of+5-HT1A+receptors+in+human+brain+with+PET+and+%5Bcarbonyl-11C%5DWAY-100635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DOsman%26aufirst%3DS.%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DSargent%26aufirst%3DP.%2BA.%26aulast%3DBench%26aufirst%3DC.%2BJ.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3DExquisite%2520delineation%2520of%25205-HT1A%2520receptors%2520in%2520human%2520brain%2520with%2520PET%2520and%2520%255Bcarbonyl-11C%255DWAY-100635%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D301%26spage%3DR5%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Dahlström, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, F.</span><span> </span><span class="NLM_article-title">Evidence for the existence of monoamine-containing neurons in the central nervous system</span> <span class="citation_source-journal">Acta Physiol. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1964&pages=1-55&author=A.+Dahlstr%C3%B6mauthor=F.+Fuxe&title=Evidence+for+the+existence+of+monoamine-containing+neurons+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahlstr%25C3%25B6m%26aufirst%3DA.%26aulast%3DFuxe%26aufirst%3DF.%26atitle%3DEvidence%2520for%2520the%2520existence%2520of%2520monoamine-containing%2520neurons%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DActa%2520Physiol.%2520Scand.%26date%3D1964%26volume%3D62%26spage%3D1%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Seamans, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. R.</span><span> </span><span class="NLM_article-title">The principal features and mechanisms of dopamine modulation in the prefrontal cortex</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.pneurobio.2004.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15381316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2004&pages=1-58&author=J.+K.+Seamansauthor=C.+R.+Yang&title=The+principal+features+and+mechanisms+of+dopamine+modulation+in+the+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The principal features and mechanisms of dopamine modulation in the prefrontal cortex</span></div><div class="casAuthors">Seamans, Jeremy K.; Yang, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-58</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mesocortical dopamine (DA) inputs to the prefrontal cortex (PFC) play a crit. role in normal cognitive process and neuropsychiatic pathologies.  This DA input regulates aspects of working memory function, planning and attention, and its dysfunctions may underlie pos. and neg. symptoms and cognitive deficits assocd. with schizophrenia.  Despite intense research, there is still a lack of clear understanding of the basic principles of actions of DA in the PFC.  In recent years, there has been considerable efforts by many groups to understand the cellular mechanisms of DA modulation of PFC neurons.  However, the results of these efforts often lead to contradictions and controversies.  One principal feature of DA that is agreed by most researchers is that DA is a neuromodulator and is clearly not an excitatory or inhibitory neurotransmitter.  The present article aims to identify certain principles of DA mechanisms by drawing on published, as well as unpublished data from PFC and other CNS sites to shed light on aspects of DA neuromodulation and address some of the existing controversies.  Eighteen key features about DA modulation have been identified.  These points directly impact on the end result of DA neuromodulation, and in some cases explain why DA does not yield identical effects under all exptl. conditions.  It will become apparent that DA's actions in PFC are subtle and depend on a variety of factors that can no longer be ignored.  Some of these key factors include distinct bell-shaped dose-response profiles of postsynaptic DA effects, different postsynaptic responses that are contingent on the duration of DA receptor stimulation, prolonged duration effects, bidirectional effects following activation of D1 and D2 classes of receptors and membrane potential state and history dependence of subsequent DA actions.  It is hoped that these factors will be borne in mind in future research and as a result a more consistent picture of DA neuromodulation in the PFC will emerge.  Based on these factors, a theory is proposed for DA's action in PFC.  This theory suggests that DA acts to expand or contract the breadth of information held in working memory buffers in PFC networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEDnP_rV_xe7Vg90H21EOLACvtfcHk0lgcbuFFB-KnkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslKgtr8%253D&md5=4b6f7eb3f67960face70d60249906b16</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2004.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2004.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DSeamans%26aufirst%3DJ.%2BK.%26aulast%3DYang%26aufirst%3DC.%2BR.%26atitle%3DThe%2520principal%2520features%2520and%2520mechanisms%2520of%2520dopamine%2520modulation%2520in%2520the%2520prefrontal%2520cortex%26jtitle%3DProg.%2520Neurobiol.%26date%3D2004%26volume%3D74%26spage%3D1%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Durstewitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sejnowski, T. J.</span><span> </span><span class="NLM_article-title">Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex</span> <span class="citation_source-journal">J. Neurophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1733</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10712493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2000&pages=1733-1750&author=D.+Durstewitzauthor=J.+K.+Seamansauthor=T.+J.+Sejnowski&title=Dopamine-mediated+stabilization+of+delay-period+activity+in+a+network+model+of+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex</span></div><div class="casAuthors">Durstewitz, Daniel; Seamans, Jeremy K.; Sejnowski, Terrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1733-1750</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">The prefrontal cortex (PFC) is critically involved in working memory, which underlies memory-guided, goal-directed behavior.  During working-memory tasks, PFC neurons exhibit sustained elevated activity, which may reflect the active holding of goal-related information or the prepn. of forthcoming actions.  Dopamine via the D1 receptor strongly modulates both this sustained (delay-period) activity and behavioral performance in working-memory tasks.  However, the function of dopamine during delay-period activity and the underlying neural mechanisms are only poorly understood.  Recently we proposed that dopamine might stabilize active neural representations in PFC circuits during tasks involving working memory and render them robust against interfering stimuli and noise.  To further test this idea and to examine the dopamine-modulated ionic currents that could give rise to increased stability of neural representations, we developed a network model of the PFC consisting of multicompartment neurons equipped with Hodgkin-Huxley-like channel kinetics that could reproduce in vitro whole cell and in vivo recordings from PFC neurons.  Dopaminergic effects on intrinsic ionic and synaptic conductances were implemented in the model based on in vitro data.  Simulated dopamine strongly enhanced high, delay-type activity but not low, spontaneous activity in the model network.  Furthermore the strength of an afferent stimulation needed to disrupt delay-type activity increased with the magnitude of the dopamine-induced shifts in network parameters, making the currently active representation much more stable.  Stability could be increased by dopamine-induced enhancements of the persistent Na+ and N-methyl-D-aspartate (NMDA) conductances.  Stability also was enhanced by a redn. in AMPA conductances.  The increase in GABAA conductances that occurs after stimulation of dopaminergic D1 receptors was necessary in this context to prevent uncontrolled, spontaneous switches into high-activity states (i.e., spontaneous activation of task-irrelevant representations).  In conclusion, the dopamine-induced changes in the biophys. properties of intrinsic ionic and synaptic conductances conjointly acted to highly increase stability of activated representations in PFC networks and at the same time retain control over network behavior and thus preserve its ability to adequately respond to task-related stimuli.  Predictions of the model can be tested in vivo by locally applying specific D1 receptor, NMDA, or GABAA antagonists while recording from PFC neurons in delayed reaction-type tasks with interfering stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiimtDszYfL7Vg90H21EOLACvtfcHk0ljn1DaYGIUOQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVartLk%253D&md5=08b4ecc8d58dea1494b29ab4bd3d4b5c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurstewitz%26aufirst%3DD.%26aulast%3DSeamans%26aufirst%3DJ.%2BK.%26aulast%3DSejnowski%26aufirst%3DT.%2BJ.%26atitle%3DDopamine-mediated%2520stabilization%2520of%2520delay-period%2520activity%2520in%2520a%2520network%2520model%2520of%2520prefrontal%2520cortex%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2000%26volume%3D83%26spage%3D1733%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindqvist, M.</span><span> </span><span class="NLM_article-title">Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine on mouse brain</span> <span class="citation_source-journal">Acta Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1600-0773.1963.tb01730.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=14060771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaF2cXjsVWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1963&pages=140-144&author=A.+Carlssonauthor=M.+Lindqvist&title=Effect+of+chlorpromazine+and+haloperidol+on+formation+of+3-methoxytyramine+and+normetanephrine+on+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain</span></div><div class="casAuthors">Carlsson, Arvid; Lindqvist, Margit</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica et Toxicologica</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140-4</span>CODEN:
                <span class="NLM_cas:coden">APTOA6</span>;
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">Mice were injected intraperitoneally with nialamide (100 mg./kg.); 1 hr. later various doses of chlorpromazine (I), haloperidol (II), phenoxybenzamine (III), or promethazine (IV) were given intraperitoneally and the mice beheaded 3 hrs. later.  The accumulation in the brain of O-methylated catechol amine metabolites 3-methoxytyramine and normetanephrine brought about by nialamide was enhanced by I and II, whereas III and IV were ineffective.  It was suggested that the effect is due to a compensatory activation of monoaminergic neurons after blockade of monoaminergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4IP5WRzj4r7Vg90H21EOLACvtfcHk0ljn1DaYGIUOQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXjsVWhug%253D%253D&md5=1dff235769b12e0bb4b7a077b484b887</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1963.tb01730.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1963.tb01730.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindqvist%26aufirst%3DM.%26atitle%3DEffect%2520of%2520chlorpromazine%2520and%2520haloperidol%2520on%2520formation%2520of%25203-methoxytyramine%2520and%2520normetanephrine%2520on%2520mouse%2520brain%26jtitle%3DActa%2520Pharmacol.%2520Toxicol.%26date%3D1963%26volume%3D20%26spage%3D140%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Costall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, R. J.</span><span> </span><span class="NLM_article-title">Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1975&pages=69-74&author=B.+Costallauthor=R.+J.+Naylor&title=Detection+of+the+neuroleptic+properties+of+clozapine%2C+sulpiride+and+thioridazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostall%26aufirst%3DB.%26aulast%3DNaylor%26aufirst%3DR.%2BJ.%26atitle%3DDetection%2520of%2520the%2520neuroleptic%2520properties%2520of%2520clozapine%252C%2520sulpiride%2520and%2520thioridazine%26jtitle%3DPsychopharmacology%26date%3D1975%26volume%3D43%26spage%3D69%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Angst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bente, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmchen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippius, H.</span><span> </span><span class="NLM_article-title">Das klinische Wirkungsbild von Clozapin</span> <span class="citation_source-journal">Pharmakopsychiatrie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1055%2Fs-0028-1094313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1971&pages=201-221&author=J.+Angstauthor=D.+Benteauthor=P.+Bernerauthor=H.+Heimannauthor=H.+Helmchenauthor=H.+Hippius&title=Das+klinische+Wirkungsbild+von+Clozapin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1094313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1094313%26sid%3Dliteratum%253Aachs%26aulast%3DAngst%26aufirst%3DJ.%26aulast%3DBente%26aufirst%3DD.%26aulast%3DBerner%26aufirst%3DP.%26aulast%3DHeimann%26aufirst%3DH.%26aulast%3DHelmchen%26aufirst%3DH.%26aulast%3DHippius%26aufirst%3DH.%26atitle%3DDas%2520klinische%2520Wirkungsbild%2520von%2520Clozapin%26jtitle%3DPharmakopsychiatrie%26date%3D1971%26volume%3D4%26spage%3D201%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Glowinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, L. L.</span><span> </span><span class="NLM_article-title">Regional studies of catecholamines in the rat brain. I. The disposition of [<sup>3</sup>H]norepinephrine, [<sup>3</sup>H]dopamine and [<sup>3</sup>H]dopa in various regions of the brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1471-4159.1966.tb09873.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=5950056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaF28Xks1Kqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1966&pages=655-669&author=J.+Glowinskiauthor=L.+L.+Iversen&title=Regional+studies+of+catecholamines+in+the+rat+brain.+I.+The+disposition+of+%5B3H%5Dnorepinephrine%2C+%5B3H%5Ddopamine+and+%5B3H%5Ddopa+in+various+regions+of+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol amines in rat brain. I. Disposition of norepinephrine-3H, dopamine-3H, and dopa-3H in various regions of the brain</span></div><div class="casAuthors">Glowinski, Jacques; Iversen, Leslie L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">655-69</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">The hypothalamus, medulla oblongata, midbrain, striatum, cortex, hippocampus, and cerebellum of rat brain contained 1.79, 0.72, 0.37, 0.25, 0.24, 0.20, and 0.17 γ endogenous norepinephrine (I) per g., resp., and accumulated 2.13, 0.81, 0.97, 1.16, 0.30, 0.96, and 0.42 μc. tritiated norepinephrine (II) per g., resp., 1 hr. after intraventricular injection of 6.3 μc. II.  Since the levels of II in the hypothalamus were 5- and 16-fold greater than in the cerebellum 1 and 24 hrs. after the injection, resp., II disappears at different rates in different brain regions.  There were no qual. differences in the metabolism of II in the different brain regions, although quant. differences in II metabolites occurred.  In all regions except the cerebellum and cortex, the ratio of unchanged II to II metabolites decreased with time.  Labeled O-methylated deaminated metabolites of II accounted for 70% of total II metabolites, 1 hr. after injection, while labeled normetanephrine (III) or catechol deaminated metabolites of II did not exceed 10% of the total activity in any brain region.  Labeled III remained a const. fraction of the total radioactivity in all regions at various times after injection even though O-methylated deaminated and catechol deaminated metabolites of II decreased in most regions; labeled III represented the major metabolite in the hypothalamus, 24 hrs. after the injections.  The hypothalamus, medulla oblongata, midbrain, striatum, cortex, hippocampus, and cerebellum contained 667, 311, 326, 734, 126, 353, and 153 mμc. labeled catechol amine/g., resp., 1 hr. after intraventricular injection of 17 μc. dopamine-3H; the distribution was similar to that occurring after injection of II, although the levels of dopamine-3H were 64.0, 53.4, 68.0, 93.5, 70.7, 69.8, and 40.7%, resp., of the total catechol amines.  The max. levels of II were reached at different times in the various regions; this max. occurred 15, 30, and 60 min. after the injection in the medulla oblongata, hypothalamus, and striatum, resp., which indicates varying conversion rates of dopamine to I in the different brain regions.  A limited conversion to catechol amines occurred following injection of dopa-3H (105 μc.); the highest concns. of dopamine-3H and II were in the hypothalamus (2.2 and 0.18 μc./g., resp.) and the lowest in the cortex (0.4 and 0.03 μc./g., resp.), 5 hrs. after injection.  At this time, the levels of labeled dopamine were 45-fold greater than those of II in the striatum, and 10- to 15-fold greater in the other regions.  There was more labeled dopa than labeled catechol amines in all brain areas.  36 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhhlcUdIr08LVg90H21EOLACvtfcHk0lh8iEKR6asEBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28Xks1Kqtrw%253D&md5=636423937e98d736d783e0d05c36d83c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1966.tb09873.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1966.tb09873.x%26sid%3Dliteratum%253Aachs%26aulast%3DGlowinski%26aufirst%3DJ.%26aulast%3DIversen%26aufirst%3DL.%2BL.%26atitle%3DRegional%2520studies%2520of%2520catecholamines%2520in%2520the%2520rat%2520brain.%2520I.%2520The%2520disposition%2520of%2520%255B3H%255Dnorepinephrine%252C%2520%255B3H%255Ddopamine%2520and%2520%255B3H%255Ddopa%2520in%2520various%2520regions%2520of%2520the%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1966%26volume%3D13%26spage%3D655%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Firnau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahmias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, S.</span><span> </span><span class="NLM_article-title">The preparation of [<sup>18</sup>F]5-fluoro-DOPA with reactor-produced fluorine-18</span> <span class="citation_source-journal">Int. J. Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0020-708X%2873%2990008-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=4689915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaE3sXhsVyhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1973&pages=182-184&author=G.+Firnauauthor=C.+Nahmiasauthor=S.+Garnett&title=The+preparation+of+%5B18F%5D5-fluoro-DOPA+with+reactor-produced+fluorine-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of fluorine-18-labeled 5-fluoro-DOPA with reactor-produced fluorine-18</span></div><div class="casAuthors">Firnau, Gunter; Nahmias, C.; Garnett, S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-4</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">5,3,4-18F (HO)2C6H2CH2CH(NH2)CO2H (I) with sp. activities of 0.2-2 μCi/mg was prepd. by isotope exchange of 5,3,4-BF4.N2- (MeO)2C6H2CH2C(CO2Et)2NHAc with 18F, prepd. by neutron bombardment of Li2CO3.  The diazonium salt was then decompd. by boiling in a dioxane-xylene mixt with a b.p. of 132° to give 5,3,4-18F(MeO2C6H2CH2C(CO2Et)2 NHAc, which with 47% HBr gave I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rhbx1DV43LVg90H21EOLACvtfcHk0lh8iEKR6asEBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsVyhsro%253D&md5=0a286ffdd3f459aefe170424893f7335</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2873%2990008-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252873%252990008-2%26sid%3Dliteratum%253Aachs%26aulast%3DFirnau%26aufirst%3DG.%26aulast%3DNahmias%26aufirst%3DC.%26aulast%3DGarnett%26aufirst%3DS.%26atitle%3DThe%2520preparation%2520of%2520%255B18F%255D5-fluoro-DOPA%2520with%2520reactor-produced%2520fluorine-18%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1973%26volume%3D24%26spage%3D182%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Goldstein, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhofer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacharach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersecovitch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopin, I. J.</span><span> </span><span class="NLM_article-title">Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[<sup>18</sup>F]fluorodopamine: initial findings in humans</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0735-1097%2893%2990786-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8245356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2c%252FmsFSmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=1961-71&author=D.+S.+Goldsteinauthor=G.+Eisenhoferauthor=B.+B.+Dunnauthor=I.+Armandoauthor=J.+Lendersauthor=E.+Grossmanauthor=C.+Holmesauthor=K.+L.+Kirkauthor=S.+Bacharachauthor=R.+Adamsauthor=P.+Hersecovitchauthor=I.+J.+Kopin&title=Positron+emission+tomographic+imaging+of+cardiac+sympathetic+innervation+using+6-%5B18F%5Dfluorodopamine%3A+initial+findings+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans</span></div><div class="casAuthors">Goldstein D S; Eisenhofer G; Dunn B B; Armando I; Lenders J; Grossman E; Holmes C; Kirk K L; Bacharach S; Adams R; et al</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-71</span>
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    </div><div class="casAbstract">OBJECTIVES:  This study evaluated the safety, efficacy and validity of 6-[18F]fluorodopamine positron emission tomographic scanning of cardiac sympathetic innervation and function in humans.  METHODS:  Positron emission tomography (PET) scans, arterial blood and urine were obtained after a 3-min intravenous infusion of 6-[18F]fluorodopamine (1 to 4 mCi, 188 to 809 mCi/mmol) in healthy volunteers, with or without pretreatment with oral desipramine to inhibit neuronal uptake of catecholamines.  RESULTS:  6-[18F]Fluorodopamine PET scanning visualized the left ventricular myocardium.  Blood pressure increased slightly and transiently.  The estimated absorbed radiation dose to the main target organ, the wall of the urinary bladder, was 0.8 to 1.0 rad/mCi of injected 6-[18F]fluorodopamine.  By 24 h after the injection, the main 6F-compound in urine was 6F-vanillymandelic acid, a metabolite of 6F-norepinephrine.  Desipramine attenuated accumulation of myocardial 6-[18F]fluorodopamine-derived radioactivity and plasma 6F-dihydroxyphenylacetic acid.  CONCLUSIONS:  6-[18F]Fluorodopamine produces negligible hemodynamic effects and acceptable radiation exposure at doses that visualize the left ventricular myocardium.  Sympathetic nerves take up 6-[18F]fluorodopamine, which is translocated from the axoplasm into storage vesicles, where is it beta-hydroxylated to the fluorinated analogue of the sympathetic neurotransmitter norepinephrine.  Therefore, the basis for visualization of myocardium after 6-[18F]fluorodopamine injection in humans is radiolabeling by 6-[18F]fluorodopamine and 6-[18F]fluoronorepinephrine of vesicles in sympathetic terminals. 6-[18F]Fluorodopamine PET scanning provides a novel means for assessing sympathetic innervation and function noninvasively in the human heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtp6qcyYVsV825P7XSLhESfW6udTcc2ebeomWugLlLW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FmsFSmsQ%253D%253D&md5=ab16095eb49be839b3c98f99a140fc30</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2F0735-1097%2893%2990786-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0735-1097%252893%252990786-Z%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BS.%26aulast%3DEisenhofer%26aufirst%3DG.%26aulast%3DDunn%26aufirst%3DB.%2BB.%26aulast%3DArmando%26aufirst%3DI.%26aulast%3DLenders%26aufirst%3DJ.%26aulast%3DGrossman%26aufirst%3DE.%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DBacharach%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DHersecovitch%26aufirst%3DP.%26aulast%3DKopin%26aufirst%3DI.%2BJ.%26atitle%3DPositron%2520emission%2520tomographic%2520imaging%2520of%2520cardiac%2520sympathetic%2520innervation%2520using%25206-%255B18F%255Dfluorodopamine%253A%2520initial%2520findings%2520in%2520humans%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D1993%26volume%3D22%26spage%3D1961%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span> </span><span class="NLM_article-title">Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1998&pages=37-61&author=P.+Cummingauthor=A.+Gjedde&title=Compartmental+analysis+of+dopa+decarboxylation+in+living+brain+from+dynamic+positron+emission+tomograms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DGjedde%26aufirst%3DA.%26atitle%3DCompartmental%2520analysis%2520of%2520dopa%2520decarboxylation%2520in%2520living%2520brain%2520from%2520dynamic%2520positron%2520emission%2520tomograms%26jtitle%3DSynapse%26date%3D1998%26volume%3D29%26spage%3D37%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Weeks, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Positron emission tomography and central neurotransmitter systems in movement disorders</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1472-8206.1994.tb00831.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=7721227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2M3jslOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=503-517&author=R.+A.+Weeksauthor=D.+J.+Brooks&title=Positron+emission+tomography+and+central+neurotransmitter+systems+in+movement+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography and central neurotransmitter systems in movement disorders</span></div><div class="casAuthors">Weeks R A; Brooks D J</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & clinical pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">503-17</span>
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    </div><div class="casAbstract">This article discusses the anatomical and neurochemical structure of the basal ganglia and reviews the Positron Emission Tomographic (PET) ligands available for investigating these pathways.  We discuss how clinical PET studies have improved our understanding of the neurochemical changes underlying principal movement disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSPPQe1MzpFrJzI8owOhpDfW6udTcc2ebeomWugLlLW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3jslOmsQ%253D%253D&md5=faa0176e174754331f6204595edbb58e</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1994.tb00831.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1994.tb00831.x%26sid%3Dliteratum%253Aachs%26aulast%3DWeeks%26aufirst%3DR.%2BA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DPositron%2520emission%2520tomography%2520and%2520central%2520neurotransmitter%2520systems%2520in%2520movement%2520disorders%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D8%26spage%3D503%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Snow, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygaard, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span> </span><span class="NLM_article-title">Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2Fana.410340518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8239569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2c%252FlvVWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=733-738&author=B.+J.+Snowauthor=T.+G.+Nygaardauthor=H.+Takahashiauthor=D.+B.+Calne&title=Positron+emission+tomographic+studies+of+dopa-responsive+dystonia+and+early-onset+idiopathic+parkinsonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism</span></div><div class="casAuthors">Snow B J; Nygaard T G; Takahashi H; Calne D B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">733-8</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">There are two major syndromes presenting in the early decades of life with dystonia and parkinsonism: dopa-responsive dystonia (DRD) and early-onset idiopathic parkinsonism (EOIP).  DRD presents predominantly in childhood with prominent dystonia and lesser degrees of parkinsonism.  EOIP presents before age 40 with parkinsonism (often with associated dystonia).  Both disorders are exquisitely sensitive to levodopa, although the long-term prognosis in each appears to be different.  Some have suggested, however, that DRD is a form of EOIP.  We performed positron emission tomography with 6-fluoro-dopa in 10 patients with DRD and 18 patients with EOIP to study the integrity of their nigrostriatal dopaminergic systems.  In DRD, we found normal striatal FD uptake.  In contrast, patients with EOIP had reduced striatal FD uptake.  We conclude that the patho-physiologies of DRD and EOIP are distinct.  Although both disorders presumably represent a deficiency of striatal dopamine, the results suggest that in DRD dopa uptake, decarboxylation, and storage mechanisms are intact.  This may explain the sustained response of DRD to low doses of levodopa. 6-Fluoro-dopa positron emission tomography distinguishes DRD from EOIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO-26-VAILeHqj_yg7twvpfW6udTcc2eaqUza5M_iMy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FlvVWntA%253D%253D&md5=2c2486577ba5b12d2a1cc005bb2975d7</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fana.410340518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410340518%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DB.%2BJ.%26aulast%3DNygaard%26aufirst%3DT.%2BG.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26atitle%3DPositron%2520emission%2520tomographic%2520studies%2520of%2520dopa-responsive%2520dystonia%2520and%2520early-onset%2520idiopathic%2520parkinsonism%26jtitle%3DAnn.%2520Neurol.%26date%3D1993%26volume%3D34%26spage%3D733%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Frankle, W. G.</span><span> </span><span class="NLM_article-title">Neuroreceptor imaging studies in schizophrenia</span> <span class="citation_source-journal">Harv. Rev. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1080%2F10673220701679812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17924257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2sngtFaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=212-232&author=W.+G.+Frankle&title=Neuroreceptor+imaging+studies+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroreceptor imaging studies in schizophrenia</span></div><div class="casAuthors">Frankle W Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Harvard review of psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">212-32</span>
        ISSN:<span class="NLM_cas:issn">1067-3229</span>.
    </div><div class="casAbstract">The ability of SPECT and PET to image specific biomolecules in the living brain provides a unique tool for clinical researchers.  It is therefore not surprising that the use of neuroreceptor-imaging techniques has become more widespread over the past decade.  This article reviews the application of these techniques to the study of schizophrenia.  The design of neuroreceptor-imaging studies performed in the field of schizophrenia research can be broadly divided into two categories: (1) studies of pathophysiology and (2) studies of pharmacology.  The former examines neuroreceptor and neurotransmitter parameters in individuals with schizophrenia compared to control subjects in order to provide a better understanding of the disease process.  Studies of pharmacology seek to elucidate the mechanism of action for the treatments utilized in schizophrenia.  This review will consider both studies of pathophysiology and pharmacology, with a discussion of the application of these techniques to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6eZZmu_sT9potVjB3IRIyfW6udTcc2eaqUza5M_iMy7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngtFaisw%253D%253D&md5=f636793730b50c4081caa7a5653b8a50</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1080%2F10673220701679812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10673220701679812%26sid%3Dliteratum%253Aachs%26aulast%3DFrankle%26aufirst%3DW.%2BG.%26atitle%3DNeuroreceptor%2520imaging%2520studies%2520in%2520schizophrenia%26jtitle%3DHarv.%2520Rev.%2520Psychiatry%26date%3D2007%26volume%3D15%26spage%3D212%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, J. E.</span><span> </span><span class="NLM_article-title">A reversible tracer analysis approach to the study of effective dopamine turnover</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2F00004647-200104000-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11323532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFKisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=469-476&author=V.+Sossiauthor=D.+J.+Doudetauthor=J.+E.+Holden&title=A+reversible+tracer+analysis+approach+to+the+study+of+effective+dopamine+turnover"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">A reversible tracer analysis approach to the study of effective dopamine turnover</span></div><div class="casAuthors">Sossi, Vesna; Doudet, Doris J.; Holden, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Changes in dopamine turnover resulting from disease states such as Parkinson's disease may be reflected in corresponding changes in the kinetics of the positron emission tomog. tracer [18F]fluorodopa.  The authors had previously refined the conventional irreversible-tracer graphical approach to det. both the uptake rate const. Ki and the rate const. kloss that describes the slow loss of the trapped kinetic component.  Because these parameters change in the opposite sense with disease, their ratios may be more powerfully discriminating than either one alone.  The ratio kloss/Ki is indicative of effective dopamine turnover.  Its inverse, Ki/kloss, can be interpreted as the effective distribution vol. (EDV) of the specific uptake compartment referred to the fluorodopa concn. in plasma.  Here the authors present a new approach to the estn. of EDV based on reversible-tracer graphical methods.  When implemented with a plasma input function, the method evaluates EDV directly.  When implemented with a tissue input function, the outcome is proportional to the ratio of the distribution vols. of the specific uptake and precursor compartments.  Comparison of the new and previous approaches strongly validates this alternative approach to the study of effective dopamine turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyQiF9C_WyorVg90H21EOLACvtfcHk0lilio95pOgtpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFKisr0%253D&md5=665ee1b251c5b6c589dc626b6993ef5e</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1097%2F00004647-200104000-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200104000-00015%26sid%3Dliteratum%253Aachs%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DDoudet%26aufirst%3DD.%2BJ.%26aulast%3DHolden%26aufirst%3DJ.%2BE.%26atitle%3DA%2520reversible%2520tracer%2520analysis%2520approach%2520to%2520the%2520study%2520of%2520effective%2520dopamine%2520turnover%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2001%26volume%3D21%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D.</span><span> </span><span class="NLM_article-title">Loss of metabolites from monkey striatum during PET with FDOPA</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=212-218&author=P.+Cummingauthor=O.+L.+Munkauthor=D.+Doudet&title=Loss+of+metabolites+from+monkey+striatum+during+PET+with+FDOPA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DMunk%26aufirst%3DO.%2BL.%26aulast%3DDoudet%26aufirst%3DD.%26atitle%3DLoss%2520of%2520metabolites%2520from%2520monkey%2520striatum%2520during%2520PET%2520with%2520FDOPA%26jtitle%3DSynapse%26date%3D2001%26volume%3D41%26spage%3D212%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">PET studies of net blood–brain clearance of FDOPA to human brain: age-dependent decline of [<sup>18</sup>F]fluorodopamine storage capacity</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fsj.jcbfm.9600079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15729292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsV2ktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=807-819&author=Y.+Kumakuraauthor=I.+Vernalekenauthor=G.+Grunderauthor=P.+Bartensteinauthor=A.+Gjeddeauthor=P.+Cumming&title=PET+studies+of+net+blood%E2%80%93brain+clearance+of+FDOPA+to+human+brain%3A+age-dependent+decline+of+%5B18F%5Dfluorodopamine+storage+capacity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">PET studies of net blood-brain clearance of FDOPA to human brain: Age-dependent decline of [18F]fluorodopamine storage capacity</span></div><div class="casAuthors">Kumakura, Yoshitaka; Vernaleken, Ingo; Gruender, Gerhard; Bartenstein, Peter; Gjedde, Albert; Cumming, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">807-819</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Conventional methods for the graphical anal. of 6-[18F]fluorodopa (FDOPA)/positron emission tomog. (PET) recordings (Kappin) may be prone to neg. bias because of oversubtraction of the precursor pool in the region of interest, and because of diffusion of decarboxylated FDOPA metabolites from the brain.  These effects may reduce the sensitivity of FDOPA/PET for the detection of age-related changes in dopamine innervations.  To test for these biasing effects, we have used a constrained compartmental anal. to calc. the brain concns. of the plasma metabolite 3-O-methyl-FDOPA (OMFD) during 120 mins of FDOPA circulation in healthy young, healthy elderly, and Parkinson's disease subjects.  Calcd. brain OMFD concns. were subtracted frame-by-frame from the dynamic PET recordings, and maps of the FDOPA net influx to brain were calcd. assuming irreversible trapping (Kapp).  Comparison of Kappin and Kapp maps revealed a global neg. bias in the conventional ests. of FDOPA clearance.  The present OMFD subtraction method revealed curvature in plots of Kapp at early times, making possible the calcn. of the cor. net influx (K) and also the rate const. for diffusion of decarboxylated metabolites from the brain (kloss).  The effective distribution vol. (EDV2; K/kloss) for FDOPA, an index of dopamine storage capacity in brain, was reduced by 85% in putamen of patients with Parkinson's disease, and by 58% in the healthy elderly relative to the healthy young control subjects.  Results of the present study support claims that storage capacity for dopamine in both caudate and putamen is more profoundly impaired in patients with Parkinson's disease than is the capacity for DOPA utilization, calcd. by conventional FDOPA net influx plots.  The present results furthermore constitute the first demonstration of an abnormality in the cerebral utilization of FDOPA in caudate and putamen as a function of normal aging, which we attribute to loss of vesicular storage capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofif_2dTRQ8bVg90H21EOLACvtfcHk0lilio95pOgtpA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsV2ktrc%253D&md5=75044843f583b4674061a808f36ff9a2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600079%26sid%3Dliteratum%253Aachs%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DGrunder%26aufirst%3DG.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DPET%2520studies%2520of%2520net%2520blood%25E2%2580%2593brain%2520clearance%2520of%2520FDOPA%2520to%2520human%2520brain%253A%2520age-dependent%2520decline%2520of%2520%255B18F%255Dfluorodopamine%2520storage%2520capacity%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2005%26volume%3D25%26spage%3D807%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Elevated [<sup>18</sup>F]fluorodopamine turnover in brain of patients with schizophrenia: an [<sup>18</sup>F]fluorodopa/positron emission tomography study</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">8080</span><span class="NLM_x">–</span> <span class="NLM_lpage">8087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1523%2FJNEUROSCI.0805-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17652599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=8080-8087&author=Y.+Kumakuraauthor=P.+Cummingauthor=I.+Vernalekenauthor=H.+G.+Buchholzauthor=T.+Siessmeierauthor=A.+Heinzauthor=T.+Kienastauthor=P.+Bartensteinauthor=G.+Grunder&title=Elevated+%5B18F%5Dfluorodopamine+turnover+in+brain+of+patients+with+schizophrenia%3A+an+%5B18F%5Dfluorodopa%2Fpositron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study</span></div><div class="casAuthors">Kumakura, Yoshitaka; Cumming, Paul; Vernaleken, Ingo; Buchholz, Hans-Georg; Siessmeier, Thomas; Heinz, Andreas; Kienast, Thorsten; Bartenstein, Peter; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">8080-8087</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Previous positron emission tomog. (PET) studies with levodopa analogs have revealed a modestly increased capacity for dopamine synthesis in the striatum of patients with schizophrenia compared with healthy age-matched control subjects.  We hypothesized that not just the synthesis but also the turnover of radiolabeled dopamine is elevated in patients.  To test the hypothesis, we reanalyzed 2-h-long [18F]fluorodopa (FDOPA)/PET recordings from eight unmedicated patients with schizophrenia and 15 healthy age-matched control subjects, using new methods for the quantification of [18F]fluorodopamine steady-state kinetics.  The fractional rate const. for the catabolism and elimination of [18F]fluorodopamine was elevated nearly twofold in striatum, the largest biochem. difference in brain of schizophrenics yet reported.  The magnitude of the intrinsic blood-brain FDOPA clearance with correction for this loss of [18F]fluorodopamine metabolites was increased by 20% in caudate and putamen and by 50% in amygdala and midbrain of the patients.  However, the magnitude of the steady-state storage of FDOPA and its decarboxylated metabolites (Vd) was reduced by one-third in the caudate nucleus and amygdala of the schizophrenic group.  Thus, reduced steady-state storage of [18F]fluorodopamine occurs in the midst of accelerated synthesis in brain of untreated patients.  Pos. scores of the pos. and neg. syndrome scale correlated inversely with the magnitude of Vd in amygdala, suggesting an assocn. between pos. symptoms and impaired steady-state storage of FDOPA metabolites in that structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobB4Pys1yhj7Vg90H21EOLACvtfcHk0liHI5qp4UmTrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjtrw%253D&md5=4a2275e665be5672628ab12819382b64</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0805-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0805-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DHeinz%26aufirst%3DA.%26aulast%3DKienast%26aufirst%3DT.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DElevated%2520%255B18F%255Dfluorodopamine%2520turnover%2520in%2520brain%2520of%2520patients%2520with%2520schizophrenia%253A%2520an%2520%255B18F%255Dfluorodopa%252Fpositron%2520emission%2520tomography%2520study%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D8080%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davids, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=787-794&author=G.+Gr%C3%BCnderauthor=I.+Vernalekenauthor=M.+J.+Mullerauthor=E.+Davidsauthor=N.+Heydariauthor=H.+G.+Buchholzauthor=P.+Bartensteinauthor=O.+L.+Munkauthor=P.+Stoeterauthor=D.+F.+Wongauthor=A.+Gjeddeauthor=P.+Cumming&title=Subchronic+haloperidol+downregulates+dopamine+synthesis+capacity+in+the+brain+of+schizophrenic+patients+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DM.%2BJ.%26aulast%3DDavids%26aufirst%3DE.%26aulast%3DHeydari%26aufirst%3DN.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DMunk%26aufirst%3DO.%2BL.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DSubchronic%2520haloperidol%2520downregulates%2520dopamine%2520synthesis%2520capacity%2520in%2520the%2520brain%2520of%2520schizophrenic%2520patients%2520in%2520vivo%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D787%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgers, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Baseline [<sup>18</sup>F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: a positron emission tomography study in healthy subjects</span> <span class="citation_source-journal">Neuroimage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=1222-1231&author=I.+Vernalekenauthor=Y.+Kumakuraauthor=H.+G.+Buchholzauthor=T.+Siessmeierauthor=R.+D.+Hilgersauthor=P.+Bartensteinauthor=P.+Cummingauthor=G.+Grunder&title=Baseline+%5B18F%5D-FDOPA+kinetics+are+predictive+of+haloperidol-induced+changes+in+dopamine+turnover+and+cognitive+performance%3A+a+positron+emission+tomography+study+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DHilgers%26aufirst%3DR.%2BD.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DBaseline%2520%255B18F%255D-FDOPA%2520kinetics%2520are%2520predictive%2520of%2520haloperidol-induced%2520changes%2520in%2520dopamine%2520turnover%2520and%2520cognitive%2520performance%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520in%2520healthy%2520subjects%26jtitle%3DNeuroimage%26date%3D2008%26volume%3D40%26spage%3D1222%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Modulation of [<sup>18</sup>F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1332</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=1332-1339&author=I.+Vernalekenauthor=Y.+Kumakuraauthor=P.+Cummingauthor=H.+G.+Buchholzauthor=T.+Siessmeierauthor=P.+Stoeterauthor=M.+J.+Mullerauthor=P.+Bartensteinauthor=G.+Grunder&title=Modulation+of+%5B18F%5Dfluorodopa+%28FDOPA%29+kinetics+in+the+brain+of+healthy+volunteers+after+acute+haloperidol+challenge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DM.%2BJ.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DModulation%2520of%2520%255B18F%255Dfluorodopa%2520%2528FDOPA%2529%2520kinetics%2520in%2520the%2520brain%2520of%2520healthy%2520volunteers%2520after%2520acute%2520haloperidol%2520challenge%26jtitle%3DNeuroImage%26date%3D2006%26volume%3D30%26spage%3D1332%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Danielsen, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermansen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=172-175&author=E.+H.+Danielsenauthor=D.+Smithauthor=F.+Hermansenauthor=A.+Gjeddeauthor=P.+Cumming&title=Acute+neuroleptic+stimulates+DOPA+decarboxylase+in+porcine+brain+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDanielsen%26aufirst%3DE.%2BH.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DHermansen%26aufirst%3DF.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DAcute%2520neuroleptic%2520stimulates%2520DOPA%2520decarboxylase%2520in%2520porcine%2520brain%2520in%2520vivo%26jtitle%3DSynapse%26date%3D2001%26volume%3D41%26spage%3D172%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Sharma, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaid, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicak, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K.</span><span> </span><span class="NLM_article-title">Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0006-3223%2893%2990381-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8104508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2c%252Fgt1OjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=128-134&author=R.+P.+Sharmaauthor=J.+I.+Javaidauthor=P.+G.+Janicakauthor=J.+M.+Davisauthor=K.+Faull&title=Homovanillic+acid+in+the+cerebrospinal+fluid%3A+patterns+of+response+after+four+weeks+of+neuroleptic+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment</span></div><div class="casAuthors">Sharma R P; Javaid J I; Janicak P G; Davis J M; Faull K</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">128-34</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">Lumbar cerebrospinal fluid (CSF) homovanillic acid (HVA) concentrations were measured before and after 4 weeks of neuroleptic treatment in schizophrenic (n = 15) and schizoaffective (n = 4) patients.  Neuroleptic treatment induced a nonsignificant (17%) increase in CSF HVA group mean levels.  For the total group, no correlations were found between pretreatment CSF HVA and clinical measures, or between changes in HVA and clinical response.  An alternative interpretation was attempted by defining "tolerant" and "nontolerant" subgroups.  A "tolerant" response was defined as a reduction in posttreatment HVA values below pretreatment levels, whereas a "nontolerant" response was characterized by posttreatment values above pretreatment levels.  When thus defined, nontolerant patients had a significantly inferior clinical response to neuroleptics, in contrast to their tolerant counterparts.  Further, although there was no difference in pretreatment CSF HVA values between these two groups, pretreatment clinical profiles did differ significantly.  Also, in a retrospective analysis, nontolerant patients were found to have a significantly earlier age of illness onset, a greater number of prior psychiatric hospitalizations, and more time spent in psychiatric hospitals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcer2-1vHqZ2Gmni0r9GoKfW6udTcc2eY3kkbDgtuFwLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252Fgt1OjtA%253D%253D&md5=612a5b9453acbd45f32d75107d03e16c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2F0006-3223%2893%2990381-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3223%252893%252990381-M%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BP.%26aulast%3DJavaid%26aufirst%3DJ.%2BI.%26aulast%3DJanicak%26aufirst%3DP.%2BG.%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DFaull%26aufirst%3DK.%26atitle%3DHomovanillic%2520acid%2520in%2520the%2520cerebrospinal%2520fluid%253A%2520patterns%2520of%2520response%2520after%2520four%2520weeks%2520of%2520neuroleptic%2520treatment%26jtitle%3DBiol.%2520Psychiatry%26date%3D1993%26volume%3D34%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Egerton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaddock, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winton-Brown, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, O. D.</span><span> </span><span class="NLM_article-title">Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.biopsych.2012.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=23312565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=106-112&author=A.+Egertonauthor=C.+A.+Chaddockauthor=T.+T.+Winton-Brownauthor=M.+A.+Bloomfieldauthor=S.+Bhattacharyyaauthor=P.+Allenauthor=P.+K.+McGuireauthor=O.+D.+Howes&title=Presynaptic+striatal+dopamine+dysfunction+in+people+at+ultra-high+risk+for+psychosis%3A+findings+in+a+second+cohort"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort</span></div><div class="casAuthors">Egerton, Alice; Chaddock, Christopher A.; Winton-Brown, Toby T.; Bloomfield, Michael A. P.; Bhattacharyya, Sagnik; Allen, Paul; McGuire, Philip K.; Howes, Oliver D.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-112</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Using positron emission tomog. (PET), we previously obsd. increases in 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine (18F-DOPA) uptake in the striatum of subjects at ultra-high risk (UHR) for psychosis, indicating elevated presynaptic dopamine synthesis capacity.  The purpose of this study was to test if this finding would be replicated in a second UHR cohort.  18F-DOPA PET was used to est. dopamine synthesis capacity in the striatum of an entirely new cohort of 26 individuals at UHR for psychosis (14 males, mean±SD age = 22.7±4.7 years) and 20 healthy volunteers matched for age and gender (11 males, mean±SD age = 24.5±4.5 years).  Dopamine synthesis capacity was elevated in the whole [t(44) = 2.6; p = .01, effect size = .81] and associative striatum [t(44) = 2.6; p = .01, effect size = .73] of UHR compared with control subjects.  When the two samples were combined to give a final sample of 32 control and 50 UHR subjects, the higher levels of dopamine synthesis capacity in the UHR group reached significance across the whole [F(1,81) = 11.0; p = .001], associative [F(1,81) = 12.7; p = .001], and sensorimotor [F(1,81) = 4.7; p = .03], but not the limbic [F(1,81) = 2.1; p = .2], striatum.  The findings indicate that elevated dopamine synthesis capacity in the dorsal striatum is a robust feature of individuals at UHR for psychosis and provide further evidence that dopaminergic abnormalities precede the onset of psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMpxjYAIVgLVg90H21EOLACvtfcHk0ljZ0__t2lB53g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWmtA%253D%253D&md5=2e350eac28c1371b51f716125b224ae8</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DEgerton%26aufirst%3DA.%26aulast%3DChaddock%26aufirst%3DC.%2BA.%26aulast%3DWinton-Brown%26aufirst%3DT.%2BT.%26aulast%3DBloomfield%26aufirst%3DM.%2BA.%26aulast%3DBhattacharyya%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DP.%26aulast%3DMcGuire%26aufirst%3DP.%2BK.%26aulast%3DHowes%26aufirst%3DO.%2BD.%26atitle%3DPresynaptic%2520striatal%2520dopamine%2520dysfunction%2520in%2520people%2520at%2520ultra-high%2520risk%2520for%2520psychosis%253A%2520findings%2520in%2520a%2520second%2520cohort%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D106%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Howes, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asselin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramon-Bosch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valmaggia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">Elevated striatal dopamine function linked to prodromal signs of schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchgenpsychiatry.2008.514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=19124684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FltlOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=13-20&author=O.+D.+Howesauthor=A.+J.+Montgomeryauthor=M.+C.+Asselinauthor=R.+M.+Murrayauthor=I.+Valliauthor=P.+Tabrahamauthor=E.+Bramon-Boschauthor=L.+Valmaggiaauthor=L.+Johnsauthor=M.+Broomeauthor=P.+K.+McGuireauthor=P.+M.+Grasby&title=Elevated+striatal+dopamine+function+linked+to+prodromal+signs+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated striatal dopamine function linked to prodromal signs of schizophrenia</span></div><div class="casAuthors">Howes Oliver D; Montgomery Andrew J; Asselin Marie-Claude; Murray Robin M; Valli Isabel; Tabraham Paul; Bramon-Bosch Elvira; Valmaggia Lucia; Johns Louise; Broome Matthew; McGuire Philip K; Grasby Paul M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  A major limitation on the development of biomarkers and novel interventions for schizophrenia is that its pathogenesis is unknown.  Although elevated striatal dopamine activity is thought to be fundamental to schizophrenia, it is unclear when this neurochemical abnormality develops in relation to the onset of illness and how this relates to the symptoms and neurocognitive impairment seen in individuals with prodromal symptoms of schizophrenia.  OBJECTIVES:  To determine whether striatal dopamine function is elevated in individuals with prodromal symptoms of schizophrenia before the onset of psychosis and to assess how this relates to the symptoms and neurocognitive impairment.  DESIGN:  Case-control study of in vivo striatal dopaminergic function.  SETTING:  Academic research.  Patients Patients were recruited from a community mental health service.  Twenty-four patients having prodromal symptoms of schizophrenia were compared with 7 patients having schizophrenia and with 12 matched healthy control subjects from the same community.  Main Outcome Measure Striatal 6-fluoro-l-dopa F 18-dopa uptake measured using positron emission tomographic (18)F-dopa imaging.  RESULTS:  Striatal (18)F-dopa uptake was elevated in patients with prodromal symptoms of schizophrenia (effect size, 0.75) to an intermediate degree compared with that in patients with schizophrenia (effect size, 1.25).  The elevation was localized in the associative striatum in both groups.  Moreover, striatal (18)F-dopa uptake in patients with prodromal symptoms of schizophrenia was correlated with the severity of prodromal psychopathologic and neuropsychological impairment but not with the severity of anxiety or depressive symptoms.  CONCLUSIONS:  These findings indicate that dopamine overactivity predates the onset of schizophrenia in individuals with prodromal psychotic symptoms, is predominantly localized in the associative striatum, and is correlated with the severity of symptoms and neurocognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTw8vPTbrE9VCM8MEzWGjS9fW6udTcc2eY7C3MNGxFK2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FltlOmsg%253D%253D&md5=eb76439348e574ec24367132e0b6fb4a</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1001%2Farchgenpsychiatry.2008.514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchgenpsychiatry.2008.514%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DO.%2BD.%26aulast%3DMontgomery%26aufirst%3DA.%2BJ.%26aulast%3DAsselin%26aufirst%3DM.%2BC.%26aulast%3DMurray%26aufirst%3DR.%2BM.%26aulast%3DValli%26aufirst%3DI.%26aulast%3DTabraham%26aufirst%3DP.%26aulast%3DBramon-Bosch%26aufirst%3DE.%26aulast%3DValmaggia%26aufirst%3DL.%26aulast%3DJohns%26aufirst%3DL.%26aulast%3DBroome%26aufirst%3DM.%26aulast%3DMcGuire%26aufirst%3DP.%2BK.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3DElevated%2520striatal%2520dopamine%2520function%2520linked%2520to%2520prodromal%2520signs%2520of%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2009%26volume%3D66%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Allen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luigjes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egerton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambeitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar-Poli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, P.</span><span> </span><span class="NLM_article-title">Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals</span> <span class="citation_source-journal">Schizophr. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1093%2Fschbul%2Fsbr194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=22290265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BC38vhsFKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=1268-1276&author=P.+Allenauthor=J.+Luigjesauthor=O.+D.+Howesauthor=A.+Egertonauthor=K.+Hiraoauthor=I.+Valliauthor=J.+Kambeitzauthor=P.+Fusar-Poliauthor=M.+Broomeauthor=P.+McGuire&title=Transition+to+psychosis+associated+with+prefrontal+and+subcortical+dysfunction+in+ultra+high-risk+individuals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals</span></div><div class="casAuthors">Allen Paul; Luigjes Judy; Howes Oliver D; Egerton Alice; Hirao Kazuyuki; Valli Isabel; Kambeitz Joseph; Fusar-Poli Paolo; Broome Matthew; McGuire Philip</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1268-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  People at ultra high risk (UHR) of psychosis have an elevated risk of developing a psychotic disorder, but it is difficult to predict which individuals will make a transition to frank illness.  We investigated whether functional magnetic resonance imaging (fMRI) in conjunction with a phonological fluency task at presentation could distinguish subjects who subsequently developed psychosis from those who did not.  METHODS:  Sixty-five subjects (41 with an UHR and 24 healthy controls) were assessed at clinical presentation using fMRI, in conjunction with a verbal fluency task. [18F]-DOPA positron emission tomography (PET) data were also available in a subgroup of 21 UHR and 14 healthy controls subjects.  UHR subjects were followed clinically for at least 2 years.  RESULTS:  Compared with UHR subjects who did not become psychotic, UHR subjects who subsequently developed psychosis showed increased activation in bilateral prefrontal cortex (PFC), brainstem (midbrain/basilar pons), the left hippocampus, and greater midbrain-PFC connectivity.  Furthermore, exploratory analysis of [18F]-DOPA PET data showed that transition to psychosis was associated with elevated dopaminergic function in the brainstem region.  CONCLUSIONS:  In people at high risk of psychosis, increased activation in a network of cortical and subcortical regions may predict the subsequent onset of illness.  Functional neuroimaging, in conjunction with clinical assessment and other investigations, may facilitate the prediction of outcome in subjects who are vulnerable to psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2frwdYJiOL7qxQ2mb9Pu8fW6udTcc2eY7C3MNGxFK2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhsFKmtw%253D%253D&md5=1295a60fc02ea0ff1228ef6d263e9f2b</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbr194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbr194%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DP.%26aulast%3DLuigjes%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DO.%2BD.%26aulast%3DEgerton%26aufirst%3DA.%26aulast%3DHirao%26aufirst%3DK.%26aulast%3DValli%26aufirst%3DI.%26aulast%3DKambeitz%26aufirst%3DJ.%26aulast%3DFusar-Poli%26aufirst%3DP.%26aulast%3DBroome%26aufirst%3DM.%26aulast%3DMcGuire%26aufirst%3DP.%26atitle%3DTransition%2520to%2520psychosis%2520associated%2520with%2520prefrontal%2520and%2520subcortical%2520dysfunction%2520in%2520ultra%2520high-risk%2520individuals%26jtitle%3DSchizophr.%2520Bull.%26date%3D2012%26volume%3D38%26spage%3D1268%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Weinberger, D. R.; Laruelle, M.</span><span> </span><span class="NLM_article-title">Neurochemical and neuropharmacological imaging in schizophrenia</span>. In  <span class="citation_source-book">Neuropharmacology: The Fifth Generation of Progress</span>; <span class="NLM_contrib-group">Davis, K. L.; Charney, D. S.; Coyle, J. T.; Nemeroff, C.</span>, Eds.; <span class="NLM_publisher-name">Lippincott, Williams, & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=D.+R.+Weinberger&author=M.+Laruelleauthor=K.+L.+Davis&author=D.+S.+Charney&author=J.+T.+Coyle&author=C.+Nemeroff&title=Neuropharmacology%3A+The+Fifth+Generation+of+Progress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DNeurochemical%2520and%2520neuropharmacological%2520imaging%2520in%2520schizophrenia%26btitle%3DNeuropharmacology%253A%2520The%2520Fifth%2520Generation%2520of%2520Progress%26aulast%3DDavis%26aufirst%3DK.%2BL.%26pub%3DLippincott%252C%2520Williams%252C%2520%2526%2520Wilkins%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Decreased dopamine D<sub>2</sub> receptor binding in the anterior cingulate cortex in schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.59.1.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11779278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFWqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=25-30&author=T.+Suharaauthor=Y.+Okuboauthor=F.+Yasunoauthor=Y.+Sudoauthor=M.+Inoueauthor=T.+Ichimiyaauthor=Y.+Nakashimaauthor=K.+Nakayamaauthor=S.+Tanadaauthor=K.+Suzukiauthor=C.+Halldinauthor=L.+Farde&title=Decreased+dopamine+D2+receptor+binding+in+the+anterior+cingulate+cortex+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia</span></div><div class="casAuthors">Suhara, Tetsuya; Okubo, Yoshiro; Yasuno, Fumihiko; Sudo, Yasuhiko; Inoue, Makoto; Ichimiya, Tetsuya; Nakashima, Yoshifumi; Nakayama, Kazuhiko; Tanada, Shuji; Suzuki, Kazutoshi; Halldin, Christer; Farde, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">The aim of this study was to examine the extrastriatal D2 receptors of patients with schizophrenia.  Eleven drug-naive male patients with schizophrenia were examd. with positron emission tomog.. using carbon 11-labeled FLB 457.  Symptoms were assessed using the Brief Psychiatric Rating Scale.  Eighteen healthy controls were used for comparison.  Region-of-interest anal. was performed using the ref. tissue method, and binding potential (BP) was used for the index of dopamine D2 receptor binding.  The BP value was significantly lower, by ∼12.5%, in the anterior cingulate cortex in drug-naive patients with schizophrenia than in healthy controls.  A significant neg. correlation was obsd. between BP in the anterior cingulate cortex and the pos. symptom score on Brief Psychiatric Rating Scale.  The lower BP values indicate fewer D2 receptors in the anterior cingulate cortex in patients with schizophrenia.  Alterations in D2 receptor function in the extrastriatal region may underlie the pos. symptoms of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrGhZKaUanubVg90H21EOLACvtfcHk0lhttaJ9Nz5AJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFWqtbc%253D&md5=3e2e3594b274bb9e0bd9210cccdc25a4</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.59.1.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.59.1.25%26sid%3Dliteratum%253Aachs%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DY.%26aulast%3DYasuno%26aufirst%3DF.%26aulast%3DSudo%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIchimiya%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DTanada%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DDecreased%2520dopamine%2520D2%2520receptor%2520binding%2520in%2520the%2520anterior%2520cingulate%2520cortex%2520in%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2002%26volume%3D59%26spage%3D25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Yasuno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Low dopamine D<sub>2</sub> receptor binding in subregions of the thalamus in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.161.6.1016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15169689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ntVCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=1016-1022&author=F.+Yasunoauthor=T.+Suharaauthor=Y.+Okuboauthor=Y.+Sudoauthor=M.+Inoueauthor=T.+Ichimiyaauthor=A.+Takanoauthor=K.+Nakayamaauthor=C.+Halldinauthor=L.+Farde&title=Low+dopamine+D2+receptor+binding+in+subregions+of+the+thalamus+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia</span></div><div class="casAuthors">Yasuno Fumihiko; Suhara Tetsuya; Okubo Yoshiro; Sudo Yasuhiko; Inoue Makoto; Ichimiya Tetsuya; Takano Akihiro; Nakayama Kazuhiko; Halldin Christer; Farde Lars</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1016-22</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Several structural and functional brain imaging studies have pointed to a disturbance of thalamic subnuclei in patients with schizophrenia.  The dopamine hypothesis of schizophrenia has, however, not been thoroughly examined in terms of this complex structure, which has connections with most brain regions of central interest in schizophrenia research.  The aim of the present study was to examine dopamine D(2) receptor binding in subregions of the thalamus in patients with schizophrenia.  METHOD:  The authors used positron emission tomography and the radioligand [(11)C]FLB457 to examine dopamine D(2) receptor binding in thalamic subregions of 10 drug-naive patients with schizophrenia.  Binding potential was calculated by the reference tissue method and used as an index for dopamine D(2) receptor binding.  Comparisons were made with 19 healthy subjects.  Subregions of interest were defined on individual magnetic resonance images using a percentage-based operational approach.  Clinical symptoms were rated by using the Brief Psychiatric Rating Scale (BPRS).  RESULTS:  The [(11)C]FLB457 binding potential was lower in the central medial and posterior subregions of the thalamus in patients with schizophrenia.  At a functional level, there was a significant negative correlation between binding potential and BPRS positive symptom scores.  CONCLUSIONS:  The subregions with low D(2) receptor binding comprise primarily the dorsomedial nucleus and pulvinar, two important components in circuitries previously suggested in the pathophysiology of schizophrenia.  Aberrant dopaminergic neurotransmission in thalamic subregions might be a mechanism underlying positive symptoms in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbpx6dOjcHacrRqEXsZufAfW6udTcc2ebzE0CNq-zLu7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ntVCksw%253D%253D&md5=6e2db4962f54c375560c1574e381b6b0</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.6.1016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.6.1016%26sid%3Dliteratum%253Aachs%26aulast%3DYasuno%26aufirst%3DF.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DY.%26aulast%3DSudo%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIchimiya%26aufirst%3DT.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DLow%2520dopamine%2520D2%2520receptor%2520binding%2520in%2520subregions%2520of%2520the%2520thalamus%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D1016%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Buchsbaum, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemether, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, J.</span><span> </span><span class="NLM_article-title">D<sub>2</sub>/D<sub>3</sub> dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.schres.2006.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16713185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD28vmtVGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=232-244&author=M.+S.+Buchsbaumauthor=B.+T.+Christianauthor=D.+S.+Lehrerauthor=T.+K.+Narayananauthor=B.+Shiauthor=J.+Mantilauthor=E.+Kemetherauthor=T.+R.+Oakesauthor=J.+Mukherjee&title=D2%2FD3+dopamine+receptor+binding+with+%5BF-18%5Dfallypride+in+thalamus+and+cortex+of+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia</span></div><div class="casAuthors">Buchsbaum Monte S; Christian Bradley T; Lehrer Douglas S; Narayanan Tanjore K; Shi Bingzhi; Mantil Joseph; Kemether Eileen; Oakes Terrence R; Mukherjee Jogeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">232-44</span>
        ISSN:<span class="NLM_cas:issn">0920-9964</span>.
    </div><div class="casAbstract">BACKGROUND:  Abnormalities in the dopaminergic system are implicated in schizophrenia. [F-18]fallypride is a highly selective, high affinity PET ligand well suited for measuring D2/D3 receptor availability in the extrastriatal regions of the brain including thalamus, prefrontal, cingulate, and temporal cortex, brain regions implicated in schizophrenia with other imaging modalities.  METHODS:  Resting [F-18]fallypride PET studies were acquired together with anatomical MRI for accurate coregistration and image analysis on 15 drug naive schizophrenics (10 men, 5 women, mean age 28.5 years) and 15 matched controls (9 men, 6 women, mean age 27.4 years).  Dopamine D2/D3 receptor levels were measured as binding potential (BP).  The fallypride BP images of each subject were spatially normalized and subsequently smoothed for group comparison.  Measures of significance between the schizophrenic and control groups were determined using statistical parametric mapping (SPM).  The medial dorsal nucleus and pulvinar were also traced on coregistered MRI for detailed assessment of BP in these regions.  RESULTS:  The thalamus of patients with schizophrenia had lower [F-18]fallypride BP than normal controls and this was the brain area with the greatest difference (range -8.5% to -27.2%).  Left medial dorsal nucleus and left pulvinar showed the greatest decreases (-21.6% and -27.2% respectively).  The patients with schizophrenia also demonstrated D2/D3 BP reduction in the amygdala region, cingulate gyrus, and the temporal cortices.  CONCLUSIONS:  These findings suggest that drug naive patients with schizophrenia have significant reductions in extrastratial D2/D3 receptor availability.  The reductions were most prominent in regions of the thalamus, replicating other studies both with high affinity D2/D3 ligands and consistent with FDG-PET studies, further supporting the hypothesis of thalamic abnormalities in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTk6d9Veicsu-2qxNLjzXe8fW6udTcc2eZ7lqaGUStQOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vmtVGgsQ%253D%253D&md5=c359e5efbb024a6757335f72dabe0e60</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2006.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2006.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DBuchsbaum%26aufirst%3DM.%2BS.%26aulast%3DChristian%26aufirst%3DB.%2BT.%26aulast%3DLehrer%26aufirst%3DD.%2BS.%26aulast%3DNarayanan%26aufirst%3DT.%2BK.%26aulast%3DShi%26aufirst%3DB.%26aulast%3DMantil%26aufirst%3DJ.%26aulast%3DKemether%26aufirst%3DE.%26aulast%3DOakes%26aufirst%3DT.%2BR.%26aulast%3DMukherjee%26aufirst%3DJ.%26atitle%3DD2%252FD3%2520dopamine%2520receptor%2520binding%2520with%2520%255BF-18%255Dfallypride%2520in%2520thalamus%2520and%2520cortex%2520of%2520patients%2520with%2520schizophrenia%26jtitle%3DSchizophr.%2520Res.%26date%3D2006%26volume%3D85%26spage%3D232%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">D<sub>2/3</sub>-receptor availability in schizophrenia decreases with progression of psychosis</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=80&author=I.+Vernalekenauthor=M.+Raptisauthor=P.+Bartensteinauthor=D.+F.+Wongauthor=W.+M.+Schaeferauthor=F.+Roeschauthor=G.+Grunder&title=D2%2F3-receptor+availability+in+schizophrenia+decreases+with+progression+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DRaptis%26aufirst%3DM.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DSchaefer%26aufirst%3DW.%2BM.%26aulast%3DRoesch%26aufirst%3DF.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DD2%252F3-receptor%2520availability%2520in%2520schizophrenia%2520decreases%2520with%2520progression%2520of%2520psychosis%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Haase, H.-J.</span><span> </span><span class="NLM_article-title">Die Dosierung der Neuroleptika unter feinmotorischer Kontrolle als konstruktiver Beitrag zum Thema der “Pharmakeule”.</span> In  <span class="citation_source-book">Psychopharmakotherapie. Optimale Dosierung der Neuroleptika</span>; <span class="NLM_contrib-group">Haase, H.-J.</span>, Ed.; <span class="NLM_publisher-name">Perimed</span>: <span class="NLM_publisher-loc">Erlangen</span>,<span class="NLM_x"> </span><span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=H.-J.+Haaseauthor=H.-J.+Haase&title=Psychopharmakotherapie.+Optimale+Dosierung+der+Neuroleptika"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHaase%26aufirst%3DH.-J.%26atitle%3DDie%2520Dosierung%2520der%2520Neuroleptika%2520unter%2520feinmotorischer%2520Kontrolle%2520als%2520konstruktiver%2520Beitrag%2520zum%2520Thema%2520der%2520%25E2%2580%259CPharmakeule%25E2%2580%259D.%26btitle%3DPsychopharmakotherapie.%2520Optimale%2520Dosierung%2520der%2520Neuroleptika%26aulast%3DHaase%26aufirst%3DH.-J.%26pub%3DPerimed%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Baron, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazière, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loc’h, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgouropoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Loss of striatal [<sup>76</sup>Br]bromospiperone binding sites demonstrated by positron emission tomography in progressive supranuclear palsy</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fjcbfm.1986.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=3485639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL287mvVGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1986&pages=131-136&author=J.+C.+Baronauthor=B.+Mazi%C3%A8reauthor=C.+Loc%E2%80%99hauthor=H.+Cambonauthor=P.+Sgouropoulosauthor=A.+M.+Bonnetauthor=Y.+Agid&title=Loss+of+striatal+%5B76Br%5Dbromospiperone+binding+sites+demonstrated+by+positron+emission+tomography+in+progressive+supranuclear+palsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy</span></div><div class="casAuthors">Baron J C; Maziere B; Loc'h C; Cambon H; Sgouropoulos P; Bonnet A M; Agid Y</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-6</span>
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">Using positron tomography and 76Br-labeled bromospiperone, a neuroleptic drug with high affinity for the dopamine (DA) receptors, we have estimated the specific binding of the radiotracer to striatal DA receptors in seven patients suffering from progressive supranuclear palsy.  Compared with age- and sex-matched control subjects, we found a significant (p less than 0.02) decrease of the striatum-cerebellum uptake ratio in progressive supranuclear palsy patients, suggesting loss of striatal DA receptors.  This in vivo study confirms recent postmortem data on progressive supranuclear palsy patients and provides an explanation for the lack of benefit from L-DOPA and DA agonists in this condition, despite reduced nigrostriatal dopaminergic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReY1vrHbtEtEGy1nwu7K2mfW6udTcc2eYcsKWs-Otri7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287mvVGrsw%253D%253D&md5=5eddf4d12de469456e37201d94563487</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1986.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1986.26%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DJ.%2BC.%26aulast%3DMazi%25C3%25A8re%26aufirst%3DB.%26aulast%3DLoc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DCambon%26aufirst%3DH.%26aulast%3DSgouropoulos%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DA.%2BM.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DLoss%2520of%2520striatal%2520%255B76Br%255Dbromospiperone%2520binding%2520sites%2520demonstrated%2520by%2520positron%2520emission%2520tomography%2520in%2520progressive%2520supranuclear%2520palsy%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1986%26volume%3D6%26spage%3D131%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Cambon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulenger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loc’h, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarifian, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziere, B.</span><span> </span><span class="NLM_article-title">In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">824</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1192%2Fbjp.151.6.824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2901886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL1M%252FgtFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1987&pages=824-830&author=H.+Cambonauthor=J.+C.+Baronauthor=J.+P.+Boulengerauthor=C.+Loc%E2%80%99hauthor=E.+Zarifianauthor=B.+Maziere&title=In+vivo+assay+for+neuroleptic+receptor+binding+in+the+striatum.+Positron+tomography+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans</span></div><div class="casAuthors">Cambon H; Baron J C; Boulenger J P; Loc'h C; Zarifian E; Maziere B</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">824-30</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">Using PET, we investigated the potency in six patients of therapeutic doses of neuroleptic drugs for preventing specific binding of trace doses of intravenously administered 76Br-labelled bromospiperone to corpus striatum in vivo.  Measured receptor occupancy showed a clear-cut dose-dependent saturation curve with increasing daily oral dose of neuroleptics, indicating the validity and reliability of the method when used as an in vivo radioreceptor assay.  Following drug withdrawal in eight patients, recovery to normal or supranormal receptor availability occurred in a matter of days.  The results demonstrate an approach that may help resolve controversies about, and design better strategies for, neuroleptic treatment schedules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmEICGWj3F_u98rul4nhSdfW6udTcc2eYcsKWs-Otri7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252FgtFKitg%253D%253D&md5=c8c283cc0472f120ce22b25e99813076</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1192%2Fbjp.151.6.824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.151.6.824%26sid%3Dliteratum%253Aachs%26aulast%3DCambon%26aufirst%3DH.%26aulast%3DBaron%26aufirst%3DJ.%2BC.%26aulast%3DBoulenger%26aufirst%3DJ.%2BP.%26aulast%3DLoc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DZarifian%26aufirst%3DE.%26aulast%3DMaziere%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520assay%2520for%2520neuroleptic%2520receptor%2520binding%2520in%2520the%2520striatum.%2520Positron%2520tomography%2520in%2520humans%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1987%26volume%3D151%26spage%3D824%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomquist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span> </span><span class="NLM_article-title">Kinetic analysis of central [<sup>11</sup>C]raclopride binding to D<sub>2</sub>-dopamine receptors studied by PET – a comparison to the equilibrium analysis</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fjcbfm.1989.98" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2528555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL1MXmtV2msLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=696-708&author=L.+Fardeauthor=L.+Erikssonauthor=G.+Blomquistauthor=C.+Halldin&title=Kinetic+analysis+of+central+%5B11C%5Draclopride+binding+to+D2-dopamine+receptors+studied+by+PET+%E2%80%93+a+comparison+to+the+equilibrium+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET  - a comparison to the equilibrium analysis</span></div><div class="casAuthors">Farde, L.; Eriksson, L.; Blomquist, G.; Halldin, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">696-708</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">[11C]raclopride binding to central D2-dopamine receptors in humans has previously been examd. by positron emission tomog. (PET).  Based on the rapid occurrence of binding equil., a satn. anal. was developed for the detn. of receptor d. (Bmax) and affinity (Kd).  For anal. of PET measurements obtained with other ligands, a kinetic 3-compartment model was used.  In the present study, the brain uptake of [11C]raclopride was analyzed further by applying both a kinetic and an equil. anal. to data obtained from 4 PET expts. in each of 3 healthy subjects.  First regional cerebral blood vol. was detd.  In the second and third expt., [11C]raclopride with high and low specific activity was used.  In a fourth expt., the [11C]raclopride enantiomer [11C]FLB472 was used to examine the concn. of free radioligand and nonspecific binding in brain.  Radioactivity in arterial blood was measured using an automated blood sampling system.  Bmax And Kd values for [11C]raclopride binding could be detd. also with the kinetic anal.  As expected theor., those values were similar to those obtained with the equil. anal.  In addn., the kinetic anal. allowed sep. detn. of the assocn. and dissocn. rate consts., kon and koff, resp.  Examn. of [11C]raclopride and [11C]FLB472 uptake in brain regions devoid of specific D2-dopamine receptor binding indicated a fourth compartment in which uptake was reversible, nonstereoselective, and nonsaturable in the dose range studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3LZ2tR-SRlLVg90H21EOLACvtfcHk0lidutvySlEhdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtV2msLY%253D&md5=86b7f5f4a1d44222f2009990c889b1b7</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1989.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1989.98%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DEriksson%26aufirst%3DL.%26aulast%3DBlomquist%26aufirst%3DG.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DKinetic%2520analysis%2520of%2520central%2520%255B11C%255Draclopride%2520binding%2520to%2520D2-dopamine%2520receptors%2520studied%2520by%2520PET%2520%25E2%2580%2593%2520a%2520comparison%2520to%2520the%2520equilibrium%2520analysis%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1989%26volume%3D9%26spage%3D696%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Baron, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulenger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caillard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huret, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loc’h, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziere, B.</span><span> </span><span class="NLM_article-title">Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1989&pages=463-472&author=J.+C.+Baronauthor=J.+L.+Martinotauthor=H.+Cambonauthor=J.+P.+Boulengerauthor=M.+F.+Poirierauthor=V.+Caillardauthor=J.+Blinauthor=J.+D.+Huretauthor=C.+Loc%E2%80%99hauthor=B.+Maziere&title=Striatal+dopamine+receptor+occupancy+during+and+following+withdrawal+from+neuroleptic+treatment%3A+correlative+evaluation+by+positron+emission+tomography+and+plasma+prolactin+levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DJ.%2BC.%26aulast%3DMartinot%26aufirst%3DJ.%2BL.%26aulast%3DCambon%26aufirst%3DH.%26aulast%3DBoulenger%26aufirst%3DJ.%2BP.%26aulast%3DPoirier%26aufirst%3DM.%2BF.%26aulast%3DCaillard%26aufirst%3DV.%26aulast%3DBlin%26aufirst%3DJ.%26aulast%3DHuret%26aufirst%3DJ.%2BD.%26aulast%3DLoc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DMaziere%26aufirst%3DB.%26atitle%3DStriatal%2520dopamine%2520receptor%2520occupancy%2520during%2520and%2520following%2520withdrawal%2520from%2520neuroleptic%2520treatment%253A%2520correlative%2520evaluation%2520by%2520positron%2520emission%2520tomography%2520and%2520plasma%2520prolactin%2520levels%26jtitle%3DPsychopharmacology%26date%3D1989%26volume%3D99%26spage%3D463%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Ehrin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Paulis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstrom, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone-Elander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ögren, S.</span><span> </span><span class="NLM_article-title">Preparation of <sup>11</sup>C-labelled raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey</span> <span class="citation_source-journal">Int. J. Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0020-708X%2885%2990083-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=3874833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL2MXls1Sgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1985&pages=269-273&author=E.+Ehrinauthor=L.+Fardeauthor=T.+de+Paulisauthor=L.+Erikssonauthor=T.+Greitzauthor=P.+Johnstromauthor=J.+E.+Littonauthor=J.+L.+Nilssonauthor=G.+Sedvallauthor=S.+Stone-Elanderauthor=S.+%C3%96gren&title=Preparation+of+11C-labelled+raclopride%2C+a+new+potent+dopamine+receptor+antagonist%3A+preliminary+PET+studies+of+cerebral+dopamine+receptors+in+the+monkey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of carbon-11-labeled raclopride, a new potent dopamine receptor antagonist:  preliminary PET studies of cerebral dopamine receptors in the monkey</span></div><div class="casAuthors">Ehrin, Erling; Farde, Lars; De Paulis, Tomas; Eriksson, Lars; Greitz, Torgny; Johnstroem, Peter; Litton, Jan Erik; Nilsson, J. Lars G.; Sedvall, Goeran; et al.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">269-73</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">A new dopamine receptor antagonist, Raclopride (I) was labeled using [11C]ethyl iodide for alkylation of the nitrogen of the pyrrolidine ring in the corresponding secondary amine II.  The synthesis of I and an efficient method for the prepn. of [11C]ethyl iodide are described.  The 11C-labeled I was purified by HPLC and then used in positron emission tomog. to visualize the dopamine receptor-rich areas of the monkey brain.  The images obtained show selective accumulation of I in striatum and a 10-fold sepn. between the binding to caudate vs. cerebellum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl0nX9qAJNMbVg90H21EOLACvtfcHk0lidutvySlEhdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXls1Sgsb4%253D&md5=a76e923c95e6cd19ba04e5981d47af25</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2885%2990083-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252885%252990083-3%26sid%3Dliteratum%253Aachs%26aulast%3DEhrin%26aufirst%3DE.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3Dde%2BPaulis%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DL.%26aulast%3DGreitz%26aufirst%3DT.%26aulast%3DJohnstrom%26aufirst%3DP.%26aulast%3DLitton%26aufirst%3DJ.%2BE.%26aulast%3DNilsson%26aufirst%3DJ.%2BL.%26aulast%3DSedvall%26aufirst%3DG.%26aulast%3DStone-Elander%26aufirst%3DS.%26aulast%3D%25C3%2596gren%26aufirst%3DS.%26atitle%3DPreparation%2520of%252011C-labelled%2520raclopride%252C%2520a%2520new%2520potent%2520dopamine%2520receptor%2520antagonist%253A%2520preliminary%2520PET%2520studies%2520of%2520cerebral%2520dopamine%2520receptors%2520in%2520the%2520monkey%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1985%26volume%3D36%26spage%3D269%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span> </span><span class="NLM_article-title">Central D<sub>2</sub>-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.1988.01800250087012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2892477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL1cXosl2lug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1988&pages=71-76&author=L.+Fardeauthor=F.+A.+Wieselauthor=C.+Halldinauthor=G.+Sedvall&title=Central+D2-dopamine+receptor+occupancy+in+schizophrenic+patients+treated+with+antipsychotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs</span></div><div class="casAuthors">Farde, Lars; Wiesel, Fritz Axel; Halldin, Christer; Sedvall, Goeran</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-6</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">By use of positron emission tomog. and the 11C-labeled ligand raclopride, central D2-dopamine receptor occupancy in the putamen was detd. in psychiatric patients treated with clin. doses of psychoactive drugs.  Receptor occupancy in drug-treated patients was defined as the percent redn. of specific [11C]raclopride binding in relation to the expected binding in the absence of drug treatment.  Clin. treatment of schizophrenic patients with 11 chem. distinct antipsychotic drugs (including both classic and atypical neuroleptics such as clozapine) resulted in a 65%-85% occupancy of D2-dopamine receptors.  In a depressed patient treated with the tricyclic antidepressant nortriptyline, no occupancy was found.  The time course for receptor occupancy and drug levels was followed after withdrawal of sulpiride or haloperidol.  D2-dopamine receptor occupancy remained above 65% for many hours despite a substantial redn. of serum drug concns.  In a sulpiride-treated patient, the dosage was reduced in 4 steps over a 9-wk period and a curvilinear relationship was demonstrated between central D2-dopamine receptor occupancy and serum drug concns.  The results demonstrate that clin. doses of all the currently used classes of antipsychotic drugs cause a substantial blockage of central D2-dopamine receptors in humans.  This effect appears to be selective for the antipsychotics, since it was not induced by the antidepressant nortriptyline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD7dN3f4CHVrVg90H21EOLACvtfcHk0li0Vk6oN3g1wg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXosl2lug%253D%253D&md5=c4961c5ed90837994b550db1a4e4aafe</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1988.01800250087012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1988.01800250087012%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DWiesel%26aufirst%3DF.%2BA.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DSedvall%26aufirst%3DG.%26atitle%3DCentral%2520D2-dopamine%2520receptor%2520occupancy%2520in%2520schizophrenic%2520patients%2520treated%2520with%2520antipsychotic%2520drugs%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1988%26volume%3D45%26spage%3D71%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Nordström, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forslund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppfeldt, G.</span><span> </span><span class="NLM_article-title">Central D<sub>2</sub>-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0006-3223%2893%2990288-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8097114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK3s3ivFKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1993&pages=227-235&author=A.+L.+Nordstr%C3%B6mauthor=L.+Fardeauthor=F.+A.+Wieselauthor=K.+Forslundauthor=S.+Pauliauthor=C.+Halldinauthor=G.+Uppfeldt&title=Central+D2-dopamine+receptor+occupancy+in+relation+to+antipsychotic+drug+effects%3A+a+double-blind+PET+study+of+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients</span></div><div class="casAuthors">Nordstrom A L; Farde L; Wiesel F A; Forslund K; Pauli S; Halldin C; Uppfeldt G</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-35</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">The relationship between central D2-dopamine receptor occupancy and antipsychotic drug effects was examined in a double-blind study.  Raclopride was the compound used to induce a selective occupancy of the D2-dopamine receptors.  In addition, 11C-labeled raclopride was the radioligand used to measure occupancy by positron emission tomography (PET).  Seventeen schizophrenic patients were randomly assigned to one of three parallel groups treated for 4 weeks with daily doses of 2, 6, or 12 mg of raclopride.  D2-receptor occupancy was determined by PET at steady-state conditions in 13 patients who completed the study.  A statistically significant relationship was demonstrated between antipsychotic effect and degree of D2-receptor occupancy (p < 0.05).  Patients with extrapyramidal side effects had significantly higher D2-receptor occupancy than those without (p = 0.02).  The finding of a relationship between selective occupancy of the D2-dopamine receptors and clinical effects in schizophrenic patients principally provides new support for the dopamine hypothesis of antipsychotic drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0DIDXWk9_NwxyojvcjibhfW6udTcc2eaSch-818fRRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3ivFKjtw%253D%253D&md5=b3abcb9071739d89f676ebfd876355e2</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2F0006-3223%2893%2990288-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3223%252893%252990288-O%26sid%3Dliteratum%253Aachs%26aulast%3DNordstr%25C3%25B6m%26aufirst%3DA.%2BL.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DWiesel%26aufirst%3DF.%2BA.%26aulast%3DForslund%26aufirst%3DK.%26aulast%3DPauli%26aufirst%3DS.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DUppfeldt%26aufirst%3DG.%26atitle%3DCentral%2520D2-dopamine%2520receptor%2520occupancy%2520in%2520relation%2520to%2520antipsychotic%2520drug%2520effects%253A%2520a%2520double-blind%2520PET%2520study%2520of%2520schizophrenic%2520patients%26jtitle%3DBiol.%2520Psychiatry%26date%3D1993%26volume%3D33%26spage%3D227%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordstrom, A. L.</span><span> </span><span class="NLM_article-title">PET examination of central D<sub>2</sub> dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs</span> <span class="citation_source-journal">Psychopharmacol. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8103229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK3sXmtFOitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=94-100&author=L.+Fardeauthor=A.+L.+Nordstrom&title=PET+examination+of+central+D2+dopamine+receptor+occupancy+in+relation+to+extrapyramidal+syndromes+in+patients+being+treated+with+neuroleptic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs</span></div><div class="casAuthors">Farde, L.; Nordstroem, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Series</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Clinical Pharmacology in Psychiatry</span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">PSSEEP</span>;
        ISSN:<span class="NLM_cas:issn">0931-6795</span>.
    </div><div class="casAbstract">Positron emission tomog. was used to localize D2 dopamine receptors in humans treated with neuroleptics.  The relation between extrapyramidal syndromes and neuroleptic treatment is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppHPX5_Dbqi7Vg90H21EOLACvtfcHk0li2EXaO1fjAjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmtFOitr4%253D&md5=e834443826f3dae61d164530f39d865b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DNordstrom%26aufirst%3DA.%2BL.%26atitle%3DPET%2520examination%2520of%2520central%2520D2%2520dopamine%2520receptor%2520occupancy%2520in%2520relation%2520to%2520extrapyramidal%2520syndromes%2520in%2520patients%2520being%2520treated%2520with%2520neuroleptic%2520drugs%26jtitle%3DPsychopharmacol.%2520Ser.%26date%3D1993%26volume%3D10%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordstrom, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span> </span><span class="NLM_article-title">Positron emission tomographic analysis of central D<sub>1</sub> and D<sub>2</sub> dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.1992.01820070032005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=1352677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK38zivVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1992&pages=538-544&author=L.+Fardeauthor=A.+L.+Nordstromauthor=F.+A.+Wieselauthor=S.+Pauliauthor=C.+Halldinauthor=G.+Sedvall&title=Positron+emission+tomographic+analysis+of+central+D1+and+D2+dopamine+receptor+occupancy+in+patients+treated+with+classical+neuroleptics+and+clozapine.+Relation+to+extrapyramidal+side+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects</span></div><div class="casAuthors">Farde L; Nordstrom A L; Wiesel F A; Pauli S; Halldin C; Sedvall G</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-44</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">Positron emission tomography and selective radioligands were used to determine D1 and D2 dopamine receptor occupancy induced by neuroleptics in the basal ganglia of drug-treated schizophrenic patients.  In 22 patients treated with conventional dosages of classical neuroleptics, the D2 occupancy was 70% to 89%.  Patients with acute extrapyramidal syndromes had a higher D2 occupancy than those without side effects.  This finding indicates that neuroleptic-induced extrapyramidal syndromes are related to the degree of central D2 occupancy induced in the basal ganglia.  In five patients treated with clozapine, the prototype atypical antipsychotic drug, a lower D2 occupancy of 38% to 63% was found.  This finding demonstrates that clozapine is also "atypical" with respect to the central D2 occupancy in patients.  During treatment with clozapine, there is a low frequency of extrapyramidal syndromes, which accordingly may reflect the comparatively low D2 occupancy induced by clinical doses of clozapine.  Classical neuroleptics, like haloperidol or sulpiride, did not cause any evident D1 occupancy, but the thioxanthene flupentixol induced a 36% to 44% occupancy.  In four patients treated with clozapine, the D1 occupancy was 38% to 52%.  The D1 occupancy induced by clozapine and flupentixol may contribute to the antipsychotic effect of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8O-69J5LclwvupmecNw_lfW6udTcc2eYJS7DoIsZrkrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zivVKgug%253D%253D&md5=9c70724d8c7ca998bd4f0154101b0d7d</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1992.01820070032005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1992.01820070032005%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DNordstrom%26aufirst%3DA.%2BL.%26aulast%3DWiesel%26aufirst%3DF.%2BA.%26aulast%3DPauli%26aufirst%3DS.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DSedvall%26aufirst%3DG.%26atitle%3DPositron%2520emission%2520tomographic%2520analysis%2520of%2520central%2520D1%2520and%2520D2%2520dopamine%2520receptor%2520occupancy%2520in%2520patients%2520treated%2520with%2520classical%2520neuroleptics%2520and%2520clozapine.%2520Relation%2520to%2520extrapyramidal%2520side%2520effects%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1992%26volume%3D49%26spage%3D538%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Shintomi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, M.</span><span> </span><span class="NLM_article-title">Letter: Effects of antiparkinsonian drugs on neuroleptic-induced extrapyramidal signs in monkeys</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.2042-7158.1973.tb10661.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=4148443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVChtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1973&pages=666-667&author=K.+Shintomiauthor=M.+Yamamura&title=Letter%3A+Effects+of+antiparkinsonian+drugs+on+neuroleptic-induced+extrapyramidal+signs+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of antiparkinsonian drugs on neuroleptic-induced extrapyramidal signs in monkeys</span></div><div class="casAuthors">Shintomi, K.; Yamamura, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">666-7</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">S.c. administration of the antiparkinsonian drugs, ethopropazine-HCl (I) [1094-08-2] (5 mg/kg), benztropine mesylate [132-17-2] (2 mg/kg), trihexyphenidyl-HCl [52-49-3] (2 mg/kg), and 6,6,9-trimethyl-9-azabicyclo[3,3,1]non-3β-yl α,α-di(2-thienyl)glycolate-HCl [32891-29-5] (2 mg/kg) antagonized the cataleptic features induced by s.c. injection of haloperidol [52-86-8] (1 mg/kg) or perphenazine [58-39-9] (2 mg/kg) into male cynomolgus monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6h7Nu1JIJWLVg90H21EOLACvtfcHk0li2EXaO1fjAjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVChtg%253D%253D&md5=19498f3c8c89c59dfe81a014c80483d6</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1973.tb10661.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1973.tb10661.x%26sid%3Dliteratum%253Aachs%26aulast%3DShintomi%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DM.%26atitle%3DLetter%253A%2520Effects%2520of%2520antiparkinsonian%2520drugs%2520on%2520neuroleptic-induced%2520extrapyramidal%2520signs%2520in%2520monkeys%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1973%26volume%3D25%26spage%3D666%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">The ratios of serotonin and dopamine affinities differentiate atypical and typical antipsychotic drugs</span> <span class="citation_source-journal">Psychopharmacol. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2576319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK3cXhsFWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1989&pages=390-392&author=H.+Y.+Meltzerauthor=S.+Matsubaraauthor=J.+C.+Lee&title=The+ratios+of+serotonin+and+dopamine+affinities+differentiate+atypical+and+typical+antipsychotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs</span></div><div class="casAuthors">Meltzer, Herbert Y.; Matsubara, Shigehiro; Lee, Jar Chi</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Bulletin</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-2</span>CODEN:
                <span class="NLM_cas:coden">PSYBB9</span>;
        ISSN:<span class="NLM_cas:issn">0048-5764</span>.
    </div><div class="casAbstract">Atypical antipsychotic drugs such as clozapine, fluperlapine, and melperone produce weak catalepsy in rodents, and minimal extrapyramidal symptoms and serum prolactin elevations in humans, compared to typical antipsychotic drugs such as haloperidol.  The biol. basis for these differences has been attributed to relatively weak blockade at D2 dopamine (DA) receptors, various effects at D1 receptors, or potent serotonin2 (5-HT2) antagonism, although other possibilities exist.  To clarify the relative importance of actions of D1, D2, and 5-HT2 receptors for identification of candidate typical and atypical drugs, the authors detd. the neg. log of the Ki (pKi) value of 21 typical and 17 atypical antipsychotic drugs for the striatal D1 and D2 and frontal cortex 5-HT2 receptors of rodent brain.  Cluster anal. identified that the 5-HT2/D2 ratio was the most successful means of utilizing this data to classify typical and atypical antipsychotic drugs correctly.  A 92% accuracy was achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0Xqr2TSGcLVg90H21EOLACvtfcHk0ljznueP-zijnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhsFWmu7Y%253D&md5=3f5c199f61ada18f6210532b086b0e13</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DMatsubara%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520ratios%2520of%2520serotonin%2520and%2520dopamine%2520affinities%2520differentiate%2520atypical%2520and%2520typical%2520antipsychotic%2520drugs%26jtitle%3DPsychopharmacol.%2520Bull.%26date%3D1989%26volume%3D25%26spage%3D390%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Mamo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shammi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papatheodorou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therrien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, G.</span><span> </span><span class="NLM_article-title">A PET study of dopamine D<sub>2</sub> and serotonin 5-HT<sub>2</sub> receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.161.5.818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15121646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itFyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=818-825&author=D.+Mamoauthor=S.+Kapurauthor=C.+M.+Shammiauthor=G.+Papatheodorouauthor=S.+Mannauthor=F.+Therrienauthor=G.+Remington&title=A+PET+study+of+dopamine+D2+and+serotonin+5-HT2+receptor+occupancy+in+patients+with+schizophrenia+treated+with+therapeutic+doses+of+ziprasidone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone</span></div><div class="casAuthors">Mamo David; Kapur Shitij; Shammi C M; Papatheodorou George; Mann Steve; Therrien Francois; Remington Gary</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">818-25</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Ziprasidone is an atypical antipsychotic drug that shows a higher affinity for serotonin 5-HT(2) receptors compared with dopamine D(2) receptors in vitro.  The affinity of ziprasidone for these receptors in vivo in patients was examined in a positron emission tomography (PET) study.  METHOD:  The authors conducted a PET study to evaluate D(2) occupancy (using [(11)C]raclopride) and 5-HT(2) occupancy (using [(18)F]setoperone) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40, 80, 120, or 160 mg/day of ziprasidone, which reflected the recommended dose range.  PET scanning was done after 3 weeks of administration and at trough plasma levels, i.e., 12-16 hours after the last dose.  RESULTS:  The mean 5-HT(2) receptor occupancy was significantly higher than the mean D(2) receptor occupancy (mean=76%, SD=15%, and mean=56%, SD=18%, respectively).  The estimated plasma ziprasidone concentration associated with 50% maximal 5-HT(2) receptor occupancy was almost four times lower than that for D(2) receptor occupancy.  CONCLUSIONS:  These data affirm that ziprasidone is similar to other novel antipsychotics in having greater 5-HT(2) than D(2) receptor occupancy at therapeutic doses and suggest that the optimal effective dose of ziprasidone is closer to 120 mg/day than to the lower doses suggested by previous PET studies.  The relatively high D(2) receptor occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.  Since ziprasidone plasma levels show significant (more than twofold) variation within a single dose cycle, studies that are aimed at peak plasma levels (6 hours after the last dose) and that examine extrastriatal regions are required to fully characterize the in vivo occupancy profile of ziprasidone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo4wIPTXNjldHxxy173TfNfW6udTcc2ebvYBgwaftK8rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itFyhuw%253D%253D&md5=85dfc81d925db394aa327198673a41ff</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.5.818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.5.818%26sid%3Dliteratum%253Aachs%26aulast%3DMamo%26aufirst%3DD.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DShammi%26aufirst%3DC.%2BM.%26aulast%3DPapatheodorou%26aufirst%3DG.%26aulast%3DMann%26aufirst%3DS.%26aulast%3DTherrien%26aufirst%3DF.%26aulast%3DRemington%26aufirst%3DG.%26atitle%3DA%2520PET%2520study%2520of%2520dopamine%2520D2%2520and%2520serotonin%25205-HT2%2520receptor%2520occupancy%2520in%2520patients%2520with%2520schizophrenia%2520treated%2520with%2520therapeutic%2520doses%2520of%2520ziprasidone%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D818%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group">Nyberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxenstierna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Suggested minimal effective dose of risperidone based on PET-measured D<sub>2</sub> and 5-HT<sub>2A</sub> receptor occupancy in schizophrenic patients</span> <span class="citation_source-journal">Am. J. Psychiatry.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10360125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK1M3ovVeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1999&pages=869-875&author=S.+Nybergauthor=B.+Erikssonauthor=G.+Oxenstiernaauthor=C.+Halldinauthor=L.+Farde&title=Suggested+minimal+effective+dose+of+risperidone+based+on+PET-measured+D2+and+5-HT2A+receptor+occupancy+in+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients</span></div><div class="casAuthors">Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">869-75</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Multicenter trials with the novel antipsychotic risperidone have suggested a standard dose of 6 mg/day.  However, a dose producing the highest response rate in fixed-dose studies is likely to exceed the minimal effective dose in most patients.  The aim of this positron emission tomography (PET) study was to suggest a minimal effective dose of risperidone based on measurements of dopamine D2 and serotonin 5-HT2A receptor occupancy.  METHOD:  Eight first-episode or drug-free schizophrenic patients were treated with risperidone, 6 mg/day, for 4 weeks and then 3 mg/day for 2 weeks.  PET was performed after 4 and 6 weeks, with [11C]raclopride to measure D2 receptor occupancy and [11C]N-methylspiperone to measure 5-HT2A receptor occupancy.  RESULTS:  Seven patients completed the study and responded to treatment with risperidone.  No patient had extrapyramidal side effects at the time of inclusion in the study.  At the 6-mg/day dose, mean D2 receptor occupancy was 82% (range = 79%-85%), 5-HT2A receptor occupancy was 95% (range = 86%-109%), and six patients had developed extrapyramidal side effects.  After dose reduction to 3 mg/day, D2 receptor occupancy was 72% (range = 53%-78%), and 5-HT2A receptor occupancy was 83% (range = 65%-112%).  Three patients had extrapyramidal side effects at this time.  CONCLUSIONS:  Treatment with risperidone, 6 mg/day, is likely to induce unnecessarily high D2 receptor occupancy, with a consequent risk of extrapyramidal side effects.  High 5-HT2A receptor occupancy did not prevent extrapyramidal side effects completely.  The authors previously suggested an optimal interval for D2 receptor occupancy of 70%-80%.  To achieve this, resperidone, 4 mg/day, should be a suitable initial dose for antipsychotic effect with a minimal risk of extrapyramidal side effects in most patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShWRknW98LMN1QT_1O5WBYfW6udTcc2eZp-3eRAi6i6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3ovVeqtQ%253D%253D&md5=9fa83e833bd3d68d1b880fb506e0b429</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNyberg%26aufirst%3DS.%26aulast%3DEriksson%26aufirst%3DB.%26aulast%3DOxenstierna%26aufirst%3DG.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DSuggested%2520minimal%2520effective%2520dose%2520of%2520risperidone%2520based%2520on%2520PET-measured%2520D2%2520and%25205-HT2A%2520receptor%2520occupancy%2520in%2520schizophrenic%2520patients%26jtitle%3DAm.%2520J.%2520Psychiatry.%26date%3D1999%26volume%3D156%26spage%3D869%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipursky, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, G.</span><span> </span><span class="NLM_article-title">Clinical and theoretical implications of 5-HT<sub>2</sub> and D<sub>2</sub> receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=9989565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK1M7kt1Kksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1999&pages=286-293&author=S.+Kapurauthor=R.+B.+Zipurskyauthor=G.+Remington&title=Clinical+and+theoretical+implications+of+5-HT2+and+D2+receptor+occupancy+of+clozapine%2C+risperidone%2C+and+olanzapine+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia</span></div><div class="casAuthors">Kapur S; Zipursky R B; Remington G</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">286-93</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Dopamine D2 receptor occupancy measurements provide a valid predictor of antipsychotic response, extrapyramidal side effects, and elevation of prolactin levels.  The new antipsychotics clozapine, risperidone, and olanzapine obtain antipsychotic response with few extrapyramidal side effects and little prolactin elevation.  The purpose of this study was to compare the D2 and serotonin 5-HT2 receptor occupancies of these drugs in patients receiving multiple-dose, steady-state regimens.  METHOD:  Forty-four patients with schizophrenia (16 taking risperidone, 2-12 mg/day; 17 taking olanzapine, 5-60 mg/day; and 11 taking clozapine, 75-900 mg/day) had their D2 and 5-HT2 occupancies determined with the use of [11C]raclopride and [18F]setoperone, respectively, and positron emission tomography imaging.  RESULTS:  Clozapine showed a much lower D2 occupancy (16%-68%) than risperidone (63%-89%) and olanzapine (43%-89%).  Risperidone and olanzapine gave equal D2 occupancies at doses of 5 and 20 mg/day, respectively.  All three drugs showed greater 5-HT2 than D2 occupancy at all doses, although the difference was greatest for clozapine.  CONCLUSIONS:  Clozapine, at doses known to be effective in routine clinical settings, showed a D2 occupancy clearly lower than that of typical antipsychotics, while risperidone and olanzapine at their usual clinical doses gave the same level of D2 occupancy as low-dose typical antipsychotics.  The results also suggest that some previous clinical comparisons of antipsychotics may have been confounded by different levels of D2 occupancy.  Clinical comparisons of these drugs, matching for D2 occupancy, may provide a better measure of their true "atypicality" and will help in understanding the contribution of non-D2 receptors to antipsychotic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8__ZcHLPhBjW1zwg2yUK5fW6udTcc2eZp-3eRAi6i6rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7kt1Kksw%253D%253D&md5=30cdcea9c4ae28aa2e8a978635baa894</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DZipursky%26aufirst%3DR.%2BB.%26aulast%3DRemington%26aufirst%3DG.%26atitle%3DClinical%2520and%2520theoretical%2520implications%2520of%25205-HT2%2520and%2520D2%2520receptor%2520occupancy%2520of%2520clozapine%252C%2520risperidone%252C%2520and%2520olanzapine%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1999%26volume%3D156%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group">Nakazawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onoe, H.</span><span> </span><span class="NLM_article-title">Evaluation of dopamine D<sub>2</sub>/D<sub>3</sub> and serotonin 5-HT<sub>2A</sub> receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2013&pages=329-339&author=S.+Nakazawaauthor=C.+Yokoyamaauthor=N.+Nishimuraauthor=T.+Horisawaauthor=A.+Kawasakiauthor=H.+Mizumaauthor=H.+Doiauthor=H.+Onoe&title=Evaluation+of+dopamine+D2%2FD3+and+serotonin+5-HT2A+receptor+occupancy+for+a+novel+antipsychotic%2C+lurasidone%2C+in+conscious+common+marmosets+using+small-animal+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakazawa%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DHorisawa%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DMizuma%26aufirst%3DH.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DOnoe%26aufirst%3DH.%26atitle%3DEvaluation%2520of%2520dopamine%2520D2%252FD3%2520and%2520serotonin%25205-HT2A%2520receptor%2520occupancy%2520for%2520a%2520novel%2520antipsychotic%252C%2520lurasidone%252C%2520in%2520conscious%2520common%2520marmosets%2520using%2520small-animal%2520positron%2520emission%2520tomography%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D225%26spage%3D329%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasic, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gean, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loebel, A.</span><span> </span><span class="NLM_article-title">Determination of dopamine D<sub>2</sub> receptor occupancy by lurasidone using positron emission tomography in healthy male subjects</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=245-252&author=D.+F.+Wongauthor=H.+Kuwabaraauthor=J.+R.+Brasicauthor=T.+Stockauthor=A.+Mainiauthor=E.+G.+Geanauthor=A.+Loebel&title=Determination+of+dopamine+D2+receptor+occupancy+by+lurasidone+using+positron+emission+tomography+in+healthy+male+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DBrasic%26aufirst%3DJ.%2BR.%26aulast%3DStock%26aufirst%3DT.%26aulast%3DMaini%26aufirst%3DA.%26aulast%3DGean%26aufirst%3DE.%2BG.%26aulast%3DLoebel%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520dopamine%2520D2%2520receptor%2520occupancy%2520by%2520lurasidone%2520using%2520positron%2520emission%2520tomography%2520in%2520healthy%2520male%2520subjects%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D245%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Potkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keator, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesler-West, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Erp, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preda, A.</span><span> </span><span class="NLM_article-title">D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder</span> <span class="citation_source-journal">CNS Spectr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=1-6&author=S.+G.+Potkinauthor=D.+B.+Keatorauthor=M.+L.+Kesler-Westauthor=D.+D.+Nguyenauthor=T.+G.+van+Erpauthor=J.+Mukherjeeauthor=N.+Shahauthor=A.+Preda&title=D2+receptor+occupancy+following+lurasidone+treatment+in+patients+with+schizophrenia+or+schizoaffective+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotkin%26aufirst%3DS.%2BG.%26aulast%3DKeator%26aufirst%3DD.%2BB.%26aulast%3DKesler-West%26aufirst%3DM.%2BL.%26aulast%3DNguyen%26aufirst%3DD.%2BD.%26aulast%3Dvan%2BErp%26aufirst%3DT.%2BG.%26aulast%3DMukherjee%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DPreda%26aufirst%3DA.%26atitle%3DD2%2520receptor%2520occupancy%2520following%2520lurasidone%2520treatment%2520in%2520patients%2520with%2520schizophrenia%2520or%2520schizoaffective%2520disorder%26jtitle%3DCNS%2520Spectr.%26date%3D2013%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Muller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenbogen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eich, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span> </span><span class="NLM_article-title">Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia</span> <span class="citation_source-journal">J. Psychiatr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.jpsychires.2005.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16324716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2s7pvVOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=673-679&author=M.+J.+Mullerauthor=B.+Regenbogenauthor=S.+Hartterauthor=F.+X.+Eichauthor=C.+Hiemke&title=Therapeutic+drug+monitoring+for+optimizing+amisulpride+therapy+in+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia</span></div><div class="casAuthors">Muller Matthias J; Regenbogen Boris; Hartter Sebastian; Eich Franz X; Hiemke Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">673-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Amisulpride is a clinically effective antipsychotic drug in a broad dose range with low propensity for extrapyramidal symptoms (EPS).  Daily doses and plasma levels of amisulpride were analyzed within a large-scale therapeutic drug monitoring (TDM) survey to find plasma level ranges for optimized treatment under naturalistic conditions.  Data of 378 schizophrenic patients treated with amisulpride (100-1550 mg) were included (40% female).  Amisulpride plasma levels were analyzed at steady state; assessment comprised improvement (CGI-I) and side-effects, particularly EPS.  For detection of cut-off values regarding non-response or EPS, receiver operating characteristics (ROC) curves were applied and the area under the ROC curve (AUC) was calculated.  Amisulpride daily doses (594+/-262 mg) and plasma levels (315+/-277 ng/ml) were significantly correlated (r=0.53; P<0.0001).  Patients with non-response to amisulpride (8.9%) had significantly (P<0.05) lower plasma levels (248+/-291 ng/ml) than patients with at least moderate improvement (316+/-253 ng/ml) despite comparable amisulpride doses (628+/-253 vs. 590+/-263 mg).  Patients with EPS (14.6%) had significantly (P<0.05) higher amisulpride plasma levels (377+/-290 ng/ml) than patients without EPS (305+/-274 ng/ml) despite similar doses in both groups (595+/-266 vs. 594+/-246 mg).  ROC analyses revealed significant predictive properties of amisulpride plasma levels (P<0.05) for non-response (AUC=0.65+/-0.05) and EPS (AUC=0.62+/-0.05), respectively.  Daily amisulpride doses did not significantly predict non-response or EPS.  Optimal amisulpride plasma level values to avoid non-response and EPS were 100 or 320 ng/ml, respectively.  Analysis of clinical utility revealed that blood levels must be analyzed in 7 patients until one patient benefits from the TDM procedure by avoiding non-response or EPS.  Although our results were mainly explorative, TDM of amisulpride seems very useful for clinical decision making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8SfH-nDqG-f_I8Jvzw4xCfW6udTcc2eaNY8ZHT-sAvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7pvVOiug%253D%253D&md5=ba28af8d65b22559d6ddab430fe60f2b</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.jpsychires.2005.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpsychires.2005.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%2BJ.%26aulast%3DRegenbogen%26aufirst%3DB.%26aulast%3DHartter%26aufirst%3DS.%26aulast%3DEich%26aufirst%3DF.%2BX.%26aulast%3DHiemke%26aufirst%3DC.%26atitle%3DTherapeutic%2520drug%2520monitoring%2520for%2520optimizing%2520amisulpride%2520therapy%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D2007%26volume%3D41%26spage%3D673%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Catafau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penengo, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corripio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parellada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ribera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomeni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and time-course of D<sub>2</sub> receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8828</span><span class="NLM_x">–</span> <span class="NLM_lpage">8894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1177%2F0269881107083810" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=8828-8894&author=A.+M.+Catafauauthor=M.+M.+Penengoauthor=G.+Nucciauthor=S.+Bullichauthor=I.+Corripioauthor=E.+Parelladaauthor=C.+Garcia-Riberaauthor=R.+Gomeniauthor=E.+Merlo-Pich&title=Pharmacokinetics+and+time-course+of+D2+receptor+occupancy+induced+by+atypical+antipsychotics+in+stabilized+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1177%2F0269881107083810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881107083810%26sid%3Dliteratum%253Aachs%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26aulast%3DPenengo%26aufirst%3DM.%2BM.%26aulast%3DNucci%26aufirst%3DG.%26aulast%3DBullich%26aufirst%3DS.%26aulast%3DCorripio%26aufirst%3DI.%26aulast%3DParellada%26aufirst%3DE.%26aulast%3DGarcia-Ribera%26aufirst%3DC.%26aulast%3DGomeni%26aufirst%3DR.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26atitle%3DPharmacokinetics%2520and%2520time-course%2520of%2520D2%2520receptor%2520occupancy%2520induced%2520by%2520atypical%2520antipsychotics%2520in%2520stabilized%2520schizophrenic%2520patients%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2008%26volume%3D22%26spage%3D8828%26epage%3D8894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janouschek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselinovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocheler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>2/3</sub> receptor occupancy by quetiapine in striatal and extrastriatal areas</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1017%2FS1461145710000374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=20392299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=951-960&author=I.+Vernalekenauthor=H.+Janouschekauthor=M.+Raptisauthor=S.+Hellmannauthor=T.+Veselinovicauthor=A.+Brochelerauthor=C.+Boyauthor=P.+Cummingauthor=C.+Hiemkeauthor=F.+Roschauthor=W.+M.+Schaferauthor=G.+Grunder&title=Dopamine+D2%2F3+receptor+occupancy+by+quetiapine+in+striatal+and+extrastriatal+areas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas</span></div><div class="casAuthors">Vernaleken, Ingo; Janouschek, Hildegard; Raptis, Mardjan; Hellmann, Sandra; Veselinovic, Tanja; Broecheler, Anno; Boy, Christian; Cumming, Paul; Hiemke, Christoph; Roesch, Frank; Schaefer, Wolfgang M.; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-960</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Quetiapine is next to clozapine an antipsychotic agent that exerts hardly any extrapyramidal side-effects at clin. efficacious doses.  Some previous receptor occupancy studies reported preferential extrastriatal D2/3 receptor (D2/3R)-binding properties of second-generation antipsychotics and suggested this as possible reason for improved tolerability.  This positron emission tomog. (PET) investigation was designed to compare the occupancy of dopamine D2/3Rs by quetiapine in striatal and extrastriatal brain regions.  Therefore, a cohort of 16 quetiapine-treated psychotic patients underwent an [18F]fallypride (FP) PET scan.  Due to the high affinity of FP and its comparatively long half-life, striatal and extrastriatal binding potentials could be detd. in one single scan.  Receptor occupancy was calcd. as percent redn. in binding potential relative to age-matched medication-free patients suffering from schizophrenia.  Quetiapine occupied 44±18% in the temporal cortex and 26±17% in the putamen, a difference significant at the level of p=0.005 (Student's t test).  Quetiapine showed a mean occupancy of 36±16% and in the thalamus.  In the caudate nucleus there was an occupancy of 29±16% (p=0.0072).  Individual occupancy levels did not exceed 59% in any of the striatal vols. of interest.  The time-interval between scan and last drug ingestion did not influence the relationship between plasma concn. and central D2/3R occupancy.  Taken together, quetiapine shows preferential extrastriatal binding at D2/3Rs; the extent of this difference is comparable to that previously described for clozapine.  Both antipsychotics show very low affinity for D2/3Rs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAZfVLh5YTbVg90H21EOLACvtfcHk0lhFbJtAe4bQ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtro%253D&md5=bce1703c4937952a4f4601bc01c99c53</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000374%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DJanouschek%26aufirst%3DH.%26aulast%3DRaptis%26aufirst%3DM.%26aulast%3DHellmann%26aufirst%3DS.%26aulast%3DVeselinovic%26aufirst%3DT.%26aulast%3DBrocheler%26aufirst%3DA.%26aulast%3DBoy%26aufirst%3DC.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DSchafer%26aufirst%3DW.%2BM.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DDopamine%2520D2%252F3%2520receptor%2520occupancy%2520by%2520quetiapine%2520in%2520striatal%2520and%2520extrastriatal%2520areas%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2010%26volume%3D13%26spage%3D951%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Shimoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nengaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1-[2-(4-[<sup>11</sup>C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT<sub>7</sub> receptor in the rat brain</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5316</span><span class="NLM_x">–</span> <span class="NLM_lpage">5322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=5316-5322&author=Y.+Shimodaauthor=J.+Yuiauthor=L.+Xieauthor=M.+Fujinagaauthor=T.+Yamasakiauthor=M.+Ogawaauthor=N.+Nengakiauthor=K.+Kumataauthor=A.+Hatoriauthor=K.+Kawamuraauthor=M.+R.+Zhang&title=Synthesis+and+evaluation+of+1-%5B2-%284-%5B11C%5Dmethoxyphenyl%29phenyl%5Dpiperazine+for+imaging+of+the+serotonin+5-HT7+receptor+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimoda%26aufirst%3DY.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DNengaki%26aufirst%3DN.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201-%255B2-%25284-%255B11C%255Dmethoxyphenyl%2529phenyl%255Dpiperazine%2520for%2520imaging%2520of%2520the%2520serotonin%25205-HT7%2520receptor%2520in%2520the%2520rat%2520brain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D5316%26epage%3D5322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span> </span><span class="NLM_article-title">Visualisation of serotonin-1A (5-HT<sub>1A</sub>) receptors in the central nervous system</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs002590000394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11202445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFyjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=113-129&author=J.+Passchierauthor=A.+van+Waarde&title=Visualisation+of+serotonin-1A+%285-HT1A%29+receptors+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system</span></div><div class="casAuthors">Passchier, Jan; van Waarde, Aren</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-129</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review with 131 refs.  The 5-HT1A subtype of receptors for the neurotransmitter serotonin is predominantly located in the limbic forebrain and is involved in the modulation of emotion and the function of the hypothalamus.  Since 5-HT1A receptors are implicated in the pathogenesis of anxiety, depression, hallucinogenic behavior, motion sickness and eating disorders, they are an important target for drug therapy.  Here, the authors review the radioligands which are available for visualization and quantification of this important neuroreceptor in the human brain, using positron emission tomog. (PET) or single-photon emission tomog. (SPET).  More than 20 compds. have been labeled with carbon-11 (half-life 20 min), fluorine-18 (half-life 109.8 min) or iodine-123 (half-life 13.2 h): structural analogs of the agonist, 8-OH-DPAT, structural analogs of the antagonist, WAY 100635, and apomorphines.  The most successful radioligands thus far are [carbonyl-11C] WAY-100635 (WAY), [carbonyl-11C]desmethyl-WAY-100635 (DWAY),p-[18F]MPPF and [11C]robalzotan (NAD-299).  The high-affinity ligands WAY and DWAY produce excellent images of 5-HT1A receptor distribution in the brain (even the raphe nuclei are visualized), but they cannot be distributed to remote facilities and they probably cannot be used to measure changes in endogenous serotonin.  Binding of the moderate-affinity ligands MPPF and NAD-299 may be more sensitive to serotonin competition and MPPF can be distributed to PET centers within a flying distance of a few hours.  Future research should be directed towards: (a) improvement of the metabolic stability in primates; (b) development of a fluorinated radioligand which can be produced in large quantities and (c) prodn. of a radioiodinated or technetium-labeled ligand for SPET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8QaK1VyAyrrVg90H21EOLACvtfcHk0lhFbJtAe4bQ5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFyjt7g%253D&md5=3964aa4056633399d6ac2843fafaceb1</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1007%2Fs002590000394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590000394%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26atitle%3DVisualisation%2520of%2520serotonin-1A%2520%25285-HT1A%2529%2520receptors%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D28%26spage%3D113%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group">Costall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, R. J.</span><span> </span><span class="NLM_article-title">A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0014-2999%2876%2990348-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=791660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaE2sXltVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1976&pages=9-19&author=B.+Costallauthor=R.+J.+Naylor&title=A+comparison+of+the+abilities+of+typical+neuroleptic+agents+and+of+thioridazine%2C+clozapine%2C+sulpiride+and+metoclopramide+to+antagonise+the+hyperactivity+induced+by+dopamine+applied+intracerebrally+to+areas+of+the+extrapyramidal+and+mesolimbic+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems</span></div><div class="casAuthors">Costall, Brenda; Naylor, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-19</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Dopamine-HCl (I-HCl) [62-31-7] injected directly into the caudate-putamen, nucleus accumbens or tuberculum olfactorium of rat brain, following a nialamide pretreatment, caused dose-dependent hyperactivity.  The hyperactivity was more intense after injections into the nucleus accumbens, but was limited by the development of stereotyped biting when larger doses of I were injected into the caudate-putamen or tuberculum olfactorium.  Haloperidol [52-86-8], fluphenazine-HCl [146-56-5] and pimozide [2062-78-4] antagonized, in a dose-dependent manner, the hyperactivity induced by I from all 3 areas.  Pimozide appeared equieffective against the 3 hyperactivity responses but haloperidol and fluphenazine more readily antagonized the hyperactivity mediated from the mesolimibic areas, the nucleus accumbens and tuberculum olfactorium.  Sulpiride [15676-16-1], clozapine [5786-21-0] and thioridazine-HCl [130-61-0] also caused dose-dependent redns. in the hyperactivity induced by I injections into the caudate-putamen, nucleus accumbens and tuberculum olfactorium, although the doses required to effect this inhibition were notably larger than for the typical neuroleptics.  Generally, these atypical agents were also least effective as antagonists of the hyperactivity following intrastriatal I.  Metoclopramide-HCl [7232-21-5] differed from all other agents tested in failing to antagonize the hyperactivity induced by I injections into the nucleus accumbens.  However, the responses to I from the caudate-putamen and tuberculum olfactorium were both antagonized by metoclopramide, the striatal response being the least sensitive.  The α- and β-adrenergic blocking agents, aceperone and propranolol, failed to reduce the hyperactivity induced by I injections into the caudate-putamen, nucleus accumbens or tuberculum olfactorium.  The abilities of the agents tested to antagonize a hyperactivity induced by I in the striatum or in the mesolimbic areas, the nucleus accumbens and tuberculum olfactorium, were compared with the potential of these agents to induce extrapyramidal side effects and to exert an antipsychotic action in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGric43JQN9fsrVg90H21EOLACvtfcHk0lj_odsaM6bRYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXltVKrsA%253D%253D&md5=094b7bac1617b8690ac7c5fd17e4678e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2876%2990348-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252876%252990348-4%26sid%3Dliteratum%253Aachs%26aulast%3DCostall%26aufirst%3DB.%26aulast%3DNaylor%26aufirst%3DR.%2BJ.%26atitle%3DA%2520comparison%2520of%2520the%2520abilities%2520of%2520typical%2520neuroleptic%2520agents%2520and%2520of%2520thioridazine%252C%2520clozapine%252C%2520sulpiride%2520and%2520metoclopramide%2520to%2520antagonise%2520the%2520hyperactivity%2520induced%2520by%2520dopamine%2520applied%2520intracerebrally%2520to%2520areas%2520of%2520the%2520extrapyramidal%2520and%2520mesolimbic%2520systems%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1976%26volume%3D40%26spage%3D9%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group">Bressan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlandsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilowsky, L. S.</span><span> </span><span class="NLM_article-title">Is regionally selective D<sub>2</sub>/D<sub>3</sub> dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [<sup>123</sup>I]epidepride SPET study of amisulpride-treated patients</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.160.8.1413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=12900302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD3szmsFOrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2003&pages=1413-1420&author=R.+A.+Bressanauthor=K.+Erlandssonauthor=H.+M.+Jonesauthor=R.+Mulliganauthor=R.+J.+Flanaganauthor=P.+J.+Ellauthor=L.+S.+Pilowsky&title=Is+regionally+selective+D2%2FD3+dopamine+occupancy+sufficient+for+atypical+antipsychotic+effect%3F+An+in+vivo+quantitative+%5B123I%5Depidepride+SPET+study+of+amisulpride-treated+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients</span></div><div class="casAuthors">Bressan Rodrigo A; Erlandsson Kjell; Jones Hugh M; Mulligan Rachel; Flanagan Robert J; Ell Peter J; Pilowsky Lyn S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1413-20</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Atypical antipsychotic drug treatment is clinically effective with a low risk of extrapyramidal symptoms.  Explanations for the mechanism underlying this beneficial therapeutic profile of atypical over typical antipsychotic agents include 1) simultaneous antagonism of dopamine D(2) and serotonin 5-HT(2A) receptors or 2) selective action at limbic cortical dopamine D(2)-like receptors with modest striatal D(2) receptor occupancy.  Amisulpride is an atypical antipsychotic drug with selective affinity for D(2)/D(3) dopamine receptors and provides a useful pharmacological model for examining these hypotheses.  The authors' goal was to evaluate whether treatment with amisulpride results in "limbic selective" D(2)/D(3) receptor blockade in vivo.  METHOD:  Five hours of dynamic single photon emission tomography data were acquired after injection of [(123)I]epidepride (approximately 150 MBq).  Kinetic modeling was performed by using the simplified reference region model to obtain binding potential values.  Estimates of receptor occupancy were made relative to a healthy volunteer comparison group (N=6).  RESULTS:  Eight amisulpride-treated patients (mean dose=406 mg/day) showed moderate levels of D(2)/D(3) receptor occupancy in the striatum (56%), and significantly higher levels were seen in the thalamus (78%) and temporal cortex (82%).  CONCLUSIONS:  Treatment with amisulpride results in a similar pattern of limbic cortical over striatal D(2)/D(3) receptor blockade to that of other atypical antipsychotic drugs.  This finding suggests that modest striatal D(2) receptor occupancy and preferential occupancy of limbic cortical dopamine D(2)/D(3) receptors may be sufficient to explain the therapeutic efficacy and low extrapyramidal symptom profile of atypical antipsychotic drugs, without the need for 5-HT(2A) receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvHN4dj4eq0VVwdslNBF-tfW6udTcc2eaM7QshkInu3rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szmsFOrtA%253D%253D&md5=eccd79f178c8447d93426f0607e533e4</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.160.8.1413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.160.8.1413%26sid%3Dliteratum%253Aachs%26aulast%3DBressan%26aufirst%3DR.%2BA.%26aulast%3DErlandsson%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DMulligan%26aufirst%3DR.%26aulast%3DFlanagan%26aufirst%3DR.%2BJ.%26aulast%3DEll%26aufirst%3DP.%2BJ.%26aulast%3DPilowsky%26aufirst%3DL.%2BS.%26atitle%3DIs%2520regionally%2520selective%2520D2%252FD3%2520dopamine%2520occupancy%2520sufficient%2520for%2520atypical%2520antipsychotic%2520effect%253F%2520An%2520in%2520vivo%2520quantitative%2520%255B123I%255Depidepride%2520SPET%2520study%2520of%2520amisulpride-treated%2520patients%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2003%26volume%3D160%26spage%3D1413%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">High striatal occupancy of D<sub>2</sub>-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1017%2FS1461145704004353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15683553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=421-430&author=I.+Vernalekenauthor=T.+Siessmeierauthor=H.+G.+Buchholzauthor=S.+Hartterauthor=C.+Hiemkeauthor=P.+Stoeterauthor=F.+Roschauthor=P.+Bartensteinauthor=G.+Grunder&title=High+striatal+occupancy+of+D2-like+dopamine+receptors+by+amisulpride+in+the+brain+of+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span></div><div class="casAuthors">Vernaleken, Ingo; Siessmeier, Thomas; Buchholz, Hans-Georg; Haertter, Sebastian; Hiemke, Christoph; Stoeter, Peter; Roesch, Frank; Bartenstein, Peter; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The 'atypicality' of the antipsychotic drug, amisulpride, has been attributed to preferential extrastriatal binding.  Previous investigations of striatal D2 receptor occupancy by amisulpride revealed conflicting results.  The aim of this PET study was to measure the striatal occupancy by amisulpride and to correlate it with the corresponding drug plasma concns.  Nine amisulpride-treated patients and 12 healthy volunteers serving as controls were studied with PET and [18F]desmethoxyfallypride.  Occupancy values and plasma concns. were nonlinearly fitted to an Emax model.  Results showed 43-85% (putamen) and 67-90% (caudate) D2-like receptor occupancy.  Plasma amisulpride concns. at the time of tracer injection, but not administered doses, were significantly nonlinearly correlated to occupancy levels (putamen: rS=0.88, p=0.0017; caudate: rS=0.78, p=0.0127).  Calcd. Emax was similar in both caudate and putamen, but occupancy levels were lower in caudate at lower amisulpride plasma concns.  Calcd. plasma levels to attain 60-80% receptor occupancy ranged from 119 to 474 ng/mL (caudate) and from 241 to 732 ng/mL (putamen).  This reveals a broad range of plasma concns. producing less than 80% striatal receptor occupancy.  However, our data show high striatal D2-like receptor occupancies under rising plasma concns.  Using the full range of recommended amisulpride dosage, striatal occupancies up to 90% can be measured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6q7vccCXi7Vg90H21EOLACvtfcHk0lhYpi-iuQ5P5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D&md5=deadbde0ae4eaf69e5f3d96ab47f1e25</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1017%2FS1461145704004353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145704004353%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DHartter%26aufirst%3DS.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DHigh%2520striatal%2520occupancy%2520of%2520D2-like%2520dopamine%2520receptors%2520by%2520amisulpride%2520in%2520the%2520brain%2520of%2520patients%2520with%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2004%26volume%3D7%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Abbas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Amisulpride is a potent 5-HT<sub>7</sub> antagonist: relevance for antidepressant actions in vivo</span> <span class="citation_source-journal">Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs00213-009-1521-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=19337725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=119-128&author=A.+I.+Abbasauthor=P.+B.+Hedlundauthor=X.+P.+Huangauthor=T.+B.+Tranauthor=H.+Y.+Meltzerauthor=B.+L.+Roth&title=Amisulpride+is+a+potent+5-HT7+antagonist%3A+relevance+for+antidepressant+actions+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo</span></div><div class="casAuthors">Abbas, Atheir I.; Hedlund, Peter B.; Huang, Xi-Ping; Tran, Thuy B.; Meltzer, Herbert Y.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Amisulpride is approved for clin. use in treating schizophrenia in a no. of European countries and also for treating dysthymia, a mild form of depression, in Italy.  Amisulpride has also been demonstrated to be an antidepressant for patients with major depression in many clin. trials.  In part because of the selective D2/D3 receptor antagonist properties of amisulpride, it has long been widely assumed that dopaminergic modulation is the proximal event responsible for mediating its antidepressant and antipsychotic properties.  The purpose of these studies was to det. if amisulpride's antidepressant actions are mediated by off-target interactions with other receptors.  We performed expts. that: (1) examd. the pharmacol. profile of amisulpride at a large no. of central nervous system (CNS) mol. targets and, (2) after finding high potency antagonist affinity for human 5-HT7a serotonin receptors, characterized the actions of amisulpride as an antidepressant in wild-type and 5-HT7 receptor knockout mice.  We discovered that amisulpride was a potent competitive antagonist at 5-HT7a receptors and that interactions with no other mol. target investigated in this paper could explain its antidepressant actions in vivo.  Significantly, and in contrast to their wild-type littermates, 5-HT7 receptor knockout mice did not respond to amisulpride in two widely used rodent models of depression, the tail suspension test and the forced swim test.  These results indicate that 5-HT7a receptor antagonism, and not D2/D3 receptor antagonism, likely underlies the antidepressant actions of amisulpride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOQ7Oab_nRLVg90H21EOLACvtfcHk0lhYpi-iuQ5P5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ks78%253D&md5=e8d0dcddac51117b910464d7faf07555</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1521-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1521-8%26sid%3Dliteratum%253Aachs%26aulast%3DAbbas%26aufirst%3DA.%2BI.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DTran%26aufirst%3DT.%2BB.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DAmisulpride%2520is%2520a%2520potent%25205-HT7%2520antagonist%253A%2520relevance%2520for%2520antidepressant%2520actions%2520in%2520vivo%26jtitle%3DPsychopharmacol.%26date%3D2009%26volume%3D205%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Pilowsky, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerwin, R. W.</span><span> </span><span class="NLM_article-title">Limbic selectivity of clozapine</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=490-491&author=L.+S.+Pilowskyauthor=R.+S.+Mulliganauthor=P.+D.+Actonauthor=P.+J.+Ellauthor=D.+C.+Costaauthor=R.+W.+Kerwin&title=Limbic+selectivity+of+clozapine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPilowsky%26aufirst%3DL.%2BS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DActon%26aufirst%3DP.%2BD.%26aulast%3DEll%26aufirst%3DP.%2BJ.%26aulast%3DCosta%26aufirst%3DD.%2BC.%26aulast%3DKerwin%26aufirst%3DR.%2BW.%26atitle%3DLimbic%2520selectivity%2520of%2520clozapine%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26spage%3D490%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Bressan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlandsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilowsky, L. S.</span><span> </span><span class="NLM_article-title">Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [<sup>123</sup>I]-epidepride SPET study</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2F00004714-200302000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=12544369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=5-14&author=R.+A.+Bressanauthor=K.+Erlandssonauthor=H.+M.+Jonesauthor=R.+S.+Mulliganauthor=P.+J.+Ellauthor=L.+S.+Pilowsky&title=Optimizing+limbic+selective+D2%2FD3+receptor+occupancy+by+risperidone%3A+a+%5B123I%5D-epidepride+SPET+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Limbic Selective D2/D3 Receptor Occupancy by Risperidone: A [123I]-Epidepride SPET Study</span></div><div class="casAuthors">Bressan, Rodrigo A.; Erlandsson, Kjell; Jones, Hugh M.; Mulligan, Rachel S.; Ell, Peter J.; Pilowsky, Lyn S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-14</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Selective action at limbic cortical dopamine D2-like receptors is a putative mechanism of atypical antipsychotic efficacy with few extrapyramidal side effects.  Although risperidone is an atypical antipsychotic with high affinity for D receptors, low-dose risperidone treatment is effective without inducing extrapyramidal symptoms.  The objective was to test the hypothesis that treatment with low-dose risperidone results in 'limbic selective' D2/D3 receptor blockade Dynamic single photon emission tomog. (SPET) sequences were obtained over 5 h after injection of [ I]-epidepride (∼150 MBq), using a high-resoln. triple-headed brain scanner (Marconi Prism 3000XP).  Kinetic modeling was performed using the simplified ref. region model to obtain binding potential values.  Ests. of receptor occupancy were made relative to a normal volunteer control group (n = 5).  Six patients treated with low-dose risperidone (mean = 2.6 mg) showed moderate levels of D2/D3 occupancy in striatum (49.9%), but higher levels of D2/D3 occupancy in thalamus (70.8%) and temporal cortex (75.2%).  Occupancy values in striatum were significantly different from thalamus (F (1,4) = 26.3, p < 0.01) and from temporal cortex (F (1,4) = 53.4, p < 0.01).  This is the first study to evaluate striatal and extrastriatal occupancy of risperidone.  Low dose treatment with risperidone achieves a similar selectivity of limbic cortical over striatal D2/D3 receptor blockade to that of atypical antipsychotics with lower D2/D3 affinity such as clozapine, olanzapine and quetiapine.  This finding is consistent with the relevance of 'limbic selective' D2/D3 receptor occupancy to the therapeutic efficacy of atypical antipsychotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8QN7jpgpfrVg90H21EOLACvtfcHk0lhYpi-iuQ5P5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVSntA%253D%253D&md5=9777c5c4e516fa5c5626ea4ea381f842</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1097%2F00004714-200302000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-200302000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DBressan%26aufirst%3DR.%2BA.%26aulast%3DErlandsson%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DEll%26aufirst%3DP.%2BJ.%26aulast%3DPilowsky%26aufirst%3DL.%2BS.%26atitle%3DOptimizing%2520limbic%2520selective%2520D2%252FD3%2520receptor%2520occupancy%2520by%2520risperidone%253A%2520a%2520%255B123I%255D-epidepride%2520SPET%2520study%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2003%26volume%3D23%26spage%3D5%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvogt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondracek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreckenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span> </span><span class="NLM_article-title">The striatal and extrastriatal D<sub>2</sub>/D<sub>3</sub> receptor-binding profile of clozapine in patients with schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1027-1035&author=G.+Gr%C3%BCnderauthor=C.+Landvogtauthor=I.+Vernalekenauthor=H.+G.+Buchholzauthor=J.+Ondracekauthor=T.+Siessmeierauthor=S.+Hartterauthor=M.+Schreckenbergerauthor=P.+Stoeterauthor=C.+Hiemkeauthor=F.+Roschauthor=D.+F.+Wongauthor=P.+Bartenstein&title=The+striatal+and+extrastriatal+D2%2FD3+receptor-binding+profile+of+clozapine+in+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DLandvogt%26aufirst%3DC.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DOndracek%26aufirst%3DJ.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DHartter%26aufirst%3DS.%26aulast%3DSchreckenberger%26aufirst%3DM.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DBartenstein%26aufirst%3DP.%26atitle%3DThe%2520striatal%2520and%2520extrastriatal%2520D2%252FD3%2520receptor-binding%2520profile%2520of%2520clozapine%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D1027%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Mukherjee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T.</span><span> </span><span class="NLM_article-title">Fluorinated benzamide neuroleptics. III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[<sup>18</sup>F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0969-8051%2894%2900117-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=7627142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK2MXlvFGls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1995&pages=283-296&author=J.+Mukherjeeauthor=Z.+Y.+Yangauthor=M.+K.+Dasauthor=T.+Brown&title=Fluorinated+benzamide+neuroleptics.+III.+Development+of+%28S%29-N-%5B%281-allyl-2-pyrrolidinyl%29methyl%5D-5-%283-%5B18F%5Dfluoropropyl%29-2%2C3-dimethoxybenzamide+as+an+improved+dopamine+D-2+receptor+tracer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3- dimethoxybenzamide as an improved dopamine D-2 receptor tracer</span></div><div class="casAuthors">Mukherjee, Jogeshwar; Yang, Zhi-Ying; Das, Malay K.; Brown, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-96</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">We have prepd. five new analogs (Pr, iso-Pr, allyl, Bu, and iso-butyl) of the dopamine D-2 receptor antagonist, FPMB which result from modifications of the Et group at the pyrrolidine nitrogen in FPMB.  As expected, all new derivs. showed higher apparent lipophilicity (log kw), with iso-Bu being the most lipophilic (log kw = 2.52), followed by the allyl deriv. (log kw = 2.43).  The allyl group showed the largest increase in affinity (from 0.26 nM for the Et substituent to 0.03 nM for the allyl substituent, almost 10-fold), followed by the Pr substituent which showed approx. five-fold better affinity than did the Et substituent.  Radiosynthesis of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3- dimethoxybenzamide ([18F]fallypride) was carried out by nucleophilic substitution reaction of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-tosyloxypropyl)-2,3- dimethoxybenzamide with no carrier added 18F-.  [18F]Fallypride was obtained in approx. 20-40% yields (EOS/EOB, decay cor.) in specific activities of 900-1700 Ci/mmol after reverse phase HPLC purifn. in 60 min from EOB.  High striatal uptake (up to 2.5% injected dose/g) of [18F]fallypride in rats was obsd. with striatal/cerebellar ratios of 17, 42, 63 and 122 at 30, 60, 90 and 120 min postinjection, resp.  PET expts. with [18F]fallypride in a cebus monkey showed a brain uptake of 0.10% injected dose/mL.  In rhesus monkeys [18F]fallypride showed rapid specific uptake in the striata (0.04-0.06% injected dose/mL) with striata/cerebellum ratios of approx. 3.0 at 14 min, 5.0 at 35 min and 8 at 70 min postinjection.  Specifically bound [18F]fallypride was displaced with haloperidol (1 mg/kg) with a half-life of 18 min in the rhesus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp397GU3dNOEbVg90H21EOLACvtfcHk0lhQopPHWjtjhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvFGls74%253D&md5=8651074bc9b54d8a5f918da6c9892f55</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2894%2900117-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252894%252900117-3%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DDas%26aufirst%3DM.%2BK.%26aulast%3DBrown%26aufirst%3DT.%26atitle%3DFluorinated%2520benzamide%2520neuroleptics.%2520III.%2520Development%2520of%2520%2528S%2529-N-%255B%25281-allyl-2-pyrrolidinyl%2529methyl%255D-5-%25283-%255B18F%255Dfluoropropyl%2529-2%252C3-dimethoxybenzamide%2520as%2520an%2520improved%2520dopamine%2520D-2%2520receptor%2520tracer%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1995%26volume%3D22%26spage%3D283%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janouschek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselinovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocheler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreckelmeyer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span> </span><span class="NLM_article-title">Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [<sup>18</sup>F]fallypride PET study</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.2008.07101574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=18381901" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2008&pages=988-995&author=G.+Gr%C3%BCnderauthor=C.+Fellowsauthor=H.+Janouschekauthor=T.+Veselinovicauthor=C.+Boyauthor=A.+Brochelerauthor=K.+M.+Kirschbaumauthor=S.+Hellmannauthor=K.+M.+Spreckelmeyerauthor=C.+Hiemkeauthor=F.+Roschauthor=W.+M.+Schaeferauthor=I.+Vernaleken&title=Brain+and+plasma+pharmacokinetics+of+aripiprazole+in+patients+with+schizophrenia%3A+an+%5B18F%5Dfallypride+PET+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.07101574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.07101574%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DFellows%26aufirst%3DC.%26aulast%3DJanouschek%26aufirst%3DH.%26aulast%3DVeselinovic%26aufirst%3DT.%26aulast%3DBoy%26aufirst%3DC.%26aulast%3DBrocheler%26aufirst%3DA.%26aulast%3DKirschbaum%26aufirst%3DK.%2BM.%26aulast%3DHellmann%26aufirst%3DS.%26aulast%3DSpreckelmeyer%26aufirst%3DK.%2BM.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DSchaefer%26aufirst%3DW.%2BM.%26aulast%3DVernaleken%26aufirst%3DI.%26atitle%3DBrain%2520and%2520plasma%2520pharmacokinetics%2520of%2520aripiprazole%2520in%2520patients%2520with%2520schizophrenia%253A%2520an%2520%255B18F%255Dfallypride%2520PET%2520study%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2008%26volume%3D165%26spage%3D988%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prioleau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=612-627&author=C.+P.+Lawlerauthor=C.+Prioleauauthor=M.+M.+Lewisauthor=C.+Makauthor=D.+Jiangauthor=J.+A.+Schetzauthor=A.+M.+Gonzalezauthor=D.+R.+Sibleyauthor=R.+B.+Mailman&title=Interactions+of+the+novel+antipsychotic+aripiprazole+%28OPC-14597%29+with+dopamine+and+serotonin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DPrioleau%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DInteractions%2520of%2520the%2520novel%2520antipsychotic%2520aripiprazole%2520%2528OPC-14597%2529%2520with%2520dopamine%2520and%2520serotonin%2520receptor%2520subtypes%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D612%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Swainston Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. M.</span><span> </span><span class="NLM_article-title">Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1715</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1715-1736&author=T.+Swainston+Harrisonauthor=C.+M.+Perry&title=Aripiprazole%3A+a+review+of+its+use+in+schizophrenia+and+schizoaffective+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwainston%2BHarrison%26aufirst%3DT.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DAripiprazole%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520schizophrenia%2520and%2520schizoaffective%2520disorder%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D1715%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Agid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitcu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipursky, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">Striatal vs extrastriatal dopamine D<sub>2</sub> receptors in antipsychotic response--a double-blind PET study in schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=1209-1215&author=O.+Agidauthor=D.+Mamoauthor=N.+Ginovartauthor=I.+Vitcuauthor=A.+A.+Wilsonauthor=R.+B.+Zipurskyauthor=S.+Kapur&title=Striatal+vs+extrastriatal+dopamine+D2+receptors+in+antipsychotic+response%2D%2Da+double-blind+PET+study+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAgid%26aufirst%3DO.%26aulast%3DMamo%26aufirst%3DD.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DVitcu%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DZipursky%26aufirst%3DR.%2BB.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DStriatal%2520vs%2520extrastriatal%2520dopamine%2520D2%2520receptors%2520in%2520antipsychotic%2520response--a%2520double-blind%2520PET%2520study%2520in%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D1209%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, M. L.</span><span> </span><span class="NLM_article-title">A glutamatergic deficiency model of schizophrenia</span> <span class="citation_source-journal">Br. J. Psychiatry Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10211132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK1M3islGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=2-6&author=A.+Carlssonauthor=L.+O.+Hanssonauthor=N.+Watersauthor=M.+L.+Carlsson&title=A+glutamatergic+deficiency+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">A glutamatergic deficiency model of schizophrenia</span></div><div class="casAuthors">Carlsson A; Hansson L O; Waters N; Carlsson M L</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry. Supplement</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">2-6</span>
        ISSN:<span class="NLM_cas:issn">0960-5371</span>.
    </div><div class="casAbstract">Although the presence of hyperdopaminergia has been demonstrated in the brains of people with schizophrenia, at least in some circumstances, other neurotransmitters are important in this disorder, and a glutamatergic deficiency model of schizophrenia is proposed.  It is suggested that the amount of sensory input allowed to reach the cerebral cortex is restricted by an inhibitory effect of the striatal complexes on the thalamus, thereby protecting it from being overwhelmed.  Several strands of evidence are presented to support the concept that a weakened glutamatergic tone increases the risk of sensory overload and of exaggerated responses in the monoaminergic systems that could result in psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8BN9igqnju4YPsCkJIw00fW6udTcc2ebbUJHncsFGxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3islGkug%253D%253D&md5=9316d3b8ae8ecf245048e1bf7e968a17</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DHansson%26aufirst%3DL.%2BO.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DCarlsson%26aufirst%3DM.%2BL.%26atitle%3DA%2520glutamatergic%2520deficiency%2520model%2520of%2520schizophrenia%26jtitle%3DBr.%2520J.%2520Psychiatry%2520Suppl.%26date%3D1999%26spage%3D2%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Andreasen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boles Ponto, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hichwa, R. D.</span><span> </span><span class="NLM_article-title">Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">1730</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1997&pages=1730-1734&author=N.+C.+Andreasenauthor=D.+S.+O%E2%80%99Learyauthor=M.+Flaumauthor=P.+Nopoulosauthor=G.+L.+Watkinsauthor=L.+L.+Boles+Pontoauthor=R.+D.+Hichwa&title=Hypofrontality+in+schizophrenia%3A+distributed+dysfunctional+circuits+in+neuroleptic-naive+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreasen%26aufirst%3DN.%2BC.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DD.%2BS.%26aulast%3DFlaum%26aufirst%3DM.%26aulast%3DNopoulos%26aufirst%3DP.%26aulast%3DWatkins%26aufirst%3DG.%2BL.%26aulast%3DBoles%2BPonto%26aufirst%3DL.%2BL.%26aulast%3DHichwa%26aufirst%3DR.%2BD.%26atitle%3DHypofrontality%2520in%2520schizophrenia%253A%2520distributed%2520dysfunctional%2520circuits%2520in%2520neuroleptic-naive%2520patients%26jtitle%3DLancet%26date%3D1997%26volume%3D349%26spage%3D1730%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia</span> <span class="citation_source-journal">Hillside J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2820854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL1c%252Fgs1Sguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1987&pages=12-35&author=D.+C.+Javitt&title=Negative+schizophrenic+symptomatology+and+the+PCP+%28phencyclidine%29+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia</span></div><div class="casAuthors">Javitt D C</div><div class="citationInfo"><span class="NLM_cas:title">The Hillside journal of clinical psychiatry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-35</span>
        ISSN:<span class="NLM_cas:issn">0193-5216</span>.
    </div><div class="casAbstract">Amphetamine induced psychosis has for the past 30 years provided a useful model for the study of schizophrenia.  The amphetamine model, however, has been shown to have a number of shortcomings including an inability to model the deficit symptoms of schizophrenia.  PCP (phencyclidine) has been shown to be capable of inducing a schizophreniform psychosis consisting of both productive and defict symptomatology.  PCP induced psychosis, therefore, may provide a useful model of schizophrenia.  This paper reviews the literature concerning the PCP model of schizophrenia and provides some independent confirmation of the ability of PCP to modulate mesocortical dopaminergic activity.  Since PCP appears to mediate its CNS effects via a subclass of glutamate receptors, a possible glutamate theory of schizophrenia is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_VspipBivSdNTrvPZP1IpfW6udTcc2ebbUJHncsFGxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252Fgs1Sguw%253D%253D&md5=2642fbe1f8afac42b0f6c092b6f053e0</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DNegative%2520schizophrenic%2520symptomatology%2520and%2520the%2520PCP%2520%2528phencyclidine%2529%2520model%2520of%2520schizophrenia%26jtitle%3DHillside%2520J.%2520Clin.%2520Psychiatry%26date%3D1987%26volume%3D9%26spage%3D12%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Krystal, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karper, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Dargham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Saab, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassello, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vegso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heninger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charney, D. S.</span><span> </span><span class="NLM_article-title">Interactive effects of subanesthetic ketamine and haloperidol in healthy humans</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1999&pages=193-204&author=J.+H.+Krystalauthor=D.+C.+D%E2%80%99Souzaauthor=L.+P.+Karperauthor=A.+Bennettauthor=A.+Abi-Darghamauthor=D.+Abi-Saabauthor=K.+Casselloauthor=M.+B.+Bowersauthor=S.+Vegsoauthor=G.+R.+Heningerauthor=D.+S.+Charney&title=Interactive+effects+of+subanesthetic+ketamine+and+haloperidol+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BC.%26aulast%3DKarper%26aufirst%3DL.%2BP.%26aulast%3DBennett%26aufirst%3DA.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26aulast%3DAbi-Saab%26aufirst%3DD.%26aulast%3DCassello%26aufirst%3DK.%26aulast%3DBowers%26aufirst%3DM.%2BB.%26aulast%3DVegso%26aufirst%3DS.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DInteractive%2520effects%2520of%2520subanesthetic%2520ketamine%2520and%2520haloperidol%2520in%2520healthy%2520humans%26jtitle%3DPsychopharmacology%26date%3D1999%26volume%3D145%26spage%3D193%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Heresco-Levy, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermilov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, D.</span><span> </span><span class="NLM_article-title">Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1192%2Fbjp.169.5.610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8932891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2s%252Fos1ylsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=1996&pages=610-617&author=U.+Heresco-Levyauthor=D.+C.+Javittauthor=M.+Ermilovauthor=C.+Mordelauthor=A.+Horowitzauthor=D.+Kelly&title=Double-blind%2C+placebo-controlled%2C+crossover+trial+of+glycine+adjuvant+therapy+for+treatment-resistant+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia</span></div><div class="casAuthors">Heresco-Levy U; Javitt D C; Ermilov M; Mordel C; Horowitz A; Kelly D</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">610-7</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">BACKGROUND:  It has been proposed that schizophrenia is associated with underactivity of brain glutamatergic neurotransmission, especially at the level of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor.  Glycine potentiates NMDA receptor-mediated neurotransmission, indicating that it may serve as an effective therapeutic agent in the treatment of schizophrenia.  METHOD:  Eleven treatment-resistant patients with chronic schizophrenia completed a double-blind, placebo-controlled, six-week, randomly assigned, crossover treatment trial of 0.8 g/kg body weight/day of glycine, added to their prior antipsychotic treatment.  RESULTS:  Glycine was well tolerated, resulted in significantly increased serum glycine levels and induced a mean 36 (7%) reduction in negative symptoms (P < 0.0001).  Significant improvements were also induced in depressive and cognitive symptoms.  The greatest reduction in negative symptoms was registered in the patients who had the lowest baseline serum glycine levels.  CONCLUSIONS:  These results extend previous findings and suggest an additional approach to the pharmacotherapy of negative symptoms and cognitive deficits in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpFTBbWohkEu98rul4nhSdfW6udTcc2ebbUJHncsFGxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252Fos1ylsA%253D%253D&md5=a86628944202f1511e73a5b0aad42445</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1192%2Fbjp.169.5.610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.169.5.610%26sid%3Dliteratum%253Aachs%26aulast%3DHeresco-Levy%26aufirst%3DU.%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26aulast%3DErmilov%26aufirst%3DM.%26aulast%3DMordel%26aufirst%3DC.%26aulast%3DHorowitz%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DD.%26atitle%3DDouble-blind%252C%2520placebo-controlled%252C%2520crossover%2520trial%2520of%2520glycine%2520adjuvant%2520therapy%2520for%2520treatment-resistant%2520schizophrenia%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1996%26volume%3D169%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audrain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">Identification and evaluation of [<sup>11</sup>C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2010&pages=542-549&author=J.+Passchierauthor=G.+Gentileauthor=R.+Porterauthor=H.+Herdonauthor=C.+Salinasauthor=S.+Jakobsenauthor=H.+Audrainauthor=M.+Laruelleauthor=R.+N.+Gunn&title=Identification+and+evaluation+of+%5B11C%5DGSK931145+as+a+novel+ligand+for+imaging+the+type+1+glycine+transporter+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DHerdon%26aufirst%3DH.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DAudrain%26aufirst%3DH.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DIdentification%2520and%2520evaluation%2520of%2520%255B11C%255DGSK931145%2520as%2520a%2520novel%2520ligand%2520for%2520imaging%2520the%2520type%25201%2520glycine%2520transporter%2520with%2520positron%2520emission%2520tomography%26jtitle%3DSynapse%26date%3D2010%26volume%3D64%26spage%3D542%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group">Hamill, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohorquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span> </span><span class="NLM_article-title">The synthesis and preclinical evaluation in Rhesus monkey of [<sup>18</sup>F]MK-6577 and [<sup>11</sup>C]CMPyPB, glycine transporter 1 (GlyT1) PET radiotracers</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=261-270&author=T.+G.+Hamillauthor=W.+Engauthor=A.+Jenningsauthor=R.+Lewisauthor=S.+Thomasauthor=S.+Woodauthor=L.+Streetauthor=D.+Wisnoskiauthor=S.+Wolkenbergauthor=C.+Lindsleyauthor=S.+Sanabria-Bohorquezauthor=S.+Patelauthor=K.+Riffelauthor=C.+Ryanauthor=J.+Cookauthor=C.+Surauthor=D.+Burnsauthor=R.+Hargreaves&title=The+synthesis+and+preclinical+evaluation+in+Rhesus+monkey+of+%5B18F%5DMK-6577+and+%5B11C%5DCMPyPB%2C+glycine+transporter+1+%28GlyT1%29+PET+radiotracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DStreet%26aufirst%3DL.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DWolkenberg%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DSanabria-Bohorquez%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DD.%26aulast%3DHargreaves%26aufirst%3DR.%26atitle%3DThe%2520synthesis%2520and%2520preclinical%2520evaluation%2520in%2520Rhesus%2520monkey%2520of%2520%255B18F%255DMK-6577%2520and%2520%255B11C%255DCMPyPB%252C%2520glycine%2520transporter%25201%2520%2528GlyT1%2529%2520PET%2520radiotracers%26jtitle%3DSynapse%26date%3D2011%26volume%3D65%26spage%3D261%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Alberati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengyel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mory, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoflach, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlotterbeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainzl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span> </span><span class="NLM_article-title">Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1152-1161&author=D.+Alberatiauthor=J.+L.+Moreauauthor=J.+Lengyelauthor=N.+Hauserauthor=R.+Moryauthor=E.+Borroniauthor=E.+Pinardauthor=F.+Knoflachauthor=G.+Schlotterbeckauthor=D.+Hainzlauthor=J.+G.+Wettstein&title=Glycine+reuptake+inhibitor+RG1678%3A+a+pharmacologic+characterization+of+an+investigational+agent+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DLengyel%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DN.%26aulast%3DMory%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DKnoflach%26aufirst%3DF.%26aulast%3DSchlotterbeck%26aufirst%3DG.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26atitle%3DGlycine%2520reuptake%2520inhibitor%2520RG1678%253A%2520a%2520pharmacologic%2520characterization%2520of%2520an%2520investigational%2520agent%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1152%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohorquez, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=511-519&author=D.+Eddinsauthor=T.+G.+Hamillauthor=V.+Puriauthor=C.+E.+Cannonauthor=J.+A.+Vivianauthor=S.+M.+Sanabria-Bohorquezauthor=J.+J.+Cookauthor=J.+A.+Morrowauthor=F.+Thomsonauthor=J.+M.+Uslaner&title=The+relationship+between+glycine+transporter+1+occupancy+and+the+effects+of+the+glycine+transporter+1+inhibitor+RG1678+or+ORG25935+on+object+retrieval+performance+in+scopolamine+impaired+rhesus+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DPuri%26aufirst%3DV.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DSanabria-Bohorquez%26aufirst%3DS.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DThomson%26aufirst%3DF.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520relationship%2520between%2520glycine%2520transporter%25201%2520occupancy%2520and%2520the%2520effects%2520of%2520the%2520glycine%2520transporter%25201%2520inhibitor%2520RG1678%2520or%2520ORG25935%2520on%2520object%2520retrieval%2520performance%2520in%2520scopolamine%2520impaired%2520rhesus%2520monkey%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Martin-Facklam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzagalli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowitzki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasic, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umbricht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwater, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span> </span><span class="NLM_article-title">Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=504-512&author=M.+Martin-Facklamauthor=F.+Pizzagalliauthor=Y.+Zhouauthor=S.+Ostrowitzkiauthor=V.+Raymontauthor=J.+R.+Brasicauthor=N.+Parkarauthor=D.+Umbrichtauthor=R.+F.+Dannalsauthor=R.+Goldwaterauthor=D.+F.+Wong&title=Glycine+transporter+type+1+occupancy+by+bitopertin%3A+a+positron+emission+tomography+study+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Facklam%26aufirst%3DM.%26aulast%3DPizzagalli%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DOstrowitzki%26aufirst%3DS.%26aulast%3DRaymont%26aufirst%3DV.%26aulast%3DBrasic%26aufirst%3DJ.%2BR.%26aulast%3DParkar%26aufirst%3DN.%26aulast%3DUmbricht%26aufirst%3DD.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DGoldwater%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DD.%2BF.%26atitle%3DGlycine%2520transporter%2520type%25201%2520occupancy%2520by%2520bitopertin%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520in%2520healthy%2520volunteers%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D504%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Siuciak, J. A.</span><span> </span><span class="NLM_article-title">The role of phosphodiesterases in schizophrenia: therapeutic implications</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=983-993&author=J.+A.+Siuciak&title=The+role+of+phosphodiesterases+in+schizophrenia%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520phosphodiesterases%2520in%2520schizophrenia%253A%2520therapeutic%2520implications%26jtitle%3DCNS%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D983%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group">Redrobe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montezinho, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnerup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerdrup, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plath, N.</span><span> </span><span class="NLM_article-title">In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">3151</span><span class="NLM_x">–</span> <span class="NLM_lpage">3167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=3151-3167&author=J.+P.+Redrobeauthor=M.+J%C3%B8rgensenauthor=C.+T.+Christoffersenauthor=L.+P.+Montezinhoauthor=J.+F.+Bastlundauthor=M.+Carnerupauthor=C.+Bundgaardauthor=L.+Lerdrupauthor=N.+Plath&title=In+vitro+and+in+vivo+characterisation+of+Lu+AF64280%2C+a+novel%2C+brain+penetrant+phosphodiesterase+%28PDE%29+2A+inhibitor%3A+potential+relevance+to+cognitive+deficits+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRedrobe%26aufirst%3DJ.%2BP.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DM.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DMontezinho%26aufirst%3DL.%2BP.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DCarnerup%26aufirst%3DM.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DLerdrup%26aufirst%3DL.%26aulast%3DPlath%26aufirst%3DN.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterisation%2520of%2520Lu%2520AF64280%252C%2520a%2520novel%252C%2520brain%2520penetrant%2520phosphodiesterase%2520%2528PDE%2529%25202A%2520inhibitor%253A%2520potential%2520relevance%2520to%2520cognitive%2520deficits%2520in%2520schizophrenia%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D3151%26epage%3D3167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group">Andrés, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaerts, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Synthesis, in vivo occupancy and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5820</span><span class="NLM_x">–</span> <span class="NLM_lpage">5835</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200536d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5820-5835&author=J.-I.+Andr%C3%A9sauthor=M.+De+Angelisauthor=J.+Alcazarauthor=L.+Iturrinoauthor=X.+Langloisauthor=S.+Dedeurwaerdereauthor=I.+Lenaertsauthor=G.+Vanhoofauthor=S.+Celenauthor=G.+Bormans&title=Synthesis%2C+in+vivo+occupancy+and+radiolabeling+of+potent+phosphodiesterase+subtype-10+inhibitors+as+candidates+for+positron+emission+tomography+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm200536d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200536d%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.-I.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DIturrino%26aufirst%3DL.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DLenaerts%26aufirst%3DI.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520in%2520vivo%2520occupancy%2520and%2520radiolabeling%2520of%2520potent%2520phosphodiesterase%2520subtype-10%2520inhibitors%2520as%2520candidates%2520for%2520positron%2520emission%2520tomography%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5820%26epage%3D5835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitneni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andr%C3%A9sauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ41510417+as+a+radioligand+for+PET+imaging+of+phosphodiesterase-10A+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Mäding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsen, B.</span><span> </span><span class="NLM_article-title">No-carrier-added <sup>11</sup>C-labelling of benzenoid compounds in ring positions by condensation of nitro-[<sup>11</sup>C]methane with pyrylium salts</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2F%28SICI%291099-1344%28200005%2943%3A6%3C565%3A%3AAID-JLCR342%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1GitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=565-583&author=P.+M%C3%A4dingauthor=J.+Steinbachauthor=B.+Johannsen&title=No-carrier-added+11C-labelling+of+benzenoid+compounds+in+ring+positions+by+condensation+of+nitro-%5B11C%5Dmethane+with+pyrylium+salts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">No-carrier-added 11C-labeling of benzenoid compounds in ring positions by condensation of nitro-[11C]methane with pyrylium salts</span></div><div class="casAuthors">Mading, P.; Steinbach, J.; Johannsen, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-583</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A new synthesis is described for three no-carrier-added nitro-[1-11C]benzenes by condensation of nitro-[11C]methane (I) with the appropriate pyrylium salts in the presence of a base such as t-BuOK in t-BuOH.  For synthesizing 4-nitro-[4-11C]anisole, tetrabutylammonium fluoride was successfully used as an auxiliary base.  The conversion of I with 4-methoxypyrylium perchlorate yielded a product of a radiochem. purity of up to 82% and a mean specific radioactivity of 30 GBq/μmol (0.8 Ci/μmol) within 20 min.  Related to I, the reproducible radiochem. yields are in the range of 77 ± 5% (decay-cor.).  2,6-Dimethyl-4-methoxy-nitro-[1-11C]benzene was prepd. by reaction of I with 2,6-dimethyl-4-methoxypyrylium perchlorate in radiochem. yields of about 37% (decay-cor.) within 10 min.  2-Nitro-[2-11C]mesitylene was obtained by condensation of I with 2,4,6-trimethylpyrylium tetrafluoroborate in radiochem. yields of about 29% (decay-cor.) within 20 min.  13C/11C Co-labeling expts. were carried out in order to confirm the identity and the position of the label.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD8SEy3K0J3rVg90H21EOLACvtfcHk0lj0U9p5CEzlCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1GitrY%253D&md5=af0a8be10640d677fb69f02ff00e3e7a</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1344%28200005%2943%3A6%3C565%3A%3AAID-JLCR342%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1344%2528200005%252943%253A6%253C565%253A%253AAID-JLCR342%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4ding%26aufirst%3DP.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DJohannsen%26aufirst%3DB.%26atitle%3DNo-carrier-added%252011C-labelling%2520of%2520benzenoid%2520compounds%2520in%2520ring%2520positions%2520by%2520condensation%2520of%2520nitro-%255B11C%255Dmethane%2520with%2520pyrylium%2520salts%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2000%26volume%3D43%26spage%3D565%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamlet, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursalian, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, T.</span><span> </span><span class="NLM_article-title">A fluoride-derived electrophilic late-stage fluorination reagent for PET imaging</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1126%2Fscience.1212625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=22053044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=639-642&author=E.+Leeauthor=A.+S.+Kamletauthor=D.+C.+Powersauthor=C.+N.+Neumannauthor=G.+B.+Boursalianauthor=T.+Furuyaauthor=D.+C.+Choiauthor=J.+M.+Hookerauthor=T.+Ritter&title=A+fluoride-derived+electrophilic+late-stage+fluorination+reagent+for+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluoride-Derived Electrophilic Late-Stage Fluorination Reagent for PET Imaging</span></div><div class="casAuthors">Lee, Eunsung; Kamlet, Adam S.; Powers, David C.; Neumann, Constanze N.; Boursalian, Gregory B.; Furuya, Takeru; Choi, Daniel C.; Hooker, Jacob M.; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6056</span>),
    <span class="NLM_cas:pages">639-642</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The unnatural isotope fluorine-18 (18F) is used as a positron emitter in mol. imaging.  Currently, many potentially useful 18F-labeled probe mols. are inaccessible for imaging because no fluorination chem. is available to make them.  The 110-min half-life of 18F requires rapid syntheses for which [18F]fluoride is the preferred source of fluorine because of its practical access and suitable isotope enrichment.  However, conventional [18F]fluoride chem. has been limited to nucleophilic fluorination reactions.  We report the development of a palladium-based electrophilic fluorination reagent derived from fluoride and its application to the synthesis of arom. 18F-labeled mols. via late-stage fluorination.  Late-stage fluorination enables the synthesis of conventionally unavailable positron emission tomog. (PET) tracers for anticipated applications in pharmaceutical development as well as preclin. and clin. PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6eb1WB355J7Vg90H21EOLACvtfcHk0ljrZYLJZwzU9w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqu7vL&md5=ede2fa164d6ce80035e5482966b5b57e</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1126%2Fscience.1212625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1212625%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKamlet%26aufirst%3DA.%2BS.%26aulast%3DPowers%26aufirst%3DD.%2BC.%26aulast%3DNeumann%26aufirst%3DC.%2BN.%26aulast%3DBoursalian%26aufirst%3DG.%2BB.%26aulast%3DFuruya%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DD.%2BC.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DA%2520fluoride-derived%2520electrophilic%2520late-stage%2520fluorination%2520reagent%2520for%2520PET%2520imaging%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D639%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 84 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Antonio Giordani, Maria Cristina Menziani, Rosa Maria Moresco, Mario Matarrese, Marco Paolino, Mario Saletti, Germano Giuliani, Maurizio Anzini, <span class="NLM_string-name hlFld-ContribAuthor">Andrea Cappelli</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Translocator Protein (TSPO) Medicinal Chemistry: An Approach for Targeting Radionuclides and Boron Atoms to Mitochondria. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (14)
                                     , 9649-9676. <a href="https://doi.org/10.1021/acs.jmedchem.1c00379" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00379</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00379%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DExploring%252BTranslocator%252BProtein%252B%252528TSPO%252529%252BMedicinal%252BChemistry%25253A%252BAn%252BApproach%252Bfor%252BTargeting%252BRadionuclides%252Band%252BBoron%252BAtoms%252Bto%252BMitochondria%26aulast%3DGiordani%26aufirst%3DAntonio%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D02032021%26date%3D13072021%26volume%3D64%26issue%3D14%26spage%3D9649%26epage%3D9676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christian B. M. Poulie, Anders A. Jensen, Adam L. Halberstadt, <span class="NLM_string-name hlFld-ContribAuthor">Jesper L. Kristensen</span>. </span><span class="cited-content_cbyCitation_article-title">DARK Classics in Chemical Neuroscience: NBOMes. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2020,</strong> <em>11 </em>
                                    (23)
                                     , 3860-3869. <a href="https://doi.org/10.1021/acschemneuro.9b00528" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00528%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDARK%252BClassics%252Bin%252BChemical%252BNeuroscience%25253A%252BNBOMes%26aulast%3DPoulie%26aufirst%3DChristian%2BB.%2BM.%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D01102019%26date%3D28102019%26date%3D12112019%26date%3D28102019%26volume%3D11%26issue%3D23%26spage%3D3860%26epage%3D3869" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Chibueze I. Onyeagusi, <span class="NLM_string-name hlFld-ContribAuthor">Steven J. Malcolmson</span>. </span><span class="cited-content_cbyCitation_article-title">Strategies for the Catalytic Enantioselective Synthesis of α-Trifluoromethyl Amines. </span><span class="cited-content_cbyCitation_journal-name">ACS Catalysis</span><span> <strong>2020,</strong> <em>10 </em>
                                    (21)
                                     , 12507-12536. <a href="https://doi.org/10.1021/acscatal.0c03569" title="DOI URL">https://doi.org/10.1021/acscatal.0c03569</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscatal.0c03569&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscatal.0c03569%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Catalysis%26atitle%3DStrategies%252Bfor%252Bthe%252BCatalytic%252BEnantioselective%252BSynthesis%252Bof%252B%2525CE%2525B1-Trifluoromethyl%252BAmines%26aulast%3DOnyeagusi%26aufirst%3DChibueze%2BI.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D14082020%26date%3D02102020%26date%3D12102020%26volume%3D10%26issue%3D21%26spage%3D12507%26epage%3D12536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Klas Bratteby, Edvard Torkelsson, Elina Tampio L’Estrade, Kristoffer Peterson, Vladimir Shalgunov, Mengfei Xiong, Hakon Leffler, Fredrik R. Zetterberg, Tomas G. Olsson, Nic Gillings, Ulf J. Nilsson, Matthias M. Herth, <span class="NLM_string-name hlFld-ContribAuthor">Maria Erlandsson</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Veritas: 18F-Radiolabeled Glycomimetics Allow Insights into the Pharmacological Fate of Galectin-3 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (2)
                                     , 747-755. <a href="https://doi.org/10.1021/acs.jmedchem.9b01692" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01692%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVivo%252BVeritas%25253A%252B18F-Radiolabeled%252BGlycomimetics%252BAllow%252BInsights%252Binto%252Bthe%252BPharmacological%252BFate%252Bof%252BGalectin-3%252BInhibitors%26aulast%3DBratteby%26aufirst%3DKlas%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D13102019%26date%3D03012020%26date%3D17122019%26volume%3D63%26issue%3D2%26spage%3D747%26epage%3D755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Vivian Hsieh, Satoshi Okada, He Wei, Isabel García-Álvarez, Ali Barandov, Santiago Recuenco Alvarado, Robert Ohlendorf, Jingxuan Fan, Athena Ortega, <span class="NLM_string-name hlFld-ContribAuthor">Alan Jasanoff</span>. </span><span class="cited-content_cbyCitation_article-title">Neurotransmitter-Responsive Nanosensors for T2-Weighted Magnetic Resonance Imaging. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2019,</strong> <em>141 </em>
                                    (40)
                                     , 15751-15754. <a href="https://doi.org/10.1021/jacs.9b08744" title="DOI URL">https://doi.org/10.1021/jacs.9b08744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.9b08744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.9b08744%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DNeurotransmitter-Responsive%252BNanosensors%252Bfor%252BT2-Weighted%252BMagnetic%252BResonance%252BImaging%26aulast%3DHsieh%26aufirst%3DVivian%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D13082019%26date%3D30092019%26date%3D16092019%26volume%3D141%26issue%3D40%26spage%3D15751%26epage%3D15754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elina Tampio L’Estrade, Mengfei Xiong, Vladimir Shalgunov, Fraser G. Edgar, Balázs Volk, Simone L. Baerentzen, Mikael Palner, Maria Erlandsson, Tomas Ohlsson, Gitte M. Knudsen, <span class="NLM_string-name hlFld-ContribAuthor">Matthias M. Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Evaluation of Two Potential 5-HT7 Receptor PET Tracers: [18F]ENL09 and [18F]ENL10. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 3961-3968. <a href="https://doi.org/10.1021/acschemneuro.9b00132" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00132</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00132&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00132%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDevelopment%252Band%252BEvaluation%252Bof%252BTwo%252BPotential%252B5-HT7%252BReceptor%252BPET%252BTracers%25253A%252B%25255B18F%25255DENL09%252Band%252B%25255B18F%25255DENL10%26aulast%3DTampio%2BL%25E2%2580%2599Estrade%26aufirst%3DElina%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06032019%26date%3D11042019%26date%3D22042019%26date%3D11042019%26volume%3D10%26issue%3D9%26spage%3D3961%26epage%3D3968" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Elina Tampio L’Estrade, Fraser G. Edgar, Mengfei Xiong, Vladimir Shalgunov, Simone L. Baerentzen, Maria Erlandsson, Tomas G. Ohlsson, Mikael Palner, Gitte M. Knudsen, <span class="NLM_string-name hlFld-ContribAuthor">Matthias M. Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Radiolabeling, and in Vitro and in Vivo Evaluation of [18F]ENL30: A Potential PET Radiotracer for the 5-HT7 Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2019,</strong> <em>4 </em>
                                    (4)
                                     , 7344-7353. <a href="https://doi.org/10.1021/acsomega.9b00394" title="DOI URL">https://doi.org/10.1021/acsomega.9b00394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.9b00394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.9b00394%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DSynthesis%25252C%252BRadiolabeling%25252C%252Band%252Bin%252BVitro%252Band%252Bin%252BVivo%252BEvaluation%252Bof%252B%25255B18F%25255DENL30%25253A%252BA%252BPotential%252BPET%252BRadiotracer%252Bfor%252Bthe%252B5-HT7%252BReceptor%26aulast%3DTampio%2BL%25E2%2580%2599Estrade%26aufirst%3DElina%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D12022019%26date%3D12042019%26volume%3D4%26issue%3D4%26spage%3D7344%26epage%3D7353" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinqiang  Hou</span>, <span class="hlFld-ContribAuthor ">Michael S.  Kovacs</span>, <span class="hlFld-ContribAuthor ">Savita  Dhanvantari</span>, and <span class="hlFld-ContribAuthor ">Leonard G.  Luyt</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of Candidates for Positron Emission Tomography (PET) Imaging of Ghrelin Receptor in Disease: Design, Synthesis, and Evaluation of Fluorine-Bearing Quinazolinone Derivatives. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1261-1275. <a href="https://doi.org/10.1021/acs.jmedchem.7b01754" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01754</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01754%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252BCandidates%252Bfor%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%252Bof%252BGhrelin%252BReceptor%252Bin%252BDisease%25253A%252BDesign%25252C%252BSynthesis%25252C%252Band%252BEvaluation%252Bof%252BFluorine-Bearing%252BQuinazolinone%252BDerivatives%26aulast%3DHou%26aufirst%3DJinqiang%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29112017%26date%3D30012018%26date%3D08022018%26date%3D12012018%26volume%3D61%26issue%3D3%26spage%3D1261%26epage%3D1275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanatorn  Khotavivattana</span>, <span class="hlFld-ContribAuthor ">Samuel  Calderwood</span>, <span class="hlFld-ContribAuthor ">Stefan  Verhoog</span>, <span class="hlFld-ContribAuthor ">Lukas  Pfeifer</span>, <span class="hlFld-ContribAuthor ">Sean  Preshlock</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>, <span class="hlFld-ContribAuthor ">Thomas L.  Collier</span>, and <span class="hlFld-ContribAuthor ">Véronique  Gouverneur</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Reactivity of 18F-Labeled α,α-Difluoro-α-(aryloxy)acetic Acids. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2017,</strong> <em>19 </em>
                                    (3)
                                     , 568-571. <a href="https://doi.org/10.1021/acs.orglett.6b03730" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b03730</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b03730&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b03730%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Band%252BReactivity%252Bof%252B18F-Labeled%252B%2525CE%2525B1%25252C%2525CE%2525B1-Difluoro-%2525CE%2525B1-%252528aryloxy%252529acetic%252BAcids%26aulast%3DKhotavivattana%26aufirst%3DTanatorn%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D14122016%26date%3D13012017%26date%3D03022017%26volume%3D19%26issue%3D3%26spage%3D568%26epage%3D571" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claus H.  Jensen</span>, <span class="hlFld-ContribAuthor ">Hanne D.  Hansen</span>, <span class="hlFld-ContribAuthor ">Tina  Bay</span>, <span class="hlFld-ContribAuthor ">Stine B.  Vogensen</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Louise  Thiesen</span>, <span class="hlFld-ContribAuthor ">Christoffer  Bundgaard</span>, <span class="hlFld-ContribAuthor ">Rasmus P.  Clausen</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Petrine  Wellendorph</span>, and <span class="hlFld-ContribAuthor ">Bente  Frølund</span>  . </span><span class="cited-content_cbyCitation_article-title">Radiosynthesis and Evaluation of [11C]3-Hydroxycyclopent-1-enecarboxylic Acid as Potential PET Ligand for the High-Affinity γ-Hydroxybutyric Acid Binding Sites. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 22-27. <a href="https://doi.org/10.1021/acschemneuro.6b00335" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00335</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00335&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00335%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DRadiosynthesis%252Band%252BEvaluation%252Bof%252B%25255B11C%25255D3-Hydroxycyclopent-1-enecarboxylic%252BAcid%252Bas%252BPotential%252BPET%252BLigand%252Bfor%252Bthe%252BHigh-Affinity%252B%2525CE%2525B3-Hydroxybutyric%252BAcid%252BBinding%252BSites%26aulast%3DJensen%26aufirst%3DClaus%2BH.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30092016%26date%3D14112016%26date%3D17112016%26date%3D18012017%26date%3D14112016%26volume%3D8%26issue%3D1%26spage%3D22%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bichitra Nandi  Ganguly</span>, <span class="hlFld-ContribAuthor ">Vivek  Verma</span>, <span class="hlFld-ContribAuthor ">Debanuj  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Biswarup  Satpati</span>, <span class="hlFld-ContribAuthor ">Sushanta  Debnath</span>, and <span class="hlFld-ContribAuthor ">Partha  Saha</span>  . </span><span class="cited-content_cbyCitation_article-title">Study of Gallium Oxide Nanoparticles Conjugated with β-Cyclodextrin: An Application To Combat Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2016,</strong> <em>8 </em>
                                    (27)
                                     , 17127-17137. <a href="https://doi.org/10.1021/acsami.6b04807" title="DOI URL">https://doi.org/10.1021/acsami.6b04807</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.6b04807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.6b04807%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DStudy%252Bof%252BGallium%252BOxide%252BNanoparticles%252BConjugated%252Bwith%252B%2525CE%2525B2-Cyclodextrin%25253A%252BAn%252BApplication%252BTo%252BCombat%252BCancer%26aulast%3DGanguly%26aufirst%3DBichitra%2BNandi%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D25042016%26date%3D22062016%26date%3D30062016%26date%3D13072016%26date%3D22062016%26volume%3D8%26issue%3D27%26spage%3D17127%26epage%3D17137" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sean  Preshlock</span>, <span class="hlFld-ContribAuthor ">Matthew  Tredwell</span>, and <span class="hlFld-ContribAuthor ">Véronique  Gouverneur</span>  . </span><span class="cited-content_cbyCitation_article-title">18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (2)
                                     , 719-766. <a href="https://doi.org/10.1021/acs.chemrev.5b00493" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00493%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3D18F-Labeling%252Bof%252BArenes%252Band%252BHeteroarenes%252Bfor%252BApplications%252Bin%252BPositron%252BEmission%252BTomography%26aulast%3DPreshlock%26aufirst%3DSean%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D20082015%26date%3D11012016%26date%3D27012016%26volume%3D116%26issue%3D2%26spage%3D719%26epage%3D766" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric P.  Gillis</span>, <span class="hlFld-ContribAuthor ">Kyle J.  Eastman</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hill</span>, <span class="hlFld-ContribAuthor ">David J.  Donnelly</span>, and <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>  . </span><span class="cited-content_cbyCitation_article-title">Applications of Fluorine in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (21)
                                     , 8315-8359. <a href="https://doi.org/10.1021/acs.jmedchem.5b00258" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00258%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252BFluorine%252Bin%252BMedicinal%252BChemistry%26aulast%3DGillis%26aufirst%3DEric%2BP.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D13022015%26date%3D22072015%26date%3D12112015%26volume%3D58%26issue%3D21%26spage%3D8315%26epage%3D8359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Liu</span> and <span class="hlFld-ContribAuthor ">Amanda B.  Hummon</span>  . </span><span class="cited-content_cbyCitation_article-title">Mass Spectrometry Imaging of Therapeutics from Animal Models to Three-Dimensional Cell Cultures. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2015,</strong> <em>87 </em>
                                    (19)
                                     , 9508-9519. <a href="https://doi.org/10.1021/acs.analchem.5b00419" title="DOI URL">https://doi.org/10.1021/acs.analchem.5b00419</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.5b00419&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.5b00419%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DMass%252BSpectrometry%252BImaging%252Bof%252BTherapeutics%252Bfrom%252BAnimal%252BModels%252Bto%252BThree-Dimensional%252BCell%252BCultures%26aulast%3DLiu%26aufirst%3DXin%26date%3D2015%26date%3D2015%26date%3D22062015%26date%3D02072015%26date%3D06102015%26date%3D18062015%26volume%3D87%26issue%3D19%26spage%3D9508%26epage%3D9519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuela  Ariza</span>, <span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">Dieder  Moechars</span>, <span class="hlFld-ContribAuthor ">Frederik  Rombouts</span>, and <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>  . </span><span class="cited-content_cbyCitation_article-title">Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (11)
                                     , 4365-4382. <a href="https://doi.org/10.1021/jm5017544" title="DOI URL">https://doi.org/10.1021/jm5017544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5017544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5017544%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTau%252BPositron%252BEmission%252BTomography%252B%252528PET%252529%252BImaging%25253A%252BPast%25252C%252BPresent%25252C%252Band%252BFuture%26aulast%3DAriza%26aufirst%3DManuela%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D12112014%26date%3D25022015%26date%3D11062015%26date%3D11022015%26volume%3D58%26issue%3D11%26spage%3D4365%26epage%3D4382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>  . </span><span class="cited-content_cbyCitation_article-title">CNS Drug Design: Balancing Physicochemical Properties for Optimal Brain Exposure. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (6)
                                     , 2584-2608. <a href="https://doi.org/10.1021/jm501535r" title="DOI URL">https://doi.org/10.1021/jm501535r</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501535r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501535r%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DCNS%252BDrug%252BDesign%25253A%252BBalancing%252BPhysicochemical%252BProperties%252Bfor%252BOptimal%252BBrain%252BExposure%26aulast%3DRankovic%26aufirst%3DZoran%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D05102014%26date%3D06012015%26date%3D26032015%26date%3D11122014%26volume%3D58%26issue%3D6%26spage%3D2584%26epage%3D2608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sachin A.  Ingale</span>, <span class="hlFld-ContribAuthor ">Peter  Leonard</span>, <span class="hlFld-ContribAuthor ">Quang Nhat  Tran</span>, and <span class="hlFld-ContribAuthor ">Frank  Seela</span>  . </span><span class="cited-content_cbyCitation_article-title">Duplex DNA and DNA–RNA Hybrids with Parallel Strand Orientation: 2′-Deoxy-2′-fluoroisocytidine, 2′-Deoxy-2′-fluoroisoguanosine, and Canonical Nucleosides with 2′-Fluoro Substituents Cause Unexpected Changes on the Double Helix Stability. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2015,</strong> <em>80 </em>
                                    (6)
                                     , 3124-3138. <a href="https://doi.org/10.1021/acs.joc.5b00040" title="DOI URL">https://doi.org/10.1021/acs.joc.5b00040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.5b00040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.5b00040%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DDuplex%252BDNA%252Band%252BDNA%2525E2%252580%252593RNA%252BHybrids%252Bwith%252BParallel%252BStrand%252BOrientation%25253A%252B2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-fluoroisocytidine%25252C%252B2%2525E2%252580%2525B2-Deoxy-2%2525E2%252580%2525B2-fluoroisoguanosine%25252C%252Band%252BCanonical%252BNucleosides%252Bwith%252B2%2525E2%252580%2525B2-Fluoro%252BSubstituents%252BCause%252BUnexpected%252BChanges%252Bon%252Bthe%252BDouble%252BHelix%252BStability%26aulast%3DIngale%26aufirst%3DSachin%2BA.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D07012015%26date%3D05032015%26date%3D20032015%26volume%3D80%26issue%3D6%26spage%3D3124%26epage%3D3138" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Olga  Ovdiichuk</span>, <span class="hlFld-ContribAuthor ">Hemantha  Mallapura</span>, <span class="hlFld-ContribAuthor ">Florian  Pineda</span>, <span class="hlFld-ContribAuthor ">Virginie  Hourtané</span>, <span class="hlFld-ContribAuthor ">Bengt  Långström</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Sangram  Nag</span>, <span class="hlFld-ContribAuthor ">Fatiha  Maskali</span>, <span class="hlFld-ContribAuthor ">Gilles  Karcher</span>, <span class="hlFld-ContribAuthor ">Charlotte  Collet</span>. </span><span class="cited-content_cbyCitation_article-title">Implementation of iMiDEV™, a new fully automated microfluidic platform for radiopharmaceutical production. </span><span class="cited-content_cbyCitation_journal-name">Lab on a Chip</span><span> <strong>2021,</strong> <em>21 </em>
                                    (11)
                                     , 2272-2282. <a href="https://doi.org/10.1039/D1LC00148E" title="DOI URL">https://doi.org/10.1039/D1LC00148E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1LC00148E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1LC00148E%26sid%3Dliteratum%253Aachs%26jtitle%3DLab%2520on%2520a%2520Chip%26atitle%3DImplementation%252Bof%252BiMiDEV%2525E2%252584%2525A2%25252C%252Ba%252Bnew%252Bfully%252Bautomated%252Bmicrofluidic%252Bplatform%252Bfor%252Bradiopharmaceutical%252Bproduction%26aulast%3DOvdiichuk%26aufirst%3DOlga%26date%3D2021%26date%3D2021%26volume%3D21%26issue%3D11%26spage%3D2272%26epage%3D2282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andy  Welch</span>, <span class="hlFld-ContribAuthor ">Adriana A. S.  Tavares</span>, <span class="hlFld-ContribAuthor ">Sally  Pimlott</span>, <span class="hlFld-ContribAuthor ">Andrew  Sutherland</span>. </span><span class="cited-content_cbyCitation_article-title">PET and SPECT in Drug Development. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-18. <a href="https://doi.org/10.1002/0471266949.bmc254.pub2" title="DOI URL">https://doi.org/10.1002/0471266949.bmc254.pub2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc254.pub2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc254.pub2%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252Band%252BSPECT%252Bin%252BDrug%252BDevelopment%26aulast%3DWelch%26aufirst%3DAndy%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D18%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D43" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eduardo Felipe Alves  Fernandes</span>, <span class="hlFld-ContribAuthor ">Dennis  Özcelik</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging Biomarkers for Monitoring the Inflammatory Redox Landscape in the Brain. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants</span><span> <strong>2021,</strong> <em>10 </em>
                                    (4)
                                     , 528. <a href="https://doi.org/10.3390/antiox10040528" title="DOI URL">https://doi.org/10.3390/antiox10040528</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/antiox10040528&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fantiox10040528%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%26atitle%3DImaging%252BBiomarkers%252Bfor%252BMonitoring%252Bthe%252BInflammatory%252BRedox%252BLandscape%252Bin%252Bthe%252BBrain%26aulast%3DFernandes%26aufirst%3DEduardo%2BFelipe%2BAlves%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D4%26spage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sascha  Häseli</span>, <span class="hlFld-ContribAuthor ">Marion  Holy</span>, <span class="hlFld-ContribAuthor ">Markus  Joksch</span>, <span class="hlFld-ContribAuthor ">Carina  Bergner</span>, <span class="hlFld-ContribAuthor ">Andreas  Wree</span>, <span class="hlFld-ContribAuthor ">Jens  Kurth</span>, <span class="hlFld-ContribAuthor ">Aylin  Cankaya</span>, <span class="hlFld-ContribAuthor ">Markus  Piel</span>, <span class="hlFld-ContribAuthor ">Bernd J.  Krause</span>, <span class="hlFld-ContribAuthor ">Harald H.  Sitte</span>, <span class="hlFld-ContribAuthor ">Frank  Rösch</span>. </span><span class="cited-content_cbyCitation_article-title">68
              Ga‐Labelled Tropane Analogues for the Visualization of the Dopaminergic System. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>16 </em>
                                    (5)
                                     , 804-808. <a href="https://doi.org/10.1002/cmdc.202000820" title="DOI URL">https://doi.org/10.1002/cmdc.202000820</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202000820&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202000820%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3D68%252BGa%2525E2%252580%252590Labelled%252BTropane%252BAnalogues%252Bfor%252Bthe%252BVisualization%252Bof%252Bthe%252BDopaminergic%252BSystem%26aulast%3DH%25C3%25A4seli%26aufirst%3DSascha%26date%3D2021%26date%3D2020%26volume%3D16%26issue%3D5%26spage%3D804%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pritam  Thapa</span>, <span class="hlFld-ContribAuthor ">Sunil P.  Upadhyay</span>, <span class="hlFld-ContribAuthor ">William Z.  Suo</span>, <span class="hlFld-ContribAuthor ">Vikas  Singh</span>, <span class="hlFld-ContribAuthor ">Prajwal  Gurung</span>, <span class="hlFld-ContribAuthor ">Eung Seok  Lee</span>, <span class="hlFld-ContribAuthor ">Ram  Sharma</span>, <span class="hlFld-ContribAuthor ">Mukut  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>108 </em>, 104681. <a href="https://doi.org/10.1016/j.bioorg.2021.104681" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104681</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104681&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104681%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DChalcone%252Band%252Bits%252Banalogs%25253A%252BTherapeutic%252Band%252Bdiagnostic%252Bapplications%252Bin%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DThapa%26aufirst%3DPritam%26date%3D2021%26volume%3D108%26spage%3D104681" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rekha  Pilliadugula</span>, <span class="hlFld-ContribAuthor ">Jebiti  Haribabu</span>, <span class="hlFld-ContribAuthor ">Mohamed Kasim  Mohamed Subarkhan</span>, <span class="hlFld-ContribAuthor ">Cesar  Echeverria</span>, <span class="hlFld-ContribAuthor ">Ramasamy  Karvembu</span>, <span class="hlFld-ContribAuthor ">N.  Gopalakrishnan</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of morphology and (Sn, Cr) doping on in vitro antiproliferation properties of hydrothermally synthesized 1D GaOOH nanostructures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Science: Advanced Materials and Devices</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1016/j.jsamd.2021.03.003" title="DOI URL">https://doi.org/10.1016/j.jsamd.2021.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jsamd.2021.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jsamd.2021.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Science%253A%2520Advanced%2520Materials%2520and%2520Devices%26atitle%3DEffect%252Bof%252Bmorphology%252Band%252B%252528Sn%25252C%252BCr%252529%252Bdoping%252Bon%252Bin%2525C2%2525A0vitro%252Bantiproliferation%252Bproperties%252Bof%252Bhydrothermally%252Bsynthesized%252B1D%252BGaOOH%252Bnanostructures%26aulast%3DPilliadugula%26aufirst%3DRekha%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akitaka  Yokawa</span>, <span class="hlFld-ContribAuthor ">Miho  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Koichi  Mikami</span>. </span><span class="cited-content_cbyCitation_article-title">Facile C−F Bond Activation Approach to FAMT‐Based Difluoromethyl‐BNCT Drug Candidates. </span><span class="cited-content_cbyCitation_journal-name">Helvetica Chimica Acta</span><span> <strong>2021,</strong> <em>104 </em>
                                    (2)
                                     <a href="https://doi.org/10.1002/hlca.202000211" title="DOI URL">https://doi.org/10.1002/hlca.202000211</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/hlca.202000211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fhlca.202000211%26sid%3Dliteratum%253Aachs%26jtitle%3DHelvetica%2520Chimica%2520Acta%26atitle%3DFacile%252BC%2525E2%252588%252592F%252BBond%252BActivation%252BApproach%252Bto%252BFAMT%2525E2%252580%252590Based%252BDifluoromethyl%2525E2%252580%252590BNCT%252BDrug%252BCandidates%26aulast%3DYokawa%26aufirst%3DAkitaka%26date%3D2021%26date%3D2021%26volume%3D104%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert W.  Pipal</span>, <span class="hlFld-ContribAuthor ">Kenneth T.  Stout</span>, <span class="hlFld-ContribAuthor ">Patricia Z.  Musacchio</span>, <span class="hlFld-ContribAuthor ">Sumei  Ren</span>, <span class="hlFld-ContribAuthor ">Thomas J. A.  Graham</span>, <span class="hlFld-ContribAuthor ">Stefan  Verhoog</span>, <span class="hlFld-ContribAuthor ">Liza  Gantert</span>, <span class="hlFld-ContribAuthor ">Talakad G.  Lohith</span>, <span class="hlFld-ContribAuthor ">Alexander  Schmitz</span>, <span class="hlFld-ContribAuthor ">Hsiaoju S.  Lee</span>, <span class="hlFld-ContribAuthor ">David  Hesk</span>, <span class="hlFld-ContribAuthor ">Eric D.  Hostetler</span>, <span class="hlFld-ContribAuthor ">Ian W.  Davies</span>, <span class="hlFld-ContribAuthor ">David W. C.  MacMillan</span>. </span><span class="cited-content_cbyCitation_article-title">Metallaphotoredox aryl and alkyl radiomethylation for PET ligand discovery. </span><span class="cited-content_cbyCitation_journal-name">Nature</span><span> <strong>2021,</strong> <em>589 </em>
                                    (7843)
                                     , 542-547. <a href="https://doi.org/10.1038/s41586-020-3015-0" title="DOI URL">https://doi.org/10.1038/s41586-020-3015-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41586-020-3015-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41586-020-3015-0%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%26atitle%3DMetallaphotoredox%252Baryl%252Band%252Balkyl%252Bradiomethylation%252Bfor%252BPET%252Bligand%252Bdiscovery%26aulast%3DPipal%26aufirst%3DRobert%2BW.%26date%3D2021%26date%3D2020%26volume%3D589%26issue%3D7843%26spage%3D542%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linjing  Mu</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>. </span><span class="cited-content_cbyCitation_article-title">Current Radioligands for the PET Imaging of Metabotropic Glutamate Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 427-481. <a href="https://doi.org/10.1007/978-3-030-53176-8_13" title="DOI URL">https://doi.org/10.1007/978-3-030-53176-8_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53176-8_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53176-8_13%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BRadioligands%252Bfor%252Bthe%252BPET%252BImaging%252Bof%252BMetabotropic%252BGlutamate%252BReceptors%26aulast%3DMu%26aufirst%3DLinjing%26date%3D2021%26date%3D2020%26spage%3D427%26epage%3D481%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bof%252BNeurobiological%252BSystems%26aulast%3DDierckx%26aufirst%3DRudi%2BA.J.O.%26date%3D2021%26volume%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael R.  Kilbourn</span>, <span class="hlFld-ContribAuthor ">Erin L.  Cole</span>, <span class="hlFld-ContribAuthor ">Peter J.H.  Scott</span>. </span><span class="cited-content_cbyCitation_article-title">In vitro binding affinity vs. in vivo site occupancy: A PET study of four diastereomers of dihydrotetrabenazine (DTBZ) in monkey brain. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2021,</strong> <em>92 </em>, 38-42. <a href="https://doi.org/10.1016/j.nucmedbio.2020.02.008" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2020.02.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2020.02.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2020.02.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DIn%252Bvitro%252Bbinding%252Baffinity%252Bvs.%252Bin%252Bvivo%252Bsite%252Boccupancy%25253A%252BA%252BPET%252Bstudy%252Bof%252Bfour%252Bdiastereomers%252Bof%252Bdihydrotetrabenazine%252B%252528DTBZ%252529%252Bin%252Bmonkey%252Bbrain%26aulast%3DKilbourn%26aufirst%3DMichael%2BR.%26date%3D2021%26volume%3D92%26spage%3D38%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniela  Perani</span>, <span class="hlFld-ContribAuthor ">Silvia Paola  Caminiti</span>, <span class="hlFld-ContribAuthor ">Giulia  Carli</span>, <span class="hlFld-ContribAuthor ">Giacomo  Tondo</span>. </span><span class="cited-content_cbyCitation_article-title">PET Neuroimaging in Dementia Conditions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 211-282. <a href="https://doi.org/10.1007/978-3-030-53168-3_9" title="DOI URL">https://doi.org/10.1007/978-3-030-53168-3_9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-53168-3_9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-53168-3_9%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252BNeuroimaging%252Bin%252BDementia%252BConditions%26aulast%3DPerani%26aufirst%3DDaniela%26date%3D2021%26date%3D2020%26spage%3D211%26epage%3D282%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DPET%252Band%252BSPECT%252Bin%252BNeurology%26aulast%3DDierckx%26aufirst%3DRudi%2BA.%2BJ.%2BO.%26date%3D2021%26volume%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuan  Zhu</span>, <span class="hlFld-ContribAuthor ">Leyuan  Chen</span>, <span class="hlFld-ContribAuthor ">Wenbin  Hou</span>, <span class="hlFld-ContribAuthor ">Yiliang  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in Nucleophilic Fluoride Mediated Fluorine-18 Labeling of Arenes and Heteroarenes. </span><span class="cited-content_cbyCitation_journal-name">Chinese Journal of Organic Chemistry</span><span> <strong>2021,</strong> <em> </em>, 1774. <a href="https://doi.org/10.6023/cjoc202010030" title="DOI URL">https://doi.org/10.6023/cjoc202010030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.6023/cjoc202010030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.6023%2Fcjoc202010030%26sid%3Dliteratum%253Aachs%26jtitle%3DChinese%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DRecent%252BProgress%252Bin%252BNucleophilic%252BFluoride%252BMediated%252BFluorine-18%252BLabeling%252Bof%252BArenes%252Band%252BHeteroarenes%26aulast%3DZhu%26aufirst%3DYuan%26date%3D2021%26spage%3D1774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Annunziata  D'Elia</span>, <span class="hlFld-ContribAuthor ">Sara  Schiavi</span>, <span class="hlFld-ContribAuthor ">Andrea  Soluri</span>, <span class="hlFld-ContribAuthor ">Roberto  Massari</span>, <span class="hlFld-ContribAuthor ">Alessandro  Soluri</span>, <span class="hlFld-ContribAuthor ">Viviana  Trezza</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Nuclear Imaging to Understand the Neural Substrates of Brain Disorders in Laboratory Animals: Current Status and Future Prospects. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Behavioral Neuroscience</span><span> <strong>2020,</strong> <em>14 </em><a href="https://doi.org/10.3389/fnbeh.2020.596509" title="DOI URL">https://doi.org/10.3389/fnbeh.2020.596509</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnbeh.2020.596509&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnbeh.2020.596509%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Behavioral%2520Neuroscience%26atitle%3DRole%252Bof%252BNuclear%252BImaging%252Bto%252BUnderstand%252Bthe%252BNeural%252BSubstrates%252Bof%252BBrain%252BDisorders%252Bin%252BLaboratory%252BAnimals%25253A%252BCurrent%252BStatus%252Band%252BFuture%252BProspects%26aulast%3DD%2527Elia%26aufirst%3DAnnunziata%26date%3D2020%26date%3D2020%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elina  Tampio L’Estrade</span>, <span class="hlFld-ContribAuthor ">Vladimir  Shalgunov</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Ida  Nymann Petersen</span>, <span class="hlFld-ContribAuthor ">Christian Bernard Matthijs  Poulie</span>, <span class="hlFld-ContribAuthor ">Fraser G.  Edgar</span>, <span class="hlFld-ContribAuthor ">Balázs  Volk</span>, <span class="hlFld-ContribAuthor ">Tomas  Ohlsson</span>, <span class="hlFld-ContribAuthor ">Maria  Erlandsson</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-based labeling using condensation reactions of six potential 5-HT7R PET tracers. </span><span class="cited-content_cbyCitation_journal-name">Journal of Radioanalytical and Nuclear Chemistry</span><span> <strong>2020,</strong> <em>326 </em>
                                    (3)
                                     , 1749-1762. <a href="https://doi.org/10.1007/s10967-020-07475-0" title="DOI URL">https://doi.org/10.1007/s10967-020-07475-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10967-020-07475-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10967-020-07475-0%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Radioanalytical%2520and%2520Nuclear%2520Chemistry%26atitle%3DFragment-based%252Blabeling%252Busing%252Bcondensation%252Breactions%252Bof%252Bsix%252Bpotential%252B5-HT7R%252BPET%252Btracers%26aulast%3DTampio%2BL%25E2%2580%2599Estrade%26aufirst%3DElina%26date%3D2020%26date%3D2020%26volume%3D326%26issue%3D3%26spage%3D1749%26epage%3D1762" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chloe E  Spencer</span>, <span class="hlFld-ContribAuthor ">Lucy E  Flint</span>, <span class="hlFld-ContribAuthor ">Catherine J  Duckett</span>, <span class="hlFld-ContribAuthor ">Laura M  Cole</span>, <span class="hlFld-ContribAuthor ">Neil  Cross</span>, <span class="hlFld-ContribAuthor ">David P  Smith</span>, <span class="hlFld-ContribAuthor ">Malcolm R  Clench</span>. </span><span class="cited-content_cbyCitation_article-title">Role of MALDI-MSI in combination with 3D tissue models for early stage efficacy and safety testing of drugs and toxicants. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Proteomics</span><span> <strong>2020,</strong> <em>17 </em>
                                    (11-12)
                                     , 827-841. <a href="https://doi.org/10.1080/14789450.2021.1876568" title="DOI URL">https://doi.org/10.1080/14789450.2021.1876568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14789450.2021.1876568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14789450.2021.1876568%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Proteomics%26atitle%3DRole%252Bof%252BMALDI-MSI%252Bin%252Bcombination%252Bwith%252B3D%252Btissue%252Bmodels%252Bfor%252Bearly%252Bstage%252Befficacy%252Band%252Bsafety%252Btesting%252Bof%252Bdrugs%252Band%252Btoxicants%26aulast%3DSpencer%26aufirst%3DChloe%2BE%26date%3D2020%26date%3D2021%26volume%3D17%26issue%3D11-12%26spage%3D827%26epage%3D841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Claire  Rabut</span>, <span class="hlFld-ContribAuthor ">Jérémy  Ferrier</span>, <span class="hlFld-ContribAuthor ">Adrien  Bertolo</span>, <span class="hlFld-ContribAuthor ">Bruno  Osmanski</span>, <span class="hlFld-ContribAuthor ">Xavier  Mousset</span>, <span class="hlFld-ContribAuthor ">Sophie  Pezet</span>, <span class="hlFld-ContribAuthor ">Thomas  Deffieux</span>, <span class="hlFld-ContribAuthor ">Zsolt  Lenkei</span>, <span class="hlFld-ContribAuthor ">Mickaël  Tanter</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmaco-fUS: Quantification of pharmacologically-induced dynamic changes in brain perfusion and connectivity by functional ultrasound imaging in awake mice. </span><span class="cited-content_cbyCitation_journal-name">NeuroImage</span><span> <strong>2020,</strong> <em>222 </em>, 117231. <a href="https://doi.org/10.1016/j.neuroimage.2020.117231" title="DOI URL">https://doi.org/10.1016/j.neuroimage.2020.117231</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroimage.2020.117231&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroimage.2020.117231%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroImage%26atitle%3DPharmaco-fUS%25253A%252BQuantification%252Bof%252Bpharmacologically-induced%252Bdynamic%252Bchanges%252Bin%252Bbrain%252Bperfusion%252Band%252Bconnectivity%252Bby%252Bfunctional%252Bultrasound%252Bimaging%252Bin%252Bawake%252Bmice%26aulast%3DRabut%26aufirst%3DClaire%26date%3D2020%26volume%3D222%26spage%3D117231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elina T.  L'Estrade</span>, <span class="hlFld-ContribAuthor ">Maria  Erlandsson</span>, <span class="hlFld-ContribAuthor ">Fraser G.  Edgar</span>, <span class="hlFld-ContribAuthor ">Tomas  Ohlsson</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Towards selective CNS PET imaging of the 5-HT7 receptor system: Past, present and future. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2020,</strong> <em>172 </em>, 107830. <a href="https://doi.org/10.1016/j.neuropharm.2019.107830" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2019.107830</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2019.107830&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2019.107830%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DTowards%252Bselective%252BCNS%252BPET%252Bimaging%252Bof%252Bthe%252B5-HT7%252Breceptor%252Bsystem%25253A%252BPast%25252C%252Bpresent%252Band%252Bfuture%26aulast%3DL%2527Estrade%26aufirst%3DElina%2BT.%26date%3D2020%26volume%3D172%26spage%3D107830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Mohammad B.  Haskali</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Ruley</span>, <span class="hlFld-ContribAuthor ">Nicolas J.-F.  Dreyfus</span>, <span class="hlFld-ContribAuthor ">Susan L.  DuBois</span>, <span class="hlFld-ContribAuthor ">Soumen  Paul</span>, <span class="hlFld-ContribAuthor ">Jeih-San  Liow</span>, <span class="hlFld-ContribAuthor ">Cheryl L.  Morse</span>, <span class="hlFld-ContribAuthor ">Aneta  Kowalski</span>, <span class="hlFld-ContribAuthor ">Robert L.  Gladding</span>, <span class="hlFld-ContribAuthor ">Jeremy  Gilmore</span>, <span class="hlFld-ContribAuthor ">Adrian J.  Mogg</span>, <span class="hlFld-ContribAuthor ">S. Michelle  Morin</span>, <span class="hlFld-ContribAuthor ">Peter J.  Lindsay-Scott</span>, <span class="hlFld-ContribAuthor ">J. Craig  Ruble</span>, <span class="hlFld-ContribAuthor ">Nancy A.  Kant</span>, <span class="hlFld-ContribAuthor ">Sergey  Shcherbinin</span>, <span class="hlFld-ContribAuthor ">Vanessa N.  Barth</span>, <span class="hlFld-ContribAuthor ">Michael P.  Johnson</span>, <span class="hlFld-ContribAuthor ">Maria  Cuadrado</span>, <span class="hlFld-ContribAuthor ">Enrique  Jambrina</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Mannes</span>, <span class="hlFld-ContribAuthor ">Hugh N.  Nuthall</span>, <span class="hlFld-ContribAuthor ">Sami S.  Zoghbi</span>, <span class="hlFld-ContribAuthor ">Cynthia D.  Jesudason</span>, <span class="hlFld-ContribAuthor ">Robert B.  Innis</span>, <span class="hlFld-ContribAuthor ">Victor W.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">PET ligands [
              18
              F]LSN3316612 and [
              11
              C]LSN3316612 quantify
              O
              -linked-β-
              N
              -acetyl-glucosamine hydrolase in the brain. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2020,</strong> <em>12 </em>
                                    (543)
                                     , eaau2939. <a href="https://doi.org/10.1126/scitranslmed.aau2939" title="DOI URL">https://doi.org/10.1126/scitranslmed.aau2939</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aau2939&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aau2939%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DPET%252Bligands%252B%25255B%252B18%252BF%25255DLSN3316612%252Band%252B%25255B%252B11%252BC%25255DLSN3316612%252Bquantify%252BO%252B-linked-%2525CE%2525B2-%252BN%252B-acetyl-glucosamine%252Bhydrolase%252Bin%252Bthe%252Bbrain%26aulast%3DLu%26aufirst%3DShuiyu%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D543%26spage%3Deaau2939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harshit  Arora</span>, <span class="hlFld-ContribAuthor ">Madhu  Ramesh</span>, <span class="hlFld-ContribAuthor ">Kolla  Rajasekhar</span>, <span class="hlFld-ContribAuthor ">Thimmaiah  Govindaraju</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Tools to Detect Alloforms of Aβ and Tau: Implications for Multiplexing and Multimodal Diagnosis of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Chemical Society of Japan</span><span> <strong>2020,</strong> <em>93 </em>
                                    (4)
                                     , 507-546. <a href="https://doi.org/10.1246/bcsj.20190356" title="DOI URL">https://doi.org/10.1246/bcsj.20190356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1246/bcsj.20190356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1246%2Fbcsj.20190356%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Chemical%2520Society%2520of%2520Japan%26atitle%3DMolecular%252BTools%252Bto%252BDetect%252BAlloforms%252Bof%252BA%2525CE%2525B2%252Band%252BTau%25253A%252BImplications%252Bfor%252BMultiplexing%252Band%252BMultimodal%252BDiagnosis%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DArora%26aufirst%3DHarshit%26date%3D2020%26volume%3D93%26issue%3D4%26spage%3D507%26epage%3D546" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vasko  Kramer</span>, <span class="hlFld-ContribAuthor ">Agnete  Dyssegaard</span>, <span class="hlFld-ContribAuthor ">Jonathan  Flores</span>, <span class="hlFld-ContribAuthor ">Cristian  Soza-Ried</span>, <span class="hlFld-ContribAuthor ">Frank  Rösch</span>, <span class="hlFld-ContribAuthor ">Gitte Moos  Knudsen</span>, <span class="hlFld-ContribAuthor ">Horacio  Amaral</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of the serotonin 2A receptor selective PET tracer (R)-[18F]MH.MZ in the human brain. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Nuclear Medicine and Molecular Imaging</span><span> <strong>2020,</strong> <em>47 </em>
                                    (2)
                                     , 355-365. <a href="https://doi.org/10.1007/s00259-019-04527-w" title="DOI URL">https://doi.org/10.1007/s00259-019-04527-w</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00259-019-04527-w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00259-019-04527-w%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Nuclear%2520Medicine%2520and%2520Molecular%2520Imaging%26atitle%3DCharacterization%252Bof%252Bthe%252Bserotonin%252B2A%252Breceptor%252Bselective%252BPET%252Btracer%252B%252528R%252529-%25255B18F%25255DMH.MZ%252Bin%252Bthe%252Bhuman%252Bbrain%26aulast%3DKramer%26aufirst%3DVasko%26date%3D2020%26date%3D2019%26volume%3D47%26issue%3D2%26spage%3D355%26epage%3D365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natasha L.  Grimsey</span>, <span class="hlFld-ContribAuthor ">Juha R.  Savinainen</span>, <span class="hlFld-ContribAuthor ">Bala  Attili</span>, <span class="hlFld-ContribAuthor ">Muneer  Ahamed</span>. </span><span class="cited-content_cbyCitation_article-title">Regulating membrane lipid levels at the synapse by small-molecule inhibitors of monoacylglycerol lipase: new developments in therapeutic and PET imaging applications. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today</span><span> <strong>2020,</strong> <em>25 </em>
                                    (2)
                                     , 330-343. <a href="https://doi.org/10.1016/j.drudis.2019.10.004" title="DOI URL">https://doi.org/10.1016/j.drudis.2019.10.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.drudis.2019.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.drudis.2019.10.004%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%26atitle%3DRegulating%252Bmembrane%252Blipid%252Blevels%252Bat%252Bthe%252Bsynapse%252Bby%252Bsmall-molecule%252Binhibitors%252Bof%252Bmonoacylglycerol%252Blipase%25253A%252Bnew%252Bdevelopments%252Bin%252Btherapeutic%252Band%252BPET%252Bimaging%252Bapplications%26aulast%3DGrimsey%26aufirst%3DNatasha%2BL.%26date%3D2020%26volume%3D25%26issue%3D2%26spage%3D330%26epage%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sanae  Hosomi</span>, <span class="hlFld-ContribAuthor ">Mitsuo  Ohnishi</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Ogura</span>, <span class="hlFld-ContribAuthor ">Takeshi  Shimazu</span>. </span><span class="cited-content_cbyCitation_article-title">Traumatic brain injury‐related inflammatory projection: beyond local inflammatory responses. </span><span class="cited-content_cbyCitation_journal-name">Acute Medicine & Surgery</span><span> <strong>2020,</strong> <em>7 </em>
                                    (1)
                                     <a href="https://doi.org/10.1002/ams2.520" title="DOI URL">https://doi.org/10.1002/ams2.520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ams2.520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fams2.520%26sid%3Dliteratum%253Aachs%26jtitle%3DAcute%2520Medicine%2520%2526%2520Surgery%26atitle%3DTraumatic%252Bbrain%252Binjury%2525E2%252580%252590related%252Binflammatory%252Bprojection%25253A%252Bbeyond%252Blocal%252Binflammatory%252Bresponses%26aulast%3DHosomi%26aufirst%3DSanae%26date%3D2020%26date%3D2020%26volume%3D7%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Johannes  Ermert</span>, <span class="hlFld-ContribAuthor ">Martina  Benešová</span>, <span class="hlFld-ContribAuthor ">Verena  Hugenberg</span>, <span class="hlFld-ContribAuthor ">Viplav  Gupta</span>, <span class="hlFld-ContribAuthor ">Ingo  Spahn</span>, <span class="hlFld-ContribAuthor ">Hans-Jürgen  Pietzsch</span>, <span class="hlFld-ContribAuthor ">Christos  Liolios</span>, <span class="hlFld-ContribAuthor ">Klaus  Kopka</span>. </span><span class="cited-content_cbyCitation_article-title">Radiopharmaceutical Sciences. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 49-191. <a href="https://doi.org/10.1007/978-3-030-39457-8_2" title="DOI URL">https://doi.org/10.1007/978-3-030-39457-8_2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-39457-8_2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-39457-8_2%26sid%3Dliteratum%253Aachs%26atitle%3DRadiopharmaceutical%252BSciences%26aulast%3DErmert%26aufirst%3DJohannes%26date%3D2020%26date%3D2020%26spage%3D49%26epage%3D191%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DClinical%252BNuclear%252BMedicine%26aulast%3DAhmadzadehfar%26aufirst%3DHojjat%26date%3D2020%26volume%3D70-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Scott R.  Clark</span>, <span class="hlFld-ContribAuthor ">Micah  Cearns</span>, <span class="hlFld-ContribAuthor ">Klaus Oliver  Schubert</span>, <span class="hlFld-ContribAuthor ">Bernhard T.  Baune</span>. </span><span class="cited-content_cbyCitation_article-title">Multimodal modeling for personalized psychiatry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 521-536. <a href="https://doi.org/10.1016/B978-0-12-813176-3.00043-2" title="DOI URL">https://doi.org/10.1016/B978-0-12-813176-3.00043-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-813176-3.00043-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-813176-3.00043-2%26sid%3Dliteratum%253Aachs%26atitle%3DMultimodal%252Bmodeling%252Bfor%252Bpersonalized%252Bpsychiatry%26aulast%3DClark%26aufirst%3DScott%2BR.%26date%3D2020%26spage%3D521%26epage%3D536%26pub%3DElsevier%26atitle%3DPersonalized%252BPsychiatry%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antony D.  Gee</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Michelle L.  James</span>, <span class="hlFld-ContribAuthor ">Aruna  Korde</span>, <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Radionuclide Imaging for Neuroscience: Current Opinion and Future Directions. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging</span><span> <strong>2020,</strong> <em>19 </em>, 153601212093639. <a href="https://doi.org/10.1177/1536012120936397" title="DOI URL">https://doi.org/10.1177/1536012120936397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1536012120936397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1536012120936397%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%26atitle%3DRadionuclide%252BImaging%252Bfor%252BNeuroscience%25253A%252BCurrent%252BOpinion%252Band%252BFuture%252BDirections%26aulast%3DGee%26aufirst%3DAntony%2BD.%26date%3D2020%26date%3D2020%26volume%3D19%26spage%3D153601212093639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elina T.  L’Estrade</span>, <span class="hlFld-ContribAuthor ">Ida N.  Petersen</span>, <span class="hlFld-ContribAuthor ">Mengfei  Xiong</span>, <span class="hlFld-ContribAuthor ">Adam S.  Hogendorf</span>, <span class="hlFld-ContribAuthor ">Agata  Hogendorf</span>, <span class="hlFld-ContribAuthor ">Jesper L.  Kristensen</span>, <span class="hlFld-ContribAuthor ">Andreas  Kjær</span>, <span class="hlFld-ContribAuthor ">Andrzej J.  Bojarski</span>, <span class="hlFld-ContribAuthor ">Maria  Erlandsson</span>, <span class="hlFld-ContribAuthor ">Tomas  Ohlsson</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Radiolabeling and in vivo evaluation of [11C]AGH-44: a potential lead structure to develop a positron emission tomography radioligand for the 5-HT7 receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Radioanalytical and Nuclear Chemistry</span><span> <strong>2019,</strong> <em>322 </em>
                                    (2)
                                     , 847-851. <a href="https://doi.org/10.1007/s10967-019-06687-3" title="DOI URL">https://doi.org/10.1007/s10967-019-06687-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10967-019-06687-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10967-019-06687-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Radioanalytical%2520and%2520Nuclear%2520Chemistry%26atitle%3DRadiolabeling%252Band%252Bin%252Bvivo%252Bevaluation%252Bof%252B%25255B11C%25255DAGH-44%25253A%252Ba%252Bpotential%252Blead%252Bstructure%252Bto%252Bdevelop%252Ba%252Bpositron%252Bemission%252Btomography%252Bradioligand%252Bfor%252Bthe%252B5-HT7%252Breceptor%26aulast%3DL%25E2%2580%2599Estrade%26aufirst%3DElina%2BT.%26date%3D2019%26date%3D2019%26volume%3D322%26issue%3D2%26spage%3D847%26epage%3D851" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Burgess B.  Freeman</span>, <span class="hlFld-ContribAuthor ">Lei  Yang</span>, <span class="hlFld-ContribAuthor ">Zoran  Rankovic</span>. </span><span class="cited-content_cbyCitation_article-title">Practical approaches to evaluating and optimizing brain exposure in early drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>182 </em>, 111643. <a href="https://doi.org/10.1016/j.ejmech.2019.111643" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111643</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111643%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPractical%252Bapproaches%252Bto%252Bevaluating%252Band%252Boptimizing%252Bbrain%252Bexposure%252Bin%252Bearly%252Bdrug%252Bdiscovery%26aulast%3DFreeman%26aufirst%3DBurgess%2BB.%26date%3D2019%26volume%3D182%26spage%3D111643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jonas E.  Svensson</span>, <span class="hlFld-ContribAuthor ">Martin  Schain</span>, <span class="hlFld-ContribAuthor ">Pontus  Plavén-Sigray</span>, <span class="hlFld-ContribAuthor ">Simon  Cervenka</span>, <span class="hlFld-ContribAuthor ">Mikael  Tiger</span>, <span class="hlFld-ContribAuthor ">Magdalena  Nord</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Lars  Farde</span>, <span class="hlFld-ContribAuthor ">Johan  Lundberg</span>. </span><span class="cited-content_cbyCitation_article-title">Validity and reliability of extrastriatal [11C]raclopride binding quantification in the living human brain. </span><span class="cited-content_cbyCitation_journal-name">NeuroImage</span><span> <strong>2019,</strong> <em>202 </em>, 116143. <a href="https://doi.org/10.1016/j.neuroimage.2019.116143" title="DOI URL">https://doi.org/10.1016/j.neuroimage.2019.116143</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuroimage.2019.116143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuroimage.2019.116143%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuroImage%26atitle%3DValidity%252Band%252Breliability%252Bof%252Bextrastriatal%252B%25255B11C%25255Draclopride%252Bbinding%252Bquantification%252Bin%252Bthe%252Bliving%252Bhuman%252Bbrain%26aulast%3DSvensson%26aufirst%3DJonas%2BE.%26date%3D2019%26volume%3D202%26spage%3D116143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacob M.  Hooker</span>, <span class="hlFld-ContribAuthor ">Richard E.  Carson</span>. </span><span class="cited-content_cbyCitation_article-title">Human Positron Emission Tomography Neuroimaging. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Biomedical Engineering</span><span> <strong>2019,</strong> <em>21 </em>
                                    (1)
                                     , 551-581. <a href="https://doi.org/10.1146/annurev-bioeng-062117-121056" title="DOI URL">https://doi.org/10.1146/annurev-bioeng-062117-121056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-bioeng-062117-121056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-bioeng-062117-121056%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Biomedical%2520Engineering%26atitle%3DHuman%252BPositron%252BEmission%252BTomography%252BNeuroimaging%26aulast%3DHooker%26aufirst%3DJacob%2BM.%26date%3D2019%26volume%3D21%26issue%3D1%26spage%3D551%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">E. Johanna L.  Stéen</span>, <span class="hlFld-ContribAuthor ">Vladimir  Shalgunov</span>, <span class="hlFld-ContribAuthor ">Christoph  Denk</span>, <span class="hlFld-ContribAuthor ">Hannes  Mikula</span>, <span class="hlFld-ContribAuthor ">Andreas  Kjaer</span>, <span class="hlFld-ContribAuthor ">Jesper L.  Kristensen</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>. </span><span class="cited-content_cbyCitation_article-title">Convenient Entry to
              18
              F-Labeled Amines through the Staudinger Reduction. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>2019 </em>
                                    (8)
                                     , 1722-1725. <a href="https://doi.org/10.1002/ejoc.201801457" title="DOI URL">https://doi.org/10.1002/ejoc.201801457</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201801457&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201801457%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DConvenient%252BEntry%252Bto%252B18%252BF-Labeled%252BAmines%252Bthrough%252Bthe%252BStaudinger%252BReduction%26aulast%3DSt%25C3%25A9en%26aufirst%3DE.%2BJohanna%2BL.%26date%3D2019%26date%3D2019%26volume%3D2019%26issue%3D8%26spage%3D1722%26epage%3D1725" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Chemie der Positronenemissionstomographie: Aktuelle Fortschritte bei
              11
              C‐,
              18
              F‐,
              13
              N‐ und
              15
              O‐Markierungsreaktionen. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (9)
                                     , 2604-2631. <a href="https://doi.org/10.1002/ange.201805501" title="DOI URL">https://doi.org/10.1002/ange.201805501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201805501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201805501%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DChemie%252Bder%252BPositronenemissionstomographie%25253A%252BAktuelle%252BFortschritte%252Bbei%252B11%252BC%2525E2%252580%252590%25252C%252B18%252BF%2525E2%252580%252590%25252C%252B13%252BN%2525E2%252580%252590%252Bund%252B15%252BO%2525E2%252580%252590Markierungsreaktionen%26aulast%3DDeng%26aufirst%3DXiaoyun%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D9%26spage%3D2604%26epage%3D2631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Deng</span>, <span class="hlFld-ContribAuthor ">Jian  Rong</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>, <span class="hlFld-ContribAuthor ">Lei  Zhang</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Steven H.  Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry for Positron Emission Tomography: Recent Advances in
              11
              C‐,
              18
              F‐,
              13
              N‐, and
              15
              O‐Labeling Reactions. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (9)
                                     , 2580-2605. <a href="https://doi.org/10.1002/anie.201805501" title="DOI URL">https://doi.org/10.1002/anie.201805501</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201805501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201805501%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DChemistry%252Bfor%252BPositron%252BEmission%252BTomography%25253A%252BRecent%252BAdvances%252Bin%252B11%252BC%2525E2%252580%252590%25252C%252B18%252BF%2525E2%252580%252590%25252C%252B13%252BN%2525E2%252580%252590%25252C%252Band%252B15%252BO%2525E2%252580%252590Labeling%252BReactions%26aulast%3DDeng%26aufirst%3DXiaoyun%26date%3D2019%26volume%3D58%26issue%3D9%26spage%3D2580%26epage%3D2605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aileen B.  Frost</span>, <span class="hlFld-ContribAuthor ">Marta  Brambilla</span>, <span class="hlFld-ContribAuthor ">Rüdiger M.  Exner</span>, <span class="hlFld-ContribAuthor ">Matthew  Tredwell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Derivatization of 1,1-[
              18
              F]Difluorinated Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2019,</strong> <em>131 </em>
                                    (2)
                                     , 482-486. <a href="https://doi.org/10.1002/ange.201810413" title="DOI URL">https://doi.org/10.1002/ange.201810413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201810413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201810413%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DSynthesis%252Band%252BDerivatization%252Bof%252B1%25252C1-%25255B%252B18%252BF%25255DDifluorinated%252BAlkenes%26aulast%3DFrost%26aufirst%3DAileen%2BB.%26date%3D2019%26date%3D2018%26volume%3D131%26issue%3D2%26spage%3D482%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aileen B.  Frost</span>, <span class="hlFld-ContribAuthor ">Marta  Brambilla</span>, <span class="hlFld-ContribAuthor ">Rüdiger M.  Exner</span>, <span class="hlFld-ContribAuthor ">Matthew  Tredwell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Derivatization of 1,1-[
              18
              F]Difluorinated Alkenes. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2019,</strong> <em>58 </em>
                                    (2)
                                     , 472-476. <a href="https://doi.org/10.1002/anie.201810413" title="DOI URL">https://doi.org/10.1002/anie.201810413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201810413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201810413%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DSynthesis%252Band%252BDerivatization%252Bof%252B1%25252C1-%25255B%252B18%252BF%25255DDifluorinated%252BAlkenes%26aulast%3DFrost%26aufirst%3DAileen%2BB.%26date%3D2019%26date%3D2018%26volume%3D58%26issue%3D2%26spage%3D472%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hanne D.  Hansen</span>, <span class="hlFld-ContribAuthor ">Cristian C.  Constantinescu</span>, <span class="hlFld-ContribAuthor ">Olivier  Barret</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Janus H.  Magnussen</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Agnete  Dyssegaard</span>, <span class="hlFld-ContribAuthor ">Julie  Colomb</span>, <span class="hlFld-ContribAuthor ">Thierry  Billard</span>, <span class="hlFld-ContribAuthor ">Luc  Zimmer</span>, <span class="hlFld-ContribAuthor ">Gilles  Tamagnan</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of [
              18
              F]2FP3 in pigs and non-human primates. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2019,</strong> <em>62 </em>
                                    (1)
                                     , 34-42. <a href="https://doi.org/10.1002/jlcr.3692" title="DOI URL">https://doi.org/10.1002/jlcr.3692</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3692&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3692%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DEvaluation%252Bof%252B%25255B%252B18%252BF%25255D2FP3%252Bin%252Bpigs%252Band%252Bnon-human%252Bprimates%26aulast%3DHansen%26aufirst%3DHanne%2BD.%26date%3D2019%26date%3D2018%26volume%3D62%26issue%3D1%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Adam J.  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Michael L.  Nickels</span>, <span class="hlFld-ContribAuthor ">Michael L.  Schulte</span>, <span class="hlFld-ContribAuthor ">H. Charles  Manning</span>. </span><span class="cited-content_cbyCitation_article-title">Automated radiosynthesis of 5-[11C]l-glutamine, an important tracer for glutamine utilization. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2018,</strong> <em>67 </em>, 10-14. <a href="https://doi.org/10.1016/j.nucmedbio.2018.09.002" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2018.09.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2018.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2018.09.002%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DAutomated%252Bradiosynthesis%252Bof%252B5-%25255B11C%25255Dl-glutamine%25252C%252Ban%252Bimportant%252Btracer%252Bfor%252Bglutamine%252Butilization%26aulast%3DRosenberg%26aufirst%3DAdam%2BJ.%26date%3D2018%26volume%3D67%26spage%3D10%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jeih-San  Liow</span>, <span class="hlFld-ContribAuthor ">Cheryl  Morse</span>, <span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Michael  Frankland</span>, <span class="hlFld-ContribAuthor ">George  Tye</span>, <span class="hlFld-ContribAuthor ">Sami  Zoghbi</span>, <span class="hlFld-ContribAuthor ">Robert  Gladding</span>, <span class="hlFld-ContribAuthor ">Anver  Shaik</span>, <span class="hlFld-ContribAuthor ">Robert  Innis</span>, <span class="hlFld-ContribAuthor ">Amy  Newman</span>, <span class="hlFld-ContribAuthor ">Victor  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">[O-methyl-11C]N-(4-(4-(3-Chloro-2-methoxyphenyl)-piperazin-1-yl)butyl)-1H-indole-2-carboxamide ([11C]BAK4-51) Is an Efflux Transporter Substrate and Ineffective for PET Imaging of Brain D3 Receptors in Rodents and Monkey. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2018,</strong> <em>23 </em>
                                    (11)
                                     , 2737. <a href="https://doi.org/10.3390/molecules23112737" title="DOI URL">https://doi.org/10.3390/molecules23112737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules23112737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules23112737%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3D%25255BO-methyl-11C%25255DN-%2525284-%2525284-%2525283-Chloro-2-methoxyphenyl%252529-piperazin-1-yl%252529butyl%252529-1H-indole-2-carboxamide%252B%252528%25255B11C%25255DBAK4-51%252529%252BIs%252Ban%252BEfflux%252BTransporter%252BSubstrate%252Band%252BIneffective%252Bfor%252BPET%252BImaging%252Bof%252BBrain%252BD3%252BReceptors%252Bin%252BRodents%252Band%252BMonkey%26aulast%3DLiow%26aufirst%3DJeih-San%26date%3D2018%26date%3D2018%26volume%3D23%26issue%3D11%26spage%3D2737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Arijit  Ghosh</span>, <span class="hlFld-ContribAuthor ">Karen  Woolum</span>, <span class="hlFld-ContribAuthor ">Michael V.  Knopp</span>, <span class="hlFld-ContribAuthor ">Krishan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Development and optimization of a novel automated loop method for production of [11C]nicotine. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2018,</strong> <em>140 </em>, 76-82. <a href="https://doi.org/10.1016/j.apradiso.2018.05.030" title="DOI URL">https://doi.org/10.1016/j.apradiso.2018.05.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2018.05.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2018.05.030%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DDevelopment%252Band%252Boptimization%252Bof%252Ba%252Bnovel%252Bautomated%252Bloop%252Bmethod%252Bfor%252Bproduction%252Bof%252B%25255B11C%25255Dnicotine%26aulast%3DGhosh%26aufirst%3DArijit%26date%3D2018%26volume%3D140%26spage%3D76%26epage%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sara  Roslin</span>, <span class="hlFld-ContribAuthor ">Kenneth  Dahl</span>, <span class="hlFld-ContribAuthor ">Patrik  Nordeman</span>. </span><span class="cited-content_cbyCitation_article-title">Reaction of
              11
              C-benzoyl chlorides with metalloid reagents:
              11
              C-labeling of benzyl alcohols, benzaldehydes, and phenyl ketones from [
              11
              C]CO. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2018,</strong> <em>61 </em>
                                    (5)
                                     , 447-454. <a href="https://doi.org/10.1002/jlcr.3609" title="DOI URL">https://doi.org/10.1002/jlcr.3609</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3609%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DReaction%252Bof%252B11%252BC-benzoyl%252Bchlorides%252Bwith%252Bmetalloid%252Breagents%25253A%252B11%252BC-labeling%252Bof%252Bbenzyl%252Balcohols%25252C%252Bbenzaldehydes%25252C%252Band%252Bphenyl%252Bketones%252Bfrom%252B%25255B%252B11%252BC%25255DCO%26aulast%3DRoslin%26aufirst%3DSara%26date%3D2018%26date%3D2018%26volume%3D61%26issue%3D5%26spage%3D447%26epage%3D454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manuel  Braun</span>, <span class="hlFld-ContribAuthor ">Sascha  Häseli</span>, <span class="hlFld-ContribAuthor ">Frank  Rösch</span>, <span class="hlFld-ContribAuthor ">Markus  Piel</span>, <span class="hlFld-ContribAuthor ">Kerstin  Münnemann</span>. </span><span class="cited-content_cbyCitation_article-title">NMR Hyperpolarization of Established PET Tracers. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2018,</strong> <em>3 </em>
                                    (18)
                                     , 5176-5184. <a href="https://doi.org/10.1002/slct.201800364" title="DOI URL">https://doi.org/10.1002/slct.201800364</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.201800364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.201800364%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DNMR%252BHyperpolarization%252Bof%252BEstablished%252BPET%252BTracers%26aulast%3DBraun%26aufirst%3DManuel%26date%3D2018%26date%3D2018%26volume%3D3%26issue%3D18%26spage%3D5176%26epage%3D5184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph  Downey</span>, <span class="hlFld-ContribAuthor ">Salvatore  Bongarzone</span>, <span class="hlFld-ContribAuthor ">Stefan  Hader</span>, <span class="hlFld-ContribAuthor ">Antony D.  Gee</span>. </span><span class="cited-content_cbyCitation_article-title">In-loop flow [
              11
              C]CO
              2
              fixation and radiosynthesis of
              N
              ,
              N
              ′-[
              11
              C]dibenzylurea. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 263-271. <a href="https://doi.org/10.1002/jlcr.3568" title="DOI URL">https://doi.org/10.1002/jlcr.3568</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3568%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DIn-loop%252Bflow%252B%25255B%252B11%252BC%25255DCO%252B2%252Bfixation%252Band%252Bradiosynthesis%252Bof%252BN%252B%25252C%252BN%252B%2525E2%252580%2525B2-%25255B%252B11%252BC%25255Ddibenzylurea%26aulast%3DDowney%26aufirst%3DJoseph%26date%3D2018%26date%3D2017%26volume%3D61%26issue%3D3%26spage%3D263%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dominik  Heimann</span>, <span class="hlFld-ContribAuthor ">Frederik  Börgel</span>, <span class="hlFld-ContribAuthor ">Henk  de Vries</span>, <span class="hlFld-ContribAuthor ">Marius  Patberg</span>, <span class="hlFld-ContribAuthor ">Eliot  Jan-Smith</span>, <span class="hlFld-ContribAuthor ">Bastian  Frehland</span>, <span class="hlFld-ContribAuthor ">Dirk  Schepmann</span>, <span class="hlFld-ContribAuthor ">Laura H.  Heitman</span>, <span class="hlFld-ContribAuthor ">Bernhard  Wünsch</span>. </span><span class="cited-content_cbyCitation_article-title">Optimization of the metabolic stability of a fluorinated cannabinoid receptor subtype 2 (CB2) ligand designed for PET studies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>146 </em>, 409-422. <a href="https://doi.org/10.1016/j.ejmech.2018.01.048" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.01.048</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.01.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.01.048%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DOptimization%252Bof%252Bthe%252Bmetabolic%252Bstability%252Bof%252Ba%252Bfluorinated%252Bcannabinoid%252Breceptor%252Bsubtype%252B2%252B%252528CB2%252529%252Bligand%252Bdesigned%252Bfor%252BPET%252Bstudies%26aulast%3DHeimann%26aufirst%3DDominik%26date%3D2018%26volume%3D146%26spage%3D409%26epage%3D422" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of the 5-HT2A Receptor System: A Tool to Study the Receptor’s In Vivo Brain Function. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 85-134. <a href="https://doi.org/10.1007/978-3-319-70474-6_5" title="DOI URL">https://doi.org/10.1007/978-3-319-70474-6_5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-70474-6_5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-70474-6_5%26sid%3Dliteratum%253Aachs%26atitle%3DPET%252BImaging%252Bof%252Bthe%252B5-HT2A%252BReceptor%252BSystem%25253A%252BA%252BTool%252Bto%252BStudy%252Bthe%252BReceptor%2525E2%252580%252599s%252BIn%252BVivo%252BBrain%252BFunction%26aulast%3DHerth%26aufirst%3DMatthias%2BM.%26date%3D2018%26date%3D2018%26spage%3D85%26epage%3D134%26pub%3DSpringer%2520International%2520Publishing%26atitle%3D5-HT2A%252BReceptors%252Bin%252Bthe%252BCentral%252BNervous%252BSystem%26aulast%3DGuiard%26aufirst%3DBruno%2BP.%26date%3D2018%26volume%3D99" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vidya  Narayanaswami</span>, <span class="hlFld-ContribAuthor ">Kenneth  Dahl</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Lee  Josephson</span>, <span class="hlFld-ContribAuthor ">Paul  Cumming</span>, <span class="hlFld-ContribAuthor ">Neil  Vasdev</span>. </span><span class="cited-content_cbyCitation_article-title">Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO. </span><span class="cited-content_cbyCitation_journal-name">Molecular Imaging</span><span> <strong>2018,</strong> <em>17 </em>, 153601211879231. <a href="https://doi.org/10.1177/1536012118792317" title="DOI URL">https://doi.org/10.1177/1536012118792317</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1536012118792317&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1536012118792317%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Imaging%26atitle%3DEmerging%252BPET%252BRadiotracers%252Band%252BTargets%252Bfor%252BImaging%252Bof%252BNeuroinflammation%252Bin%252BNeurodegenerative%252BDiseases%25253A%252BOutlook%252BBeyond%252BTSPO%26aulast%3DNarayanaswami%26aufirst%3DVidya%26date%3D2018%26date%3D2018%26volume%3D17%26spage%3D153601211879231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory R.  Naumiec</span>, <span class="hlFld-ContribAuthor ">Lisheng  Cai</span>, <span class="hlFld-ContribAuthor ">Shuiyu  Lu</span>, <span class="hlFld-ContribAuthor ">Victor W.  Pike</span>. </span><span class="cited-content_cbyCitation_article-title">Quinuclidine and DABCO Enhance the Radiofluorination of 5-Substituted 2-Halopyridines. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2017,</strong> <em>2017 </em>
                                    (45)
                                     , 6593-6603. <a href="https://doi.org/10.1002/ejoc.201700970" title="DOI URL">https://doi.org/10.1002/ejoc.201700970</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201700970&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201700970%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DQuinuclidine%252Band%252BDABCO%252BEnhance%252Bthe%252BRadiofluorination%252Bof%252B5-Substituted%252B2-Halopyridines%26aulast%3DNaumiec%26aufirst%3DGregory%2BR.%26date%3D2017%26date%3D2017%26volume%3D2017%26issue%3D45%26spage%3D6593%26epage%3D6603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>, <span class="hlFld-ContribAuthor ">Mark  Schmidt</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry strategies for PET tracer discovery. </span><span class="cited-content_cbyCitation_journal-name">Drug Discovery Today: Technologies</span><span> <strong>2017,</strong> <em>25 </em>, 11-17. <a href="https://doi.org/10.1016/j.ddtec.2017.10.002" title="DOI URL">https://doi.org/10.1016/j.ddtec.2017.10.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ddtec.2017.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ddtec.2017.10.002%26sid%3Dliteratum%253Aachs%26jtitle%3DDrug%2520Discovery%2520Today%253A%2520Technologies%26atitle%3DMedicinal%252BChemistry%252Bstrategies%252Bfor%252BPET%252Btracer%252Bdiscovery%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJos%25C3%25A9%2BIgnacio%26date%3D2017%26volume%3D25%26spage%3D11%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David Tibor  Lauber</span>, <span class="hlFld-ContribAuthor ">András  Fülöp</span>, <span class="hlFld-ContribAuthor ">Tibor  Kovács</span>, <span class="hlFld-ContribAuthor ">Krisztián  Szigeti</span>, <span class="hlFld-ContribAuthor ">Domokos  Máthé</span>, <span class="hlFld-ContribAuthor ">Attila  Szijártó</span>. </span><span class="cited-content_cbyCitation_article-title">State of the art in vivo imaging techniques for laboratory animals. </span><span class="cited-content_cbyCitation_journal-name">Laboratory Animals</span><span> <strong>2017,</strong> <em>51 </em>
                                    (5)
                                     , 465-478. <a href="https://doi.org/10.1177/0023677217695852" title="DOI URL">https://doi.org/10.1177/0023677217695852</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/0023677217695852&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F0023677217695852%26sid%3Dliteratum%253Aachs%26jtitle%3DLaboratory%2520Animals%26atitle%3DState%252Bof%252Bthe%252Bart%252Bin%252Bvivo%252Bimaging%252Btechniques%252Bfor%252Blaboratory%252Banimals%26aulast%3DLauber%26aufirst%3DDavid%2BTibor%26date%3D2017%26date%3D2017%26volume%3D51%26issue%3D5%26spage%3D465%26epage%3D478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohamed  Ibrahim</span>, <span class="hlFld-ContribAuthor ">Abir  El-Alfy</span>, <span class="hlFld-ContribAuthor ">Kelly  Ezel</span>, <span class="hlFld-ContribAuthor ">Mohamed  Radwan</span>, <span class="hlFld-ContribAuthor ">Abbas  Shilabin</span>, <span class="hlFld-ContribAuthor ">Anna  Kochanowska-Karamyan</span>, <span class="hlFld-ContribAuthor ">Howaida  Abd-Alla</span>, <span class="hlFld-ContribAuthor ">Masami  Otsuka</span>, <span class="hlFld-ContribAuthor ">Mark  Hamann</span>. </span><span class="cited-content_cbyCitation_article-title">Marine Inspired 2-(5-Halo-1H-indol-3-yl)-N,N-dimethylethanamines as Modulators of Serotonin Receptors: An Example Illustrating the Power of Bromine as Part of the Uniquely Marine Chemical Space. </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2017,</strong> <em>15 </em>
                                    (8)
                                     , 248. <a href="https://doi.org/10.3390/md15080248" title="DOI URL">https://doi.org/10.3390/md15080248</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md15080248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd15080248%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DMarine%252BInspired%252B2-%2525285-Halo-1H-indol-3-yl%252529-N%25252CN-dimethylethanamines%252Bas%252BModulators%252Bof%252BSerotonin%252BReceptors%25253A%252BAn%252BExample%252BIllustrating%252Bthe%252BPower%252Bof%252BBromine%252Bas%252BPart%252Bof%252Bthe%252BUniquely%252BMarine%252BChemical%252BSpace%26aulast%3DIbrahim%26aufirst%3DMohamed%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D8%26spage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hartmuth C.  Kolb</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>. </span><span class="cited-content_cbyCitation_article-title">Tau Positron Emission Tomography Imaging. </span><span class="cited-content_cbyCitation_journal-name">Cold Spring Harbor Perspectives in Biology</span><span> <strong>2017,</strong> <em>9 </em>
                                    (5)
                                     , a023721. <a href="https://doi.org/10.1101/cshperspect.a023721" title="DOI URL">https://doi.org/10.1101/cshperspect.a023721</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1101/cshperspect.a023721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1101%2Fcshperspect.a023721%26sid%3Dliteratum%253Aachs%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspectives%2520in%2520Biology%26atitle%3DTau%252BPositron%252BEmission%252BTomography%252BImaging%26aulast%3DKolb%26aufirst%3DHartmuth%2BC.%26date%3D2017%26date%3D2016%26volume%3D9%26issue%3D5%26spage%3Da023721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaomin  Li</span>, <span class="hlFld-ContribAuthor ">Zhengping  Chen</span>, <span class="hlFld-ContribAuthor ">Chunyi  Liu</span>, <span class="hlFld-ContribAuthor ">Jie  Tang</span>, <span class="hlFld-ContribAuthor ">Danlu  Xue</span>, <span class="hlFld-ContribAuthor ">Lihua  Cao</span>, <span class="hlFld-ContribAuthor ">Dong  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Method Development and Validation for Determination of p-Toluenesulfonoxypropyl-(+)-Dihydrotetrabenazine Enantiomeric Purity by HPLC on a Chiral Stationary Phase. </span><span class="cited-content_cbyCitation_journal-name">Chromatographia</span><span> <strong>2017,</strong> <em>80 </em>
                                    (3)
                                     , 483-488. <a href="https://doi.org/10.1007/s10337-017-3255-9" title="DOI URL">https://doi.org/10.1007/s10337-017-3255-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10337-017-3255-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10337-017-3255-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChromatographia%26atitle%3DMethod%252BDevelopment%252Band%252BValidation%252Bfor%252BDetermination%252Bof%252Bp-Toluenesulfonoxypropyl-%252528%25252B%252529-Dihydrotetrabenazine%252BEnantiomeric%252BPurity%252Bby%252BHPLC%252Bon%252Ba%252BChiral%252BStationary%252BPhase%26aulast%3DLi%26aufirst%3DXiaomin%26date%3D2017%26date%3D2017%26volume%3D80%26issue%3D3%26spage%3D483%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark E  Schmidt</span>, <span class="hlFld-ContribAuthor ">José Ignacio  Andrés</span>. </span><span class="cited-content_cbyCitation_article-title">The value of PET ligand discovery to CNS drug development. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2017,</strong> <em>9 </em>
                                    (4)
                                     , 351-356. <a href="https://doi.org/10.4155/fmc-2017-0018" title="DOI URL">https://doi.org/10.4155/fmc-2017-0018</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc-2017-0018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc-2017-0018%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DThe%252Bvalue%252Bof%252BPET%252Bligand%252Bdiscovery%252Bto%252BCNS%252Bdrug%252Bdevelopment%26aulast%3DSchmidt%26aufirst%3DMark%2BE%26date%3D2017%26volume%3D9%26issue%3D4%26spage%3D351%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L.  Moreira</span>, <span class="hlFld-ContribAuthor ">N.M.  Guimarães</span>, <span class="hlFld-ContribAuthor ">N.F.  Azevedo</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging strategies for bioinspired materials. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 215-239. <a href="https://doi.org/10.1016/B978-0-08-100741-9.00008-5" title="DOI URL">https://doi.org/10.1016/B978-0-08-100741-9.00008-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-100741-9.00008-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-100741-9.00008-5%26sid%3Dliteratum%253Aachs%26atitle%3DImaging%252Bstrategies%252Bfor%252Bbioinspired%252Bmaterials%26aulast%3DMoreira%26aufirst%3DL.%26date%3D2017%26spage%3D215%26epage%3D239%26pub%3DElsevier%26atitle%3DBioinspired%252BMaterials%252Bfor%252BMedical%252BApplications%26date%3D2017%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M.L.  Bolognesi</span>. </span><span class="cited-content_cbyCitation_article-title">From Imaging Agents to Theranostic Drugs in Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 74-106. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12285-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12285-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12285-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12285-1%26sid%3Dliteratum%253Aachs%26atitle%3DFrom%252BImaging%252BAgents%252Bto%252BTheranostic%252BDrugs%252Bin%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DBolognesi%26aufirst%3DM.L.%26date%3D2017%26spage%3D74%26epage%3D106%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J.  Mercier</span>, <span class="hlFld-ContribAuthor ">L.  Provins</span>, <span class="hlFld-ContribAuthor ">J.  Hannestad</span>. </span><span class="cited-content_cbyCitation_article-title">Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 20-64. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12437-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12437-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12437-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12437-0%26sid%3Dliteratum%253Aachs%26atitle%3DProgress%252Band%252BChallenges%252Bin%252Bthe%252BDevelopment%252Bof%252BPET%252BLigands%252Bto%252BAid%252BCNS%252BDrug%252BDiscovery%26aulast%3DMercier%26aufirst%3DJ.%26date%3D2017%26spage%3D20%26epage%3D64%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">H.  Tsui</span>, <span class="hlFld-ContribAuthor ">Q.  Zeng</span>, <span class="hlFld-ContribAuthor ">K.  Chen</span>, <span class="hlFld-ContribAuthor ">X.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibiting Kinases in the CNS. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 408-446. <a href="https://doi.org/10.1016/B978-0-12-409547-2.13815-6" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.13815-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.13815-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.13815-6%26sid%3Dliteratum%253Aachs%26atitle%3DInhibiting%252BKinases%252Bin%252Bthe%252BCNS%26aulast%3DTsui%26aufirst%3DH.%26date%3D2017%26spage%3D408%26epage%3D446%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jia  Wang</span>, <span class="hlFld-ContribAuthor ">Philip H.  Chao</span>, <span class="hlFld-ContribAuthor ">Sebastian  Hanet</span>, <span class="hlFld-ContribAuthor ">R. Michael  van Dam</span>. </span><span class="cited-content_cbyCitation_article-title">Performing multi-step chemical reactions in microliter-sized droplets by leveraging a simple passive transport mechanism. </span><span class="cited-content_cbyCitation_journal-name">Lab on a Chip</span><span> <strong>2017,</strong> <em>17 </em>
                                    (24)
                                     , 4342-4355. <a href="https://doi.org/10.1039/C7LC01009E" title="DOI URL">https://doi.org/10.1039/C7LC01009E</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7LC01009E&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7LC01009E%26sid%3Dliteratum%253Aachs%26jtitle%3DLab%2520on%2520a%2520Chip%26atitle%3DPerforming%252Bmulti-step%252Bchemical%252Breactions%252Bin%252Bmicroliter-sized%252Bdroplets%252Bby%252Bleveraging%252Ba%252Bsimple%252Bpassive%252Btransport%252Bmechanism%26aulast%3DWang%26aufirst%3DJia%26date%3D2017%26date%3D2017%26volume%3D17%26issue%3D24%26spage%3D4342%26epage%3D4355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">I. N.  Petersen</span>, <span class="hlFld-ContribAuthor ">J.  Villadsen</span>, <span class="hlFld-ContribAuthor ">H. D.  Hansen</span>, <span class="hlFld-ContribAuthor ">J.  Madsen</span>, <span class="hlFld-ContribAuthor ">A. A.  Jensen</span>, <span class="hlFld-ContribAuthor ">N.  Gillings</span>, <span class="hlFld-ContribAuthor ">S.  Lehel</span>, <span class="hlFld-ContribAuthor ">M. M.  Herth</span>, <span class="hlFld-ContribAuthor ">G. M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">J. L.  Kristensen</span>. </span><span class="cited-content_cbyCitation_article-title">18
              F-Labelling of electron rich iodonium ylides: application to the radiosynthesis of potential 5-HT
              2A
              receptor PET ligands. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2017,</strong> <em>15 </em>
                                    (20)
                                     , 4351-4358. <a href="https://doi.org/10.1039/C7OB00628D" title="DOI URL">https://doi.org/10.1039/C7OB00628D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7OB00628D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7OB00628D%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3D18%252BF-Labelling%252Bof%252Belectron%252Brich%252Biodonium%252Bylides%25253A%252Bapplication%252Bto%252Bthe%252Bradiosynthesis%252Bof%252Bpotential%252B5-HT%252B2A%252Breceptor%252BPET%252Bligands%26aulast%3DPetersen%26aufirst%3DI.%2BN.%26date%3D2017%26date%3D2017%26volume%3D15%26issue%3D20%26spage%3D4351%26epage%3D4358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanglin  Kuang</span>, <span class="hlFld-ContribAuthor ">Yang  Zhou</span>, <span class="hlFld-ContribAuthor ">Rongfeng  Zou</span>, <span class="hlFld-ContribAuthor ">Christer  Halldin</span>, <span class="hlFld-ContribAuthor ">Agneta  Nordberg</span>, <span class="hlFld-ContribAuthor ">Bengt  Långström</span>, <span class="hlFld-ContribAuthor ">Hans  Ågren</span>, <span class="hlFld-ContribAuthor ">Yaoquan  Tu</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of the binding mode of the PET tracer [
              18
              F]ASEM to a chimera structure of the α7 nicotinic acetylcholine receptor. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2017,</strong> <em>7 </em>
                                    (32)
                                     , 19787-19793. <a href="https://doi.org/10.1039/C7RA00496F" title="DOI URL">https://doi.org/10.1039/C7RA00496F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7RA00496F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7RA00496F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCharacterization%252Bof%252Bthe%252Bbinding%252Bmode%252Bof%252Bthe%252BPET%252Btracer%252B%25255B%252B18%252BF%25255DASEM%252Bto%252Ba%252Bchimera%252Bstructure%252Bof%252Bthe%252B%2525CE%2525B17%252Bnicotinic%252Bacetylcholine%252Breceptor%26aulast%3DKuang%26aufirst%3DGuanglin%26date%3D2017%26date%3D2017%26volume%3D7%26issue%3D32%26spage%3D19787%26epage%3D19793" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Youwen  Xu</span>, <span class="hlFld-ContribAuthor ">Sung Won  Kim</span>, <span class="hlFld-ContribAuthor ">Dohyun  Kim</span>, <span class="hlFld-ContribAuthor ">David  Alexoff</span>, <span class="hlFld-ContribAuthor ">Michael J.  Schueller</span>, <span class="hlFld-ContribAuthor ">Joanna S.  Fowler</span>. </span><span class="cited-content_cbyCitation_article-title">A mild, rapid synthesis of freebase [11C]nicotine from [11C]methyl triflate. </span><span class="cited-content_cbyCitation_journal-name">Applied Radiation and Isotopes</span><span> <strong>2016,</strong> <em>118 </em>, 62-66. <a href="https://doi.org/10.1016/j.apradiso.2016.08.020" title="DOI URL">https://doi.org/10.1016/j.apradiso.2016.08.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apradiso.2016.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apradiso.2016.08.020%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Radiation%2520and%2520Isotopes%26atitle%3DA%252Bmild%25252C%252Brapid%252Bsynthesis%252Bof%252Bfreebase%252B%25255B11C%25255Dnicotine%252Bfrom%252B%25255B11C%25255Dmethyl%252Btriflate%26aulast%3DXu%26aufirst%3DYouwen%26date%3D2016%26volume%3D118%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ida Nymann  Petersen</span>, <span class="hlFld-ContribAuthor ">Jonas  Villadsen</span>, <span class="hlFld-ContribAuthor ">Hanne Demant  Hansen</span>, <span class="hlFld-ContribAuthor ">Anders A.  Jensen</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Nic  Gillings</span>, <span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Jesper L.  Kristensen</span>. </span><span class="cited-content_cbyCitation_article-title">Convergent 18 F-labeling and evaluation of N -benzyl-phenethylamines as 5-HT 2A receptor PET ligands. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (21)
                                     , 5353-5356. <a href="https://doi.org/10.1016/j.bmc.2016.08.056" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.08.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.08.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.08.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DConvergent%252B18%252BF-labeling%252Band%252Bevaluation%252Bof%252BN%252B-benzyl-phenethylamines%252Bas%252B5-HT%252B2A%252Breceptor%252BPET%252Bligands%26aulast%3DPetersen%26aufirst%3DIda%2BNymann%26date%3D2016%26volume%3D24%26issue%3D21%26spage%3D5353%26epage%3D5356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zih-Rou  Huang</span>, <span class="hlFld-ContribAuthor ">Chia-Ling  Tsai</span>, <span class="hlFld-ContribAuthor ">Ya-Yao  Huang</span>, <span class="hlFld-ContribAuthor ">Chyng-Yann  Shiue</span>, <span class="hlFld-ContribAuthor ">Kai-Yuan  Tzen</span>, <span class="hlFld-ContribAuthor ">Ruoh-Fang  Yen</span>, <span class="hlFld-ContribAuthor ">Ling-Wei  Hsin</span>, . </span><span class="cited-content_cbyCitation_article-title">A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2. </span><span class="cited-content_cbyCitation_journal-name">PLOS ONE</span><span> <strong>2016,</strong> <em>11 </em>
                                    (9)
                                     , e0161295. <a href="https://doi.org/10.1371/journal.pone.0161295" title="DOI URL">https://doi.org/10.1371/journal.pone.0161295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pone.0161295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pone.0161295%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520ONE%26atitle%3DA%252BNovel%252BPotential%252BPositron%252BEmission%252BTomography%252BImaging%252BAgent%252Bfor%252BVesicular%252BMonoamine%252BTransporter%252BType%252B2%26aulast%3DHuang%26aufirst%3DZih-Rou%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D9%26spage%3De0161295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Roger  Slavik</span>, <span class="hlFld-ContribAuthor ">Adrienne  Müller Herde</span>, <span class="hlFld-ContribAuthor ">Ahmed  Haider</span>, <span class="hlFld-ContribAuthor ">Stefanie D.  Krämer</span>, <span class="hlFld-ContribAuthor ">Markus  Weber</span>, <span class="hlFld-ContribAuthor ">Roger  Schibli</span>, <span class="hlFld-ContribAuthor ">Simon M.  Ametamey</span>, <span class="hlFld-ContribAuthor ">Linjing  Mu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neurochemistry</span><span> <strong>2016,</strong> <em>138 </em>
                                    (6)
                                     , 874-886. <a href="https://doi.org/10.1111/jnc.13716" title="DOI URL">https://doi.org/10.1111/jnc.13716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jnc.13716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjnc.13716%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neurochemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bfluorinated%252B4-oxo-quinoline%252Bderivative%252Bas%252Ba%252Bpotential%252Bpositron%252Bemission%252Btomography%252Bradiotracer%252Bfor%252Bimaging%252Bcannabinoid%252Breceptor%252Btype%252B2%26aulast%3DSlavik%26aufirst%3DRoger%26date%3D2016%26date%3D2016%26volume%3D138%26issue%3D6%26spage%3D874%26epage%3D886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias M.  Herth</span>, <span class="hlFld-ContribAuthor ">Ida Nymann  Petersen</span>, <span class="hlFld-ContribAuthor ">Hanne Demant  Hansen</span>, <span class="hlFld-ContribAuthor ">Martin  Hansen</span>, <span class="hlFld-ContribAuthor ">Anders  Ettrup</span>, <span class="hlFld-ContribAuthor ">Anders A.  Jensen</span>, <span class="hlFld-ContribAuthor ">Szabolcs  Lehel</span>, <span class="hlFld-ContribAuthor ">Agnete  Dyssegaard</span>, <span class="hlFld-ContribAuthor ">Nic  Gillings</span>, <span class="hlFld-ContribAuthor ">Gitte M.  Knudsen</span>, <span class="hlFld-ContribAuthor ">Jesper L.  Kristensen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of 18F-labeled 5-HT2A receptor agonists as PET ligands. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2016,</strong> <em>43 </em>
                                    (8)
                                     , 455-462. <a href="https://doi.org/10.1016/j.nucmedbio.2016.02.011" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2016.02.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2016.02.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2016.02.011%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252B18F-labeled%252B5-HT2A%252Breceptor%252Bagonists%252Bas%252BPET%252Bligands%26aulast%3DHerth%26aufirst%3DMatthias%2BM.%26date%3D2016%26volume%3D43%26issue%3D8%26spage%3D455%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Masafumi  Shimojo</span>, <span class="hlFld-ContribAuthor ">Makoto  Higuchi</span>, <span class="hlFld-ContribAuthor ">Tetsuya  Suhara</span>, <span class="hlFld-ContribAuthor ">Naruhiko  Sahara</span>. </span><span class="cited-content_cbyCitation_article-title">Imaging Multimodalities for Dissecting Alzheimer's Disease: Advanced Technologies of Positron Emission Tomography and Fluorescence Imaging. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neuroscience</span><span> <strong>2015,</strong> <em>9 </em><a href="https://doi.org/10.3389/fnins.2015.00482" title="DOI URL">https://doi.org/10.3389/fnins.2015.00482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fnins.2015.00482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffnins.2015.00482%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neuroscience%26atitle%3DImaging%252BMultimodalities%252Bfor%252BDissecting%252BAlzheimer%252527s%252BDisease%25253A%252BAdvanced%252BTechnologies%252Bof%252BPositron%252BEmission%252BTomography%252Band%252BFluorescence%252BImaging%26aulast%3DShimojo%26aufirst%3DMasafumi%26date%3D2015%26date%3D2015%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew G.  Horti</span>. </span><span class="cited-content_cbyCitation_article-title">Development of [ 18 F]ASEM, a specific radiotracer for quantification of the α7-nAChR with positron-emission tomography. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2015,</strong> <em>97 </em>
                                    (4)
                                     , 566-575. <a href="https://doi.org/10.1016/j.bcp.2015.07.030" title="DOI URL">https://doi.org/10.1016/j.bcp.2015.07.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2015.07.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2015.07.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DDevelopment%252Bof%252B%25255B%252B18%252BF%25255DASEM%25252C%252Ba%252Bspecific%252Bradiotracer%252Bfor%252Bquantification%252Bof%252Bthe%252B%2525CE%2525B17-nAChR%252Bwith%252Bpositron-emission%252Btomography%26aulast%3DHorti%26aufirst%3DAndrew%2BG.%26date%3D2015%26volume%3D97%26issue%3D4%26spage%3D566%26epage%3D575" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianying  Wu</span>, <span class="hlFld-ContribAuthor ">Xue  Zhou</span>, <span class="hlFld-ContribAuthor ">Shuxian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Zhang</span>, <span class="hlFld-ContribAuthor ">Aifang  Deng</span>, <span class="hlFld-ContribAuthor ">Jie  Han</span>, <span class="hlFld-ContribAuthor ">Lin  Zhu</span>, <span class="hlFld-ContribAuthor ">Hank F.  Kung</span>, <span class="hlFld-ContribAuthor ">Jinping  Qiao</span>. </span><span class="cited-content_cbyCitation_article-title">Brain uptake of a non-radioactive pseudo-carrier and its effect on the biodistribution of [18F]AV-133 in mouse brain. </span><span class="cited-content_cbyCitation_journal-name">Nuclear Medicine and Biology</span><span> <strong>2015,</strong> <em>42 </em>
                                    (7)
                                     , 630-636. <a href="https://doi.org/10.1016/j.nucmedbio.2015.03.009" title="DOI URL">https://doi.org/10.1016/j.nucmedbio.2015.03.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.nucmedbio.2015.03.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.nucmedbio.2015.03.009%26sid%3Dliteratum%253Aachs%26jtitle%3DNuclear%2520Medicine%2520and%2520Biology%26atitle%3DBrain%252Buptake%252Bof%252Ba%252Bnon-radioactive%252Bpseudo-carrier%252Band%252Bits%252Beffect%252Bon%252Bthe%252Bbiodistribution%252Bof%252B%25255B18F%25255DAV-133%252Bin%252Bmouse%252Bbrain%26aulast%3DWu%26aufirst%3DXianying%26date%3D2015%26volume%3D42%26issue%3D7%26spage%3D630%26epage%3D636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Torsten  Kniess</span>, <span class="hlFld-ContribAuthor ">Markus  Laube</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Jörg  Steinbach</span>. </span><span class="cited-content_cbyCitation_article-title">2-[
              18
              F]Fluoroethyl tosylate – a versatile tool for building
              18
              F-based radiotracers for positron emission tomography. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (10)
                                     , 1714-1754. <a href="https://doi.org/10.1039/C5MD00303B" title="DOI URL">https://doi.org/10.1039/C5MD00303B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00303B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00303B%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3D2-%25255B%252B18%252BF%25255DFluoroethyl%252Btosylate%252B%2525E2%252580%252593%252Ba%252Bversatile%252Btool%252Bfor%252Bbuilding%252B18%252BF-based%252Bradiotracers%252Bfor%252Bpositron%252Bemission%252Btomography%26aulast%3DKniess%26aufirst%3DTorsten%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D10%26spage%3D1714%26epage%3D1754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0025.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Automated synthesis module (SynChrom R&D, RAYTEST) for the synthesis of <sup>18</sup>F-labeled tracers (left). The programming and control of the different reaction steps is performed via a graphical interface (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Schematic diagram of a radionuclide emitting a positron, resulting annihilation, production of two 511 keV photons, and the coincident detection of the photons in a PET scanner.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Diagrammatic representation of the two-tissue compartment model, consisting of blood (<i>C</i><sub>FP</sub>), free tracer in tissue (<i>C</i><sub>FT</sub>), specific binding (<i>C</i><sub>S</sub>) and nonspecific binding (<i>C</i><sub>NS</sub>) compartments, and the blood–brain unidirectional clearance (<i>K</i><sub>1</sub>), rate constant for clearance back to circulation (<i>k</i><sub>2</sub>), and the relevant association and dissociation rate constants (<i>k</i><sub>3</sub><i>–k</i><sub>6</sub>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Images of a human PET/CT-Scanner (Discovery PET/CT 610; GE Healthcare) and a preclinical μPET/MRI-Scanner (nanoScanPM; Mediso Medical Imaging Systems).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structures of the dopamine and serotonin receptor antagonists <i>N</i>-[<sup>11</sup>C]methyl-spiperone (left), <i>N</i>-(2-[<sup>18</sup>F]fluoroethyl)-spiperone (middle), and <i>N</i>-(3-[<sup>18</sup>F]fluoropropyl)-spiperone (right).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Synthesis of 2-[<sup>18</sup>F]fluoroethyltosylate (<b>2</b>) and subsequent labeling step using this secondary labeling precursor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Synthesis of the GABA uptake inhibitor <b>6</b> via <sup>18</sup>F-direct fluorination of <b>4</b> in a five-step reaction sequence.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Production pathways for the synthesis of aliphatic (upper row) and aromatic (lower row) <sup>18</sup>F-labeled trifluoromethyl moieties.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Labeling reaction and metabolization of [<sup>11</sup>C]volinanserin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Structures of the lead compounds for the diagnosis of Alzheimer’s disease and the corresponding <sup>18</sup>F-fluorinated tracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Graphical representation of new molecular entities developed versus research and development (R&D) expenditure of the pharmaceutical industry during the past 20 years.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Diagrammatic representation of the critical path initiative for drug development, showing the typical time span for each development phase and percentage chance that a drug candidate in that phase has of achieving final approval.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Determination of pharmacokinetics and pharmacodynamics via direct or indirect measurement. Labeling for the direct method is mainly performed using <sup>11</sup>C-carbon, but <sup>18</sup>F-fluorine may be preferred if the molecule contains fluorine. For indirect methods, the radionuclide used depends on the molecular structure of the established tracer, which usually entails <sup>11</sup>C- or <sup>18</sup>F-labeling, although radionuclides such as <sup>76</sup>Br or <sup>124</sup>I are occasionally used.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Reduced [<sup>18</sup>F]desmethoxyfallypride binding at dopamine D<sub>2/3</sub> receptors due to increasing receptor occupancy level by amisulpride. The image shows tracer binding under drug-free conditions (0 mg/day) and under stable daily doses of 400 and 1000 mg of amisulpride, respectively. The normally high binding (indicated by red) of the radiotracer in striatum, where D<sub>2/3</sub> receptors are most abundant, is 80% blocked at very high doses of amisulpride. The 80% threshold is considered to be relevant to the emergence of extrapyramidal side effects of AP treatment.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Metabolic pathways of glucose and 2-[<sup>18</sup>F]FDG (GLUT, glucose transporter; HK, hexokinase).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Structures of 2-[<sup>18</sup>F]FDG and selegiline.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Synthesis of [<sup>11</sup>C]flumazenil and [<sup>18</sup>F]flumazenil, via <sup>11</sup>C-methylation of the desmethyl precursor <b>8</b> and direct nucleophilic <sup>18</sup>F-fluorination of the nitro-functionalized precursor <b>9</b>, respectively. The asterisks indicate the potential labeling positions.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Structures of the <sup>11</sup>C-labeled NK1 receptor radiotracers [<sup>11</sup>C]GR203040 and [<sup>11</sup>C]GR205171.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Structures of the 5-HT<sub>2A</sub> receptor antagonist pruvanserin and the <sup>18</sup>F-labeled 5-HT<sub>2A</sub> radiotracer [<sup>18</sup>F]setoperone.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. 5-HT<sub>2A</sub> receptor occupancy in the frontal cortex (mean 6 SD), expressed in percent decrease in <i>BP<sub>ND</sub></i> of <i>N</i>-[<sup>11</sup>C]methylspiperone from baseline (left <i>y</i> axis, represented by circles), and plasma concentrations for 10 mg (black) and 20 mg (white) oral doses of volinanserin (right <i>y</i> axis, represented by squares).<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Structure of [<sup>11</sup>C]WAY-100,635, indicating the possible labeling positions by an asterik ([carbonyl-<sup>11</sup>C]WAY-100,635 and [<i>O</i>-methyl-<sup>11</sup>C]WAY-100,635) causing different metabolic pathways in rats and humans.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Diagrammatic representation of a striatal dopaminergic synapse, showing relevant steps of dopaminergic neurotransmission: (1) presynaptic <span class="smallcaps smallerCapital">l</span>-Dopa uptake and decarboxylation, (2) vesicular monoamine uptake, (3) oxidative deamination of dopamine by the MAO, (4) presynaptic dopamine transporter binding, and (5) postsynaptic dopamine receptor binding; the corresponding most prominent radiotracers for visualizing the individual biological targets are also shown.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Association between steepness of D<sub>2</sub> receptor binding characteristics as well as preferential extrastriatal binding with respect to the drug’s affinity at D<sub>2</sub> receptors. Occupancy curves for striatum (blue) and temporal cortex (red) are illustrated for three antipsychotics: clozapine<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> (low affinity), amisulpride<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> (moderate affinity), and aripiprazole<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> (high affinity) using [<sup>18</sup>F]fallypride. The green bar depicts the desired 60–80% occupancy range.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/medium/jm-2014-001858_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Structures of bitopertin and the <sup>11</sup>C- and <sup>18</sup>F-labeled PET tracers [<sup>11</sup>C]GSK931145 and [<sup>18</sup>F]MK-6577 for visualization of GlyT1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-22/jm5001858/20141120/images/large/jm-2014-001858_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5001858&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i50">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15753" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15753" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 161 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Phelps, M. E.</span><span> </span><span class="NLM_article-title">Positron emission tomography provides molecular imaging of biological processes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">9226</span><span class="NLM_x">–</span> <span class="NLM_lpage">9233</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1073%2Fpnas.97.16.9226" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10922074" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXls12ksb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=9226-9233&author=M.+E.+Phelps&title=Positron+emission+tomography+provides+molecular+imaging+of+biological+processes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography provides molecular imaging of biological processes</span></div><div class="casAuthors">Phelps, Michael E.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">9226-9233</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review with 55 refs.  Diseases are biol. processes, and mol. imaging with positron emission tomog. (PET) is sensitive to and informative of these processes.  This is illustrated by detection of biol. abnormalities in neurol. disorders with no computed tomog. or MRI anat. changes, as well as even before symptoms are expressed.  PET whole body imaging in cancer provides the means to (i) identify early disease, (ii) differentiate benign from malignant lesions, (iii) examine all organs for metastases, and (iv) det. therapeutic effectiveness.  Diagnostic accuracy of PET is 8-43% higher than conventional procedures and changes treatment in 20-40% of the patients, depending on the clin. question, in lung and colorectal cancers, melanoma, and lymphoma, with similar findings in breast, ovarian, head and neck, and renal cancers.  A microPET scanner for mice, in concert with human PET systems, provides a novel technol. for mol. imaging assays of metab. and signal transduction to gene expression, from mice to patients: e.g., PET reporter gene assays are used to trace the location and temporal level of expression of therapeutic and endogenous genes.  PET probes and drugs are being developed together-in low mass amts., as mol. imaging probes to image the function of targets without disturbing them, and in mass amts. to modify the target's function as a drug.  Mol. imaging by PET, optical technologies, magnetic resonance imaging, single photon emission tomog., and other technologies are assisting in moving research findings from in vitro biol. to in vivo integrative mammalian biol. of disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmqGEDEVXsm7Vg90H21EOLACvtfcHk0lir-PsQo5m4ig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXls12ksb8%253D&md5=626fe877fe63468137626fd9f3744558</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.16.9226&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.16.9226%26sid%3Dliteratum%253Aachs%26aulast%3DPhelps%26aufirst%3DM.%2BE.%26atitle%3DPositron%2520emission%2520tomography%2520provides%2520molecular%2520imaging%2520of%2520biological%2520processes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2000%26volume%3D97%26spage%3D9226%26epage%3D9233" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Rahmim, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zaidi, H.</span><span> </span><span class="NLM_article-title">PET versus SPECT: strengths, limitations and challenges</span> <span class="citation_source-journal">Nucl. Med. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2FMNM.0b013e3282f3a515" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=18349789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD1c7ptFSqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2008&pages=193-207&author=A.+Rahmimauthor=H.+Zaidi&title=PET+versus+SPECT%3A+strengths%2C+limitations+and+challenges"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">PET versus SPECT: strengths, limitations and challenges</span></div><div class="casAuthors">Rahmim Arman; Zaidi Habib</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear medicine communications</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">193-207</span>
        ISSN:<span class="NLM_cas:issn">0143-3636</span>.
    </div><div class="casAbstract">The recent introduction of high-resolution molecular imaging technology is considered by many experts as a major breakthrough that will potentially lead to a revolutionary paradigm shift in health care and revolutionize clinical practice.  This paper intends to balance the capabilities of the two major molecular imaging modalities used in nuclear medicine, namely positron emission tomography (PET) and single photon emission computed tomography (SPECT).  The motivations are many-fold: (1) to gain a better understanding of the strengths and limitations of the two imaging modalities in the context of recent and ongoing developments in hardware and software design; (2) to emphasize that certain issues, historically and commonly thought as limitations of one technology, may now instead be viewed as challenges that can be addressed; (3) to point out that current state of the art PET and SPECT scanners can (greatly) benefit from improvements in innovative image reconstruction algorithms; and (4) to identify important areas of research in PET and SPECT imaging that will be instrumental to further improvements in the two modalities.  Both technologies are poised to advance molecular imaging and have a direct impact on clinical and research practice to influence the future of molecular medicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSduSpNz8K1GresJRIHUP1ofW6udTcc2eZ2H04Rdc_3Mrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c7ptFSqsA%253D%253D&md5=514250c2c02cbf69bb9a73b2c068aae3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1097%2FMNM.0b013e3282f3a515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FMNM.0b013e3282f3a515%26sid%3Dliteratum%253Aachs%26aulast%3DRahmim%26aufirst%3DA.%26aulast%3DZaidi%26aufirst%3DH.%26atitle%3DPET%2520versus%2520SPECT%253A%2520strengths%252C%2520limitations%2520and%2520challenges%26jtitle%3DNucl.%2520Med.%2520Commun.%26date%3D2008%26volume%3D29%26spage%3D193%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Qaim, S. M.</span><span> </span><span class="NLM_article-title">Cyclotron production of medical radionuclides</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1903</span><span class="NLM_x">–</span> <span class="NLM_lpage">1933</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-4419-0720-2_39" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1903-1933&author=S.+M.+Qaimauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0720-2_39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-0720-2_39%26sid%3Dliteratum%253Aachs%26aulast%3DQaim%26aufirst%3DS.%2BM.%26atitle%3DCyclotron%2520production%2520of%2520medical%2520radionuclides%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011%26spage%3D1903%26epage%3D1933" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span>PET Drugs—Current Good  Manufacturing Practice (CGMP); <span class="NLM_publisher-name">U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM266640.pdf" class="extLink">http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM266640.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PET+Drugs%E2%80%94Current+Good+Manufacturing+Practice+%28CGMP%29%3B+U.S.+Department+of+Health+and+Human+Services%2C+Food+and+Drug+Administration%2C+Center+for+Drug+Evaluation+and+Research%3A+Silver+Spring%2C+MD%2C+2011%3B+http%3A%2F%2Fwww.fda.gov%2Fdownloads%2FDrugs%2FGuidanceComplianceRegulatoryInformation%2FGuidances%2FUCM266640.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DPET%2520Drugs%25E2%2580%2594Current%2520Good%2520%2520Manufacturing%2520Practice%2520%2528CGMP%2529%26pub%3DU.S.%2520Department%2520of%2520Health%2520and%2520Human%2520Services%252C%2520Food%2520and%2520Drug%2520Administration%252C%2520Center%2520for%2520Drug%2520Evaluation%2520and%2520Research%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Norenberg, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VanBrocklin, H.</span><span> </span><span class="NLM_article-title">FDA cGMP requirements for PET drugs</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">16N</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=16N&author=J.+P.+Norenbergauthor=S.+Schwarzauthor=H.+VanBrocklin&title=FDA+cGMP+requirements+for+PET+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNorenberg%26aufirst%3DJ.%2BP.%26aulast%3DSchwarz%26aufirst%3DS.%26aulast%3DVanBrocklin%26aufirst%3DH.%26atitle%3DFDA%2520cGMP%2520requirements%2520for%2520PET%2520drugs%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D16N" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Ache, H. J.</span><span> </span><span class="NLM_article-title">Chemistry of the positron and of positronium</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1972</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">179</span><span class="NLM_x">–</span> <span class="NLM_lpage">199</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1972&pages=179-199&author=H.+J.+Ache&title=Chemistry+of+the+positron+and+of+positronium"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAche%26aufirst%3DH.%2BJ.%26atitle%3DChemistry%2520of%2520the%2520positron%2520and%2520of%2520positronium%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D1972%26volume%3D11%26spage%3D179%26epage%3D199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Watabe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsumoto, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, H.</span><span> </span><span class="NLM_article-title">Performance of list mode data acquisition with ECAT EXACT HR and ECAT EXACT HR positron emission scanners</span> <span class="citation_source-journal">Ann. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">194</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2FBF03027429" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16715949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD283os1Cqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2006&pages=189-194&author=H.+Watabeauthor=K.+Matsumotoauthor=M.+Sendaauthor=H.+Iida&title=Performance+of+list+mode+data+acquisition+with+ECAT+EXACT+HR+and+ECAT+EXACT+HR+positron+emission+scanners"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Performance of list mode data acquisition with ECAT EXACT HR and ECAT EXACT HR+ positron emission scanners</span></div><div class="casAuthors">Watabe Hiroshi; Matsumoto Keiichi; Senda Michio; Iida Hidehiro</div><div class="citationInfo"><span class="NLM_cas:title">Annals of nuclear medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-94</span>
        ISSN:<span class="NLM_cas:issn">0914-7187</span>.
    </div><div class="casAbstract">Recently, list mode (event-by-event) data acquisition with positron emission tomography (PET) has been widely noticed because list mode acquisition is superior to conventional frame mode data acquisition in terms of (1) higher efficiency of data storage, (2) higher temporal resolution, and (3) higher flexibility of data manipulation.  The aim of this study is to investigate the performance of list mode data acquisition with ECAT EXACT HR and HR+ PET scanners (CTI PET Systems) and its feasibility in clinical applications.  A cylindrical phantom (16 cm in diameter and length) filled with a 11C solution for the HR and a 15O solution for the HR+ was scanned several times by varying the radioactivity concentration with the list mode and frame mode acquisitions.  The scans were also carried out with a septa (2D mode) and without a septa (3D mode) in order to evaluate the effect of the interplane septa on the quality of the list mode data.  The acquired list mode data were sorted into a sinogram and reconstructed using a filtered back-projection algorithm.  The count rate performance of the list mode data was comparable to that of the frame mode data.  However, the list mode acquisition could not be performed when the radioactivity concentration in the field-of-view was high (exceeding 24 kBq/ml for the 3D mode) due to a lack of sufficient transfer speed for sending data from the memory to hard disk.  In order to estimate the pixel noise in a reconstructed image, ten replicated data sets were generated from one list mode data.  The reconstructed images with the 3D mode had a signal-to-noise ratio that was more than 60% better than that of the image with the 2D mode.  The file size of the generated list mode data was also evaluated.  In the case of ECAT EXACT HR+ with the 3D list mode, the list mode data with a generated file size of 2.31 Mbytes/ s were generated for 37 MBq injections.  Our results suggest that careful attention must be paid to the protocol of the list mode data acquisition in order to obtain the highest performance of the PET scanner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS_-rk2FbzBdFVwdslNBF-tfW6udTcc2eZgug3SOcMYEbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD283os1Cqsg%253D%253D&md5=62c3e6bc6e8675dc93d99ed3c54a2a2f</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2FBF03027429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF03027429%26sid%3Dliteratum%253Aachs%26aulast%3DWatabe%26aufirst%3DH.%26aulast%3DMatsumoto%26aufirst%3DK.%26aulast%3DSenda%26aufirst%3DM.%26aulast%3DIida%26aufirst%3DH.%26atitle%3DPerformance%2520of%2520list%2520mode%2520data%2520acquisition%2520with%2520ECAT%2520EXACT%2520HR%2520and%2520ECAT%2520EXACT%2520HR%2520positron%2520emission%2520scanners%26jtitle%3DAnn.%2520Nucl.%2520Med.%26date%3D2006%26volume%3D20%26spage%3D189%26epage%3D194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Gallagher, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fowler, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutterson, N. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacGregor, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolf, A. P.</span><span> </span><span class="NLM_article-title">Metabolic trapping as a principle of radiopharmaceutical design: Some factors responsible for the biodistribution of [<sup>18</sup>F] 2-deoxy-2-fluoro-<span class="smallcaps smallerCapital">d</span>-glucose</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1978</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1154</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1978&pages=1154-1161&author=B.+M.+Gallagherauthor=J.+S.+Fowlerauthor=N.+I.+Guttersonauthor=R.+R.+MacGregorauthor=C.+W.+Wanauthor=A.+P.+Wolf&title=Metabolic+trapping+as+a+principle+of+radiopharmaceutical+design%3A+Some+factors+responsible+for+the+biodistribution+of+%5B18F%5D+2-deoxy-2-fluoro-d-glucose"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGallagher%26aufirst%3DB.%2BM.%26aulast%3DFowler%26aufirst%3DJ.%2BS.%26aulast%3DGutterson%26aufirst%3DN.%2BI.%26aulast%3DMacGregor%26aufirst%3DR.%2BR.%26aulast%3DWan%26aufirst%3DC.%2BW.%26aulast%3DWolf%26aufirst%3DA.%2BP.%26atitle%3DMetabolic%2520trapping%2520as%2520a%2520principle%2520of%2520radiopharmaceutical%2520design%253A%2520Some%2520factors%2520responsible%2520for%2520the%2520biodistribution%2520of%2520%255B18F%255D%25202-deoxy-2-fluoro-d-glucose%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D1978%26volume%3D19%26spage%3D1154%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Reig, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gispert, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pascau, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanchez-Gonzalez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Barreno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Desco, M.</span><span> </span><span class="NLM_article-title">Impact of ventricular enlargement on the measurement of metabolic activity in spatially normalized PET</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">758</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2007&pages=748-758&author=S.+Reigauthor=M.+Penedoauthor=J.+D.+Gispertauthor=J.+Pascauauthor=J.+Sanchez-Gonzalezauthor=P.+Garcia-Barrenoauthor=M.+Desco&title=Impact+of+ventricular+enlargement+on+the+measurement+of+metabolic+activity+in+spatially+normalized+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DReig%26aufirst%3DS.%26aulast%3DPenedo%26aufirst%3DM.%26aulast%3DGispert%26aufirst%3DJ.%2BD.%26aulast%3DPascau%26aufirst%3DJ.%26aulast%3DSanchez-Gonzalez%26aufirst%3DJ.%26aulast%3DGarcia-Barreno%26aufirst%3DP.%26aulast%3DDesco%26aufirst%3DM.%26atitle%3DImpact%2520of%2520ventricular%2520enlargement%2520on%2520the%2520measurement%2520of%2520metabolic%2520activity%2520in%2520spatially%2520normalized%2520PET%26jtitle%3DNeuroImage%26date%3D2007%26volume%3D35%26spage%3D748%26epage%3D758" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Garnett, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Firnau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahmias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirakal, R.</span><span> </span><span class="NLM_article-title">Striatal dopamine metabolism in living monkeys examined by positron emission tomography</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">169</span><span class="NLM_x">–</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0006-8993%2883%2991187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=6418330" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL2cXhvVemug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1983&pages=169-171&author=E.+S.+Garnettauthor=G.+Firnauauthor=C.+Nahmiasauthor=R.+Chirakal&title=Striatal+dopamine+metabolism+in+living+monkeys+examined+by+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal dopamine metabolism in living monkeys examined by positron emission tomography</span></div><div class="casAuthors">Garnett, Stephen; Firnau, Gunter; Nahmias, Claude; Chirakal, Raman</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">169-71</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">Positron emission tomog., using the dopa analog [18F]6-fluoro-L-dopa, was used to depict the neostriatum in living monkeys.  The amt. of 18F that accumulated preferentially in the striatum could be augmented by a peripheral decarboxylase inhibitor.  Striatal 18F could also be discharged with reserpine.  This is the 1st time that the regional distribution of a neurotransmitter has been demonstrated in monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaUqU57b1dsLVg90H21EOLACvtfcHk0lhE7jPxPR5hGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhvVemug%253D%253D&md5=831f99f6a5652bc09e516d8254f2d249</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2883%2991187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252883%252991187-3%26sid%3Dliteratum%253Aachs%26aulast%3DGarnett%26aufirst%3DE.%2BS.%26aulast%3DFirnau%26aufirst%3DG.%26aulast%3DNahmias%26aufirst%3DC.%26aulast%3DChirakal%26aufirst%3DR.%26atitle%3DStriatal%2520dopamine%2520metabolism%2520in%2520living%2520monkeys%2520examined%2520by%2520positron%2520emission%2520tomography%26jtitle%3DBrain%2520Res.%26date%3D1983%26volume%3D280%26spage%3D169%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches</span> <span class="citation_source-journal">Neuroscientist</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">–</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=635-650&author=Y.+Kumakuraauthor=P.+Cumming&title=PET+studies+of+cerebral+levodopa+metabolism%3A+a+review+of+clinical+findings+and+modeling+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DPET%2520studies%2520of%2520cerebral%2520levodopa%2520metabolism%253A%2520a%2520review%2520of%2520clinical%2520findings%2520and%2520modeling%2520approaches%26jtitle%3DNeuroscientist%26date%3D2009%26volume%3D15%26spage%3D635%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Innis, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunningham, V. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delforge, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujita, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichise, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iida, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ito, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koeppe, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knudsen, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knuuti, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Logan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maguire, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parsey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votaw, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carson, R. E.</span><span> </span><span class="NLM_article-title">Consensus nomenclature for in vivo imaging of reversibly binding radioligands</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">1533</span><span class="NLM_x">–</span> <span class="NLM_lpage">1539</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fsj.jcbfm.9600493" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2009&pages=1533-1539&author=R.+B.+Innisauthor=V.+J.+Cunninghamauthor=J.+Delforgeauthor=M.+Fujitaauthor=A.+Gjeddeauthor=R.+N.+Gunnauthor=J.+Holdenauthor=S.+Houleauthor=S.+C.+Huangauthor=M.+Ichiseauthor=H.+Iidaauthor=H.+Itoauthor=Y.+Kimuraauthor=R.+A.+Koeppeauthor=G.+M.+Knudsenauthor=J.+Knuutiauthor=A.+A.+Lammertsmaauthor=M.+Laruelleauthor=J.+Loganauthor=R.+P.+Maguireauthor=M.+A.+Mintunauthor=E.+D.+Morrisauthor=R.+Parseyauthor=J.+C.+Priceauthor=M.+Slifsteinauthor=V.+Sossiauthor=T.+Suharaauthor=J.+R.+Votawauthor=D.+F.+Wongauthor=R.+E.+Carson&title=Consensus+nomenclature+for+in+vivo+imaging+of+reversibly+binding+radioligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600493%26sid%3Dliteratum%253Aachs%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DCunningham%26aufirst%3DV.%2BJ.%26aulast%3DDelforge%26aufirst%3DJ.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DHolden%26aufirst%3DJ.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DS.%2BC.%26aulast%3DIchise%26aufirst%3DM.%26aulast%3DIida%26aufirst%3DH.%26aulast%3DIto%26aufirst%3DH.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DKoeppe%26aufirst%3DR.%2BA.%26aulast%3DKnudsen%26aufirst%3DG.%2BM.%26aulast%3DKnuuti%26aufirst%3DJ.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DLogan%26aufirst%3DJ.%26aulast%3DMaguire%26aufirst%3DR.%2BP.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26aulast%3DMorris%26aufirst%3DE.%2BD.%26aulast%3DParsey%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DVotaw%26aufirst%3DJ.%2BR.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26atitle%3DConsensus%2520nomenclature%2520for%2520in%2520vivo%2520imaging%2520of%2520reversibly%2520binding%2520radioligands%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2009%26volume%3D27%26spage%3D1533%26epage%3D1539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Griffeth, L. K.</span><span> </span><span class="NLM_article-title">Use of PET/CT scanning in cancer patients: technical and practical considerations</span> <span class="citation_source-journal">Proc. (Bayl. Univ. Med. Cent.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">–</span> <span class="NLM_lpage">330</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16252023" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2MrnsVeksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2005&pages=321-330&author=L.+K.+Griffeth&title=Use+of+PET%2FCT+scanning+in+cancer+patients%3A+technical+and+practical+considerations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Use of PET/CT scanning in cancer patients: technical and practical considerations</span></div><div class="casAuthors">Griffeth Landis K</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings (Baylor University. Medical Center)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">321-30</span>
        ISSN:<span class="NLM_cas:issn">0899-8280</span>.
    </div><div class="casAbstract">This overview of the oncologic applications of positron emission tomography (PET) focuses on the technical aspects and clinical applications of a newer technique: the combination of a PET scanner and a computed tomography (CT) scanner in a single (PET/CT) device.  Examples illustrate how PET/CT contributes to patient care and improves upon the previous state-of-the-art method of comparing a PET scan with a separate CT scan.  Finally, the author presents some of the results from studies of PET/CT imaging that are beginning to appear in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTLHmLk27e9DZPq5LRczm8ffW6udTcc2ebk1RjYZFFn7bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2MrnsVeksw%253D%253D&md5=e6572567e1b0839a035220b0ed95820b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGriffeth%26aufirst%3DL.%2BK.%26atitle%3DUse%2520of%2520PET%252FCT%2520scanning%2520in%2520cancer%2520patients%253A%2520technical%2520and%2520practical%2520considerations%26jtitle%3DProc.%2520%2528Bayl.%2520Univ.%2520Med.%2520Cent.%2529%26date%3D2005%26volume%3D18%26spage%3D321%26epage%3D330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Catana, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drzezga, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiss, W.-D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosen, B. R.</span><span> </span><span class="NLM_article-title">PET/MRI for neurologic applications</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1916</span><span class="NLM_x">–</span> <span class="NLM_lpage">1925</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2012&pages=1916-1925&author=C.+Catanaauthor=A.+Drzezgaauthor=W.-D.+Heissauthor=B.+R.+Rosen&title=PET%2FMRI+for+neurologic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCatana%26aufirst%3DC.%26aulast%3DDrzezga%26aufirst%3DA.%26aulast%3DHeiss%26aufirst%3DW.-D.%26aulast%3DRosen%26aufirst%3DB.%2BR.%26atitle%3DPET%252FMRI%2520for%2520neurologic%2520applications%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D53%26spage%3D1916%26epage%3D1925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Rösch, F.</span><span> </span><span class="NLM_article-title">Radiochemistry and radiopharmaceutical chemistry in life sciences</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>, <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=F.+R%C3%B6schauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26atitle%3DRadiochemistry%2520and%2520radiopharmaceutical%2520chemistry%2520in%2520life%2520sciences%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Saha, G. B.</span> <span class="citation_source-book">Basics of PET Imaging</span>; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=G.+B.+Saha&title=Basics+of+PET+Imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSaha%26aufirst%3DG.%2BB.%26btitle%3DBasics%2520of%2520PET%2520Imaging%26pub%3DSpringer%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Virdee, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caprioli, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jupp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fryer, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalley, J. W.</span><span> </span><span class="NLM_article-title">Applications of positron emission tomography in animal models of neurological and neuropsychiatric disorders</span> <span class="citation_source-journal">Neurosci. Biobehav. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">1188</span><span class="NLM_x">–</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2012&pages=1188-1216&author=K.+Virdeeauthor=P.+Cummingauthor=D.+Caprioliauthor=B.+Juppauthor=A.+Romingerauthor=F.+I.+Aigbirhioauthor=T.+D.+Fryerauthor=P.+J.+Rissauthor=J.+W.+Dalley&title=Applications+of+positron+emission+tomography+in+animal+models+of+neurological+and+neuropsychiatric+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVirdee%26aufirst%3DK.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DCaprioli%26aufirst%3DD.%26aulast%3DJupp%26aufirst%3DB.%26aulast%3DRominger%26aufirst%3DA.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26aulast%3DFryer%26aufirst%3DT.%2BD.%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DDalley%26aufirst%3DJ.%2BW.%26atitle%3DApplications%2520of%2520positron%2520emission%2520tomography%2520in%2520animal%2520models%2520of%2520neurological%2520and%2520neuropsychiatric%2520disorders%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2012%26volume%3D36%26spage%3D1188%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Frankle, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Talbot, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span> </span><span class="NLM_article-title">Neuroreceptor imaging in psychiatry: theory and applications</span> <span class="citation_source-journal">Neuroimaging, Part B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">385</span><span class="NLM_x">–</span> <span class="NLM_lpage">440</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2FS0074-7742%2805%2967011-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=385-440&author=W.+G.+Frankleauthor=M.+Slifsteinauthor=P.+S.+Talbotauthor=M.+Laruelle&title=Neuroreceptor+imaging+in+psychiatry%3A+theory+and+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2FS0074-7742%2805%2967011-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0074-7742%252805%252967011-0%26sid%3Dliteratum%253Aachs%26aulast%3DFrankle%26aufirst%3DW.%2BG.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DTalbot%26aufirst%3DP.%2BS.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DNeuroreceptor%2520imaging%2520in%2520psychiatry%253A%2520theory%2520and%2520applications%26jtitle%3DNeuroimaging%252C%2520Part%2520B%26date%3D2005%26volume%3D67%26spage%3D385%26epage%3D440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Gründer, G.</span> <span class="citation_source-book">Molecular Imaging in the Clinical Neurosciences</span>; <span class="NLM_publisher-name">Humana Press</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-61779-989-1" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=G.+Gr%C3%BCnder&title=Molecular+Imaging+in+the+Clinical+Neurosciences"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1007%2F978-1-61779-989-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-61779-989-1%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26btitle%3DMolecular%2520Imaging%2520in%2520the%2520Clinical%2520Neurosciences%26pub%3DHumana%2520Press%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Fischer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmid, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thunemann, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, F. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judenhofer, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannheim, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reischl, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichler, B. J.</span><span> </span><span class="NLM_article-title">Noninvasive nuclear imaging enables the in vivo quantification of striatal dopamine receptor expression and raclopride affinity in mice</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">1133</span><span class="NLM_x">–</span> <span class="NLM_lpage">1141</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=1133-1141&author=K.+Fischerauthor=V.+Sossiauthor=A.+Schmidauthor=M.+Thunemannauthor=F.+C.+Maierauthor=M.+S.+Judenhoferauthor=J.+G.+Mannheimauthor=G.+Reischlauthor=B.+J.+Pichler&title=Noninvasive+nuclear+imaging+enables+the+in+vivo+quantification+of+striatal+dopamine+receptor+expression+and+raclopride+affinity+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DSchmid%26aufirst%3DA.%26aulast%3DThunemann%26aufirst%3DM.%26aulast%3DMaier%26aufirst%3DF.%2BC.%26aulast%3DJudenhofer%26aufirst%3DM.%2BS.%26aulast%3DMannheim%26aufirst%3DJ.%2BG.%26aulast%3DReischl%26aufirst%3DG.%26aulast%3DPichler%26aufirst%3DB.%2BJ.%26atitle%3DNoninvasive%2520nuclear%2520imaging%2520enables%2520the%2520in%2520vivo%2520quantification%2520of%2520striatal%2520dopamine%2520receptor%2520expression%2520and%2520raclopride%2520affinity%2520in%2520mice%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D1133%26epage%3D1141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T.</span><span> </span><span class="NLM_article-title">Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">173</span><span class="NLM_x">–</span> <span class="NLM_lpage">176</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs002590050211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=9473266" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK1cXhtVWisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1998&pages=173-176&author=S.+P.+Humeauthor=R.+N.+Gunnauthor=T.+Jones&title=Pharmacological+constraints+associated+with+positron+emission+tomographic+scanning+of+small+laboratory+animals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological constraints associated with positron emission tomographic scanning of small laboratory animals</span></div><div class="casAuthors">Hume, Susan P.; Gunn, Roger N.; Jones, Terry</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">173-176</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">With the stated aim of scanning small regions of interest in mice, several high-resoln. positron emission tomog. (PET) systems are presently under development.  Some, however, have low sensitivity and require high doses of radioactivity to achieve count statistics adequate to reconstruct small vols.  Using in vivo dissocn. consts. for three carbon-11 labeled ligands previously measured in rat brain, the present paper utilises simple satn. kinetics to est. the limits on radioactivity and specific activity, to minimize the degree of receptor occupancy and achieve maximal specific binding of the radioligand.  The extent of the problem is exemplified by considering a high-affinity ligand (dissocn. const. in vitro ∼0.1 nM; in vivo ∼5 nmol/kg i.v. injected dose), where routinely produced levels of specific activity (∼100 MBq/nmol) would limit the activity injected into mice to ∼0.1 MBq for a 1 receptor occupancy.  If, as is feasible, the new generation of high resoln. PET systems requires an injected activity >10 MBq, then a >100-fold increase in specific activity would be needed for tracer kinetics to hold.  The paper highlights the need to consider realistically achievable goals if high-resoln. PET is to be accepted as a viable methodol. to acquire pharmacol. and physiol. accurate ligand-receptor binding data in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbaBeWHthNKLVg90H21EOLACvtfcHk0lhDwGNKTokIVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXhtVWisL4%253D&md5=93ff49dc00c72a50016e7a028db9f5b6</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs002590050211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590050211%26sid%3Dliteratum%253Aachs%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DJones%26aufirst%3DT.%26atitle%3DPharmacological%2520constraints%2520associated%2520with%2520positron%2520emission%2520tomographic%2520scanning%2520of%2520small%2520laboratory%2520animals%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D1998%26volume%3D25%26spage%3D173%26epage%3D176" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Meanwell, N. A.</span><span> </span><span class="NLM_article-title">Synopsis of some recent tactical application of bioisoteres in drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">2529</span><span class="NLM_x">–</span> <span class="NLM_lpage">2591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1013693" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=2529-2591&author=N.+A.+Meanwell&title=Synopsis+of+some+recent+tactical+application+of+bioisoteres+in+drug+design"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Fjm1013693&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1013693%26sid%3Dliteratum%253Aachs%26aulast%3DMeanwell%26aufirst%3DN.%2BA.%26atitle%3DSynopsis%2520of%2520some%2520recent%2520tactical%2520application%2520of%2520bioisoteres%2520in%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D2529%26epage%3D2591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span> </span><span class="NLM_article-title">Fluorine-for-hydrogen: a strategy for radiolabeling, not a replacement</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">956</span><span class="NLM_x">–</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.nucmedbio.2013.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=24074943" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFent7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=956-958&author=M.+R.+Kilbourn&title=Fluorine-for-hydrogen%3A+a+strategy+for+radiolabeling%2C+not+a+replacement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-for-hydrogen: a strategy for radiolabeling, not a replacement</span></div><div class="casAuthors">Kilbourn, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">956-958</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  This article discusses the development of fluorine-for-hydrogen substitutions using fluorinated radiotracer provide useful biochem. information compared to the parent, hydrogen-contg. radiotracer.  The fluorine-for-hydrogen substitutions actually improve in vivo characteristics of the radiotracer for radiotracers targeting high-affinity binding sites on proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7sIy0u8sOFrVg90H21EOLACvtfcHk0lhDwGNKTokIVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFent7vL&md5=4c5969b83b5a74f49128f3575aea4326</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2013.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2013.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26atitle%3DFluorine-for-hydrogen%253A%2520a%2520strategy%2520for%2520radiolabeling%252C%2520not%2520a%2520replacement%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2013%26volume%3D40%26spage%3D956%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Hagglund, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aquilonius, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eckernas, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartvig, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundquist, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gullberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langström, B.</span><span> </span><span class="NLM_article-title">Dopamine receptor properties in Parkinson’s disease and Huntington’s chorea evaluated by positron emission tomography using <sup>11</sup>C-N-methyl-spiperone</span> <span class="citation_source-journal">Acta Neurol. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">75</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">94</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1600-0404.1987.tb07900.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2953165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL2s3gvV2nug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=1987&pages=87-94&author=J.+Hagglundauthor=S.+M.+Aquiloniusauthor=S.+A.+Eckernasauthor=P.+Hartvigauthor=H.+Lundquistauthor=P.+Gullbergauthor=B.+Langstr%C3%B6m&title=Dopamine+receptor+properties+in+Parkinson%E2%80%99s+disease+and+Huntington%E2%80%99s+chorea+evaluated+by+positron+emission+tomography+using+11C-N-methyl-spiperone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine receptor properties in Parkinson's disease and Huntington's chorea evaluated by positron emission tomography using 11C-N-methyl-spiperone</span></div><div class="casAuthors">Hagglund J; Aquilonius S M; Eckernas S A; Hartvig P; Lundquist H; Gullberg P; Langstrom B</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurologica Scandinavica</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">75</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">87-94</span>
        ISSN:<span class="NLM_cas:issn">0001-6314</span>.
    </div><div class="casAbstract">Dopaminergic receptor properties in the striatum of patients with Parkinson's disease (PD) and Huntington's chorea (HD) were studied by positron emission tomography (PET), using 11C-N-methyl-spiperone as a dopamine D2 receptor ligand.  The time-dependent regional radioactive uptake in the caudate nucleus and the putamen was measured and fitted to a 3-compartment pharmacokinetic model.  The rate constant k3 for specific binding to the receptor compartment in the striatum was determined in relation to the binding in regions with a low density of specific binding sites, such as the cerebellum and the frontal cortex . k3, which is a measure of the receptor density, was reduced in one patient with HD but less affected in PD in comparison with healthy controls.  The pattern of k3 values calculated from the 6 PD patients is discussed in relation to any side-to-side differences in dopamine receptor densities in hemiparkinsonism and to possible "hypersensitivity" of dopamine receptors in the early stage of the disease and down-regulation in more advanced disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxnTGIhuBxXrHHuJhbyicZfW6udTcc2eYT3PFZvE0NxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2s3gvV2nug%253D%253D&md5=57fb827ab6f60a16b32ba228aac5aaef</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0404.1987.tb07900.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0404.1987.tb07900.x%26sid%3Dliteratum%253Aachs%26aulast%3DHagglund%26aufirst%3DJ.%26aulast%3DAquilonius%26aufirst%3DS.%2BM.%26aulast%3DEckernas%26aufirst%3DS.%2BA.%26aulast%3DHartvig%26aufirst%3DP.%26aulast%3DLundquist%26aufirst%3DH.%26aulast%3DGullberg%26aufirst%3DP.%26aulast%3DLangstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DDopamine%2520receptor%2520properties%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520Huntington%25E2%2580%2599s%2520chorea%2520evaluated%2520by%2520positron%2520emission%2520tomography%2520using%252011C-N-methyl-spiperone%26jtitle%3DActa%2520Neurol.%2520Scand.%26date%3D1987%26volume%3D75%26spage%3D87%26epage%3D94" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Welch, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katzenellenbogen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathias, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brodack, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, K. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chi, D. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dence, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilboum, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perlmutter, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raichle, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">TerPogossian, M. M.</span><span> </span><span class="NLM_article-title">N-(3-[<sup>18</sup>F]Fluoropropyl)-spiperone: the preferred <sup>18</sup>F labeled spiperone analog for positron emission tomographic studies of the dopamine receptor</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=83-97&author=M.+J.+Welchauthor=J.+A.+Katzenellenbogenauthor=C.+J.+Mathiasauthor=J.+W.+Brodackauthor=K.+E.+Carlsonauthor=D.+Y.+Chiauthor=C.+S.+Denceauthor=M.+R.+Kilboumauthor=J.+S.+Perlmutterauthor=M.+E.+Raichleauthor=M.+M.+TerPogossian&title=N-%283-%5B18F%5DFluoropropyl%29-spiperone%3A+the+preferred+18F+labeled+spiperone+analog+for+positron+emission+tomographic+studies+of+the+dopamine+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26aulast%3DKatzenellenbogen%26aufirst%3DJ.%2BA.%26aulast%3DMathias%26aufirst%3DC.%2BJ.%26aulast%3DBrodack%26aufirst%3DJ.%2BW.%26aulast%3DCarlson%26aufirst%3DK.%2BE.%26aulast%3DChi%26aufirst%3DD.%2BY.%26aulast%3DDence%26aufirst%3DC.%2BS.%26aulast%3DKilboum%26aufirst%3DM.%2BR.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DRaichle%26aufirst%3DM.%2BE.%26aulast%3DTerPogossian%26aufirst%3DM.%2BM.%26atitle%3DN-%25283-%255B18F%255DFluoropropyl%2529-spiperone%253A%2520the%2520preferred%252018F%2520labeled%2520spiperone%2520analog%2520for%2520positron%2520emission%2520tomographic%2520studies%2520of%2520the%2520dopamine%2520receptor%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1998%26volume%3D15%26spage%3D83%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Kilbourn, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavia, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gregor, V. E.</span><span> </span><span class="NLM_article-title">Synthesis of fluorine-18 labeled GABA uptake inhibitors</span> <span class="citation_source-journal">Int. J. Radiat. Appl. Instrum., Part A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">823</span><span class="NLM_x">–</span> <span class="NLM_lpage">828</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0883-2889%2890%2990059-P" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2176190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK3M%252Fpt12hsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1990&pages=823-828&author=M.+R.+Kilbournauthor=M.+R.+Paviaauthor=V.+E.+Gregor&title=Synthesis+of+fluorine-18+labeled+GABA+uptake+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of fluorine-18 labeled GABA uptake inhibitors</span></div><div class="casAuthors">Kilbourn M R; Pavia M R; Gregor V E</div><div class="citationInfo"><span class="NLM_cas:title">International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">823-8</span>
        ISSN:<span class="NLM_cas:issn">0883-2889</span>.
    </div><div class="casAbstract">The first syntheses of fluorine-18 labeled inhibitors of GABA reuptake [(R,S)-1-[2-[4-[18F]fluorophenyl]phenyl]methoxyethyl]piperidine- 3-carboxylic acid, (R,S)-1-[2-[(4-[18F]trifluoromethyl)phenyl][(4- trifluoromethyl)phenyl]-methoxyethyl]piperidine-3-carboxylic acid] are described.  These N-substituted nipecotic acid derivatives were prepared in no-carrier-added form by the condensation of the appropriately substituted [18F]benzhydryl chlorides (prepared in three steps from [18F]fluoride ion) with N-(2-hydroxyethyl)nipecotic acid ethyl ester, followed by ester hydrolysis.  Overall radiochemical yields were 17-28% (corrected, 150 min synthesis time).  A simple new method for synthesis of a [18F]trifluoromethyl group by the nucleophilic substitution of a bromodifluoromethyl substituent has also been developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTUG33o-4GNvZHZzFRCXxVKfW6udTcc2eYT3PFZvE0NxLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M%252Fpt12hsg%253D%253D&md5=b4541a2621812cd9d629ae10a1d79824</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2F0883-2889%2890%2990059-P&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0883-2889%252890%252990059-P%26sid%3Dliteratum%253Aachs%26aulast%3DKilbourn%26aufirst%3DM.%2BR.%26aulast%3DPavia%26aufirst%3DM.%2BR.%26aulast%3DGregor%26aufirst%3DV.%2BE.%26atitle%3DSynthesis%2520of%2520fluorine-18%2520labeled%2520GABA%2520uptake%2520inhibitors%26jtitle%3DInt.%2520J.%2520Radiat.%2520Appl.%2520Instrum.%252C%2520Part%2520A%26date%3D1990%26volume%3D41%26spage%3D823%26epage%3D828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Josse, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Georges, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grégoire, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marchand-Brynaert, J.</span><span> </span><span class="NLM_article-title">Synthesis of [<sup>18</sup>F]-labeled EF3 [2-(2-nitroimidazol-1-yl)-N-(3,3,3-trifluoropropyl)-acetamide], a marker for PET detection of hypoxia</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">675</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=665-675&author=O.+Josseauthor=D.+Labarauthor=B.+Georgesauthor=V.+Gr%C3%A9goireauthor=J.+Marchand-Brynaert&title=Synthesis+of+%5B18F%5D-labeled+EF3+%5B2-%282-nitroimidazol-1-yl%29-N-%283%2C3%2C3-trifluoropropyl%29-acetamide%5D%2C+a+marker+for+PET+detection+of+hypoxia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJosse%26aufirst%3DO.%26aulast%3DLabar%26aufirst%3DD.%26aulast%3DGeorges%26aufirst%3DB.%26aulast%3DGr%25C3%25A9goire%26aufirst%3DV.%26aulast%3DMarchand-Brynaert%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520%255B18F%255D-labeled%2520EF3%2520%255B2-%25282-nitroimidazol-1-yl%2529-N-%25283%252C3%252C3-trifluoropropyl%2529-acetamide%255D%252C%2520a%2520marker%2520for%2520PET%2520detection%2520of%2520hypoxia%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D665%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Dolbier, W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiue, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachur, A. V.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure</span> <span class="citation_source-journal">Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2FS0969-8043%2800%2900102-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11144255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVKrtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2001&pages=73-80&author=W.+R.+Dolbierauthor=A.+R.+Liauthor=C.+J.+Kochauthor=C.+Y.+Shiueauthor=A.+V.+Kachur&title=%5B18F%5D-EF5%2C+a+marker+for+PET+detection+of+hypoxia%3A+synthesis+of+precursor+and+a+new+fluorination+procedure"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]-EF5, a marker for PET detection of hypoxia: synthesis of precursor and a new fluorination procedure</span></div><div class="casAuthors">Dolbier, W. R.; Li, A.-R.; Koch, C. J.; Shiue, C.-Y.; Kachur, A. V.</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">73-80</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">There is a great deal of clin. and exptl. interest in detg. tissue hypoxia using non-invasive imaging methods.  The authors have previously developed EF5, 2-(2-nitro-1[H]-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide, with both invasive and non-invasive hypoxia detection in mind.  EF5 and other 2-nitroimidazoles are used to detect hypoxia, because the rate of their bioreductive metab. is inversely dependent on oxygen partial pressure.  Such metab. leads to the formation of covalent adducts within the metabolizing cells.  Previously, the authors have described the invasive detection of these adducts by highly specific monoclonal antibodies after tissue biopsy.  In this work, the authors synthesized 18F-labeled EF5, [18F]-2-(2-nitro-1[H]-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl)acetamide, in greater than 10% yield by direct fluorination of the newly synthesized precursor 2-(2-nitro-1[H]-imidazol-1-yl)-N-(2,3,3-trifluoroallyl)acetamide by [18F]-F2 in trifluoroacetic acid.  The objective was to optimize the electrophilic fluorination of the fluorinated alkene bond with fluorine gas, a new method of 18F-labeling of polyfluorinated mols.  Previous biodistribution studies in mice have demonstrated uniform access of EF5 to all tissues with bioelimination dominated by renal excretion.  When [18F]-EF5 was injected into a rat followed by urine collection and anal., the authors found no detectable metab. to other radioactive compds.  Thus, [18F]-EF5 should be well suited for use as a non-invasive hypoxia marker with detection using positron emission tomog. (PET).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprUnx1N3heu7Vg90H21EOLACvtfcHk0lh0T5aT4Vh4Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVKrtb8%253D&md5=252b721bc6e98e72c1108e7ceacb891c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2FS0969-8043%2800%2900102-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8043%252800%252900102-0%26sid%3Dliteratum%253Aachs%26aulast%3DDolbier%26aufirst%3DW.%2BR.%26aulast%3DLi%26aufirst%3DA.%2BR.%26aulast%3DKoch%26aufirst%3DC.%2BJ.%26aulast%3DShiue%26aufirst%3DC.%2BY.%26aulast%3DKachur%26aufirst%3DA.%2BV.%26atitle%3D%255B18F%255D-EF5%252C%2520a%2520marker%2520for%2520PET%2520detection%2520of%2520hypoxia%253A%2520synthesis%2520of%2520precursor%2520and%2520a%2520new%2520fluorination%2520procedure%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2001%26volume%3D54%26spage%3D73%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Riss, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aigbirhio, F. I.</span><span> </span><span class="NLM_article-title">A simple rapid procedure for nucleophilic radiosynthesis of aliphatic [<sup>18</sup>F]trifluoromethyl groups</span> <span class="citation_source-journal">Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">11873</span><span class="NLM_x">–</span> <span class="NLM_lpage">11875</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=11873-11875&author=P.+J.+Rissauthor=F.+I.+Aigbirhio&title=A+simple+rapid+procedure+for+nucleophilic+radiosynthesis+of+aliphatic+%5B18F%5Dtrifluoromethyl+groups"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRiss%26aufirst%3DP.%2BJ.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DA%2520simple%2520rapid%2520procedure%2520for%2520nucleophilic%2520radiosynthesis%2520of%2520aliphatic%2520%255B18F%255Dtrifluoromethyl%2520groups%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D11873%26epage%3D11875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Huiban, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tredwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gouverneur, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Passchier, J.</span><span> </span><span class="NLM_article-title">A broadly applicable [<sup>18</sup>F]trifluoromethylation of aryl and heteroaryl iodides for PET imaging</span> <span class="citation_source-journal">Nat. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">941</span><span class="NLM_x">–</span> <span class="NLM_lpage">944</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fnchem.1756" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=24153372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVSht7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2013&pages=941-944&author=M.+Huibanauthor=M.+Tredwellauthor=S.+Mizutaauthor=Z.+Wanauthor=X.+Zhangauthor=T.+L.+Collierauthor=V.+Gouverneurauthor=J.+Passchier&title=A+broadly+applicable+%5B18F%5Dtrifluoromethylation+of+aryl+and+heteroaryl+iodides+for+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A broadly applicable [18F]trifluoromethylation of aryl and heteroaryl iodides for PET imaging</span></div><div class="casAuthors">Huiban, Mickael; Tredwell, Matthew; Mizuta, Satoshi; Wan, Zehong; Zhang, Xiaomin; Collier, Thomas Lee; Gouverneur, Veronique; Passchier, Jan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">941-944</span>CODEN:
                <span class="NLM_cas:coden">NCAHBB</span>;
        ISSN:<span class="NLM_cas:issn">1755-4330</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mols. labeled with the unnatural isotope fluorine-18 are used for positron emission tomog.  Currently, this mol. imaging technol. is not exploited at its full potential because many 18F-labeled probes are inaccessible or notoriously difficult to produce.  Typical challenges assocd. with 18F radiochem. are the short half-life of 18F (<2 h), the use of sub-stoichiometric amts. of 18F, relative to the precursor and other reagents, as well as the limited availability of parent 18F sources of suitable reactivity ([18F]F- and [18F]F2).  There is a high-priority demand for general methods allowing access to [18F]CF3-substituted mols. for application in pharmaceutical discovery programs.  We report the development of a process for the late-stage [18F]trifluoromethylation of (hetero)arenes from [18F]fluoride using com. available reagents and (hetero)aryl iodides.  This [18F]CuCF3-based protocol benefits from a large substrate scope and is characterized by its operational simplicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2wsZQqGFtZbVg90H21EOLACvtfcHk0lh0T5aT4Vh4Fw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVSht7fF&md5=3afb862eeb57e84a6a0c194ee7dfcb78</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fnchem.1756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchem.1756%26sid%3Dliteratum%253Aachs%26aulast%3DHuiban%26aufirst%3DM.%26aulast%3DTredwell%26aufirst%3DM.%26aulast%3DMizuta%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DCollier%26aufirst%3DT.%2BL.%26aulast%3DGouverneur%26aufirst%3DV.%26aulast%3DPasschier%26aufirst%3DJ.%26atitle%3DA%2520broadly%2520applicable%2520%255B18F%255Dtrifluoromethylation%2520of%2520aryl%2520and%2520heteroaryl%2520iodides%2520for%2520PET%2520imaging%26jtitle%3DNat.%2520Chem.%26date%3D2013%26volume%3D5%26spage%3D941%26epage%3D944" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Mille, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rominger, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Fougère, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Böning, G.</span><span> </span><span class="NLM_article-title">Compensation for cranial spilling into the cerebellum improves quantitation of striatal dopamine D<sub>2/3</sub> receptors in rats with prolonged [<sup>18</sup>F]DMFP infusions</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">–</span> <span class="NLM_lpage">713</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2012&pages=705-713&author=E.+Milleauthor=P.+Cummingauthor=A.+Romingerauthor=C.+La+Foug%C3%A8reauthor=K.+Tatschauthor=B.+W%C3%A4nglerauthor=P.+Bartensteinauthor=G.+B%C3%B6ning&title=Compensation+for+cranial+spilling+into+the+cerebellum+improves+quantitation+of+striatal+dopamine+D2%2F3+receptors+in+rats+with+prolonged+%5B18F%5DDMFP+infusions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMille%26aufirst%3DE.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DRominger%26aufirst%3DA.%26aulast%3DLa%2BFoug%25C3%25A8re%26aufirst%3DC.%26aulast%3DTatsch%26aufirst%3DK.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DB%25C3%25B6ning%26aufirst%3DG.%26atitle%3DCompensation%2520for%2520cranial%2520spilling%2520into%2520the%2520cerebellum%2520improves%2520quantitation%2520of%2520striatal%2520dopamine%2520D2%252F3%2520receptors%2520in%2520rats%2520with%2520prolonged%2520%255B18F%255DDMFP%2520infusions%26jtitle%3DSynapse%26date%3D2012%26volume%3D66%26spage%3D705%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Lundkvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nyberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carr, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, F.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]MDL 100907, a radioligand for selective imaging of 5-HT<sub>2A</sub> receptors with positron emission tomography</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">–</span> <span class="NLM_lpage">192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1996&pages=187-192&author=C.+Lundkvistauthor=C.+Halldinauthor=N.+Ginovartauthor=S.+Nybergauthor=C.+G.+Swahnauthor=A.+A.+Carrauthor=F.+Brunnerauthor=F.+Farde&title=%5B11C%5DMDL+100907%2C+a+radioligand+for+selective+imaging+of+5-HT2A+receptors+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLundkvist%26aufirst%3DC.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DNyberg%26aufirst%3DS.%26aulast%3DSwahn%26aufirst%3DC.%2BG.%26aulast%3DCarr%26aufirst%3DA.%2BA.%26aulast%3DBrunner%26aufirst%3DF.%26aulast%3DFarde%26aufirst%3DF.%26atitle%3D%255B11C%255DMDL%2520100907%252C%2520a%2520radioligand%2520for%2520selective%2520imaging%2520of%25205-HT2A%2520receptors%2520with%2520positron%2520emission%2520tomography%26jtitle%3DLife%2520Sci.%26date%3D1996%26volume%3D58%26spage%3D187%26epage%3D192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Lipinski, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominy, B. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feeney, P. J.</span><span> </span><span class="NLM_article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">26</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2FS0169-409X%2800%2900129-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11259830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2001&pages=3-26&author=C.+A.+Lipinskiauthor=F.+Lombardoauthor=B.+W.+Dominyauthor=P.+J.+Feeney&title=Experimental+and+computational+approaches+to+estimate+solubility+and+permeability+in+drug+discovery+and+development+settings"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span></div><div class="casAuthors">Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J.</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">3-26</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review with 50 refs.  Exptl. and computational approaches to est. soly. and permeability in discovery and development settings are described.  In the discovery setting 'the rule of 5' predicts that poor absorption or permeation is more likely when there are more than 5 H-bond donors, 10 H-bond acceptors, the mol. wt. (MWT) is greater than 500 and the calcd. Log P (CLogP) is greater than 5 (or MlogP >4.15).  Computational methodol. for the rule-based Moriguchi Log P (MLogP) calcn. is described.  Turbidimetric soly. measurement is described and applied to known drugs.  High throughput screening (HTS) leads tend to have higher MWT and Log P and lower turbidimetric soly. than leads in the pre-HTS era.  In the development setting, soly. calcns. focus on exact value prediction and are difficult because of polymorphism.  Recent work on linear free energy relationships and Log P approaches are critically reviewed.  Useful predictions are possible in closely related analog series when coupled with exptl. thermodn. soly. measurements.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYDqa02g16urVg90H21EOLACvtfcHk0lgQh8iLVELr4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitVOhs7o%253D&md5=c60bb89da68f051c0ee7ac4c0468a0e4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2800%2900129-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252800%252900129-0%26sid%3Dliteratum%253Aachs%26aulast%3DLipinski%26aufirst%3DC.%2BA.%26aulast%3DLombardo%26aufirst%3DF.%26aulast%3DDominy%26aufirst%3DB.%2BW.%26aulast%3DFeeney%26aufirst%3DP.%2BJ.%26atitle%3DExperimental%2520and%2520computational%2520approaches%2520to%2520estimate%2520solubility%2520and%2520permeability%2520in%2520drug%2520discovery%2520and%2520development%2520settings%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2001%26volume%3D46%26spage%3D3%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bocan, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heck, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaddan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarthy, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zasadny, K.</span><span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4568</span><span class="NLM_x">–</span> <span class="NLM_lpage">4579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lgQh8iLVELr4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Dutheil, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dauchy, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sazdovitch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cloarec, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mellottée, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bièche, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingelman-Sundberg, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flinois, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Waziers, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaune, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Declèves, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duyckaerts, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loriot, M. A.</span><span> </span><span class="NLM_article-title">Xenobiotic-metabolizing enzymes and transporters in the normal human brain: regional and cellular mapping as a basis for putative roles in cerebral function</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">–</span> <span class="NLM_lpage">174</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2009&pages=165-174&author=F.+Dutheilauthor=S.+Dauchyauthor=M.+Diryauthor=V.+Sazdovitchauthor=O.+Cloarecauthor=L.+Mellott%C3%A9eauthor=I.+Bi%C3%A8cheauthor=M.+Ingelman-Sundbergauthor=J.+P.+Flinoisauthor=I.+de+Waziersauthor=P.+Beauneauthor=X.+Decl%C3%A8vesauthor=C.+Duyckaertsauthor=M.+A.+Loriot&title=Xenobiotic-metabolizing+enzymes+and+transporters+in+the+normal+human+brain%3A+regional+and+cellular+mapping+as+a+basis+for+putative+roles+in+cerebral+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDutheil%26aufirst%3DF.%26aulast%3DDauchy%26aufirst%3DS.%26aulast%3DDiry%26aufirst%3DM.%26aulast%3DSazdovitch%26aufirst%3DV.%26aulast%3DCloarec%26aufirst%3DO.%26aulast%3DMellott%25C3%25A9e%26aufirst%3DL.%26aulast%3DBi%25C3%25A8che%26aufirst%3DI.%26aulast%3DIngelman-Sundberg%26aufirst%3DM.%26aulast%3DFlinois%26aufirst%3DJ.%2BP.%26aulast%3Dde%2BWaziers%26aufirst%3DI.%26aulast%3DBeaune%26aufirst%3DP.%26aulast%3DDecl%25C3%25A8ves%26aufirst%3DX.%26aulast%3DDuyckaerts%26aufirst%3DC.%26aulast%3DLoriot%26aufirst%3DM.%2BA.%26atitle%3DXenobiotic-metabolizing%2520enzymes%2520and%2520transporters%2520in%2520the%2520normal%2520human%2520brain%253A%2520regional%2520and%2520cellular%2520mapping%2520as%2520a%2520basis%2520for%2520putative%2520roles%2520in%2520cerebral%2520function%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2009%26volume%3D37%26spage%3D165%26epage%3D174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Bartmann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuest, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">la Fougere, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Just, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlichtiger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wängler, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pekcec, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soerensen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potschka, H.</span><span> </span><span class="NLM_article-title">Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy</span> <span class="citation_source-journal">Epilepsia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1780</span><span class="NLM_x">–</span> <span class="NLM_lpage">1790</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1780-1790&author=H.+Bartmannauthor=C.+Fuestauthor=C.+la+Fougereauthor=G.+Xiongauthor=T.+Justauthor=J.+Schlichtigerauthor=P.+Winterauthor=G.+Boningauthor=B.+W%C3%A4nglerauthor=A.+Pekcecauthor=J.+Soerensenauthor=P.+Bartensteinauthor=P.+Cummingauthor=H.+Potschka&title=Imaging+of+P-glycoprotein-mediated+pharmacoresistance+in+the+hippocampus%3A+proof-of-concept+in+a+chronic+rat+model+of+temporal+lobe+epilepsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartmann%26aufirst%3DH.%26aulast%3DFuest%26aufirst%3DC.%26aulast%3Dla%2BFougere%26aufirst%3DC.%26aulast%3DXiong%26aufirst%3DG.%26aulast%3DJust%26aufirst%3DT.%26aulast%3DSchlichtiger%26aufirst%3DJ.%26aulast%3DWinter%26aufirst%3DP.%26aulast%3DBoning%26aufirst%3DG.%26aulast%3DW%25C3%25A4ngler%26aufirst%3DB.%26aulast%3DPekcec%26aufirst%3DA.%26aulast%3DSoerensen%26aufirst%3DJ.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DPotschka%26aufirst%3DH.%26atitle%3DImaging%2520of%2520P-glycoprotein-mediated%2520pharmacoresistance%2520in%2520the%2520hippocampus%253A%2520proof-of-concept%2520in%2520a%2520chronic%2520rat%2520model%2520of%2520temporal%2520lobe%2520epilepsy%26jtitle%3DEpilepsia%26date%3D2010%26volume%3D51%26spage%3D1780%26epage%3D1790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Tournier, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valette, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peyronneau, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saba, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goutal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuhnast, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollé, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherrmann, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cisternino, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bottlaender, M.</span><span> </span><span class="NLM_article-title">Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">–</span> <span class="NLM_lpage">423</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=415-423&author=N.+Tournierauthor=H.+Valetteauthor=M.+A.+Peyronneauauthor=W.+Sabaauthor=S.+Goutalauthor=B.+Kuhnastauthor=F.+Doll%C3%A9author=J.+M.+Scherrmannauthor=S.+Cisterninoauthor=M.+Bottlaender&title=Transport+of+selected+PET+radiotracers+by+human+P-glycoprotein+%28ABCB1%29+and+breast+cancer+resistance+protein+%28ABCG2%29%3A+an+in+vitro+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTournier%26aufirst%3DN.%26aulast%3DValette%26aufirst%3DH.%26aulast%3DPeyronneau%26aufirst%3DM.%2BA.%26aulast%3DSaba%26aufirst%3DW.%26aulast%3DGoutal%26aufirst%3DS.%26aulast%3DKuhnast%26aufirst%3DB.%26aulast%3DDoll%25C3%25A9%26aufirst%3DF.%26aulast%3DScherrmann%26aufirst%3DJ.%2BM.%26aulast%3DCisternino%26aufirst%3DS.%26aulast%3DBottlaender%26aufirst%3DM.%26atitle%3DTransport%2520of%2520selected%2520PET%2520radiotracers%2520by%2520human%2520P-glycoprotein%2520%2528ABCB1%2529%2520and%2520breast%2520cancer%2520resistance%2520protein%2520%2528ABCG2%2529%253A%2520an%2520in%2520vitro%2520screening%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D415%26epage%3D423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of <sup>11</sup>C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">2740</span><span class="NLM_x">–</span> <span class="NLM_lpage">2754</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030026b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=2740-2754&author=C.+A.+Mathisauthor=Y.+Wangauthor=D.+P.+Holtauthor=G.-F.+Huangauthor=M.+L.+Debnathauthor=W.+E.+Klunk&title=Synthesis+and+evaluation+of+11C-labeled+6-substituted+2-arylbenzothiazoles+as+amyloid+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm030026b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030026b%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DHuang%26aufirst%3DG.-F.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%252011C-labeled%25206-substituted%25202-arylbenzothiazoles%2520as%2520amyloid%2520imaging%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D2740%26epage%3D2754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Klunk, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engler, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomqvist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holt, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savitcheva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estrada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ausén, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debnath, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barletta, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sandell, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koivisto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antoni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Longström, B.</span><span> </span><span class="NLM_article-title">Imaging brain amyloid in Alzheimer’s disease with Pittsburg Compound-B</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">306</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2Fana.20009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=14991808" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2004&pages=306-319&author=W.+E.+Klunkauthor=H.+Englerauthor=A.+Nordbergauthor=Y.+Wangauthor=G.+Blomqvistauthor=D.+P.+Holtauthor=M.+Bergstr%C3%B6mauthor=I.+Savitchevaauthor=G.+F.+Huangauthor=S.+Estradaauthor=B.+Aus%C3%A9nauthor=M.+L.+Debnathauthor=J.+Barlettaauthor=J.+C.+Priceauthor=J.+Sandellauthor=B.+J.+Loprestiauthor=A.+Wallauthor=P.+Koivistoauthor=G.+Antoniauthor=C.+A.+Mathisauthor=B.+Longstr%C3%B6m&title=Imaging+brain+amyloid+in+Alzheimer%E2%80%99s+disease+with+Pittsburg+Compound-B"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B</span></div><div class="casAuthors">Klunk, William E.; Engler, Henry; Nordberg, Agneta; Wang, Yanming; Blomqvist, Gunnar; Holt, Daniel P.; Bergstrom, Mats; Savitcheva, Irina; Huang, Guo-feng; Estrada, Sergio; Ausen, Birgitta; Debnath, Manik L.; Barletta, Julien; Price, Julie C.; Sandell, Johan; Lopresti, Brian J.; Wall, Anders; Koivisto, Pernilla; Antoni, Gunnar; Mathis, Chester A.; Langstrom, Bengt</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">306-319</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">This report describes the first human study of a novel amyloid-imaging positron emission tomog. (PET) tracer, termed Pittsburgh Compd.-B (PIB), in 16 patients with diagnosed mild AD and 9 controls.  Compared with controls, AD patients typically showed marked retention of PIB in areas of assocn. cortex known to contain large amts. of amyloid deposits in AD.  In the AD patient group, PIB retention was increased most prominently in frontal cortex (1.94-fold, p = 0.0001).  Large increases also were obsd. in parietal (1.71-fold, p = 0.0002), temporal (1.52-fold, p = 0.002), and occipital (1.54-fold, p = 0.002) cortex and the striatum (1.76-fold, p = 0.0001).  PIB retention was equiv. in AD patients and controls in areas known to be relatively unaffected by amyloid deposition (such as subcortical white matter, pons, and cerebellum).  Studies in three young (21 yr) and six older healthy controls (69.5±11 yr) showed low PIB retention in cortical areas and no significant group differences between young and older controls.  In cortical areas, PIB retention correlated inversely with cerebral glucose metab. detd. with 18F-fluorodeoxyglucose.  This relationship was most robust in the parietal cortex (r = -0.72; p = 0.0001).  The results suggest that PET imaging with the novel tracer, PIB, can provide quant. information on amyloid deposits in living subjects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXxBSvpITSxLVg90H21EOLACvtfcHk0lgHwr5hKEreMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFKntb8%253D&md5=3e036dca56dcb81e0cf131a5b100f95f</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1002%2Fana.20009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.20009%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26aulast%3DEngler%26aufirst%3DH.%26aulast%3DNordberg%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBlomqvist%26aufirst%3DG.%26aulast%3DHolt%26aufirst%3DD.%2BP.%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DSavitcheva%26aufirst%3DI.%26aulast%3DHuang%26aufirst%3DG.%2BF.%26aulast%3DEstrada%26aufirst%3DS.%26aulast%3DAus%25C3%25A9n%26aufirst%3DB.%26aulast%3DDebnath%26aufirst%3DM.%2BL.%26aulast%3DBarletta%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DJ.%2BC.%26aulast%3DSandell%26aufirst%3DJ.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DKoivisto%26aufirst%3DP.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DLongstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DImaging%2520brain%2520amyloid%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%2520with%2520Pittsburg%2520Compound-B%26jtitle%3DAnn.%2520Neurol.%26date%3D2004%26volume%3D55%26spage%3D306%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Klunk, W. E.; Mathis, C. A.,  Jr.; Wang, Y.</span>Benzothiazole Derivative Compounds, Compositions and Uses. Patent WO2004083195 A1,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span>p  <span class="NLM_fpage">134</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=W.+E.+Klunk&author=C.+A.+Mathis&author=Y.+Wang&title=Benzothiazole+Derivative+Compounds%2C+Compositions+and+Uses"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26jtitle%3DBenzothiazole%2520Derivative%2520Compounds%252C%2520Compositions%2520and%2520Uses%26date%3D2004%26spage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Hatashita, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakebe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayakawa, H.</span><span> </span><span class="NLM_article-title">[<sup>18</sup>F]Flutemetamol amyloid-beta PET imaging compared with [<sup>11</sup>C]PIB across the spectrum of Alzheimer’s disease</span> <span class="citation_source-journal">Eur. J. Nucl. Med. Mol. Imaging</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">290</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs00259-013-2564-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=24085503" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFKjurjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=290-300&author=S.+Hatashitaauthor=H.+Yamasakiauthor=Y.+Suzukiauthor=K.+Tanakaauthor=D.+Wakebeauthor=H.+Hayakawa&title=%5B18F%5DFlutemetamol+amyloid-beta+PET+imaging+compared+with+%5B11C%5DPIB+across+the+spectrum+of+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]Flutemetamol amyloid-beta PET imaging compared with [11C]PIB across the spectrum of Alzheimer's disease</span></div><div class="casAuthors">Hatashita, Shizuo; Yamasaki, Hidetomo; Suzuki, Yutaka; Tanaka, Kumiko; Wakebe, Daichi; Hayakawa, Hideki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">290-300</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: The aim was to identify the amyloid beta (Aβ) deposition by positron emission tomog. (PET) imaging with the 18F-labeled Pittsburgh compd. B (PIB) deriv. [18F]flutemetamol (FMM) across a spectrum of Alzheimer's disease (AD) and to compare Aβ deposition between [18F]FMM and [11C]PIB PET imaging.  Methods: The study included 36 patients with AD, 68 subjects with mild cognitive impairment (MCI), 41 older healthy controls (HC) (aged ≥56), 11 young HC (aged ≤45), and 10 transitional HC (aged 46-55).  All 166 subjects underwent 30-min static [18F]FMM PET 85 min after injection, 60-min dynamic [11C]PIB PET, and cognitive testing. [18F]FMM scans were assessed visually, and standardized uptake value ratios (SUVR) were defined quant. in regions of interest identified on coregistered MRI (cerebellar cortex as a ref. region).  The PIB distribution vol. ratios (DVR) were detd. in the same regions.  Results: Of 36 AD patients, 35 had pos. scans, while 36 of 41 older HC subjects had neg. scans. [18F]FMM scans had a sensitivity of 97.2 % and specificity of 85.3 % in distinguishing AD patients from older HC subjects, and a specificity of 100 % for young and transitional HC subjects.  The [11C]PIB scan had the same results.  Interreader agreement was excellent (kappa score = 0.81).  The cortical FMM SUVR in AD patients was significantly greater than in older HC subjects (1.76 ± 0.23 vs 1.30 ± 0.26, p < 0.01).  Of the MCI patients, 68 had a bimodal distribution of SUVR, and 29 of them (42.6 %) had pos. scans.  Cortical FMM SUVR values were strongly correlated with PIB DVR (r = 0.94, n = 145, p < 0.001).  Conclusion: [18F]FMM PET imaging detects Aβ deposition in patients along the continuum from normal cognitive status to dementia of AD and discriminates AD patients from HC subjects, similar to [11C]PIB PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUDZFRg1D2WbVg90H21EOLACvtfcHk0lgHwr5hKEreMg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFKjurjE&md5=55ac4685816a4c192a811bd19229f1b3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1007%2Fs00259-013-2564-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-013-2564-y%26sid%3Dliteratum%253Aachs%26aulast%3DHatashita%26aufirst%3DS.%26aulast%3DYamasaki%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DK.%26aulast%3DWakebe%26aufirst%3DD.%26aulast%3DHayakawa%26aufirst%3DH.%26atitle%3D%255B18F%255DFlutemetamol%2520amyloid-beta%2520PET%2520imaging%2520compared%2520with%2520%255B11C%255DPIB%2520across%2520the%2520spectrum%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2014%26volume%3D41%26spage%3D290%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopresti, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klunk, W. E.</span><span> </span><span class="NLM_article-title">Development of positron emission tomography beta-amyloid plaque imaging agents</span> <span class="citation_source-journal">Semin. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">423</span><span class="NLM_x">–</span> <span class="NLM_lpage">432</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1053%2Fj.semnuclmed.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=23026364" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2012&pages=423-432&author=C.+A.+Mathisauthor=N.+S.+Masonauthor=B.+J.+Loprestiauthor=W.+E.+Klunk&title=Development+of+positron+emission+tomography+beta-amyloid+plaque+imaging+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Development of positron emission tomography β-amyloid plaque imaging agents</span></div><div class="casAuthors">Mathis Chester A; Mason N Scott; Lopresti Brian J; Klunk William E</div><div class="citationInfo"><span class="NLM_cas:title">Seminars in nuclear medicine</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">423-32</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">For 100 years, β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) have been recognized as the neuropathological hallmarks of Alzheimer's disease (AD), and their presence or absence could only be assessed postmortem using stains and dyes that identified these microscopic structures.  Approximately 10 years ago, the first successful Aβ plaque-specific positron emission tomography (PET) imaging study was conducted in a living human subject clinically diagnosed with probable AD using the (11)C-labeled radiopharmaceutical Pittsburgh Compound B (PiB).  Laboratory studies and preclinical evaluations to design PiB began a decade earlier than the first human PiB PET study and involved chemical modifications of different well-known dyes that bound specifically to the extended β-pleated sheets that comprise the fibrils of amyloid proteins such as Aβ plaques, NFTs, α-synuclein deposits, and prions.  These preclinical studies were conducted in our laboratories at the University of Pittsburgh, starting with Congo red derivatives, followed by Chrysamine G derivatives, followed by X-series compounds, and finally with neutral derivatives of thioflavin-T.  The in vitro and in vivo evaluations of the different derivatives as candidate PET radioligands for imaging Aβ plaques and neurofibrillary tangles in human brain are described in this review, along with the specific evaluation criteria by which the candidate radioligands were judged.  Out of these studies came PiB, a PET radioligand that binds selectively and with high affinity to only fibrillar forms of Aβ.  PiB has been used in many different human research protocols throughout the world and has demonstrated the usefulness of assessing the Aβ plaque status of subjects many years before the clinical diagnosis of probable AD.  Recently, longer-lived (18)F-radiolabeled Aβ-selective radiopharmaceuticals have been developed.  It is likely that the full clinical impact of these imaging agents will be realized by identifying presymptomatic subjects who would benefit from early drug treatments with future disease-modifying AD therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS5GsYnd2H3WtyzdcP07UmufW6udTcc2eYATPAYwjg7pLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s%252FhsFGiug%253D%253D&md5=e9c01e3c4335a6b85dd838c64277e0ee</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1053%2Fj.semnuclmed.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1053%252Fj.semnuclmed.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DMason%26aufirst%3DN.%2BS.%26aulast%3DLopresti%26aufirst%3DB.%2BJ.%26aulast%3DKlunk%26aufirst%3DW.%2BE.%26atitle%3DDevelopment%2520of%2520positron%2520emission%2520tomography%2520beta-amyloid%2520plaque%2520imaging%2520agents%26jtitle%3DSemin.%2520Nucl.%2520Med.%26date%3D2012%26volume%3D42%26spage%3D423%26epage%3D432" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Barthel, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sabri, O.</span><span> </span><span class="NLM_article-title">Florbetaben to trance amyloid-β in the Alzheimer brain by means of PET</span> <span class="citation_source-journal">J. Alzheimer’s Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">117</span><span class="NLM_x">–</span> <span class="NLM_lpage">121</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=21971456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht12gs7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2011&pages=117-121&author=H.+Barthelauthor=O.+Sabri&title=Florbetaben+to+trance+amyloid-%CE%B2+in+the+Alzheimer+brain+by+means+of+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Florbetaben to Trace Amyloid-β in the Alzheimer Brain by Means of PET</span></div><div class="casAuthors">Ashford, J. Wesson; Rosen, Allyson; Adamson, Maheen; Bayley, Peter; Sabri, Osama; Furst, Ansgar; Black, Sandra E.; Weiner, Michael; Barthel, Henryk; Sabri, Osama</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's Disease</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">Suppl. 3</span>),
    <span class="NLM_cas:pages">117-121</span>CODEN:
                <span class="NLM_cas:coden">JADIF9</span>;
        ISSN:<span class="NLM_cas:issn">1387-2877</span>.
    
            (<span class="NLM_cas:orgname">IOS Press</span>)
        </div><div class="casAbstract">A review.  PET imaging of amyloid-β has recently emerged as a valuable biomarker to support the in vivo diagnosis of Alzheimer's disease (AD).  So far, however, no tracer is available suitable for general clin. routine application.  Florbetaben is a promising 18F-labeled amyloid-β-targeted PET tracer currently in Phase2/3 clin. development.  This review provides an overview on the current knowledge and future research activities on florbetaben.  Recently, the first worldwide multi-center trial to test the diagnostic performance of amyloid-β PET in AD was conducted with this tracer.  From this trial, a sensitivity and specificity of 80 and 91% in the discrimination between patients with probable AD and age-matched healthy controls was reported.  Ongoing florbetaben PET trials deal with correlating the in vivo PET signal to post mortem histopathol. evaluation, and with investigating the value of the tracer to predict progression to AD at the stage of mild cognitive impairment.  The preclin. and clin. data currently available verify florbetaben as a safe and efficacious PET tracer suitable for detection of amyloid-β deposition in the brain.  The results of the ongoing trials will contribute to current knowledge on the characteristics of florbetaben, and will help to det. the future potential of florbetaben PET imaging as a visual adjunct to supplement the routine clin. "AD diagnostic toolbox".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoevrjRGosWBrVg90H21EOLACvtfcHk0lhkJIdkNlSHRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht12gs7%252FO&md5=1b61b0f7e6fcba764d905fd87d403105</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBarthel%26aufirst%3DH.%26aulast%3DSabri%26aufirst%3DO.%26atitle%3DFlorbetaben%2520to%2520trance%2520amyloid-%25CE%25B2%2520in%2520the%2520Alzheimer%2520brain%2520by%2520means%2520of%2520PET%26jtitle%3DJ.%2520Alzheimer%25E2%2580%2599s%2520Dis.%26date%3D2011%26volume%3D26%26spage%3D117%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanessa Raymont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nandi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brašić, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilton, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyketsos, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kung, H. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skovronsky, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pontecorvo, M. J.</span><span> </span><span class="NLM_article-title">In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand <sup>18</sup>F-AV-45 (flobetapir F-18)</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">–</span> <span class="NLM_lpage">920</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=913-920&author=D.+F.+Wongauthor=P.+B.+Rosenbergauthor=Y.+Zhouauthor=A.+Kumarauthor=V.+Vanessa+Raymontauthor=H.+T.+Ravertauthor=R.+F.+Dannalsauthor=A.+Nandiauthor=J.+R.+Bra%C5%A1i%C4%87author=W.+Yeauthor=J.+Hiltonauthor=C.+Lyketsosauthor=H.+F.+Kungauthor=A.+D.+Joshiauthor=D.+M.+Skovronskyauthor=M.+J.+Pontecorvo&title=In+vivo+imaging+of+amyloid+deposition+in+Alzheimer+disease+using+the+radioligand+18F-AV-45+%28flobetapir+F-18%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DRosenberg%26aufirst%3DP.%2BB.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DVanessa%2BRaymont%26aufirst%3DV.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DNandi%26aufirst%3DA.%26aulast%3DBra%25C5%25A1i%25C4%2587%26aufirst%3DJ.%2BR.%26aulast%3DYe%26aufirst%3DW.%26aulast%3DHilton%26aufirst%3DJ.%26aulast%3DLyketsos%26aufirst%3DC.%26aulast%3DKung%26aufirst%3DH.%2BF.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DSkovronsky%26aufirst%3DD.%2BM.%26aulast%3DPontecorvo%26aufirst%3DM.%2BJ.%26atitle%3DIn%2520vivo%2520imaging%2520of%2520amyloid%2520deposition%2520in%2520Alzheimer%2520disease%2520using%2520the%2520radioligand%252018F-AV-45%2520%2528flobetapir%2520F-18%2529%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D913%26epage%3D920" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Lopéz-Muñoz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alamos, C.</span><span> </span><span class="NLM_article-title">The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice</span> <span class="citation_source-journal">Brain Res. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">130</span><span class="NLM_x">–</span> <span class="NLM_lpage">141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.brainresbull.2009.01.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=19186209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjsVOju7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2009&pages=130-141&author=F.+Lop%C3%A9z-Mu%C3%B1ozauthor=C.+Alamos&title=The+consolidation+of+neuroleptic+therapy%3A+Janssen%2C+the+discovery+of+haloperidol+and+its+introduction+into+clinical+practice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice</span></div><div class="casAuthors">Lopez-Munoz, Francisco; Alamo, Cecilio</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">130-141</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The discovery of haloperidol at the end of the 1950s constitutes one of the greatest advances of 20th century psychiatry.  This antipsychotic drug has their origin in the research process of central analgesic mols. derived from pethidine and methadone, carried out by the Belgian company Janssen Phamaceutica.  After the synthesis of phenoperidine, numerous analogs of this compd. were studied, and chemists at Janssen took the decision to substitute the propiophenone group for a butyrophenone group.  One of these compds. went the R-1625, a stronger agent with specifically neuroleptic properties but lacking morphine-like activity.  This substance was synthesized on the 11th Feb. 1958 and received the generic name of haloperidol because of the two halogenated substitutes incorporated into the mol.  Clin. development of haloperidol was conducted, primarily, by psychiatric research team at the University of Liege that confirmed its efficacy in the treatment of various psychiatric disorders such as acute and chronic paranoid psychosis, mania, or chronic treatment-resistant schizophrenia.  Under the brand name Haldol, haloperidol was licensed and marketed in Belgium in Oct. 1959.  The direct and differed consequences of its introduction into the psychiatric practice have been multiple, involving different areas of socio-sanitary reality.  Moreover, haloperidol has contributed substantially to the development of biol. psychiatry and currently neuroscience, because it made possible the development of new exptl. models for predicting the effects of antipsychotics, and allowed the postulate of the firsts biol. hypotheses about the schizophrenia etiol.  Haloperidol has been included in the World Health Organization's list of essential medicines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2lPuh0GeqILVg90H21EOLACvtfcHk0livXcRxlfJfFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjsVOju7o%253D&md5=76765632a32254cc2386150a6ce52cfa</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.brainresbull.2009.01.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainresbull.2009.01.005%26sid%3Dliteratum%253Aachs%26aulast%3DLop%25C3%25A9z-Mu%25C3%25B1oz%26aufirst%3DF.%26aulast%3DAlamos%26aufirst%3DC.%26atitle%3DThe%2520consolidation%2520of%2520neuroleptic%2520therapy%253A%2520Janssen%252C%2520the%2520discovery%2520of%2520haloperidol%2520and%2520its%2520introduction%2520into%2520clinical%2520practice%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2009%26volume%3D79%26spage%3D130%26epage%3D141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Berger, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaminski, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Cruz, O. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pleasure, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feldman, E. L.</span><span> </span><span class="NLM_article-title">Importance and hurdles to drug discovery for neurological disease</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">441</span><span class="NLM_x">–</span> <span class="NLM_lpage">446</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2Fana.23893" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnt77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=441-446&author=J.+R.+Bergerauthor=D.+Choiauthor=H.+J.+Kaminskiauthor=M.+F.+Gordonauthor=O.+Hurkoauthor=O.+N.+D%E2%80%99Cruzauthor=S.+J.+Pleasureauthor=E.+L.+Feldman&title=Importance+and+hurdles+to+drug+discovery+for+neurological+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Importance and hurdles to drug discovery for neurological disease</span></div><div class="casAuthors">Berger, Joseph R.; Choi, Dennis; Kaminski, Henry J.; Gordon, Mark F.; Hurko, Orest; D'Cruz, O'Neill; Pleasure, Samuel J.; Feldman, Eva L.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">441-446</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  This is a crit. time in neurotherapeutics.  The prevalence of neurol. disease, such as dementia, stroke, and peripheral neuropathy, is large and growing consequent to the aging population.  The personal and societal impact of these disorders is enormous, and the no. of novel therapies in the pipeline for these disorders has been contracting.  Support for the development of neurotherapies must continue from the bench to their ultimate place at the bedside.  Academic medicine must continue to play a crit. role, in league with industry and government, in the development of novel neurotherapies desperately needed by an ever-expanding population.  Crit. steps include the identification and adoption of reliable, valid, and reproducible biomarkers to serve as primary endpoints in clin. trials of neurol. disease.  Ann Neurol 2013;74:441-446.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwRhoCCkdeOLVg90H21EOLACvtfcHk0livXcRxlfJfFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1Wnt77L&md5=b363326145d8692f997ce4e1d8be67c5</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1002%2Fana.23893&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.23893%26sid%3Dliteratum%253Aachs%26aulast%3DBerger%26aufirst%3DJ.%2BR.%26aulast%3DChoi%26aufirst%3DD.%26aulast%3DKaminski%26aufirst%3DH.%2BJ.%26aulast%3DGordon%26aufirst%3DM.%2BF.%26aulast%3DHurko%26aufirst%3DO.%26aulast%3DD%25E2%2580%2599Cruz%26aufirst%3DO.%2BN.%26aulast%3DPleasure%26aufirst%3DS.%2BJ.%26aulast%3DFeldman%26aufirst%3DE.%2BL.%26atitle%3DImportance%2520and%2520hurdles%2520to%2520drug%2520discovery%2520for%2520neurological%2520disease%26jtitle%3DAnn.%2520Neurol.%26date%3D2013%26volume%3D74%26spage%3D441%26epage%3D446" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span>Innovation or Stagnation:  Challenge and Opportunity on the Critical Path to New Medical Products; <span class="NLM_publisher-name">U.S. Food and Drug Administration</span>: <span class="NLM_publisher-loc">Silver Spring, MD</span>,<span class="NLM_x"> </span><span class="NLM_year">2004</span><span class="NLM_x">; </span><a href="http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm" class="extLink">http://www.fda.gov/ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Innovation+or+Stagnation%3A+Challenge+and+Opportunity+on+the+Critical+Path+to+New+Medical+Products%3B+U.S.+Food+and+Drug+Administration%3A+Silver+Spring%2C+MD%2C+2004%3B+http%3A%2F%2Fwww.fda.gov%2FScienceResearch%2FSpecialTopics%2FCriticalPathInitiative%2FCriticalPathOpportunitiesReports%2Fucm077262.htm."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DInnovation%2520or%2520Stagnation%253A%2520%2520Challenge%2520and%2520Opportunity%2520on%2520the%2520Critical%2520Path%2520to%2520New%2520Medical%2520Products%26pub%3DU.S.%2520Food%2520and%2520Drug%2520Administration%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span>The Pharmaceutical Industry in Figures; <span class="NLM_publisher-name">European Federation of Pharmaceutica Industries and Associations</span>: <span class="NLM_publisher-loc">Brussels, Belgium</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span><a href="http://www.efpia.eu/uploads/Modules/Documents/figures-key-data-2013.pdf" class="extLink">http://www.efpia.eu/uploads/Modules/Documents/figures-key-data-2013.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Pharmaceutical+Industry+in+Figures%3B+European+Federation+of+Pharmaceutica+Industries+and+Associations%3A+Brussels%2C+Belgium%2C+2013%3B+http%3A%2F%2Fwww.efpia.eu%2Fuploads%2FModules%2FDocuments%2Ffigures-key-data-2013.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Pharmaceutical%2520Industry%2520in%2520Figures%26pub%3DEuropean%2520Federation%2520of%2520Pharmaceutica%2520Industries%2520and%2520Associations%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Woodcock, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woosley, R.</span><span> </span><span class="NLM_article-title">The FDA critical path initiative and its influence on new drug development</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">12</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2008&pages=1-12&author=J.+Woodcockauthor=R.+Woosley&title=The+FDA+critical+path+initiative+and+its+influence+on+new+drug+development"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWoodcock%26aufirst%3DJ.%26aulast%3DWoosley%26aufirst%3DR.%26atitle%3DThe%2520FDA%2520critical%2520path%2520initiative%2520and%2520its%2520influence%2520on%2520new%2520drug%2520development%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D2008%26volume%3D59%26spage%3D1%26epage%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span>Annual R&D General Metrics Study Highlights: New Success Rate and Cycle Time Data. <a href="https://www.kmrgroup.com/PressReleases/2012_08_08%20KMR%20PBF%20Success%20Rate%20&amp;%20Cycle%20Time%20Press%20Release.pdf" class="extLink">https://www.kmrgroup.com/PressReleases/2012_08_08%20KMR%20PBF%20Success%20Rate%20&%20Cycle%20Time%20Press%20Release.pdf</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Annual+R%26D+General+Metrics+Study+Highlights%3A+New+Success+Rate+and+Cycle+Time+Data.+https%3A%2F%2Fwww.kmrgroup.com%2FPressReleases%2F2012_08_08%2520KMR%2520PBF%2520Success%2520Rate%2520%26%2520Cycle%2520Time%2520Press%2520Release.pdf."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520R%2526D%2520General%2520Metrics%2520Study%2520Highlights%253A%2520New%2520Success%2520Rate%2520and%2520Cycle%2520Time%2520Data" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Matsuoka, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ainer, T. G.</span><span> </span><span class="NLM_article-title">FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">1201</span><span class="NLM_x">–</span> <span class="NLM_lpage">1209</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=9067304" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK2sXhvF2mt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=1997&pages=1201-1209&author=N.+Matsuokaauthor=T.+G.+Ainer&title=FK960+%5BN-%284-acetyl-1-piperazinyl%29-p-fluorobenzamide+monohydrate%5D%2C+a+novel+potential+antidementia+drug%2C+improves+visual+recognition+memory+in+rhesus+monkeys%3A+comparison+with+physostigmine"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel potential antidementia drug, improves visual recognition memory in rhesus monkeys: comparison with physostigmine</span></div><div class="casAuthors">Matsuoka, Nobuya; Aigner, Thomas G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">280</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1201-1209</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">Our previous studies demonstrated that FK960 [N-(4-acetyl-1-piperazinyl)-p-fluorobenzamide monohydrate], a novel antidementia piperazine deriv., exerts beneficial effects on memory deficits in various rodent models of amnesia, through activation of the somatostatin neuronal system.  To extend the antiamnesic action of FK960 to nonhuman primates, FK960 was evaluated for its ability to reverse the deficits in visual recognition memory produced by muscarinic cholinergic receptor blockade by scopolamine or N-methyl-D-aspartate receptor blockade by dizocilpine (MK-801) in four rhesus monkeys performing a computer-automated version of delayed nonmatching to sample, with a list length of 20 trial-unique graphic symbols.  Furthermore, the effects of FK960 were compared with those of physostigmine, a cholinesterase inhibitor.  Doses of FK960 (1, 3.2, 10, 32, 100, 320 or 1000 μg/kg) injected i.m. 30 min before testing minimally affected visual recognition memory when administered alone.  FK960 (1, 3.2, 10 or 32 μg/kg) significantly antagonized the deficits in visual recognition memory produced by scopolamine (10 μg/kg); the same doses of the drug minimally affected the deficits produced by dizocilpine (32 μg/kg).  Similarly, physostigmine (3.2, 10 or 32 μg/kg) significantly and dose-dependently restored the visual recognition memory deficits produced by scopolamine (10 μg/kg) but not those produced by dizocilpine (32 μg/kg).  From these results, we conclude that FK960 improves deficits in recognition memory assocd. with central cholinergic hypofunction in nonhuman primates, and we suggest that the therapeutic potential of this drug for patients with dementia should be evaluated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxySX2vsdGZrVg90H21EOLACvtfcHk0livXcRxlfJfFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhvF2mt7k%253D&md5=01cdae99e56666dc054dc7a22e08a64a</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatsuoka%26aufirst%3DN.%26aulast%3DAiner%26aufirst%3DT.%2BG.%26atitle%3DFK960%2520%255BN-%25284-acetyl-1-piperazinyl%2529-p-fluorobenzamide%2520monohydrate%255D%252C%2520a%2520novel%2520potential%2520antidementia%2520drug%252C%2520improves%2520visual%2520recognition%2520memory%2520in%2520rhesus%2520monkeys%253A%2520comparison%2520with%2520physostigmine%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1997%26volume%3D280%26spage%3D1201%26epage%3D1209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takamatsu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yajima, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tatsumi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichise, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span> </span><span class="NLM_article-title">Measurement of brain concentration of FK960 for development of a novel antidementia drug: a PET study in conscious rhesus monkeys</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">105</span><span class="NLM_x">–</span> <span class="NLM_lpage">108</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2003&pages=105-108&author=A.+Nodaauthor=H.+Takamatsuauthor=Y.+Murakamiauthor=K.+Yajimaauthor=M.+Tatsumiauthor=R.+Ichiseauthor=S.+Nishimura&title=Measurement+of+brain+concentration+of+FK960+for+development+of+a+novel+antidementia+drug%3A+a+PET+study+in+conscious+rhesus+monkeys"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DTakamatsu%26aufirst%3DH.%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DYajima%26aufirst%3DK.%26aulast%3DTatsumi%26aufirst%3DM.%26aulast%3DIchise%26aufirst%3DR.%26aulast%3DNishimura%26aufirst%3DS.%26atitle%3DMeasurement%2520of%2520brain%2520concentration%2520of%2520FK960%2520for%2520development%2520of%2520a%2520novel%2520antidementia%2520drug%253A%2520a%2520PET%2520study%2520in%2520conscious%2520rhesus%2520monkeys%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2003%26volume%3D44%26spage%3D105%26epage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Härtter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gründer, G.</span><span> </span><span class="NLM_article-title">High striatal occupancy of D<sub>2</sub>-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1017%2FS1461145704004353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15683553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=421-430&author=I.+Vernalekenauthor=T.+Siessmeierauthor=H.+G.+Buchholzauthor=S.+H%C3%A4rtterauthor=C.+Hiemkeauthor=P.+Stoeterauthor=F.+R%C3%B6schauthor=P.+Bartensteinauthor=G.+Gr%C3%BCnder&title=High+striatal+occupancy+of+D2-like+dopamine+receptors+by+amisulpride+in+the+brain+of+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span></div><div class="casAuthors">Vernaleken, Ingo; Siessmeier, Thomas; Buchholz, Hans-Georg; Haertter, Sebastian; Hiemke, Christoph; Stoeter, Peter; Roesch, Frank; Bartenstein, Peter; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The 'atypicality' of the antipsychotic drug, amisulpride, has been attributed to preferential extrastriatal binding.  Previous investigations of striatal D2 receptor occupancy by amisulpride revealed conflicting results.  The aim of this PET study was to measure the striatal occupancy by amisulpride and to correlate it with the corresponding drug plasma concns.  Nine amisulpride-treated patients and 12 healthy volunteers serving as controls were studied with PET and [18F]desmethoxyfallypride.  Occupancy values and plasma concns. were nonlinearly fitted to an Emax model.  Results showed 43-85% (putamen) and 67-90% (caudate) D2-like receptor occupancy.  Plasma amisulpride concns. at the time of tracer injection, but not administered doses, were significantly nonlinearly correlated to occupancy levels (putamen: rS=0.88, p=0.0017; caudate: rS=0.78, p=0.0127).  Calcd. Emax was similar in both caudate and putamen, but occupancy levels were lower in caudate at lower amisulpride plasma concns.  Calcd. plasma levels to attain 60-80% receptor occupancy ranged from 119 to 474 ng/mL (caudate) and from 241 to 732 ng/mL (putamen).  This reveals a broad range of plasma concns. producing less than 80% striatal receptor occupancy.  However, our data show high striatal D2-like receptor occupancies under rising plasma concns.  Using the full range of recommended amisulpride dosage, striatal occupancies up to 90% can be measured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6q7vccCXi7Vg90H21EOLACvtfcHk0lhTduThlzi2Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D&md5=deadbde0ae4eaf69e5f3d96ab47f1e25</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1017%2FS1461145704004353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145704004353%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DH%25C3%25A4rtter%26aufirst%3DS.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DHigh%2520striatal%2520occupancy%2520of%2520D2-like%2520dopamine%2520receptors%2520by%2520amisulpride%2520in%2520the%2520brain%2520of%2520patients%2520with%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2004%26volume%3D7%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Willeit, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graff, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusjan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitcu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houle, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">First human evidence of <span class="smallcaps smallerCapital">d</span>-amphetamine induced displacement of a D<sub>2/3</sub> agonist radioligand: a [<sup>11</sup>C]-(+)-PHNO positron emission tomography study</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">279</span><span class="NLM_x">–</span> <span class="NLM_lpage">289</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2008&pages=279-289&author=M.+Willeitauthor=N.+Ginovartauthor=A.+Graffauthor=P.+Rusjanauthor=I.+Vitcuauthor=S.+Houleauthor=P.+Seemanauthor=A.+A.+Wilsonauthor=S.+Kapur&title=First+human+evidence+of+d-amphetamine+induced+displacement+of+a+D2%2F3+agonist+radioligand%3A+a+%5B11C%5D-%28%2B%29-PHNO+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilleit%26aufirst%3DM.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DGraff%26aufirst%3DA.%26aulast%3DRusjan%26aufirst%3DP.%26aulast%3DVitcu%26aufirst%3DI.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DSeeman%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DFirst%2520human%2520evidence%2520of%2520d-amphetamine%2520induced%2520displacement%2520of%2520a%2520D2%252F3%2520agonist%2520radioligand%253A%2520a%2520%255B11C%255D-%2528%252B%2529-PHNO%2520positron%2520emission%2520tomography%2520study%26jtitle%3DNeuropsychopharmacology%26date%3D2008%26volume%3D33%26spage%3D279%26epage%3D289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">London, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cascella, N. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Philips, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Links, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herning, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grayson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffe, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, H. N.</span><span> </span><span class="NLM_article-title">Cocaine-induced reduction of glucose utilization in human brain</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">–</span> <span class="NLM_lpage">574</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.1990.01810180067010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2350209" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK3MXlsFKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1990&pages=567-574&author=E.+D.+Londonauthor=N.+G.+Cascellaauthor=D.+F.+Wongauthor=R.+L.+Philipsauthor=R.+F.+Dannalsauthor=J.+M.+Linksauthor=R.+Herningauthor=R.+Graysonauthor=J.+H.+Jaffeauthor=H.+N.+Wagner&title=Cocaine-induced+reduction+of+glucose+utilization+in+human+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Cocaine-induced reduction of glucose utilization in human brain.  A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose</span></div><div class="casAuthors">London, Edythe D.; Cascella, Nicola G.; Wong, Dean F.; Phillips, Robert L.; Dannals, Robert F.; Links, Jonathan M.; Herning, Ronald; Grayson, Roger; Jaffe, Jerome H.; Wagner, Henry N., Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">567-74</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">The authors examd. the effects of cocaine hydrochloride (40 mg i.v.) on regional cerebral metabolic rates for glucose and on subjective self-reports of eight polydrug abusers in a double-blind, placebo-controlled, crossover study.  The regional cerebral metabolic rate for glucose was measured by the [fluorine 18]-fluorodeoxyglucose method, using positron emission tomog.  With eyes covered, subjects listened to a tape that presented white noise, "beep" prompts, and questions about subjective effects of cocaine or saline.  Cocaine produced euphoria and reduced glucose utilization globally (mean redn., 14%).  Twenty-six of 29 brain regions (all neocortical areas, basal ganglia, portions of the hippocampal formation, thalamus, and midbrain) showed significant decrements (5-26%) in the regional cerebral metabolic rate for glucose.  No significant effects of cocaine were obsd. in the pons, the cerebellar cortex, or the vermis.  Right-greater-than-left hemispheric asymmetry of regional cerebral metabolic rates for glucose occurred in the lateral thalamus.  The findings demonstrate that reduced cerebral metab. is assocd. with cocaine-induced euphoria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRzDNuNkul5LVg90H21EOLACvtfcHk0lhTduThlzi2Ew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsFKitw%253D%253D&md5=d3877ead43d8d2a21b346cafd49b4ce4</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1990.01810180067010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1990.01810180067010%26sid%3Dliteratum%253Aachs%26aulast%3DLondon%26aufirst%3DE.%2BD.%26aulast%3DCascella%26aufirst%3DN.%2BG.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DPhilips%26aufirst%3DR.%2BL.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DLinks%26aufirst%3DJ.%2BM.%26aulast%3DHerning%26aufirst%3DR.%26aulast%3DGrayson%26aufirst%3DR.%26aulast%3DJaffe%26aufirst%3DJ.%2BH.%26aulast%3DWagner%26aufirst%3DH.%2BN.%26atitle%3DCocaine-induced%2520reduction%2520of%2520glucose%2520utilization%2520in%2520human%2520brain%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1990%26volume%3D47%26spage%3D567%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Bartzokis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beckson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Newton, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mandelkern, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bridge, T. P.</span><span> </span><span class="NLM_article-title">Selegiline effects on cocaine-induced changes in medial temporal lobe metabolism and subjective ratings of euphoria</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">583</span><span class="NLM_x">–</span> <span class="NLM_lpage">590</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=583-590&author=G.+Bartzokisauthor=M.+Becksonauthor=T.+Newtonauthor=M.+Mandelkernauthor=J.+Mintzauthor=J.+A.+Fosterauthor=W.+Lingauthor=T.+P.+Bridge&title=Selegiline+effects+on+cocaine-induced+changes+in+medial+temporal+lobe+metabolism+and+subjective+ratings+of+euphoria"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBartzokis%26aufirst%3DG.%26aulast%3DBeckson%26aufirst%3DM.%26aulast%3DNewton%26aufirst%3DT.%26aulast%3DMandelkern%26aufirst%3DM.%26aulast%3DMintz%26aufirst%3DJ.%26aulast%3DFoster%26aufirst%3DJ.%2BA.%26aulast%3DLing%26aufirst%3DW.%26aulast%3DBridge%26aufirst%3DT.%2BP.%26atitle%3DSelegiline%2520effects%2520on%2520cocaine-induced%2520changes%2520in%2520medial%2520temporal%2520lobe%2520metabolism%2520and%2520subjective%2520ratings%2520of%2520euphoria%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D583%26epage%3D590" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stump, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruno, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemmerer, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McWherter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mosser, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohórquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staas, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zartman, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]MK-4232: the first positron emission tomography tracer for the calcitonin gene-related peptide receptor</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">863</span><span class="NLM_x">–</span> <span class="NLM_lpage">868</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml400199p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=863-868&author=I.+M.+Bellauthor=S.+N.+Gallicchioauthor=C.+A.+Stumpauthor=J.+G.+Brunoauthor=H.+Fanauthor=L.+T.+Gantertauthor=E.+D.+Hostetlerauthor=A.+L.+Kemmererauthor=M.+McWherterauthor=E.+L.+Mooreauthor=S.+D.+Mosserauthor=M.+L.+Purcellauthor=K.+Riffelauthor=C.+A.+Salvatoreauthor=S.+Sanabria-Boh%C3%B3rquezauthor=D.+D.+Staasauthor=R.+B.+Whiteauthor=M.+Williamsauthor=C.+B.+Zartmanauthor=J.+J.+Cookauthor=R.+J.+Hargreavesauthor=S.+A.+Kaneauthor=S.+L.+Grahamauthor=H.+G.+Selnick&title=%5B11C%5DMK-4232%3A+the+first+positron+emission+tomography+tracer+for+the+calcitonin+gene-related+peptide+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1021%2Fml400199p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml400199p%26sid%3Dliteratum%253Aachs%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DStump%26aufirst%3DC.%2BA.%26aulast%3DBruno%26aufirst%3DJ.%2BG.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DGantert%26aufirst%3DL.%2BT.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DKemmerer%26aufirst%3DA.%2BL.%26aulast%3DMcWherter%26aufirst%3DM.%26aulast%3DMoore%26aufirst%3DE.%2BL.%26aulast%3DMosser%26aufirst%3DS.%2BD.%26aulast%3DPurcell%26aufirst%3DM.%2BL.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DSanabria-Boh%25C3%25B3rquez%26aufirst%3DS.%26aulast%3DStaas%26aufirst%3DD.%2BD.%26aulast%3DWhite%26aufirst%3DR.%2BB.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DZartman%26aufirst%3DC.%2BB.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DGraham%26aufirst%3DS.%2BL.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26atitle%3D%255B11C%255DMK-4232%253A%2520the%2520first%2520positron%2520emission%2520tomography%2520tracer%2520for%2520the%2520calcitonin%2520gene-related%2520peptide%2520receptor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D4%26spage%3D863%26epage%3D868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Hostetler, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joshi, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohórquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Purcell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gantert, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Malley, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selnick, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallicchio, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvatore, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kane, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groot, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Hecken, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Derdelinckx, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Hoon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reynders, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Declercq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Lepeleire, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kennedy, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcantonio, E. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evelhoch, J. L.</span><span> </span><span class="NLM_article-title">In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [<sup>11</sup>C]MK-4232</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">347</span><span class="NLM_x">, </span> <span class="NLM_fpage">478</span><span class="NLM_x">–</span> <span class="NLM_lpage">486</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1124%2Fjpet.113.206458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=23975906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=2013&pages=478-486&author=E.+D.+Hostetlerauthor=A.+D.+Joshiauthor=S.+Sanabria-Boh%C3%B3rquezauthor=H.+Fanauthor=Z.+Zengauthor=M.+Purcellauthor=L.+Gantertauthor=K.+Riffelauthor=M.+Williamsauthor=S.+O%E2%80%99Malleyauthor=P.+Millerauthor=H.+G.+Selnickauthor=S.+N.+Gallicchioauthor=I.+M.+Bellauthor=C.+A.+Salvatoreauthor=S.+A.+Kaneauthor=C.+C.+Liauthor=R.+J.+Hargreavesauthor=T.+de+Grootauthor=G.+Bormansauthor=A.+Van+Heckenauthor=I.+Derdelinckxauthor=J.+de+Hoonauthor=T.+Reyndersauthor=R.+Declercqauthor=I.+De+Lepeleireauthor=W.+P.+Kennedyauthor=R.+Blanchardauthor=E.+E.+Marcantonioauthor=C.+Surauthor=J.+J.+Cookauthor=K.+Van+Laereauthor=J.+L.+Evelhoch&title=In+vivo+quantification+of+calcitonin+gene-related+peptide+receptor+occupancy+by+telcagepant+in+rhesus+monkey+and+human+brain+using+the+positron+emission+tomography+tracer+%5B11C%5DMK-4232"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo quantification of calcitonin gene-related peptide receptor occupancy by Telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232</span></div><div class="casAuthors">Hostetler, Eric D.; Joshi, Aniket D.; Sanabria-Bohorquez, Sandra; Fan, Hong; Zeng, Zhizhen; Purcell, Mona; Gantert, Liza; Riffel, Kerry; Williams, Mangay; O'Malley, Stacey; Miller, Patricia; Selnick, Harold G.; Gallicchio, Steven N.; Bell, Ian M.; Salvatore, Christopher A.; Kane, Stefanie A.; Li, Chi-Chung; Hargreaves, Richard J.; de Groot, Tjibbe; Bormans, Guy; Van Hecken, Anne; Derdelinckx, Inge; de Hoon, Jan; Reynders, Tom; Declercq, Ruben; De Lepeleire, Inge; Kennedy, W. P.; Blanchard, Rebecca; Marcantonio, Eugene E.; Sur, Cyrille; Cook, Jacquelynn J.; Van Laere, Koen; Evelhoch, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">347</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">478-486</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Calcitonin gene-related peptide (CGRP) is a potent neuropeptide whose agonist interaction with the CGRP receptor (CGRP-R) in the periphery promotes vasodilation, neurogenic inflammation and trigemino-vascular sensory activation.  This process is implicated in the cause of migraine headaches, and CGRP-R antagonists in clin. development have proven effective in treating migraine-related pain in humans.  CGRP-R is expressed on blood vessel smooth muscle and sensory trigeminal neurons and fibers in the periphery as well as in the central nervous system.  However, it is not clear what role the inhibition of central CGRP-R plays in migraine pain relief.  To this end, the CGRP-R positron emission tomog. (PET) tracer [11C]MK-4232 (2-[(8R)-8-(3,5-difluorophenyl)-6,8-[6-11C]dimethyl-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(2R)-2'-oxospiro[1,3-dihydroindene-2,3'-1H-pyrrolo[2,3-b]pyridine]-5-yl]acetamide) was discovered and developed for use in clin. PET studies.  In rhesus monkeys and humans, [11C]MK-4232 displayed rapid brain uptake and a regional brain distribution consistent with the known distribution of CGRP-R.  Monkey PET studies with [11C]MK-4232 after i.v. dosing with CGRP-R antagonists validated the ability of [11C]MK-4232 to detect changes in CGRP-R occupancy in proportion to drug plasma concn.  Application of [11C]MK-4232 in human PET studies revealed that Telcagepant achieved only low receptor occupancy at an efficacious dose (140 mg PO).  Therefore, it is unlikely that antagonism of central CGRP-R is required for migraine efficacy.  However, it is not known whether high central CGRP-R antagonism may provide addnl. therapeutic benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9-pRUySstGbVg90H21EOLACvtfcHk0ljOPiYtaG5lrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslSqsLrK&md5=75cb284982d94eea2117ed26697a6cfd</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1124%2Fjpet.113.206458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.113.206458%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DSanabria-Boh%25C3%25B3rquez%26aufirst%3DS.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DSelnick%26aufirst%3DH.%2BG.%26aulast%3DGallicchio%26aufirst%3DS.%2BN.%26aulast%3DBell%26aufirst%3DI.%2BM.%26aulast%3DSalvatore%26aufirst%3DC.%2BA.%26aulast%3DKane%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DC.%2BC.%26aulast%3DHargreaves%26aufirst%3DR.%2BJ.%26aulast%3Dde%2BGroot%26aufirst%3DT.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BHecken%26aufirst%3DA.%26aulast%3DDerdelinckx%26aufirst%3DI.%26aulast%3Dde%2BHoon%26aufirst%3DJ.%26aulast%3DReynders%26aufirst%3DT.%26aulast%3DDeclercq%26aufirst%3DR.%26aulast%3DDe%2BLepeleire%26aufirst%3DI.%26aulast%3DKennedy%26aufirst%3DW.%2BP.%26aulast%3DBlanchard%26aufirst%3DR.%26aulast%3DMarcantonio%26aufirst%3DE.%2BE.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26atitle%3DIn%2520vivo%2520quantification%2520of%2520calcitonin%2520gene-related%2520peptide%2520receptor%2520occupancy%2520by%2520telcagepant%2520in%2520rhesus%2520monkey%2520and%2520human%2520brain%2520using%2520the%2520positron%2520emission%2520tomography%2520tracer%2520%255B11C%255DMK-4232%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2013%26volume%3D347%26spage%3D478%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Antoni, G.; Kihlberg, T.; Langström, B.</span><span> </span><span class="NLM_article-title"><sup>11</sup>C: Labeling chemistry and labeled compounds</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">1977</span><span class="NLM_x">–</span> <span class="NLM_lpage">2019</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-4419-0720-2_41" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=1977-2019&author=G.+Antoni&author=T.+Kihlberg&author=B.+Langstr%C3%B6mauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0720-2_41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-0720-2_41%26sid%3Dliteratum%253Aachs%26aulast%3DAntoni%26aufirst%3DG.%26atitle%3D11C%253A%2520Labeling%2520chemistry%2520and%2520labeled%2520compounds%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011%26spage%3D1977%26epage%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Müller, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faeh, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diederich, F.</span><span> </span><span class="NLM_article-title">Fluorine in pharmaceuticals: looking beyond intuition</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">317</span><span class="NLM_x">, </span> <span class="NLM_fpage">1881</span><span class="NLM_x">–</span> <span class="NLM_lpage">1886</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1126%2Fscience.1131943" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17901324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2007&pages=1881-1886&author=K.+M%C3%BCllerauthor=C.+Faehauthor=F.+Diederich&title=Fluorine+in+pharmaceuticals%3A+looking+beyond+intuition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine in Pharmaceuticals: Looking Beyond Intuition</span></div><div class="casAuthors">Mueller, Klaus; Faeh, Christoph; Diederich, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">5846</span>),
    <span class="NLM_cas:pages">1881-1886</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">A review.  Fluorine substituents have become a widespread and important drug component, their introduction facilitated by the development of safe and selective fluorinating agents.  Organofluorine affects nearly all phys. and adsorption, distribution, metab., and excretion properties of a lead compd.  Its inductive effects are relatively well understood, enhancing bioavailability, for example, by reducing the basicity of neighboring amines.  In contrast, exploration of the specific influence of carbon-fluorine single bonds on docking interactions, whether through direct contact with the protein or through stereoelectronic effects on mol. conformation of the drug, has only recently begun.  Here, we review exptl. progress in this vein and add complementary anal. based on comprehensive searches in the Cambridge Structural Database and the Protein Data Bank.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwX-YnONRc3LVg90H21EOLACvtfcHk0lg3AiFl8ATzZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVOlt7rN&md5=f804876c801518e48d0bdb7d87b7fb1c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1126%2Fscience.1131943&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1131943%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26aulast%3DFaeh%26aufirst%3DC.%26aulast%3DDiederich%26aufirst%3DF.%26atitle%3DFluorine%2520in%2520pharmaceuticals%253A%2520looking%2520beyond%2520intuition%26jtitle%3DScience%26date%3D2007%26volume%3D317%26spage%3D1881%26epage%3D1886" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Ross, T. L.; Wester, H. J.</span><span> </span><span class="NLM_article-title"><sup>18</sup>F: labeling chemistry and labeled compounds</span>. In  <span class="citation_source-book">Handbook of Nuclear Chemistry</span>, <span class="NLM_edition">2</span>nd ed.; <span class="NLM_contrib-group">Vértes, A.; Nagy, S.; Klencsár, Z.; Lovas, R. G.; Rösch, F.</span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Dordrecht, The Netherlands</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">2021</span><span class="NLM_x">–</span> <span class="NLM_lpage">2071</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2F978-1-4419-0720-2_42" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=2021-2071&author=T.+L.+Ross&author=H.+J.+Westerauthor=A.+V%C3%A9rtes&author=S.+Nagy&author=Z.+Klencs%C3%A1r&author=R.+G.+Lovas&author=F.+R%C3%B6sch&title=Handbook+of+Nuclear+Chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2F978-1-4419-0720-2_42&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-1-4419-0720-2_42%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DT.%2BL.%26atitle%3D18F%253A%2520labeling%2520chemistry%2520and%2520labeled%2520compounds%26btitle%3DHandbook%2520of%2520Nuclear%2520Chemistry%26aulast%3DV%25C3%25A9rtes%26aufirst%3DA.%26pub%3DSpringer%26date%3D2011%26spage%3D2021%26epage%3D2071" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Snyder, S. E.; Kilbourn, M. R.</span><span> </span><span class="NLM_article-title">Chemistry of fluorine-18 radiopharmaceuticals</span>. In  <span class="citation_source-book">Handbook of Radiopharmaceuticals, Radiochemistry and Applications</span>; <span class="NLM_contrib-group">Welch, M. J.; Redvanly, C. S.</span>, Eds.; <span class="NLM_publisher-name">Wiley & Sons Ltd</span>, <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2003</span><span class="NLM_x">; </span>pp  <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">228</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2003&pages=195-228&author=S.+E.+Snyder&author=M.+R.+Kilbournauthor=M.+J.+Welch&author=C.+S.+Redvanly&title=Handbook+of+Radiopharmaceuticals%2C+Radiochemistry+and+Applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DS.%2BE.%26atitle%3DChemistry%2520of%2520fluorine-18%2520radiopharmaceuticals%26btitle%3DHandbook%2520of%2520Radiopharmaceuticals%252C%2520Radiochemistry%2520and%2520Applications%26aulast%3DWelch%26aufirst%3DM.%2BJ.%26pub%3DWiley%2520%2526%2520Sons%2520Ltd%26date%3D2003%26spage%3D195%26epage%3D228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Beattie, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, H. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hancock, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagan, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birch, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span> </span><span class="NLM_article-title">The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">116</span><span class="NLM_x">, </span> <span class="NLM_fpage">3149</span><span class="NLM_x">–</span> <span class="NLM_lpage">3157</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1476-5381.1995.tb15117.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8719789" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK28XitFWktA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=1995&pages=3149-3157&author=D.+T.+Beattieauthor=I.+J.+Beresfordauthor=H.+E.+Connorauthor=F.+Marshallauthor=A.+B.+Hancockauthor=R.+M.+Haganauthor=J.+Bowersauthor=P.+J.+Birchauthor=P.+Ward&title=The+pharmacology+of+GR203040%2C+a+novel%2C+potent+and+selective+non-peptide+tachykinin+NK1+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist</span></div><div class="casAuthors">Beattie, D. T.; Beresford, I. J. M.; Connor, H. E.; Marshall, F. H.; Hawcock, A. B.; Hagan, R. M.; Bowers, J.; Birch, P. J.; Ward, P.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3149-57</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The in vitro and in vivo pharmacol. of GR203040 ((2S, 3S)-2-methoxy-5-tetrazol-1-yl-benzyl-(2-phenyl-piperidin-3-yl)-amine), a novel, highly potent and selective non-peptide tachykinin NK1 receptor antagonist, was investigated in the present study.  GR203040 potently inhibited [3H]-substance P binding to human NK1 receptors expressed in Chinese hamster ovary (CHO) and U373 MG astrocytoma cells, and NK1 receptors in ferret and gerbil cortex (pKi values of 10.3, 10.5, 10.1 and 10.1 resp.).  GR203040 had lower affinity at rat NK1 receptors (pKi = 8.6) and little affinity for human NK2 receptors (pKi <5.0) in CHO cells and NK3 receptors in guinea-pig cortex (pKi <6.0).  With the exception of the histamine H1 receptor (pIC50 = 7.5), GR203040 had little affinity (pIC50 <6.0) at all non-NK1 receptors and ion channels examd.  Furthermore, GR203040 produced only weak inhibition of Na+ currents in SH-SY5Y neuroblastoma and superior cervical ganglion cells (pIC50 values <4.0).  GR203040 produced only weak antagonism of Ca2+-evoked contractions of rat isolated portal vein (pKB = 4.1).  The enantiomer of GR203040, GR205608 ((2R, 3R)-2-methoxy-5-tetrazol-1-yl-benzyl-(2-phenyl-piperidin-3-yl)-amine), had 10,000 fold lower affinity at the human NK1 receptor expressed in CHO cells (pKi = 6.3).  In gerbil ex vivo binding expts., GR203040 produced a dose-dependent inhibition of the binding of [3H]-substance P to cerebral cortical membranes (ED50 = 15 μg kg-1 s.c. and 0.42 mg kg-1 p.o.).  At 10 μg kg-1 s.c., the inhibition of [3H]-substance P binding was maintained for >6 h.  In the rat, GR203040 was less potent (ED50 = 15.4 mg kg-1 s.c.) probably reflecting, at least in part, its lower affinity at the rat NK1 receptor.  In guinea-pig isolated ileum and dog isolated middle cerebral and basilar arteries GR203040 produced a rightward displacement of the concn.-effect curves to substance P Me ester (SPOMe) with suppression of the max. agonist response (apparent pKB values of 11.9, 11.2 and 11.1 resp.).  In anesthetized rabbits, GR203040 antagonized redns. in carotid arterial vascular resistance evoked by SPOMe, injected via the lingual artery (DR10 (i.e. the dose producing a dose-ratio of 10) = 1.1 μg kg-1 i.v.).  At a dose 20 fold grater than its DR10 value (i.e. 22 μg kg-1, i.v.) significant antagonism was evident more than 2 h after GR203040 administration.  In anesthetized rats, GR203040 (3 and 10 mg kg-1, i.v.) produced a dose-dependent inhibition of plasma protein extravasation in dura mater, conjunctiva, eyelid and lip in response to elec. stimulation of the trigeminal ganglion.  It is concluded that GR203040 is one of the most potent and selective NK1 receptor antagonists yet described, and as such, has considerable potential as a pharmacol. tool to characterize the physiol. and pathol. roles of substance P and NK1 receptors.  GR203040 may also have potential as a novel therapeutic agent for the treatment of conditions such as migraine, emesis and pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkMSmUHY0bbrVg90H21EOLACvtfcHk0lg3AiFl8ATzZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XitFWktA%253D%253D&md5=f8825fcc8f891c49604619a1ff31ae31</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb15117.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb15117.x%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DBeresford%26aufirst%3DI.%2BJ.%26aulast%3DConnor%26aufirst%3DH.%2BE.%26aulast%3DMarshall%26aufirst%3DF.%26aulast%3DHancock%26aufirst%3DA.%2BB.%26aulast%3DHagan%26aufirst%3DR.%2BM.%26aulast%3DBowers%26aufirst%3DJ.%26aulast%3DBirch%26aufirst%3DP.%2BJ.%26aulast%3DWard%26aufirst%3DP.%26atitle%3DThe%2520pharmacology%2520of%2520GR203040%252C%2520a%2520novel%252C%2520potent%2520and%2520selective%2520non-peptide%2520tachykinin%2520NK1%2520receptor%2520antagonist%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D116%26spage%3D3149%26epage%3D3157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Gardner, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armour, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beattie, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gale, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hawcock, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Twissell, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span> </span><span class="NLM_article-title">GR 205171: A novel antagonist with high affinity for the tachykinin NK-1 receptor and potent broad-spectrum anti-emetic activity</span> <span class="citation_source-journal">Regul. Pept.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">45</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0167-0115%2896%2900071-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8876035" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK28XkvFansro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1996&pages=45-53&author=C.+J.+Gardnerauthor=D.+R.+Armourauthor=D.+T.+Beattieauthor=J.+D.+Galeauthor=A.+B.+Hawcockauthor=G.+J.+Kilpatrickauthor=D.+J.+Twissellauthor=P.+Ward&title=GR+205171%3A+A+novel+antagonist+with+high+affinity+for+the+tachykinin+NK-1+receptor+and+potent+broad-spectrum+anti-emetic+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">GR 205171: A novel antagonist with high affinity for the tachykinin NK1 receptor, and potent broad-spectrum anti-emetic activity</span></div><div class="casAuthors">Gardner, C. J.; Armour, D. R.; Beattie, D. T.; Gale, J. D.; Hawcock, A. B.; Kilpatrick, G. J.; Twissell, D. J.; Ward, P.</div><div class="citationInfo"><span class="NLM_cas:title">Regulatory Peptides</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-53</span>CODEN:
                <span class="NLM_cas:coden">REPPDY</span>;
        ISSN:<span class="NLM_cas:issn">0167-0115</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">It has been demonstrated recently that antagonists of the tachykinin NK1 receptor, specifically CP-99994 and GR 203040, possess antiemetic activity in a range of species.  To optimize this activity, a series of analogs based around the structure of GR 203040 have been synthesized and their affinity at the human tachykinin NK1 receptor detd.  In addn., the potency of these analogs to inhibit emesis induced in the ferret by whole-body X-irradn. has been examd.  A range of substitutions at the C-1 position of the tetrazole moiety in GR 203040 were explored in vitro and in vivo.  The trifluoromethyl compd., GR 205171, was the most potent antagonist with regard to the ability to inhibit emesis induced by X-irradn.  This compd. was demonstrated to have a broad spectrum of anti-emetic activity, inhibiting emesis in the ferret induced by cisplatin, cyclophosphamide, morphine, ipecacuanha and copper sulfate.  Furthermore, emesis was also inhibited in the house-musk shrew, Suncus murinus, when induced by either motion or cisplatin, and in the dog when induced by ipecacuanha.  GR 205171 has the most potent anti-emetic activity of any tachykinin NK1 receptor antagonist described to date.  The compd. is orally active in the ferret and dog, long-lasting, and warrants further investigation as a potential broad-spectrum anti-emetic agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom-dLTgedcZ7Vg90H21EOLACvtfcHk0lg3AiFl8ATzZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkvFansro%253D&md5=79cba2eb7f51dfc4a0d90c7fa5859fcf</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0167-0115%2896%2900071-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0167-0115%252896%252900071-7%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DC.%2BJ.%26aulast%3DArmour%26aufirst%3DD.%2BR.%26aulast%3DBeattie%26aufirst%3DD.%2BT.%26aulast%3DGale%26aufirst%3DJ.%2BD.%26aulast%3DHawcock%26aufirst%3DA.%2BB.%26aulast%3DKilpatrick%26aufirst%3DG.%2BJ.%26aulast%3DTwissell%26aufirst%3DD.%2BJ.%26aulast%3DWard%26aufirst%3DP.%26atitle%3DGR%2520205171%253A%2520A%2520novel%2520antagonist%2520with%2520high%2520affinity%2520for%2520the%2520tachykinin%2520NK-1%2520receptor%2520and%2520potent%2520broad-spectrum%2520anti-emetic%2520activity%26jtitle%3DRegul.%2520Pept.%26date%3D1996%26volume%3D65%26spage%3D45%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Muñoz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coveñaz, R.</span><span> </span><span class="NLM_article-title">NK-1 receptor antagonists: a new paradigm in pharmacological therapy</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1820</span><span class="NLM_x">–</span> <span class="NLM_lpage">1831</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.2174%2F092986711795496746" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=21466470" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXnt1Cntr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=1820-1831&author=M.+Mu%C3%B1ozauthor=R.+Cove%C3%B1az&title=NK-1+receptor+antagonists%3A+a+new+paradigm+in+pharmacological+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">NK-1 receptor antagonists: a new paradigm in pharmacological therapy</span></div><div class="casAuthors">Munoz, M.; Covenas, R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1820-1831</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The neuropeptide substance P (SP) shows a widespread distribution in both the central and peripheral nervous systems and it is known that after binding to the neurokinin-1 (NK-1) receptors, SP regulates many biol. functions in the central nervous system such as emotional behavior, stress, depression, anxiety, emesis, migraine, alc. addiction and neurodegeneration.  SP was also implicated in pain, inflammation, hepatotoxicity and in virus proliferation, and it plays an important role in cancer (e.g., tumor cell proliferation, angiogenesis, and the migration of tumor cells for invasion and metastasis).  By contrast, it is known that after binding to NK-1 receptors, NK-1 receptor antagonists specifically inhibit the above-mentioned biol. functions mediated by SP.  Thus, these antagonists exert an anxyolitic, antidepressant, antiemetic, antimigraine, antialc. addiction or neuroprotector effect in the central nervous system, and they play a role in analgesic, antiinflammatory, hepatoprotector processes and in antivirus proliferation.  Regarding cancer, NK-1 receptor antagonists exert an antitumor action (inducing tumor cell death by apoptosis), and induce antiangiogenesis and inhibit the migration of tumor cells.  It is also known that NK-1 receptors have a widespread distribution and that they are overexpressed in tumor cells.  Thus, NK-1 receptor antagonists are molecularly targeted agents.  In general, current drugs have a single therapeutic effect, although less commonly they may exert several.  However, the data reported above indicate that NK-1 receptor antagonists are promising drugs, exerting many therapeutic effects (the action of such antagonists is dose-dependent and, depending on the concn., has more pos. effects).  In this review, we update the multiple therapeutic effects exerted by NK-1 receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJXrZR2GmS8rVg90H21EOLACvtfcHk0ljXnoWK7sJ7mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXnt1Cntr0%253D&md5=570fec14114e3ae37b9db8ff7b07cac8</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.2174%2F092986711795496746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795496746%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%26aulast%3DCove%25C3%25B1az%26aufirst%3DR.%26atitle%3DNK-1%2520receptor%2520antagonists%253A%2520a%2520new%2520paradigm%2520in%2520pharmacological%2520therapy%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D1820%26epage%3D1831" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Bergström, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fasth, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kilpatrick, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cable, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wipperman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sutherland, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langström, B.</span><span> </span><span class="NLM_article-title">Brain uptake and receptor binding of two [<sup>11</sup>C]labelled selective high affinity NK1-antagonists, GR203040 and GR205171 – PET studies in rhesus monkey</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">39</span><span class="NLM_x">, </span> <span class="NLM_fpage">664</span><span class="NLM_x">–</span> <span class="NLM_lpage">670</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2000&pages=664-670&author=M.+Bergstr%C3%B6mauthor=K.+J.+Fasthauthor=G.+Kilpatrickauthor=P.+Wardauthor=K.+M.+Cableauthor=M.+D.+Wippermanauthor=D.+R.+Sutherlandauthor=B.+Langstr%C3%B6m&title=Brain+uptake+and+receptor+binding+of+two+%5B11C%5Dlabelled+selective+high+affinity+NK1-antagonists%2C+GR203040+and+GR205171+%E2%80%93+PET+studies+in+rhesus+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBergstr%25C3%25B6m%26aufirst%3DM.%26aulast%3DFasth%26aufirst%3DK.%2BJ.%26aulast%3DKilpatrick%26aufirst%3DG.%26aulast%3DWard%26aufirst%3DP.%26aulast%3DCable%26aufirst%3DK.%2BM.%26aulast%3DWipperman%26aufirst%3DM.%2BD.%26aulast%3DSutherland%26aufirst%3DD.%2BR.%26aulast%3DLangstr%25C3%25B6m%26aufirst%3DB.%26atitle%3DBrain%2520uptake%2520and%2520receptor%2520binding%2520of%2520two%2520%255B11C%255Dlabelled%2520selective%2520high%2520affinity%2520NK1-antagonists%252C%2520GR203040%2520and%2520GR205171%2520%25E2%2580%2593%2520PET%2520studies%2520in%2520rhesus%2520monkey%26jtitle%3DNeuropharmacology%26date%3D2000%26volume%3D39%26spage%3D664%26epage%3D670" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Quartara, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, M.</span><span> </span><span class="NLM_article-title">Tachykinin receptors antagonists: from research to clinic</span> <span class="citation_source-journal">Curr. Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">975</span><span class="NLM_x">–</span> <span class="NLM_lpage">992</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.2174%2F138945006778019381" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16918326" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslCls7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2006&pages=975-992&author=L.+Quartaraauthor=M.+Altamura&title=Tachykinin+receptors+antagonists%3A+from+research+to+clinic"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Tachykinin receptors antagonists: from research to clinic</span></div><div class="casAuthors">Quartara, Laura; Altamura, Maria</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">975-992</span>CODEN:
                <span class="NLM_cas:coden">CDTUAU</span>;
        ISSN:<span class="NLM_cas:issn">1389-4501</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  In this chapter it is described how, starting from different approaches and through extensive medicinal chem. studies, several discovery compds. were optimized and reached the development stage.  The first tachykinin receptor antagonist to reach the market in 2003 for chemotherapy-induced emesis has been aprepitant.  Other clin. candidates (for central nervous system disorders: osanetant, talnetant and saredutant; for irritable bowel syndrome: nepadutant and saredutant) are in advanced clin. phase.  The clin. studies reported in the literature and the destiny of the clin. candidates, where available, will be reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqyVMlWvL_ibVg90H21EOLACvtfcHk0ljXnoWK7sJ7mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslCls7o%253D&md5=b7b74fa43a517992ff90306e9ca470e2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.2174%2F138945006778019381&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138945006778019381%26sid%3Dliteratum%253Aachs%26aulast%3DQuartara%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DM.%26atitle%3DTachykinin%2520receptors%2520antagonists%253A%2520from%2520research%2520to%2520clinic%26jtitle%3DCurr.%2520Drug%2520Targets%26date%3D2006%26volume%3D7%26spage%3D975%26epage%3D992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Hurko, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, J. L.</span><span> </span><span class="NLM_article-title">Translational research in central nervous system drug discovery</span> <span class="citation_source-journal">NeuroRx</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">–</span> <span class="NLM_lpage">682</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2005&pages=671-682&author=O.+Hurkoauthor=J.+L.+Ryan&title=Translational+research+in+central+nervous+system+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHurko%26aufirst%3DO.%26aulast%3DRyan%26aufirst%3DJ.%2BL.%26atitle%3DTranslational%2520research%2520in%2520central%2520nervous%2520system%2520drug%2520discovery%26jtitle%3DNeuroRx%26date%3D2005%26volume%3D2%26spage%3D671%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gee, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willemsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaalburg, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span> </span><span class="NLM_article-title">Measuring drug-related receptor occupancy with positron emission tomography</span> <span class="citation_source-journal">Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">278</span><span class="NLM_x">–</span> <span class="NLM_lpage">286</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2002&pages=278-286&author=J.+Passchierauthor=A.+Geeauthor=A.+Willemsenauthor=W.+Vaalburgauthor=A.+van+Waarde&title=Measuring+drug-related+receptor+occupancy+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGee%26aufirst%3DA.%26aulast%3DWillemsen%26aufirst%3DA.%26aulast%3DVaalburg%26aufirst%3DW.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26atitle%3DMeasuring%2520drug-related%2520receptor%2520occupancy%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMethods%26date%3D2002%26volume%3D27%26spage%3D278%26epage%3D286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Muly, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Votaw, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howell, L. L.</span><span> </span><span class="NLM_article-title">Relationship between dose, drug levels, and D<sub>2</sub> receptor occupancy for the atypical antipsychotics risperidone and paliperidone</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">81</span><span class="NLM_x">–</span> <span class="NLM_lpage">89</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1124%2Fjpet.111.189076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=22214649" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVagtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=81-89&author=E.+C.+Mulyauthor=J.+R.+Votawauthor=L.+L.+Howell&title=Relationship+between+dose%2C+drug+levels%2C+and+D2+receptor+occupancy+for+the+atypical+antipsychotics+risperidone+and+paliperidone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Relationship between dose, drug levels, and D2 receptor occupancy for the atypical antipsychotics risperidone and paliperidone</span></div><div class="casAuthors">Muly, E. C.; Votaw, J. R.; Ritchie, J.; Howell, L. L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-89</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Blockade of D2 family dopamine receptors (D2Rs) is a fundamental property of antipsychotics, and the degree of striatal D2R occupancy has been related to antipsychotic and motor effects of these drugs.  Recent studies suggest the D2R occupancy of antipsychotics may differ in extrastriatal regions compared with the dorsal striatum.  We studied this issue in macaque monkeys by using a within-subjects design.  [18F]fallypride positron emission tomog. scans were obtained on four different doses of risperidone and paliperidone (the 9-OH metabolite of risperidone) and compared with multiple off-drug scans in each animal.  The half-life of the two drugs in these monkeys was detd. to be between 3 and 4 h, and drug was administered by a const. infusion through an intragastric catheter.  The D2R occupancy of antipsychotic was detd. in the caudate, putamen, ventral striatum, and four prefrontal and temporal cortical regions and was related to serum and cerebrospinal fluid drug levels.  Repeated 2-wk treatment with risperidone or paliperidone did not produce lasting changes in D2R binding potential in any region examd.  As expected, D2R binding potential was highest in the caudate and putamen and was approx. one-third that level in the ventral striatum and 2% of that level in the cortical regions.  We found dose-dependent D2R occupancy for both risperidone and paliperidone in both basal ganglia and cortical regions of interest.  We could not find evidence of regional variation in D2R occupancy of either drug.  Comparison of D2R occupancy and serum drug levels supports a target of 40 to 80 ng/mL active drug for these two atypical antipsychotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9w7SZvp2gbLVg90H21EOLACvtfcHk0li6ENfQ-6XKAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVagtbs%253D&md5=c81293066e4db710684b7d5ade14872f</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.189076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.189076%26sid%3Dliteratum%253Aachs%26aulast%3DMuly%26aufirst%3DE.%2BC.%26aulast%3DVotaw%26aufirst%3DJ.%2BR.%26aulast%3DHowell%26aufirst%3DL.%2BL.%26atitle%3DRelationship%2520between%2520dose%252C%2520drug%2520levels%252C%2520and%2520D2%2520receptor%2520occupancy%2520for%2520the%2520atypical%2520antipsychotics%2520risperidone%2520and%2520paliperidone%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D81%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Monti, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jantos, H.</span><span> </span><span class="NLM_article-title">Effects of the serotonin 5-HT<sub>2A/2C</sub> receptor agonist and of the selective 5-HT<sub>2A</sub> or 5-HT<sub>2C</sub> receptor antagonists EMD 281014 and SB- 243213, respectively, on sleep and waking in the rat</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">553</span><span class="NLM_x">, </span> <span class="NLM_fpage">163</span><span class="NLM_x">–</span> <span class="NLM_lpage">167</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.ejphar.2006.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17059817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=553&publication_year=2006&pages=163-167&author=J.+M.+Montiauthor=H.+Jantos&title=Effects+of+the+serotonin+5-HT2A%2F2C+receptor+agonist+and+of+the+selective+5-HT2A+or+5-HT2C+receptor+antagonists+EMD+281014+and+SB-+243213%2C+respectively%2C+on+sleep+and+waking+in+the+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat</span></div><div class="casAuthors">Monti, Jaime M.; Jantos, Hector</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">553</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">163-170</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The effects of the serotonin 5-HT2A/2C receptor agonist 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and of the selective 5-HT2A or 5-HT2C receptor antagonists 7-{4-[2-(4-fluoro-phenyl)-ethyl]-piperazine-1-carbonyl}-1H-indole-3-carbonitrile HCl (EMD 281014) and 5-methyl-1-[[-2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline HCl (SB-243213), resp., on spontaneous sleep were studied in adult rats implanted for chronic sleep recordings.  S.c. administration of DOI (0.35-0.7 mmol/kg) significantly increased waking and light sleep and reduced slow wave sleep, rapid-eye-movement (REM) sleep, and the no. of REM periods.  With s.c. EMD 281014 (1.2-4.8 mmol/kg) or SB-243213 (1.2-4.8 mmol/kg) a significant redn. in time spent in REM sleep was also seen.  Pretreatment with EMD 281014 prevented the DOI-induced increase of waking and light sleep and the redn. of slow wave sleep.  However, REM sleep remained suppressed.  SB-243213 failed to reverse the changes of sleep and waking induced by DOI.  Thus, on the basis of these results it appears that serotonin 5-HT2A receptor mechanisms might be responsible for the DOI-induced effects on waking and slow wave sleep.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNYNE3-PqoT7Vg90H21EOLACvtfcHk0li6ENfQ-6XKAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Ciu7bM&md5=562384708b4da429f87b73286570f5de</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DMonti%26aufirst%3DJ.%2BM.%26aulast%3DJantos%26aufirst%3DH.%26atitle%3DEffects%2520of%2520the%2520serotonin%25205-HT2A%252F2C%2520receptor%2520agonist%2520and%2520of%2520the%2520selective%25205-HT2A%2520or%25205-HT2C%2520receptor%2520antagonists%2520EMD%2520281014%2520and%2520SB-%2520243213%252C%2520respectively%252C%2520on%2520sleep%2520and%2520waking%2520in%2520the%2520rat%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D553%26spage%3D163%26epage%3D167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Adamec, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Creamer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoszyk, G. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burton, P.</span><span> </span><span class="NLM_article-title">Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">504</span><span class="NLM_x">, </span> <span class="NLM_fpage">79</span><span class="NLM_x">–</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.ejphar.2004.09.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15507224" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXovFansLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=504&publication_year=2004&pages=79-96&author=R.+Adamecauthor=K.+Creamerauthor=G.+D.+Bartoszykauthor=P.+Burton&title=Prophylactic+and+therapeutic+effects+of+acute+systemic+injections+of+EMD+281014%2C+a+selective+serotonin+2A+receptor+antagonist+on+anxiety+induced+by+predator+stress+in+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Prophylactic and therapeutic effects of acute systemic injections of EMD 281014, a selective serotonin 2A receptor antagonist on anxiety induced by predator stress in rats</span></div><div class="casAuthors">Adamec, Robert; Creamer, Katherine; Bartoszyk, Gerd D.; Burton, Paul</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">504</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">79-96</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We examd. the effect of the selective serotonin 2A (5-HT2A) receptor antagonist 7-[4-[2-(4-fluorophenyl)ethyl]piperazine-1-carbonyl]-1H-indole-3-carbonitrile HCl (EMD 281014) [Bartoszyk, G.D., van Amsterdam, C., Bottcher, H., Seyfried, C.A., 2003. EMD 281014, a new selective serotonin 5-HT2A receptor antagonist. Eur. J. Pharmacol. 473, 229-230.] on change in affect following predator stress.  Predator stress involved a 5 min unprotected exposure of rats to a domestic cat.  Behavioral effects of stress were evaluated with hole board, plus maze, light/dark box and acoustic startle tests 1 wk after stress.  Predator stress increased anxiety-like behavior in the plus maze, light/dark box, and elevated response to acoustic startle.  EMD 281014 (0.001, 0.01, 0.1, 1 or 10 mg/kg) and vehicle injection (i.p.) occurred either 10 min after predator stress (prophylactic testing), or 90 min prior to behavioral testing for the effects of predator stress (therapeutic testing 1 wk after predator stress).  In prophylactic testing, EMD 281014 prevented stress potentiation of startle in a dose dependent manner, though the most EDs were midrange (0.01 and 0.1 mg/kg).  Prophylactic administration of EMD 281014 also prevented stress-induced increase of open arm avoidance in the plus maze in a clear dose dependent manner (from 0.01 mg/kg onward).  In therapeutic testing, EMD 281014 had no clear drug dependent effects on stress elevation of startle or on behavior of stressed rats in the elevated plus maze.  Finally, EMD 281014 did not block the effects of stress on behavior in the light/dark box when given prophylactically or therapeutically.  Findings implicate 5-HT2A receptors in initiation of some but not all lasting changes in anxiety-like behavior following predator stress.  Potential clin. significance of findings are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHlt-leiRZjrVg90H21EOLACvtfcHk0li6ENfQ-6XKAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXovFansLw%253D&md5=0c2c8d980c46cbd2714df6d44dfb9ef7</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.09.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.09.017%26sid%3Dliteratum%253Aachs%26aulast%3DAdamec%26aufirst%3DR.%26aulast%3DCreamer%26aufirst%3DK.%26aulast%3DBartoszyk%26aufirst%3DG.%2BD.%26aulast%3DBurton%26aufirst%3DP.%26atitle%3DProphylactic%2520and%2520therapeutic%2520effects%2520of%2520acute%2520systemic%2520injections%2520of%2520EMD%2520281014%252C%2520a%2520selective%2520serotonin%25202A%2520receptor%2520antagonist%2520on%2520anxiety%2520induced%2520by%2520predator%2520stress%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D504%26spage%3D79%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Mamo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tillner, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellers, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romach, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">EMD 281014, a specific and potent 5-HT<sub>2</sub> antagonist in humans: a dose-finding PET study</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">175</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">–</span> <span class="NLM_lpage">388</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=175&publication_year=2004&pages=382-388&author=D.+Mamoauthor=E.+Sedmanauthor=J.+Tillnerauthor=E.+M.+Sellersauthor=M.+K.+Romachauthor=S.+Kapur&title=EMD+281014%2C+a+specific+and+potent+5-HT2+antagonist+in+humans%3A+a+dose-finding+PET+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMamo%26aufirst%3DD.%26aulast%3DSedman%26aufirst%3DE.%26aulast%3DTillner%26aufirst%3DJ.%26aulast%3DSellers%26aufirst%3DE.%2BM.%26aulast%3DRomach%26aufirst%3DM.%2BK.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DEMD%2520281014%252C%2520a%2520specific%2520and%2520potent%25205-HT2%2520antagonist%2520in%2520humans%253A%2520a%2520dose-finding%2520PET%2520study%26jtitle%3DPsychopharmacology%26date%3D2004%26volume%3D175%26spage%3D382%26epage%3D388" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Offord, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravert, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salzmann, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szymanski, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span> </span><span class="NLM_article-title">Time course of 5-HT<sub>2A</sub> receptor occupancy in the human brain after a single oral dose of the putative antipsychotic drug MDL 100,907 measured by positron emission tomography</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">175</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1997&pages=175-185&author=G.+Gr%C3%BCnderauthor=F.+Yokoiauthor=S.+J.+Offordauthor=H.+T.+Ravertauthor=R.+F.+Dannalsauthor=J.+K.+Salzmannauthor=S.+Szymanskiauthor=P.+D.+Wilsonauthor=D.+R.+Howardauthor=D.+F.+Wong&title=Time+course+of+5-HT2A+receptor+occupancy+in+the+human+brain+after+a+single+oral+dose+of+the+putative+antipsychotic+drug+MDL+100%2C907+measured+by+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DYokoi%26aufirst%3DF.%26aulast%3DOfford%26aufirst%3DS.%2BJ.%26aulast%3DRavert%26aufirst%3DH.%2BT.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DSalzmann%26aufirst%3DJ.%2BK.%26aulast%3DSzymanski%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DP.%2BD.%26aulast%3DHoward%26aufirst%3DD.%2BR.%26aulast%3DWong%26aufirst%3DD.%2BF.%26atitle%3DTime%2520course%2520of%25205-HT2A%2520receptor%2520occupancy%2520in%2520the%2520human%2520brain%2520after%2520a%2520single%2520oral%2520dose%2520of%2520the%2520putative%2520antipsychotic%2520drug%2520MDL%2520100%252C907%2520measured%2520by%2520positron%2520emission%2520tomography%26jtitle%3DNeuropsychopharmacology%26date%3D1997%26volume%3D17%26spage%3D175%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Spreckelmeyer, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paulzen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baltus, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaffrath, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Waesberghe, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zalewski, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rösch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schäfer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gründer, G.</span><span> </span><span class="NLM_article-title">Opiate-induced dopamine release is modulated by severity of alcohol dependence: an [<sup>18</sup>F]fallypride positron emission tomography study</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">770</span><span class="NLM_x">–</span> <span class="NLM_lpage">776</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.biopsych.2011.05.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=21802658" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GntrnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2011&pages=770-776&author=K.+N.+Spreckelmeyerauthor=M.+Paulzenauthor=M.+Raptisauthor=T.+Baltusauthor=S.+Schaffrathauthor=J.+Van+Waesbergheauthor=M.+M.+Zalewskiauthor=F.+R%C3%B6schauthor=I.+Vernalekenauthor=W.+M.+Sch%C3%A4ferauthor=G.+Gr%C3%BCnder&title=Opiate-induced+dopamine+release+is+modulated+by+severity+of+alcohol+dependence%3A+an+%5B18F%5Dfallypride+positron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Opiate-Induced Dopamine Release Is Modulated by Severity of Alcohol Dependence: An [18F]Fallypride Positron Emission Tomography Study</span></div><div class="casAuthors">Spreckelmeyer, Katja N.; Paulzen, Michael; Raptis, Mardjan; Baltus, Thomas; Schaffrath, Sabrina; Van Waesberghe, Julia; Zalewski, Magdalena M.; Roesch, Frank; Vernaleken, Ingo; Schaefer, Wolfgang M.; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">770-776</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Preclin. data implicate the reinforcing effects of alc. to be mediated by interaction between the opioid and dopamine systems of the brain.  Specifically, alc.-induced release of β-endorphins stimulates μ-opioid receptors (MORs), which is believed to cause dopamine release in the brain reward system.  Individual differences in opioid or dopamine neurotransmission have been suggested to be responsible for enhanced liability to abuse alc.  In the present study, a single dose of the MOR agonist remifentanil was administered in detoxified alc.-dependent patients and healthy control subjects to mimic the β-endorphin-releasing properties of ethanol and to assess the effects of direct MOR stimulation on dopamine release in the mesolimbic reward system.  Methods: Availability of D2/3 receptors was assessed before and after single-dose administration of the MOR agonist remifentanil in 11 detoxified alc.-dependent patients and 11 healthy control subjects with positron emission tomog. with the radiotracer [18F]fallypride.  Severity of dependence as assessed with the Alc. Use Disorders Identification Test was compared with remifentanil-induced percentage change in [18F]fallypride binding (Δ%BPND).  Results: The [18F]fallypride binding potentials (BPNDs) were significantly reduced in the ventral striatum, dorsal putamen, and amygdala after remifentanil application in both patients and control subjects.  In the patient group, ventral striatum Δ%BPND was correlated with the Alc. Use Disorders Identification Test score.  Conclusions: The data provide evidence for a MOR-mediated interaction between the opioid and the dopamine system, supporting the assumption that one way by which alc. unfolds its rewarding effects is via a MOR-(γ-aminobutyric acid)-dopamine pathway.  No difference in dopamine release was found between patients and control subjects, but evidence for a patient-specific assocn. between sensitivity to MOR stimulation and severity of alc. dependence was found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9_rmQS3VgALVg90H21EOLACvtfcHk0ligpkFk2Df3vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GntrnI&md5=e744c940295d315c45a9f50c83e8aa12</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2011.05.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2011.05.035%26sid%3Dliteratum%253Aachs%26aulast%3DSpreckelmeyer%26aufirst%3DK.%2BN.%26aulast%3DPaulzen%26aufirst%3DM.%26aulast%3DRaptis%26aufirst%3DM.%26aulast%3DBaltus%26aufirst%3DT.%26aulast%3DSchaffrath%26aufirst%3DS.%26aulast%3DVan%2BWaesberghe%26aufirst%3DJ.%26aulast%3DZalewski%26aufirst%3DM.%2BM.%26aulast%3DR%25C3%25B6sch%26aufirst%3DF.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DSch%25C3%25A4fer%26aufirst%3DW.%2BM.%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26atitle%3DOpiate-induced%2520dopamine%2520release%2520is%2520modulated%2520by%2520severity%2520of%2520alcohol%2520dependence%253A%2520an%2520%255B18F%255Dfallypride%2520positron%2520emission%2520tomography%2520study%26jtitle%3DBiol.%2520Psychiatry%26date%3D2011%26volume%3D70%26spage%3D770%26epage%3D776" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Mathis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, N. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mahmood, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinahan, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mintun, M. A.</span><span> </span><span class="NLM_article-title">[<sup>11</sup>C]WAY-100,635: a radioligand for imaging 5-HT<sub>1A</sub> receptors with position emission tomography</span> <span class="citation_source-journal">Life Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">–</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1994&pages=403-407&author=C.+A.+Mathisauthor=N.+R.+Simpsonauthor=K.+Mahmoodauthor=P.+E.+Kinahanauthor=M.+A.+Mintun&title=%5B11C%5DWAY-100%2C635%3A+a+radioligand+for+imaging+5-HT1A+receptors+with+position+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMathis%26aufirst%3DC.%2BA.%26aulast%3DSimpson%26aufirst%3DN.%2BR.%26aulast%3DMahmood%26aufirst%3DK.%26aulast%3DKinahan%26aufirst%3DP.%2BE.%26aulast%3DMintun%26aufirst%3DM.%2BA.%26atitle%3D%255B11C%255DWAY-100%252C635%253A%2520a%2520radioligand%2520for%2520imaging%25205-HT1A%2520receptors%2520with%2520position%2520emission%2520tomography%26jtitle%3DLife%2520Sci.%26date%3D1994%26volume%3D55%26spage%3D403%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malizia, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, C. J.</span><span> </span><span class="NLM_article-title">First delineation of 5-HT1A receptors in human brain with PET and [<sup>11</sup>C]WAY-100,635</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">283</span><span class="NLM_x">, </span> <span class="NLM_fpage">R1</span><span class="NLM_x">–</span> <span class="NLM_lpage">3</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=283&publication_year=1995&pages=R1-3&author=V.+W.+Pikeauthor=J.+A.+McCarronauthor=A.+A.+Lammertsmaauthor=S.+P.+Humeauthor=K.+Pooleauthor=P.+M.+Grasbyauthor=A.+Maliziaauthor=I.+A.+Cliffeauthor=A.+Fletcherauthor=C.+J.+Bench&title=First+delineation+of+5-HT1A+receptors+in+human+brain+with+PET+and+%5B11C%5DWAY-100%2C635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DPoole%26aufirst%3DK.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26aulast%3DMalizia%26aufirst%3DA.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DBench%26aufirst%3DC.%2BJ.%26atitle%3DFirst%2520delineation%2520of%25205-HT1A%2520receptors%2520in%2520human%2520brain%2520with%2520PET%2520and%2520%255B11C%255DWAY-100%252C635%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D283%26spage%3DR1%26epage%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Osman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundkvist, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swahn, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lut5hra, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wikström, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barf, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Characterization of the radioactive metabolites of the 5-HT<sub>1A</sub> receptor radioligand, [O-methyl-<sup>11</sup>C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behaviour of an identified radioactive metabolite with parent radioligand in monkey using PET</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">627</span><span class="NLM_x">–</span> <span class="NLM_lpage">634</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0969-8051%2896%2900061-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8905828" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK28XlsVamur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1996&pages=627-634&author=S.+Osmanauthor=C.+Lundkvistauthor=V.+W.+Pikeauthor=C.+Halldinauthor=J.+A.+McCarronauthor=C.+G.+Swahnauthor=N.+Ginovartauthor=S.+K.+Lut5hraauthor=C.+J.+Benchauthor=P.+M.+Grasbyauthor=H.+Wikstr%C3%B6mauthor=T.+Barfauthor=I.+A.+Cliffeauthor=A.+Fletcherauthor=L.+Farde&title=Characterization+of+the+radioactive+metabolites+of+the+5-HT1A+receptor+radioligand%2C+%5BO-methyl-11C%5DWAY-100635%2C+in+monkey+and+human+plasma+by+HPLC%3A+comparison+of+the+behaviour+of+an+identified+radioactive+metabolite+with+parent+radioligand+in+monkey+using+PET"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the radioactive metabolites of the 5-HT1A receptor radioligand, [O-methyl-11C]WAY-100635, in monkey and human plasma by HPLC: comparison of the behavior of an identified radioactive metabolite with parent radioligand in monkey using PET</span></div><div class="casAuthors">Osman, Safiye; Lundkvist, Camilla; Pike, Victor W.; Halldin, Christer; McCarron, Julie A.; Swahn, Carl-Gunnar; Ginovart, Natalie; Luthra, Sajinder K.; Bench, Christopher J.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">627-634</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">N-(2-(4-(2-Methoxy-phenyl)-1-piperazin-1-yl)ethyl)-N-(2-pyridyl)cyclohexanecarboxamide (WAY-100635), labeled in the O-Me group with carbon-11 (t1/2 = 20.4 min), is a promising radioligand for application with positron emission tomog. (PET) to the study of 5-HT1A receptors in living human brain.  An understanding of the metab. of this new radioligand is crucial to the development of a biomathematical model for the interpretation of the kinetics of radioactivity uptake in brain in terms of receptor-binding parameters.  After i.v. injection of [O-methyl-11C]WAY-100635 into humans, radioactivity was found to clear rapidly from blood and plasma.  By using established methods for the anal. of radioactivity in plasma, it was found that i.v. injected [O-methyl-11C]WAY-100635 is rapidly metabolized to more polar radioactive compds. in a cynomolgus monkey and in humans.  Thus, at 60 min postinjection, parent radioligand represented 40% and 5% of the radioactivity in monkey and human plasma, resp.  In monkey and human, one of the radioactive metabolites was identified as the descyclohexanecarbonyl analog of the parent radioligand, namely [O-methyl-11C]WAY-100634.  This compd. a known to have high affinity for 5-HT1A receptors and α1-adrenoceptors.  In a PET expt. it was demonstrated that, after IV injection of [O-methyl-11C]WAY-100634 into a cynomolgus monkey, radioactivity was avidly taken up by brain.  Uptake of radioactivity was higher in 5-HT1A receptor-rich frontal cortex than in cerebellum, which is devoid of 5-HT1A receptors.  Polar radioactive metabolites appeared in plasma.  The results suggest that the use of WAY-100635 labeled with carbon-11 in its cyclohexanecarbonyl moiety may provide enhanced signal contrast in PET studies and a possibility to develop a simple biomathematical model for regional brain radioactivity uptake.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTwy2VRP0sXLVg90H21EOLACvtfcHk0lizE86_Urvjew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XlsVamur0%253D&md5=dacf9d3783924316113749f6efc63a9c</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2896%2900061-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252896%252900061-3%26sid%3Dliteratum%253Aachs%26aulast%3DOsman%26aufirst%3DS.%26aulast%3DLundkvist%26aufirst%3DC.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DSwahn%26aufirst%3DC.%2BG.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DLut5hra%26aufirst%3DS.%2BK.%26aulast%3DBench%26aufirst%3DC.%2BJ.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26aulast%3DWikstr%25C3%25B6m%26aufirst%3DH.%26aulast%3DBarf%26aufirst%3DT.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DCharacterization%2520of%2520the%2520radioactive%2520metabolites%2520of%2520the%25205-HT1A%2520receptor%2520radioligand%252C%2520%255BO-methyl-11C%255DWAY-100635%252C%2520in%2520monkey%2520and%2520human%2520plasma%2520by%2520HPLC%253A%2520comparison%2520of%2520the%2520behaviour%2520of%2520an%2520identified%2520radioactive%2520metabolite%2520with%2520parent%2520radioligand%2520in%2520monkey%2520using%2520PET%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1996%26volume%3D23%26spage%3D627%26epage%3D634" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Parsey, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slifstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hwang, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Dargham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simpson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mawlawi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, N. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span> </span><span class="NLM_article-title">Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-<sup>11</sup>C]WAY-100635 in humans: comparison of arterial and reference tissue input functions</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1111</span><span class="NLM_x">–</span> <span class="NLM_lpage">1133</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2F00004647-200007000-00011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10908045" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXltFOmu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=1111-1133&author=R.+V.+Parseyauthor=M.+Slifsteinauthor=D.+R.+Hwangauthor=A.+Abi-Darghamauthor=N.+Simpsonauthor=O.+Mawlawiauthor=N.+N.+Guoauthor=H.+R.+Vanauthor=J.+J.+Mannauthor=M.+Laruelle&title=Validation+and+reproducibility+of+measurement+of+5-HT1A+receptor+parameters+with+%5Bcarbonyl-11C%5DWAY-100635+in+humans%3A+comparison+of+arterial+and+reference+tissue+input+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: Comparison of arterial and reference tissue input functions</span></div><div class="casAuthors">Parsey, Ramin V.; Slifstein, Mark; Hwang, Dah-Ren; Abi-Dargham, Anissa; Simpson, Norman; Mawlawi, Osama; Guo, Ning-Ning; Van Heertum, Ronald; Mann, J. John; Laruelle, Marc</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1111-1133</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Serotonin 5-HT1A receptors are implicated in the pathophysiol. of neuropsychiatric conditions.  The goal of this study was to evaluate methods to derive 5-HT1A receptor parameters in the human brain with positron emission tomog. (PET) and [carbonyl-11C]WAY 100635.  Five healthy volunteer subjects were studied twice.  Three methods of anal. were used to derive the binding potential (BP), and the specific to nonspecific equil. partition coeff. (k3/k4).  Two methods, kinetic anal. based on a three compartment model and graphical anal., used the arterial plasma time-activity curves as the input function to derive BP and k3/k4.  A third method, the simplified ref. tissue model (SRTM), derived the input function from uptake data of a region of ref., the cerebellum, and provided only k3/k4.  All methods provided ests. of regional 5-HT1A receptor parameters that were highly correlated.  Results were consistent with the known distribution of 5-HT1A receptors in the human brain.  Compared with kinetic BP, graphical anal. slightly underestimated BP, and this phenomenon was mostly apparent in small size-high noise regions.  Compared with kinetic k3/k4, the ref. tissue method underestimated k3/k4 and the underestimation was apparent primarily in regions with high receptor d.  Derivation of BP by both kinetic and graphical anal. was highly reliable, with an intraclass correlation coeff. (ICC) of 0.84 ± 0.14 (mean ± SD of 15 regions) and 0.84 ± 0.19, resp.  In contrast, the reliability of k3/k4 was lower, with ICC of 0.53 ± 0.28, 0.47 ± 0.28, and 0.55 ± 0.29 for kinetic, graphical, and ref. tissue methods, resp.  In conclusion, derivation of BP by kinetic anal. using the arterial plasma input function appeared as the method of choice because of its higher test-retest reproducibility, lower vulnerability to exptl. noise, and absence of bias.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWSXlzXvpqdLVg90H21EOLACvtfcHk0lizE86_Urvjew"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXltFOmu74%253D&md5=2e708aa8a52b0e2fb28f5fac867e92ff</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1097%2F00004647-200007000-00011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200007000-00011%26sid%3Dliteratum%253Aachs%26aulast%3DParsey%26aufirst%3DR.%2BV.%26aulast%3DSlifstein%26aufirst%3DM.%26aulast%3DHwang%26aufirst%3DD.%2BR.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26aulast%3DSimpson%26aufirst%3DN.%26aulast%3DMawlawi%26aufirst%3DO.%26aulast%3DGuo%26aufirst%3DN.%2BN.%26aulast%3DVan%26aufirst%3DH.%2BR.%26aulast%3DMann%26aufirst%3DJ.%2BJ.%26aulast%3DLaruelle%26aufirst%3DM.%26atitle%3DValidation%2520and%2520reproducibility%2520of%2520measurement%2520of%25205-HT1A%2520receptor%2520parameters%2520with%2520%255Bcarbonyl-11C%255DWAY-100635%2520in%2520humans%253A%2520comparison%2520of%2520arterial%2520and%2520reference%2520tissue%2520input%2520functions%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2000%26volume%3D20%26spage%3D1111%26epage%3D1133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Pike, V. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCarron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lammertsma, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hume, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sargent, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bench, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fletcher, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">Exquisite delineation of 5-HT<sub>1A</sub> receptors in human brain with PET and [carbonyl-<sup>11</sup>C]WAY-100635</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">301</span><span class="NLM_x">, </span> <span class="NLM_fpage">R5</span><span class="NLM_x">–</span> <span class="NLM_lpage">7</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=301&publication_year=1996&pages=R5-7&author=V.+W.+Pikeauthor=J.+A.+McCarronauthor=A.+A.+Lammertsmaauthor=S.+Osmanauthor=S.+P.+Humeauthor=P.+A.+Sargentauthor=C.+J.+Benchauthor=I.+A.+Cliffeauthor=A.+Fletcherauthor=P.+M.+Grasby&title=Exquisite+delineation+of+5-HT1A+receptors+in+human+brain+with+PET+and+%5Bcarbonyl-11C%5DWAY-100635"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DMcCarron%26aufirst%3DJ.%2BA.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DOsman%26aufirst%3DS.%26aulast%3DHume%26aufirst%3DS.%2BP.%26aulast%3DSargent%26aufirst%3DP.%2BA.%26aulast%3DBench%26aufirst%3DC.%2BJ.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DFletcher%26aufirst%3DA.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3DExquisite%2520delineation%2520of%25205-HT1A%2520receptors%2520in%2520human%2520brain%2520with%2520PET%2520and%2520%255Bcarbonyl-11C%255DWAY-100635%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D301%26spage%3DR5%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Dahlström, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, F.</span><span> </span><span class="NLM_article-title">Evidence for the existence of monoamine-containing neurons in the central nervous system</span> <span class="citation_source-journal">Acta Physiol. Scand.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1964</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">55</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=1964&pages=1-55&author=A.+Dahlstr%C3%B6mauthor=F.+Fuxe&title=Evidence+for+the+existence+of+monoamine-containing+neurons+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDahlstr%25C3%25B6m%26aufirst%3DA.%26aulast%3DFuxe%26aufirst%3DF.%26atitle%3DEvidence%2520for%2520the%2520existence%2520of%2520monoamine-containing%2520neurons%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DActa%2520Physiol.%2520Scand.%26date%3D1964%26volume%3D62%26spage%3D1%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Seamans, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C. R.</span><span> </span><span class="NLM_article-title">The principal features and mechanisms of dopamine modulation in the prefrontal cortex</span> <span class="citation_source-journal">Prog. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">58</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.pneurobio.2004.05.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15381316" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnslKgtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2004&pages=1-58&author=J.+K.+Seamansauthor=C.+R.+Yang&title=The+principal+features+and+mechanisms+of+dopamine+modulation+in+the+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">The principal features and mechanisms of dopamine modulation in the prefrontal cortex</span></div><div class="casAuthors">Seamans, Jeremy K.; Yang, Charles R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-58</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Mesocortical dopamine (DA) inputs to the prefrontal cortex (PFC) play a crit. role in normal cognitive process and neuropsychiatic pathologies.  This DA input regulates aspects of working memory function, planning and attention, and its dysfunctions may underlie pos. and neg. symptoms and cognitive deficits assocd. with schizophrenia.  Despite intense research, there is still a lack of clear understanding of the basic principles of actions of DA in the PFC.  In recent years, there has been considerable efforts by many groups to understand the cellular mechanisms of DA modulation of PFC neurons.  However, the results of these efforts often lead to contradictions and controversies.  One principal feature of DA that is agreed by most researchers is that DA is a neuromodulator and is clearly not an excitatory or inhibitory neurotransmitter.  The present article aims to identify certain principles of DA mechanisms by drawing on published, as well as unpublished data from PFC and other CNS sites to shed light on aspects of DA neuromodulation and address some of the existing controversies.  Eighteen key features about DA modulation have been identified.  These points directly impact on the end result of DA neuromodulation, and in some cases explain why DA does not yield identical effects under all exptl. conditions.  It will become apparent that DA's actions in PFC are subtle and depend on a variety of factors that can no longer be ignored.  Some of these key factors include distinct bell-shaped dose-response profiles of postsynaptic DA effects, different postsynaptic responses that are contingent on the duration of DA receptor stimulation, prolonged duration effects, bidirectional effects following activation of D1 and D2 classes of receptors and membrane potential state and history dependence of subsequent DA actions.  It is hoped that these factors will be borne in mind in future research and as a result a more consistent picture of DA neuromodulation in the PFC will emerge.  Based on these factors, a theory is proposed for DA's action in PFC.  This theory suggests that DA acts to expand or contract the breadth of information held in working memory buffers in PFC networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEDnP_rV_xe7Vg90H21EOLACvtfcHk0lgIJZki0wi3Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnslKgtr8%253D&md5=4b6f7eb3f67960face70d60249906b16</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2Fj.pneurobio.2004.05.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pneurobio.2004.05.006%26sid%3Dliteratum%253Aachs%26aulast%3DSeamans%26aufirst%3DJ.%2BK.%26aulast%3DYang%26aufirst%3DC.%2BR.%26atitle%3DThe%2520principal%2520features%2520and%2520mechanisms%2520of%2520dopamine%2520modulation%2520in%2520the%2520prefrontal%2520cortex%26jtitle%3DProg.%2520Neurobiol.%26date%3D2004%26volume%3D74%26spage%3D1%26epage%3D58" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Durstewitz, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seamans, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sejnowski, T. J.</span><span> </span><span class="NLM_article-title">Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex</span> <span class="citation_source-journal">J. Neurophysiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">83</span><span class="NLM_x">, </span> <span class="NLM_fpage">1733</span><span class="NLM_x">–</span> <span class="NLM_lpage">1750</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10712493" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXisVartLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2000&pages=1733-1750&author=D.+Durstewitzauthor=J.+K.+Seamansauthor=T.+J.+Sejnowski&title=Dopamine-mediated+stabilization+of+delay-period+activity+in+a+network+model+of+prefrontal+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine-mediated stabilization of delay-period activity in a network model of prefrontal cortex</span></div><div class="casAuthors">Durstewitz, Daniel; Seamans, Jeremy K.; Sejnowski, Terrence J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurophysiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1733-1750</span>CODEN:
                <span class="NLM_cas:coden">JONEA4</span>;
        ISSN:<span class="NLM_cas:issn">0022-3077</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">The prefrontal cortex (PFC) is critically involved in working memory, which underlies memory-guided, goal-directed behavior.  During working-memory tasks, PFC neurons exhibit sustained elevated activity, which may reflect the active holding of goal-related information or the prepn. of forthcoming actions.  Dopamine via the D1 receptor strongly modulates both this sustained (delay-period) activity and behavioral performance in working-memory tasks.  However, the function of dopamine during delay-period activity and the underlying neural mechanisms are only poorly understood.  Recently we proposed that dopamine might stabilize active neural representations in PFC circuits during tasks involving working memory and render them robust against interfering stimuli and noise.  To further test this idea and to examine the dopamine-modulated ionic currents that could give rise to increased stability of neural representations, we developed a network model of the PFC consisting of multicompartment neurons equipped with Hodgkin-Huxley-like channel kinetics that could reproduce in vitro whole cell and in vivo recordings from PFC neurons.  Dopaminergic effects on intrinsic ionic and synaptic conductances were implemented in the model based on in vitro data.  Simulated dopamine strongly enhanced high, delay-type activity but not low, spontaneous activity in the model network.  Furthermore the strength of an afferent stimulation needed to disrupt delay-type activity increased with the magnitude of the dopamine-induced shifts in network parameters, making the currently active representation much more stable.  Stability could be increased by dopamine-induced enhancements of the persistent Na+ and N-methyl-D-aspartate (NMDA) conductances.  Stability also was enhanced by a redn. in AMPA conductances.  The increase in GABAA conductances that occurs after stimulation of dopaminergic D1 receptors was necessary in this context to prevent uncontrolled, spontaneous switches into high-activity states (i.e., spontaneous activation of task-irrelevant representations).  In conclusion, the dopamine-induced changes in the biophys. properties of intrinsic ionic and synaptic conductances conjointly acted to highly increase stability of activated representations in PFC networks and at the same time retain control over network behavior and thus preserve its ability to adequately respond to task-related stimuli.  Predictions of the model can be tested in vivo by locally applying specific D1 receptor, NMDA, or GABAA antagonists while recording from PFC neurons in delayed reaction-type tasks with interfering stimuli.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoiimtDszYfL7Vg90H21EOLACvtfcHk0lgIJZki0wi3Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXisVartLk%253D&md5=08b4ecc8d58dea1494b29ab4bd3d4b5c</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDurstewitz%26aufirst%3DD.%26aulast%3DSeamans%26aufirst%3DJ.%2BK.%26aulast%3DSejnowski%26aufirst%3DT.%2BJ.%26atitle%3DDopamine-mediated%2520stabilization%2520of%2520delay-period%2520activity%2520in%2520a%2520network%2520model%2520of%2520prefrontal%2520cortex%26jtitle%3DJ.%2520Neurophysiol.%26date%3D2000%26volume%3D83%26spage%3D1733%26epage%3D1750" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindqvist, M.</span><span> </span><span class="NLM_article-title">Effect of chlorpromazine and haloperidol on formation of 3-methoxytyramine and normetanephrine on mouse brain</span> <span class="citation_source-journal">Acta Pharmacol. Toxicol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1963</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1600-0773.1963.tb01730.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=14060771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaF2cXjsVWhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1963&pages=140-144&author=A.+Carlssonauthor=M.+Lindqvist&title=Effect+of+chlorpromazine+and+haloperidol+on+formation+of+3-methoxytyramine+and+normetanephrine+on+mouse+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chlorpromazine or haloperidol on formation of 3-methoxytyramine and normetanephrine in mouse brain</span></div><div class="casAuthors">Carlsson, Arvid; Lindqvist, Margit</div><div class="citationInfo"><span class="NLM_cas:title">Acta Pharmacologica et Toxicologica</span>
        (<span class="NLM_cas:date">1963</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140-4</span>CODEN:
                <span class="NLM_cas:coden">APTOA6</span>;
        ISSN:<span class="NLM_cas:issn">0001-6683</span>.
    </div><div class="casAbstract">Mice were injected intraperitoneally with nialamide (100 mg./kg.); 1 hr. later various doses of chlorpromazine (I), haloperidol (II), phenoxybenzamine (III), or promethazine (IV) were given intraperitoneally and the mice beheaded 3 hrs. later.  The accumulation in the brain of O-methylated catechol amine metabolites 3-methoxytyramine and normetanephrine brought about by nialamide was enhanced by I and II, whereas III and IV were ineffective.  It was suggested that the effect is due to a compensatory activation of monoaminergic neurons after blockade of monoaminergic receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4IP5WRzj4r7Vg90H21EOLACvtfcHk0lgIJZki0wi3Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2cXjsVWhug%253D%253D&md5=1dff235769b12e0bb4b7a077b484b887</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-0773.1963.tb01730.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-0773.1963.tb01730.x%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DLindqvist%26aufirst%3DM.%26atitle%3DEffect%2520of%2520chlorpromazine%2520and%2520haloperidol%2520on%2520formation%2520of%25203-methoxytyramine%2520and%2520normetanephrine%2520on%2520mouse%2520brain%26jtitle%3DActa%2520Pharmacol.%2520Toxicol.%26date%3D1963%26volume%3D20%26spage%3D140%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Costall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, R. J.</span><span> </span><span class="NLM_article-title">Detection of the neuroleptic properties of clozapine, sulpiride and thioridazine</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">–</span> <span class="NLM_lpage">74</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1975&pages=69-74&author=B.+Costallauthor=R.+J.+Naylor&title=Detection+of+the+neuroleptic+properties+of+clozapine%2C+sulpiride+and+thioridazine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostall%26aufirst%3DB.%26aulast%3DNaylor%26aufirst%3DR.%2BJ.%26atitle%3DDetection%2520of%2520the%2520neuroleptic%2520properties%2520of%2520clozapine%252C%2520sulpiride%2520and%2520thioridazine%26jtitle%3DPsychopharmacology%26date%3D1975%26volume%3D43%26spage%3D69%26epage%3D74" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Angst, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bente, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimann, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helmchen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hippius, H.</span><span> </span><span class="NLM_article-title">Das klinische Wirkungsbild von Clozapin</span> <span class="citation_source-journal">Pharmakopsychiatrie</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1971</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">201</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1055%2Fs-0028-1094313" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1971&pages=201-221&author=J.+Angstauthor=D.+Benteauthor=P.+Bernerauthor=H.+Heimannauthor=H.+Helmchenauthor=H.+Hippius&title=Das+klinische+Wirkungsbild+von+Clozapin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1055%2Fs-0028-1094313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0028-1094313%26sid%3Dliteratum%253Aachs%26aulast%3DAngst%26aufirst%3DJ.%26aulast%3DBente%26aufirst%3DD.%26aulast%3DBerner%26aufirst%3DP.%26aulast%3DHeimann%26aufirst%3DH.%26aulast%3DHelmchen%26aufirst%3DH.%26aulast%3DHippius%26aufirst%3DH.%26atitle%3DDas%2520klinische%2520Wirkungsbild%2520von%2520Clozapin%26jtitle%3DPharmakopsychiatrie%26date%3D1971%26volume%3D4%26spage%3D201%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Glowinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iversen, L. L.</span><span> </span><span class="NLM_article-title">Regional studies of catecholamines in the rat brain. I. The disposition of [<sup>3</sup>H]norepinephrine, [<sup>3</sup>H]dopamine and [<sup>3</sup>H]dopa in various regions of the brain</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1966</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">655</span><span class="NLM_x">–</span> <span class="NLM_lpage">669</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1471-4159.1966.tb09873.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=5950056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaF28Xks1Kqtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=1966&pages=655-669&author=J.+Glowinskiauthor=L.+L.+Iversen&title=Regional+studies+of+catecholamines+in+the+rat+brain.+I.+The+disposition+of+%5B3H%5Dnorepinephrine%2C+%5B3H%5Ddopamine+and+%5B3H%5Ddopa+in+various+regions+of+the+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Catechol amines in rat brain. I. Disposition of norepinephrine-3H, dopamine-3H, and dopa-3H in various regions of the brain</span></div><div class="casAuthors">Glowinski, Jacques; Iversen, Leslie L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1966</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">655-69</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">The hypothalamus, medulla oblongata, midbrain, striatum, cortex, hippocampus, and cerebellum of rat brain contained 1.79, 0.72, 0.37, 0.25, 0.24, 0.20, and 0.17 γ endogenous norepinephrine (I) per g., resp., and accumulated 2.13, 0.81, 0.97, 1.16, 0.30, 0.96, and 0.42 μc. tritiated norepinephrine (II) per g., resp., 1 hr. after intraventricular injection of 6.3 μc. II.  Since the levels of II in the hypothalamus were 5- and 16-fold greater than in the cerebellum 1 and 24 hrs. after the injection, resp., II disappears at different rates in different brain regions.  There were no qual. differences in the metabolism of II in the different brain regions, although quant. differences in II metabolites occurred.  In all regions except the cerebellum and cortex, the ratio of unchanged II to II metabolites decreased with time.  Labeled O-methylated deaminated metabolites of II accounted for 70% of total II metabolites, 1 hr. after injection, while labeled normetanephrine (III) or catechol deaminated metabolites of II did not exceed 10% of the total activity in any brain region.  Labeled III remained a const. fraction of the total radioactivity in all regions at various times after injection even though O-methylated deaminated and catechol deaminated metabolites of II decreased in most regions; labeled III represented the major metabolite in the hypothalamus, 24 hrs. after the injections.  The hypothalamus, medulla oblongata, midbrain, striatum, cortex, hippocampus, and cerebellum contained 667, 311, 326, 734, 126, 353, and 153 mμc. labeled catechol amine/g., resp., 1 hr. after intraventricular injection of 17 μc. dopamine-3H; the distribution was similar to that occurring after injection of II, although the levels of dopamine-3H were 64.0, 53.4, 68.0, 93.5, 70.7, 69.8, and 40.7%, resp., of the total catechol amines.  The max. levels of II were reached at different times in the various regions; this max. occurred 15, 30, and 60 min. after the injection in the medulla oblongata, hypothalamus, and striatum, resp., which indicates varying conversion rates of dopamine to I in the different brain regions.  A limited conversion to catechol amines occurred following injection of dopa-3H (105 μc.); the highest concns. of dopamine-3H and II were in the hypothalamus (2.2 and 0.18 μc./g., resp.) and the lowest in the cortex (0.4 and 0.03 μc./g., resp.), 5 hrs. after injection.  At this time, the levels of labeled dopamine were 45-fold greater than those of II in the striatum, and 10- to 15-fold greater in the other regions.  There was more labeled dopa than labeled catechol amines in all brain areas.  36 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhhlcUdIr08LVg90H21EOLACvtfcHk0lif8clLe7cGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF28Xks1Kqtrw%253D&md5=636423937e98d736d783e0d05c36d83c</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1966.tb09873.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1966.tb09873.x%26sid%3Dliteratum%253Aachs%26aulast%3DGlowinski%26aufirst%3DJ.%26aulast%3DIversen%26aufirst%3DL.%2BL.%26atitle%3DRegional%2520studies%2520of%2520catecholamines%2520in%2520the%2520rat%2520brain.%2520I.%2520The%2520disposition%2520of%2520%255B3H%255Dnorepinephrine%252C%2520%255B3H%255Ddopamine%2520and%2520%255B3H%255Ddopa%2520in%2520various%2520regions%2520of%2520the%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1966%26volume%3D13%26spage%3D655%26epage%3D669" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Firnau, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nahmias, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garnett, S.</span><span> </span><span class="NLM_article-title">The preparation of [<sup>18</sup>F]5-fluoro-DOPA with reactor-produced fluorine-18</span> <span class="citation_source-journal">Int. J. Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">184</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0020-708X%2873%2990008-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=4689915" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaE3sXhsVyhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1973&pages=182-184&author=G.+Firnauauthor=C.+Nahmiasauthor=S.+Garnett&title=The+preparation+of+%5B18F%5D5-fluoro-DOPA+with+reactor-produced+fluorine-18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of fluorine-18-labeled 5-fluoro-DOPA with reactor-produced fluorine-18</span></div><div class="casAuthors">Firnau, Gunter; Nahmias, C.; Garnett, S.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">182-4</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">5,3,4-18F (HO)2C6H2CH2CH(NH2)CO2H (I) with sp. activities of 0.2-2 μCi/mg was prepd. by isotope exchange of 5,3,4-BF4.N2- (MeO)2C6H2CH2C(CO2Et)2NHAc with 18F, prepd. by neutron bombardment of Li2CO3.  The diazonium salt was then decompd. by boiling in a dioxane-xylene mixt with a b.p. of 132° to give 5,3,4-18F(MeO2C6H2CH2C(CO2Et)2 NHAc, which with 47% HBr gave I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2rhbx1DV43LVg90H21EOLACvtfcHk0lif8clLe7cGww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE3sXhsVyhsro%253D&md5=0a286ffdd3f459aefe170424893f7335</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2873%2990008-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252873%252990008-2%26sid%3Dliteratum%253Aachs%26aulast%3DFirnau%26aufirst%3DG.%26aulast%3DNahmias%26aufirst%3DC.%26aulast%3DGarnett%26aufirst%3DS.%26atitle%3DThe%2520preparation%2520of%2520%255B18F%255D5-fluoro-DOPA%2520with%2520reactor-produced%2520fluorine-18%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1973%26volume%3D24%26spage%3D182%26epage%3D184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Goldstein, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eisenhofer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunn, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Armando, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grossman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holmes, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirk, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bacharach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adams, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hersecovitch, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kopin, I. J.</span><span> </span><span class="NLM_article-title">Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[<sup>18</sup>F]fluorodopamine: initial findings in humans</span> <span class="citation_source-journal">J. Am. Coll. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">1961</span><span class="NLM_x">–</span> <span class="NLM_lpage">71</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0735-1097%2893%2990786-Z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8245356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2c%252FmsFSmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1993&pages=1961-71&author=D.+S.+Goldsteinauthor=G.+Eisenhoferauthor=B.+B.+Dunnauthor=I.+Armandoauthor=J.+Lendersauthor=E.+Grossmanauthor=C.+Holmesauthor=K.+L.+Kirkauthor=S.+Bacharachauthor=R.+Adamsauthor=P.+Hersecovitchauthor=I.+J.+Kopin&title=Positron+emission+tomographic+imaging+of+cardiac+sympathetic+innervation+using+6-%5B18F%5Dfluorodopamine%3A+initial+findings+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic imaging of cardiac sympathetic innervation using 6-[18F]fluorodopamine: initial findings in humans</span></div><div class="casAuthors">Goldstein D S; Eisenhofer G; Dunn B B; Armando I; Lenders J; Grossman E; Holmes C; Kirk K L; Bacharach S; Adams R; et al</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American College of Cardiology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1961-71</span>
        ISSN:<span class="NLM_cas:issn">0735-1097</span>.
    </div><div class="casAbstract">OBJECTIVES:  This study evaluated the safety, efficacy and validity of 6-[18F]fluorodopamine positron emission tomographic scanning of cardiac sympathetic innervation and function in humans.  METHODS:  Positron emission tomography (PET) scans, arterial blood and urine were obtained after a 3-min intravenous infusion of 6-[18F]fluorodopamine (1 to 4 mCi, 188 to 809 mCi/mmol) in healthy volunteers, with or without pretreatment with oral desipramine to inhibit neuronal uptake of catecholamines.  RESULTS:  6-[18F]Fluorodopamine PET scanning visualized the left ventricular myocardium.  Blood pressure increased slightly and transiently.  The estimated absorbed radiation dose to the main target organ, the wall of the urinary bladder, was 0.8 to 1.0 rad/mCi of injected 6-[18F]fluorodopamine.  By 24 h after the injection, the main 6F-compound in urine was 6F-vanillymandelic acid, a metabolite of 6F-norepinephrine.  Desipramine attenuated accumulation of myocardial 6-[18F]fluorodopamine-derived radioactivity and plasma 6F-dihydroxyphenylacetic acid.  CONCLUSIONS:  6-[18F]Fluorodopamine produces negligible hemodynamic effects and acceptable radiation exposure at doses that visualize the left ventricular myocardium.  Sympathetic nerves take up 6-[18F]fluorodopamine, which is translocated from the axoplasm into storage vesicles, where is it beta-hydroxylated to the fluorinated analogue of the sympathetic neurotransmitter norepinephrine.  Therefore, the basis for visualization of myocardium after 6-[18F]fluorodopamine injection in humans is radiolabeling by 6-[18F]fluorodopamine and 6-[18F]fluoronorepinephrine of vesicles in sympathetic terminals. 6-[18F]Fluorodopamine PET scanning provides a novel means for assessing sympathetic innervation and function noninvasively in the human heart.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQtp6qcyYVsV825P7XSLhESfW6udTcc2ebEjTHN3T9OvLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FmsFSmsQ%253D%253D&md5=ab16095eb49be839b3c98f99a140fc30</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2F0735-1097%2893%2990786-Z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0735-1097%252893%252990786-Z%26sid%3Dliteratum%253Aachs%26aulast%3DGoldstein%26aufirst%3DD.%2BS.%26aulast%3DEisenhofer%26aufirst%3DG.%26aulast%3DDunn%26aufirst%3DB.%2BB.%26aulast%3DArmando%26aufirst%3DI.%26aulast%3DLenders%26aufirst%3DJ.%26aulast%3DGrossman%26aufirst%3DE.%26aulast%3DHolmes%26aufirst%3DC.%26aulast%3DKirk%26aufirst%3DK.%2BL.%26aulast%3DBacharach%26aufirst%3DS.%26aulast%3DAdams%26aufirst%3DR.%26aulast%3DHersecovitch%26aufirst%3DP.%26aulast%3DKopin%26aufirst%3DI.%2BJ.%26atitle%3DPositron%2520emission%2520tomographic%2520imaging%2520of%2520cardiac%2520sympathetic%2520innervation%2520using%25206-%255B18F%255Dfluorodopamine%253A%2520initial%2520findings%2520in%2520humans%26jtitle%3DJ.%2520Am.%2520Coll.%2520Cardiol.%26date%3D1993%26volume%3D22%26spage%3D1961%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span> </span><span class="NLM_article-title">Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">37</span><span class="NLM_x">–</span> <span class="NLM_lpage">61</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1998&pages=37-61&author=P.+Cummingauthor=A.+Gjedde&title=Compartmental+analysis+of+dopa+decarboxylation+in+living+brain+from+dynamic+positron+emission+tomograms"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DGjedde%26aufirst%3DA.%26atitle%3DCompartmental%2520analysis%2520of%2520dopa%2520decarboxylation%2520in%2520living%2520brain%2520from%2520dynamic%2520positron%2520emission%2520tomograms%26jtitle%3DSynapse%26date%3D1998%26volume%3D29%26spage%3D37%26epage%3D61" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Weeks, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Positron emission tomography and central neurotransmitter systems in movement disorders</span> <span class="citation_source-journal">Fundam. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">503</span><span class="NLM_x">–</span> <span class="NLM_lpage">517</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.1472-8206.1994.tb00831.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=7721227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2M3jslOmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1994&pages=503-517&author=R.+A.+Weeksauthor=D.+J.+Brooks&title=Positron+emission+tomography+and+central+neurotransmitter+systems+in+movement+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomography and central neurotransmitter systems in movement disorders</span></div><div class="casAuthors">Weeks R A; Brooks D J</div><div class="citationInfo"><span class="NLM_cas:title">Fundamental & clinical pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">503-17</span>
        ISSN:<span class="NLM_cas:issn">0767-3981</span>.
    </div><div class="casAbstract">This article discusses the anatomical and neurochemical structure of the basal ganglia and reviews the Positron Emission Tomographic (PET) ligands available for investigating these pathways.  We discuss how clinical PET studies have improved our understanding of the neurochemical changes underlying principal movement disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSSPPQe1MzpFrJzI8owOhpDfW6udTcc2eZQatY-SZAHlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3jslOmsQ%253D%253D&md5=faa0176e174754331f6204595edbb58e</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1111%2Fj.1472-8206.1994.tb00831.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1472-8206.1994.tb00831.x%26sid%3Dliteratum%253Aachs%26aulast%3DWeeks%26aufirst%3DR.%2BA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DPositron%2520emission%2520tomography%2520and%2520central%2520neurotransmitter%2520systems%2520in%2520movement%2520disorders%26jtitle%3DFundam.%2520Clin.%2520Pharmacol.%26date%3D1994%26volume%3D8%26spage%3D503%26epage%3D517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Snow, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nygaard, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takahashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calne, D. B.</span><span> </span><span class="NLM_article-title">Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">733</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2Fana.410340518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8239569" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2c%252FlvVWntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=733-738&author=B.+J.+Snowauthor=T.+G.+Nygaardauthor=H.+Takahashiauthor=D.+B.+Calne&title=Positron+emission+tomographic+studies+of+dopa-responsive+dystonia+and+early-onset+idiopathic+parkinsonism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism</span></div><div class="casAuthors">Snow B J; Nygaard T G; Takahashi H; Calne D B</div><div class="citationInfo"><span class="NLM_cas:title">Annals of neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">733-8</span>
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    </div><div class="casAbstract">There are two major syndromes presenting in the early decades of life with dystonia and parkinsonism: dopa-responsive dystonia (DRD) and early-onset idiopathic parkinsonism (EOIP).  DRD presents predominantly in childhood with prominent dystonia and lesser degrees of parkinsonism.  EOIP presents before age 40 with parkinsonism (often with associated dystonia).  Both disorders are exquisitely sensitive to levodopa, although the long-term prognosis in each appears to be different.  Some have suggested, however, that DRD is a form of EOIP.  We performed positron emission tomography with 6-fluoro-dopa in 10 patients with DRD and 18 patients with EOIP to study the integrity of their nigrostriatal dopaminergic systems.  In DRD, we found normal striatal FD uptake.  In contrast, patients with EOIP had reduced striatal FD uptake.  We conclude that the patho-physiologies of DRD and EOIP are distinct.  Although both disorders presumably represent a deficiency of striatal dopamine, the results suggest that in DRD dopa uptake, decarboxylation, and storage mechanisms are intact.  This may explain the sustained response of DRD to low doses of levodopa. 6-Fluoro-dopa positron emission tomography distinguishes DRD from EOIP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTO-26-VAILeHqj_yg7twvpfW6udTcc2eZQatY-SZAHlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252FlvVWntA%253D%253D&md5=2c2486577ba5b12d2a1cc005bb2975d7</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fana.410340518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410340518%26sid%3Dliteratum%253Aachs%26aulast%3DSnow%26aufirst%3DB.%2BJ.%26aulast%3DNygaard%26aufirst%3DT.%2BG.%26aulast%3DTakahashi%26aufirst%3DH.%26aulast%3DCalne%26aufirst%3DD.%2BB.%26atitle%3DPositron%2520emission%2520tomographic%2520studies%2520of%2520dopa-responsive%2520dystonia%2520and%2520early-onset%2520idiopathic%2520parkinsonism%26jtitle%3DAnn.%2520Neurol.%26date%3D1993%26volume%3D34%26spage%3D733%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Frankle, W. G.</span><span> </span><span class="NLM_article-title">Neuroreceptor imaging studies in schizophrenia</span> <span class="citation_source-journal">Harv. Rev. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1080%2F10673220701679812" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17924257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2sngtFaisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=212-232&author=W.+G.+Frankle&title=Neuroreceptor+imaging+studies+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Neuroreceptor imaging studies in schizophrenia</span></div><div class="casAuthors">Frankle W Gordon</div><div class="citationInfo"><span class="NLM_cas:title">Harvard review of psychiatry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">212-32</span>
        ISSN:<span class="NLM_cas:issn">1067-3229</span>.
    </div><div class="casAbstract">The ability of SPECT and PET to image specific biomolecules in the living brain provides a unique tool for clinical researchers.  It is therefore not surprising that the use of neuroreceptor-imaging techniques has become more widespread over the past decade.  This article reviews the application of these techniques to the study of schizophrenia.  The design of neuroreceptor-imaging studies performed in the field of schizophrenia research can be broadly divided into two categories: (1) studies of pathophysiology and (2) studies of pharmacology.  The former examines neuroreceptor and neurotransmitter parameters in individuals with schizophrenia compared to control subjects in order to provide a better understanding of the disease process.  Studies of pharmacology seek to elucidate the mechanism of action for the treatments utilized in schizophrenia.  This review will consider both studies of pathophysiology and pharmacology, with a discussion of the application of these techniques to drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS6eZZmu_sT9potVjB3IRIyfW6udTcc2eZQatY-SZAHlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2sngtFaisw%253D%253D&md5=f636793730b50c4081caa7a5653b8a50</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1080%2F10673220701679812&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10673220701679812%26sid%3Dliteratum%253Aachs%26aulast%3DFrankle%26aufirst%3DW.%2BG.%26atitle%3DNeuroreceptor%2520imaging%2520studies%2520in%2520schizophrenia%26jtitle%3DHarv.%2520Rev.%2520Psychiatry%26date%3D2007%26volume%3D15%26spage%3D212%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Sossi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holden, J. E.</span><span> </span><span class="NLM_article-title">A reversible tracer analysis approach to the study of effective dopamine turnover</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">469</span><span class="NLM_x">–</span> <span class="NLM_lpage">476</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2F00004647-200104000-00015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11323532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3MXntFKisr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=469-476&author=V.+Sossiauthor=D.+J.+Doudetauthor=J.+E.+Holden&title=A+reversible+tracer+analysis+approach+to+the+study+of+effective+dopamine+turnover"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">A reversible tracer analysis approach to the study of effective dopamine turnover</span></div><div class="casAuthors">Sossi, Vesna; Doudet, Doris J.; Holden, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">469-476</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Changes in dopamine turnover resulting from disease states such as Parkinson's disease may be reflected in corresponding changes in the kinetics of the positron emission tomog. tracer [18F]fluorodopa.  The authors had previously refined the conventional irreversible-tracer graphical approach to det. both the uptake rate const. Ki and the rate const. kloss that describes the slow loss of the trapped kinetic component.  Because these parameters change in the opposite sense with disease, their ratios may be more powerfully discriminating than either one alone.  The ratio kloss/Ki is indicative of effective dopamine turnover.  Its inverse, Ki/kloss, can be interpreted as the effective distribution vol. (EDV) of the specific uptake compartment referred to the fluorodopa concn. in plasma.  Here the authors present a new approach to the estn. of EDV based on reversible-tracer graphical methods.  When implemented with a plasma input function, the method evaluates EDV directly.  When implemented with a tissue input function, the outcome is proportional to the ratio of the distribution vols. of the specific uptake and precursor compartments.  Comparison of the new and previous approaches strongly validates this alternative approach to the study of effective dopamine turnover.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyQiF9C_WyorVg90H21EOLACvtfcHk0lhxRe3HtJXXMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXntFKisr0%253D&md5=665ee1b251c5b6c589dc626b6993ef5e</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1097%2F00004647-200104000-00015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004647-200104000-00015%26sid%3Dliteratum%253Aachs%26aulast%3DSossi%26aufirst%3DV.%26aulast%3DDoudet%26aufirst%3DD.%2BJ.%26aulast%3DHolden%26aufirst%3DJ.%2BE.%26atitle%3DA%2520reversible%2520tracer%2520analysis%2520approach%2520to%2520the%2520study%2520of%2520effective%2520dopamine%2520turnover%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2001%26volume%3D21%26spage%3D469%26epage%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doudet, D.</span><span> </span><span class="NLM_article-title">Loss of metabolites from monkey striatum during PET with FDOPA</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">212</span><span class="NLM_x">–</span> <span class="NLM_lpage">218</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=212-218&author=P.+Cummingauthor=O.+L.+Munkauthor=D.+Doudet&title=Loss+of+metabolites+from+monkey+striatum+during+PET+with+FDOPA"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DMunk%26aufirst%3DO.%2BL.%26aulast%3DDoudet%26aufirst%3DD.%26atitle%3DLoss%2520of%2520metabolites%2520from%2520monkey%2520striatum%2520during%2520PET%2520with%2520FDOPA%26jtitle%3DSynapse%26date%3D2001%26volume%3D41%26spage%3D212%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">PET studies of net blood–brain clearance of FDOPA to human brain: age-dependent decline of [<sup>18</sup>F]fluorodopamine storage capacity</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">807</span><span class="NLM_x">–</span> <span class="NLM_lpage">819</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fsj.jcbfm.9600079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15729292" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmsV2ktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2005&pages=807-819&author=Y.+Kumakuraauthor=I.+Vernalekenauthor=G.+Grunderauthor=P.+Bartensteinauthor=A.+Gjeddeauthor=P.+Cumming&title=PET+studies+of+net+blood%E2%80%93brain+clearance+of+FDOPA+to+human+brain%3A+age-dependent+decline+of+%5B18F%5Dfluorodopamine+storage+capacity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">PET studies of net blood-brain clearance of FDOPA to human brain: Age-dependent decline of [18F]fluorodopamine storage capacity</span></div><div class="casAuthors">Kumakura, Yoshitaka; Vernaleken, Ingo; Gruender, Gerhard; Bartenstein, Peter; Gjedde, Albert; Cumming, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">807-819</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Conventional methods for the graphical anal. of 6-[18F]fluorodopa (FDOPA)/positron emission tomog. (PET) recordings (Kappin) may be prone to neg. bias because of oversubtraction of the precursor pool in the region of interest, and because of diffusion of decarboxylated FDOPA metabolites from the brain.  These effects may reduce the sensitivity of FDOPA/PET for the detection of age-related changes in dopamine innervations.  To test for these biasing effects, we have used a constrained compartmental anal. to calc. the brain concns. of the plasma metabolite 3-O-methyl-FDOPA (OMFD) during 120 mins of FDOPA circulation in healthy young, healthy elderly, and Parkinson's disease subjects.  Calcd. brain OMFD concns. were subtracted frame-by-frame from the dynamic PET recordings, and maps of the FDOPA net influx to brain were calcd. assuming irreversible trapping (Kapp).  Comparison of Kappin and Kapp maps revealed a global neg. bias in the conventional ests. of FDOPA clearance.  The present OMFD subtraction method revealed curvature in plots of Kapp at early times, making possible the calcn. of the cor. net influx (K) and also the rate const. for diffusion of decarboxylated metabolites from the brain (kloss).  The effective distribution vol. (EDV2; K/kloss) for FDOPA, an index of dopamine storage capacity in brain, was reduced by 85% in putamen of patients with Parkinson's disease, and by 58% in the healthy elderly relative to the healthy young control subjects.  Results of the present study support claims that storage capacity for dopamine in both caudate and putamen is more profoundly impaired in patients with Parkinson's disease than is the capacity for DOPA utilization, calcd. by conventional FDOPA net influx plots.  The present results furthermore constitute the first demonstration of an abnormality in the cerebral utilization of FDOPA in caudate and putamen as a function of normal aging, which we attribute to loss of vesicular storage capacity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofif_2dTRQ8bVg90H21EOLACvtfcHk0lhelIdzIYRptw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmsV2ktrc%253D&md5=75044843f583b4674061a808f36ff9a2</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1038%2Fsj.jcbfm.9600079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.jcbfm.9600079%26sid%3Dliteratum%253Aachs%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DGrunder%26aufirst%3DG.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DPET%2520studies%2520of%2520net%2520blood%25E2%2580%2593brain%2520clearance%2520of%2520FDOPA%2520to%2520human%2520brain%253A%2520age-dependent%2520decline%2520of%2520%255B18F%255Dfluorodopamine%2520storage%2520capacity%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2005%26volume%3D25%26spage%3D807%26epage%3D819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heinz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienast, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Elevated [<sup>18</sup>F]fluorodopamine turnover in brain of patients with schizophrenia: an [<sup>18</sup>F]fluorodopa/positron emission tomography study</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">8080</span><span class="NLM_x">–</span> <span class="NLM_lpage">8087</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1523%2FJNEUROSCI.0805-07.2007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=17652599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2007&pages=8080-8087&author=Y.+Kumakuraauthor=P.+Cummingauthor=I.+Vernalekenauthor=H.+G.+Buchholzauthor=T.+Siessmeierauthor=A.+Heinzauthor=T.+Kienastauthor=P.+Bartensteinauthor=G.+Grunder&title=Elevated+%5B18F%5Dfluorodopamine+turnover+in+brain+of+patients+with+schizophrenia%3A+an+%5B18F%5Dfluorodopa%2Fpositron+emission+tomography+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated [18F]fluorodopamine turnover in brain of patients with schizophrenia: an [18F]fluorodopa/positron emission tomography study</span></div><div class="casAuthors">Kumakura, Yoshitaka; Cumming, Paul; Vernaleken, Ingo; Buchholz, Hans-Georg; Siessmeier, Thomas; Heinz, Andreas; Kienast, Thorsten; Bartenstein, Peter; Grunder, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">30</span>),
    <span class="NLM_cas:pages">8080-8087</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Previous positron emission tomog. (PET) studies with levodopa analogs have revealed a modestly increased capacity for dopamine synthesis in the striatum of patients with schizophrenia compared with healthy age-matched control subjects.  We hypothesized that not just the synthesis but also the turnover of radiolabeled dopamine is elevated in patients.  To test the hypothesis, we reanalyzed 2-h-long [18F]fluorodopa (FDOPA)/PET recordings from eight unmedicated patients with schizophrenia and 15 healthy age-matched control subjects, using new methods for the quantification of [18F]fluorodopamine steady-state kinetics.  The fractional rate const. for the catabolism and elimination of [18F]fluorodopamine was elevated nearly twofold in striatum, the largest biochem. difference in brain of schizophrenics yet reported.  The magnitude of the intrinsic blood-brain FDOPA clearance with correction for this loss of [18F]fluorodopamine metabolites was increased by 20% in caudate and putamen and by 50% in amygdala and midbrain of the patients.  However, the magnitude of the steady-state storage of FDOPA and its decarboxylated metabolites (Vd) was reduced by one-third in the caudate nucleus and amygdala of the schizophrenic group.  Thus, reduced steady-state storage of [18F]fluorodopamine occurs in the midst of accelerated synthesis in brain of untreated patients.  Pos. scores of the pos. and neg. syndrome scale correlated inversely with the magnitude of Vd in amygdala, suggesting an assocn. between pos. symptoms and impaired steady-state storage of FDOPA metabolites in that structure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobB4Pys1yhj7Vg90H21EOLACvtfcHk0lhelIdzIYRptw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSjtrw%253D&md5=4a2275e665be5672628ab12819382b64</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.0805-07.2007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.0805-07.2007%26sid%3Dliteratum%253Aachs%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DHeinz%26aufirst%3DA.%26aulast%3DKienast%26aufirst%3DT.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DElevated%2520%255B18F%255Dfluorodopamine%2520turnover%2520in%2520brain%2520of%2520patients%2520with%2520schizophrenia%253A%2520an%2520%255B18F%255Dfluorodopa%252Fpositron%2520emission%2520tomography%2520study%26jtitle%3DJ.%2520Neurosci.%26date%3D2007%26volume%3D27%26spage%3D8080%26epage%3D8087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davids, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heydari, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munk, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">Subchronic haloperidol downregulates dopamine synthesis capacity in the brain of schizophrenic patients in vivo</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">787</span><span class="NLM_x">–</span> <span class="NLM_lpage">794</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2003&pages=787-794&author=G.+Gr%C3%BCnderauthor=I.+Vernalekenauthor=M.+J.+Mullerauthor=E.+Davidsauthor=N.+Heydariauthor=H.+G.+Buchholzauthor=P.+Bartensteinauthor=O.+L.+Munkauthor=P.+Stoeterauthor=D.+F.+Wongauthor=A.+Gjeddeauthor=P.+Cumming&title=Subchronic+haloperidol+downregulates+dopamine+synthesis+capacity+in+the+brain+of+schizophrenic+patients+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DMuller%26aufirst%3DM.%2BJ.%26aulast%3DDavids%26aufirst%3DE.%26aulast%3DHeydari%26aufirst%3DN.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DMunk%26aufirst%3DO.%2BL.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DSubchronic%2520haloperidol%2520downregulates%2520dopamine%2520synthesis%2520capacity%2520in%2520the%2520brain%2520of%2520schizophrenic%2520patients%2520in%2520vivo%26jtitle%3DNeuropsychopharmacology%26date%3D2003%26volume%3D28%26spage%3D787%26epage%3D794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hilgers, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Baseline [<sup>18</sup>F]-FDOPA kinetics are predictive of haloperidol-induced changes in dopamine turnover and cognitive performance: a positron emission tomography study in healthy subjects</span> <span class="citation_source-journal">Neuroimage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">1222</span><span class="NLM_x">–</span> <span class="NLM_lpage">1231</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2008&pages=1222-1231&author=I.+Vernalekenauthor=Y.+Kumakuraauthor=H.+G.+Buchholzauthor=T.+Siessmeierauthor=R.+D.+Hilgersauthor=P.+Bartensteinauthor=P.+Cummingauthor=G.+Grunder&title=Baseline+%5B18F%5D-FDOPA+kinetics+are+predictive+of+haloperidol-induced+changes+in+dopamine+turnover+and+cognitive+performance%3A+a+positron+emission+tomography+study+in+healthy+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DHilgers%26aufirst%3DR.%2BD.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DBaseline%2520%255B18F%255D-FDOPA%2520kinetics%2520are%2520predictive%2520of%2520haloperidol-induced%2520changes%2520in%2520dopamine%2520turnover%2520and%2520cognitive%2520performance%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520in%2520healthy%2520subjects%26jtitle%3DNeuroimage%26date%3D2008%26volume%3D40%26spage%3D1222%26epage%3D1231" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumakura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Modulation of [<sup>18</sup>F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge</span> <span class="citation_source-journal">NeuroImage</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">30</span><span class="NLM_x">, </span> <span class="NLM_fpage">1332</span><span class="NLM_x">–</span> <span class="NLM_lpage">1339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2006&pages=1332-1339&author=I.+Vernalekenauthor=Y.+Kumakuraauthor=P.+Cummingauthor=H.+G.+Buchholzauthor=T.+Siessmeierauthor=P.+Stoeterauthor=M.+J.+Mullerauthor=P.+Bartensteinauthor=G.+Grunder&title=Modulation+of+%5B18F%5Dfluorodopa+%28FDOPA%29+kinetics+in+the+brain+of+healthy+volunteers+after+acute+haloperidol+challenge"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DKumakura%26aufirst%3DY.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DMuller%26aufirst%3DM.%2BJ.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DModulation%2520of%2520%255B18F%255Dfluorodopa%2520%2528FDOPA%2529%2520kinetics%2520in%2520the%2520brain%2520of%2520healthy%2520volunteers%2520after%2520acute%2520haloperidol%2520challenge%26jtitle%3DNeuroImage%26date%3D2006%26volume%3D30%26spage%3D1332%26epage%3D1339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Danielsen, E. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hermansen, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gjedde, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span> </span><span class="NLM_article-title">Acute neuroleptic stimulates DOPA decarboxylase in porcine brain in vivo</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">172</span><span class="NLM_x">–</span> <span class="NLM_lpage">175</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2001&pages=172-175&author=E.+H.+Danielsenauthor=D.+Smithauthor=F.+Hermansenauthor=A.+Gjeddeauthor=P.+Cumming&title=Acute+neuroleptic+stimulates+DOPA+decarboxylase+in+porcine+brain+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDanielsen%26aufirst%3DE.%2BH.%26aulast%3DSmith%26aufirst%3DD.%26aulast%3DHermansen%26aufirst%3DF.%26aulast%3DGjedde%26aufirst%3DA.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DAcute%2520neuroleptic%2520stimulates%2520DOPA%2520decarboxylase%2520in%2520porcine%2520brain%2520in%2520vivo%26jtitle%3DSynapse%26date%3D2001%26volume%3D41%26spage%3D172%26epage%3D175" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Sharma, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javaid, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janicak, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faull, K.</span><span> </span><span class="NLM_article-title">Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">128</span><span class="NLM_x">–</span> <span class="NLM_lpage">134</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0006-3223%2893%2990381-M" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8104508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2c%252Fgt1OjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1993&pages=128-134&author=R.+P.+Sharmaauthor=J.+I.+Javaidauthor=P.+G.+Janicakauthor=J.+M.+Davisauthor=K.+Faull&title=Homovanillic+acid+in+the+cerebrospinal+fluid%3A+patterns+of+response+after+four+weeks+of+neuroleptic+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment</span></div><div class="casAuthors">Sharma R P; Javaid J I; Janicak P G; Davis J M; Faull K</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">128-34</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">Lumbar cerebrospinal fluid (CSF) homovanillic acid (HVA) concentrations were measured before and after 4 weeks of neuroleptic treatment in schizophrenic (n = 15) and schizoaffective (n = 4) patients.  Neuroleptic treatment induced a nonsignificant (17%) increase in CSF HVA group mean levels.  For the total group, no correlations were found between pretreatment CSF HVA and clinical measures, or between changes in HVA and clinical response.  An alternative interpretation was attempted by defining "tolerant" and "nontolerant" subgroups.  A "tolerant" response was defined as a reduction in posttreatment HVA values below pretreatment levels, whereas a "nontolerant" response was characterized by posttreatment values above pretreatment levels.  When thus defined, nontolerant patients had a significantly inferior clinical response to neuroleptics, in contrast to their tolerant counterparts.  Further, although there was no difference in pretreatment CSF HVA values between these two groups, pretreatment clinical profiles did differ significantly.  Also, in a retrospective analysis, nontolerant patients were found to have a significantly earlier age of illness onset, a greater number of prior psychiatric hospitalizations, and more time spent in psychiatric hospitals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTcer2-1vHqZ2Gmni0r9GoKfW6udTcc2eZXJcC6G10g1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2c%252Fgt1OjtA%253D%253D&md5=612a5b9453acbd45f32d75107d03e16c</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2F0006-3223%2893%2990381-M&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3223%252893%252990381-M%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BP.%26aulast%3DJavaid%26aufirst%3DJ.%2BI.%26aulast%3DJanicak%26aufirst%3DP.%2BG.%26aulast%3DDavis%26aufirst%3DJ.%2BM.%26aulast%3DFaull%26aufirst%3DK.%26atitle%3DHomovanillic%2520acid%2520in%2520the%2520cerebrospinal%2520fluid%253A%2520patterns%2520of%2520response%2520after%2520four%2520weeks%2520of%2520neuroleptic%2520treatment%26jtitle%3DBiol.%2520Psychiatry%26date%3D1993%26volume%3D34%26spage%3D128%26epage%3D134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Egerton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaddock, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winton-Brown, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloomfield, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharyya, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, O. D.</span><span> </span><span class="NLM_article-title">Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: findings in a second cohort</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">106</span><span class="NLM_x">–</span> <span class="NLM_lpage">112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.biopsych.2012.11.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=23312565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFWmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2013&pages=106-112&author=A.+Egertonauthor=C.+A.+Chaddockauthor=T.+T.+Winton-Brownauthor=M.+A.+Bloomfieldauthor=S.+Bhattacharyyaauthor=P.+Allenauthor=P.+K.+McGuireauthor=O.+D.+Howes&title=Presynaptic+striatal+dopamine+dysfunction+in+people+at+ultra-high+risk+for+psychosis%3A+findings+in+a+second+cohort"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Presynaptic Striatal Dopamine Dysfunction in People at Ultra-high Risk for Psychosis: Findings in a Second Cohort</span></div><div class="casAuthors">Egerton, Alice; Chaddock, Christopher A.; Winton-Brown, Toby T.; Bloomfield, Michael A. P.; Bhattacharyya, Sagnik; Allen, Paul; McGuire, Philip K.; Howes, Oliver D.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">106-112</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Using positron emission tomog. (PET), we previously obsd. increases in 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine (18F-DOPA) uptake in the striatum of subjects at ultra-high risk (UHR) for psychosis, indicating elevated presynaptic dopamine synthesis capacity.  The purpose of this study was to test if this finding would be replicated in a second UHR cohort.  18F-DOPA PET was used to est. dopamine synthesis capacity in the striatum of an entirely new cohort of 26 individuals at UHR for psychosis (14 males, mean±SD age = 22.7±4.7 years) and 20 healthy volunteers matched for age and gender (11 males, mean±SD age = 24.5±4.5 years).  Dopamine synthesis capacity was elevated in the whole [t(44) = 2.6; p = .01, effect size = .81] and associative striatum [t(44) = 2.6; p = .01, effect size = .73] of UHR compared with control subjects.  When the two samples were combined to give a final sample of 32 control and 50 UHR subjects, the higher levels of dopamine synthesis capacity in the UHR group reached significance across the whole [F(1,81) = 11.0; p = .001], associative [F(1,81) = 12.7; p = .001], and sensorimotor [F(1,81) = 4.7; p = .03], but not the limbic [F(1,81) = 2.1; p = .2], striatum.  The findings indicate that elevated dopamine synthesis capacity in the dorsal striatum is a robust feature of individuals at UHR for psychosis and provide further evidence that dopaminergic abnormalities precede the onset of psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQMpxjYAIVgLVg90H21EOLACvtfcHk0lhEVzVqU9fzFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFWmtA%253D%253D&md5=2e350eac28c1371b51f716125b224ae8</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.11.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.11.017%26sid%3Dliteratum%253Aachs%26aulast%3DEgerton%26aufirst%3DA.%26aulast%3DChaddock%26aufirst%3DC.%2BA.%26aulast%3DWinton-Brown%26aufirst%3DT.%2BT.%26aulast%3DBloomfield%26aufirst%3DM.%2BA.%26aulast%3DBhattacharyya%26aufirst%3DS.%26aulast%3DAllen%26aufirst%3DP.%26aulast%3DMcGuire%26aufirst%3DP.%2BK.%26aulast%3DHowes%26aufirst%3DO.%2BD.%26atitle%3DPresynaptic%2520striatal%2520dopamine%2520dysfunction%2520in%2520people%2520at%2520ultra-high%2520risk%2520for%2520psychosis%253A%2520findings%2520in%2520a%2520second%2520cohort%26jtitle%3DBiol.%2520Psychiatry%26date%3D2013%26volume%3D74%26spage%3D106%26epage%3D112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Howes, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montgomery, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asselin, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabraham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramon-Bosch, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valmaggia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johns, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, P. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grasby, P. M.</span><span> </span><span class="NLM_article-title">Elevated striatal dopamine function linked to prodromal signs of schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchgenpsychiatry.2008.514" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=19124684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD1M%252FltlOmsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2009&pages=13-20&author=O.+D.+Howesauthor=A.+J.+Montgomeryauthor=M.+C.+Asselinauthor=R.+M.+Murrayauthor=I.+Valliauthor=P.+Tabrahamauthor=E.+Bramon-Boschauthor=L.+Valmaggiaauthor=L.+Johnsauthor=M.+Broomeauthor=P.+K.+McGuireauthor=P.+M.+Grasby&title=Elevated+striatal+dopamine+function+linked+to+prodromal+signs+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Elevated striatal dopamine function linked to prodromal signs of schizophrenia</span></div><div class="casAuthors">Howes Oliver D; Montgomery Andrew J; Asselin Marie-Claude; Murray Robin M; Valli Isabel; Tabraham Paul; Bramon-Bosch Elvira; Valmaggia Lucia; Johns Louise; Broome Matthew; McGuire Philip K; Grasby Paul M</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">13-20</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">CONTEXT:  A major limitation on the development of biomarkers and novel interventions for schizophrenia is that its pathogenesis is unknown.  Although elevated striatal dopamine activity is thought to be fundamental to schizophrenia, it is unclear when this neurochemical abnormality develops in relation to the onset of illness and how this relates to the symptoms and neurocognitive impairment seen in individuals with prodromal symptoms of schizophrenia.  OBJECTIVES:  To determine whether striatal dopamine function is elevated in individuals with prodromal symptoms of schizophrenia before the onset of psychosis and to assess how this relates to the symptoms and neurocognitive impairment.  DESIGN:  Case-control study of in vivo striatal dopaminergic function.  SETTING:  Academic research.  Patients Patients were recruited from a community mental health service.  Twenty-four patients having prodromal symptoms of schizophrenia were compared with 7 patients having schizophrenia and with 12 matched healthy control subjects from the same community.  Main Outcome Measure Striatal 6-fluoro-l-dopa F 18-dopa uptake measured using positron emission tomographic (18)F-dopa imaging.  RESULTS:  Striatal (18)F-dopa uptake was elevated in patients with prodromal symptoms of schizophrenia (effect size, 0.75) to an intermediate degree compared with that in patients with schizophrenia (effect size, 1.25).  The elevation was localized in the associative striatum in both groups.  Moreover, striatal (18)F-dopa uptake in patients with prodromal symptoms of schizophrenia was correlated with the severity of prodromal psychopathologic and neuropsychological impairment but not with the severity of anxiety or depressive symptoms.  CONCLUSIONS:  These findings indicate that dopamine overactivity predates the onset of schizophrenia in individuals with prodromal psychotic symptoms, is predominantly localized in the associative striatum, and is correlated with the severity of symptoms and neurocognitive dysfunction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTw8vPTbrE9VCM8MEzWGjS9fW6udTcc2eaq-S87l21nprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M%252FltlOmsg%253D%253D&md5=eb76439348e574ec24367132e0b6fb4a</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1001%2Farchgenpsychiatry.2008.514&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchgenpsychiatry.2008.514%26sid%3Dliteratum%253Aachs%26aulast%3DHowes%26aufirst%3DO.%2BD.%26aulast%3DMontgomery%26aufirst%3DA.%2BJ.%26aulast%3DAsselin%26aufirst%3DM.%2BC.%26aulast%3DMurray%26aufirst%3DR.%2BM.%26aulast%3DValli%26aufirst%3DI.%26aulast%3DTabraham%26aufirst%3DP.%26aulast%3DBramon-Bosch%26aufirst%3DE.%26aulast%3DValmaggia%26aufirst%3DL.%26aulast%3DJohns%26aufirst%3DL.%26aulast%3DBroome%26aufirst%3DM.%26aulast%3DMcGuire%26aufirst%3DP.%2BK.%26aulast%3DGrasby%26aufirst%3DP.%2BM.%26atitle%3DElevated%2520striatal%2520dopamine%2520function%2520linked%2520to%2520prodromal%2520signs%2520of%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2009%26volume%3D66%26spage%3D13%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Allen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luigjes, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egerton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirao, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valli, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kambeitz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusar-Poli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broome, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, P.</span><span> </span><span class="NLM_article-title">Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals</span> <span class="citation_source-journal">Schizophr. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1268</span><span class="NLM_x">–</span> <span class="NLM_lpage">1276</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1093%2Fschbul%2Fsbr194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=22290265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BC38vhsFKmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2012&pages=1268-1276&author=P.+Allenauthor=J.+Luigjesauthor=O.+D.+Howesauthor=A.+Egertonauthor=K.+Hiraoauthor=I.+Valliauthor=J.+Kambeitzauthor=P.+Fusar-Poliauthor=M.+Broomeauthor=P.+McGuire&title=Transition+to+psychosis+associated+with+prefrontal+and+subcortical+dysfunction+in+ultra+high-risk+individuals"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals</span></div><div class="casAuthors">Allen Paul; Luigjes Judy; Howes Oliver D; Egerton Alice; Hirao Kazuyuki; Valli Isabel; Kambeitz Joseph; Fusar-Poli Paolo; Broome Matthew; McGuire Philip</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia bulletin</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1268-76</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  People at ultra high risk (UHR) of psychosis have an elevated risk of developing a psychotic disorder, but it is difficult to predict which individuals will make a transition to frank illness.  We investigated whether functional magnetic resonance imaging (fMRI) in conjunction with a phonological fluency task at presentation could distinguish subjects who subsequently developed psychosis from those who did not.  METHODS:  Sixty-five subjects (41 with an UHR and 24 healthy controls) were assessed at clinical presentation using fMRI, in conjunction with a verbal fluency task. [18F]-DOPA positron emission tomography (PET) data were also available in a subgroup of 21 UHR and 14 healthy controls subjects.  UHR subjects were followed clinically for at least 2 years.  RESULTS:  Compared with UHR subjects who did not become psychotic, UHR subjects who subsequently developed psychosis showed increased activation in bilateral prefrontal cortex (PFC), brainstem (midbrain/basilar pons), the left hippocampus, and greater midbrain-PFC connectivity.  Furthermore, exploratory analysis of [18F]-DOPA PET data showed that transition to psychosis was associated with elevated dopaminergic function in the brainstem region.  CONCLUSIONS:  In people at high risk of psychosis, increased activation in a network of cortical and subcortical regions may predict the subsequent onset of illness.  Functional neuroimaging, in conjunction with clinical assessment and other investigations, may facilitate the prediction of outcome in subjects who are vulnerable to psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS2frwdYJiOL7qxQ2mb9Pu8fW6udTcc2eaq-S87l21nprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38vhsFKmtw%253D%253D&md5=1295a60fc02ea0ff1228ef6d263e9f2b</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1093%2Fschbul%2Fsbr194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fschbul%252Fsbr194%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DP.%26aulast%3DLuigjes%26aufirst%3DJ.%26aulast%3DHowes%26aufirst%3DO.%2BD.%26aulast%3DEgerton%26aufirst%3DA.%26aulast%3DHirao%26aufirst%3DK.%26aulast%3DValli%26aufirst%3DI.%26aulast%3DKambeitz%26aufirst%3DJ.%26aulast%3DFusar-Poli%26aufirst%3DP.%26aulast%3DBroome%26aufirst%3DM.%26aulast%3DMcGuire%26aufirst%3DP.%26atitle%3DTransition%2520to%2520psychosis%2520associated%2520with%2520prefrontal%2520and%2520subcortical%2520dysfunction%2520in%2520ultra%2520high-risk%2520individuals%26jtitle%3DSchizophr.%2520Bull.%26date%3D2012%26volume%3D38%26spage%3D1268%26epage%3D1276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Weinberger, D. R.; Laruelle, M.</span><span> </span><span class="NLM_article-title">Neurochemical and neuropharmacological imaging in schizophrenia</span>. In  <span class="citation_source-book">Neuropharmacology: The Fifth Generation of Progress</span>; <span class="NLM_contrib-group">Davis, K. L.; Charney, D. S.; Coyle, J. T.; Nemeroff, C.</span>, Eds.; <span class="NLM_publisher-name">Lippincott, Williams, & Wilkins</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=D.+R.+Weinberger&author=M.+Laruelleauthor=K.+L.+Davis&author=D.+S.+Charney&author=J.+T.+Coyle&author=C.+Nemeroff&title=Neuropharmacology%3A+The+Fifth+Generation+of+Progress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DWeinberger%26aufirst%3DD.%2BR.%26atitle%3DNeurochemical%2520and%2520neuropharmacological%2520imaging%2520in%2520schizophrenia%26btitle%3DNeuropharmacology%253A%2520The%2520Fifth%2520Generation%2520of%2520Progress%26aulast%3DDavis%26aufirst%3DK.%2BL.%26pub%3DLippincott%252C%2520Williams%252C%2520%2526%2520Wilkins%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakashima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Decreased dopamine D<sub>2</sub> receptor binding in the anterior cingulate cortex in schizophrenia</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">59</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.59.1.25" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11779278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFWqtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2002&pages=25-30&author=T.+Suharaauthor=Y.+Okuboauthor=F.+Yasunoauthor=Y.+Sudoauthor=M.+Inoueauthor=T.+Ichimiyaauthor=Y.+Nakashimaauthor=K.+Nakayamaauthor=S.+Tanadaauthor=K.+Suzukiauthor=C.+Halldinauthor=L.+Farde&title=Decreased+dopamine+D2+receptor+binding+in+the+anterior+cingulate+cortex+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Decreased dopamine D2 receptor binding in the anterior cingulate cortex in schizophrenia</span></div><div class="casAuthors">Suhara, Tetsuya; Okubo, Yoshiro; Yasuno, Fumihiko; Sudo, Yasuhiko; Inoue, Makoto; Ichimiya, Tetsuya; Nakashima, Yoshifumi; Nakayama, Kazuhiko; Tanada, Shuji; Suzuki, Kazutoshi; Halldin, Christer; Farde, Lars</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-30</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">The aim of this study was to examine the extrastriatal D2 receptors of patients with schizophrenia.  Eleven drug-naive male patients with schizophrenia were examd. with positron emission tomog.. using carbon 11-labeled FLB 457.  Symptoms were assessed using the Brief Psychiatric Rating Scale.  Eighteen healthy controls were used for comparison.  Region-of-interest anal. was performed using the ref. tissue method, and binding potential (BP) was used for the index of dopamine D2 receptor binding.  The BP value was significantly lower, by ∼12.5%, in the anterior cingulate cortex in drug-naive patients with schizophrenia than in healthy controls.  A significant neg. correlation was obsd. between BP in the anterior cingulate cortex and the pos. symptom score on Brief Psychiatric Rating Scale.  The lower BP values indicate fewer D2 receptors in the anterior cingulate cortex in patients with schizophrenia.  Alterations in D2 receptor function in the extrastriatal region may underlie the pos. symptoms of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrGhZKaUanubVg90H21EOLACvtfcHk0lhgC_p9ND1Wlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFWqtbc%253D&md5=3e2e3594b274bb9e0bd9210cccdc25a4</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.59.1.25&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.59.1.25%26sid%3Dliteratum%253Aachs%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DY.%26aulast%3DYasuno%26aufirst%3DF.%26aulast%3DSudo%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIchimiya%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DY.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DTanada%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DDecreased%2520dopamine%2520D2%2520receptor%2520binding%2520in%2520the%2520anterior%2520cingulate%2520cortex%2520in%2520schizophrenia%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D2002%26volume%3D59%26spage%3D25%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Yasuno, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suhara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okubo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ichimiya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takano, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakayama, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Low dopamine D<sub>2</sub> receptor binding in subregions of the thalamus in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">1016</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.161.6.1016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15169689" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ntVCksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=1016-1022&author=F.+Yasunoauthor=T.+Suharaauthor=Y.+Okuboauthor=Y.+Sudoauthor=M.+Inoueauthor=T.+Ichimiyaauthor=A.+Takanoauthor=K.+Nakayamaauthor=C.+Halldinauthor=L.+Farde&title=Low+dopamine+D2+receptor+binding+in+subregions+of+the+thalamus+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Low dopamine d(2) receptor binding in subregions of the thalamus in schizophrenia</span></div><div class="casAuthors">Yasuno Fumihiko; Suhara Tetsuya; Okubo Yoshiro; Sudo Yasuhiko; Inoue Makoto; Ichimiya Tetsuya; Takano Akihiro; Nakayama Kazuhiko; Halldin Christer; Farde Lars</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1016-22</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Several structural and functional brain imaging studies have pointed to a disturbance of thalamic subnuclei in patients with schizophrenia.  The dopamine hypothesis of schizophrenia has, however, not been thoroughly examined in terms of this complex structure, which has connections with most brain regions of central interest in schizophrenia research.  The aim of the present study was to examine dopamine D(2) receptor binding in subregions of the thalamus in patients with schizophrenia.  METHOD:  The authors used positron emission tomography and the radioligand [(11)C]FLB457 to examine dopamine D(2) receptor binding in thalamic subregions of 10 drug-naive patients with schizophrenia.  Binding potential was calculated by the reference tissue method and used as an index for dopamine D(2) receptor binding.  Comparisons were made with 19 healthy subjects.  Subregions of interest were defined on individual magnetic resonance images using a percentage-based operational approach.  Clinical symptoms were rated by using the Brief Psychiatric Rating Scale (BPRS).  RESULTS:  The [(11)C]FLB457 binding potential was lower in the central medial and posterior subregions of the thalamus in patients with schizophrenia.  At a functional level, there was a significant negative correlation between binding potential and BPRS positive symptom scores.  CONCLUSIONS:  The subregions with low D(2) receptor binding comprise primarily the dorsomedial nucleus and pulvinar, two important components in circuitries previously suggested in the pathophysiology of schizophrenia.  Aberrant dopaminergic neurotransmission in thalamic subregions might be a mechanism underlying positive symptoms in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQbpx6dOjcHacrRqEXsZufAfW6udTcc2eaWL3qgsOroarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ntVCksw%253D%253D&md5=6e2db4962f54c375560c1574e381b6b0</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.6.1016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.6.1016%26sid%3Dliteratum%253Aachs%26aulast%3DYasuno%26aufirst%3DF.%26aulast%3DSuhara%26aufirst%3DT.%26aulast%3DOkubo%26aufirst%3DY.%26aulast%3DSudo%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIchimiya%26aufirst%3DT.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNakayama%26aufirst%3DK.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DLow%2520dopamine%2520D2%2520receptor%2520binding%2520in%2520subregions%2520of%2520the%2520thalamus%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D1016%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Buchsbaum, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christian, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lehrer, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narayanan, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shi, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantil, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kemether, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakes, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, J.</span><span> </span><span class="NLM_article-title">D<sub>2</sub>/D<sub>3</sub> dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia</span> <span class="citation_source-journal">Schizophr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">85</span><span class="NLM_x">, </span> <span class="NLM_fpage">232</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.schres.2006.03.042" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16713185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD28vmtVGgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2006&pages=232-244&author=M.+S.+Buchsbaumauthor=B.+T.+Christianauthor=D.+S.+Lehrerauthor=T.+K.+Narayananauthor=B.+Shiauthor=J.+Mantilauthor=E.+Kemetherauthor=T.+R.+Oakesauthor=J.+Mukherjee&title=D2%2FD3+dopamine+receptor+binding+with+%5BF-18%5Dfallypride+in+thalamus+and+cortex+of+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">D2/D3 dopamine receptor binding with [F-18]fallypride in thalamus and cortex of patients with schizophrenia</span></div><div class="casAuthors">Buchsbaum Monte S; Christian Bradley T; Lehrer Douglas S; Narayanan Tanjore K; Shi Bingzhi; Mantil Joseph; Kemether Eileen; Oakes Terrence R; Mukherjee Jogeshwar</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">232-44</span>
        ISSN:<span class="NLM_cas:issn">0920-9964</span>.
    </div><div class="casAbstract">BACKGROUND:  Abnormalities in the dopaminergic system are implicated in schizophrenia. [F-18]fallypride is a highly selective, high affinity PET ligand well suited for measuring D2/D3 receptor availability in the extrastriatal regions of the brain including thalamus, prefrontal, cingulate, and temporal cortex, brain regions implicated in schizophrenia with other imaging modalities.  METHODS:  Resting [F-18]fallypride PET studies were acquired together with anatomical MRI for accurate coregistration and image analysis on 15 drug naive schizophrenics (10 men, 5 women, mean age 28.5 years) and 15 matched controls (9 men, 6 women, mean age 27.4 years).  Dopamine D2/D3 receptor levels were measured as binding potential (BP).  The fallypride BP images of each subject were spatially normalized and subsequently smoothed for group comparison.  Measures of significance between the schizophrenic and control groups were determined using statistical parametric mapping (SPM).  The medial dorsal nucleus and pulvinar were also traced on coregistered MRI for detailed assessment of BP in these regions.  RESULTS:  The thalamus of patients with schizophrenia had lower [F-18]fallypride BP than normal controls and this was the brain area with the greatest difference (range -8.5% to -27.2%).  Left medial dorsal nucleus and left pulvinar showed the greatest decreases (-21.6% and -27.2% respectively).  The patients with schizophrenia also demonstrated D2/D3 BP reduction in the amygdala region, cingulate gyrus, and the temporal cortices.  CONCLUSIONS:  These findings suggest that drug naive patients with schizophrenia have significant reductions in extrastratial D2/D3 receptor availability.  The reductions were most prominent in regions of the thalamus, replicating other studies both with high affinity D2/D3 ligands and consistent with FDG-PET studies, further supporting the hypothesis of thalamic abnormalities in this patient population.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTk6d9Veicsu-2qxNLjzXe8fW6udTcc2eaWL3qgsOroarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD28vmtVGgsQ%253D%253D&md5=c359e5efbb024a6757335f72dabe0e60</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2006.03.042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2006.03.042%26sid%3Dliteratum%253Aachs%26aulast%3DBuchsbaum%26aufirst%3DM.%2BS.%26aulast%3DChristian%26aufirst%3DB.%2BT.%26aulast%3DLehrer%26aufirst%3DD.%2BS.%26aulast%3DNarayanan%26aufirst%3DT.%2BK.%26aulast%3DShi%26aufirst%3DB.%26aulast%3DMantil%26aufirst%3DJ.%26aulast%3DKemether%26aufirst%3DE.%26aulast%3DOakes%26aufirst%3DT.%2BR.%26aulast%3DMukherjee%26aufirst%3DJ.%26atitle%3DD2%252FD3%2520dopamine%2520receptor%2520binding%2520with%2520%255BF-18%255Dfallypride%2520in%2520thalamus%2520and%2520cortex%2520of%2520patients%2520with%2520schizophrenia%26jtitle%3DSchizophr.%2520Res.%26date%3D2006%26volume%3D85%26spage%3D232%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roesch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">D<sub>2/3</sub>-receptor availability in schizophrenia decreases with progression of psychosis</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">80</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=80&author=I.+Vernalekenauthor=M.+Raptisauthor=P.+Bartensteinauthor=D.+F.+Wongauthor=W.+M.+Schaeferauthor=F.+Roeschauthor=G.+Grunder&title=D2%2F3-receptor+availability+in+schizophrenia+decreases+with+progression+of+psychosis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DRaptis%26aufirst%3DM.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DSchaefer%26aufirst%3DW.%2BM.%26aulast%3DRoesch%26aufirst%3DF.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DD2%252F3-receptor%2520availability%2520in%2520schizophrenia%2520decreases%2520with%2520progression%2520of%2520psychosis%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2009%26volume%3D50%26spage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Haase, H.-J.</span><span> </span><span class="NLM_article-title">Die Dosierung der Neuroleptika unter feinmotorischer Kontrolle als konstruktiver Beitrag zum Thema der “Pharmakeule”.</span> In  <span class="citation_source-book">Psychopharmakotherapie. Optimale Dosierung der Neuroleptika</span>; <span class="NLM_contrib-group">Haase, H.-J.</span>, Ed.; <span class="NLM_publisher-name">Perimed</span>: <span class="NLM_publisher-loc">Erlangen</span>,<span class="NLM_x"> </span><span class="NLM_year">1982</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1982&author=H.-J.+Haaseauthor=H.-J.+Haase&title=Psychopharmakotherapie.+Optimale+Dosierung+der+Neuroleptika"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHaase%26aufirst%3DH.-J.%26atitle%3DDie%2520Dosierung%2520der%2520Neuroleptika%2520unter%2520feinmotorischer%2520Kontrolle%2520als%2520konstruktiver%2520Beitrag%2520zum%2520Thema%2520der%2520%25E2%2580%259CPharmakeule%25E2%2580%259D.%26btitle%3DPsychopharmakotherapie.%2520Optimale%2520Dosierung%2520der%2520Neuroleptika%26aulast%3DHaase%26aufirst%3DH.-J.%26pub%3DPerimed%26date%3D1982" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Baron, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazière, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loc’h, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sgouropoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agid, Y.</span><span> </span><span class="NLM_article-title">Loss of striatal [<sup>76</sup>Br]bromospiperone binding sites demonstrated by positron emission tomography in progressive supranuclear palsy</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">131</span><span class="NLM_x">–</span> <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fjcbfm.1986.26" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=3485639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL287mvVGrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1986&pages=131-136&author=J.+C.+Baronauthor=B.+Mazi%C3%A8reauthor=C.+Loc%E2%80%99hauthor=H.+Cambonauthor=P.+Sgouropoulosauthor=A.+M.+Bonnetauthor=Y.+Agid&title=Loss+of+striatal+%5B76Br%5Dbromospiperone+binding+sites+demonstrated+by+positron+emission+tomography+in+progressive+supranuclear+palsy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of striatal [76Br]bromospiperone binding sites demonstrated by positron tomography in progressive supranuclear palsy</span></div><div class="casAuthors">Baron J C; Maziere B; Loc'h C; Cambon H; Sgouropoulos P; Bonnet A M; Agid Y</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">131-6</span>
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">Using positron tomography and 76Br-labeled bromospiperone, a neuroleptic drug with high affinity for the dopamine (DA) receptors, we have estimated the specific binding of the radiotracer to striatal DA receptors in seven patients suffering from progressive supranuclear palsy.  Compared with age- and sex-matched control subjects, we found a significant (p less than 0.02) decrease of the striatum-cerebellum uptake ratio in progressive supranuclear palsy patients, suggesting loss of striatal DA receptors.  This in vivo study confirms recent postmortem data on progressive supranuclear palsy patients and provides an explanation for the lack of benefit from L-DOPA and DA agonists in this condition, despite reduced nigrostriatal dopaminergic function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcReY1vrHbtEtEGy1nwu7K2mfW6udTcc2ebRhwaD39OWI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL287mvVGrsw%253D%253D&md5=5eddf4d12de469456e37201d94563487</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1986.26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1986.26%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DJ.%2BC.%26aulast%3DMazi%25C3%25A8re%26aufirst%3DB.%26aulast%3DLoc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DCambon%26aufirst%3DH.%26aulast%3DSgouropoulos%26aufirst%3DP.%26aulast%3DBonnet%26aufirst%3DA.%2BM.%26aulast%3DAgid%26aufirst%3DY.%26atitle%3DLoss%2520of%2520striatal%2520%255B76Br%255Dbromospiperone%2520binding%2520sites%2520demonstrated%2520by%2520positron%2520emission%2520tomography%2520in%2520progressive%2520supranuclear%2520palsy%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1986%26volume%3D6%26spage%3D131%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Cambon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baron, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulenger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loc’h, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zarifian, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziere, B.</span><span> </span><span class="NLM_article-title">In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">824</span><span class="NLM_x">–</span> <span class="NLM_lpage">830</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1192%2Fbjp.151.6.824" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2901886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL1M%252FgtFKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=151&publication_year=1987&pages=824-830&author=H.+Cambonauthor=J.+C.+Baronauthor=J.+P.+Boulengerauthor=C.+Loc%E2%80%99hauthor=E.+Zarifianauthor=B.+Maziere&title=In+vivo+assay+for+neuroleptic+receptor+binding+in+the+striatum.+Positron+tomography+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo assay for neuroleptic receptor binding in the striatum. Positron tomography in humans</span></div><div class="casAuthors">Cambon H; Baron J C; Boulenger J P; Loc'h C; Zarifian E; Maziere B</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">151</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">824-30</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">Using PET, we investigated the potency in six patients of therapeutic doses of neuroleptic drugs for preventing specific binding of trace doses of intravenously administered 76Br-labelled bromospiperone to corpus striatum in vivo.  Measured receptor occupancy showed a clear-cut dose-dependent saturation curve with increasing daily oral dose of neuroleptics, indicating the validity and reliability of the method when used as an in vivo radioreceptor assay.  Following drug withdrawal in eight patients, recovery to normal or supranormal receptor availability occurred in a matter of days.  The results demonstrate an approach that may help resolve controversies about, and design better strategies for, neuroleptic treatment schedules.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRmEICGWj3F_u98rul4nhSdfW6udTcc2ebRhwaD39OWI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1M%252FgtFKitg%253D%253D&md5=c8c283cc0472f120ce22b25e99813076</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1192%2Fbjp.151.6.824&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.151.6.824%26sid%3Dliteratum%253Aachs%26aulast%3DCambon%26aufirst%3DH.%26aulast%3DBaron%26aufirst%3DJ.%2BC.%26aulast%3DBoulenger%26aufirst%3DJ.%2BP.%26aulast%3DLoc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DZarifian%26aufirst%3DE.%26aulast%3DMaziere%26aufirst%3DB.%26atitle%3DIn%2520vivo%2520assay%2520for%2520neuroleptic%2520receptor%2520binding%2520in%2520the%2520striatum.%2520Positron%2520tomography%2520in%2520humans%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1987%26volume%3D151%26spage%3D824%26epage%3D830" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blomquist, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span> </span><span class="NLM_article-title">Kinetic analysis of central [<sup>11</sup>C]raclopride binding to D<sub>2</sub>-dopamine receptors studied by PET – a comparison to the equilibrium analysis</span> <span class="citation_source-journal">J. Cereb. Blood Flow Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">696</span><span class="NLM_x">–</span> <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1038%2Fjcbfm.1989.98" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2528555" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL1MXmtV2msLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1989&pages=696-708&author=L.+Fardeauthor=L.+Erikssonauthor=G.+Blomquistauthor=C.+Halldin&title=Kinetic+analysis+of+central+%5B11C%5Draclopride+binding+to+D2-dopamine+receptors+studied+by+PET+%E2%80%93+a+comparison+to+the+equilibrium+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Kinetic analysis of central [11C]raclopride binding to D2-dopamine receptors studied by PET  - a comparison to the equilibrium analysis</span></div><div class="casAuthors">Farde, L.; Eriksson, L.; Blomquist, G.; Halldin, C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow and Metabolism</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">696-708</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    </div><div class="casAbstract">[11C]raclopride binding to central D2-dopamine receptors in humans has previously been examd. by positron emission tomog. (PET).  Based on the rapid occurrence of binding equil., a satn. anal. was developed for the detn. of receptor d. (Bmax) and affinity (Kd).  For anal. of PET measurements obtained with other ligands, a kinetic 3-compartment model was used.  In the present study, the brain uptake of [11C]raclopride was analyzed further by applying both a kinetic and an equil. anal. to data obtained from 4 PET expts. in each of 3 healthy subjects.  First regional cerebral blood vol. was detd.  In the second and third expt., [11C]raclopride with high and low specific activity was used.  In a fourth expt., the [11C]raclopride enantiomer [11C]FLB472 was used to examine the concn. of free radioligand and nonspecific binding in brain.  Radioactivity in arterial blood was measured using an automated blood sampling system.  Bmax And Kd values for [11C]raclopride binding could be detd. also with the kinetic anal.  As expected theor., those values were similar to those obtained with the equil. anal.  In addn., the kinetic anal. allowed sep. detn. of the assocn. and dissocn. rate consts., kon and koff, resp.  Examn. of [11C]raclopride and [11C]FLB472 uptake in brain regions devoid of specific D2-dopamine receptor binding indicated a fourth compartment in which uptake was reversible, nonstereoselective, and nonsaturable in the dose range studied.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3LZ2tR-SRlLVg90H21EOLACvtfcHk0ljOyU4ZIpcVlw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXmtV2msLY%253D&md5=86b7f5f4a1d44222f2009990c889b1b7</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1038%2Fjcbfm.1989.98&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fjcbfm.1989.98%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DEriksson%26aufirst%3DL.%26aulast%3DBlomquist%26aufirst%3DG.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DKinetic%2520analysis%2520of%2520central%2520%255B11C%255Draclopride%2520binding%2520to%2520D2-dopamine%2520receptors%2520studied%2520by%2520PET%2520%25E2%2580%2593%2520a%2520comparison%2520to%2520the%2520equilibrium%2520analysis%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D1989%26volume%3D9%26spage%3D696%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Baron, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinot, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cambon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulenger, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caillard, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huret, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loc’h, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maziere, B.</span><span> </span><span class="NLM_article-title">Striatal dopamine receptor occupancy during and following withdrawal from neuroleptic treatment: correlative evaluation by positron emission tomography and plasma prolactin levels</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">463</span><span class="NLM_x">–</span> <span class="NLM_lpage">472</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=1989&pages=463-472&author=J.+C.+Baronauthor=J.+L.+Martinotauthor=H.+Cambonauthor=J.+P.+Boulengerauthor=M.+F.+Poirierauthor=V.+Caillardauthor=J.+Blinauthor=J.+D.+Huretauthor=C.+Loc%E2%80%99hauthor=B.+Maziere&title=Striatal+dopamine+receptor+occupancy+during+and+following+withdrawal+from+neuroleptic+treatment%3A+correlative+evaluation+by+positron+emission+tomography+and+plasma+prolactin+levels"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaron%26aufirst%3DJ.%2BC.%26aulast%3DMartinot%26aufirst%3DJ.%2BL.%26aulast%3DCambon%26aufirst%3DH.%26aulast%3DBoulenger%26aufirst%3DJ.%2BP.%26aulast%3DPoirier%26aufirst%3DM.%2BF.%26aulast%3DCaillard%26aufirst%3DV.%26aulast%3DBlin%26aufirst%3DJ.%26aulast%3DHuret%26aufirst%3DJ.%2BD.%26aulast%3DLoc%25E2%2580%2599h%26aufirst%3DC.%26aulast%3DMaziere%26aufirst%3DB.%26atitle%3DStriatal%2520dopamine%2520receptor%2520occupancy%2520during%2520and%2520following%2520withdrawal%2520from%2520neuroleptic%2520treatment%253A%2520correlative%2520evaluation%2520by%2520positron%2520emission%2520tomography%2520and%2520plasma%2520prolactin%2520levels%26jtitle%3DPsychopharmacology%26date%3D1989%26volume%3D99%26spage%3D463%26epage%3D472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Ehrin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Paulis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greitz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnstrom, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Litton, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone-Elander, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ögren, S.</span><span> </span><span class="NLM_article-title">Preparation of <sup>11</sup>C-labelled raclopride, a new potent dopamine receptor antagonist: preliminary PET studies of cerebral dopamine receptors in the monkey</span> <span class="citation_source-journal">Int. J. Appl. Radiat. Isot.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">269</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0020-708X%2885%2990083-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=3874833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL2MXls1Sgsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1985&pages=269-273&author=E.+Ehrinauthor=L.+Fardeauthor=T.+de+Paulisauthor=L.+Erikssonauthor=T.+Greitzauthor=P.+Johnstromauthor=J.+E.+Littonauthor=J.+L.+Nilssonauthor=G.+Sedvallauthor=S.+Stone-Elanderauthor=S.+%C3%96gren&title=Preparation+of+11C-labelled+raclopride%2C+a+new+potent+dopamine+receptor+antagonist%3A+preliminary+PET+studies+of+cerebral+dopamine+receptors+in+the+monkey"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Preparation of carbon-11-labeled raclopride, a new potent dopamine receptor antagonist:  preliminary PET studies of cerebral dopamine receptors in the monkey</span></div><div class="casAuthors">Ehrin, Erling; Farde, Lars; De Paulis, Tomas; Eriksson, Lars; Greitz, Torgny; Johnstroem, Peter; Litton, Jan Erik; Nilsson, J. Lars G.; Sedvall, Goeran; et al.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">269-73</span>CODEN:
                <span class="NLM_cas:coden">IJARAY</span>;
        ISSN:<span class="NLM_cas:issn">0020-708X</span>.
    </div><div class="casAbstract">A new dopamine receptor antagonist, Raclopride (I) was labeled using [11C]ethyl iodide for alkylation of the nitrogen of the pyrrolidine ring in the corresponding secondary amine II.  The synthesis of I and an efficient method for the prepn. of [11C]ethyl iodide are described.  The 11C-labeled I was purified by HPLC and then used in positron emission tomog. to visualize the dopamine receptor-rich areas of the monkey brain.  The images obtained show selective accumulation of I in striatum and a 10-fold sepn. between the binding to caudate vs. cerebellum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl0nX9qAJNMbVg90H21EOLACvtfcHk0lijlzeoIXphZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXls1Sgsb4%253D&md5=a76e923c95e6cd19ba04e5981d47af25</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1016%2F0020-708X%2885%2990083-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0020-708X%252885%252990083-3%26sid%3Dliteratum%253Aachs%26aulast%3DEhrin%26aufirst%3DE.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3Dde%2BPaulis%26aufirst%3DT.%26aulast%3DEriksson%26aufirst%3DL.%26aulast%3DGreitz%26aufirst%3DT.%26aulast%3DJohnstrom%26aufirst%3DP.%26aulast%3DLitton%26aufirst%3DJ.%2BE.%26aulast%3DNilsson%26aufirst%3DJ.%2BL.%26aulast%3DSedvall%26aufirst%3DG.%26aulast%3DStone-Elander%26aufirst%3DS.%26aulast%3D%25C3%2596gren%26aufirst%3DS.%26atitle%3DPreparation%2520of%252011C-labelled%2520raclopride%252C%2520a%2520new%2520potent%2520dopamine%2520receptor%2520antagonist%253A%2520preliminary%2520PET%2520studies%2520of%2520cerebral%2520dopamine%2520receptors%2520in%2520the%2520monkey%26jtitle%3DInt.%2520J.%2520Appl.%2520Radiat.%2520Isot.%26date%3D1985%26volume%3D36%26spage%3D269%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span> </span><span class="NLM_article-title">Central D<sub>2</sub>-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1988</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">71</span><span class="NLM_x">–</span> <span class="NLM_lpage">76</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.1988.01800250087012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2892477" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaL1cXosl2lug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=1988&pages=71-76&author=L.+Fardeauthor=F.+A.+Wieselauthor=C.+Halldinauthor=G.+Sedvall&title=Central+D2-dopamine+receptor+occupancy+in+schizophrenic+patients+treated+with+antipsychotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs</span></div><div class="casAuthors">Farde, Lars; Wiesel, Fritz Axel; Halldin, Christer; Sedvall, Goeran</div><div class="citationInfo"><span class="NLM_cas:title">Archives of General Psychiatry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-6</span>CODEN:
                <span class="NLM_cas:coden">ARGPAQ</span>;
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">By use of positron emission tomog. and the 11C-labeled ligand raclopride, central D2-dopamine receptor occupancy in the putamen was detd. in psychiatric patients treated with clin. doses of psychoactive drugs.  Receptor occupancy in drug-treated patients was defined as the percent redn. of specific [11C]raclopride binding in relation to the expected binding in the absence of drug treatment.  Clin. treatment of schizophrenic patients with 11 chem. distinct antipsychotic drugs (including both classic and atypical neuroleptics such as clozapine) resulted in a 65%-85% occupancy of D2-dopamine receptors.  In a depressed patient treated with the tricyclic antidepressant nortriptyline, no occupancy was found.  The time course for receptor occupancy and drug levels was followed after withdrawal of sulpiride or haloperidol.  D2-dopamine receptor occupancy remained above 65% for many hours despite a substantial redn. of serum drug concns.  In a sulpiride-treated patient, the dosage was reduced in 4 steps over a 9-wk period and a curvilinear relationship was demonstrated between central D2-dopamine receptor occupancy and serum drug concns.  The results demonstrate that clin. doses of all the currently used classes of antipsychotic drugs cause a substantial blockage of central D2-dopamine receptors in humans.  This effect appears to be selective for the antipsychotics, since it was not induced by the antidepressant nortriptyline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoD7dN3f4CHVrVg90H21EOLACvtfcHk0lijlzeoIXphZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXosl2lug%253D%253D&md5=c4961c5ed90837994b550db1a4e4aafe</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1988.01800250087012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1988.01800250087012%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DWiesel%26aufirst%3DF.%2BA.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DSedvall%26aufirst%3DG.%26atitle%3DCentral%2520D2-dopamine%2520receptor%2520occupancy%2520in%2520schizophrenic%2520patients%2520treated%2520with%2520antipsychotic%2520drugs%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1988%26volume%3D45%26spage%3D71%26epage%3D76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Nordström, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forslund, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uppfeldt, G.</span><span> </span><span class="NLM_article-title">Central D<sub>2</sub>-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients</span> <span class="citation_source-journal">Biol. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">235</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0006-3223%2893%2990288-O" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8097114" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK3s3ivFKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1993&pages=227-235&author=A.+L.+Nordstr%C3%B6mauthor=L.+Fardeauthor=F.+A.+Wieselauthor=K.+Forslundauthor=S.+Pauliauthor=C.+Halldinauthor=G.+Uppfeldt&title=Central+D2-dopamine+receptor+occupancy+in+relation+to+antipsychotic+drug+effects%3A+a+double-blind+PET+study+of+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients</span></div><div class="casAuthors">Nordstrom A L; Farde L; Wiesel F A; Forslund K; Pauli S; Halldin C; Uppfeldt G</div><div class="citationInfo"><span class="NLM_cas:title">Biological psychiatry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">227-35</span>
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    </div><div class="casAbstract">The relationship between central D2-dopamine receptor occupancy and antipsychotic drug effects was examined in a double-blind study.  Raclopride was the compound used to induce a selective occupancy of the D2-dopamine receptors.  In addition, 11C-labeled raclopride was the radioligand used to measure occupancy by positron emission tomography (PET).  Seventeen schizophrenic patients were randomly assigned to one of three parallel groups treated for 4 weeks with daily doses of 2, 6, or 12 mg of raclopride.  D2-receptor occupancy was determined by PET at steady-state conditions in 13 patients who completed the study.  A statistically significant relationship was demonstrated between antipsychotic effect and degree of D2-receptor occupancy (p < 0.05).  Patients with extrapyramidal side effects had significantly higher D2-receptor occupancy than those without (p = 0.02).  The finding of a relationship between selective occupancy of the D2-dopamine receptors and clinical effects in schizophrenic patients principally provides new support for the dopamine hypothesis of antipsychotic drug action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR0DIDXWk9_NwxyojvcjibhfW6udTcc2eYI0yRO_CDbmrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3s3ivFKjtw%253D%253D&md5=b3abcb9071739d89f676ebfd876355e2</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1016%2F0006-3223%2893%2990288-O&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-3223%252893%252990288-O%26sid%3Dliteratum%253Aachs%26aulast%3DNordstr%25C3%25B6m%26aufirst%3DA.%2BL.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DWiesel%26aufirst%3DF.%2BA.%26aulast%3DForslund%26aufirst%3DK.%26aulast%3DPauli%26aufirst%3DS.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DUppfeldt%26aufirst%3DG.%26atitle%3DCentral%2520D2-dopamine%2520receptor%2520occupancy%2520in%2520relation%2520to%2520antipsychotic%2520drug%2520effects%253A%2520a%2520double-blind%2520PET%2520study%2520of%2520schizophrenic%2520patients%26jtitle%3DBiol.%2520Psychiatry%26date%3D1993%26volume%3D33%26spage%3D227%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordstrom, A. L.</span><span> </span><span class="NLM_article-title">PET examination of central D<sub>2</sub> dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs</span> <span class="citation_source-journal">Psychopharmacol. Ser.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">94</span><span class="NLM_x">–</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8103229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK3sXmtFOitr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1993&pages=94-100&author=L.+Fardeauthor=A.+L.+Nordstrom&title=PET+examination+of+central+D2+dopamine+receptor+occupancy+in+relation+to+extrapyramidal+syndromes+in+patients+being+treated+with+neuroleptic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">PET examination of central D2 dopamine receptor occupancy in relation to extrapyramidal syndromes in patients being treated with neuroleptic drugs</span></div><div class="casAuthors">Farde, L.; Nordstroem, A. L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Series</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">Clinical Pharmacology in Psychiatry</span>),
    <span class="NLM_cas:pages">94-100</span>CODEN:
                <span class="NLM_cas:coden">PSSEEP</span>;
        ISSN:<span class="NLM_cas:issn">0931-6795</span>.
    </div><div class="casAbstract">Positron emission tomog. was used to localize D2 dopamine receptors in humans treated with neuroleptics.  The relation between extrapyramidal syndromes and neuroleptic treatment is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppHPX5_Dbqi7Vg90H21EOLACvtfcHk0lgB2flkLBjcUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmtFOitr4%253D&md5=e834443826f3dae61d164530f39d865b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DNordstrom%26aufirst%3DA.%2BL.%26atitle%3DPET%2520examination%2520of%2520central%2520D2%2520dopamine%2520receptor%2520occupancy%2520in%2520relation%2520to%2520extrapyramidal%2520syndromes%2520in%2520patients%2520being%2520treated%2520with%2520neuroleptic%2520drugs%26jtitle%3DPsychopharmacol.%2520Ser.%26date%3D1993%26volume%3D10%26spage%3D94%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Farde, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nordstrom, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiesel, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sedvall, G.</span><span> </span><span class="NLM_article-title">Positron emission tomographic analysis of central D<sub>1</sub> and D<sub>2</sub> dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects</span> <span class="citation_source-journal">Arch. Gen. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">538</span><span class="NLM_x">–</span> <span class="NLM_lpage">544</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1001%2Farchpsyc.1992.01820070032005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=1352677" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK38zivVKgug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1992&pages=538-544&author=L.+Fardeauthor=A.+L.+Nordstromauthor=F.+A.+Wieselauthor=S.+Pauliauthor=C.+Halldinauthor=G.+Sedvall&title=Positron+emission+tomographic+analysis+of+central+D1+and+D2+dopamine+receptor+occupancy+in+patients+treated+with+classical+neuroleptics+and+clozapine.+Relation+to+extrapyramidal+side+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects</span></div><div class="casAuthors">Farde L; Nordstrom A L; Wiesel F A; Pauli S; Halldin C; Sedvall G</div><div class="citationInfo"><span class="NLM_cas:title">Archives of general psychiatry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">538-44</span>
        ISSN:<span class="NLM_cas:issn">0003-990X</span>.
    </div><div class="casAbstract">Positron emission tomography and selective radioligands were used to determine D1 and D2 dopamine receptor occupancy induced by neuroleptics in the basal ganglia of drug-treated schizophrenic patients.  In 22 patients treated with conventional dosages of classical neuroleptics, the D2 occupancy was 70% to 89%.  Patients with acute extrapyramidal syndromes had a higher D2 occupancy than those without side effects.  This finding indicates that neuroleptic-induced extrapyramidal syndromes are related to the degree of central D2 occupancy induced in the basal ganglia.  In five patients treated with clozapine, the prototype atypical antipsychotic drug, a lower D2 occupancy of 38% to 63% was found.  This finding demonstrates that clozapine is also "atypical" with respect to the central D2 occupancy in patients.  During treatment with clozapine, there is a low frequency of extrapyramidal syndromes, which accordingly may reflect the comparatively low D2 occupancy induced by clinical doses of clozapine.  Classical neuroleptics, like haloperidol or sulpiride, did not cause any evident D1 occupancy, but the thioxanthene flupentixol induced a 36% to 44% occupancy.  In four patients treated with clozapine, the D1 occupancy was 38% to 52%.  The D1 occupancy induced by clozapine and flupentixol may contribute to the antipsychotic effect of these drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8O-69J5LclwvupmecNw_lfW6udTcc2eakjDqo-iT9E7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK38zivVKgug%253D%253D&md5=9c70724d8c7ca998bd4f0154101b0d7d</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1001%2Farchpsyc.1992.01820070032005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Farchpsyc.1992.01820070032005%26sid%3Dliteratum%253Aachs%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DNordstrom%26aufirst%3DA.%2BL.%26aulast%3DWiesel%26aufirst%3DF.%2BA.%26aulast%3DPauli%26aufirst%3DS.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DSedvall%26aufirst%3DG.%26atitle%3DPositron%2520emission%2520tomographic%2520analysis%2520of%2520central%2520D1%2520and%2520D2%2520dopamine%2520receptor%2520occupancy%2520in%2520patients%2520treated%2520with%2520classical%2520neuroleptics%2520and%2520clozapine.%2520Relation%2520to%2520extrapyramidal%2520side%2520effects%26jtitle%3DArch.%2520Gen.%2520Psychiatry%26date%3D1992%26volume%3D49%26spage%3D538%26epage%3D544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Shintomi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamura, M.</span><span> </span><span class="NLM_article-title">Letter: Effects of antiparkinsonian drugs on neuroleptic-induced extrapyramidal signs in monkeys</span> <span class="citation_source-journal">J. Pharm. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">–</span> <span class="NLM_lpage">667</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1111%2Fj.2042-7158.1973.tb10661.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=4148443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaE2cXhtVChtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1973&pages=666-667&author=K.+Shintomiauthor=M.+Yamamura&title=Letter%3A+Effects+of+antiparkinsonian+drugs+on+neuroleptic-induced+extrapyramidal+signs+in+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of antiparkinsonian drugs on neuroleptic-induced extrapyramidal signs in monkeys</span></div><div class="casAuthors">Shintomi, K.; Yamamura, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacy and Pharmacology</span>
        (<span class="NLM_cas:date">1973</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">666-7</span>CODEN:
                <span class="NLM_cas:coden">JPPMAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">S.c. administration of the antiparkinsonian drugs, ethopropazine-HCl (I) [1094-08-2] (5 mg/kg), benztropine mesylate [132-17-2] (2 mg/kg), trihexyphenidyl-HCl [52-49-3] (2 mg/kg), and 6,6,9-trimethyl-9-azabicyclo[3,3,1]non-3β-yl α,α-di(2-thienyl)glycolate-HCl [32891-29-5] (2 mg/kg) antagonized the cataleptic features induced by s.c. injection of haloperidol [52-86-8] (1 mg/kg) or perphenazine [58-39-9] (2 mg/kg) into male cynomolgus monkeys.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6h7Nu1JIJWLVg90H21EOLACvtfcHk0lgB2flkLBjcUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXhtVChtg%253D%253D&md5=19498f3c8c89c59dfe81a014c80483d6</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1973.tb10661.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1973.tb10661.x%26sid%3Dliteratum%253Aachs%26aulast%3DShintomi%26aufirst%3DK.%26aulast%3DYamamura%26aufirst%3DM.%26atitle%3DLetter%253A%2520Effects%2520of%2520antiparkinsonian%2520drugs%2520on%2520neuroleptic-induced%2520extrapyramidal%2520signs%2520in%2520monkeys%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1973%26volume%3D25%26spage%3D666%26epage%3D667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsubara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. C.</span><span> </span><span class="NLM_article-title">The ratios of serotonin and dopamine affinities differentiate atypical and typical antipsychotic drugs</span> <span class="citation_source-journal">Psychopharmacol. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">390</span><span class="NLM_x">–</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2576319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK3cXhsFWmu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1989&pages=390-392&author=H.+Y.+Meltzerauthor=S.+Matsubaraauthor=J.+C.+Lee&title=The+ratios+of+serotonin+and+dopamine+affinities+differentiate+atypical+and+typical+antipsychotic+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs</span></div><div class="casAuthors">Meltzer, Herbert Y.; Matsubara, Shigehiro; Lee, Jar Chi</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology Bulletin</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">390-2</span>CODEN:
                <span class="NLM_cas:coden">PSYBB9</span>;
        ISSN:<span class="NLM_cas:issn">0048-5764</span>.
    </div><div class="casAbstract">Atypical antipsychotic drugs such as clozapine, fluperlapine, and melperone produce weak catalepsy in rodents, and minimal extrapyramidal symptoms and serum prolactin elevations in humans, compared to typical antipsychotic drugs such as haloperidol.  The biol. basis for these differences has been attributed to relatively weak blockade at D2 dopamine (DA) receptors, various effects at D1 receptors, or potent serotonin2 (5-HT2) antagonism, although other possibilities exist.  To clarify the relative importance of actions of D1, D2, and 5-HT2 receptors for identification of candidate typical and atypical drugs, the authors detd. the neg. log of the Ki (pKi) value of 21 typical and 17 atypical antipsychotic drugs for the striatal D1 and D2 and frontal cortex 5-HT2 receptors of rodent brain.  Cluster anal. identified that the 5-HT2/D2 ratio was the most successful means of utilizing this data to classify typical and atypical antipsychotic drugs correctly.  A 92% accuracy was achieved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGos0Xqr2TSGcLVg90H21EOLACvtfcHk0ljDQxVbZdwZLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhsFWmu7Y%253D&md5=3f5c199f61ada18f6210532b086b0e13</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DMatsubara%26aufirst%3DS.%26aulast%3DLee%26aufirst%3DJ.%2BC.%26atitle%3DThe%2520ratios%2520of%2520serotonin%2520and%2520dopamine%2520affinities%2520differentiate%2520atypical%2520and%2520typical%2520antipsychotic%2520drugs%26jtitle%3DPsychopharmacol.%2520Bull.%26date%3D1989%26volume%3D25%26spage%3D390%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Mamo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shammi, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papatheodorou, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Therrien, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, G.</span><span> </span><span class="NLM_article-title">A PET study of dopamine D<sub>2</sub> and serotonin 5-HT<sub>2</sub> receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">161</span><span class="NLM_x">, </span> <span class="NLM_fpage">818</span><span class="NLM_x">–</span> <span class="NLM_lpage">825</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.161.5.818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15121646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2c3itFyhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2004&pages=818-825&author=D.+Mamoauthor=S.+Kapurauthor=C.+M.+Shammiauthor=G.+Papatheodorouauthor=S.+Mannauthor=F.+Therrienauthor=G.+Remington&title=A+PET+study+of+dopamine+D2+and+serotonin+5-HT2+receptor+occupancy+in+patients+with+schizophrenia+treated+with+therapeutic+doses+of+ziprasidone"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">A PET study of dopamine D2 and serotonin 5-HT2 receptor occupancy in patients with schizophrenia treated with therapeutic doses of ziprasidone</span></div><div class="casAuthors">Mamo David; Kapur Shitij; Shammi C M; Papatheodorou George; Mann Steve; Therrien Francois; Remington Gary</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">818-25</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Ziprasidone is an atypical antipsychotic drug that shows a higher affinity for serotonin 5-HT(2) receptors compared with dopamine D(2) receptors in vitro.  The affinity of ziprasidone for these receptors in vivo in patients was examined in a positron emission tomography (PET) study.  METHOD:  The authors conducted a PET study to evaluate D(2) occupancy (using [(11)C]raclopride) and 5-HT(2) occupancy (using [(18)F]setoperone) in brain regions of interest in 16 patients with schizophrenia or schizoaffective disorder randomly assigned to receive 40, 80, 120, or 160 mg/day of ziprasidone, which reflected the recommended dose range.  PET scanning was done after 3 weeks of administration and at trough plasma levels, i.e., 12-16 hours after the last dose.  RESULTS:  The mean 5-HT(2) receptor occupancy was significantly higher than the mean D(2) receptor occupancy (mean=76%, SD=15%, and mean=56%, SD=18%, respectively).  The estimated plasma ziprasidone concentration associated with 50% maximal 5-HT(2) receptor occupancy was almost four times lower than that for D(2) receptor occupancy.  CONCLUSIONS:  These data affirm that ziprasidone is similar to other novel antipsychotics in having greater 5-HT(2) than D(2) receptor occupancy at therapeutic doses and suggest that the optimal effective dose of ziprasidone is closer to 120 mg/day than to the lower doses suggested by previous PET studies.  The relatively high D(2) receptor occupancy, even at trough plasma levels, suggests that ziprasidone is more similar to risperidone and olanzapine in receptor occupancy profile than to clozapine and quetiapine.  Since ziprasidone plasma levels show significant (more than twofold) variation within a single dose cycle, studies that are aimed at peak plasma levels (6 hours after the last dose) and that examine extrastriatal regions are required to fully characterize the in vivo occupancy profile of ziprasidone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQo4wIPTXNjldHxxy173TfNfW6udTcc2eZPhYFW9ZT4P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3itFyhuw%253D%253D&md5=85dfc81d925db394aa327198673a41ff</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.161.5.818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.161.5.818%26sid%3Dliteratum%253Aachs%26aulast%3DMamo%26aufirst%3DD.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DShammi%26aufirst%3DC.%2BM.%26aulast%3DPapatheodorou%26aufirst%3DG.%26aulast%3DMann%26aufirst%3DS.%26aulast%3DTherrien%26aufirst%3DF.%26aulast%3DRemington%26aufirst%3DG.%26atitle%3DA%2520PET%2520study%2520of%2520dopamine%2520D2%2520and%2520serotonin%25205-HT2%2520receptor%2520occupancy%2520in%2520patients%2520with%2520schizophrenia%2520treated%2520with%2520therapeutic%2520doses%2520of%2520ziprasidone%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2004%26volume%3D161%26spage%3D818%26epage%3D825" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group">Nyberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eriksson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oxenstierna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halldin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farde, L.</span><span> </span><span class="NLM_article-title">Suggested minimal effective dose of risperidone based on PET-measured D<sub>2</sub> and 5-HT<sub>2A</sub> receptor occupancy in schizophrenic patients</span> <span class="citation_source-journal">Am. J. Psychiatry.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">869</span><span class="NLM_x">–</span> <span class="NLM_lpage">875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10360125" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK1M3ovVeqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1999&pages=869-875&author=S.+Nybergauthor=B.+Erikssonauthor=G.+Oxenstiernaauthor=C.+Halldinauthor=L.+Farde&title=Suggested+minimal+effective+dose+of+risperidone+based+on+PET-measured+D2+and+5-HT2A+receptor+occupancy+in+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients</span></div><div class="casAuthors">Nyberg S; Eriksson B; Oxenstierna G; Halldin C; Farde L</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">869-75</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Multicenter trials with the novel antipsychotic risperidone have suggested a standard dose of 6 mg/day.  However, a dose producing the highest response rate in fixed-dose studies is likely to exceed the minimal effective dose in most patients.  The aim of this positron emission tomography (PET) study was to suggest a minimal effective dose of risperidone based on measurements of dopamine D2 and serotonin 5-HT2A receptor occupancy.  METHOD:  Eight first-episode or drug-free schizophrenic patients were treated with risperidone, 6 mg/day, for 4 weeks and then 3 mg/day for 2 weeks.  PET was performed after 4 and 6 weeks, with [11C]raclopride to measure D2 receptor occupancy and [11C]N-methylspiperone to measure 5-HT2A receptor occupancy.  RESULTS:  Seven patients completed the study and responded to treatment with risperidone.  No patient had extrapyramidal side effects at the time of inclusion in the study.  At the 6-mg/day dose, mean D2 receptor occupancy was 82% (range = 79%-85%), 5-HT2A receptor occupancy was 95% (range = 86%-109%), and six patients had developed extrapyramidal side effects.  After dose reduction to 3 mg/day, D2 receptor occupancy was 72% (range = 53%-78%), and 5-HT2A receptor occupancy was 83% (range = 65%-112%).  Three patients had extrapyramidal side effects at this time.  CONCLUSIONS:  Treatment with risperidone, 6 mg/day, is likely to induce unnecessarily high D2 receptor occupancy, with a consequent risk of extrapyramidal side effects.  High 5-HT2A receptor occupancy did not prevent extrapyramidal side effects completely.  The authors previously suggested an optimal interval for D2 receptor occupancy of 70%-80%.  To achieve this, resperidone, 4 mg/day, should be a suitable initial dose for antipsychotic effect with a minimal risk of extrapyramidal side effects in most patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcShWRknW98LMN1QT_1O5WBYfW6udTcc2eZPhYFW9ZT4P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3ovVeqtQ%253D%253D&md5=9fa83e833bd3d68d1b880fb506e0b429</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNyberg%26aufirst%3DS.%26aulast%3DEriksson%26aufirst%3DB.%26aulast%3DOxenstierna%26aufirst%3DG.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26atitle%3DSuggested%2520minimal%2520effective%2520dose%2520of%2520risperidone%2520based%2520on%2520PET-measured%2520D2%2520and%25205-HT2A%2520receptor%2520occupancy%2520in%2520schizophrenic%2520patients%26jtitle%3DAm.%2520J.%2520Psychiatry.%26date%3D1999%26volume%3D156%26spage%3D869%26epage%3D875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Kapur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipursky, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Remington, G.</span><span> </span><span class="NLM_article-title">Clinical and theoretical implications of 5-HT<sub>2</sub> and D<sub>2</sub> receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">156</span><span class="NLM_x">, </span> <span class="NLM_fpage">286</span><span class="NLM_x">–</span> <span class="NLM_lpage">293</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=9989565" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK1M7kt1Kksw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=156&publication_year=1999&pages=286-293&author=S.+Kapurauthor=R.+B.+Zipurskyauthor=G.+Remington&title=Clinical+and+theoretical+implications+of+5-HT2+and+D2+receptor+occupancy+of+clozapine%2C+risperidone%2C+and+olanzapine+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia</span></div><div class="casAuthors">Kapur S; Zipursky R B; Remington G</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">156</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">286-93</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Dopamine D2 receptor occupancy measurements provide a valid predictor of antipsychotic response, extrapyramidal side effects, and elevation of prolactin levels.  The new antipsychotics clozapine, risperidone, and olanzapine obtain antipsychotic response with few extrapyramidal side effects and little prolactin elevation.  The purpose of this study was to compare the D2 and serotonin 5-HT2 receptor occupancies of these drugs in patients receiving multiple-dose, steady-state regimens.  METHOD:  Forty-four patients with schizophrenia (16 taking risperidone, 2-12 mg/day; 17 taking olanzapine, 5-60 mg/day; and 11 taking clozapine, 75-900 mg/day) had their D2 and 5-HT2 occupancies determined with the use of [11C]raclopride and [18F]setoperone, respectively, and positron emission tomography imaging.  RESULTS:  Clozapine showed a much lower D2 occupancy (16%-68%) than risperidone (63%-89%) and olanzapine (43%-89%).  Risperidone and olanzapine gave equal D2 occupancies at doses of 5 and 20 mg/day, respectively.  All three drugs showed greater 5-HT2 than D2 occupancy at all doses, although the difference was greatest for clozapine.  CONCLUSIONS:  Clozapine, at doses known to be effective in routine clinical settings, showed a D2 occupancy clearly lower than that of typical antipsychotics, while risperidone and olanzapine at their usual clinical doses gave the same level of D2 occupancy as low-dose typical antipsychotics.  The results also suggest that some previous clinical comparisons of antipsychotics may have been confounded by different levels of D2 occupancy.  Clinical comparisons of these drugs, matching for D2 occupancy, may provide a better measure of their true "atypicality" and will help in understanding the contribution of non-D2 receptors to antipsychotic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR8__ZcHLPhBjW1zwg2yUK5fW6udTcc2eZPhYFW9ZT4P7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7kt1Kksw%253D%253D&md5=30cdcea9c4ae28aa2e8a978635baa894</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DZipursky%26aufirst%3DR.%2BB.%26aulast%3DRemington%26aufirst%3DG.%26atitle%3DClinical%2520and%2520theoretical%2520implications%2520of%25205-HT2%2520and%2520D2%2520receptor%2520occupancy%2520of%2520clozapine%252C%2520risperidone%252C%2520and%2520olanzapine%2520in%2520schizophrenia%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D1999%26volume%3D156%26spage%3D286%26epage%3D293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group">Nakazawa, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horisawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawasaki, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizuma, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Onoe, H.</span><span> </span><span class="NLM_article-title">Evaluation of dopamine D<sub>2</sub>/D<sub>3</sub> and serotonin 5-HT<sub>2A</sub> receptor occupancy for a novel antipsychotic, lurasidone, in conscious common marmosets using small-animal positron emission tomography</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">225</span><span class="NLM_x">, </span> <span class="NLM_fpage">329</span><span class="NLM_x">–</span> <span class="NLM_lpage">339</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=225&publication_year=2013&pages=329-339&author=S.+Nakazawaauthor=C.+Yokoyamaauthor=N.+Nishimuraauthor=T.+Horisawaauthor=A.+Kawasakiauthor=H.+Mizumaauthor=H.+Doiauthor=H.+Onoe&title=Evaluation+of+dopamine+D2%2FD3+and+serotonin+5-HT2A+receptor+occupancy+for+a+novel+antipsychotic%2C+lurasidone%2C+in+conscious+common+marmosets+using+small-animal+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNakazawa%26aufirst%3DS.%26aulast%3DYokoyama%26aufirst%3DC.%26aulast%3DNishimura%26aufirst%3DN.%26aulast%3DHorisawa%26aufirst%3DT.%26aulast%3DKawasaki%26aufirst%3DA.%26aulast%3DMizuma%26aufirst%3DH.%26aulast%3DDoi%26aufirst%3DH.%26aulast%3DOnoe%26aufirst%3DH.%26atitle%3DEvaluation%2520of%2520dopamine%2520D2%252FD3%2520and%2520serotonin%25205-HT2A%2520receptor%2520occupancy%2520for%2520a%2520novel%2520antipsychotic%252C%2520lurasidone%252C%2520in%2520conscious%2520common%2520marmosets%2520using%2520small-animal%2520positron%2520emission%2520tomography%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D225%26spage%3D329%26epage%3D339" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwabara, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasic, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stock, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gean, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loebel, A.</span><span> </span><span class="NLM_article-title">Determination of dopamine D<sub>2</sub> receptor occupancy by lurasidone using positron emission tomography in healthy male subjects</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">229</span><span class="NLM_x">, </span> <span class="NLM_fpage">245</span><span class="NLM_x">–</span> <span class="NLM_lpage">252</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=229&publication_year=2013&pages=245-252&author=D.+F.+Wongauthor=H.+Kuwabaraauthor=J.+R.+Brasicauthor=T.+Stockauthor=A.+Mainiauthor=E.+G.+Geanauthor=A.+Loebel&title=Determination+of+dopamine+D2+receptor+occupancy+by+lurasidone+using+positron+emission+tomography+in+healthy+male+subjects"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DKuwabara%26aufirst%3DH.%26aulast%3DBrasic%26aufirst%3DJ.%2BR.%26aulast%3DStock%26aufirst%3DT.%26aulast%3DMaini%26aufirst%3DA.%26aulast%3DGean%26aufirst%3DE.%2BG.%26aulast%3DLoebel%26aufirst%3DA.%26atitle%3DDetermination%2520of%2520dopamine%2520D2%2520receptor%2520occupancy%2520by%2520lurasidone%2520using%2520positron%2520emission%2520tomography%2520in%2520healthy%2520male%2520subjects%26jtitle%3DPsychopharmacology%26date%3D2013%26volume%3D229%26spage%3D245%26epage%3D252" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Potkin, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keator, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kesler-West, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Erp, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukherjee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preda, A.</span><span> </span><span class="NLM_article-title">D2 receptor occupancy following lurasidone treatment in patients with schizophrenia or schizoaffective disorder</span> <span class="citation_source-journal">CNS Spectr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=1-6&author=S.+G.+Potkinauthor=D.+B.+Keatorauthor=M.+L.+Kesler-Westauthor=D.+D.+Nguyenauthor=T.+G.+van+Erpauthor=J.+Mukherjeeauthor=N.+Shahauthor=A.+Preda&title=D2+receptor+occupancy+following+lurasidone+treatment+in+patients+with+schizophrenia+or+schizoaffective+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPotkin%26aufirst%3DS.%2BG.%26aulast%3DKeator%26aufirst%3DD.%2BB.%26aulast%3DKesler-West%26aufirst%3DM.%2BL.%26aulast%3DNguyen%26aufirst%3DD.%2BD.%26aulast%3Dvan%2BErp%26aufirst%3DT.%2BG.%26aulast%3DMukherjee%26aufirst%3DJ.%26aulast%3DShah%26aufirst%3DN.%26aulast%3DPreda%26aufirst%3DA.%26atitle%3DD2%2520receptor%2520occupancy%2520following%2520lurasidone%2520treatment%2520in%2520patients%2520with%2520schizophrenia%2520or%2520schizoaffective%2520disorder%26jtitle%3DCNS%2520Spectr.%26date%3D2013%26spage%3D1%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Muller, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regenbogen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eich, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span> </span><span class="NLM_article-title">Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia</span> <span class="citation_source-journal">J. Psychiatr. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">673</span><span class="NLM_x">–</span> <span class="NLM_lpage">679</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2Fj.jpsychires.2005.10.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=16324716" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD2s7pvVOiug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2007&pages=673-679&author=M.+J.+Mullerauthor=B.+Regenbogenauthor=S.+Hartterauthor=F.+X.+Eichauthor=C.+Hiemke&title=Therapeutic+drug+monitoring+for+optimizing+amisulpride+therapy+in+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia</span></div><div class="casAuthors">Muller Matthias J; Regenbogen Boris; Hartter Sebastian; Eich Franz X; Hiemke Christoph</div><div class="citationInfo"><span class="NLM_cas:title">Journal of psychiatric research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">673-9</span>
        ISSN:<span class="NLM_cas:issn">0022-3956</span>.
    </div><div class="casAbstract">Amisulpride is a clinically effective antipsychotic drug in a broad dose range with low propensity for extrapyramidal symptoms (EPS).  Daily doses and plasma levels of amisulpride were analyzed within a large-scale therapeutic drug monitoring (TDM) survey to find plasma level ranges for optimized treatment under naturalistic conditions.  Data of 378 schizophrenic patients treated with amisulpride (100-1550 mg) were included (40% female).  Amisulpride plasma levels were analyzed at steady state; assessment comprised improvement (CGI-I) and side-effects, particularly EPS.  For detection of cut-off values regarding non-response or EPS, receiver operating characteristics (ROC) curves were applied and the area under the ROC curve (AUC) was calculated.  Amisulpride daily doses (594+/-262 mg) and plasma levels (315+/-277 ng/ml) were significantly correlated (r=0.53; P<0.0001).  Patients with non-response to amisulpride (8.9%) had significantly (P<0.05) lower plasma levels (248+/-291 ng/ml) than patients with at least moderate improvement (316+/-253 ng/ml) despite comparable amisulpride doses (628+/-253 vs. 590+/-263 mg).  Patients with EPS (14.6%) had significantly (P<0.05) higher amisulpride plasma levels (377+/-290 ng/ml) than patients without EPS (305+/-274 ng/ml) despite similar doses in both groups (595+/-266 vs. 594+/-246 mg).  ROC analyses revealed significant predictive properties of amisulpride plasma levels (P<0.05) for non-response (AUC=0.65+/-0.05) and EPS (AUC=0.62+/-0.05), respectively.  Daily amisulpride doses did not significantly predict non-response or EPS.  Optimal amisulpride plasma level values to avoid non-response and EPS were 100 or 320 ng/ml, respectively.  Analysis of clinical utility revealed that blood levels must be analyzed in 7 patients until one patient benefits from the TDM procedure by avoiding non-response or EPS.  Although our results were mainly explorative, TDM of amisulpride seems very useful for clinical decision making.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcS8SfH-nDqG-f_I8Jvzw4xCfW6udTcc2ea_qYJ8WuM6l7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2s7pvVOiug%253D%253D&md5=ba28af8d65b22559d6ddab430fe60f2b</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.jpsychires.2005.10.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpsychires.2005.10.003%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DM.%2BJ.%26aulast%3DRegenbogen%26aufirst%3DB.%26aulast%3DHartter%26aufirst%3DS.%26aulast%3DEich%26aufirst%3DF.%2BX.%26aulast%3DHiemke%26aufirst%3DC.%26atitle%3DTherapeutic%2520drug%2520monitoring%2520for%2520optimizing%2520amisulpride%2520therapy%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DJ.%2520Psychiatr.%2520Res.%26date%3D2007%26volume%3D41%26spage%3D673%26epage%3D679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Catafau, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penengo, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullich, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corripio, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parellada, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garcia-Ribera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomeni, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merlo-Pich, E.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and time-course of D<sub>2</sub> receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients</span> <span class="citation_source-journal">J. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">8828</span><span class="NLM_x">–</span> <span class="NLM_lpage">8894</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1177%2F0269881107083810" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=8828-8894&author=A.+M.+Catafauauthor=M.+M.+Penengoauthor=G.+Nucciauthor=S.+Bullichauthor=I.+Corripioauthor=E.+Parelladaauthor=C.+Garcia-Riberaauthor=R.+Gomeniauthor=E.+Merlo-Pich&title=Pharmacokinetics+and+time-course+of+D2+receptor+occupancy+induced+by+atypical+antipsychotics+in+stabilized+schizophrenic+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1177%2F0269881107083810&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F0269881107083810%26sid%3Dliteratum%253Aachs%26aulast%3DCatafau%26aufirst%3DA.%2BM.%26aulast%3DPenengo%26aufirst%3DM.%2BM.%26aulast%3DNucci%26aufirst%3DG.%26aulast%3DBullich%26aufirst%3DS.%26aulast%3DCorripio%26aufirst%3DI.%26aulast%3DParellada%26aufirst%3DE.%26aulast%3DGarcia-Ribera%26aufirst%3DC.%26aulast%3DGomeni%26aufirst%3DR.%26aulast%3DMerlo-Pich%26aufirst%3DE.%26atitle%3DPharmacokinetics%2520and%2520time-course%2520of%2520D2%2520receptor%2520occupancy%2520induced%2520by%2520atypical%2520antipsychotics%2520in%2520stabilized%2520schizophrenic%2520patients%26jtitle%3DJ.%2520Psychopharmacol.%26date%3D2008%26volume%3D22%26spage%3D8828%26epage%3D8894" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janouschek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raptis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselinovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocheler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cumming, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schafer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">Dopamine D<sub>2/3</sub> receptor occupancy by quetiapine in striatal and extrastriatal areas</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">951</span><span class="NLM_x">–</span> <span class="NLM_lpage">960</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1017%2FS1461145710000374" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=20392299" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=951-960&author=I.+Vernalekenauthor=H.+Janouschekauthor=M.+Raptisauthor=S.+Hellmannauthor=T.+Veselinovicauthor=A.+Brochelerauthor=C.+Boyauthor=P.+Cummingauthor=C.+Hiemkeauthor=F.+Roschauthor=W.+M.+Schaferauthor=G.+Grunder&title=Dopamine+D2%2F3+receptor+occupancy+by+quetiapine+in+striatal+and+extrastriatal+areas"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine D2/3 receptor occupancy by quetiapine in striatal and extrastriatal areas</span></div><div class="casAuthors">Vernaleken, Ingo; Janouschek, Hildegard; Raptis, Mardjan; Hellmann, Sandra; Veselinovic, Tanja; Broecheler, Anno; Boy, Christian; Cumming, Paul; Hiemke, Christoph; Roesch, Frank; Schaefer, Wolfgang M.; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">951-960</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Quetiapine is next to clozapine an antipsychotic agent that exerts hardly any extrapyramidal side-effects at clin. efficacious doses.  Some previous receptor occupancy studies reported preferential extrastriatal D2/3 receptor (D2/3R)-binding properties of second-generation antipsychotics and suggested this as possible reason for improved tolerability.  This positron emission tomog. (PET) investigation was designed to compare the occupancy of dopamine D2/3Rs by quetiapine in striatal and extrastriatal brain regions.  Therefore, a cohort of 16 quetiapine-treated psychotic patients underwent an [18F]fallypride (FP) PET scan.  Due to the high affinity of FP and its comparatively long half-life, striatal and extrastriatal binding potentials could be detd. in one single scan.  Receptor occupancy was calcd. as percent redn. in binding potential relative to age-matched medication-free patients suffering from schizophrenia.  Quetiapine occupied 44±18% in the temporal cortex and 26±17% in the putamen, a difference significant at the level of p=0.005 (Student's t test).  Quetiapine showed a mean occupancy of 36±16% and in the thalamus.  In the caudate nucleus there was an occupancy of 29±16% (p=0.0072).  Individual occupancy levels did not exceed 59% in any of the striatal vols. of interest.  The time-interval between scan and last drug ingestion did not influence the relationship between plasma concn. and central D2/3R occupancy.  Taken together, quetiapine shows preferential extrastriatal binding at D2/3Rs; the extent of this difference is comparable to that previously described for clozapine.  Both antipsychotics show very low affinity for D2/3Rs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkAZfVLh5YTbVg90H21EOLACvtfcHk0liHQ_Uge3venw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1Gjtro%253D&md5=bce1703c4937952a4f4601bc01c99c53</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1017%2FS1461145710000374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145710000374%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DJanouschek%26aufirst%3DH.%26aulast%3DRaptis%26aufirst%3DM.%26aulast%3DHellmann%26aufirst%3DS.%26aulast%3DVeselinovic%26aufirst%3DT.%26aulast%3DBrocheler%26aufirst%3DA.%26aulast%3DBoy%26aufirst%3DC.%26aulast%3DCumming%26aufirst%3DP.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DSchafer%26aufirst%3DW.%2BM.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DDopamine%2520D2%252F3%2520receptor%2520occupancy%2520by%2520quetiapine%2520in%2520striatal%2520and%2520extrastriatal%2520areas%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2010%26volume%3D13%26spage%3D951%26epage%3D960" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Shimoda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yui, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fujinaga, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamasaki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nengaki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hatori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawamura, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, M. R.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 1-[2-(4-[<sup>11</sup>C]methoxyphenyl)phenyl]piperazine for imaging of the serotonin 5-HT<sub>7</sub> receptor in the rat brain</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">5316</span><span class="NLM_x">–</span> <span class="NLM_lpage">5322</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2013&pages=5316-5322&author=Y.+Shimodaauthor=J.+Yuiauthor=L.+Xieauthor=M.+Fujinagaauthor=T.+Yamasakiauthor=M.+Ogawaauthor=N.+Nengakiauthor=K.+Kumataauthor=A.+Hatoriauthor=K.+Kawamuraauthor=M.+R.+Zhang&title=Synthesis+and+evaluation+of+1-%5B2-%284-%5B11C%5Dmethoxyphenyl%29phenyl%5Dpiperazine+for+imaging+of+the+serotonin+5-HT7+receptor+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShimoda%26aufirst%3DY.%26aulast%3DYui%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DNengaki%26aufirst%3DN.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25201-%255B2-%25284-%255B11C%255Dmethoxyphenyl%2529phenyl%255Dpiperazine%2520for%2520imaging%2520of%2520the%2520serotonin%25205-HT7%2520receptor%2520in%2520the%2520rat%2520brain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2013%26volume%3D21%26spage%3D5316%26epage%3D5322" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Waarde, A.</span><span> </span><span class="NLM_article-title">Visualisation of serotonin-1A (5-HT<sub>1A</sub>) receptors in the central nervous system</span> <span class="citation_source-journal">Eur. J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">113</span><span class="NLM_x">–</span> <span class="NLM_lpage">129</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs002590000394" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=11202445" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXovFyjt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=113-129&author=J.+Passchierauthor=A.+van+Waarde&title=Visualisation+of+serotonin-1A+%285-HT1A%29+receptors+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Visualisation of serotonin-1A (5-HT1A) receptors in the central nervous system</span></div><div class="casAuthors">Passchier, Jan; van Waarde, Aren</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">113-129</span>CODEN:
                <span class="NLM_cas:coden">EJNMD9</span>;
        ISSN:<span class="NLM_cas:issn">0340-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review with 131 refs.  The 5-HT1A subtype of receptors for the neurotransmitter serotonin is predominantly located in the limbic forebrain and is involved in the modulation of emotion and the function of the hypothalamus.  Since 5-HT1A receptors are implicated in the pathogenesis of anxiety, depression, hallucinogenic behavior, motion sickness and eating disorders, they are an important target for drug therapy.  Here, the authors review the radioligands which are available for visualization and quantification of this important neuroreceptor in the human brain, using positron emission tomog. (PET) or single-photon emission tomog. (SPET).  More than 20 compds. have been labeled with carbon-11 (half-life 20 min), fluorine-18 (half-life 109.8 min) or iodine-123 (half-life 13.2 h): structural analogs of the agonist, 8-OH-DPAT, structural analogs of the antagonist, WAY 100635, and apomorphines.  The most successful radioligands thus far are [carbonyl-11C] WAY-100635 (WAY), [carbonyl-11C]desmethyl-WAY-100635 (DWAY),p-[18F]MPPF and [11C]robalzotan (NAD-299).  The high-affinity ligands WAY and DWAY produce excellent images of 5-HT1A receptor distribution in the brain (even the raphe nuclei are visualized), but they cannot be distributed to remote facilities and they probably cannot be used to measure changes in endogenous serotonin.  Binding of the moderate-affinity ligands MPPF and NAD-299 may be more sensitive to serotonin competition and MPPF can be distributed to PET centers within a flying distance of a few hours.  Future research should be directed towards: (a) improvement of the metabolic stability in primates; (b) development of a fluorinated radioligand which can be produced in large quantities and (c) prodn. of a radioiodinated or technetium-labeled ligand for SPET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8QaK1VyAyrrVg90H21EOLACvtfcHk0liHQ_Uge3venw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXovFyjt7g%253D&md5=3964aa4056633399d6ac2843fafaceb1</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1007%2Fs002590000394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002590000394%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3Dvan%2BWaarde%26aufirst%3DA.%26atitle%3DVisualisation%2520of%2520serotonin-1A%2520%25285-HT1A%2529%2520receptors%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%26date%3D2001%26volume%3D28%26spage%3D113%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group">Costall, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naylor, R. J.</span><span> </span><span class="NLM_article-title">A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1976</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">–</span> <span class="NLM_lpage">19</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0014-2999%2876%2990348-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=791660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaE2sXltVKrsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1976&pages=9-19&author=B.+Costallauthor=R.+J.+Naylor&title=A+comparison+of+the+abilities+of+typical+neuroleptic+agents+and+of+thioridazine%2C+clozapine%2C+sulpiride+and+metoclopramide+to+antagonise+the+hyperactivity+induced+by+dopamine+applied+intracerebrally+to+areas+of+the+extrapyramidal+and+mesolimbic+systems"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonize the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems</span></div><div class="casAuthors">Costall, Brenda; Naylor, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-19</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Dopamine-HCl (I-HCl) [62-31-7] injected directly into the caudate-putamen, nucleus accumbens or tuberculum olfactorium of rat brain, following a nialamide pretreatment, caused dose-dependent hyperactivity.  The hyperactivity was more intense after injections into the nucleus accumbens, but was limited by the development of stereotyped biting when larger doses of I were injected into the caudate-putamen or tuberculum olfactorium.  Haloperidol [52-86-8], fluphenazine-HCl [146-56-5] and pimozide [2062-78-4] antagonized, in a dose-dependent manner, the hyperactivity induced by I from all 3 areas.  Pimozide appeared equieffective against the 3 hyperactivity responses but haloperidol and fluphenazine more readily antagonized the hyperactivity mediated from the mesolimibic areas, the nucleus accumbens and tuberculum olfactorium.  Sulpiride [15676-16-1], clozapine [5786-21-0] and thioridazine-HCl [130-61-0] also caused dose-dependent redns. in the hyperactivity induced by I injections into the caudate-putamen, nucleus accumbens and tuberculum olfactorium, although the doses required to effect this inhibition were notably larger than for the typical neuroleptics.  Generally, these atypical agents were also least effective as antagonists of the hyperactivity following intrastriatal I.  Metoclopramide-HCl [7232-21-5] differed from all other agents tested in failing to antagonize the hyperactivity induced by I injections into the nucleus accumbens.  However, the responses to I from the caudate-putamen and tuberculum olfactorium were both antagonized by metoclopramide, the striatal response being the least sensitive.  The α- and β-adrenergic blocking agents, aceperone and propranolol, failed to reduce the hyperactivity induced by I injections into the caudate-putamen, nucleus accumbens or tuberculum olfactorium.  The abilities of the agents tested to antagonize a hyperactivity induced by I in the striatum or in the mesolimbic areas, the nucleus accumbens and tuberculum olfactorium, were compared with the potential of these agents to induce extrapyramidal side effects and to exert an antipsychotic action in man.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGric43JQN9fsrVg90H21EOLACvtfcHk0liHQ_Uge3venw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2sXltVKrsA%253D%253D&md5=094b7bac1617b8690ac7c5fd17e4678e</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2876%2990348-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252876%252990348-4%26sid%3Dliteratum%253Aachs%26aulast%3DCostall%26aufirst%3DB.%26aulast%3DNaylor%26aufirst%3DR.%2BJ.%26atitle%3DA%2520comparison%2520of%2520the%2520abilities%2520of%2520typical%2520neuroleptic%2520agents%2520and%2520of%2520thioridazine%252C%2520clozapine%252C%2520sulpiride%2520and%2520metoclopramide%2520to%2520antagonise%2520the%2520hyperactivity%2520induced%2520by%2520dopamine%2520applied%2520intracerebrally%2520to%2520areas%2520of%2520the%2520extrapyramidal%2520and%2520mesolimbic%2520systems%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1976%26volume%3D40%26spage%3D9%26epage%3D19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group">Bressan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlandsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flanagan, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilowsky, L. S.</span><span> </span><span class="NLM_article-title">Is regionally selective D<sub>2</sub>/D<sub>3</sub> dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [<sup>123</sup>I]epidepride SPET study of amisulpride-treated patients</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">160</span><span class="NLM_x">, </span> <span class="NLM_fpage">1413</span><span class="NLM_x">–</span> <span class="NLM_lpage">1420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.160.8.1413" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=12900302" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADC%252BD3szmsFOrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=160&publication_year=2003&pages=1413-1420&author=R.+A.+Bressanauthor=K.+Erlandssonauthor=H.+M.+Jonesauthor=R.+Mulliganauthor=R.+J.+Flanaganauthor=P.+J.+Ellauthor=L.+S.+Pilowsky&title=Is+regionally+selective+D2%2FD3+dopamine+occupancy+sufficient+for+atypical+antipsychotic+effect%3F+An+in+vivo+quantitative+%5B123I%5Depidepride+SPET+study+of+amisulpride-treated+patients"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients</span></div><div class="casAuthors">Bressan Rodrigo A; Erlandsson Kjell; Jones Hugh M; Mulligan Rachel; Flanagan Robert J; Ell Peter J; Pilowsky Lyn S</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">160</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1413-20</span>
        ISSN:<span class="NLM_cas:issn">0002-953X</span>.
    </div><div class="casAbstract">OBJECTIVE:  Atypical antipsychotic drug treatment is clinically effective with a low risk of extrapyramidal symptoms.  Explanations for the mechanism underlying this beneficial therapeutic profile of atypical over typical antipsychotic agents include 1) simultaneous antagonism of dopamine D(2) and serotonin 5-HT(2A) receptors or 2) selective action at limbic cortical dopamine D(2)-like receptors with modest striatal D(2) receptor occupancy.  Amisulpride is an atypical antipsychotic drug with selective affinity for D(2)/D(3) dopamine receptors and provides a useful pharmacological model for examining these hypotheses.  The authors' goal was to evaluate whether treatment with amisulpride results in "limbic selective" D(2)/D(3) receptor blockade in vivo.  METHOD:  Five hours of dynamic single photon emission tomography data were acquired after injection of [(123)I]epidepride (approximately 150 MBq).  Kinetic modeling was performed by using the simplified reference region model to obtain binding potential values.  Estimates of receptor occupancy were made relative to a healthy volunteer comparison group (N=6).  RESULTS:  Eight amisulpride-treated patients (mean dose=406 mg/day) showed moderate levels of D(2)/D(3) receptor occupancy in the striatum (56%), and significantly higher levels were seen in the thalamus (78%) and temporal cortex (82%).  CONCLUSIONS:  Treatment with amisulpride results in a similar pattern of limbic cortical over striatal D(2)/D(3) receptor blockade to that of other atypical antipsychotic drugs.  This finding suggests that modest striatal D(2) receptor occupancy and preferential occupancy of limbic cortical dopamine D(2)/D(3) receptors may be sufficient to explain the therapeutic efficacy and low extrapyramidal symptom profile of atypical antipsychotic drugs, without the need for 5-HT(2A) receptor antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvHN4dj4eq0VVwdslNBF-tfW6udTcc2ebh9MGxA203Frntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3szmsFOrtA%253D%253D&md5=eccd79f178c8447d93426f0607e533e4</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.160.8.1413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.160.8.1413%26sid%3Dliteratum%253Aachs%26aulast%3DBressan%26aufirst%3DR.%2BA.%26aulast%3DErlandsson%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DMulligan%26aufirst%3DR.%26aulast%3DFlanagan%26aufirst%3DR.%2BJ.%26aulast%3DEll%26aufirst%3DP.%2BJ.%26aulast%3DPilowsky%26aufirst%3DL.%2BS.%26atitle%3DIs%2520regionally%2520selective%2520D2%252FD3%2520dopamine%2520occupancy%2520sufficient%2520for%2520atypical%2520antipsychotic%2520effect%253F%2520An%2520in%2520vivo%2520quantitative%2520%255B123I%255Depidepride%2520SPET%2520study%2520of%2520amisulpride-treated%2520patients%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2003%26volume%3D160%26spage%3D1413%26epage%3D1420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grunder, G.</span><span> </span><span class="NLM_article-title">High striatal occupancy of D<sub>2</sub>-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">421</span><span class="NLM_x">–</span> <span class="NLM_lpage">430</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1017%2FS1461145704004353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=15683553" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2004&pages=421-430&author=I.+Vernalekenauthor=T.+Siessmeierauthor=H.+G.+Buchholzauthor=S.+Hartterauthor=C.+Hiemkeauthor=P.+Stoeterauthor=F.+Roschauthor=P.+Bartensteinauthor=G.+Grunder&title=High+striatal+occupancy+of+D2-like+dopamine+receptors+by+amisulpride+in+the+brain+of+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">High striatal occupancy of D2-like dopamine receptors by amisulpride in the brain of patients with schizophrenia</span></div><div class="casAuthors">Vernaleken, Ingo; Siessmeier, Thomas; Buchholz, Hans-Georg; Haertter, Sebastian; Hiemke, Christoph; Stoeter, Peter; Roesch, Frank; Bartenstein, Peter; Gruender, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">421-430</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">The 'atypicality' of the antipsychotic drug, amisulpride, has been attributed to preferential extrastriatal binding.  Previous investigations of striatal D2 receptor occupancy by amisulpride revealed conflicting results.  The aim of this PET study was to measure the striatal occupancy by amisulpride and to correlate it with the corresponding drug plasma concns.  Nine amisulpride-treated patients and 12 healthy volunteers serving as controls were studied with PET and [18F]desmethoxyfallypride.  Occupancy values and plasma concns. were nonlinearly fitted to an Emax model.  Results showed 43-85% (putamen) and 67-90% (caudate) D2-like receptor occupancy.  Plasma amisulpride concns. at the time of tracer injection, but not administered doses, were significantly nonlinearly correlated to occupancy levels (putamen: rS=0.88, p=0.0017; caudate: rS=0.78, p=0.0127).  Calcd. Emax was similar in both caudate and putamen, but occupancy levels were lower in caudate at lower amisulpride plasma concns.  Calcd. plasma levels to attain 60-80% receptor occupancy ranged from 119 to 474 ng/mL (caudate) and from 241 to 732 ng/mL (putamen).  This reveals a broad range of plasma concns. producing less than 80% striatal receptor occupancy.  However, our data show high striatal D2-like receptor occupancies under rising plasma concns.  Using the full range of recommended amisulpride dosage, striatal occupancies up to 90% can be measured.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrH6q7vccCXi7Vg90H21EOLACvtfcHk0ljfYq-v_Dpp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVOru7Y%253D&md5=deadbde0ae4eaf69e5f3d96ab47f1e25</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1017%2FS1461145704004353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145704004353%26sid%3Dliteratum%253Aachs%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DHartter%26aufirst%3DS.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DBartenstein%26aufirst%3DP.%26aulast%3DGrunder%26aufirst%3DG.%26atitle%3DHigh%2520striatal%2520occupancy%2520of%2520D2-like%2520dopamine%2520receptors%2520by%2520amisulpride%2520in%2520the%2520brain%2520of%2520patients%2520with%2520schizophrenia%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2004%26volume%3D7%26spage%3D421%26epage%3D430" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Abbas, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meltzer, H. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span> </span><span class="NLM_article-title">Amisulpride is a potent 5-HT<sub>7</sub> antagonist: relevance for antidepressant actions in vivo</span> <span class="citation_source-journal">Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">205</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">–</span> <span class="NLM_lpage">128</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1007%2Fs00213-009-1521-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=19337725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjvV2ks78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=2009&pages=119-128&author=A.+I.+Abbasauthor=P.+B.+Hedlundauthor=X.+P.+Huangauthor=T.+B.+Tranauthor=H.+Y.+Meltzerauthor=B.+L.+Roth&title=Amisulpride+is+a+potent+5-HT7+antagonist%3A+relevance+for+antidepressant+actions+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Amisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivo</span></div><div class="casAuthors">Abbas, Atheir I.; Hedlund, Peter B.; Huang, Xi-Ping; Tran, Thuy B.; Meltzer, Herbert Y.; Roth, Bryan L.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">205</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">119-128</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Amisulpride is approved for clin. use in treating schizophrenia in a no. of European countries and also for treating dysthymia, a mild form of depression, in Italy.  Amisulpride has also been demonstrated to be an antidepressant for patients with major depression in many clin. trials.  In part because of the selective D2/D3 receptor antagonist properties of amisulpride, it has long been widely assumed that dopaminergic modulation is the proximal event responsible for mediating its antidepressant and antipsychotic properties.  The purpose of these studies was to det. if amisulpride's antidepressant actions are mediated by off-target interactions with other receptors.  We performed expts. that: (1) examd. the pharmacol. profile of amisulpride at a large no. of central nervous system (CNS) mol. targets and, (2) after finding high potency antagonist affinity for human 5-HT7a serotonin receptors, characterized the actions of amisulpride as an antidepressant in wild-type and 5-HT7 receptor knockout mice.  We discovered that amisulpride was a potent competitive antagonist at 5-HT7a receptors and that interactions with no other mol. target investigated in this paper could explain its antidepressant actions in vivo.  Significantly, and in contrast to their wild-type littermates, 5-HT7 receptor knockout mice did not respond to amisulpride in two widely used rodent models of depression, the tail suspension test and the forced swim test.  These results indicate that 5-HT7a receptor antagonism, and not D2/D3 receptor antagonism, likely underlies the antidepressant actions of amisulpride.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozOQ7Oab_nRLVg90H21EOLACvtfcHk0ljfYq-v_Dpp8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjvV2ks78%253D&md5=e8d0dcddac51117b910464d7faf07555</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1007%2Fs00213-009-1521-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-009-1521-8%26sid%3Dliteratum%253Aachs%26aulast%3DAbbas%26aufirst%3DA.%2BI.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DHuang%26aufirst%3DX.%2BP.%26aulast%3DTran%26aufirst%3DT.%2BB.%26aulast%3DMeltzer%26aufirst%3DH.%2BY.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26atitle%3DAmisulpride%2520is%2520a%2520potent%25205-HT7%2520antagonist%253A%2520relevance%2520for%2520antidepressant%2520actions%2520in%2520vivo%26jtitle%3DPsychopharmacol.%26date%3D2009%26volume%3D205%26spage%3D119%26epage%3D128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Pilowsky, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Acton, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kerwin, R. W.</span><span> </span><span class="NLM_article-title">Limbic selectivity of clozapine</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">350</span><span class="NLM_x">, </span> <span class="NLM_fpage">490</span><span class="NLM_x">–</span> <span class="NLM_lpage">491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=490-491&author=L.+S.+Pilowskyauthor=R.+S.+Mulliganauthor=P.+D.+Actonauthor=P.+J.+Ellauthor=D.+C.+Costaauthor=R.+W.+Kerwin&title=Limbic+selectivity+of+clozapine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPilowsky%26aufirst%3DL.%2BS.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DActon%26aufirst%3DP.%2BD.%26aulast%3DEll%26aufirst%3DP.%2BJ.%26aulast%3DCosta%26aufirst%3DD.%2BC.%26aulast%3DKerwin%26aufirst%3DR.%2BW.%26atitle%3DLimbic%2520selectivity%2520of%2520clozapine%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26spage%3D490%26epage%3D491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Bressan, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erlandsson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mulligan, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ell, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilowsky, L. S.</span><span> </span><span class="NLM_article-title">Optimizing limbic selective D2/D3 receptor occupancy by risperidone: a [<sup>123</sup>I]-epidepride SPET study</span> <span class="citation_source-journal">J. Clin. Psychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">14</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1097%2F00004714-200302000-00002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=12544369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmsVSntA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=5-14&author=R.+A.+Bressanauthor=K.+Erlandssonauthor=H.+M.+Jonesauthor=R.+S.+Mulliganauthor=P.+J.+Ellauthor=L.+S.+Pilowsky&title=Optimizing+limbic+selective+D2%2FD3+receptor+occupancy+by+risperidone%3A+a+%5B123I%5D-epidepride+SPET+study"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Limbic Selective D2/D3 Receptor Occupancy by Risperidone: A [123I]-Epidepride SPET Study</span></div><div class="casAuthors">Bressan, Rodrigo A.; Erlandsson, Kjell; Jones, Hugh M.; Mulligan, Rachel S.; Ell, Peter J.; Pilowsky, Lyn S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">5-14</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Selective action at limbic cortical dopamine D2-like receptors is a putative mechanism of atypical antipsychotic efficacy with few extrapyramidal side effects.  Although risperidone is an atypical antipsychotic with high affinity for D receptors, low-dose risperidone treatment is effective without inducing extrapyramidal symptoms.  The objective was to test the hypothesis that treatment with low-dose risperidone results in 'limbic selective' D2/D3 receptor blockade Dynamic single photon emission tomog. (SPET) sequences were obtained over 5 h after injection of [ I]-epidepride (∼150 MBq), using a high-resoln. triple-headed brain scanner (Marconi Prism 3000XP).  Kinetic modeling was performed using the simplified ref. region model to obtain binding potential values.  Ests. of receptor occupancy were made relative to a normal volunteer control group (n = 5).  Six patients treated with low-dose risperidone (mean = 2.6 mg) showed moderate levels of D2/D3 occupancy in striatum (49.9%), but higher levels of D2/D3 occupancy in thalamus (70.8%) and temporal cortex (75.2%).  Occupancy values in striatum were significantly different from thalamus (F (1,4) = 26.3, p < 0.01) and from temporal cortex (F (1,4) = 53.4, p < 0.01).  This is the first study to evaluate striatal and extrastriatal occupancy of risperidone.  Low dose treatment with risperidone achieves a similar selectivity of limbic cortical over striatal D2/D3 receptor blockade to that of atypical antipsychotics with lower D2/D3 affinity such as clozapine, olanzapine and quetiapine.  This finding is consistent with the relevance of 'limbic selective' D2/D3 receptor occupancy to the therapeutic efficacy of atypical antipsychotic drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG8QN7jpgpfrVg90H21EOLACvtfcHk0lhakvxn3dBUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmsVSntA%253D%253D&md5=9777c5c4e516fa5c5626ea4ea381f842</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1097%2F00004714-200302000-00002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00004714-200302000-00002%26sid%3Dliteratum%253Aachs%26aulast%3DBressan%26aufirst%3DR.%2BA.%26aulast%3DErlandsson%26aufirst%3DK.%26aulast%3DJones%26aufirst%3DH.%2BM.%26aulast%3DMulligan%26aufirst%3DR.%2BS.%26aulast%3DEll%26aufirst%3DP.%2BJ.%26aulast%3DPilowsky%26aufirst%3DL.%2BS.%26atitle%3DOptimizing%2520limbic%2520selective%2520D2%252FD3%2520receptor%2520occupancy%2520by%2520risperidone%253A%2520a%2520%255B123I%255D-epidepride%2520SPET%2520study%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2003%26volume%3D23%26spage%3D5%26epage%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Landvogt, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchholz, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ondracek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siessmeier, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartter, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schreckenberger, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoeter, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenstein, P.</span><span> </span><span class="NLM_article-title">The striatal and extrastriatal D<sub>2</sub>/D<sub>3</sub> receptor-binding profile of clozapine in patients with schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x">, </span> <span class="NLM_fpage">1027</span><span class="NLM_x">–</span> <span class="NLM_lpage">1035</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2006&pages=1027-1035&author=G.+Gr%C3%BCnderauthor=C.+Landvogtauthor=I.+Vernalekenauthor=H.+G.+Buchholzauthor=J.+Ondracekauthor=T.+Siessmeierauthor=S.+Hartterauthor=M.+Schreckenbergerauthor=P.+Stoeterauthor=C.+Hiemkeauthor=F.+Roschauthor=D.+F.+Wongauthor=P.+Bartenstein&title=The+striatal+and+extrastriatal+D2%2FD3+receptor-binding+profile+of+clozapine+in+patients+with+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DLandvogt%26aufirst%3DC.%26aulast%3DVernaleken%26aufirst%3DI.%26aulast%3DBuchholz%26aufirst%3DH.%2BG.%26aulast%3DOndracek%26aufirst%3DJ.%26aulast%3DSiessmeier%26aufirst%3DT.%26aulast%3DHartter%26aufirst%3DS.%26aulast%3DSchreckenberger%26aufirst%3DM.%26aulast%3DStoeter%26aufirst%3DP.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DWong%26aufirst%3DD.%2BF.%26aulast%3DBartenstein%26aufirst%3DP.%26atitle%3DThe%2520striatal%2520and%2520extrastriatal%2520D2%252FD3%2520receptor-binding%2520profile%2520of%2520clozapine%2520in%2520patients%2520with%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2006%26volume%3D31%26spage%3D1027%26epage%3D1035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Mukherjee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Z. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Das, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, T.</span><span> </span><span class="NLM_article-title">Fluorinated benzamide neuroleptics. III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[<sup>18</sup>F]fluoropropyl)-2,3-dimethoxybenzamide as an improved dopamine D-2 receptor tracer</span> <span class="citation_source-journal">Nucl. Med. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">283</span><span class="NLM_x">–</span> <span class="NLM_lpage">296</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1016%2F0969-8051%2894%2900117-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=7627142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADyaK2MXlvFGls74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=1995&pages=283-296&author=J.+Mukherjeeauthor=Z.+Y.+Yangauthor=M.+K.+Dasauthor=T.+Brown&title=Fluorinated+benzamide+neuroleptics.+III.+Development+of+%28S%29-N-%5B%281-allyl-2-pyrrolidinyl%29methyl%5D-5-%283-%5B18F%5Dfluoropropyl%29-2%2C3-dimethoxybenzamide+as+an+improved+dopamine+D-2+receptor+tracer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorinated benzamide neuroleptics--III. Development of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3- dimethoxybenzamide as an improved dopamine D-2 receptor tracer</span></div><div class="casAuthors">Mukherjee, Jogeshwar; Yang, Zhi-Ying; Das, Malay K.; Brown, Terry</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">283-96</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0883-2897</span>.
    </div><div class="casAbstract">We have prepd. five new analogs (Pr, iso-Pr, allyl, Bu, and iso-butyl) of the dopamine D-2 receptor antagonist, FPMB which result from modifications of the Et group at the pyrrolidine nitrogen in FPMB.  As expected, all new derivs. showed higher apparent lipophilicity (log kw), with iso-Bu being the most lipophilic (log kw = 2.52), followed by the allyl deriv. (log kw = 2.43).  The allyl group showed the largest increase in affinity (from 0.26 nM for the Et substituent to 0.03 nM for the allyl substituent, almost 10-fold), followed by the Pr substituent which showed approx. five-fold better affinity than did the Et substituent.  Radiosynthesis of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-[18F]fluoropropyl)-2,3- dimethoxybenzamide ([18F]fallypride) was carried out by nucleophilic substitution reaction of (S)-N-[(1-allyl-2-pyrrolidinyl)methyl]-5-(3-tosyloxypropyl)-2,3- dimethoxybenzamide with no carrier added 18F-.  [18F]Fallypride was obtained in approx. 20-40% yields (EOS/EOB, decay cor.) in specific activities of 900-1700 Ci/mmol after reverse phase HPLC purifn. in 60 min from EOB.  High striatal uptake (up to 2.5% injected dose/g) of [18F]fallypride in rats was obsd. with striatal/cerebellar ratios of 17, 42, 63 and 122 at 30, 60, 90 and 120 min postinjection, resp.  PET expts. with [18F]fallypride in a cebus monkey showed a brain uptake of 0.10% injected dose/mL.  In rhesus monkeys [18F]fallypride showed rapid specific uptake in the striata (0.04-0.06% injected dose/mL) with striata/cerebellum ratios of approx. 3.0 at 14 min, 5.0 at 35 min and 8 at 70 min postinjection.  Specifically bound [18F]fallypride was displaced with haloperidol (1 mg/kg) with a half-life of 18 min in the rhesus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp397GU3dNOEbVg90H21EOLACvtfcHk0lhakvxn3dBUWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXlvFGls74%253D&md5=8651074bc9b54d8a5f918da6c9892f55</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1016%2F0969-8051%2894%2900117-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0969-8051%252894%252900117-3%26sid%3Dliteratum%253Aachs%26aulast%3DMukherjee%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DZ.%2BY.%26aulast%3DDas%26aufirst%3DM.%2BK.%26aulast%3DBrown%26aufirst%3DT.%26atitle%3DFluorinated%2520benzamide%2520neuroleptics.%2520III.%2520Development%2520of%2520%2528S%2529-N-%255B%25281-allyl-2-pyrrolidinyl%2529methyl%255D-5-%25283-%255B18F%255Dfluoropropyl%2529-2%252C3-dimethoxybenzamide%2520as%2520an%2520improved%2520dopamine%2520D-2%2520receptor%2520tracer%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D1995%26volume%3D22%26spage%3D283%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group">Gründer, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fellows, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janouschek, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Veselinovic, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boy, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brocheler, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirschbaum, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spreckelmeyer, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hiemke, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosch, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schaefer, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vernaleken, I.</span><span> </span><span class="NLM_article-title">Brain and plasma pharmacokinetics of aripiprazole in patients with schizophrenia: an [<sup>18</sup>F]fallypride PET study</span> <span class="citation_source-journal">Am. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">165</span><span class="NLM_x">, </span> <span class="NLM_fpage">988</span><span class="NLM_x">–</span> <span class="NLM_lpage">995</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1176%2Fappi.ajp.2008.07101574" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=18381901" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2008&pages=988-995&author=G.+Gr%C3%BCnderauthor=C.+Fellowsauthor=H.+Janouschekauthor=T.+Veselinovicauthor=C.+Boyauthor=A.+Brochelerauthor=K.+M.+Kirschbaumauthor=S.+Hellmannauthor=K.+M.+Spreckelmeyerauthor=C.+Hiemkeauthor=F.+Roschauthor=W.+M.+Schaeferauthor=I.+Vernaleken&title=Brain+and+plasma+pharmacokinetics+of+aripiprazole+in+patients+with+schizophrenia%3A+an+%5B18F%5Dfallypride+PET+study"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2008.07101574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2008.07101574%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnder%26aufirst%3DG.%26aulast%3DFellows%26aufirst%3DC.%26aulast%3DJanouschek%26aufirst%3DH.%26aulast%3DVeselinovic%26aufirst%3DT.%26aulast%3DBoy%26aufirst%3DC.%26aulast%3DBrocheler%26aufirst%3DA.%26aulast%3DKirschbaum%26aufirst%3DK.%2BM.%26aulast%3DHellmann%26aufirst%3DS.%26aulast%3DSpreckelmeyer%26aufirst%3DK.%2BM.%26aulast%3DHiemke%26aufirst%3DC.%26aulast%3DRosch%26aufirst%3DF.%26aulast%3DSchaefer%26aufirst%3DW.%2BM.%26aulast%3DVernaleken%26aufirst%3DI.%26atitle%3DBrain%2520and%2520plasma%2520pharmacokinetics%2520of%2520aripiprazole%2520in%2520patients%2520with%2520schizophrenia%253A%2520an%2520%255B18F%255Dfallypride%2520PET%2520study%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2008%26volume%3D165%26spage%3D988%26epage%3D995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Lawler, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prioleau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schetz, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sibley, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mailman, R. B.</span><span> </span><span class="NLM_article-title">Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">612</span><span class="NLM_x">–</span> <span class="NLM_lpage">627</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=1999&pages=612-627&author=C.+P.+Lawlerauthor=C.+Prioleauauthor=M.+M.+Lewisauthor=C.+Makauthor=D.+Jiangauthor=J.+A.+Schetzauthor=A.+M.+Gonzalezauthor=D.+R.+Sibleyauthor=R.+B.+Mailman&title=Interactions+of+the+novel+antipsychotic+aripiprazole+%28OPC-14597%29+with+dopamine+and+serotonin+receptor+subtypes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLawler%26aufirst%3DC.%2BP.%26aulast%3DPrioleau%26aufirst%3DC.%26aulast%3DLewis%26aufirst%3DM.%2BM.%26aulast%3DMak%26aufirst%3DC.%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DSchetz%26aufirst%3DJ.%2BA.%26aulast%3DGonzalez%26aufirst%3DA.%2BM.%26aulast%3DSibley%26aufirst%3DD.%2BR.%26aulast%3DMailman%26aufirst%3DR.%2BB.%26atitle%3DInteractions%2520of%2520the%2520novel%2520antipsychotic%2520aripiprazole%2520%2528OPC-14597%2529%2520with%2520dopamine%2520and%2520serotonin%2520receptor%2520subtypes%26jtitle%3DNeuropsychopharmacology%26date%3D1999%26volume%3D20%26spage%3D612%26epage%3D627" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Swainston Harrison, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, C. M.</span><span> </span><span class="NLM_article-title">Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder</span> <span class="citation_source-journal">Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">1715</span><span class="NLM_x">–</span> <span class="NLM_lpage">1736</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=1715-1736&author=T.+Swainston+Harrisonauthor=C.+M.+Perry&title=Aripiprazole%3A+a+review+of+its+use+in+schizophrenia+and+schizoaffective+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSwainston%2BHarrison%26aufirst%3DT.%26aulast%3DPerry%26aufirst%3DC.%2BM.%26atitle%3DAripiprazole%253A%2520a%2520review%2520of%2520its%2520use%2520in%2520schizophrenia%2520and%2520schizoaffective%2520disorder%26jtitle%3DDrugs%26date%3D2004%26volume%3D64%26spage%3D1715%26epage%3D1736" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Agid, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mamo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ginovart, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitcu, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zipursky, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapur, S.</span><span> </span><span class="NLM_article-title">Striatal vs extrastriatal dopamine D<sub>2</sub> receptors in antipsychotic response--a double-blind PET study in schizophrenia</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1209</span><span class="NLM_x">–</span> <span class="NLM_lpage">1215</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2007&pages=1209-1215&author=O.+Agidauthor=D.+Mamoauthor=N.+Ginovartauthor=I.+Vitcuauthor=A.+A.+Wilsonauthor=R.+B.+Zipurskyauthor=S.+Kapur&title=Striatal+vs+extrastriatal+dopamine+D2+receptors+in+antipsychotic+response%2D%2Da+double-blind+PET+study+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAgid%26aufirst%3DO.%26aulast%3DMamo%26aufirst%3DD.%26aulast%3DGinovart%26aufirst%3DN.%26aulast%3DVitcu%26aufirst%3DI.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DZipursky%26aufirst%3DR.%2BB.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DStriatal%2520vs%2520extrastriatal%2520dopamine%2520D2%2520receptors%2520in%2520antipsychotic%2520response--a%2520double-blind%2520PET%2520study%2520in%2520schizophrenia%26jtitle%3DNeuropsychopharmacology%26date%3D2007%26volume%3D32%26spage%3D1209%26epage%3D1215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Carlsson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansson, L. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waters, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlsson, M. L.</span><span> </span><span class="NLM_article-title">A glutamatergic deficiency model of schizophrenia</span> <span class="citation_source-journal">Br. J. Psychiatry Suppl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_fpage">2</span><span class="NLM_x">–</span> <span class="NLM_lpage">6</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=10211132" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK1M3islGkug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&pages=2-6&author=A.+Carlssonauthor=L.+O.+Hanssonauthor=N.+Watersauthor=M.+L.+Carlsson&title=A+glutamatergic+deficiency+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">A glutamatergic deficiency model of schizophrenia</span></div><div class="casAuthors">Carlsson A; Hansson L O; Waters N; Carlsson M L</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry. Supplement</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">2-6</span>
        ISSN:<span class="NLM_cas:issn">0960-5371</span>.
    </div><div class="casAbstract">Although the presence of hyperdopaminergia has been demonstrated in the brains of people with schizophrenia, at least in some circumstances, other neurotransmitters are important in this disorder, and a glutamatergic deficiency model of schizophrenia is proposed.  It is suggested that the amount of sensory input allowed to reach the cerebral cortex is restricted by an inhibitory effect of the striatal complexes on the thalamus, thereby protecting it from being overwhelmed.  Several strands of evidence are presented to support the concept that a weakened glutamatergic tone increases the risk of sensory overload and of exaggerated responses in the monoaminergic systems that could result in psychosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ8BN9igqnju4YPsCkJIw00fW6udTcc2eZ7EFnFtpmtJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M3islGkug%253D%253D&md5=9316d3b8ae8ecf245048e1bf7e968a17</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCarlsson%26aufirst%3DA.%26aulast%3DHansson%26aufirst%3DL.%2BO.%26aulast%3DWaters%26aufirst%3DN.%26aulast%3DCarlsson%26aufirst%3DM.%2BL.%26atitle%3DA%2520glutamatergic%2520deficiency%2520model%2520of%2520schizophrenia%26jtitle%3DBr.%2520J.%2520Psychiatry%2520Suppl.%26date%3D1999%26spage%3D2%26epage%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Andreasen, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Leary, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flaum, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boles Ponto, L. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hichwa, R. D.</span><span> </span><span class="NLM_article-title">Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">349</span><span class="NLM_x">, </span> <span class="NLM_fpage">1730</span><span class="NLM_x">–</span> <span class="NLM_lpage">1734</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=349&publication_year=1997&pages=1730-1734&author=N.+C.+Andreasenauthor=D.+S.+O%E2%80%99Learyauthor=M.+Flaumauthor=P.+Nopoulosauthor=G.+L.+Watkinsauthor=L.+L.+Boles+Pontoauthor=R.+D.+Hichwa&title=Hypofrontality+in+schizophrenia%3A+distributed+dysfunctional+circuits+in+neuroleptic-naive+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreasen%26aufirst%3DN.%2BC.%26aulast%3DO%25E2%2580%2599Leary%26aufirst%3DD.%2BS.%26aulast%3DFlaum%26aufirst%3DM.%26aulast%3DNopoulos%26aufirst%3DP.%26aulast%3DWatkins%26aufirst%3DG.%2BL.%26aulast%3DBoles%2BPonto%26aufirst%3DL.%2BL.%26aulast%3DHichwa%26aufirst%3DR.%2BD.%26atitle%3DHypofrontality%2520in%2520schizophrenia%253A%2520distributed%2520dysfunctional%2520circuits%2520in%2520neuroleptic-naive%2520patients%26jtitle%3DLancet%26date%3D1997%26volume%3D349%26spage%3D1730%26epage%3D1734" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Javitt, D. C.</span><span> </span><span class="NLM_article-title">Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia</span> <span class="citation_source-journal">Hillside J. Clin. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">12</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=2820854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaL1c%252Fgs1Sguw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1987&pages=12-35&author=D.+C.+Javitt&title=Negative+schizophrenic+symptomatology+and+the+PCP+%28phencyclidine%29+model+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia</span></div><div class="casAuthors">Javitt D C</div><div class="citationInfo"><span class="NLM_cas:title">The Hillside journal of clinical psychiatry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">12-35</span>
        ISSN:<span class="NLM_cas:issn">0193-5216</span>.
    </div><div class="casAbstract">Amphetamine induced psychosis has for the past 30 years provided a useful model for the study of schizophrenia.  The amphetamine model, however, has been shown to have a number of shortcomings including an inability to model the deficit symptoms of schizophrenia.  PCP (phencyclidine) has been shown to be capable of inducing a schizophreniform psychosis consisting of both productive and defict symptomatology.  PCP induced psychosis, therefore, may provide a useful model of schizophrenia.  This paper reviews the literature concerning the PCP model of schizophrenia and provides some independent confirmation of the ability of PCP to modulate mesocortical dopaminergic activity.  Since PCP appears to mediate its CNS effects via a subclass of glutamate receptors, a possible glutamate theory of schizophrenia is proposed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_VspipBivSdNTrvPZP1IpfW6udTcc2eaePdLmm8Ronbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL1c%252Fgs1Sguw%253D%253D&md5=2642fbe1f8afac42b0f6c092b6f053e0</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26atitle%3DNegative%2520schizophrenic%2520symptomatology%2520and%2520the%2520PCP%2520%2528phencyclidine%2529%2520model%2520of%2520schizophrenia%26jtitle%3DHillside%2520J.%2520Clin.%2520Psychiatry%26date%3D1987%26volume%3D9%26spage%3D12%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Krystal, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Souza, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karper, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Dargham, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abi-Saab, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassello, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bowers, M. B.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vegso, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heninger, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charney, D. S.</span><span> </span><span class="NLM_article-title">Interactive effects of subanesthetic ketamine and haloperidol in healthy humans</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">145</span><span class="NLM_x">, </span> <span class="NLM_fpage">193</span><span class="NLM_x">–</span> <span class="NLM_lpage">204</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=1999&pages=193-204&author=J.+H.+Krystalauthor=D.+C.+D%E2%80%99Souzaauthor=L.+P.+Karperauthor=A.+Bennettauthor=A.+Abi-Darghamauthor=D.+Abi-Saabauthor=K.+Casselloauthor=M.+B.+Bowersauthor=S.+Vegsoauthor=G.+R.+Heningerauthor=D.+S.+Charney&title=Interactive+effects+of+subanesthetic+ketamine+and+haloperidol+in+healthy+humans"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKrystal%26aufirst%3DJ.%2BH.%26aulast%3DD%25E2%2580%2599Souza%26aufirst%3DD.%2BC.%26aulast%3DKarper%26aufirst%3DL.%2BP.%26aulast%3DBennett%26aufirst%3DA.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26aulast%3DAbi-Saab%26aufirst%3DD.%26aulast%3DCassello%26aufirst%3DK.%26aulast%3DBowers%26aufirst%3DM.%2BB.%26aulast%3DVegso%26aufirst%3DS.%26aulast%3DHeninger%26aufirst%3DG.%2BR.%26aulast%3DCharney%26aufirst%3DD.%2BS.%26atitle%3DInteractive%2520effects%2520of%2520subanesthetic%2520ketamine%2520and%2520haloperidol%2520in%2520healthy%2520humans%26jtitle%3DPsychopharmacology%26date%3D1999%26volume%3D145%26spage%3D193%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Heresco-Levy, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Javitt, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ermilov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mordel, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horowitz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelly, D.</span><span> </span><span class="NLM_article-title">Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia</span> <span class="citation_source-journal">Br. J. Psychiatry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">169</span><span class="NLM_x">, </span> <span class="NLM_fpage">610</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1192%2Fbjp.169.5.610" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=8932891" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A280%3ADyaK2s%252Fos1ylsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=169&publication_year=1996&pages=610-617&author=U.+Heresco-Levyauthor=D.+C.+Javittauthor=M.+Ermilovauthor=C.+Mordelauthor=A.+Horowitzauthor=D.+Kelly&title=Double-blind%2C+placebo-controlled%2C+crossover+trial+of+glycine+adjuvant+therapy+for+treatment-resistant+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Double-blind, placebo-controlled, crossover trial of glycine adjuvant therapy for treatment-resistant schizophrenia</span></div><div class="casAuthors">Heresco-Levy U; Javitt D C; Ermilov M; Mordel C; Horowitz A; Kelly D</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of psychiatry : the journal of mental science</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">169</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">610-7</span>
        ISSN:<span class="NLM_cas:issn">0007-1250</span>.
    </div><div class="casAbstract">BACKGROUND:  It has been proposed that schizophrenia is associated with underactivity of brain glutamatergic neurotransmission, especially at the level of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptor.  Glycine potentiates NMDA receptor-mediated neurotransmission, indicating that it may serve as an effective therapeutic agent in the treatment of schizophrenia.  METHOD:  Eleven treatment-resistant patients with chronic schizophrenia completed a double-blind, placebo-controlled, six-week, randomly assigned, crossover treatment trial of 0.8 g/kg body weight/day of glycine, added to their prior antipsychotic treatment.  RESULTS:  Glycine was well tolerated, resulted in significantly increased serum glycine levels and induced a mean 36 (7%) reduction in negative symptoms (P < 0.0001).  Significant improvements were also induced in depressive and cognitive symptoms.  The greatest reduction in negative symptoms was registered in the patients who had the lowest baseline serum glycine levels.  CONCLUSIONS:  These results extend previous findings and suggest an additional approach to the pharmacotherapy of negative symptoms and cognitive deficits in schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQpFTBbWohkEu98rul4nhSdfW6udTcc2eaePdLmm8Ronbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2s%252Fos1ylsA%253D%253D&md5=a86628944202f1511e73a5b0aad42445</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1192%2Fbjp.169.5.610&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1192%252Fbjp.169.5.610%26sid%3Dliteratum%253Aachs%26aulast%3DHeresco-Levy%26aufirst%3DU.%26aulast%3DJavitt%26aufirst%3DD.%2BC.%26aulast%3DErmilov%26aufirst%3DM.%26aulast%3DMordel%26aufirst%3DC.%26aulast%3DHorowitz%26aufirst%3DA.%26aulast%3DKelly%26aufirst%3DD.%26atitle%3DDouble-blind%252C%2520placebo-controlled%252C%2520crossover%2520trial%2520of%2520glycine%2520adjuvant%2520therapy%2520for%2520treatment-resistant%2520schizophrenia%26jtitle%3DBr.%2520J.%2520Psychiatry%26date%3D1996%26volume%3D169%26spage%3D610%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Passchier, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gentile, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Porter, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herdon, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salinas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jakobsen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Audrain, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laruelle, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunn, R. N.</span><span> </span><span class="NLM_article-title">Identification and evaluation of [<sup>11</sup>C]GSK931145 as a novel ligand for imaging the type 1 glycine transporter with positron emission tomography</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">64</span><span class="NLM_x">, </span> <span class="NLM_fpage">542</span><span class="NLM_x">–</span> <span class="NLM_lpage">549</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2010&pages=542-549&author=J.+Passchierauthor=G.+Gentileauthor=R.+Porterauthor=H.+Herdonauthor=C.+Salinasauthor=S.+Jakobsenauthor=H.+Audrainauthor=M.+Laruelleauthor=R.+N.+Gunn&title=Identification+and+evaluation+of+%5B11C%5DGSK931145+as+a+novel+ligand+for+imaging+the+type+1+glycine+transporter+with+positron+emission+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPasschier%26aufirst%3DJ.%26aulast%3DGentile%26aufirst%3DG.%26aulast%3DPorter%26aufirst%3DR.%26aulast%3DHerdon%26aufirst%3DH.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DAudrain%26aufirst%3DH.%26aulast%3DLaruelle%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26atitle%3DIdentification%2520and%2520evaluation%2520of%2520%255B11C%255DGSK931145%2520as%2520a%2520novel%2520ligand%2520for%2520imaging%2520the%2520type%25201%2520glycine%2520transporter%2520with%2520positron%2520emission%2520tomography%26jtitle%3DSynapse%26date%3D2010%26volume%3D64%26spage%3D542%26epage%3D549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group">Hamill, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eng, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jennings, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Street, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wisnoski, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wolkenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindsley, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohorquez, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Riffel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sur, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hargreaves, R.</span><span> </span><span class="NLM_article-title">The synthesis and preclinical evaluation in Rhesus monkey of [<sup>18</sup>F]MK-6577 and [<sup>11</sup>C]CMPyPB, glycine transporter 1 (GlyT1) PET radiotracers</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x">, </span> <span class="NLM_fpage">261</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2011&pages=261-270&author=T.+G.+Hamillauthor=W.+Engauthor=A.+Jenningsauthor=R.+Lewisauthor=S.+Thomasauthor=S.+Woodauthor=L.+Streetauthor=D.+Wisnoskiauthor=S.+Wolkenbergauthor=C.+Lindsleyauthor=S.+Sanabria-Bohorquezauthor=S.+Patelauthor=K.+Riffelauthor=C.+Ryanauthor=J.+Cookauthor=C.+Surauthor=D.+Burnsauthor=R.+Hargreaves&title=The+synthesis+and+preclinical+evaluation+in+Rhesus+monkey+of+%5B18F%5DMK-6577+and+%5B11C%5DCMPyPB%2C+glycine+transporter+1+%28GlyT1%29+PET+radiotracers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DJennings%26aufirst%3DA.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DS.%26aulast%3DWood%26aufirst%3DS.%26aulast%3DStreet%26aufirst%3DL.%26aulast%3DWisnoski%26aufirst%3DD.%26aulast%3DWolkenberg%26aufirst%3DS.%26aulast%3DLindsley%26aufirst%3DC.%26aulast%3DSanabria-Bohorquez%26aufirst%3DS.%26aulast%3DPatel%26aufirst%3DS.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DRyan%26aufirst%3DC.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DSur%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DD.%26aulast%3DHargreaves%26aufirst%3DR.%26atitle%3DThe%2520synthesis%2520and%2520preclinical%2520evaluation%2520in%2520Rhesus%2520monkey%2520of%2520%255B18F%255DMK-6577%2520and%2520%255B11C%255DCMPyPB%252C%2520glycine%2520transporter%25201%2520%2528GlyT1%2529%2520PET%2520radiotracers%26jtitle%3DSynapse%26date%3D2011%26volume%3D65%26spage%3D261%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Alberati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreau, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengyel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mory, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borroni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinard, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knoflach, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlotterbeck, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hainzl, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, J. G.</span><span> </span><span class="NLM_article-title">Glycine reuptake inhibitor RG1678: a pharmacologic characterization of an investigational agent for the treatment of schizophrenia</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x">, </span> <span class="NLM_fpage">1152</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2012&pages=1152-1161&author=D.+Alberatiauthor=J.+L.+Moreauauthor=J.+Lengyelauthor=N.+Hauserauthor=R.+Moryauthor=E.+Borroniauthor=E.+Pinardauthor=F.+Knoflachauthor=G.+Schlotterbeckauthor=D.+Hainzlauthor=J.+G.+Wettstein&title=Glycine+reuptake+inhibitor+RG1678%3A+a+pharmacologic+characterization+of+an+investigational+agent+for+the+treatment+of+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlberati%26aufirst%3DD.%26aulast%3DMoreau%26aufirst%3DJ.%2BL.%26aulast%3DLengyel%26aufirst%3DJ.%26aulast%3DHauser%26aufirst%3DN.%26aulast%3DMory%26aufirst%3DR.%26aulast%3DBorroni%26aufirst%3DE.%26aulast%3DPinard%26aufirst%3DE.%26aulast%3DKnoflach%26aufirst%3DF.%26aulast%3DSchlotterbeck%26aufirst%3DG.%26aulast%3DHainzl%26aufirst%3DD.%26aulast%3DWettstein%26aufirst%3DJ.%2BG.%26atitle%3DGlycine%2520reuptake%2520inhibitor%2520RG1678%253A%2520a%2520pharmacologic%2520characterization%2520of%2520an%2520investigational%2520agent%2520for%2520the%2520treatment%2520of%2520schizophrenia%26jtitle%3DNeuropharmacology%26date%3D2012%26volume%3D62%26spage%3D1152%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamill, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puri, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cannon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanabria-Bohorquez, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cook, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morrow, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">The relationship between glycine transporter 1 occupancy and the effects of the glycine transporter 1 inhibitor RG1678 or ORG25935 on object retrieval performance in scopolamine impaired rhesus monkey</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">–</span> <span class="NLM_lpage">519</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=511-519&author=D.+Eddinsauthor=T.+G.+Hamillauthor=V.+Puriauthor=C.+E.+Cannonauthor=J.+A.+Vivianauthor=S.+M.+Sanabria-Bohorquezauthor=J.+J.+Cookauthor=J.+A.+Morrowauthor=F.+Thomsonauthor=J.+M.+Uslaner&title=The+relationship+between+glycine+transporter+1+occupancy+and+the+effects+of+the+glycine+transporter+1+inhibitor+RG1678+or+ORG25935+on+object+retrieval+performance+in+scopolamine+impaired+rhesus+monkey"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DHamill%26aufirst%3DT.%2BG.%26aulast%3DPuri%26aufirst%3DV.%26aulast%3DCannon%26aufirst%3DC.%2BE.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DSanabria-Bohorquez%26aufirst%3DS.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DMorrow%26aufirst%3DJ.%2BA.%26aulast%3DThomson%26aufirst%3DF.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520relationship%2520between%2520glycine%2520transporter%25201%2520occupancy%2520and%2520the%2520effects%2520of%2520the%2520glycine%2520transporter%25201%2520inhibitor%2520RG1678%2520or%2520ORG25935%2520on%2520object%2520retrieval%2520performance%2520in%2520scopolamine%2520impaired%2520rhesus%2520monkey%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D511%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Martin-Facklam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pizzagalli, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostrowitzki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymont, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brasic, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parkar, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umbricht, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dannals, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldwater, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, D. F.</span><span> </span><span class="NLM_article-title">Glycine transporter type 1 occupancy by bitopertin: a positron emission tomography study in healthy volunteers</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">504</span><span class="NLM_x">–</span> <span class="NLM_lpage">512</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2013&pages=504-512&author=M.+Martin-Facklamauthor=F.+Pizzagalliauthor=Y.+Zhouauthor=S.+Ostrowitzkiauthor=V.+Raymontauthor=J.+R.+Brasicauthor=N.+Parkarauthor=D.+Umbrichtauthor=R.+F.+Dannalsauthor=R.+Goldwaterauthor=D.+F.+Wong&title=Glycine+transporter+type+1+occupancy+by+bitopertin%3A+a+positron+emission+tomography+study+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartin-Facklam%26aufirst%3DM.%26aulast%3DPizzagalli%26aufirst%3DF.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DOstrowitzki%26aufirst%3DS.%26aulast%3DRaymont%26aufirst%3DV.%26aulast%3DBrasic%26aufirst%3DJ.%2BR.%26aulast%3DParkar%26aufirst%3DN.%26aulast%3DUmbricht%26aufirst%3DD.%26aulast%3DDannals%26aufirst%3DR.%2BF.%26aulast%3DGoldwater%26aufirst%3DR.%26aulast%3DWong%26aufirst%3DD.%2BF.%26atitle%3DGlycine%2520transporter%2520type%25201%2520occupancy%2520by%2520bitopertin%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520in%2520healthy%2520volunteers%26jtitle%3DNeuropsychopharmacology%26date%3D2013%26volume%3D38%26spage%3D504%26epage%3D512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Siuciak, J. A.</span><span> </span><span class="NLM_article-title">The role of phosphodiesterases in schizophrenia: therapeutic implications</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=983-993&author=J.+A.+Siuciak&title=The+role+of+phosphodiesterases+in+schizophrenia%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520phosphodiesterases%2520in%2520schizophrenia%253A%2520therapeutic%2520implications%26jtitle%3DCNS%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D983%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group">Redrobe, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jørgensen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montezinho, L. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastlund, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carnerup, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bundgaard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerdrup, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plath, N.</span><span> </span><span class="NLM_article-title">In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia</span> <span class="citation_source-journal">Psychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">231</span><span class="NLM_x">, </span> <span class="NLM_fpage">3151</span><span class="NLM_x">–</span> <span class="NLM_lpage">3167</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=231&publication_year=2014&pages=3151-3167&author=J.+P.+Redrobeauthor=M.+J%C3%B8rgensenauthor=C.+T.+Christoffersenauthor=L.+P.+Montezinhoauthor=J.+F.+Bastlundauthor=M.+Carnerupauthor=C.+Bundgaardauthor=L.+Lerdrupauthor=N.+Plath&title=In+vitro+and+in+vivo+characterisation+of+Lu+AF64280%2C+a+novel%2C+brain+penetrant+phosphodiesterase+%28PDE%29+2A+inhibitor%3A+potential+relevance+to+cognitive+deficits+in+schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRedrobe%26aufirst%3DJ.%2BP.%26aulast%3DJ%25C3%25B8rgensen%26aufirst%3DM.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DMontezinho%26aufirst%3DL.%2BP.%26aulast%3DBastlund%26aufirst%3DJ.%2BF.%26aulast%3DCarnerup%26aufirst%3DM.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DLerdrup%26aufirst%3DL.%26aulast%3DPlath%26aufirst%3DN.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520characterisation%2520of%2520Lu%2520AF64280%252C%2520a%2520novel%252C%2520brain%2520penetrant%2520phosphodiesterase%2520%2528PDE%2529%25202A%2520inhibitor%253A%2520potential%2520relevance%2520to%2520cognitive%2520deficits%2520in%2520schizophrenia%26jtitle%3DPsychopharmacology%26date%3D2014%26volume%3D231%26spage%3D3151%26epage%3D3167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group">Andrés, J.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iturrino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedeurwaerdere, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenaerts, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanhoof, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Synthesis, in vivo occupancy and radiolabeling of potent phosphodiesterase subtype-10 inhibitors as candidates for positron emission tomography imaging</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">5820</span><span class="NLM_x">–</span> <span class="NLM_lpage">5835</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200536d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=5820-5835&author=J.-I.+Andr%C3%A9sauthor=M.+De+Angelisauthor=J.+Alcazarauthor=L.+Iturrinoauthor=X.+Langloisauthor=S.+Dedeurwaerdereauthor=I.+Lenaertsauthor=G.+Vanhoofauthor=S.+Celenauthor=G.+Bormans&title=Synthesis%2C+in+vivo+occupancy+and+radiolabeling+of+potent+phosphodiesterase+subtype-10+inhibitors+as+candidates+for+positron+emission+tomography+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fjm200536d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200536d%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.-I.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DIturrino%26aufirst%3DL.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DLenaerts%26aufirst%3DI.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DSynthesis%252C%2520in%2520vivo%2520occupancy%2520and%2520radiolabeling%2520of%2520potent%2520phosphodiesterase%2520subtype-10%2520inhibitors%2520as%2520candidates%2520for%2520positron%2520emission%2520tomography%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D5820%26epage%3D5835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Celen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koole, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Angelis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sannen, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chitneni, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alcazar, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbruggen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langlois, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Laere, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrés, J. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bormans, G.</span><span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1584</span><span class="NLM_x">–</span> <span class="NLM_lpage">1591</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andr%C3%A9sauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ41510417+as+a+radioligand+for+PET+imaging+of+phosphodiesterase-10A+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndr%25C3%25A9s%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Mäding, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbach, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johannsen, B.</span><span> </span><span class="NLM_article-title">No-carrier-added <sup>11</sup>C-labelling of benzenoid compounds in ring positions by condensation of nitro-[<sup>11</sup>C]methane with pyrylium salts</span> <span class="citation_source-journal">J. Labelled Compd. Radiopharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">565</span><span class="NLM_x">–</span> <span class="NLM_lpage">583</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1002%2F%28SICI%291099-1344%28200005%2943%3A6%3C565%3A%3AAID-JLCR342%3E3.0.CO%3B2-Q" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BD3cXjs1GitrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=565-583&author=P.+M%C3%A4dingauthor=J.+Steinbachauthor=B.+Johannsen&title=No-carrier-added+11C-labelling+of+benzenoid+compounds+in+ring+positions+by+condensation+of+nitro-%5B11C%5Dmethane+with+pyrylium+salts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">No-carrier-added 11C-labeling of benzenoid compounds in ring positions by condensation of nitro-[11C]methane with pyrylium salts</span></div><div class="casAuthors">Mading, P.; Steinbach, J.; Johannsen, B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">565-583</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A new synthesis is described for three no-carrier-added nitro-[1-11C]benzenes by condensation of nitro-[11C]methane (I) with the appropriate pyrylium salts in the presence of a base such as t-BuOK in t-BuOH.  For synthesizing 4-nitro-[4-11C]anisole, tetrabutylammonium fluoride was successfully used as an auxiliary base.  The conversion of I with 4-methoxypyrylium perchlorate yielded a product of a radiochem. purity of up to 82% and a mean specific radioactivity of 30 GBq/μmol (0.8 Ci/μmol) within 20 min.  Related to I, the reproducible radiochem. yields are in the range of 77 ± 5% (decay-cor.).  2,6-Dimethyl-4-methoxy-nitro-[1-11C]benzene was prepd. by reaction of I with 2,6-dimethyl-4-methoxypyrylium perchlorate in radiochem. yields of about 37% (decay-cor.) within 10 min.  2-Nitro-[2-11C]mesitylene was obtained by condensation of I with 2,4,6-trimethylpyrylium tetrafluoroborate in radiochem. yields of about 29% (decay-cor.) within 20 min.  13C/11C Co-labeling expts. were carried out in order to confirm the identity and the position of the label.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqD8SEy3K0J3rVg90H21EOLACvtfcHk0ligNwGE_nnz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXjs1GitrY%253D&md5=af0a8be10640d677fb69f02ff00e3e7a</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291099-1344%28200005%2943%3A6%3C565%3A%3AAID-JLCR342%3E3.0.CO%3B2-Q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291099-1344%2528200005%252943%253A6%253C565%253A%253AAID-JLCR342%253E3.0.CO%253B2-Q%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25A4ding%26aufirst%3DP.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DJohannsen%26aufirst%3DB.%26atitle%3DNo-carrier-added%252011C-labelling%2520of%2520benzenoid%2520compounds%2520in%2520ring%2520positions%2520by%2520condensation%2520of%2520nitro-%255B11C%255Dmethane%2520with%2520pyrylium%2520salts%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2000%26volume%3D43%26spage%3D565%26epage%3D583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Lee, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamlet, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powers, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neumann, C. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boursalian, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hooker, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ritter, T.</span><span> </span><span class="NLM_article-title">A fluoride-derived electrophilic late-stage fluorination reagent for PET imaging</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">334</span><span class="NLM_x">, </span> <span class="NLM_fpage">639</span><span class="NLM_x">–</span> <span class="NLM_lpage">642</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Fjm5001858&amp;key=10.1126%2Fscience.1212625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Fjm5001858&amp;key=22053044" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm5001858&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlyqu7vL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2011&pages=639-642&author=E.+Leeauthor=A.+S.+Kamletauthor=D.+C.+Powersauthor=C.+N.+Neumannauthor=G.+B.+Boursalianauthor=T.+Furuyaauthor=D.+C.+Choiauthor=J.+M.+Hookerauthor=T.+Ritter&title=A+fluoride-derived+electrophilic+late-stage+fluorination+reagent+for+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A Fluoride-Derived Electrophilic Late-Stage Fluorination Reagent for PET Imaging</span></div><div class="casAuthors">Lee, Eunsung; Kamlet, Adam S.; Powers, David C.; Neumann, Constanze N.; Boursalian, Gregory B.; Furuya, Takeru; Choi, Daniel C.; Hooker, Jacob M.; Ritter, Tobias</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">6056</span>),
    <span class="NLM_cas:pages">639-642</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The unnatural isotope fluorine-18 (18F) is used as a positron emitter in mol. imaging.  Currently, many potentially useful 18F-labeled probe mols. are inaccessible for imaging because no fluorination chem. is available to make them.  The 110-min half-life of 18F requires rapid syntheses for which [18F]fluoride is the preferred source of fluorine because of its practical access and suitable isotope enrichment.  However, conventional [18F]fluoride chem. has been limited to nucleophilic fluorination reactions.  We report the development of a palladium-based electrophilic fluorination reagent derived from fluoride and its application to the synthesis of arom. 18F-labeled mols. via late-stage fluorination.  Late-stage fluorination enables the synthesis of conventionally unavailable positron emission tomog. (PET) tracers for anticipated applications in pharmaceutical development as well as preclin. and clin. PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6eb1WB355J7Vg90H21EOLACvtfcHk0ligNwGE_nnz5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlyqu7vL&md5=ede2fa164d6ce80035e5482966b5b57e</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1126%2Fscience.1212625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1212625%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DE.%26aulast%3DKamlet%26aufirst%3DA.%2BS.%26aulast%3DPowers%26aufirst%3DD.%2BC.%26aulast%3DNeumann%26aufirst%3DC.%2BN.%26aulast%3DBoursalian%26aufirst%3DG.%2BB.%26aulast%3DFuruya%26aufirst%3DT.%26aulast%3DChoi%26aufirst%3DD.%2BC.%26aulast%3DHooker%26aufirst%3DJ.%2BM.%26aulast%3DRitter%26aufirst%3DT.%26atitle%3DA%2520fluoride-derived%2520electrophilic%2520late-stage%2520fluorination%2520reagent%2520for%2520PET%2520imaging%26jtitle%3DScience%26date%3D2011%26volume%3D334%26spage%3D639%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5001858&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Barticle%3Aarticle%3A10.1021%2Fjm5001858%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-22" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5001858" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799adef7ab432d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
